Person in charge,Authors,Year,Title,DOI or PMID,Language,"Country (e.g., where RCT was performed)",Included/exclude,Reason for exclusion,Reason for exclusion,Reason for exclusion (description),Data collection,Analysis,Species,Species information,"Count, n","Count, n control group","Count, n died in control group","Count, n excluded in control group","Count, n treatment group","Count, n died in treatment group","Count, n excluded in treatment group",Comment on counts,"Sex (n, ratio, percentage)",Sex,"Sex (%, male)","Age [days, months, years]",Age (mean),Age (SD),Age (min),Age (max),Age (units),Age (comment),"Weight [g, kg , pounds]",Weight (mean),Weight (SD),Weight (min),Weight (max),Weight (unit),Weight (comment),"Injury characteristics (level, severity)",Injury level,Injury severity,Injury mechanism,Injury mechanism (details),Duration of SCI,Drug(s),Drug name harmonized,MP used as main drug?,Dose (absolute dose or mg/kg),"Time (minutes pre-injury, minutes post-injury)",Treatmetn in first 24h?,Duration of treatment,"Timing (e.g., BID, PID)",Route,Route (comment when multiple),"What was assessed? (e.g., neurological,  functional recovery, spasticity, walking function, electrophysiology)",Name/type of asessement,Name of assessment harmonised,Details on assessement,Timing of assessement,Assessment on day 28 (yes/no),Was observer blinded?,Drug effect on functional assessment,Drug effect on functional assessment (details),"What was assessed? (e.g., histological measures, cavitity measures, ect )",Name/type of asessement,Timing of assessement,Was observer blinded?,Drug effect on neuroanatomical assessment,Drug effect on neuroanatomical assessment (details),Drugs given to treat infections/pain ect.,Conclusion of study,Limitations,Remarks/Comments,Combination of drugs tested,Contradictions present in the results
Catherine,Renno et al,2014,"(-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats",10.1016/j.neuropharm.2013.09.013,English,,excluded,Out of scope,No drug of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Long et al,1994,1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury.,10.1016/0014-2999(94)90120-1,English,,excluded,Out of scope,No drug of interest,Dynorphin-induced SCI; they did not examine the effects of dynorphin on recovery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhou et al,2014,17 beta-Estradiol Protects Human Eyelid-Derived Adipose Stem Cells against Cytotoxicity and Increases Transplanted Cell Survival in Spinal Cord injury,10.1111/jcmm.12191,English,,excluded,Out of scope,No drug of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Wang et al,2014,ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury,10.1002/jnr.23371,English,,excluded,Out of scope,No drug of interest,Out of scope (other drug),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Garcia-Lopez et al,1997,Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury,10.1002/(SICI)1099-081X(199704)18:3<203::AID-BDD11>3.0.CO;2-F,English,,excluded,Out of scope,No assessments of interest,"Out of scope (bioavailability, no focus on function)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Durozard et al,2000,Metabolism of rat skeletal muscle after spinal cord transection,10.1002/1097-4598(200010)23:10<1561::AID-MUS13>3.0.CO;2-X,English,,excluded,Out of scope,No assessments of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Brennan et al,2016,IVIg attenuates complement and improves spinal cord injury outcomes in mice,10.1002/acn3.318,English,,excluded,Out of scope,No drug of interest,Out of scope (no drug of interest),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Maresh et al,2020,Buspirone decreases susceptibility to hypocapnic central sleep apnea in chronic SCI patients,10.1152/japplphysiol.00435.2020,English,,excluded,Out of scope,No assessments of interest,Out of scope: outcome is not neurological/functional --> hypocapnic central sleep apnea ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Lee et al,2012,17 beta-Estradiol Inhibits Apoptotic Cell Death of Oligodendrocytes by Inhibiting RhoA-JNK3 Activation after Spinal Cord Injury,10.1210/en.2012-1068,English,,excluded,Out of scope,No drug of interest,Oligodendrocytes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Siriphorn et al,2010,17 beta-Estradiol protects Schwann cells against H2O2-induced cytotoxicity and increases transplanted Schwann cell survival in a cervical hemicontusion spinal cord injury model,10.1111/j.1471-4159.2010.06770.x,English,,excluded,Out of scope,No assessments of interest,Effect of estradiol on schwann cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Chaovipoch et al,2006,17beta-estradiol is protective in spinal cord injury in post- and pre-menopausal rats.,10.1089/neu.2006.23.830,English,,excluded,Out of scope,No drug of interest,Menopause,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Lee et al,2012,17Œ≤-estradiol inhibits apoptotic cell death of oligodendrocytes by inhibiting Rhoa-JNK3 activation after spinal cord injury,10.1210/en.2012-1068,English,,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Chaovipoch et al,2006,17Œ≤-estradiol is protective in spinal cord injury in post- and pre-menopausal rats,10.1089/neu.2006.23.830,English,,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhou et al,2014,17Œ≤-estradiol protects human eyelid-derived adipose stem cells against cytotoxicity and increases transplanted cell survival in spinal cord injury,10.1111/jcmm.12191,English,,excluded,Out of scope,No drug of interest,Effect of estradiol on Stem Cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Jacobsen et al,1992,2-(AMINOMETHYL)CHROMANS THAT INHIBIT IRON-DEPENDENT LIPID-PEROXIDATION AND PROTECT AGAINST CENTRAL-NERVOUS-SYSTEM TRAUMA AND ISCHEMIA,10.1021/jm00101a025,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hirakawa et al,2010,"2-Decenoic acid ethyl ester, a derivative of unsaturated medium-chain fatty acids, facilitates functional recovery of locomotor activity after spinal cord injury",10.1016/j.neuroscience.2010.10.004,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhou et al,2000,5-hydroxytryptophan-induced respiratory recovery after cervical spinal cord hemisection in rats,10.1152/jappl.2000.89.4.1528 ,English,,excluded,Out of scope,No assessments of interest,Respiratory recovery,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kalotra et al,2020,5-Nonyloxytryptamine oxalate‚Äìembedded collagen‚Äìlaminin scaffolds augment functional recovery after spinal cord injury in mice,10.1111/nyas.14279,English,,excluded,Out of scope,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kyung et al,2006,"6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury",10.1111/j.1460-9568.2006.04908.x,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Carboncini et al,2014,A case of post-traumatic minimally conscious state reversed by midazolam: Clinical aspects and neurophysiological correlates,10.3233/RNN-140426,English,,excluded,Case report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Huang et al.,2007,A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury,10.1093/brain/awm223,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhilai et al,2012,A combination of taxol infusion and human umbilical cord mesenchymal stem cells transplantation for the treatment of rat spinal cord injury,10.1016/j.brainres.2012.08.051,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Bhattacharyya et al,2021,A combinatorial approach to modulate microenvironment toward regeneration and repair after spinal cord injury in rats,10.1016/j.neulet.2020.135500,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Reina et al,1995,A combined behavioral physiological method for the assessment of thermal sensibility in the rat,10.1016/0165-0270(95)00108-5,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Du et al,2014,A comparative study of gelatin sponge scaffolds and PLGA scaffolds transplanted to completely transected spinal cord of rat,10.1002/jbm.a.34835,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Coleman et al,2000,A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury,10.1097/00002517-200006000-00001,English,,excluded,Opinion,,Critical appraisal,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Diaz et al,2017,A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain,10.1523/JNEUROSCI.1630-17.2017,English,,excluded,Non-sci population,,Not spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hosier et al,2015,A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury,10.1089/neu.2015.3892,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,rats,Long-Evans,35,,,,,,,,100% female,,,10–12 weeks,,,,,,,200–225 g,,,,,,,"C7, hemilateral",,,,weight drop,6 weeks,riluzole,,,,,,,,,,,,,,,,,,,,,,,,,"Anaesthesia:ketamine, 60 mg/kg plus xylazine, 7.5 mg/kg, intraperitoneally;
",,,,,
Catherine,Wei et al,2015,A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury,10.3892/mmr.2015.3395,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Li et al,2016,A Hydrogel Bridge Incorporating Immobilized Growth Factors and Neural Stem/Progenitor Cells to Treat Spinal Cord Injury,10.1002/adhm.201500810,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Gosh et al,2019,A hydrogel engineered to deliver minocycline locally to the injured cervical spinal cord protects respiratory neural circuitry and preserves diaphragm function,10.1016/j.nbd.2019.04.014,English,,excluded,Out of scope,No assessments of interest,Diaphragma function,,,rats,Sprague-Dawley,not reported,,,,,not reported,not reported,,100% female,female,0,not reported,,,,,,Not reported,250–300 g,250-300,,,,g,,C4/5 ,,,,Unilateral cervical contusion,5 weeks,minocycline,,,3 mg/mL (injection volume: 30 μL),immediately after injury,,single dose,single dose,intrathecally,,-,-,,-,-,,-,-,-,"Immunohistochemistry, assessment of lesion volume",Lesion was defined as areas including both lost tissue (cystic cavity formation) and surrounding damaged tissue in which the normal anatomical structure of the spinal was lost.,5 weeks post injury,,positive effect,Minocycline hydrogel decreased lesion size and degeneration of cervical motor neuron cell bodies,"Anaethesia: ketamine (100 mg/kg), xylazine (5 mg/kg) and acepromazine (2 mg/kg)",MH hydrogel implantation after cervical contusion SCI preserved diaphragm function; MH hydrogel also decreased lesion size and degeneration of cervical motor neurons.,not reported,,,
Catherine,Campolo et al,2013,A hydrogen sulfide-releasing cyclooxygenase inhibitor markedly accelerates recovery from experimental spinal cord injury,10.1096/fj.13-234716,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Cragg et al,2019,A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury,10.1007/s13311-019-00713-8,English,,included,,,,prospective,retrospective,human,-,651,536,0,0,115,0,0,,female: 131 (20.1),mixed,79.9,32.5 (13.4),32.5,13.4,,,Years,,-,,,,,,,AIS A (n= 412 [63.3%]); AIS B (n=71 [10.9%]); AIS C (n=139 [21.4%]); AIS D (n=29 [4.5%]),,mixed,trauma,traumatic injury,-,baclofen,baclofen,,"Low-dose baclofen (total cumulative dose < 220 mg), 
High-dose baclofen (total cumulative dose ≥ 220 mg)",Within 30 days post injury,,between 1-30 days,not reported,oral,,neurological recovery,marked recovery,"neurological (motor and sensory), injury severity","For patients with AIS-A and AIS-B injuries at baseline, “marked recovery” was defined by a conversion to (at a minimum) AIS-C and AIS-D, respectively (i.e., regaining sensory and motor function caudal to the level of injury). To achieve “marked recovery,” AIS-C and AIS-D patients were required to recover limited or unlimited walking function, respectively, according to the Benzel grades.","4, 52 weeks",,no,no effect,Cumulative baclofen exposure was generally not significantly associated with light tough sensory scores at 4 weeks or 52 weeks or the change in light tough sensory scores from 4 weeks until 52 weeks. Cumulative baclofen exposure was generally not significantly associated with lower extremity motor scores at 4 weeks or 52 weeks or the change in lower extremity motor score from 4 weeks until 52 weeks. ,-,-,-,-,,-,no reported,This analysis provides evidence on the safety of baclofen in the early days after acute traumatic spinal cord injury with the recommended doses for symptomatic muscle spasms,"The primary limitation of the proposed study is that the Sygen data represents a historical clinical trial, first initiated in the 1992 and completed in 1997. Another common limitation of observational study design is confounding and misclassification of exposures and outcomes. ",,No,
Catherine,Li et al,2019,A MnO2 Nanoparticle-Dotted Hydrogel Promotes Spinal Cord Repair via Regulating Reactive Oxygen Species Microenvironment and Synergizing with Mesenchymal Stem Cells,10.1021/acsnano.9b07598,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Dill et al,2010,A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons,10.1523/JNEUROSCI.5045-09.2010,English,,excluded,Out of scope,No drug of interest,"Cell lines, no in-vivo experiments",,,,,,,,,,,,,100% female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Ma et al,2020,A novel hydrogel-based treatment for complete transection spinal cord injury repair is driven by microglia/macrophages repopulation,10.1016/j.biomaterials.2020.119830,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Flamm et al,1985,A Phase I trial of naloxone treatment in acute spinal cord injury,10.3171/jns.1985.63.3.0390,English,,excluded,Out of scope,No control group,"Two different treatment regimes are compared, but there is no control group.",,,human,,29,,,,,,,,4 female; 25 male,,,"37 (mean), 16-79",,,,,,,,,,,,,,21 complete SCI; 8 incomplete SCI,,,,traumatic injury,-,naloxone,,,"Group 1: 0.14 - 1.43 mg/kg;
Group 2: 2.7 - 5.4 mg/kg",mean: 12.9 hrs (range 2 to 48 hrs),,47hrs,continously,intravenously,,"electrophysiology, neurological","Somatosensory evoked potentials, neurological status",,"SEPs: no details reported
Neurological status: assessed according to a protocol developed for NASCIS",every 15 minutes for the 1st hour after drug administration and hourly thereafter,,not reported,no effect,"The observed improvement in the clinical examination and SEP's at the higher doses, while not statistically verified in this Phase I trial, is encouraging",,,,,,,Not reported,"This study demonstrates that, in spinal cord-injured patients, naloxone given as an intravenous loading dose
of 200 mg/sq m, followed by a continuous infusion of up to 150 mg/sq m/hr for 23 hours, has minimal side
effects. The observed improvement in the clinical examination and SEP's at the higher doses, while not
statistically verified in this Phase I trial, is encouraging. ",not reported,,,
Catherine,Olby et al,2016,"A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation",10.1111/jvim.13657,English,,excluded,Non-sci population,,No spinal cord injury (disc herniation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Farjah et al,2010,A potential protective effect of -tocopherol on vascular complication in spinal cord reperfusion injury in rats,10.1186/1423-0127-17-55,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Laverty et al,2004,A preliminary study of intravenous surfactants in paraplegic dogs: Polymer therapy in canine clinical SCI,10.1089/neu.2004.21.1767,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Grossman et al,2014,"A prospective, multicenter, Phase i matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury",10.1089/neu.2013.2969,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zidan et al,2018,"A randomized, blinded, prospective clinical trial of postoperative rehabilitation in dogs after surgical decompression of acute thoracolumbar intervertebral disc herniation",10.1111/jvim.15086,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bracken et al,1990,"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the second national acute spinal cord injury study",10.1056/NEJM199005173222001,English,,included,,,,prospective,prospective,human,,487,171,,,162,,,2 treatment groups on this study,"% of male in different treatment group: MP=86.4, naloxone=80.5, placebo=84.8",mixed,86.4,% per age category per group (MP/naloxone/placebo): 13-19y: 15.4/14.9/15.2; 20-24y: 29.0/33.8/22.8; 25-29y: 11.1/14.9/14.6; 30-34y: 14.8/7.1/14.6; 35-39y: 9.3/5.8/8.2; 40-44y: 3.1/5.8/8.2; 45-49y: 1.9/2.0/3.5; 50-54y: 4.3/4.6/1.8; 55-59y: 2.5/1.3/4.7; over or 60: 8.6/9.7/8.8,,,,,Years,,"weight per ttt group in kg: MP=75.0(13.0), naloxone=75.4(15.5), placebo=76.0(16.7)",75,13,,,kg,,level: not reported; severity: % complete injuries in MP/naloxone/placebo=64.6/53.9/58.8,,mixed,trauma,% per cause of injury for MP/naloxone/placebo groups: automobile accident: 37.7/46.1/43.3; motorcycle accident: 9.3/3.2/8.8; fall: 17.9/20.8/19.9; crush: 4.9/4.6/5.3; water related: 16.7/13.0/15.2; other: 13.6/12.3/7.6,randomization within 12h after injury,"methylprednisolone, naloxone",methylprednisolone,,bolus of 30 mg/kg and maintenance of 5.4 mg/kg/h,2 groups: <=8h after injury or more than 8 hours after injury,,"24h: 15 minute bolus, 45 minutes pause and 23h maintenance infusion","15 minute bolus, 45 minutes pause and 23h maintenance infusion",intravenously,,neurological function,"pinprick, light touch, motor function scale",neurological (motor and sensory),"pinprick and light touch: 24 segments (C2 to S5) evluated bilaterally and scored as absent=1, decreased=2, normal=3; expanded score for each measurements ranged from 29 (absent at all levels) and 87 (normal at all levels), classification in 1 of 5 categories: analgesic and anesthetic at or above T1 if sensation of PP and LT, respectively, were absent at T! or above and in all distal segments, analgesic and anesthetic below T!, hypalgesic and hypesthesic at or above T1 if sensation was decreased at T! or above, hypalgesic and hypesthesic below, normal if all segments were evaluated as normal; motor function: 6 classifications in 14 muscles, 0=no contraction, 1=reduced contraction, 2=active movement without gravity (side to side but not upward), 3=active movement with antigravity, 4=reduced function but active movement against resistance, 5=normal function, expanded motor scores ranged from 0=no contraction in any muscle, to 70=all normal responses and obtained separately for right and left sides, calsification as quadriplegic, paraplegic, quadriparetic, paraparetic and normal","upon admission, six-week examination (42-49 days after injury), 6-month examination (180-220 days)",,yes,positive effect,"naloxone: no difference compared to control group; MP: both at 6 weeks and 6 months patients with MP had rgeater sensory improvement than those receiving placebo (significant statistically for PP and LT), and among the patients treated within 8h of their injury, those receiving MP recovered more motor function than those given placebo and also greater recovery of PP and LT",-,-,-,-,,-,not reported,"We conclude that in patients with acute spinal-cord injury, treatment with MP in the dose used in this study improves neurologic recovery when the medication is given in the first 8 hours. We also conclude that treatment with naloxone in the dose used in this study does not improve neurologic recovery after acute spinal cord injury",not reported,"human study for MP; no effect on motor function when looking at entire MP group, significant improvement of motor function when looking only at the patients with MP within 8h",No,
Lucie,Bracken et al,1990,"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the second national acute spinal cord injury study",10.1056/NEJM199005173222001,English,,included,,,,prospective,prospective,human,,487,171,,,154,,,2 treatment groups on this study,"% of male in different treatment group: MP=86.4, naloxone=80.5, placebo=84.8",mixed,84.8,% per age category per group (MP/naloxone/placebo): 13-19y: 15.4/14.9/15.2; 20-24y: 29.0/33.8/22.8; 25-29y: 11.1/14.9/14.6; 30-34y: 14.8/7.1/14.6; 35-39y: 9.3/5.8/8.2; 40-44y: 3.1/5.8/8.2; 45-49y: 1.9/2.0/3.5; 50-54y: 4.3/4.6/1.8; 55-59y: 2.5/1.3/4.7; over or 60: 8.6/9.7/8.8,,,,,Years,,"weight per ttt group in kg: MP=75.0(13.0), naloxone=75.4(15.5), placebo=76.0(16.7)",75.4,15.5,,,kg,,level: not reported; severity: % complete injuries in MP/naloxone/placebo=64.6/53.9/58.8,,mixed,trauma,% per cause of injury for MP/naloxone/placebo groups: automobile accident: 37.7/46.1/43.3; motorcycle accident: 9.3/3.2/8.8; fall: 17.9/20.8/19.9; crush: 4.9/4.6/5.3; water related: 16.7/13.0/15.2; other: 13.6/12.3/7.6,randomization within 12h after injury,"methylprednisolone, naloxone",naloxone,,bolus of 5.4 mg/kg and maintenance of 4.0 mg/kg/h (volus and maintenance doses varied according to body-surface area),2 groups: <=8h after injury or more than 8 hours after injury,,"24h: 15 minute bolus, 45 minutes pause and 23h maintenance infusion","15 minute bolus, 45 minutes pause and 23h maintenance infusion",intravenously,,neurological function,"pinprick, light touch, motor function scale",neurological (motor and sensory),"pinprick and light touch: 24 segments (C2 to S5) evluated bilaterally and scored as absent=1, decreased=2, normal=3; expanded score for each measurements ranged from 29 (absent at all levels) and 87 (normal at all levels), classification in 1 of 5 categories: analgesic and anesthetic at or above T1 if sensation of PP and LT, respectively, were absent at T! or above and in all distal segments, analgesic and anesthetic below T!, hypalgesic and hypesthesic at or above T1 if sensation was decreased at T! or above, hypalgesic and hypesthesic below, normal if all segments were evaluated as normal; motor function: 6 classifications in 14 muscles, 0=no contraction, 1=reduced contraction, 2=active movement without gravity (side to side but not upward), 3=active movement with antigravity, 4=reduced function but active movement against resistance, 5=normal function, expanded motor scores ranged from 0=no contraction in any muscle, to 70=all normal responses and obtained separately for right and left sides, calsification as quadriplegic, paraplegic, quadriparetic, paraparetic and normal","upon admission, six-week examination (42-49 days after injury), 6-month examination (180-220 days)",,yes,no effect,"naloxone: no difference compared to control group; MP: both at 6 weeks and 6 months patients with MP had rgeater sensory improvement than those receiving placebo (significant statistically for PP and LT), and among the patients treated within 8h of their injury, those receiving MP recovered more motor function than those given placebo and also greater recovery of PP and LT",-,-,-,-,,-,not reported,"We conclude that in patients with acute spinal-cord injury, treatment with MP in the dose used in this study improves neurologic recovery when the medication is given in the first 8 hours. We also conclude that treatment with naloxone in the dose used in this study does not improve neurologic recovery after acute spinal cord injury",not reported,"human study for MP; no effect on motor function when looking at entire MP group, significant improvement of motor function when looking only at the patients with MP within 8h",No,
Catherine,Sharp et al,2014,A re-assessment of long distance growth and connectivity of neural stem cells after severe spinal cord injury,10.1016/j.expneurol.2014.04.008,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pinzon et al.,2008,A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model,10.1016/j.brainres.2008.09.047,English,,included,,,,,,rats,Sprague Dawley,45,15,,,30,,,2 subgroups for control and treatment: IP and IV ,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + weight drop contusion (no disruption of the dura mater, 10g weight dropped from a height of 12.5mm, NYU weight drop device)",6 weeks,minocycline,minocycline,,90 mg/kg then 45 mg/kg twice,immediately after surgery,,3 doses,"immediately after surgery, 12h after and 24h after",multiple,group1: IP; group2: IV than IP*2,neurological/functional/behavioral assessment,BBB scale,,"2 examiners, open field locomotor test as well as BBB subscore","24h, 72h and then weekly after the procedure",,yes,no effect,no significant difference between either of the minocycline groups and the control group,histological assessemnt,"area of spared tissue, cavitation, abnormal cord tissue (areas containing an alteration in size and number of neurons and their normal distribution in the gray matter, small cell infiltration and cavitation)",6 weeks,not reported,no effect,spared tissue area or cavitation were not significantly different between treatment and control group,anesthesia: inhaled halothane was followed by injection of chloral hydrate (300 mg/kg IP); euthanasia: anesthetized and intracardially perfused with normal saline solution followed by 4% paraformaldehyde solution,"Administration of minocycline after SCI did not lead to significant behavioral or histopathological improvement. Although positive effects with minocycline have been reported in several animal models of injury with different drug administration schemes, the use of minocycline following contusive SCI requires further investigation before clinical trials are implemented",not reported,negative results reported (i.e. no effect),No,
Catherine,Steward et al,2008,A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice,10.1016/j.expneurol.2007.12.010,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sharp et al,2013,A re-assessment of the effects of treatment with a non-steroidal anti-inflammatory (ibuprofen) on promoting axon regeneration via RhoA inhibition after spinal cord injury,10.1016/j.expneurol.2013.06.023,English,,included,,,,,,rats,Sprague Dawley,115,47,8,0,47,11,2,21 died during surgery (group allocation unknown),female 100%,female,0,9-10 weeks old (young adults),,,9,10,Weeks,Adult,not reported,,,,,,Not reported,level: T6-T7; severity: complete,T6 - T7,incomplete,transection,laminectomy + hemisection (dorseal over-hemisection produced by micro scissors at a depth of 1.5mm and then a no.11 blade attached to a stereotaxic arm was passed 4* through the lesion at a depth of 1.9mm),"5 days, 6 weeks",ibuprofen,ibuprofen,,60 mg/kg/day,immediately after hemisection,,28 days,continuous (osomotic-minipump),subcutaneous,,"neurological/functional/behavioral assessment, sensory testing, bladder function","BBB scale, grid walk test, footprint analysis, girdle test, Von Frey test, bladder function",,"blader function: amount of urine retained in the bladder in ml/day of retained urine; BBB: open field (a galvanized stock tank that was 105 cm in diameter with 30 cm high walls) for 4 min, 22-point scale, scale ranging from complete paralysis to normal locomotion, assesses hind limb joint movements, stepping, trunk position and stability, forelimb-hindlimb coordination, paw placement, toe clearance and tail position, 2 observers, one observer for each side; gridwalk test: videotaped on a metal grid walk 1.2 m long with 25 mm between grids. The number of instances that the hindpaws dropped below the plane of the grid was counted. To calculate the gridwalk failure %, the number of errors was divided by the total of steps multiplied by 100; footprint analysis: hindpaws were dipped in ink before ambulating down a 90 cm runway. Stride length on each side and stride width between two sides were calculated; girdle test: Allodynia was assessed by mechanically stimulating 13 points on the rat's trunk with a 5.46 mN von Frey hair. Rats do not normally vocalize to this stimulus, and vocalization is considered a sign of allodynia, rats were tested for 10 trials. The percent response was calculated as number of responses/total number of test sites multiplied by 100; Plantar Von Frey: Tactile sensitivity on the feet was assessed using different size von Frey filaments. Rats were placed in the testing chamber with wire mesh floors for 30 min prior to testing. The von Frey filament was brought into contact with the palms of each paw and then pressure was applied until the filament bent or the rat withdrew its paw, Mechanical threshold measurements for each paw were obtained at the end of the all procedures prior to perfusion.","bladder function: daily until 21 days post injury; BBB: prior to injury and once weekly for seven weeks post-injury; gridwalk test: Pre-injury testing occurred 5 and 6 days prior to injury in Experiment 1, 1 and 2 days prior to injury in Experiment 2, and 11 and 12 days prior to injury in Experiment 3. Post-injury testing occurred prior BDA tract tracing (29–30 days post-injury in Experiments 1 and 2 and 27 days post injury in experiment 3). A final test was run before perfusion (43 days post-injury in Experiments 1 & 2 and 37–41 days post-injury in Experiment 3); footprint analysis: Pre-injury testing occurred 1 and 2 days prior to injury in Experiment 1, 4 and 5 days prior to injury in Experiment 2, and 5 and 6 days prior to injury in Experiment 3. Post-injury testing occurred prior BDA tract tracing (26-27 days post-injury in Experiments 1 and 2 and 29 days post injury in experiment 3). A final test was run prior to perfusion 40–41 days post-injury in Experiments 1 & 2 and 38–42 days post-injury in Experiment 3); gridle test: at the end of the testing period prior to perfusion; Plantar Von Frey: at the end of the all procedures prior to perfusion",,yes,no effect,"BBB and subscores: no significant difference between treatment and control group; grid walk task: no significant difference between treatment and control group; footprint analysis: for experiment 1=rats treated with ibuprofen had a narrower base support during ambulation signifying increased hindlimb motor control, but there was no significant difference in the stride length, no difference in either for experiment 2 and 3 or combined; von frey filament testing: no significant differences in withdrawal thresholds between ibuprofen and saline-treated groups in any of the individual experiments; gridle test: no significant differences between treatment groups in any of the individual experiments; bladder function:  no differences between treatment groups in the amount of retained urine in any experiment or in the combined data",histological assessment,quantification of axons,6 weeks,yes,no effect,There were no obvious qualitative differences in CST axon distribution in rats treated with ibuprofen; no significant differences between treatment groups in total CST axons/section or separately counting axons in ventral vs. dorsal halves of the spinal cord cross-sections ,"anesthesia: ketamine 75 mg/kg and xylazine 10 mg/kg; postop: lactated ringers (5 ml/100 g, subcutaneously) for hydration for 3–7 days and Baytril (Enroflaxacin 2.5 ml/kg, subcutaneously) for 3–7 days for prophylaxis against urinary tract infections (UTI's). The analgesic Buprenex (Buprenorphine, 0.01 mg/kg) was given for 3–7 days for pain management. Staples were removed at 14 days post injury; euthanasia: euthasol and transcardially perfused with cold 1× PBS for 10 min or 4% paraformaldehyde.","Taken together, our results only partially replicate the findings that treatment with ibuprofen improves motor function after SCI but fail to replicate findings regarding enhanced axon growth",not reported,replication study where they are actually not able to replicate the positive effects,No,
Catherine,Popovic et al,2012,A reassessment of a classic neuroprotective combination therapy for spinal cord injured rats: LPS/pregnenolone/indomethacin,10.1016/j.expneurol.2011.11.045,English,,excluded,Out of scope,No drug of interest,"Drug combination, but single drug effect not assessed",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Marcillo et al,2012,A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury,10.1016/j.expneurol.2011.06.008,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Faden et al,1981,A role for endorphins in the pathophysiology of spinal cord injury.,PMID:  7211553,English,,excluded,Out of scope,No assessments of interest,No outcome of interest (hypothesion),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Yang et al,1997,A sampling artifact in the microdialysis study of changes in extracellular [Mg2+] upon spinal cord injury,10.1006/abio.1996.9972,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Sharma et al,2007,A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury.,10.1196/annals.1403.007,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhao et al,2020,A Selective P2Y Purinergic Receptor Agonist 2-MesADP Enhances Locomotor Recovery after Acute Spinal Cord Injury,10.1159/000507854,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Liu et al,2017,A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions,10.1016/j.neuron.2017.07.037,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al,2015,A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury,10.1523/JNEUROSCI.0605-15.2015,English,,included,,,,,,rats,Sprague Dawley,15 - 18,05.Jun,,,10.Dec,,,"4 groups: 1 sham, 1 control, 1 early treatment, 1 delayed treatment each group has 5 to 6 individuals (no additional details)",female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: C4-C5; severity: hemisection,C4 - C5,incomplete,transection,hemi-laminectomy + hemisection (cut made with microbalde),"1 day, 2 weeks, 21 days, 9 weeks","Omega-3 (Docosahexaenoic acid, DHA)",omega 3,,250 nmol/kg in a volume of 5 ml/kg,30 min after hemisection (early) or 3 weeks after injury (delayed),,single dose,-,intravenously,,neurological/functional/behavioral assessment,"BBB scale, staircase test, grid walk test",,"open field locomotion: ~ 1m, observed for 4 min; staircase test: placed into Montoya staircase apparatus with each side of the stairs containing a food pellet per step, left undisturbed for 20 min to perform the task, number of foos pellets displaced or eaten from each side of the stairs were recorded; grid exploration test: misplacement recorded when the limb protrudes entirely through the grid and extends below the wire surface","open field: daily for 2 weeks after surgery, then every other day until the end of the study; staircase test: trained daily for 14 days before surgery, then tested daily for 1 week and thereafter every other day after injury; grid exploration test: baseline performance 3 times before surgery, postsurgery tests performed weekly until the end of the study",,yes,mixed effects (assessment) + mixed effects (timing),"open field: forelimd and hindlimb score no significantly different in treatment compared to control group; grid exploration test: number of misplacement significantly lower in the treatment group compared to control group, both for fore- and hindlimb; staircase test: number of food pellet displacement and food pellet eaten significantly higher in the treatment group compared to the control group; no more differences in grid exploration number of misplacement or staircase food pellet displacement or pellet eaten when treatment is delayed",histological assessment,"anterograde tracing to evaluate the effect of treatment on axonal sprouting, max neurite length","1 day, 1 week, 3 weeks",yes,mixed effects (assessment),"Serotonin fibers in the rostral part of the lesion site were significantly increased in both treatment groups, but only the DHA-treated group (red circles), not the vehicle group (blue squares), had significantly increased serotonin in the caudal region compared with the sham operated animals (green triangles). J, Serotonin fibers in the rostral part of the lesion site were significantly increased at 1 week (red square) and 3 weeks (blue circle) compared with the sham operated group after lateral cervical hemisection. However, in the caudal region, 1 and 3 weeks after injury were similar to the sham operated group.","anesthesia: isoflurane; ""pain relief was provided appropriately during postoperative care""; euthanasia: deeply anesthetized with sodium phenobarbital (80 mg/kg i.p.) and perfused with 0.9% saline followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer",We conclude that acute docosahexaenoic acid (DHA) can induce anatomical and synaptic plasticity. This provides direct evidence that DHA could exert its beneficial effects in spinal cord injury via neuroplasticity enhancement.,not reported,,No,
Catherine,Liu et al,2015,A Single Bolus of Docosahexaenoic Acid Promotes Neuroplastic Changes in the Innervation of Spinal Cord Interneurons and Motor Neurons and Improves Functional Recovery after Spinal Cord Injury.,10.1523/JNEUROSCI.0605-15.2015,English,,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Bimbova et al,2018,"A Single Dose of Atorvastatin Applied Acutely after Spinal Cord Injury Suppresses Inflammation, Apoptosis, and Promotes Axon Outgrowth, Which Might Be Essential for Favorable Functional Outcome",10.3390/ijms19041106,English,,included,,,,,,rats,Wistar,48,21,,,21,,,based on total count (n=48) and individual group counts reported one animals must have died but not clearly reported in which group this occurred,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: Th9; severity: not reported,T9,Not reported,compression,"laminectomy, compression (weight of 40 g/15 min)","24h, 6 weeks",Atorvastatin,atorvastatin,,5 mg/kg,immediately after SCI,,1 dose,-,intraperitoneally,,behavioral assessment,BBB scale,,open field for a period of 5 min,"1 day after the SCI, every other day for the first two weeks, and then once a week until six weeks post-injury",,not reported,positive effect,"Up until day 24, the development of the neurological score did not differ between the SCI and ATR-treated groups. However, the outcome was significantly different from day 30 to 42. At the end of survival, the mean score for motor outcome reached 11.06 ± 0.91 in the ATR-treated group.",immunohistochemistry,"immunochemistry, cell counting","immediatly after injury, 4 and 24hrs after injury",not reported,positive effect,"Avorstatin significantly reduced the early inflammatory response and sharply decreased the expression of caspase-3 in neurons, astrocytes, and oligodendrocytes 24 h post-SCI. ","Anesthesia: Isoflurane (2-4%)
Antibiotic drug Amoksiklav (Sandoz Pharmaceuticals, Ljubljana, Slovenia; 30 mg/kg, i.m.) and the analgesic drug Novasul (Richterpharma, Wels, Austria; 2 mL/kg, i.m.) for three days","Atorvastatin (5 mg/kg, i.p.) injected in a single dose immediately after spinal cord trauma, significantly reduced the early inflammatory response and sharply decreased the expression of caspase-3 in neurons, astrocytes, and oligodendrocytes 24 h post-SCI. Acute ATR treatment effectively prevented the excessive infiltration of destructive M1 macrophages around the lesion site, while the infiltration of beneficial M2 macrophages was less affected. This statin significantly improved the regeneration capacity of the injured tissue at six weeks, leading to the promotion of axonal outgrowth and increasing neurofilament expression. We can conclude that the early modulation of the inflammatory response via effects on the M1/M2 macrophages and the inhibition of caspase-3 expression strongly promote tissue regeneration in later periods.",Not reported,,No,
Catherine,Liu et al,2017,A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat,10.1089/neu.2016.4556,English,,included,,,,,,rats,Sprague Dawley,34 - 38,08.Oct,,,08.Oct,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: C4-C5; severity: hemisection,C4 - C5,incomplete,transection,hemi-laminectomy + hemisection (cut made with microblade),"2 weeks, 21 days","Omega-3 (Docosahexaenoic acid, DHA)",omega 3,,250 nmol/kg in a volume of 5 ml/kg,30 min post-injury,,1 dose,-,intravenously,,neurological/functional/behavioral assessment,"BBB scale, staircase test, grid walk test",,"open field locomotion: ~ 1m, observed for 4 min; staircase test: placed into Montoya staircase apparatus with each side of the stairs containing a food pellet per step, left undisturbed for 20 min to perform the task, number of foos pellets displaced or eaten from each side of the stairs were recorded; grid exploration test: misplacement recorded when the limb protrudes entirely through the grid and extends below the wire surface",start: 2 days after injury for 3 weeks,,yes,no effect,"DHA was only effective in combination with extensive rehabilitation, but did not show an effect when administered alone",histological assessment,"anterograde tracing to evaluate the effect of treatment on axonal sprouting, max neurite length","1 day, 1 week, 3 weeks",yes,no effect,"DHA was only effective in combination with extensive rehabilitation, but did not show an effect when administered alone","Subcutaneous injection of analgesic (buprenorphine, 0.01 mg/kg) and saline twice
daily for 3 days following surgery","the effect of rehabilition can be enhanced administering DHA in acute stage of SCI. rehabilitation can interact with DHA treatment in terms of axonal sprouting and
synaptic upregulation",Short term rehabilitation regime in the early acute phase following,,No,
Catherine,Katoh et al,1980,A study of regional circulation of cervical spinal cord after acute experimental spinal contusion,PMID: 7381277,Japanese,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Sámano et al,2012,A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity,10.1016/j.neuroscience.2012.06.064,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Rolls et al,2006,A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration,10.1096/fj.05-4540fje,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Fang et al,2012,A Surgery Protocol for Adult Zebrafish Spinal Cord Injury,10.1016/j.jgg.2012.07.010,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Ditor et al,2006,A therapeutic time window for anti-CD11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury,10.3171/spi.2006.5.4.343,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Wang et al,2017,A Thermosensitive Heparin-Poloxamer Hydrogel Bridges aFGF to Treat Spinal Cord Injury,10.1021/acsami.6b13155,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,heparin,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,David et al,2014,A Toll-Like Receptor 9 Antagonist Improves Bladder Function and White Matter Sparing in Spinal Cord Injury,10.1089/neu.2014.3357,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Gilad et al,2000,Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats,10.1016/S0304-3940(00)01625-6,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Luo et al,2005,Accumulation of acrolein-protein adducts after traumatic spinal cord injury,10.1007/s11064-005-2602-7,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Gulino et al,2007,Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat,10.1016/j.expneurol.2006.11.011,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Tasi et al,2015,ACIDIC FGF PROMOTES NEURITE OUTGROWTH OF CORTICAL NEURONS AND IMPROVES NEUROPROTECTIVE EFFECT IN A CEREBRAL ISCHEMIC RAT MODEL,10.1016/j.neuroscience.2015.07.074,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Li et al,2000,Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury,10.1080/01616412.2000.11758605,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nantwi et al,1996,Actions of systemic theophylline on hemidiaphragmatic recovery in rats following cervical spinal cord hemisection,10.1006/exnr.1996.0114,English,,excluded,Out of scope,No assessments of interest,No outcome of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,theophylline,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Diaz-Ruiz et al,2013,Activation of heme oxygenase recovers motor function after spinal cord injury in rats,10.1016/j.neulet.2013.08.067,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Santos-Nogueira et al ,2015,Activation of lysophosphatidic acid receptor type 1 contributes to pathophysiology of spinal cord injury,10.1523/JNEUROSCI.4703-14.2015,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Jang et al,2011,Activation of Matrix Metalloproteinases-9 after Photothrombotic Spinal Cord Injury Model in Rats,10.3340/jkns.2011.50.4.288,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Byrnes et al,2009,Activation of metabotropic glutamate receptor 5 improves recovery after spinal cord injury in rodents,10.1002/ana.21673,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Yang et al,2016,"Activation of the niacin receptor HCA(2) reduces demyelination and neurofilament loss, and promotes functional recovery after spinal cord injury in mice",10.1016/j.ejphar.2016.08.020,English,,included,,,,,,mice,C57BL/6,160,80,,,70,,,,male (100%),male,100,adult (no precise age reported),,,,,,Adult,20–25 g,,,20,25,g,,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy+contusion (A controlled force-defined impact at 50 kdyne was delivered to the exposed cord with a stainless steel impactor tip)," 3 h, 1 day, 3 days, 1 week, 2 weeks, and 4 weeks",niacin,niacin,,100 mg/kg,immediately after SCI,,4 weeks,BID,oral,,behavioral,BMS scale,, Basso Mouse Scale (BMS) rating system ,"1 day pre-SCI AND 1, 3, 7, 14, 21, and 28 days post SCI",,yes,positive effect,"statistically significantly higher BBB scores only on days 7,14, and 28","histology;
immunohistochemistry",,"3h, 1d, 3d, 7d, 14d",Yes,mixed effects,,"Anaesthesia: Isoflurane;
0.5 ml of buprenorphine (0.1 mg/kg), 0.5 ml of enrofloxacin (2.5 mg/kg), and sterile saline at 2.5 ml/50 g weight","Niacin exerted anti-inflammatory and neuroprotective effects in the SCI, likely through regulating the phenotypes of macrophages infiltrated in the wound. Niacin may reduce secondary injury after SCI and benefit long term functional recovery",none reported,,No,
Catherine,Cantoria et al,2011,Adaptations in Glutamate and Glycine Content within the Lumbar Spinal Cord Are Associated with the Generation of Novel Gait Patterns in Rats following Neonatal Spinal Cord Transection,10.1523/JNEUROSCI.3499-11.2011,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Qayumi et al,1994,Additive effect of allopurinol and deferoxamine in the prevention of spinal cord injury caused by aortic crossclamping,10.1016/S0022-5223(94)70038-9,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest tested alone (pure effect cannot be evaluated),,,swine,,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nantwi et al,2003,Adenosine A(1) receptor mRNA expression and the effects of systemic theophylline administration on respiratory function in 4 months after C2 hemisection,10.1080/10790268.2003.11753707,English,,excluded,Out of scope,No drug of interest,No outcome of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Cassada et al,2001,Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.,10.1067/msy.2001.115838,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (ATL-146e, an adenosine agonist, only adenosine of interest)",,,rabbit,New Zealand,52,,,,,,,,not reported,,,not reported,,,,,,,3.0-3.5 kg,,,,,,,level: not reported; severity: not reported,,,,laparotomy + ischemic injury (abdominal aorta and vena cava were collectively clamped with Satinsky clamps just distal to the left renal artery and again proximal to the aorto-iliac bifurcation),not reported (48h?),"ATL-146e, an adenosine A_{2A} agonist",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sun et al,2013,Adenosine triphosphate promotes locomotor recovery after spinal cord injury by activating mammalian target of rapamycin pathway in rats,10.3969/j.issn.1673-5374.2013.02.001,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ATP instead of adenosine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Chen et al,2018,Administration of chlorogenic acid alleviates spinal cord injury via TLR4/NF-B and p38 signaling pathway anti-inflammatory activity,10.3892/mmr.2017.7987,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Sasaki et al,2009,Administration of Human Peripheral Blood-Derived CD133(+) Cells Accelerates Functional Recovery in a Rat Spinal Cord Injury Model,10.1097/BRS.0b013e3181913cde,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Samantaray et al,2016,Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats,10.1111/jnc.13464,English,,excluded,Out of scope,No assessments of interest,,,,rats,Sprague Dawley,>= 30,6,,,24,,,,all male,male,100,not reported,,,,,,Not reported,200-250g,,,200,250,g,,laminectomy+contusion at T10,T10,moderate - severe,contusion,dropping a constant weight (5 gm) from a height of 8 cm onto an impounder (0.3 cm in diameter) gently placed on the spinal cord,48 hours,17β-estradiol,estrogen,,"1, 5, 10, or 100 μg/kg",bolus injections at 15 min post-injury and at 24 h,,2 doses,-,intravenously,,,,,,,,,,,immunohistochemistry,"Western plot, immunofluorescent labeling",48h,not reported,positive effect,"Estrogen significantly attenuates neuronal death following SCI
Estrogen treatment significantly reduces caspase-3 expression and activity following acute SCI
Estrogen therapy significantly increases expression of the estrogen receptors ER-α and ER-β following acute SCI","Anesthesia: ketamine (80 mg/kg) and xylazine (10 mg/kg)

Buprenorphine (0.01–0.05 mg/kg) was administered for post-operative pain",Estrogen treatment at each dose reduced pro-inflammatory and proteolytic activities and protected neurons in the caudal penumbra in acute SCI. Estrogen treatment at 10 μg was found to be as effective as 100 μg in ameliorating the above parameters in injured animals. Results from this investigation indicated that estrogen at a low dose could be a promising therapeutic agent for treating acute SCI.,"Although angiogenesis is important for cell survival, the limitation in this study is that restoration of blood supply has not been thoroughly investigated in acute injury. ",,No,
Catherine,Bracken et al,1997,Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury - Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial,10.1001/jama.277.20.1597,English,,excluded,Out of scope,No control group,No control group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Satoshi et al,2014,Administration of MicroRNA-210 promotes spinal cord regeneration in mice,10.1097/BRS.0000000000000356,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Cheng et al,2016,Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury,10.1016/j.freeradbiomed.2016.09.002,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Pakuslka et al,2013,Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogel,10.1016/j.jconrel.2013.06.029,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Shaughness et al,2019,Aging alters glucose uptake in the naive and injured rodent spinal cord,10.1016/j.neulet.2018.10.004,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kim et al,2017,Agmatine Modulates the Phenotype of Macrophage Acute Phase after Spinal Cord Injury in Rats,10.5607/en.2017.26.5.278,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kim et al,2011,Agmatine-Reduced Collagen Scar Area Accompanied With Surface Righting Reflex Recovery After Complete Transection Spinal Cord Injury,10.1097/BRS.0b013e318205e3f7,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Jiang et al,2004,"AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats",10.1177/039463200401700315,English,"Canada, United States, Italy",included,,,,,,rats,Wistar,128 - 156,32 - 39,,,32 - 39,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,280g to 300g,,,280,300,g,,compression injury at T11/T12,T11 - T12,Not reported,compression,coverslip forceps closed slowly (2 sec) compressing 3.5mm of spinal cord for 15 sec,,methylprednisolone,methylprednisolone,No,"bolus: 60mg/kg
maintenance: 30mg/kg","bolus: 15min post-injury
maintenance: 2hrs, 4hrs, 6hrs post-injury",,4 doses,,intraperitoneally,,functional,"BBB scale, footprint analysis, inclined plane test",,"BBB locomotor scale, hind limb placement test, foot orienting response, inclined plane test","post-injury days 1, 2, 3, 7, 10, 14, 21",No,Yes,positive effect,"statistically signifcant increase in BBB score for methylprednisolone treatment group (compared to injured but untreated control);
other scores reported to be higher in methylprednisolone treatment group but no statement on statistical significance","histology;
immunohistochemistry","hematoxylin and eosin stain, luxol fast blue stain;
stain for GFAP (macrophages), ED-1 (microglia-positive)","post-injury days 1, 3, 21",Yes,mixed (stats/no stats),"statistically significantly reduced cavity size on post-injury day 21 in methylprednisolone treatment group, less hemorrhages/structural disruption in treatment group at 24hrs post-injury (qualitative description only!);
statistically significant reduction in reactive astrocytes (GFAP pos. cells) at post-injury day 21 for MP treatment group but not days 1 or 3, reduced ED-1 pos. cell count in MP treatment group (qualitative description only!)",,methylprednisolone can reduce tissue damage and improve locomotor recovery following SCI,,MP treatment group acted as active control/comparison for alternative treatment (AIT-082),Yes (drug of interest + drug not of interest),
Louis,Halt et al,1992,Alcohol exacerbates behavioral and neurochemical effects of rat spinal cord trauma,10.1001/archneur.1992.00530350096025,English,United States,included,,,,,,rats,Not reported,40,10,,,10,,,"calculated based on description (2 different anesthetics tested, each w/ one group n=10 receiving ethanol and another group n=10 receiving saline)",Not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,,contusion injury at T9,T9,Not reported,contusion,"modified Allen weight drop model (50g/cm impact force, 10g impactor)",,"ethanol, isoflurane",ethanol + isoflurane,,"ehtanol: 4g/kg
isoflurane: 5% induction, 1% maintenance","ethanol: 1hr pre-injury
isoflurane: pre-injury (no precise time for induction of anesthesia reported)",,,,multiple,"ethanol: oral tube to stomach,
isoflurane: presumably oral",functional,"Tarlov scale, inclined plane test",,"modified Tarlov scale, angled plane test",no details reported except that assessments were performed for period of 4 weeks post-injury,,Yes,negative effect,statistically significantly lower Tarlov scores and max. angle in group pre-treated with ethanol,histology,spinal cord water content,4hrs and 24hrs post-injury,Not reported,mixed effects (timing of assessment),"statistically significantly lower water content in ethanol treated group at 4hrs but no difference at 24hrs (see Fig. 4; no report on which anesthesia scheme the data is shown for or if the data for both have been combined, assume treatment groups have been combined for this assessment)",,"ethanol has negative effect on functional recovery after SCI in both anesthesia schemes;
animals receiving isoflurane anesthesia scored significantly higher in all behavioral tests",,strong reduction in survival for ethanol treated gorup (data only shown for ketamine and pentobarbital anesthesia group),Yes (drug of interest + drug of interest),
Louis,Halt et al,1992,Alcohol exacerbates behavioral and neurochemical effects of rat spinal cord trauma,10.1001/archneur.1992.00530350096025,English,,included,,,,,,rats,Not reported,40,10,,,10,,,"calculated based on description (2 different anesthetics tested, each w/ one group n=10 receiving ethanol and another group n=10 receiving saline)",Not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,,contusion injury at T9,T9,Not reported,contusion,"modified Allen weight drop model (50g/cm impact force, 10g impactor)",,"ethanol, ketamine hydrochloride, pentobarbital sodium",ethanol + ketamine + pentobarbital,,"ethanol: 4g/kg
ketamine hydrochloride: 50mg/kg, pentobarbital: 30mg/kg","ethanol: 1hr pre-injury
ketamine hydrochloride, pentobarbital: pre-injury (no precise time for induction of anesthesia reported)",,,,multiple,"ethanol: oral tube to stomach,
ketamine hydrochloride: intramuscularly,
pentobarbital sodium: intraperitoneally",functional,"Tarlov scale, inclined plane test",,"modified Tarlov scale, angled plane test",no details reported except that assessments were performed for period of 4 weeks post-injury,,Yes,negative effect,statistically significantly lower Tarlov scores and max. angle in group pre-treated with ethanol,histology,spinal cord water content,4hrs and 24hrs post-injury,Not reported,mixed effects (timing of assessment),"statistically significantly lower water content in ethanol treated group at 4hrs but no difference at 24hrs (see Fig. 4; no report on which anesthesia scheme the data is shown for or if the data for both have been combined, assume treatment groups have been combined for this assessment)",,,,,Yes (drug of interest + drug of interest),
Catherine,Gao et al,2019,Ameliorative effects of echinacoside against spinal cord injury via inhibiting NLRP3 inflammasome signaling pathway,10.1016/j.lfs.2019.116978,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Durham-Lee et al,2011,Amiloride improves locomotor recovery after spinal cord injury,10.1089/neu.2011.1921,English,United States,included,,,,,,rats,Sprague Dawley,18,6,,,6,,,"SCI only and SCI + vehicle as controls (6 animals each),
only SCI + vehicle used as control (see e.g. Fig 1A",all male,male,100,not reported,,,,,,Adult,not reported,,,,,,,contusion injury at T10,T10,Not reported,contusion,"Infinite Horizon impactor w/ impact force 150 kDyne, 1 sec dwell time",,amiloride,amiloride,,"days 1 to 10: 5mg/kg
days 11 to 35: 10 mg/kg",starting 24hrs post-injury,,35 days,daily,intraperitoneally,,functional,BBB scale,,BBB locomotor score,"post-injury days 1 to 14, 21, 28, 35",,Not reported,mixed effects (timing),"statistically significantly higher BBB scores only on days 21, 28 and 35 (but not days 1 to 14)",,,,,,,,amiloride may have clinically relevant therapeutical potential as assessed through locomotor recovery,,"alternative drug regime assessed (late treatment starting day 35 post-injury) but not effective (no data shown), treatment earlier than 24hrs post-injury w/ high risk of complications",No,
Louis,Imai et al,2018,Amiloride Promotes Oligodendrocyte Survival and Remyelination after Spinal Cord Injury in Rats,10.3390/jcm7030046,English,Japan,included,,,,,,rats,Sprague Dawley,>= 40,>= 20,,,>= 20,,,no exact number of animals reported; 40 is minimum as immunohistochemistry requires animals to be sacrificed and assessments are performed at 4 time points for 2 groups w/ 5 animals each,all female,female,0,8 to 10 weeks,,,8,10,Weeks,,280g to 320g,,,280,320,g,,severe contusion injury at T10,T10,severe,contusion,"Infinite Horizon impactor w/ impact force 200 kDyne, no dwell time",,amiloride,amiloride,,10mg/kg,starting 24hrs post-injury,,14 days,daily,intraperitoneally,,functional,"BBB scale, Von Frey test",,"BBB locomotor score, 
dynamic plantar esthesiometer (automated equivalent to von Frey filamen testing) ","pre-injury, weeks 1 to 8 post-injury",,Not reported,mixed effects (assessment),"statistically significantly higher BBB scores in treatment group, 
no statistically significant difference (except transient at week 2) for sensory function as assessed by force triggering paw retreat","histology;
immunohistochemistry","remyelination assessed via electron microscopy (G ratio = myelin sheath thickness / axon diameter);
stain for BrdU (trace proliferating cells), NG2 (oligodendrocyte precursors/OPCs), APC (mature oligodendrocytes), DAPI","histological: day 28 post-injury;
immunohsitochemistry: days 7, 14, 28, 56 post-injury","histological: not reported;
immunohistochemistry: not reported",positive effect,"statistically siginificantly increased remyelination (number of remyelinated fibers - no timepoint reported, G-ratio/myelin thickness at post-injury day 28) for treatment group;
statistically significantly higher number of OPCs at peak value (day 14) for treatment group and statistically significantly higher number of mature oligodendrocytes at day 56 from treatment group",,"early improvements of function (BBB score, von Frey filament test) suggest neuroprotective function for amiloride and absence of plateau of motor function at end of study (day 56) suggests possible further recovery potential; 
immunohistochemistry suggests important role for OPCs and oligodendrocytes in regenerative process",,not sure if there is no plateau for BBB scores in treatment group,No,
Catherine,Wang et al,2018,AMP-activated protein kinase-dependent induction of autophagy by erythropoietin protects against spinal cord injury in rats,10.1111/cns.12856,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Krisa et al,2012,Amphetamine-enhanced motor training after cervical contusion injury,10.1089/neu.2011.1767,English,United States,included,,,,,,rats,Sprague Dawley,142,10,,,13,,,"142 animals included initially; 26 died from surgical complications/within 24hrs of surgery; 15 animals excluded due to incorrect lesion placement; majority of animals in groups w/ training or enhanced environment -- not of interests; remaining groups: injured control (n=13), drug only (n=10)",all male,male,100,adult (no precise age reported),,,,,,Adult,not reported,,,,,,,contusion injury (unilateral right) at C3/C4,C3 - C4,Not reported,contusion,Infinite Horizon impactor w/ impact force 175 kDyne,,D-amphetamine,amphetamine,,1mg/kg,"first dose on day 13 post-injury;
no drug administered in weeks w/ locomotor tests",,72 days,every third day,intraperitoneally,,functional,"grid walk test, grasping test (food retrieval), staircase test",,"grid walk test, forelimb motor score (0 - no function, to 17 - normal function);
reach-to-grasp task (retrieve food pellet from chamber w/ 1cm wide opening, reaching attemps separated by shuttling back and forth in cage, 6 weeks of training pre-injury), staircase reaching task (wells w/ food pellets along staircase, 2 weeks of training pre-injury), both assessments scored by two trained individuals","pre-injury, week 13 post-injury;
pre-injury, weeks 1, 5, 9, 13, 17 post-injury",,Yes,no effect,no effect observed for drug-only group compared to injured control (other than improvement over time which is observed for all groups),histology,Nissl stain,week 17 post-injury (after completion of all behavioral assessments),Not reported,no effect,,,treatment w/ drug alone does not improve recovery (but combination w/ training does),,"additional groups w/ targeted training (post-injury) and/or enhanced environment;
experimental groups balanced by paralysis ranking;
dose-response experiments performed as part of study",No,
Catherine,Kong et al,2020,AMPK controls the axonal regenerative ability of dorsal root ganglia sensory neurons after spinal cord injury,10.1038/s42255-020-0252-3,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,He et al,2019,An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury,10.2147/IJN.S187854,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Tukmachev et al,2015,An effective strategy of magnetic stem cell delivery for spinal cord injury therapy,10.1039/c4nr05791k,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Liu et al,2010,An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury,10.1016/j.nbd.2009.10.018,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Mori et al.,2005,An epidural cooling catheter protects the spinal cord against ischemic injury in pigs,10.1016/j.athoracsur.2005.04.031,English,,excluded,Out of scope,No drug tested,No drug tested: effect of cooling catheter,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Poynton et al.,1997,An evaluation of the factors affecting neurological recovery following spinal cord injury,10.1016/S0020-1383(97)00090-9,English,,excluded,Out of scope,No drug of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hawryluk et al,2014,An examination of the mechanisms by which neural precursors augment recovery following spinal cord injury: A key role for remyelination,10.3727/096368912X662408,English,,excluded,Out of scope,No drug of interest,Stem cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Lue et al,2005,An experimental study of the neuroprotective effect of FK506 on acute spinal cord injury in dogs,PMID: 16194341,Chinese,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Hook et al,2011,An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury,10.1016/j.bbi.2010.10.018,English,United States,included,,,,,,rats,Sprague Dawley,108,24,,,24,,,,all male,male,100,90 days to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,moderate contusion injury at T12/T13,T12 - T13,moderate,contusion,10g impactor (2.5mm tip) dropped from 12.5mm,,morphine,morphine,,"group 1: 20mg/kg
group 2: 90microgram","group 1: 24hrs post-injury
group 2: 24hrs post-injury ",,1 dose,,multiple,"group 1: intraperitoneally
group 2: intrathecally",functional,BBB scale,,BBB locomotor score,"24 hours post-injury 
(twice, once before drug administration, again after)",,Yes,no effect,no statistically significant differences (tendency for lower scores in morphine group),immunohistochemistry,"ELISA for IL-1beta, IL-6","i. 48 hours post-injury (24 hours after drug administration)
ii. 24 hours post-injury (30 min after drug administration) and 48 hours post-injury",not reported,mixed effects,"statistically significantly higher IL-1beta levels in morphine group at both 24 and 48 hours post-injury (both experiments i. and ii.);
no difference in IL-6 levels","Pfizerpen (penicllin G potassium; 100'000 U/kg, immediately and 48 hours post-injury)",morphine administration increases levels of pro-inflammatory cytokines,,effect of interleukin receptor antagonist on longer term recovery (14 days) assessed as well,Yes (drug of interest + drug of interest),
Lucie,Wang et al,2019,An injectable heparin-Laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function,10.7150/thno.37601,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (tested heparin but only in combination with laponite which is an hydrogel, which is also not tested alone so not possible to extracted the pure effect of heparin)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bao et al,2008,An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury,10.1016/j.expneurol.2008.09.006,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (BIO5192),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al,2021,An observation of the clinical efficacy of combining riluzole with mannitol and hyperbaric oxygen in treating acute spinal cord injury T,10.12669/pjms.37.2.3418,English,,excluded,Out of scope,No pure effect studied,Out of scope: no pure effect of the drug ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Woller et al,2012,Analgesia or addiction? Implications for morphine use after spinal cord injury,10.1089/neu.2011.2100,English,United States,excluded,Out of scope,No control group,No well-defined control group,,,rats,Sprague Dawley,,,,,,,,,all male,,,90 days to 100 days,,,,,,,350g to 400g,,,,,,,moderate contusion injury at T12/T13,,,,10g impactor (2.5mm tip) dropped from 12.5mm,,,,,,,,,,,,,,,,,,,,,,,,,,,"pencillin (100'000U/kg, immediately post surgery and day 2 post injury)",,,,,
Lucie,McKerracher et al,2013,Analysis of recruitment and outcomes in the phase I/IIa cethrin clinical trial for acute spinal cord injury,10.1089/neu.2013.2909,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cethrin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Shi et al,2000,Anatomical repair of nerve membranes in crushed mammalian spinal cord with polyethylene glycol,10.1023/A:1010879219775,English,United States,excluded,Out of scope,Ex-vivo,ex-vivo experiments,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Salzman et al,1990,Anesthesia influences the outcome from experimental spinal cord injury,10.1016/0006-8993(90)91521-H,English,"United States, Israel, South Korea",excluded,Out of scope,No control group,No control group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"effect of different anesthetics (pentobarbital, halothane, nitrous oxide) on recovery assessed; control group w/ injury but no treatment not possible making assessment of individual durg effects difficult",,
Louis,Imaizumi et al,1997,Anoxic injury in the rat spinal cord: Pharmacological evidence for multiple steps in Ca<sup>2+</sup> - dependent injury of the dorsal columns,10.1089/neu.1997.14.299,English,United States,excluded,Out of scope,Ex-vivo,ex-vivo experiments,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wu et al,2007,Anti-apoptotic effect of insulin in the control of cell death and neurologic deficit after acute spinal cord injury in rats,10.1089/neu.2006.0228,English,China,excluded,Out of scope,No pure effect studied,"two drugs of interest assessed simultaneously (insulin, glucose) but not separately",,,rats,Sprague Dawley,120,,,,,,,,all male,,,adult (no precise age reported),,,,,,,250g - 300g,,,,,,,compression injury between T8 and T10,,,,Allen's stall (40 g-cm force),,insulin (human recombinant) in glucose solution,,,"1 IU/kg per day (glucose: 50%, 1 g/kg per day)","30 min post-surgery, days 1 to 7 post-injury",,,three times per day,intraperitoneally,,"locomotor function;
neurological","modified Tarlov's scale (scores from 0 to 5);
inclined plane test;
motor evoked potentials (MEPs)",,"Tarlov scale: two examiners, score aggregation not reported;
no further details for inclined plane test;
MEPs: transcranial stimulation subcutaneously, recording at tibialis anterior, amplitude and latency considered","locomotor function: pre-injury, days 1, 3, 7 and 14 post-injury;
neurological: pre-injury, 8 hours post-injury, days 1, 3, 7 and 14 post-injury",,Not reported,positive effect,"statistically significantly higher Tarlov score and inclined plan angles at all time points for treatment group;
statistically significantly higher amplitude of MEPs in treatment group, no effect on latency","histology;
physiological","TUNEL assay (no. of TUNEL-pos cells across four regions from three segments);
spinal cord blood flow (SCBF; using laser-Doppler flowmetry, mean percentage of baseline reported)","TUNEL: 8 hours post-injury, days 1, 3, 7 and 14 post-injury;
SCBF: pre-injury, 0.5, 1, 2 and 8 hours post-injury, days 1, 3, 7 and 14 post-injury",Not reported,positive effect,"statistically significantly reduced percentage of TUNEL-pos cells in treatment group at all time points;
statistically significantly increased SCBF in all assessements <=24hrs post-injury for treatment group",,insulin administration shortly after SCI promotes functional and histological preservation/improvement,,"serum glucose levels assessed, no difference between control and treatment",,
Lucie,Ríos et al,2015,Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats,10.1007/s11064-015-1588-z,English,,excluded,Out of scope,No assessments of interest,Out of scope: no outcome of interest (anti-apoptotic effects),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Liu et al,2015,Anti-edema effect of melatonin on spinal cord injury in rats,10.5507/bp.2015.012,English,China,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Sprague Dawley,>= 150,50,,,50,,,"no exact number of animals ""used"" overall reported, probably more than 50 per group as n=5 for all figure captions etc. but report on exclusion of some animals due to complications (e.g. dural tearing)",all male,male,100,adult (no precise age reported),,,,,,Adult,205g to 225g,,,205,225,g,,compression injury at T12,T12,Not reported,compression,aneurysm clip applied for 5min,,melatonin,melatonin,,100mg/kg,"immediately post-injury, 
days 1 and 2 post-injury",,2 days,daily,intraperitoneally,,,,,,,,,,,"histological;
immunohistochemistry","water content (dry weight/wet weight);
stain for AQP4 and GFAP positive cells","water content: 12, 24, 48, 72 hours post-injury;
immunohistochemistry: 24 and 72 hours post-injury","water content: not reported;
staining (cell counts): yes",positive effect,"statisticially significant reduction in water content (melatonin treatment group) compared to injured control (24, 48, 72 hours);
statistically significant reduction in AQP4 and GFAP positive cell count (melatonin treatment group) compared to injurted control (24, 72hrs)",,melatonin treatment shows good therapeutic effect as assessed by water content and AQP4/GFAP levels,,,No,
Louis,Gao et al,2014,Anti-inflammatory and anti-apoptotic effect of combined treatment with methylprednisolone and amniotic membrane mesenchymal stem cells after spinal cord injury in rats.,10.1007/s11064-014-1344-9,English,China,included,,,,,,rats,Sprague Dawley,60,12,,,12,,,"5 groups w/ 12 animals each, only one group of interest + control",all female,female,0,adult (no precise age reported),,,,,,Adult,approx. 250g,250,,,,g,,compression injury at T11,T11,Not reported,compression,microvascular clip applied for 30sec,,methylprednisolone,methylprednisolone,No,10 mg/kg,"0.5, 12, 18 hours post-injury",Yes,3 doses,,intraperitoneally,,locomotor function,BBB scale,,"assessment by two examiners for 4 minutes, no information on score aggregation","days 1, 3, 7, 14, 21, 28, 35, 56 post-injury",Yes,not reported,positive effect,"statistically significantly higher BBB scores for MP-only group at days 14, 21, 28, 34, 56",histological,"hematoxylin and eosin stain, TUNEL assay",TUNEL assay: day 7 post-injury,not reported,positive effect,"statistically significant reduction in TUNEL-positive (apoptotic) cells in MP-only group compared to saline-treated control;
no results reported for hematoxylin and eosin staining","eltacin (no dosage reported, only administered if signs of urinary infections identified)","positive effect of MP on functional recovery but plateau reached by day 21 (no further improvement), and positive effect in reducing apoptosis",,"MP-only group acted as control for MP+MSCs treatment, authors mostly interested in effect of combination therapy",Yes (drug of interest + drug not of interest),
Louis,Baiyila et al,2018,"
Anti-inflammatory effect of Mongolian drug Naru-3 on traumatic spinal cord injury and its mechanism of action",10.1177/0300060518760157,English,China,included,,,,,,rats,Sprague Dawley,114,6,,,6,,,"19 groups w/ 6 animals each, only one group of interest + control",not reported,not reported,,adult (no precise age reported),,,,,,Adult,200g to 250g,,,200,250,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,weight drop model (20g impactor dropped from 5cm),,methylprednisolone,methylprednisolone,No,30mg/kg,not reported,,not reported,not reported,intravenously,,locomotor function,BBB scale,,no details reported,"pre-injury; days 1, 8, 16, 32 ,48 post-injury",No,Not reported,positive effect,"statistically significantly higher BBB scores for MP-only group at days 16, 32 and 48",immunohistochemistry,"stain for MCP-1 (monocyte chemotactic protein-1, related immune-induced inflammation and macrophage activation)",Not reported,not reported,positive effect,statistically significant reduction in MCP-1 positive rate (MP treatment vs. injured control group),,MP can promote recovery of locomotor function,very limited reporting on drug administration for MP (active control) group,MP-only group acted as control for Naru-3 (traditional Chinese medicine),No,
Louis,Bilginer et al,2009,Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats,10.1007/s00381-009-0985-5,English,Turkey,included,,,,,,rats,Wistar,72,12,,,12,,,"6 groups w/ 12 animals each, only one group of interest + control",all female,female,0,young (no precise age reported),,,,,,Young,100g to 120g,,,100,120,g,,contusion injury between T8 and T10,T8 - T10,Not reported,contusion,"Allen's weight drop model (5g impactor dropped from 10cm, 50g/cm impact force)",,methylprednisolone,methylprednisolone,No,30mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,locomotor function,"motor function scale (Farooque), inclined plane test",,"movement of hip, knee and ankle joints",week 6 post-injury,No,not reported,positive effect,statistically significantly higher motor score and inclined plane angle (compared to injured control),"histological;
immunohistochemistry","hematoxylin and eosin stain;
stain for iNOS, eNOS (inducible/endothelial nitric oxide synthase), 
APAF-1 (Apoptotic protease activating factor 1)","histology: week 6 post-injury;
immunohistochemistry: 24hrs post-injury",not reported,mixed effects,"statistically significant reduction in lesion size (relative size of lesion to entire spinal cord) for all treatment groups;
statistically significantly lower levels of iNOS, APAF-1 levels but no difference for eNOS levels in all treatment groups","gentamycin (no dosage or route reported, twice daily for days 1 to 3 post-injury, only in subgroups followed for 6 weeks)","MMF, MP and MMF + MP reduce apoptosis as assessed 24 hours after SCI;
MMF (and MP) treatment singificantly reduce iNOS levels which could reduce cell death;
positive effect of MMF, MP and MMF + MP on recovery of locomotor functions and reduction of lesion size;
overall MMF benefits histological and functional recovery",,,No,
Louis,Bilginer et al,2009,Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats,10.1007/s00381-009-0985-5,English,Turkey,included,,,,,,rats,Wistar,72,12,,,12,,,"6 groups w/ 12 animals each, only one group of interest + control",all female,female,0,young (no precise age reported),,,,,,Young,100g to 120g,,,100,120,g,,contusion injury between T8 and T10,T8 - T10,Not reported,contusion,"Allen's weight drop model (5g impactor dropped from 10cm, 50g/cm impact force)",,mycophenolate mofetil,mycophenolate,,25mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,locomotor function,"motor function scale (Farooque), inclined plane test",,"movement of hip, knee and ankle joints",week 6 post-injury,,not reported,positive effect,statistically significantly higher motor score and inclined plane angle (compared to injured control),,,"histology: week 6 post-injury;
immunohistochemistry: 24hrs post-injury",not reported,,,"gentamycin (no dosage or route reported, twice daily for days 1 to 3 post-injury, only in subgroups followed for 6 weeks)","MMF, MP and MMF + MP reduce apoptosis as assessed 24 hours after SCI;
MMF (and MP) treatment singificantly reduce iNOS levels which could reduce cell death;
positive effect of MMF, MP and MMF + MP on recovery of locomotor functions and reduction of lesion size",,,No,
Louis,Bilginer et al,2009,Antiapoptotic and neuroprotective effects of mycophenolate mofetil after acute spinal cord injury in young rats,10.1007/s00381-009-0985-5,English,Turkey,included,,,,,,rats,Wistar,72,12,,,12,,,"6 groups w/ 12 animals each, only one group of interest + control",all female,female,0,young (no precise age reported),,,,,,Young,100g to 120g,,,100,120,g,,contusion injury between T8 and T10,T8 - T10,Not reported,contusion,"Allen's weight drop model (5g impactor dropped from 10cm, 50g/cm impact force)",,methylprednisolone + mycophenolate mofetil,methylprednisolone + mycophenolate,,30mg/kg + 25mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,locomotor function,"motor function scale (Farooque), inclined plane test",,"movement of hip, knee and ankle joints",week 6 post-injury,,not reported,positive effect,statistically significantly higher motor score and inclined plane angle (compared to injured control),,,"histology: week 6 post-injury;
immunohistochemistry: 24hrs post-injury",not reported,,,"gentamycin (no dosage or route reported, twice daily for days 1 to 3 post-injury, only in subgroups followed for 6 weeks)","MMF, MP and MMF + MP reduce apoptosis as assessed 24 hours after SCI;
MMF (and MP) treatment singificantly reduce iNOS levels which could reduce cell death;
positive effect of MMF, MP and MMF + MP on recovery of locomotor functions and reduction of lesion size",,,Yes (drug of interest + drug of interest),
Lucie,Atalay et al,2007,Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats,10.1038/sj.sc.3102113,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (NEP1-40, nogo-66)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yazdi et al,2016,Antibody-mediated inhibition of Nogo-A signaling promotes neurite growth in PC-12 cells,10.1177/2041731416629767,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (nerve growth factor , nogo-A)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Theriault et al,2018,Antispasmodic medications may be associated with reduced recovery during inpatient rehabilitation after traumatic spinal cord injury,10.1080/10790268.2016.1245010,English,,excluded,Out of scope,No pure effect studied,"groups of drugs tested, not once drug",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wu et al,2014,Apamin-mediated actively targeted drug delivery for treatment of spinal cord injury: More than just a concept,10.1021/mp500393m,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (curcumin, apamin-modified polymeric micelles)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Cheng et al,2018,Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury,10.1016/j.expneurol.2017.10.014,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested (KO mice in apolipoprotein E instead),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xie et al,2018,Application of the sodium hyaluronate-CNTF scaffolds in repairing adult rat spinal cord injury and facilitating neural network formation.,10.1007/s11427-017-9217-2,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (sodium hyaluronate-CNTF (ciliary neurotrophic factor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tunçdemir et al,2013,AR-A014418 as a glycogen synthase kinase-3 inhibitor: Anti-apoptotic and therapeutic potential in experimental spinal cord injury,10.1016/j.neucir.2011.12.006,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (AR-A014418),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Huang et al,2009,Arachidonyl Trifluoromethyl Ketone Is Neuroprotective after Spinal Cord Injury,10.1089/neu.2008.0835,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cPLA2 inhibitor arachidonyl trifluoromethyl ketone),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hong et al,2020,Ascorbic Acid Promotes Functional Restoration after Spinal Cord Injury Partly by Epigenetic Modulation,10.3390/cells9051310,English,,included,,,,,,rats,Sprague Dawley,>= 40,,,,,,,,female 100%,female,0,12 weeks old,12,,,,Weeks,,range: [230-250](g),,,230,250,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + contusion (200 kdyn, infinite horizon impactor)",3 months,ascorbic acid (AA),vitamin c,,"5, 100, 200 mg/kg",30 min after SCI,,3 months,daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, horizontal ladder test",,"BBB: 0 points (no hindlimb movement) to 21 points (normal hindlimb movement), 2 examiners, 4 min in open field, open field (cylindrical-shaped acrylic box, 90 cm in diameter and 15 cm high, with a smooth floor); horizontal ladder test: runway made of acrylic walls (10 cm tall, 127 cm long, 8 cm between walls, 1 cm between rungs), ladder score was calculated as follows: ladder score = erroneous steps of hindlimb/total steps of hindlimb × 100 (%)",weekly for 3 months,,yes,mixed effects (dosage),"AA-100 group started to show a significantly higher BBB score than the control group at 5 weeks and the difference persisted until 12 weeks, no significant difference between other groups and control; ladder test revealed a greater restoration of hind limb function in the AA-100 group than in the control group at 2 weeks (77.45 ± 11.03% vs. 93.20 ± 5.28%; AA-100 group vs. control group), and at all time points from 5 weeks (47.54 ± 17.83% vs. 73.54 ± 16.9%49%, respectively) until sacrifice at 12 weeks, no significant difference between other groups and control",histological assessment,axon quantification: five different 5HT axons were averaged for each field to measure the percentage of the intensity and density of axons,3 months after injury,not reported,mixed effects (assessment) + mixed effects (dosage),"H&E staining at 1 week revealed that the area of the cavity was smaller in the 100 mg/kg AA-treated SCI group (AA-100 group) than in the AA-200 group, but the area in the AA-100 group was not smaller than that in the control group (Figure 3A). There were fewer ED1-positive macrophages or microglia in the AA-100 group than in the control and AA-200 groups (Figure 3C)",anesthesia: 2% isoflurane; postop: Cefotiam hydrochloride (40 mg/kg) and acetaminophen syrup (10 mg/kg) were administered to all operated rats for three days to prevent bacterial infection and control postoperative pain; euthanasia: deeply anesthetized and transcardially perfused with 200 mL 0.9% normal saline followed by 4% paraformaldehyde,"Administration of ascorbic acid (100 mg/kg) to SCI rats enhanced 5hmC levels; increased the expression of the Tet1, Tet2, and Tet3 genes within the brain motor cortex; promoted axonal sprouting within the lesion cavity of the spinal cord; and enhanced recovery of locomotor function until 12 weeks. In conclusion, we found that epigenetic status in the brain motor cortex is changed after SCI and that epigenetic modulation using ascorbic acid may contribute to functional recovery after SCI","the relationships between DNA demethylation and activation of some RAGs induced by AA application are not clear in this study; our study cannot exclude that the beneficial effect of AA on SCI recovery at the acute phase might be due to the protective role of AA alone from oxidative damage around the wounded area; number of samples used for some analyses was small, while variations between samples were large, making it difficult to reach a clearer conclusion, which should be investigated through further studies","use isoflurane, acetaminophen",No,
Lucie,Luedtke et al,2014,Assessment of Depression in a Rodent Model of Spinal Cord Injury,10.1089/neu.2013.3204,English,,excluded,Out of scope,No control group,Out of scope: no comparison between treatment vs non treatment but depression vs non depression instead,,,rats,Sprague Dawley,62,,,,,,,,male 100%,,,90-110 days,,,,,,,range: [300-350](g),,,,,,,level: T12; severity: moderate,,,,"laminectomy + contusion (MASCIS device, 10-g impactor outfitted with a 2.5mm tip, dropped from 12.5mm, wound was closed using Michael clips)",22 or 32 days,fluoxetine,,,5 mg/kg,14 days post injury,,from day 14 to day 32 post injury,daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, nociceptive reactivity (tail-flick test and von Frey stimulation, tactile reactivity)",,"BBB: 21-point scale, 0= nomovement of the hindlimb (ankle, knee or hip), 14 = consistent weight-supported stepping with consistent forelimb/hindlimb coordination, 99cm diameter, 23cm deep, allowed to move freely, acclimated 5 ming on 3 consecutive days before surgery, observed for 5 min by 1 observer; tail-flick test: thermal reactivity was tested using a halogen light that was focused onto the rat’s tail, latency to flick the tail away from the radiant heat source (light) was recorded, 2 tests at 2-min intervals; von Frey stimulations: Filaments of increasing strength were applied every 2 sec in sequence to the plantar surface of the paw. The stimuli were presented until subjects exhibited a paw withdrawal/motor and vocalization response. The intensity of the stimuli that produced the responses was reported using the formula provided by Semmes-Weinstein: Intensity = log10 (10,000 * g force); tactile reactivity with girdle test: A von Frey hair with a bending force of 204.14 mN (26g force) was then applied to each point on the grid, and vocalization responses were recorded and mapped onto a grid map of that animal. Because animals do not normally vocalize with this stimulus, a vocalization response indicates that a noxious stimulus was experienced. In mapping the area of response, the number of vocalizations are recorded (Nv) and normalized by the following formula: [Nv · 100]/total number of applications (44), indicating the percent vocalizations out of the total number of applications","BBB: days 1-7, 9, 11, 13, 15, 18, 21, 24 and 27; nociceptive tests: day 4 and 22",,"BBB: yes, nociceptive tests: not reported",,,histological assessment,"total cross-sectional area of the cord, spared tissue, Four indices of lesion magnitude were derived: lesion; residual gray matter (GM); residual white matter (WM); and width --> WM area, GM area, spared tissue (white + gray), damaged tissue area, net area (white + gray + damage), and section width, for each section",day 32 post injury,yes,,,"anesthesia: isoflurane (5% mixed with oxygen and gas for initition and then lowered to 2–3%); postop:  5 mg/kg of gentocin administered subcutaneously (s.c.) to prevent infection and with 2.5 mL of s.c. saline (0.9%) to compensate for fluid loss, daily injections of gentocin (5 mg/kg, s.c.) and saline (2.5 mL) for 5 days after injury, Michel clips removed 14 days after surgery; anesthesia: deeply anesthetized (100 mg/kg of pentobarbital, i.p.) and perfused (intracardially) with 4% paraformaldehyde.","Fluoxetine significantly decreased immobility in the forced swim test (FST) in depressed subjects identified with the equation. Subjects that were depressed and treated with saline displayed significantly increased immobility on the FST, relative to not depressed, saline-treated controls. These initial experiments validate our tests of depression, generating a powerful model system for further understanding the relationships between molecular changes induced by SCI and the development of depression",not reported,,,
Catherine,Izadpanah et al,2009,Assessment of functional recovery of contusive spinal cord injury by administration of (-)-deprenyl in rats,https://www.cabdirect.org/cabdirect/FullTextPDF/2010/20103060609.pdf,Persian,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Deprenyl),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sulla et al,2014,Assessment of motor recovery and MRI correlates in a porcine spinal cord injury model,10.2754/avb201483040393,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Jaja et al,2019,"Association of Pneumonia, Wound Infection, and Sepsis with Clinical Outcomes after Acute Traumatic Spinal Cord Injury",10.1089/neu.2018.6245,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Martins et al,2018,Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats,10.1016/j.spinee.2017.10.067,English,,included,,,,,,rats,Wistar,29,6,,,6,,,"5 groups: sham (n=6), control (n=6), riluzole (n=5), dantrolene (n=6), riluzole + dantrolene (n=6)",male 100%,male,100,12 weeks,12,,,,Weeks,,range: [320-350](g),,,320,350,g,,level: T12; severity: moderate,T12,moderate,compression,"laminectomy + compression (extradural compression, moderate weight of 40 g/cm, 5 minutes)",8 days,"riluzole (not of interest), dantrolene",dantrolene,,10 mg/kg,1h after laminectomy (placebo at 15 min),,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"4 minutes, open-field arena",every day for 7 days after SCI,,yes,no effect,no stasticial difference between dantrolene group and vehicle group,histological assessment,"number of neurons, cell counts (TUNEL)",8 days,yes,no effect,"dantrolene group did not show statistical difference with control, no comparison and only description of each group for the gross and light microscopy findings","anesthesia: pre-anesthetic medication tramadol (2 mg/kg, subcutaneous) was administered, and anesthesia induction and maintenance was carried out using isoflurane administered by mask in a semi-open system, antibiotic cephalothin prophylactically (60 mg/kg, subcutaneous); postop: tramadol chloride administration (2 mg/kg, orally, every 8 hours) for 3 days, and cephalexin administration (30 mg/kg, orally, twice daily) for 5 days; euthanasia: overdose of thiopental (100 mg/kg) by intraperitoneal injection 8 days after the surgical procedure, and submitted to transcardiac perfusion with 300 mL 0.9% sodium chloride saline followed by 300 mL of 10% phosphate-buffered formalin (pH 7.4)",These results showed that riluzole and dantrolene have a synergistic effect in neuroprotection after traumatic SCI by decreasing apoptotic cell death.,not reported,"use tramadol, isoflurane, cephalexin",Yes (drug of interest + drug not of interest),
Catherine,Martins et al,2018,Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats.,10.1016/j.spinee.2017.10.067,English,,excluded,Duplicate,,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2019,Astragoloside IV loaded polycaprolactone membrane repairs blood spinal cord barrier and recovers spinal cord function in traumatic spinal cord injury,10.1166/jbn.2019.2715,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gao et al,2016,Atorvastatin activates autophagy and promotes neurological function recovery after spinal cord injury,10.4103/1673-5374.184498,English,,included,,,,,,rats,Sprague Dawley,54,18,,,18,,,"3 groups: sham (n=18), control (n=18), atorvastatin (n=18)",male 100%,male,100,8-12 weeks old,,,8,12,Weeks,,range: [260-300](g),,,260,300,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + contusion (Allen method, 10g 2mm diameter impactor vertically dropped from a 2.5cm height)",7 or 42 days,atorvastatin,atorvastatin,,5 mg/kg,immediately after injury,,2 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"21=normal, 0=complete paralysis","1, 3, 7, 14, 21, 28, 35, 42 days",,not reported,positive effect,"atovarstation group was significantly better in SCI compared to saline group, starting week 2 until week 6",histological assessment,apoptosis,7 days,not reported,positive effect,number of TUNEL positive cell significantly lower in atorvastatin group compared to control saline group,"anesthesia: 10% chloral hydrate (0.3 mL/kg, IP); postop: injected with antibiotics for 3 consecutive days; euthanasia: intraperitoneally anesthetized with 10% chloral hydrate 0.3 mL/kg","these findings suggest that atorvastatin activated autophagy after spinal cord injury, inhibited apoptosis, and promoted recovery of neurological function",not reported,use chloral hydrate,No,
Lucie,Déry et al,2009,Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery,10.1016/j.neulet.2009.01.062,English,,included,,,,,,rats,Sprague Dawley,42,17,,,14,,,"5 groups: sham (n=11), short-term control (n=11), chronic control (n=6), short-term treatment (n=8), chronic treatment (n=6)",female 100%,female,0,not reported (adults),,,,,,Adult,range: [225-250](g),,,225,250,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + contusion (weight drop, weight of 5g dropped from heihgt of 6cm, 30g cm impact)","4h, 4 weeks",atorvastatin,atorvastatin,,5 mg/kg,2h post injury,,15 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,21-point scale,weekly for 4 weeks,,not reported,positive effect,atorvastatin-treated group was significantly different (better) in terms of BBB score compared to vehicle group,histological assessment,"area of spared cord tissue at the epicenter, TUNEL assay (apoptotic neuronal cells)",4h post injury,not reported,mixed effects (assessment),area of spared spinal cord tissue at the injury epicenter in both SCI groups was not different (p = 0.12) between treatment and control group; our results showed a significant increase (p<0.05) in TUNEL-positive cells at the injury site in vehicle-treated rats compared to both the control and statin groups (i.e. more apoptosis in vehicle compared to treatment),"anesthesia: sodium pentobarbital (50 mg/kg, IP); postop: antibiotics (Duplocillin, 0.2 mg/kg, i.m.) immediately post-operatively and again 2 and 4 days later; euthanasia: entobarbital (250 mg/kg, IP) and perfused transcardially with oxygenated, calcium-free tyrodes, then with 4% paraformaldehyde solution in 0.1 M phosphate buffer, pH 7.4",These data demonstrate that atorvastatin is effective after experimental spinal cord contusion injury in preventing early apoptosis at the injury site within 2 h post-administration,not reported,use sodium pentobarbital,No,
Lucie,Hu et al,2010,ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats,10.1016/j.neuroscience.2010.05.046,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (rapamycin, ATP)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tsai et al,2019,Attenuating Spinal Cord Injury by Conditioned Medium from Bone Marrow Mesenchymal Stem Cells,10.3390/jcm8010023,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (mesenchymal stem cell conditioned mediuum),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yeng et al,2016,Attenuating spinal cord injury by conditioned medium from human umbilical cord blood-derived CD34+ cells in rats.,10.1016/j.tjog.2015.12.009,English,,included,,,,,,rats,Sprague Dawley,40,8,,,24,,,"5 groups of 8 individuals each: sham, vehicle, cultured human CD34+ cells, estradiol. estradiol + CD34+",male 100%,male,100,not reported (adults),,,,,,Adult,218 (12) (g),218,12,,,g,,level: T8-T9; severity: not reported,T8 - T9,Not reported,compression,laminectomy + compression (jaws of a calibrated aneurysm clip with a closing pressure of 55 g were placed on the dorsal and ventral surfaces of the spinal cord and left in place for 1 minute),7 days,17beta-estradiol (E2),estradiol,,10 microg/mL,immediately after SCI,,single dose,-,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"2 trained technicians, observed for 4 min in open field, 0=no observable hind limb movements t0 21=normal locomotion with consistent plantar stepping and coordinated gait, toe clearance, parallel paw position, trunk stability and tail consistency in an upper position",starting at 24 hours postinjury and once daily for 3-7 days,,yes,positive effect,BBB scores were significantly higher in rats treated with 17b-estradiol 1-7 days after SCI than in vehicle-treated rats,histological assessment,apoptosis (TUNEL assay),7 days,yes,positive effect,"17b-estradiol significantly reduced the number of TUNEL-positive cells 7 days after SCI, compared with those cells in the vehicle control.","anesthesia: sodium pentobarbital 25 mg/kg, IP, mixture of ketamine 44mg/kg IM and atropine 0.02633 mg/kg IM and xylazine 6.7 mg/kg IM; postop: 0.1 mL Baytril antibiotic daily for 3 days; euthanasia:  anesthetized with chloral hydrate and perfused with 0.1M phosphate-buffered saline (PBS; pH 7.4) and subsequently with 4% paraformaldehyde in 0.1M PBS (pH 7.4) via a cardiac puncture",The neuroprotective effects of conditioned medium (CM) from cultured human CD34+ cells are similar to those of human CD34+ cells and the CM was found to enhance the neuroprotective effects of E2 in rat SCI,not reported,"use of sodium pentobarbital, ketamine, atropine, chloral hydrate, saline",Yes (drug of interest + drug not of interest),
Lucie,Genovese et al,2005,Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin,10.1111/j.1600-079X.2004.00194.x,English,,included,,,,,,rats,Sprague Dawley,200,50,,,50,,,"4 groups: sham+vehicle (n=50), sham+treatment (n=50), SCI+vehicle (n=50), SCI+treatment (n=50)",male 100%,male,100,not reported,,,,,,Not reported,range: [300-350](g),,,300,350,g,,level: T5-T8; severity: not reported,T5 - T8,Not reported,compression,"laminectomy + compression (aneurysm clip, closing force of 50g abruptly extradurally, clip rapidly released with the clip applicator, compression for 13s)","2h, 4h, 24h, day 9",melatonin,melatonin,,50 mg/kg,"30 min before SCI, 30 min, 1h, 6h and 12h after SCI",,9 days,daily,not reported,,neurological/functional/behavioral assessment,Tarlov scale,,"0= no voluntary movement, 1=perceptible movement of joints, 2=good movement of joints but inability to stand, 3=ability to stand and walk, 4=complete recovery",once a day for 10 days after injury,,not reported,positive effect,A significant recovery of hind limb motor disturbances was observed in the SCI-operated rats which were treated with melatonin,histological assessment,"area injured, edema, alteration of the white matter, TUNEL assay",24h,yes,no stats,significant protection of the SCI was observed in the tissuecollected from the melatonin-treated rats (no additional details),anesthesia: chloral hydrate (400 mg/kg),"Taken together, our results demonstrate that treatment with melatonin reduces the development of inflammation and tissue injury events associated with spinal cord trauma",not reported,use of chloral hydrate,No,
Lucie,Pannu et al,2005,Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats,10.1002/jnr.20345,English,,included,,,,,,rats,Sprague Dawley,>= 30,> 15,,,> 15,,,"2 groups: 1 vehicle (n=9 for BBB) and 1 treatment (n=9 for BBB), 18 for neurological assessement + 12 per time point for histology",female 100%,female,0,not reported,,,,,,Not reported,range: [225-250](g),,,225,250,g,,level: T12; severity: moderate,T12,moderate,contusion,"laminectomy + weight drop contusion (dropping a weight of 5g from a height of 6 cm, 30 g-cm force, onto an impounder 0.3cm diameter gently placed on the spinal cord)","1h, 4h, 12h, 24h, 48h, 72h, 1 week and 2 weeks",atorvastatin,atorvastatin,,5 mg/kg,7 days before SCI,,until sacrifice,daily,oral,,neurological/functional/behavioral assessment,BBB scale,,21-point scale,daily for 2 weeks after surgery,,yes,positive effect,atorvastatin treatment significantly improved the neurologic outcome after SCI ompared with vehicle group in terms of BBB score,histological assessment,"tissue necrosis and demyelination, TUNEL assay",day 15 after surgery,not reported,no stats,"The amount of tissue necrosis and white matter vacuolization at the lesion epicenter medial fragment (Fig. 7K), however, as well asrostral (Fig. 7J) and caudal (Fig. 7L) to the site of injury, was reduced significantly in tissue sections of atorvastatin-treated SCI rats (Fig. 7D), also significantly attenuated demyelination in treated group, these observations strongly support the conclusion that atorvastatin treatment may prove beneficial in the attenuation of inflammation-mediated pathology of SCI; celullar apoptosis was attenuated markedly in spinal cord sections from LP-treated SCI rats, atorvastatin treatment attenuated neuron and oligodendricyte apoptosis after SCI, which translates as improved functional outcome (no stats)","anesthesia: ketamine (80 mg/kg) plus xylazine (10 mg/kg), No prophylactic antibiotics or analgesics; euthanasia: same anesthesia, sacrificed by decapitation",This study therefore reports the beneficial effect of ator-vastatin for the treatment of SCI-related pathology anddisability.,not reported,use of ketamine,No,
Lucie,Gwee et al,2018,Aurora kinase B regulates axonal outgrowth and regeneration in the spinal motor neurons of developing zebrafish,10.1007/s00018-018-2780-5,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (AZD112 elective AurkB inhibitor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yuan et al,2020,Autophagy Induction Contributes to the Neuroprotective Impact of Intermittent Fasting on the Acutely Injured Spinal Cord,10.1089/neu.2020.7166,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested (intermittent fasting),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tang et al,2014,Autophagy reduces neuronal damage and promotes locomotor recovery via inhibition of apoptosis after spinal cord injury in rats.,10.1007/s12035-013-8518-3,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (3-methyladenine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nash et al,2002,Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord.,20026746,English,,included,,,,,,rats,Sprague Dawley,61,5,,,10,,,"6 groups: sham (n=5), lesion (n=5), lesion+vehicle (n=5, considered control), MP (n=10), EC (n=9), MP + EC (n=10), excluded (total n = 17), did not survive beyond 14 days after surgery (n = 15, groups not specified), failed to train in response to a food reward before surgery (n = 2, groups not specified), rats used to harvest ECs for transplants (n = 20)",not reported,not reported,,not reported (adults),,,,,,Adult,range: [300-400](g),,,300,400,g,,level: C2-C4; severity: not reported,C2 - C4,incomplete,transection,"laminectomy + dorsal CST transection, bilaterally transect the dorsal funiculus",3 days,"ensheathing cells (not further reported), mehtylprednisolone",methylprednisolone,No,30 mg/kg,1h after injury,,5 injections (bolus + 4 injections),every 6h,intravenously,,neurological/functional/behavioral assessment,grasping test (food retrieval),,"2 compartments comprised a main compartment (30.5  6.25  5 inches) for the rat and a minor compartment (30.5  3.5  3 inches) for the food reward, which was subdivided into 14 adjacent slots of equal size (2 1.25  3 inches), single 190 mg food pellet was placed into each of the 14 slots in the minor compartment. The rats were required to extend a forelimb through the holes in the Plexiglas divider to grasp a food pellet, 5 min to complete the task during the postsurgery testing period and were allowed to make as many attempts as they wanted during this time period, data were collected in terms of total number of attempts and percentage of successful attempts, rats on food deprivation but weight should not reduce less than 80%","prior to injury:  trained twice per day for 5 d and then tested twice per day for 5 d; post injury: trained twice per week during weeks 2–5 after surgery, tested at week 6 after injury",,yes,positive effect,DFR success in MP group significanlty better than in the lesion only and vehicle groups,histological assessement,axonal counts in dorsal CST,Seven weeks and 3 d after lesioning,not reported,positive effect,"MP group had significantly more axons than the lesion and vehicle groups at 1, 4, and 7 mm (Fig. 4 A, D). However, at 10, 13, 16, and 19 mm, no significant differences were found among the means of these three groups (Fig. 4 B–D)","anesthesia: isoflurane (5%), ophtalmic ointment; post injury: buprenorphine (0.1 mg/kg immediately after surgery for pain relief; euthanasia: anesthetized with chloral hydrate (10 ml / kg; Sigma, St. L ouis, MO) and perf used transcardially with 300 ml of PBS, pH 7.4, followed by 300 ml of 4% paraformaldehyde in 0.1 M phosphate buffer","These data confirm previous reports that ensheathing cells promote axonal regeneration and functional recovery after spinal cord lesions. In addition, this research provides evidence that, when used in combination, MP and ECs improve axonal regrowth up to 13 mm caudal to the lesion at 6 weeks after injury.",not reported,"use isoflurane, chloral hydrate",Yes (drug of interest + drug not of interest),
Lucie,Bracken et al,1984,Efficacy of Methylprednisolone in Acute Spinal Cord Injury,10.1001/jama.1984.03340250025015,English,USA,excluded,Out of scope,No control group,No control group,,,human,-,"330, included: high dose = 152, low dose = 154",,,,,,,,"male: n=267 (87.3%, 88.2 VS 86.4% in high and lose dose groups respectively), female: n=39 (12.7%, 11.8 VS 13.6% in high and lose dose groups respectively)",,,"high dose group: 13-19 = 19.7%, 20-24=25.7%, 25-29=15.8%, 30-34=8.6%, 35-39=7.9%, 40-44=3.3%, 45-49=5.9%, 50-54=5.8%, 55-59=3.3%, 60+=4.0%; lose dose group: 13-19 = 20.8%, 20-24=22.7%, 25-29=16.9%, 30-34=10.4%, 35-39=5.2%, 40-44=6.5%, 45-49=2.6%, 50-54=5.8%, 55-59=1.3%, 60+=7.8%",,,,,,,"high dose group: 72.5(13.0) (kg), low dose group: 73.0(13.3) (kg)",,,,,,,"level: not reported; severity: high dose group: quadriplegic with total sensory loss=27.0%, paraplegic with total sensory loss=24.3%, quadriplegic with partial sensory loss=4.0%, paraplegic with partial sensory loss=11.8%, paraplegic with variables sensory loss=32.9%; low dose group: quadriplegic with total sensory loss=33.1%, paraplegic with total sensory loss=27.9%, quadriplegic with partial sensory loss=5.8%, paraplegic with partial sensory loss=9.1%, paraplegic with variables sensory loss=24.0%",,,,"high dose VS low dose group: automobile accident=32.2 VS 27.3%, fall=21.7 VS 21.4%, missile=15.8 VS 22.1%, water related=12.5 VS 14.9%, motorcycle accident=7.2 VS 7.8%, crush=5.3 VS 0.7%, other=5.3 VS 5.2%, unknown=0.0 VS 0.6%","high dose VS low dose group: died less or 14 days n=9 (5.9%) VS n=3 (1.9%), died between 15-28 days: n=6 (3.9%) VS n=5 (3.2%), died between 29-210 days: n=4 (2.6%) VS n=5 (3.2%), survival more than 210 days: 133 (87.5%) VS n=141 (91.6%)",methylprednisolone,,,"loading doses: 100 or 1000 mg, follow up: 25 or 250 mg",immediately after randomisation ,,10 days,bolus + every 6h,intravenously,,"neurological, motor and sensory assessment","motor function, pinprick and light touch, completeness of neurological deficit, changes in neurological status",,"motor function: 14 muscles, 1=normal function, 6=no contraction, expanded score from 14=all muscles normal to 84=no contraction in any msucle, scores from left and right obtained independently; pinprick and light touch: from C2 to S5, 1=normal, 2=decreased, 3=absent, extended from 29=normal at each level to 87=absent at all levels, 5-point scale: 1= analgesic above T1 and anesthesic above T1if PP and LT absent at T! or above and in all distal segments, (2) analgesic <T-1 and anesthesic <T-1 if sensation was absent below T-l and in all distal segments, (3) hypalgesic >T-1 and hypesthesic >T-1 if sensation was decreased at T-l or above, (4) hypalgesic <T-1 and hypesthesic <T-1 if sensation was decreased below T-l, and (5) normal for other patients; completeness: (1) quadriplegic with total sensory loss to 5=paretic with variables sensory loss; change in neurological status: obtained by subtracting the expanded neurological scores at admission from the six-week and six-month scores, treated as continuous measure","admission by steroid protocol, 6 weeks later, 6 months later",,yes,,,-,-,-,-,,-,"steroid administered before admission at study hospital, high VS low dose group in %: none= 61.4 VS 69.7, yes= 38.6 VS 30.3, dexamethasone=92.2 VS 95.0, MPSS=7.8 VS 5.0, <50mg of MP: 41.2% VS 50.0, 51-100mg=58.6 VS 50.0","The lack of a treatment effect was independent of the severity of the initial lesion or the time from injury to starting treatment. Although not statistically significant, early case fatality was greater in the high-dose protocol (relative risk of 3.1 and 1.9, <=14 and 15 to 28 days after injury, respectively) but not from 29 to 210 days after injury. Wound infections of both trauma and operative sites were more prevalent in the high-dose regimen (relative risk of 3.6)","The measures of neurological function used in this study are sensitive to small changes, Although the six-week follow-up examination was performed on 91.8% of living patients, this dropped to 65.1% at six months",no control group per se,,
Lucie,Zhang et al,2015,Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury,10.1186/s12974-015-0440-3,English,,included,,,,,,mice,C57BL/6,34 - 50,17 - 25,,,17 - 25,,,"3-5 animals per group sacrificed for histo at day 1, 3, 7 (total: 18 - 30 animals for histo), 8 - 10 animals per group for locomotion assessment (total 16 - 20 animals for locomotion)",female 100%,female,0,4 months,4,,,,Months,,not reported,,,,,,Not reported,level: T9; severity: moderate-severe,T9,mixed,contusion,"laminectomy + weight drop (Infinite Horizon (IH) injury device, 75-kdyn displacement)","1, 3, 7, 28 days after injury",azithromycin,azithromycin,,160 mg/kg,3 days prior to injury,,up to 7 days after injury,daily,oral,,neurological/functional/behavioral assessment,"BMS scale, grid walk test",,"BMS: open field, each hindlimb was scored separately based on movement (e.g., ankle placement and stepping), coordination, and trunk stability, and averaging both hindlimb scores generated a single score for each animal, 0=complete paralysis, 9=normal locomotion; gridwalk test: horizontal ladder with stainless steel rungs 4 mm in diameter spaced 1.2 cm apart, videotaped and evaluated on 30 continuous rungs on the center of the ladder, count total number of hindlimb steps/footfalls","BMS: 1, 3, 7, 14, 21, and 28 days post injury; grid walk test: 27 days after injury",,yes,positive effect,"significant overall treatment effect (F1,15 = 9.961, p = 0.007), AZM treatment significantly improved both the rate of recovery and overall level of residual deficits associated with SCI, gridwalk test: those treated with AZM had ~40 % fewer footfalls compared to vehicle-treated ""AZM-treated animals had significantly less footfalls than vehicle (p = 0.05)""",histological assessemnt,tissue sparing (area),"1, 3, 7, 28 days",yes,positive effect,"area of neurofilament-positive spared axons was also significantly improved with AZM (0.21 ± 0.05 mm2) vs. vehicle treatment (0.098 ± 0.02 mm2) (p = 0.04), AZM treatment resulted in significantly more spared tissue at 28 dpi","anesthesia: ketamine (100 mg/kg) and xylazine (10 mg/kg) IP; post surgery: buprenorphine-SR (1 mg/kg) and antibiotic (5 mg/kg, enroloxacin 2.27 %) in 2 ml saline,  continued to receive antibiotic subcutaneously in 1 ml saline for 5 days; euthanasia: ketamine (120 mg/kg) and xylazine (10 mg/kg), mice were transcardially perfused with ice cold diethyl pyrocarbonate phosphate-buffered saline","Taken together, these data suggest that pharmacologically intervening with AZM can alter SCI macrophage polarization toward a beneficial phenotype that, in turn, may potentially limit secondary injury processes. Given that pro-inflammatory macrophage activation is a hallmark of many neurological pathologies and that AZM is non-invasive and clinically viable, these data highlight a novel approach for treating SCI and other maladaptive neuroinflammatory conditions.",not reported,"use ketamine, buprenorphine, ",No,
Lucie,Zhu et al,2010,Nanofibrous Patches for Spinal Cord Regeneration,10.1002/adfm.200901889,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kim et al,2017,Functional Recovery of Contused Spinal Cord in Rat with the Injection of Optimal-Dosed Cerium Oxide Nanoparticles,10.1002/advs.201700034,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cerium oxide nanoparticles),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2006,Delayed nogo receptor therapy improves recovery from spinal cord contusion,10.1002/ana.20953,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Nogo-66 receptor  and rolipram),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Gonzenbach et al,2010,Nogo-A antibodies and training reduce muscle spasms in spinal cord-injured rats,10.1002/ana.22009,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al,1981,Endorphins in experimental spinal injury: Therapeutic effect of naloxone,10.1002/ana.410100403,English,,included,,,,,,cats,Not reported,48,,,,,,,"no details on the control/ttt group sizes, 4 studies: study I n=12, study II n=22, study III n=4, study IV n=10",female 100%,female,0,not reported (adults),,,,,,Adult,range: [2-3](kg),,,2,3,kg,,level: C7; severity: moderately severe spastic quadriparesis,C7,mixed,contusion,"laminectomy + weight drop contusion (20 g dropped from 25cm, 500gm-cm force)","24h, 3 weeks",naloxone,naloxone,,"bolus: 2 mg/kg, infusion: 2 mg/kg/h",45 minutes after injury,,administered continuously over 4h,bolus + 4h,intravenously,,neurological/functional/behavioral assessment,Tarlov scale,,"five-point ordinal scale, 0=absent voluntary movement, 5=normal, add scores for hind and fore limbs to give a single score for each animal","24h, 1-2-3 weeks",,yes,positive effect,"Naloxone-treated animals  also had significantly higher  scores than saline controls in Study I1 at one, two,  and three weeks after injury",histological assessemnt,"scoring based on a modification of a five-point scale 1=minimal injury, 5=complete transection, four individually derived scores were added to yield a single score for each animal",3 weeks,yes,no effect,pathological changes not statistically different between naloxone-  and  saline-treated groups,"anesthesia: pentobarbital 30 mg/kg, paralyzed with gallamine triethiodide and artificially ventilated",The data support a pathophysiological role for endorphins in experimental spinal cord injury and suggest that opiate antagonists might improve the treatment of spinal trauma in humans,not reported,,No,
Lucie,Giulian et al,1990,Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord,10.1002/ana.410270107,English,,included,,,,,,rabbit,New Zealand albino,>= 54,20,,5,14,,2,"3 groups: control, dexamethasone and colchicine-chloroquine, at least 4 animals per group for histology, 10 animals per group for experiment 1 (early ttt), 6 animals per group for experiment 2 (late ttt, no dexamethasone group?)",not reported,not reported,,not reported,,,,,,Not reported,~ 4 kg,4,,,,kg,,level: lumbar-sacral region; severity: not reported,lumbar - sacral,Not reported,ischemia,"ischemia (inflating balloon of the Swan-Ganz catheter with 0.5 ml of air, balloon kept inflated until 20 minutes after the postsynaptic waves of the SSEPs first disappeared)",7 days,"chloroquine + colchicine (chloroquine not of interest, not further reported), dexamethasone",dexamethasone,,1.5 mg/kg/day,30 minutes after reperfusion,,3 days,daily,intravenously,,"neurological and sensory examination, electrophysiology","motor function scale, pinprick, somatosensory evoked potentials",,"neuro: 0=no movement, 5=normal motor function, 3 observers, score expressed as a composite value representing an average rating of both hind legs; SSEPs:  sciatic-stimulating electrode, three spinal  recording  electrodes L4-L5-L6, The amplitude of the individual waves was measured  from the preshock  baseline,  and the recovery  of the individual waves was expressed as a percent of their preischemia ampli- tude","neuro: period of 8h interval for up to 7 days; SSEPs: before ischemia, every 30 minutes for the first  2 hours after reperfusion, intervals for 2h after deflation",,not reported,no effect," Poor motor function was also observed  in animals treated with dexamethasone (significance not stated), no effect with dexamethasone",histological assessemnt,"Numbers of neurons in the anterior horn of the lumbar  part of the cord, number of inflammatory cells in the gray matter",7 days,yes,no effect,"Dexamethasone-treated  rab- bits had similar numbers of inflammatory  cells in the gray matter  when  compared  with control animals, ","anesthesia:  ketamine in an initial dose of 50 mdkg given intramus- cularly, followed by 25 mglkdhr as needed during the surgi- cal procedure,  during the period of ischemia, and during the first 2 hours of reperfusion; postop: cephalothin sodium, 25 &kg intramuscularly every 12 hours;  butaphoral, 0.2 mg/kg intramuscularly every 8 hours for analgesia as needed; and intravenous  normal saline at a rate  of 1 to  2 ml/kg/hr until the animal took fluids adequately","In contrast, the glucocorticoid dexamethasone, a weak inhibitor of mononuclear phagocytes in vivo, did not  reduce the number of inflammatory cells in the spinal cord and did not improve motor and bladder functions. The suppression of mononu- clear phagocytes soon after ischemic injury may offer a new approach in the treatment of vascular disease in the central nervous system","The present  report does not, of course, identify mechanisms by which mononuclear phagocytes medi- ate the pathological  changes observed  after ischemic injury. Moreover, since the effects of chloroquine and colchicine are complex, their site of action in the CNS may involve other cellular targets 117-191. Further work will be  needed to delineate the biochemical events altered by this drug regimen. ",use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Salzman et al,1991,The serotonin antagonist mianserin improves functional recovery following experimental spinal trauma,10.1002/ana.410300405,English,,included,,,,,,rats,Sprague Dawley,277,49,,35,22,,14,"4 groups: vehicle, mianserin, cyproheptadine, ketanserin, each group as 3 different injury gorups:sham, 50mg.cm, 100 mg.cm (see Table 1 for details), only 145 rats survived for 2 weeks after injury",male 100%,male,100,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight-drop contusion (dura mater left intact, hollow steel tube with nylon impounder at the bottom 0.3cm diameter at the tip, device lowered onto the exposed dura until contact with the cord caused the impounder to move 0.2cm into the tube, 10-gm weight dropped from 5 or 10cm)",2 weeks,"mianserin, cyproheptadine (only drug of interest), ketanserin",cyproheptadine,,1 ml/kg; cyproheptadine: 2 mg/ml,15 minutes after injury,,not reporteed,daily,intravenously,,"neurological/functional/behavioral assessment, electrophysiology","somatosensory evoked potentials, Tarlov scale, inclined plane test",,"SEPs: averaged over 90ms epoch using 256 trials, constant pulses at 3 Hz, latency and amplitude of the major negatice wave; Tarlov: 0=total paraplegia of hindlimbs, 6=able to walk on ledge, both final and cumulative scoare were noted; angle board: maximum angle maintained for 5sec or longer on both horizontal directions and averaged to yield a final value","Tarlov scale: daily for 2 weeks; SEPs: befor einjury, after laminectomy, 2-5-10-15 minutes after injury; angle board: ""in later experiments""",,yes,mixed effects (assessment),"cyproheptadine resulted in a nonsignificant improvement in neuroscore, but did significantly enhance lomotor recovery (significant increase in walking frequency 2 weeks after a 50 gm cm impact)",-,-,-,-,,-,"anesthesia: pentobarbital (60 mg/kg, IP), pure oxygen delivered intraoperatively through a tight-fitting mask; euthanasia: killed by decapitation",these data lend further support to a serotonergic hypothesis of secondary spinal cord injury and suggest the potential use of mianserin for the acute treatment of spinal cord injury,not reported,use pentobarbital,No,
Lucie,Liu et al,2018,Therapeutic Effect of Curcumin and Methylprednisolone in the Rat Spinal Cord Injury.,10.1002/ar.23729,English,,excluded,Out of scope,No control group,Out of scope: no control group with SCI but no treatment to compare the MP group with no treatment but SCI only,,,rats,Sprague Dawley,60,,,,,,,,male 100%,,,not reported (adults),,,,,,,range: [220-250](g),,,,,,,level: T9-T10; severity: moderate or severe,,,,laminectomy + weight-drop contusion (10-g rod dropped from 12.5 mm or 25 mm onto the exposed dura mater),"3, 21, 35, 56 days","methylprednisolone (MP) and curcumin (not of interest, not reported further)",,,5 mg/kg,not reported,,3 days,daily?,subcutaneous,,neurological/functional/behavioral assessment,BBB locomotor rating scale,,"Two  experienced  observers  indepen-dently  graded  the  score  using  the  BBB  score  standard,ranging from 0 to 21","days 3, 7, 14, 21, 28, 35, 42, 49, and 56 after surgery",,not reported,,,,,,,,,,,,,,
Lucie,Johnson et al,2009,Controlled Release of Neurotrophin-3 From Fibrin-Based Tissue Engineering Scaffolds Enhances Neural Fiber Sprouting Following Subacute Spinal Cord Injury,10.1002/bit.22476,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (neurotrophin-3 (NT-3) from fibrin scaffolds),,,rats,Long-Evans,,,,,,,,,female 100%,,,not reported,,,,,,,range: [250-275](g),,,,,,,level: T9; severity: complete hemisection,,,,"laminectomy + complete hemisection (lateral slit in the dura was made, and microdissection scissors mounted to a micromanipulator were lowered into the spinal cord 1.2 mm from the dorsal spinal cord surface. Using the microdissection scissors, a lateral incision was made to form a complete dorsal hemisection of the spinal cord. Finally the microdissection scissors were run through the incision to assure the hemisection was complete)",2 weeks,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lu et al,2020,Operation spinal cord regeneration: Patterning information residing in extracellular matrix glycosaminoglycans,10.1002/brb3.1531,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liang et al,2016,The Ganglioside GM-1 Inhibits Bupivacaine-Induced Neurotoxicity in Mouse Neuroblastoma Neuro2a Cells,10.1002/cbf.3208,English,,excluded,Non-sci population,,No SCI induced (neuroblastoma mice),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Novikova et al,2002,Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats,10.1002/cne.10381,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (brain-derived neurotrophic factor, neurotrophin-3, nerve graft)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Siriphorn et al,2012,Postinjury Administration of 17 beta-Estradiol Induces Protection in the Gray and White Matter With Associated Functional Recovery After Cervical Spinal Cord Injury in Male Rats,10.1002/cne.23056,English,,included,,,,,,rats,Sprague Dawley,59,11,0,1,36,0,0,"5 groups: sham (n=12), control (n=11), low dose (n=12), high dose (n=12), high dose + estrogen receptor antagonist (n=12), explicitly state 1 exclusion due to urinary bladder complication and no further death or exclusion",male 100%,male,100,not reported (adults),,,,,,Adult,range: [275-300](g),,,275,300,g,,level: C5; severity: not reported,C5,Not reported,contusion,"laminectomy + hemicontusion (spinal cord was aligned under the 0.8-mm impactor tip so that the tip was entirely confined to the side ipsilateral to the dominant paw, Infinite Horizon SCI device, intended force of 200 kdyne)",50 days,17beta-estradiol (E2),estradiol,,0.5 or 5.0 mg,30 minutes after SCI,,21 days,continuous (slow release pellet implanted subcutaneously in the mithoracic back),subcutaneous,,neurological/functional/behavioral assessment,"vermicelli handling test, horizontal ladder test, CatWalk gait analysis",,"vermicelli handling test: rats individually placed in home-cages and allowed to eat three pieces of 7-cm long uncooked vermicelli for each 10-minute trial, data were recorded as the number of ipsilateral paw adjustments made per vermicelli piece averaged over three trials with adjustments defined as any grasp-regrasp motion or movement of the digits; horizontal ladder test: horizontal ladder was 129 cm long and 16.5 cm wide with rungs inserted 2.5, 3.2, or 5.7 cm apart, rung positioning was varied weekly to prevent animals from learning the rung spacing pattern, categorized as: correct placement, touch, slip, or miss, percentage of correct placements [(#correct/(#correctþslipþmiss))*100]; CatWalk gait analysis: glass walkway (109 *15*0.6 cm) with dark plastic walls (109*8 cm) spaced 15 cm length apart in a darkened room, light from an encased fluorescent bulb was internally reflected within the glass walkway and scattered when the plantar surface of the paw contacted the walkway floor, thereby producing paw prints, the parameter analyzed, maximum paw print area, is defined as the area of the ipsilateral forepaw at maximal contact.",vermicelli handling test: prior to SCI and on post-SCI day 6 and then every 7th day thereafter for the duration of the study. horizontal ladder test: prior to SCI and on post-SCI day 8 and then every 7th day thereafter for the duration of the study; CatWalk gait analysis: prior to SCI and on post-SCI day 9 and then every 7th day thereafter for the duration of the study.,,yes,mixed effects (assessment) + mixed effects (dosage),"skilled locomotion: forelimb % correct significantly higher in treatemtn group compared to SCI alone group, unskilled locomotion (CatWalk): maximum print area not signfiicantly different between treatment and control groups",histological assessment,"quantification of stereological probes: total number of neurons in the ventral horn at the lesion epicenter, spared myelin,  area of intact white matter, percentage of spared white matter area at the epicenter",day 50 after injury,yes,mixed effects (assessment) + mixed effects (dosage),"neurons in ventral horn: significantly more neurons were counted in the E2 0.5 and E2 5.0 groups than the SCI group in ipsilateral side, % white matter area: E2 5.0 group had a significantly greater percentage of intact white matter as compared with the SCI group, but not E2 0.5 group","anesthesia: 4% isoflurane in oxygen followed by a ketamine/xylazine cocktail (100/10 mg/kg, intraperitoneally [i.p.]), postop: Immediately after surgery and twice daily for 5 days thereafter, rats received subcutaneous injections of Ringer’s solution (3 ml), enrofloxacin (2.5 mg/kg), and carprofen (5 mg/kg); euthanasia: overdose of sodium pentobarbital euthanasia solution (50 mg/kg, i.p.) and then perfused intracardially with cold 0.1M phosphate-buffered saline (PBS, pH 7.4) for 5 minutes followed by 4% paraformaldehyde / 0.1M PB (PFA/PB, pH 7.4) for 20 minutes.","Taken together, these data suggest that post-SCI administration of 17b-estradiol protected both the gray and white matter in cervical SCI. Moreover, this treatment improved function on skilled motor tasks that involve both gray and white matter components, suggesting that this is likely a highly clinically relevant protective strategy.",not reported,"use isoflurane, ketamine",Yes (drug of interest + drug not of interest),
Lucie,Chen et al,2017,Collagen/heparin sulfate scaffolds fabricated by a 3D bioprinter improved mechanical properties and neurological function after spinal cord injury in rats,10.1002/jbm.a.36011,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (collagen/heparin sulfate scaffolds implant),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zaviskova et al,2018,Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair,10.1002/jbm.a.36311,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (human Wharton’s jelly-derived mesenchymal stem cells on a gel of hydroxyphenyl derivative of hyaluronic acid with the integrin-binding peptide arginine-glycine-aspartic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2018,Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats,10.1002/jcb.26392,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (quercetin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kang et al,2018,Baicalin effects on rats with spinal cord injury by anti-inflammatory and regulating the serum metabolic disorder,10.1002/jcb.27136,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (baicalin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Su et al,2019,Salidroside promotes rat spinal cord injury recovery by inhibiting inflammatory cytokine expression and NF-Œ∫B and MAPK signaling pathways,10.1002/jcp.28124,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Salidroside),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Mohammadshirazi et al,2019,Combinational therapy of lithium and human neural stem cells in rat spinal cord contusion model,10.1002/jcp.28680,English,,included,,,,,,rats,Wistar,123,14,,,15,,,"control, n=12 for BBB and n=4 for MEP; ttt, n=10 for BBB and n=5 for MEP",male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-280](g),,,250,280,g,,level: T10; severity: not reported,T10,Not reported,contusion,laminectomy + contusion (weight drop via NYU-impactor with 10g rod released from 25 mm height),2 or 7 weeks,lithium chloride (LiCl),lithium,,85 mg/kg,1 week after SCI,,14 days,once a day,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, motor evoked potentials recording",,"BBB: plexi box (100 [length] × 100 [width] cm × 20[heigh], MEP: motor evoked potentials, left motor cortex was stimulated and recording was performed from right tibia muscle, amplitude, latency and signal duration of N1 and N2 waves were analyzed and compared between experimental groups","BBB: weekly, MEP: week 1 before injury, week 1 and 4 after injury",,not reported,mixed effects (assessment),"BBB: Treated animals demonstrated a significant difference in func-tional recovery in comparison with control animals since the fourthweek (p< 0.001 in the Li group compared to controls); MEPs:  significant differencesin N1 latency between the controland the Li groups in Week 4 (p< 0.05), rested no difference or no comparison between control and lithium group",-,-,-,-,,-,"anesthesia: ketamine (100 mg/kg) and xylazine (10 mg/kg); postop: dextrose saline (5 ml) for 5 days and enrofloxacin (5 mg/kg) for 10 days, cyclosporine A solution (10 mg/kg) was adminis-tered subcutaneously every day from 5 days after SCI in all groups toprevent immunosuppression; euthanasia: perfused with 4% paraformaldehyde",Our results demonstrate that combinational therapy of hNSCs (human neural stem cells) with lithium chloride and lithium chloride individually are adequate for ameliorating more than partial functional recovery and endogenous repair in spinal cord‐injured rats.,limited number of animal subjects,"histological assessment done but nothing of interest to report, use keatmine",Yes (drug of interest + drug not of interest),
Lucie,Cheng-te Chou et al,2011,Preclinical use of longitudinal MRI for screening the efficacy of s-nitrosoglutathione in treating spinal cord injury,10.1002/jmri.22574,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (S-nitroso-glutathione),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nesic et al,2002,DNA microarray analysis of the contused spinal cord: Effect of NMDA receptor inhibition,10.1002/jnr.10171,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Dizocilpine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Rabchevsky et al,2002,Efficacy of methylprednisolone therapy for the injured rat spinal cord,10.1002/jnr.10187,English,,included,,,,,,rats,Sprague Dawley,80,30 - 40,1,,30 - 40,2,,"10 different groups (5 euthanasia time points, 1 control and 1 treatment group for each time point), n=6-8 per group, 2 more rats excluded (group not specified) leaving a total of 75 rats studied",female 100%,female,0,not reported (young adults),,,,,,Adult,range: [200-225](g),,,200,225,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + contusion (weight drop with NYU impactor, 10g brass rod with a tip diameter of 2mm dropped from 12.5mm onto the exposed intact dura)","2, 5, 7, 14, 42 days",methylprednisolone sodium succinate (MPSS),methylprednisolone sodium succinate,Yes,"60 mg/kg in 1cc sterile saline, then 5.4 mg/kg/hour",5 minutes after injury infused over 5 min period,,24h,blus + continuous delivery,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"median scores were tallied by treatment group and the ordinalBBB LRS data were plotted as a function of time post injury, Subscores of the BBB were compared between the groups","2-4 days after surgery, then once a week for 6 weeks",,yes,no effect,"After 6 weeks of behavioral testingusing the ordinal BBB locomotor rating scale, no significant differencein the functional recovery of hind-limb movements was found withMPSS  treatment  vs.  saline  vehicle, Further analysis with the BBB subscore demonstrated an insignificant trend fora decrease in thefiner details of locomotion (i.e., paw position, toeclearance, etc.) in the MPSS group over time.",histological assessment,"spared gray and white matter, % gray and white matter sparing based on pre-injury volumes, lesion extent and volume, % total area tissue spparing at lesion epicenter","2, 5, 7, 14, 42 days",yes,no effect," no  significant  effect  of  MPSS  forlesion lengths or volumes across time, The percent tissue sparing at the lesion epicenter, using the standardratio of injured area to intact tissue area, showed no effect of MPSS overtime, no effect of MPSS over time, and by 5 days there were significant reductions in both gray matter and white matter volumesfor both groups that remained stable until 42 days post injury. no effect of  MPSS  for  percent  gray  matter  sparing  over  time, overall  significant  reduction  in  percent  white  matter  sparing  inthe MPSS group over time (P <0.05), most probably attributed to the  5-day  values","anesthesia: ketamine (80 mg/kg) and xylazine (10 mg/kg); postop: 10  cc  sterilesaline  s.c.  and  33.3  mg/kg  Cefazolin  antibiotic  i.m., injections of Cefazolin twice a dayfor  up  to  1  week; euthanasia: overdosed with sodium pentobarbital and tran-scardially perfused with 0.1 M phosphate-buffered saline (PBS,pH  7.4)  followed  by  4%  paraformaldehyde  (PF)  in  PBS ","MPSS marginally reduced lesion volumes across time vs. controls, but the amount of spared gray and white matter remained unaltered between the two groups. Behavioral results further showed that MPSS failed to improve recovery of hind-limb function. Equally important, our results caution the use of lesion volume dimensions or percent tissue sparing at the epicenter as indicators of therapeutic efficacy because neither reflects the actual amount of tissue sparing.",not reported,use ketamine,No,
Lucie,Borgens et al,2001,Rapid recovery from spinal cord injury after subcutaneously administered polyethylene glycol,10.1002/jnr.1254,English,,included,,,,,,guinea pig,Not reported,20,10,,,10,,,,not reported,not reported,,not reported (adults),,,,,,Adult,<300 gm,,,,300,g,,level: midthoracic; severity: severe,mid-thoracic,severe,compression,laminectomy + crush injury (crushed bilaterally with special blunted forceps possessing a detente),"24h, at least 4 weeks",polyethylene glycol (PEG),polyethylene glycol,,1cc 30% in sterile lactated ringers,6h after injury,,single dose,-,subcutaneous,,"electrophysiology, behavioral recovery","somatosensory evoked potentials, cutaneus trunchi muscle reflex",,"SSEP: stimulation of the tibial nerve, nerves impulses recorded at the controlateral sensory cortex, 3 sets of recordings averaged, area beneath the early arriving SSEP=P1; CTM reflex: spinal cord dependent contraction of backskin  in  animals, proportion of recovered and unrecovered ani-mals, as well as the area of the recovered CTM receptivefields  between  controls  and  PEG-injected  animals  wasquantitatively compare","SSEP: precrush, postcrush, 1 day after, 1 week after, 4 weeks after; CTM reflex: 24h, over the first and second week?, week 4",,not reported,positive effect,"During the first month of observation after a singleinjection  of  PEG,  or  an  injection  of  vehicle  in  control animals, not one control animal recovered SSEP conduc-tion through the lesion (Table I) compared to a variablelevel of recovery of peaks recorded to arrive at the senso-rimotor cortex in 100% of the PEG-treated animals (P=0.001); the differ-ence  in  the  frequency  of  recovery  between  PEG-injected and sham-injected animals was statistically sig-nificant  (P<0.003)",-,-,-,-,,-,"anesthesia: ketamine HCl 100 mg/kg IM, xylazine 20 mg/kg; euthanasia: deep anesthesia and perufsion/fixation","A single subcutaneous injection (30% weight by weight in sterile saline) made 6 hr after a standardized spinal cord contusion in adult guinea pigs was sufficient to produce a rapid recovery of SSEP propagation through the lesion in only PEG-treated animals, accompanied by a statistically significant recovery of the CTM reflex. These data suggest that parenterally administered PEG may be a novel treatment for not only spinal injury, but head injury and stroke as well",not reported,use ketamine,No,
Lucie,Ditor et al,2007,Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat,10.1002/jnr.21283,English,,included,,,,,,rats,Wistar,32,10,,,11,,,same paper as the 2 below: consider PEG only group in this line (n=11),male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T4; severity: not reported,T4,Not reported,compression,compression injury (50-g clip compression),6 weeks,"polyethylene glycol (PEG), magnesium sulfate (MgSO4) and combinaison",polyethylene glycol,,1 g/kg,15 min after injury,,2 doses: 15 min and 6h after injury,-,intravenously,,neurological/functional/behavioral and pain assessment,"BBB scale, mechanical allodynia",,"BBB: 21-point scale, 2 independent observers, scores for left and right leg averages; mechanical allodynia: Semmes-Weinstein monofilament calibrated to 20 mN, applied to doral trunk, monofilament applied 10 times, number of avoidance responses recorded, each touch stimulus lasted 3s and separated by 5 sec, avoidance = flinching, escape, vocalisation, abnormal aggresive behaviors","BBB: day 1 post injury then twice per week for 6 weeks; mechanical allodynia: pretest prior to injury, 7 days afollowing injury then once per week until 6 weeks postinjury",,yes,positive effect,"PEG, MgSO4 and combinaison all showed significantly better outcome in terms of BBB score and mean number of avoidance responses/10 stimuli compared to the vehicle group",histological assessment,"area of the lesion, percentage of myelin content, lesion volume and myelin volume",6 weeks,yes,no effect,"Lesion volume was not reduced significantly when comparing the spinal cords from either the PEG-treated or the MgSO4-treated rats vs.saline-treated controls, combination of PEG and MgSO4 resulted in a significant reduction in lesion volume compared with the saline control treatment (P=0.04), volume of myelin in the spinal cord sections did not differ when comparing the PEG-treated, MgSO4-treated or combination rats with saline-treated controls, significantly greater percentage of spared myelin 750 microm dorsal from the epi-center of the lesion with both PEG + MgSO4 treatment (P=0.002) and MgSO4 treatment (P=0.026) compared with the saline-treated controls, at lesion epicenter significantly higher percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.012), at 750microm ventral from the epicenter of the lesion, there was a significantly lower percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.015) ","premedication: diazepam (3.5 mg/kg, IP), atropine (0.05 mg/kg, SC); anesthesia: 4% halothane, maintained with 1.5% halothane; euthanasia: anesthesia with 2.5 g/kg urethane, transcardial perfusion with cold 0.9% NaCl followed by 4% formaldehyde",both PEG and MgSO4 enhanced long-term clinical outcomes after SCI,not reported,"use diazepam, atropine",No,
Lucie,Ditor et al,2007,Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat,10.1002/jnr.21283,English,,included,,,,,,rats,Wistar,32,10,,,5,,,same paper as above and below: consider magnesium sulfate only group in this line (n=5),male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T4; severity: not reported,T4,Not reported,compression,compression injury (50-g clip compression),6 weeks,"polyethylene glycol (PEG), magnesium sulfate (MgSO4) and combinaison",magnesium sulfate,,300 mg/kg,15 min after injury,,2 doses: 15 min and 6h after injury,-,intravenously,,neurological/functional/behavioral and pain assessment,"BBB scale, mechanical allodynia",,"BBB: 21-point scale, 2 independent observers, scores for left and right leg averages; mechanical allodynia: Semmes-Weinstein monofilament calibrated to 20 mN, applied to doral trunk, monofilament applied 10 times, number of avoidance responses recorded, each touch stimulus lasted 3s and separated by 5 sec, avoidance = flinching, escape, vocalisation, abnormal aggresive behaviors","BBB: day 1 post injury then twice per week for 6 weeks; mechanical allodynia: pretest prior to injury, 7 days afollowing injury then once per week until 6 weeks postinjury",,yes,positive effect,"PEG, MgSO4 and combinaison all showed significantly better outcome in terms of BBB score and mean number of avoidance responses/10 stimuli compared to the vehicle group",histological assessment,"area of the lesion, percentage of myelin content, lesion volume and myelin volume",6 weeks,yes,mixed effects (assessment),"Lesion volume was not reduced significantly when comparing the spinal cords from either the PEG-treated or the MgSO4-treated rats vs.saline-treated controls, combination of PEG and MgSO4 resulted in a significant reduction in lesion volume compared with the saline control treatment (P=0.04), volume of myelin in the spinal cord sections did not differ when comparing the PEG-treated, MgSO4-treated or combination rats with saline-treated controls, significantly greater percentage of spared myelin 750 microm dorsal from the epi-center of the lesion with both PEG + MgSO4 treatment (P=0.002) and MgSO4 treatment (P=0.026) compared with the saline-treated controls, at lesion epicenter significantly higher percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.012), at 750microm ventral from the epicenter of the lesion, there was a significantly lower percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.015) ","premedication: diazepam (3.5 mg/kg, IP), atropine (0.05 mg/kg, SC); anesthesia: 4% halothane, maintained with 1.5% halothane; euthanasia: anesthesia with 2.5 g/kg urethane, transcardial perfusion with cold 0.9% NaCl followed by 4% formaldehyde",both PEG and MgSO4 enhanced long-term clinical outcomes after SCI,not reported,"use diazepam, atropine",No,
Lucie,Ditor et al,2007,Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat,10.1002/jnr.21283,English,,included,,,,,,rats,Wistar,32,10,,,6,,,same paper as the 2 above: consider PEG+magnesium sulfate group in this line (n=6),male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T4; severity: not reported,T4,Not reported,compression,compression injury (50-g clip compression),6 weeks,"polyethylene glycol (PEG), magnesium sulfate (MgSO4) and combinaison",magnesium sulfate + polyethylene glycol,,PEG: 1 g/kg; MgSO4: 300 mg/kg,15 min after injury,,2 doses: 15 min and 6h after injury,-,intravenously,,neurological/functional/behavioral and pain assessment,"BBB scale, mechanical allodynia",,"BBB: 21-point scale, 2 independent observers, scores for left and right leg averages; mechanical allodynia: Semmes-Weinstein monofilament calibrated to 20 mN, applied to doral trunk, monofilament applied 10 times, number of avoidance responses recorded, each touch stimulus lasted 3s and separated by 5 sec, avoidance = flinching, escape, vocalisation, abnormal aggresive behaviors","BBB: day 1 post injury then twice per week for 6 weeks; mechanical allodynia: pretest prior to injury, 7 days afollowing injury then once per week until 6 weeks postinjury",,yes,positive effect,"PEG, MgSO4 and combinaison all showed significantly better outcome in terms of BBB score and mean number of avoidance responses/10 stimuli compared to the vehicle group",histological assessment,"area of the lesion, percentage of myelin content, lesion volume and myelin volume",6 weeks,yes,mixed effects (assessment),"Lesion volume was not reduced significantly when comparing the spinal cords from either the PEG-treated or the MgSO4-treated rats vs.saline-treated controls, combination of PEG and MgSO4 resulted in a significant reduction in lesion volume compared with the saline control treatment (P=0.04), volume of myelin in the spinal cord sections did not differ when comparing the PEG-treated, MgSO4-treated or combination rats with saline-treated controls, significantly greater percentage of spared myelin 750 microm dorsal from the epi-center of the lesion with both PEG + MgSO4 treatment (P=0.002) and MgSO4 treatment (P=0.026) compared with the saline-treated controls, at lesion epicenter significantly higher percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.012), at 750microm ventral from the epicenter of the lesion, there was a significantly lower percentage of spared myelin with MgSO4 treatment compared with the saline-treated controls (P=0.015) ","premedication: diazepam (3.5 mg/kg, IP), atropine (0.05 mg/kg, SC); anesthesia: 4% halothane, maintained with 1.5% halothane; euthanasia: anesthesia with 2.5 g/kg urethane, transcardial perfusion with cold 0.9% NaCl followed by 4% formaldehyde",both PEG and MgSO4 enhanced long-term clinical outcomes after SCI,not reported,"use diazepam, atropine",Yes (drug of interest + drug of interest),
Lucie,Liu et al,2015,"Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats",10.1111/1440-1681.12345,English,,included,,,,,,rats,Sprague Dawley,64,16,,,16,,,"4 groups: 1 sham with placebo, 1 sham with treatement, 1 SCI with placebo (control) and 1 SCI with treatment (treatment group), all n=16",female 100%,female,0,8 weeks old (adults),8,,,,Weeks,Adult,not reported,,,,,,Not reported,level: T8; severity: not reported,T8,Not reported,contusion,"laminectomy + contusion (weight drop, 30g rod from 5cm and letting rod for 3 min on site of injury)",21 days,carvedilol,carvedilol,,10 mg/kg,1h before surgery,,21 days,once a day,oral,,neurological/functional/behavioral assessment,BBB scale,,"training starting 10 days before injury, 90cm diameter, 7cm wall height, 4 min and scored by 3 observers, 3 scores averages to give a final score","1, 3, 7, 14 and 21 days after injury",,yes,positive effect,treatment group significantly higher BBB score compared to the control vehicle group,histological assessment,"cavity area assessement, neuron counts, TUNEL assay",21 days after injury,not reported,mixed (positive/no stats),"carvedilol-treated SCI rats, there was a smaller cav-ity in the spinal cord than seen in the SCI group; In carvedilol-treated SCI rats, the path-ological damage was obviously reduced. There was an increasein the number of normal neurons and clear Nissl substance wasobserved in most neurons; carvedilol treatment of SCI rats attenuated the number of apoptotic cells (P<0.01 vs untreated SCI)",anesthesia: 10% chloral hydrate (3.5 mL/kg); postop: daily intramuscular injections of 200 000 U penicillin for 3 days; euthanasia: erfused transcardially with 0.1 mol/L PBS and then with 4% paraformaldehyde,"these results indicate that carvedilol exhibits anti-inflammatory and anti-oxidative effects in SCI rats. In addi-tion, the expression of Fas and Fas ligand was reduced bycarvedilol treatment, which, in turn, reduced cleaved caspase3 expression andfinally decreased the number of apoptoticcells in the spinal cord. In conclusion, carvedilol promotesneurological function, reduces bone loss and attenuates celldamage after acute SCI in rats.",not reported,"use chloral hydrate, penicillin",No,
Lucie,Lee et al,2009,Nicotine Attenuates iNOS Expression and Contributes to Neuroprotection in a Compressive Model of Spinal Cord Injury,10.1002/jnr.21901,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Long Evans,Not reported,,,,,,,,male 100%,male,100,9-10 weeks (adults),,,9,10,Weeks,Adult,range: [225-250](g),,,225,250,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + contusion (weight drop NYU impactor, 10-g weight drop from 12.5mm, impact rod immediately removed after injury) ","4, 12, or 24h after nicotine administration (2h after injury)",nicotine,nicotine,,"0.35, 3.5 or 7 mg/kg",2h,,single dose,-,intraperitoneally,,-,-,,-,-,,-,,-,histological assessment,number of neurons in injured spinal cord,"4, 12, or 24h after nicotine administration (2h after injury)",not reported,positive effect,"Administration  of  nicotine  both increased the number of NeuN-immunopositive cells and improved cellular morphology at dose 7 mg/kg, SCI dramatically decreased the number of NeuN-immunoreactive neurons. However, treatment with nicotine partially restored the number of neurons in injured spinal cords.","anesthesia: pentobarbital (50 mg/kg, IP); postop: mecamylamine (1 mg/kg IP, 30 min prior to nicotine administration) to block neuronal nicotinic receptors, aminoguanidine (50 or 100 mg/kg, IP) to inhibit iNOS activity, 1h before SCI; euthanasia: not reported","In conclusion, the results of the present study indicate that iNOS is induced in the early stages of SCI, leading to increased nitration of protein tyrosine residues and potentiation of inflammatory responses. Microglial cells appear to be the main cellular source of iNOS in SCI. In addition, nicotine-induced anti-inflammatory effects in SCI are mediated, at least in part, by the attenua-tion of iNOS over expression through the receptor-mediated mechanism.",not reported,"use pentobarbital, mecamylamine",No,
Lucie,Diaz-Ruiz et al,2011,Delayed administration of dapsone protects from tissue damage and improves recovery after spinal cord injury,10.1002/jnr.22555,English,,included,,,,,,rats,Wistar,44,13,3,,27,1,,"control n=16 (3 died), early treatment n=15 (no death), late treatment n=13 (1 died)",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + contusion (impact rod centered above T9, rod slowly lowered until it contactected the duram which was determined by completion of a circuite that activated a tone, then SCI produced by dropping 10-g rod from a distance of 25mm)",8 weeks or 24h,dapsone,dapsone,,12.5 mg/kg,3 or 5h (2 groups),,3 days,every 24h,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"open-field locomotor test, 120*120 cm, 5 min, 3 observers, closely monitoring limb movement, weight-baring capability, coordination and gait with scores ranging from 0 (complete paralysis) to 21 (normal locomotion) corresponding to fully coordinated and proper gait, movement at all joints, full weight support and appropriate limb, body and tail positioning","24h after SCI, once every week until 8 weeks after injury",,yes,positive effect,"BBB score significantly higher (better) in both treatment group at the end of the 8 weeks compared to the control vehicle group (p<0.01 and P<0.04, for treatment initiated after 3 and 5h after injury respectively)",histological assessment,"scar tissue, cavities, spared spinal tissue",8 weeks,not reported,positive effect,"spared area in the SCI group was 4.76 mm2, which was lower (P<0.01 andP<0.05, respectively) than that in the injured animals treated with dapsone 3 hr (6.74 mm2) or 5 hr (6.31mm2) after SCI; ","anesthesia: pentobarbital 50 mg/kg IP; euthanasia: anesthesia with pentobarbital IP, 1ml heparin, perfused ranscardailly with 10% buffered formalin",Dapsone significantly prevented mortality. Theresults show that inhibition of MPO by dapsone signifi-cantly protected the spinal cord from tissue damage andenhanced motor recovery after SCI,not reported,"use pentobarbital, heparin",No,
Lucie,Streijger et al,2014,"Combinatorial treatment of acute spinal cord injury with ghrelin, ibuprofen, C16, and ketogenic diet does not result in improved histologic or functional outcome.",10.1002/jnr.23372,English,,excluded,Out of scope,No pure effect studied,Out of scope: no possible to disentagle the pure effect of the drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Krityakiarana et al,2016,Effects of melatonin on severe crush spinal cord injury-induced reactive astrocyte and scar formation.,10.1002/jnr.23930,English,,included,,,,,,mice,Not reported,48,12,,,24,,,"4 groups: sham (n=12), control (n=12), treatment single dose (n=12), treatment 14 days (n=12)",female 100%,female,0,3 months old,3,,,,Months,,not reported,,,,,,Not reported,level: T12; severity: severe,T12,severe,compression,laminectomy + crush injury (dumont forceps number 5 used to compress the spinal cord from both sides for 5 sec),14 days,melatonin,melatonin,,10 mg/kg,10 min after injury,,single dose or 14 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,BMS scale,,"hindlimb motor performance, 0=complete paralysis, 9=complete mobility","1, 3, 5, 7, 10, 14 days after SCI",,not reported,no effect,"None  of  the  groups  with  SCI,  including SCI+Melatonin 14, showed recovery of locomotor func-tion compared with the control group",histological assessment,"neuronal axonal damage, scar formation, cavities",14 days,not reported,no stats,glial scar formation was markedly diminished in the SCI+Melatonin 14 group compared to SCI only group,"anesthesia: isoflurane, postop: saline IP 2.5 ml of 0.9%, painkillers and antibiotics administered for 3 to 7 days respectively; euthanasia: deeply anesthesized and transcardially perfused with PBS and 4% paraformaldehyde in PBS","These findings suggest that melatonin inhibits scar formation by acting on inflammatory cytokines after SCI. Overall, our results suggest that melatonin is a promising treatment strategy after SCI that deserves further investigation.",not reported,"use isoflurane, saline",No,
Lucie,Lubischer et al,1995,"Axotomy of developing rat spinal motoneurons: Cell survival, soma size, muscle recovery, and the influence of testosterone",10.1002/neu.480260207,English,,excluded,Non-sci population,,"No SCI induced, instead axotomy of motoneurons in the spinal nucleus of the bulbocavernosus",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Vanicky et al,2002,Intrathecal methylprednisolone does not improve outcome after severe spinal cord injury in the rat,10.1002/nrc.10051,English,,included,,,,,,rats,Wistar,31,,3,,,4,,detailed size groups not found,male 100%,male,100,not reported,,,,,,Not reported,range: [300-330](g),,,300,330,g,,level: T8-9; severity: paraplegic,T8 - T9,paraplegia,compression,laminectomy + compression injury (balloon was rapidly inflated with 15 microL of saline for 5 minutes),28 days,methylprednisolone sodium succinate (MPSS),methylprednisolone sodium succinate,Yes,1 mg/kg,5 min after injury,,"4 doses at 5min, 2, 4, and 6h after injury",-,intrathecally,,neurological/functional/behavioral assessment,BBB scale,,"open-field, range from 0 to 21 0=no locomotor activity, 21=normal performance",24h after injury and then weekly for 4 weeks,,yes,no effect,no difference between treatment and vehicle group,histological assessment,area of spared white and grey matter and volume of spared tissue (white and grey matter separately),28 days,not reported,no effect,no difference between vehicle and treatment groups,"anesthesia: 4% halothane in room air, maintainted with 1.5-2%; euthanasia: IM ketamine/xylazine, perfused with saline followed by 4% paraformaldehyde in 0.1M phosphate buffer",We conclude that intrathecal administration of methylprednisolone had no effect on the outcome after compressive spinal cord injury in the rat at the doses and timing used in the present study,"single degree of rather severe injury, used only 4 weeks’ survival, previously reported as sufficient for stabilization of “final” neurological recovery",,No,
Lucie,Tao et al,2013,Minocycline promotes axonal regeneration through suppression of RGMa in rat MCAO/reperfusion model,10.1002/syn.21629,English,,excluded,Non-sci population,,"No SCI induced, instead focal cerebral ischemia reperfusion",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Behrmann et al,1994,"Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673",10.1006/exnr.1994.1042,English,,included,,,,,,rats,Sprague Dawley,233,,39,,104,,,"experiment 1 n=43 (n=8/group), experiment 2 n=83 (n=16/group), experiment 3 n=107 (n=15), see ""drug administration"" for detailed description of the groups per experiment",female 100%,female,0,not reported,,,,,,Not reported,not reported,,,,,,Not reported,level: T8; severity: not reported,T8,Not reported,contusion,"laminectomy + contusion injury (tup of impactor probe 2-mm diameter touched to the dorsal surface of the cord [dura intact] with immediate feedback from a force transducer, injured by a very brief [approximately 20 ms] predetermined displacement of the cord)","29, 43 days",methylprednisolone sodium succinate (MPSS),methylprednisolone sodium succinate,No,"15, 30, 45, 60, 90, 120, 300 mg/kg (depending on time and group)",5 min after injury,,"experiment 1, 3 doses, 5 min, 2 and 6h, 30/15/15 (dose); experiments 2 and 3, 4 doses at 5 min, 2, 4 and 6h (30/15/15/15, 30/30/30/30, 45/45/45/45, 60/60/60/60, 90/90/90/90, 120/120/120/120, 300/300/300/300, experiment 3: 30/30/30/30 and 60/30/30/30)",-,intravenously,,neurological/functional/behavioral assessment,"Tarlov scale, inclined plane test, grid walk test, footprint analysis",,"open field walking: 5-min testing, 2 animals observed simultaneously to stimulate locomotor activity and were scored based upon a modified Tarlov's scale, 0=no spontaneous movement, 5=normal gait and base of support, no loss of balance on fast turns, no toe drags, ia agreement between two scores could not be reached of the 2 scores was recorded; inclined plane: Rivlin and Tator, maintain body position on an inclined board for 5s, tested at 5 degrees intervals for each of 3 positions: head up, reight side up, left side up, average score for the 3 positions was used for all analysis; grid walking: wire grid 4*4 cm spaces during 3 min, actively walk for a minimum of 30s, dividing the total numbers of footfalls through the grid spaces by the actual locomotion time provided the number of footfalls per second of locomotion; footprint analysis: permanent ink record, walk over a paper strip in a 6-ft straight alley runway to obtain a food reward, from onw to three trials were performed as necessary to obtain an adequate number of legible footprints (minimum of five right and left complete stride lengths) with the rat walking at a consistent pace, report number of front footprints/ft. walked","experiement 1: open-field walking day 1,2,8,15,22,29,43, grid walking: day 29,43, footprint analysis: day 29,43; experiment 2: open-field walking day 1,2,8,15,22,29, inclined plane day 8,15,22,29; experiement 3: open field walking day 1,2,8,15,22,29, inclined plane day 8,15,22,29, grid walk day 29",,yes,mixed effects (assessment) + mixed effects (dosage),"experiment 1: no significantly difference between groups in any of the tests; experiment 2: MPSS group significantly better than controls in open field walking at 30 and 60 ans 120 mg/kg but not at 90 mg/kg, no different from controls in inclined plane test; experiment 3: better open field walking scores with 30 mg/kg MPSS compared to controls, no difference with other groups and control",histological assessment,"area of cyst formation and cavitation, gliosis and grossly swollen axons, spared gray and white matter",29 or 43 days,yes,mixed effects (dosage),"experiment 1: MPSS percentage of tissue spared at the lesion center was not significantly different from the control group, experiment 2: only the 60 mg/kg group had significantly greater tissue sparing than the controls; experiment 3: MPSS treatment group had significantly greater tissue sparing at the lesion center than the controls","anesthesia: ketamine 80 mg/kg, xylazine 10 mg/kg both IP; before procedure: antibiotics SC as prophylaxis, experiment 1=penicillin G benzathine and procaine 6000 U BID*24h and sulfadiazine 40 mg/cc and trimethoprim 8mg/cc sc, experiment 2 and 3= durapen 20'000 U BID*48h, gentocin 0.25 mg qD*48h, gentamicin sulfate, lacrilube ophtalmic ointment to prevent drying of the eyes; after injuries, furazolidone 4% aerosol aseptic powder over the incisions, lactated ringer's solution 5cc SC, additionnal 5cc on day 1 in experiment 2 and 3, SMZ-TMP ~0.5cc 40 mg/cc sulfamethoxalone and 8 mg/cc trimethoprim oral suspension each day, cecon oral solution 10 mg ascorbic acid daily; euthanasia: intracardiac perfusion with 10% buffered formalin under deep anesthesia with ketamin-xylazine 80 and 10 mg/kg, IP",U74 demonstrated equivalent efficacy to MPSS and YM demonstrated greater efficacy than MPSS in the treatment of acute SCI,not reported,"use ketamine, gentamycin, penicillin",Yes (drug of interest + drug not of interest),
Lucie,Sadanaga et al,1989,Chlorpromazine Protects Rat Spinal Cord Against Contusion Injury,10.1089/neu.1989.6.153,English,,included,,,,,,rats,Sprague Dawley,>= 16,8,,,8,,,"mentioned a sham group but group size not found, hence ""more than 16"" as total group size",male 100%,male,100,not reported,,,,,,Not reported,range: [275-300](g),,,275,300,g,,level: T11; severity: not reported,T11,Not reported,contusion,"laminectomy + weight drop contusion (Allen method modified by Wrathall, 10g weight dropped 5cm onto an impounder placed on the exposed spinal cord, removed 5s after)",4 weeks,chlorpromazine (CPZ),chlorpromazine,,20 mg/kg,30 min prior to injury,,single dose,-,intraperitoneally,,motor assessment,Tarlov scale,,not reported,"day 1, 3, 7 and once weekly for th 4 weeks",,yes,positive effect,difference between nontreated and treated groups was statistically significant with treated group having higher (better) scores,-,-,-,-,,-,"anesthesia: pentobarbital (50 mg/kg, IP)",findings suggest CPZ may protect the spinal cord from trauma. Further studies to elucidate the mechanism of protection by CPZ will contribute to the treatment and understanding of the pathogenesis of CNS trauma.,not reported,use pentobarbital,No,
Lucie,Gueye et al,2015,Cholecalciferol (vitamin D-3) improves functional recovery when delivered during the acute phase after a spinal cord trauma,10.1016/j.jsbmb.2015.06.007,English,,included,,,,,,rats,Sprague Dawley,28,6,,,15,,,"4 groups, sham n=7, 2 treatment groups, one early treatment (starting day 1) and one later treatment (starting at day 7)",male 100%,male,100,8 weeks old (adult),8,,,,Weeks,Adult,300 g,300,,,,g,,level: C2; severity: complete,C2,incomplete,transection,"laminectomy + hemisection (spinal cord was hemisected on the left side, successive lacerations until a lesion cavity approximately 1 mm in length was obtained)",12 weeks,vitamin D3,vitamin d,,500 IU/kg/day,day 1 or day 7 after injury,,12 weeks,daily,oral,,"neurological/functional/behavioral assessment, electrophysiology","45 degrees ladder walk test, assessment of H-reflex, physiological reflexes",,"ladder walk test: placed at the bottom of the ladder which included 40 steps (20 mm intervals), foot faults for the left forepaw were counted during continuous steps, trained for 1 week (each for 10 min) before injury, correct placing, an incomplete placing and a missed bar were counted 11,0.5 and 00.5 and 0, respectively; EMG: electrode SC on the extensor digitorum muscle, stimulation of the radial nerve with 2 responses (M-wave from direct activation) and H-reflex from monosynaptic activation), amplitudes of the M- and H-waves as determined by the peak-to-peak values of each waveform were used to calculate the average Hmax/M ratio, latencies of the responses were measured as time elapsed between trigger and peak of each waveform, Hmax/M ratio at 1, 5 and 10 Hz was expressed as a percent of the Hmax/M ratio, at the baseline frequency of 0.3 Hz, in order to calculate the H-reflex rate depression; physiological reflexes: After a one-hour rest period after recording the H-reflex, to elicit electrically-induced muscle fatigue (EIF), rhythmic muscle contractions were produced by a neurostimulator, Fatigue was assessed from the decay of force throughout the 3-min EIF period. The strength of muscle contraction (the decay of force) was measured from the beginning to the end of this 3-min muscle electrical stimulation, Changes in ventilatory activity after EIF was expressed in percent [Dcycle/min (%)] of the mean cycles recorded two minutes before muscle stimulation","ladder test: day 1, 30, 60 and 90 after injury, EMG and reflexes: 12 weeks after injury",,"EMG: yes, rest: not reported",mixed effects (assessment) + mixed effects (timing),"ladder-climbing test: significantly better scores in treatment groups given at day 1 compared to vehicle group, treatment at day 7 significantly better at week 4 and week 12 compared to vehicle group; EMG: Hmmax/M ratio reduced in both treatment groups compared to vehicle at 5 and 10 Hz (treatment groups closer to sham group); ventilatory activity in response to fatigue: significantly increased in treatment group given at day 1 but not day 7 compared to vehicle group",histological assessment,number of axons within the white matter,12 weeks after injury,yes,no effect,"no significant difference between the mean number of axons in the control versus treated group in the proximal part of the spinal cord, distal part: no difference between vehicle and treated groups, but significant lower number than in the sham group","anesthesia: chloral hydrate (375 mg/kg, IP) and atropine (1 mg/kg, IP); postop: saline for hydratation (3 ml, sc), preventive antibiotic Oxytetracycline (400 mg/L, ip) during one week; euthanasia: overdose of anesthesic","This new set of data confirms that vitamin D is a potent molecule that could be tested in clinical trials assessing functional recovery in para-/tetra-plegic patients, shortly after a trauma",limitations in the extrapolations that can be made from rodent models,"use chloral hydrate, atropine, saline, tetracycline",No,
Lucie,Chabas et al,2013,Cholecalciferol (Vitamin D-3) Improves Myelination and Recovery after Nerve Injury,10.1371/journal.pone.0065034,English,,excluded,Non-sci population,,"No SCI induced, instead left peroneal nerve was cut",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,,2015,Cholecalciferol (vitamin D‚ÇÉ) improves functional recovery when delivered during the acute phase after a spinal cord trauma.,10.1016/j.jsbmb.2015.06.007,English,,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,,2013,Cholecalciferol (Vitamin D<inf>3</inf>) Improves Myelination and Recovery after Nerve Injury,10.1371/journal.pone.0065034,English,,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Guth et al,1994,Spinal cord injury in the rat: Treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function,10.1006/exnr.1994.1043,English,,included,,,,,,rats,Sprague Dawley,32,6,,,5,,,"LPS (n=7), ImuVert (n=7), LPS+indomethacin (n=7) --> groups not of interest ",female 100%,female,0,not reported,,,,,,Not reported,range: [170-200] (g) or [250-300],,,170,300,g,,level: T8; severity: not reported,T8,Not reported,compression,"laminectomy + compression (dura left intact, thinned and blunted blades of a no5 dumont jewelers forceps were introduced between the dura mater and the bone and the spinal cord was compressed for 2s or weight drop procedure, metal weight of 1.25g or 2.5 g released from 20cm onto a plastic impounder lying on the surface of the dura)",28 days,"lipopolysaccharide (LPS, not of interest), indomethacin, imuvert (not of interest)",indomethacin,,0.2 mg,not reported,,28 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,Tarlov scale,,"0=complete paralysis of both hind limbs, 1=barely perceptible hindlimb movement, 2=clearcut hindlimb movements which do not produce locomotion or support weight of body, 3=uses limb to crawl or take a few steps, can briefly support the weight of the body, 4=can walk and support body weight, but with a clearcut deficit, 5= walking ability appears to be almost normal",daily from day 0 to day 28 after injury,,yes,not reported,not tested for indomethacin drug alone (see fig 3 and table 2),histological assessment,"area of lesion, area of cavitation, number of cells/lesion, % lesion occupied by vital tissue",28 days,not reported,no effect,"are of lesion, area of cavitation, number of cell/lesion and % of lesion occupied by vital tissue are all not significantly different between indomethacin group and the control group","anesthesia: chloral hydrate 4% (400 mg/kg, IP); euthanasia: anesthesia with chloral hydrate and perfused through the aorta with 15 ml physiological saline followed by 250ml of Bouin's fixative","tissue repair and functional recovery after SCI are enhanced by combined treatment with agents to promote the secretory activities of the nonneuronal cells and that inhibit prostaglandin synthesis, these results indicate that the search for ore effective treatments should include studies on combinations of drug having different pharmacological specificities",not reported,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Fullerton et al,2001,Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice,10.1006/exnr.2001.7631,English,,excluded,Non-sci population,,no SCI induced,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kim et al,2001,The serotonergic 5-HT<inf>2C</inf> agonist m-chlorophenylpiperazine increases weight-supported locomotion without development of tolerance in rats with spinal transections,10.1006/exnr.2001.7660,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Chlorophenylpiperazine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Farooque et al,1999,"Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat",10.1007/s004010051047,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (clomethiazole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nazemi et al,2020,Co-delivery of minocycline and paclitaxel from injectable hydrogel for treatment of spinal cord injury,10.1016/j.jconrel.2020.02.009,English,,included,,,,,,rats,Wistar,29,5,,,6,,,"5 groups: control untreated (n=6), control with gel (n=5), note this is our control group since the treatment of interest is given through loaded hydrogel), gel+minocycline (n=6), gel+paclitaxel (n=6), gel+paclitaxel+minocycline (n=5)",male 100%,male,100,not reported (adult),,,,,,Adult,range: [220-280](g),,,220,280,g,,level: T8-T10; severity: hemisection,T8 - T10,incomplete,transection,"laminectomy + hemisection (left lateral hemisection made with a surgical blade in the left of the spinal cord, injury led to the creation of a gap at the length of 2–4 mm alongside the rostral-caudal axis that was extended to the midline)",7 and 28 days,minocycline hydrochloride encapsulated in poly (lactic-co-glycolic acid) PLGA microspheres,minocycline,,"50 microg, rate of injection: 4 microL/min",5 min after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"BBB scale, footprint analysis",,"BBB: 0=no functional improvement in hindlimb junctions, 21=normal functional behavior similar to a healthy rat, 2 inverstigators, 5 min, open-field, BBB sub-scoring also applied to compare trunk stabilty, paw and tail position and toe clearance; footprint analysis: di[[ing rat hind paws in the dye, walk on white paper cover with narrow runwar 1m length 7cm width, step length and width in addition to foor lnegth measures for each animal","BBB: before injury, day 1, 7, 14, 21 and 28; footprint analysis: before injury, day 7, 14, 21 and 28 after injury",,"BBB: yes, footprint analysis: not reported",no effect,"BBB and footprint analysis: no significant difference between minocycline group and control, both in total an subscores",histological assessment,"scar tissue formation, neuronal regeneration",7 and 28 days,not reported,no effect,"no significant difference in cell density, colllagen deposition ","anesthesia: ketamine (100 mg/kg) and xylazine (10 mg/kg) IP; euthanasia: deep-anesthesia and transcardially perfused with 4% w/v paraformaldehyde (PFA, Sigma) in 0.1 M phosphate-buffer","Over time, a fast and sustained functional improvement was achieved in animals that received dual-drug treatment compared with other experimental groups. This study provides a novel dual-drug delivery system that can be developed to test for a variety of SCI models or neurological disorders","""The contradictory result originates from some possible limitations present in our study.""",use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Sharma,2010,Selected Combination of Neurotrophins Potentiate Neuroprotection and Functional Recovery Following Spinal Cord Injury in the Rat,10.1007/978-3-211-98811-4_55,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (brain-, glial- derived neurotrophic factor, neurotrophin3, insulin-like growth factor 1)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Leybaert et al,1994,Interstitial and tissue cations and electrical potential after experimental spinal cord injury,10.1007/BF00229177,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (flunarizine and study of ions changes but not as drugs),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yasar Kaynar et al,1998,The effect of duration of compression on lipid peroxidation after experimental spinal cord injury,10.1007/BF02389316,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Akdemir et al,1992,"HISTOPATHOLOGY OF EXPERIMENTAL SPINAL-CORD TRAUMA - COMPARISON OF TREATMENT WITH TRH, NALOXONE, AND DEXAMETHASONE",10.1007/BF02576273,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Wistar,49,8,6,,8,3,,"report naloxone group as treatment (same paper as below), 32 for analysis, 17 died",male 100%,male,100,not reported,,,,,,Not reported,range: [200-210](g),,,200,210,g,,level: T3; severity: not reported,T3,Not reported,compression,"laminectomy + compression (method described bv Rivlin and Tator, a vascular clip (FD 753 S Yasargil aneurysm clip) was abruptly and applied to the cord extradurally for 2 min)",72h,"naloxone, dexamethasone, thryotropin-releasing hormon (TRH, not of interest, not further reported)",naloxone,,0.8 mg,45 and 120 minutes after injury,,2 doses,-,intraperitoneally,,-,-,,-,-,,-,not tested,-,histological assessment,"Histopathological scores were evaluated by following the cirteria of Hedeman and Ranajit for the presence of necrosis in gray matter (gray necrosis), hemorrhage in gray matter (gray hemorrhage), necrosis in the white matter (white necrosis), hemorrhage in the white matter (white hemorrhage), and edema in the white matter (white edema). Eeach feature was graded 0-3 according to severity (0, none; 1, mild; 2, moderate; 3, severe) ",72h,not reported,positive effect,"dexamethasone group not significantly different from the control group in terms of histological score, naloxone significantly better than control group","anesthesia: pentobarbital (40 mg/kg i.p. ); postop in case of UTI 0.2 mg/100 g body weight, i.m. gentamicin; euthanasia: intracardiac perfusion method",TRH-treated rats showed significantly better histopathological scores than either naloxone or dexamethasone-treated one,not reported,"use pentobarbital, gentamicin",No,
Lucie,Akdemir et al,1992,"HISTOPATHOLOGY OF EXPERIMENTAL SPINAL-CORD TRAUMA - COMPARISON OF TREATMENT WITH TRH, NALOXONE, AND DEXAMETHASONE",10.1007/BF02576273,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Wistar,49,8,6,,8,5,,"report dexamethasone as treatment group (same paper as above), 32 for analysis, 17 died",male 100%,male,100,not reported,,,,,,Not reported,range: [200-210](g),,,200,210,g,,level: T3; severity: not reported,T3,Not reported,compression,"laminectomy + compression (method described bv Rivlin and Tator, a vascular clip (FD 753 S Yasargil aneurysm clip) was abruptly and applied to the cord extradurally for 2 min)",72h,"naloxone, dexamethasone, thryotropin-releasing hormon (TRH, not of interest, not further reported)",dexamethasone,,0.6 mg,45 and 120 minutes after injury,,2 doses,-,intraperitoneally,,-,-,,-,-,,-,not tested,-,histological assessment,"Histopathological scores were evaluated by following the cirteria of Hedeman and Ranajit for the presence of necrosis in gray matter (gray necrosis), hemorrhage in gray matter (gray hemorrhage), necrosis in the white matter (white necrosis), hemorrhage in the white matter (white hemorrhage), and edema in the white matter (white edema). Eeach feature was graded 0-3 according to severity (0, none; 1, mild; 2, moderate; 3, severe) ",72h,not reported,no effect,"dexamethasone group not significantly different from the control group in terms of histological score, naloxone significantly better than control group","anesthesia: pentobarbital (40 mg/kg i.p. ); postop in case of UTI 0.2 mg/100 g body weight, i.m. gentamicin; euthanasia: intracardiac perfusion method",TRH-treated rats showed significantly better histopathological scores than either naloxone or dexamethasone-treated one,not reported,"use pentobarbital, gentamicin",No,
Lucie,Leybaert et al,1994,Interstitial and tissue cations and electrical potential after experimental spinal cord injury.,10.1007/BF02738397,English,,excluded,Duplicate,,duplicate paper 197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lopez et al,2004,Intrathecal bupivacaine protects against extension of lesions in an acute photochemical spinal cord injury model,10.1007/BF03018241,English,,included,,,,,,rats,Sprague Dawley,27,10,,,17,,,"2 treatment groups, treatment 15 min before lesion (n=9), or treatment 15 min after lesion (n=8)",male 100%,male,100,7.5 weeks old,7.5,,,,Weeks,,range: [218-350](g),,,218,350,g,,level: T7; severity: extensive secondary lesions,T7,Not reported,others,"laminectomy + photochemical spinal cord injury (photochemical lesion was induced according to the protocol described by Watson et al., 40 mg·kg –1 of Rose Bengal IV, immediately after light from a xeon lamp for 4 minutes, 560-nm irradiation of the translucent dorsal surface of the exposed spinal column induces excitation of the injected Rose Bengal in the spinal cord microvasculature, focused beam of the lamp was transmitted by optical fibres and directed at the vertebral level T7. The fibreoptic beam had an exit-point power of 0.82 watts per cm^2)",18 days,bupivacaine,bupivacaine,,20 microL,15 min before or after SCI (2 groups),,single dose,-,intrathecally,,"electrophysiology, motor/locomotion function, sensory function","unprompted walking motor score, inclined plane test, sensory blockade (heat), somatosensory evoked potentials",,"walking motor score: 0=normal walking, increments by 10 points until 50=no movements of the hindlimbs, 30=Vigorous and/or frequent movements of the hindlimbs, 1 observer, no stimulation on a smooth horizontal plane for 3 minutes; inclined plane: score by 10 point increments, from 0= > 65 degress to 30 = <35 degrees, rat on a plane which was horizontal initially, then successively tilted 5° every 30 sec and noting the angle at which the rat lost its balance; sensory score: withdrawal of hind paws during contact with a hot plate at 90°C, cut-off time was fixed at 20 sec to prevent thermal injury, three types of response to this test: Y (yes) for adapted withdrawal, N (no) for absence of withdrawal, or H for hyperactive flexion, equivalent to a liberated spinal reflex, sympathetic blockade was considered to exist if the animal had voiding dysfunction; SEPs: protocol of Baskin et al, right sciatic nerve was exposed and stimulated, anode was inserted in the somatopic area, two hundred responses with an acquisition time of 120 msec were averaged, SEP were analyzed for latencies (P1: first positive deflection, N1: first negative deflection, and P2: second positive deflection) and amplitudes (P1N1 and P2N2))","motor function, inclined plane, sensory: 1, 3, 5, 7, 9, 12, 15, 18 days after lesion; SEP: day 18 after injury",,motor function: yes,mixed effects (assessment) + mixed effects (timing),"motor score: treatment before SCI made motor score better starting day 3 until end compared to control, treatment after made score better from day 3 to day 9 included but then no difference with control group, inclined plane: both treatment were better than control from day 3 to day 15 included but not on day 18, sensory function: no significant difference in these values among the three groups at any time; SEPs: Latencies were longer in the control group than in the treated groups, when treatment before injury difference in latency reached statistical significance except for N1 (first negative deflection), in group treated after lesion onthe the onset and P1 (first positive deflection) were significantly shorter than in the control group, SEP amplitudes were significantly higher inboth treatment groups than in the control group",histological assessment,"total surface of intact spinal cord, repeated 3 times by the same physician and then averaged",18 days,not reported,no effect,"The surface area of healthy spinal cord in the centre of the lesion was 2.55 mm 2 (1.85 to 3.3 mm 2) in Group I treatment before injury, 2.38 mm 2 (1.7 to 2.39 mm 2) in Group II treatment after injury, and 2.03 mm 2 (0.985 to 2.66 mm 2) in the control group (P > 0.05). ","anesthesia: IP pentobarbital (0.9 g·100 mL –1) and chloral hydrate (4.2 g·100 mL –1), maintained with 0.1ml of IV mixture ; postop: 12 mg·kg–1·day–1 of gentamicin intraperitoneally for seven days following lesion induction; euthanasia: IP 1 mL of pentobarbital (6 g·100 mL –1 )",Twenty microlitres of intrathecal bupivacaine before or after acute photochemical spinal injury improves hindlimb motor recovery and SEP parameters in rats.,not reported,"use pentobarbital, chloral hydrate, gentamycin",No,
Lucie,Namjoo et al,2018,Combined effects of rat Schwann cells and 17 beta-estradiol in a spinal cord injury model,10.1007/s11011-018-0220-8,English,,included,,,,,,rats,Wistar,60,9,,,10,,,"6 group: sham (n=9), control or lesion group (n=9), vehicle or placebo group (our control group, n=9), SCI+E2 (group of interest, n=10), SCI+schwann cells (n=10), SCI+schwann cells+E2 (n=10)",male 100%,male,100,not reported (adult),,,,,,Adult,range: [280-300](g),,,280,300,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,compression,"laminectomy + compression (50g weight on the dura for 10 min, tip of the weight had an area of 6.6 mm2 (3.0–2.2 mm), equal distribution of the pressure on the spinal cord obtained by concave shape of weight)",28 days,"Schwann cell (SC, not of interest so not further reported), 17β-estradiol (E2)",estradiol,,25 microg/kg,immediately,,28 days,every 12h,subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,"complete paralysis (score 0) to normal locomotion (score 21), rats were placed in an open field-like platform with a pasteboard-covered non-slippery floor, 2 examiners, 4min, scored motor performance in both hindlimbs","7, 14, 21, 28 days after injury",,yes,positive effect,E2 group had significantly higher BB score starting week 2 until the end of the experiment compared to the trauma only group,histological assessment,"axonal regeneration and myelination, ratio of myelin to cavity sizes",28 days,not reported,positive effect,"axonl myelination at the SCI site was significantly increased in treated animals in comparison to control vehicle groups, more characteristic vacuolization was observed in the SCI group than in the treatment groups, ratio of myelin to cavity size significantly higher in treatment groups compared to SCI alone group","anesthesia: ketamine/xylazine (80/20 mg/kg, I.P.); postop: For 5 days post-surgery, injured rats received daily 1 mL lactated Ringer’s solution and 6 mg/kg gentamicin as a hydration solution and a prophylactic antibiotic respectively; euthanasia: anesthesia and transcardial perfusion 4% PFA in PBS",The present study demonstrates that a combinatory therapy with E2 and SCs is most effective for the functional recovery after SCI and outperforms the positive effects of E2 or SCs treatment alone.,not reported,"use ketamine, gentamicin",Yes (drug of interest + drug not of interest),
Lucie,Çavus et al,2014,"Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone",10.1007/s00068-013-0349-4,English,,included,,,,,,rats,Wistar,48,8,,,8,,,"6 groups: sham (n=8), laminectomy only (n=8), SCI only (n=8), MP only (n=8), NAC only (n=8), MP+NAC (n=8)",male 100%,male,100,6-8 months (adults),,,6,8,Months,Adult,range: [300-350](g),,,300,350,g,,level: T7-T9; severity: paraplegia,T7 - T9,paraplegia,contusion,"laminectomy + weight drop contuion (modified Allen weight-drop model, glass pipe with a diameter of 0.5 cm and a length of 12.2 cm used as a uide for the sterile ball weighing 4.1g, impact of 50 g/cm)",14 days,"methylprednisolone (MP), N-acetylcysteine (NAC) and combination",methylprednisolone,No,"30 mg/kg, then 5.4 mg/kg/h",bolus after injury,,24h,8h intervals,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane test, Gale scale",,"inclined plane test: placed on a straigh board parallel to the ground, board was raised from the unfixed edge and the incline was increased, greatest angle at which the animal could stay on the board without falling for 5 s was accepted as the inclined plane angle; motor function evaluation: Gale et al.’s motor scale, 0= no movement of the hind limb, 3= alternative stepping and propulsive movements of the hind limbs and no weight support, 6=normal walking","1, 7, 14 days after injury",No,yes,no effect,"MP alone: no significant difference with trauma group in terms of inclined plane angle and motor function scores, NAC: angle significantly better at day 7 compared to trauma gorup but not at day 1 or 14, motor function no significantly different from trauma group; MP +NAC: inclined plane angle better than trauma group on day 1 and 7 but not on day 14, motor function not significantly different from trauma alone group",histological assessment,"Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema",14 days after injury,not reported,mixed effects (assessment),"NAC and MP+ NAC  significantly better than trauma alone group in terms of all assessment (Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema), MP alone better than trauma alone group for all except axonal swelling, subpial hemorrhage and edema","anesthesia: xylazine and ketamine hydrochloride (IP, 10 and 50 mg/kg respectively), sterilized with 10 % polyvinylpyrrolidone iodine; euthanasia: model of blood aspiration from the heart under anesthesia","It was concluded that NAC treatment and the combined NAC + MP treatment may be more useful for healing in rats with experimental spinal cord injury in terms of neuroclinical, pathological, and biochemical results than MP-only therap","1) despite sample size estimation, the number of animals was rather small; 2) We could not apply NAC infusion therap",use ketamine,No,
Lucie,Çavus et al,2014,"Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone",10.1007/s00068-013-0349-4,English,,included,,,,,,rats,Wistar,48,8,,,8,,,"6 groups: sham (n=8), laminectomy only (n=8), SCI only (n=8), MP only (n=8), NAC only (n=8), MP+NAC (n=8)",male 100%,male,100,6-8 months (adults),,,6,8,Months,Adult,range: [300-350](g),,,300,350,g,,level: T7-T9; severity: paraplegia,T7 - T9,paraplegia,contusion,"laminectomy + weight drop contuion (modified Allen weight-drop model, glass pipe with a diameter of 0.5 cm and a length of 12.2 cm used as a uide for the sterile ball weighing 4.1g, impact of 50 g/cm)",14 days,"methylprednisolone (MP), N-acetylcysteine (NAC) and combination",acetylcysteine,,300 mg/kg,bolus after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane test, Gale scale",,"inclined plane test: placed on a straigh board parallel to the ground, board was raised from the unfixed edge and the incline was increased, greatest angle at which the animal could stay on the board without falling for 5 s was accepted as the inclined plane angle; motor function evaluation: Gale et al.’s motor scale, 0= no movement of the hind limb, 3= alternative stepping and propulsive movements of the hind limbs and no weight support, 6=normal walking","1, 7, 14 days after injury",,yes,no effect,"MP alone: no significant difference with trauma group in terms of inclined plane angle and motor function scores, NAC: angle significantly better at day 7 compared to trauma gorup but not at day 1 or 14, motor function no significantly different from trauma group; MP +NAC: inclined plane angle better than trauma group on day 1 and 7 but not on day 14, motor function not significantly different from trauma alone group",histological assessment,"Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema",14 days after injury,not reported,positive effect,"NAC and MP+ NAC  significantly better than trauma alone group in terms of all assessment (Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema), MP alone better than trauma alone group for all except axonal swelling, subpial hemorrhage and edema","anesthesia: xylazine and ketamine hydrochloride (IP, 10 and 50 mg/kg respectively), sterilized with 10 % polyvinylpyrrolidone iodine; euthanasia: model of blood aspiration from the heart under anesthesia","It was concluded that NAC treatment and the combined NAC + MP treatment may be more useful for healing in rats with experimental spinal cord injury in terms of neuroclinical, pathological, and biochemical results than MP-only therap","1) despite sample size estimation, the number of animals was rather small; 2) We could not apply NAC infusion therap",use ketamine,No,
Lucie,Çavus et al,2014,"Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone",10.1007/s00068-013-0349-4,English,,included,,,,,,rats,Wistar,48,8,,,8,,,"6 groups: sham (n=8), laminectomy only (n=8), SCI only (n=8), MP only (n=8), NAC only (n=8), MP+NAC (n=8)",male 100%,male,100,6-8 months (adults),,,6,8,Months,Adult,range: [300-350](g),,,300,350,g,,level: T7-T9; severity: paraplegia,T7 - T9,paraplegia,contusion,"laminectomy + weight drop contuion (modified Allen weight-drop model, glass pipe with a diameter of 0.5 cm and a length of 12.2 cm used as a uide for the sterile ball weighing 4.1g, impact of 50 g/cm)",14 days,"methylprednisolone (MP), N-acetylcysteine (NAC) and combination",methylprednisolone + acetylcysteine,Yes,"MP: 30 mg/kg, then 5.4 mg/kg/h; NAC: 300 mg/kg",bolus after injury,,"NAC: single dose, MP: 24h",MP: 8h intervals,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane test, Gale scale",,"inclined plane test: placed on a straigh board parallel to the ground, board was raised from the unfixed edge and the incline was increased, greatest angle at which the animal could stay on the board without falling for 5 s was accepted as the inclined plane angle; motor function evaluation: Gale et al.’s motor scale, 0= no movement of the hind limb, 3= alternative stepping and propulsive movements of the hind limbs and no weight support, 6=normal walking","1, 7, 14 days after injury",,yes,no effect,"MP alone: no significant difference with trauma group in terms of inclined plane angle and motor function scores, NAC: angle significantly better at day 7 compared to trauma gorup but not at day 1 or 14, motor function no significantly different from trauma group; MP +NAC: inclined plane angle better than trauma group on day 1 and 7 but not on day 14, motor function not significantly different from trauma alone group",histological assessment,"Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema",14 days after injury,not reported,positive effect,"NAC and MP+ NAC  significantly better than trauma alone group in terms of all assessment (Necrosis, polymorphonuclear leukocyte (PMNL) infiltration, histiocyte accumulation, congestion, intraparenchymal bleeding, axonal swelling, subpial bleeding, and edema), MP alone better than trauma alone group for all except axonal swelling, subpial hemorrhage and edema","anesthesia: xylazine and ketamine hydrochloride (IP, 10 and 50 mg/kg respectively), sterilized with 10 % polyvinylpyrrolidone iodine; euthanasia: model of blood aspiration from the heart under anesthesia","It was concluded that NAC treatment and the combined NAC + MP treatment may be more useful for healing in rats with experimental spinal cord injury in terms of neuroclinical, pathological, and biochemical results than MP-only therap","1) despite sample size estimation, the number of animals was rather small; 2) We could not apply NAC infusion therap",use ketamine,Yes (drug of interest + drug of interest),
Lucie,Mao et al,2017,Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats,10.1007/s00221-017-5023-3,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (Connexin43 mimetic peptide, Peptide5)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bobo,Kang et al,2017,Combined use of low-dose 17-beta estradiol and bone marrow mesenchymal stem cell transplantation for spinal cord repair,10.3969/j.issn.2095-4344.2017.25.014,Chinese,,included,,,,,,rats,Sprague Dawley,70,15,,,15,,,2 other groups not of interest (n=15 each) + n=10 sham,male 100%,male,100,3 months,3,,,,Months,,range: [250-300]g,,,250,300,g,,not reported,Not reported,Not reported,contusion,modified Allen's method,"6hr, 12hr, 24hr, 72hr, 7 days",17-beta estradiol (estrogen),estradiol,No,100 microg,immediately after injury,,2 doses,immediately after injury and 24 hours after injury,intramuscular,,neurological/ functional/ behavioral assessment,BBB scale,,range from 0 to 21,"1, 3, 5, 7 days after injury",No,not reported,positive effect,BBB was significant higher in the estrogen group for 5 and 7 days post injury compared to the SCI only group,histolofical assessment,"expressions of interleukin-1-beta and tumor necrosis factor-alpha were detected using ELISA, apoptosis in nerve cells was observed using TUNEL staining","6, 12, 24, 72 hours after injury",not reported,mixed effects,"the level of tumor necrosis factor-alpha in the spinal cord was significantly lower in the estrogen group at 12 and 24 hours post injury (no difference at 72 hours), level of interleukin-1beta was significantly lower at 6, 12 and 24 hours post injury compared to SCI group (no difference at 72 hours post injury)",intraperitoneal anesthesia,Conclusion was drawn on the treatment of estrogen + bone marrow transplant only (not estrogen exclusively),not reported,study's main interest is in the effects of estrogen + bone marrow transplant together,Yes (drug of interest + drug not of interest),
Lucie,Baltin et al,2021,Comparison of systemic and localized carrier-mediated delivery of methylprednisolone succinate for treatment of acute spinal cord injury.,10.1007/s00221-020-05974-w,English,,included,,,,,,rats,Sprague Dawley,31,7,,,5,,,"3 treatment group: MPS IV (n=5), MPS in combination with a neutral gel to the dura mater (n=5), MPS in combination with a trifunctional block copolymers applied to the dura mater (not of interest, n=8)",female 100%,female,0,not reported,,,,,,Not reported,range: [160-240] (g),,,160,240,g,,level: T8; severity: not reported,T8,Not reported,contusion,"laminectomy + weight drop contusion (modified method of Allen, exposed spinal cord dura intact, drop 2.5g weight from a height of 5 cm into a 20-cm long tube placed vertically on the roots of the arches of the laminectomized vertebra, severity controlled by hindlimb muscle contraction, dalling load and the tube were removed immediately agter striking)",14 days,methylprednisolone sodium succinate (MPSS),methylprednisolone sodium succinate,Yes,30 mg/kg,immediately after injury,,single dose,-,intravenously,,"electrophysiology, motor/locomotion function","evoked muscle responses (EMR), angulograms (quality and range of motion)",,"EMR: epidural stimulation at L1 was performed via single stimuli (duration 0.5 ms, intensities in a range from 0.5 to 10 V), maximum amplitude calculated as an average of seven responses, presented as a percentage of the control value, EMR of the medial gastrocnemius and soleus muscles with latency 3-6ms were recorded in all animals during electrical epidural stimulation and correspond to monosynaptic, middle response; motion video analysis: Ten passive reflective markers were placed on the back muscles, sacrum, knee, and ankle joints, data were obtained in the form of angulograms, i.e., the kinematic profile of the knee joint of rats normalized by the phase of the step","EMR: before, immediately after and every 1h during 6h after contusion; motion analysis: 1, 3, 7, 14 days",,not reported,no effect,MPSS given alone was not significantly different from the SCI alone group in terms of maximum response amplitude of the gastrocnemius and soleus muscles or in terms of volume of motion (degree) in the knee or hip joint,-,-,-,-,,-,"anesthesia: not reported, postop: enroflon (0.1 mL), euthanasia: not reported",The results of this study demonstrate that the local treatment of acute SCI with MP in the form of mixed micelles with trifunctional block copolymer of ethylene oxide and propylne oxide can provide improved therapeutic outcome by promoting drug accumulation and functional restoration of the spinal cord,not reported,,Yes (drug of interest + drug not of interest),
Lucie,Flora et al,2013,Combining neurotrophin-transduced Schwann cells and rolipram to promote functional recovery from subacute spinal cord injury,10.3727/096368912X658872,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram and neutrophin-transducted Schwann cells implantation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kouhzaei et al,2013,The neuroprotective ability of polyethylene glycol is affected by temperature in ex vivo spinal cord injury model,10.1007/s00232-013-9574-3,English,,excluded,Out of scope,Ex-vivo,"Ex-vivo SCI, isolated spinal cord",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kaya et al,2013,"Comparison of the beneficial effect of melatonin on recovery after cut and crush sciatic nerve injury: a combined study using functional, electrophysiological, biochemical, and electron microscopic analyses",10.1007/s00381-012-1936-0,English,,excluded,Non-sci population,,crush sciatic nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chen et al,2018,Effect evaluation of methylprednisolone plus mitochondrial division inhibitor-1 on spinal cord injury rats.,10.1007/s00381-018-3792-z,English,,included,,,,,,rats,Sprague Dawley,>= 65,>= 9,,,>= 9 ,,,"20 (4 per group) for the water content experiement, 20 (4 per group) for the oxidative stress/ATP content measurements, 20 (4 per group) for the western blot experiment, 5 rats for the HE morphological assessement, not reported for BBB scale assessement",male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-280](g),,,250,280,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop contusion (20-g weight, dropped from height of 25 mm)","3, 7, 28 days","methylprednisolone, mitochondrial division inhibitor-1 (not of interest, not further reported)",methylprednisolone,No,30 mg/kg,immediately after injury,Yes,1 dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"range from 0 to 21, 0= no observed movement of hindlimbs, 21 = consistent plantar stepping and coordinated gait, consistment movement of the toes, paw position is predominantly parallel to the body during the whole support stage, consistent trunk stability, consistent tail elevation (very detailled description of the entire scale in table 1)","1, 3, 7, 14, 28 days after injury",Yes,not reported,no effect,Rats in MP group did not show significantly better BBB scores compared to the SCI alone group,histological assessment,"spinal cord edema (% of tissue water content), morphology of the injury site, TUNEL assay","72h after injury, 7 days",not reported,mixed (stats/no stats),"tissue water content: no significant difference in % of tissue water content in the MP alone group compared to SCI alone group; morphology: not tested with statistical test, SCI group cells and MP group cells were both reduced measurably with many necrosis and swelling, number of TUNEL-positive cells significantly lower in the MP group compared to SCI group","anesthesia: pentobarbital sodium (45 mg/kg, i.p.); euthanasia: cervical dislocation","MP combined with Mdivi-1 may produce better neurological function recovery, through improving functional status of mitochondria and inhibiting lipid peroxidation in damaged tissue of SCI rats, and thus alleviating apoptosis.","limited numbers of biochemical parameters studied in this study, MP dosages were tried to be minimized",use pentobarbital,Yes (drug of interest + drug not of interest),
Lucie,Faden et al,1982,Comparison of early and late naloxone treatment in experimental spinal injury,10.1212/wnl.32.6.677,English,,excluded,No access,,Lucie: could not find the full paper (https://doi.org/10.1212/WNL.32.6.677),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Caliskan et al,2016,"Comparison of Etanercept, Etomidate and Erythropoietin and Their Combinations in Experimentally-Induced Spinal Cord Injury",10.5137/1019-5149.JTN.14036-15.1,English,,included,,,,,,rats,Wistar,85,10,,,10,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,compression,"laminecotmy + compression (dura left intact, extradural application of a Yaşargil aneurysm clip exerting a 0.7N closing force on the spinal cord for one minute)","24h, 72h","etanercept (not of interest, not further reported), etomidate, erythropoietin (EPO)",etomidate,,2 mg/kg,just after SCI,,24h or 48h,once a day,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, somatosensory evoked potentials (SEPs)",,"BBB: range from 0 (no observable hindlimb movement) to 21 (normal gait); SEPs: Medelec/Synergy Oxford 5 channel eMG/eP device was used to take the SeP recordings under general anesthesia, modified scale by Şirin et al. was used for the qualitative evaluation of the injury potentials in the posttraumatic SeP records, range from 0=isoelectric line to 5=normal response",BBB: 24 and 72h; SEPs: 72h after injury,,yes,no effect,"BBB: etomidate alone not significantly different from trauma only group at 24h and 72h, EPO alone and EPO+etomidate significantly better than traum only group both at 24h and 72h after injury; SEPs: no signficant difference between etomidate alone, or EPO alone or EPO+etomidate compared to trauma only group respectively",histological assessment,"lesions detected after the study were ranked in three groups as mild, moderate and severe",24h and 72h after injury,not reported,no stats,"Demyelinated areas, axonal degeneration and gliosis were detected partly in varying severity; no real comparison between groups; etomidate alone at 24h classified as moderate whilst control at 24th classified as severe (one image for each group)","anesthesia: 60 mg/kg ketamine and 10 mg/kg xylazine, both IP; postop: gentamicin sulphate to prevent urinary infection (5 mg/kg/day, IP), 2 ml 0.9% NaCl SC to all animals after surgery to prevent dehydratation; euthanasia: general anesthesia and cervical dislocation","The neuroprotective activity of etomidate was suspect. The neuroprotective effect of etanercept and erythropoietin after SCI was shown in individual and combined applications in this study. However, more experimental studies are needed for clinical use.",not reported,"no real comparison between groups for the histological assessment, use ketamine gentamicin and saline",No,
Lucie,Caliskan et al,2016,"Comparison of Etanercept, Etomidate and Erythropoietin and Their Combinations in Experimentally-Induced Spinal Cord Injury",10.5137/1019-5149.JTN.14036-15.1,English,,included,,,,,,rats,Wistar,85,10,,,10,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,compression,"laminecotmy + compression (dura left intact, extradural application of a Yaşargil aneurysm clip exerting a 0.7N closing force on the spinal cord for one minute)","24h, 72h","etanercept (not of interest, not further reported), etomidate, erythropoietin (EPO)",epoietin,,1000 IU/kg,just after SCI,,24h or 48h,once a day,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, somatosensory evoked potentials (SEPs)",,"BBB: range from 0 (no observable hindlimb movement) to 21 (normal gait); SEPs: Medelec/Synergy Oxford 5 channel eMG/eP device was used to take the SeP recordings under general anesthesia, modified scale by Şirin et al. was used for the qualitative evaluation of the injury potentials in the posttraumatic SeP records, range from 0=isoelectric line to 5=normal response",BBB: 24 and 72h; SEPs: 72h after injury,,yes,mixed effects (assessment),"BBB: etomidate alone not significantly different from trauma only group at 24h and 72h, EPO alone and EPO+etomidate significantly better than traum only group both at 24h and 72h after injury; SEPs: no signficant difference between etomidate alone, or EPO alone or EPO+etomidate compared to trauma only group respectively",histological assessment,"lesions detected after the study were ranked in three groups as mild, moderate and severe",24h and 72h after injury,not reported,no stats,"Demyelinated areas, axonal degeneration and gliosis were detected partly in varying severity; no real comparison between groups; etomidate alone at 24h classified as moderate whilst control at 24th classified as severe (one image for each group)","anesthesia: 60 mg/kg ketamine and 10 mg/kg xylazine, both IP; postop: gentamicin sulphate to prevent urinary infection (5 mg/kg/day, IP), 2 ml 0.9% NaCl SC to all animals after surgery to prevent dehydratation; euthanasia: general anesthesia and cervical dislocation","The neuroprotective activity of etomidate was suspect. The neuroprotective effect of etanercept and erythropoietin after SCI was shown in individual and combined applications in this study. However, more experimental studies are needed for clinical use.",not reported,"no real comparison between groups for the histological assessment, use ketamine gentamicin and saline",No,
Lucie,Caliskan et al,2016,"Comparison of Etanercept, Etomidate and Erythropoietin and Their Combinations in Experimentally-Induced Spinal Cord Injury",10.5137/1019-5149.JTN.14036-15.1,English,,included,,,,,,rats,Wistar,85,10,,,10,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,compression,"laminecotmy + compression (dura left intact, extradural application of a Yaşargil aneurysm clip exerting a 0.7N closing force on the spinal cord for one minute)","24h, 72h","etanercept (not of interest, not further reported), etomidate, erythropoietin (EPO)",etomidate + epoietin,,etomidate: 2 mg/kg; EPO: 1000 IU/kg,just after SCI,,24h or 48h,once a day,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, somatosensory evoked potentials (SEPs)",,"BBB: range from 0 (no observable hindlimb movement) to 21 (normal gait); SEPs: Medelec/Synergy Oxford 5 channel eMG/eP device was used to take the SeP recordings under general anesthesia, modified scale by Şirin et al. was used for the qualitative evaluation of the injury potentials in the posttraumatic SeP records, range from 0=isoelectric line to 5=normal response",BBB: 24 and 72h; SEPs: 72h after injury,,yes,mixed effects (assessment),"BBB: etomidate alone not significantly different from trauma only group at 24h and 72h, EPO alone and EPO+etomidate significantly better than traum only group both at 24h and 72h after injury; SEPs: no signficant difference between etomidate alone, or EPO alone or EPO+etomidate compared to trauma only group respectively",histological assessment,"lesions detected after the study were ranked in three groups as mild, moderate and severe",24h and 72h after injury,not reported,no stats,"Demyelinated areas, axonal degeneration and gliosis were detected partly in varying severity; no real comparison between groups; etomidate alone at 24h classified as moderate whilst control at 24th classified as severe (one image for each group)","anesthesia: 60 mg/kg ketamine and 10 mg/kg xylazine, both IP; postop: gentamicin sulphate to prevent urinary infection (5 mg/kg/day, IP), 2 ml 0.9% NaCl SC to all animals after surgery to prevent dehydratation; euthanasia: general anesthesia and cervical dislocation","The neuroprotective activity of etomidate was suspect. The neuroprotective effect of etanercept and erythropoietin after SCI was shown in individual and combined applications in this study. However, more experimental studies are needed for clinical use.",not reported,"no real comparison between groups for the histological assessment, use ketamine gentamicin and saline",Yes (drug of interest + drug of interest),
Lucie,Kopp et al,2012,Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury.,10.1007/s00441-012-1334-7,English,,excluded,Review,,review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Farag et al,2019,Histoarchitecture restoration of cerebellar sub-layers as a response to estradiol treatment following Kainic acid-induced spinal cord injury,10.1007/s00441-019-02992-1,English,,excluded,Out of scope,No assessments of interest,Out of scope: looking at the neuroprotective effects of estradiol on injured cerebellum in response to SCI (main object of study is the cerebellum),,,rats,Westar,45,,,,,,,,male 100%,,,not reported (adults),,,,,,,~ 250 g,,,,,,,level: T13-L3; severity: not reported,,,,stereotaxically toxin Kainic acid (KA) (1.5 μl of 2.5 mM) were bilaterally injected through a 10-μl Hamilton syringe attached to a Microdrive pump,"24h, 72h, 7, 14 and 30 days",estrogen (E2),,,"4 mg/kg, then 2 mg/kg",20 min after KA injection,,5 days,daily,not reported,,,,,,,,,,,,,,,,,,,,,,
Lucie,Cayli et al,2004,Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury,10.1007/s00586-003-0550-y,English,,included,,,,,,rats,Albino,96,18,,,18,,,"6 groups, 1 sham (n=6), other 5 groups n=18",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,300,g,,"level: T7-T10; severity: severe, paraplegia",T7 - T10,severe,contusion,"laminectomy + weight drop contusion (dura left intact, impact of 50 g/cm to the dorsal surface of the spinal cord)","4h, 24h 10 days","methylprednisolone (MP), melatonin, MP+melatonin, ethanol (vehicle group)",methylprednisolone,No,30 mg/kg,immediately after trauma,,single dose,-,intraperitoneally,,"neurological/behavioral assessment, electrophysiology","motor evoked potentials (MEP), cortico somatosensory evoked potentials (CSEP), motor function scale (modified Gale), inclined plane test",,"CSEP: left sciatic nerve was isolated and stimulated with a pair of hook electrodes, duration of stimuli was 0.2 ms at 3 pps and the stimulus amplitude of each test was at a threshold sufficient for moving the ipsilateral foot, tests were performed twice each time and in each test 400 CSEP were averaged in an analysis time of 50 ms, The latency of CSEP was measured from the onset of the first negative deflec tion from the baseline. The amplitudes were measured from the distance between the first negative and positive peaks; MEPs: Two silver screw electrodes were placed epidurally over the right motor cortex area and on the hard palate as active and reference electrodes, respectively, to achieve transcortical stimulation by applying square wave pulses of 0.1 ms at 3 pps, recorded from 2 pairs of electrodes on the left sciatic nerve, motor response averaged with a sweep of 50 ms, performed twice, the latency of MEP was measured from the onset of the first positive or negative deflection from the baseline and the amplitude was measured between the positive and negative peaks of averaged waveforms, the waveforms obtained from the sciatic nerve represented the motor conduction velocity rather than motor unit potentials as measured from the innervated muscle; motor function scale: slight modification of the moto score proposed by Gale et al, open field 0.7*0.9m, observed at least 1 min, movement of hips, knees and ankle joints recorded, inclined plane test: rislin and tator's angle board test, max angle at which an animal can support its weight on an inclined plane measures in degrees from 0 to 90, animals places transversely and highest angle a rat can maintain for 5s recorded and described as capacity angle ",4h. 10h and 10 days (3 different groups),No,not reported,positive effect,"MEP and CSEP: day 1- significantly longer mean latencies and lower amplitudes in the trauma group in comparison with MP, melatonin, and MP+melatonin groups, no difference in latency or amplitude between ethanol and control group, day 10- ethanol and trauma groups had significantly longer mean latencies and lower mean amplitudes of CSEP and MEP tests than those of the MP, melatonin, and MP+melatonin groups; motor function score: significant gradual recovery rate was observed in the rats treated with MP, melatonin, and MP+melatonin (P<0.05), [not clear if this is a comparison between treatment and SCI alone group]; inclined plane test: Trauma produced a highly significant decrease in angle score which, then, gradually recovered over a period of 10 days in the rats treated with MP, melatonin, and MP+melatonin (P<0.05). There was no significant increase in angle score for the rats in the trauma group (P>0.05). ",histological assessment,"ultrastructural examination: each sample evaluated according to a grading system for quantitative evaluation, MDA levels","4h, 24h or 10 days",not reported,no stats,"ultrastructural findings support that melatonin, as well as MP, protects neurons, myelin, axons, and cytoplasmic organelles such as nucleus and mitochondrion, the evaluation according to the grading system showed the neuroprotective effects of melatonin, MP, and combined treatment","anesthesia: chloral hydrate (400 mg/kg, IP); postop: All rats in the 10 days group received gentamicin twice daily during the first 3 days as prophylaxis against urinary tract infection; euthanasia: not reported","MP, melatonin, and MP and melatonin combined treatment modalities improved functional recovery at the same level. Future studies involving different doses of melatonin and different dose combinations with MP could promise better results since each drug has a different anti-oxidative mechanism of action.",tested only one dose of melatonin,"unclear to me if the motor function and inclined plane angles are actually compared between treatment and trauma only group so marked it as mixed at the moment, use chloral hydrate and gentamicin",No,
Lucie,Cayli et al,2004,Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury,10.1007/s00586-003-0550-y,English,,included,,,,,,rats,Albino,96,18,,,18,,,"6 groups, 1 sham (n=6), other 5 groups n=18",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,300,g,,"level: T7-T10; severity: severe, paraplegia",T7 - T10,severe,contusion,"laminectomy + weight drop contusion (dura left intact, impact of 50 g/cm to the dorsal surface of the spinal cord)","4h, 24h 10 days","methylprednisolone (MP), melatonin, MP+melatonin, ethanol (vehicle group)",melatonin,,10 mg/kg,immediately after trauma,,single dose,-,intraperitoneally,,"neurological/behavioral assessment, electrophysiology","motor evoked potentials (MEP), cortico somatosensory evoked potentials (CSEP), motor function scale (modified Gale), inclined plane test",,"CSEP: left sciatic nerve was isolated and stimulated with a pair of hook electrodes, duration of stimuli was 0.2 ms at 3 pps and the stimulus amplitude of each test was at a threshold sufficient for moving the ipsilateral foot, tests were performed twice each time and in each test 400 CSEP were averaged in an analysis time of 50 ms, The latency of CSEP was measured from the onset of the first negative deflec tion from the baseline. The amplitudes were measured from the distance between the first negative and positive peaks; MEPs: Two silver screw electrodes were placed epidurally over the right motor cortex area and on the hard palate as active and reference electrodes, respectively, to achieve transcortical stimulation by applying square wave pulses of 0.1 ms at 3 pps, recorded from 2 pairs of electrodes on the left sciatic nerve, motor response averaged with a sweep of 50 ms, performed twice, the latency of MEP was measured from the onset of the first positive or negative deflection from the baseline and the amplitude was measured between the positive and negative peaks of averaged waveforms, the waveforms obtained from the sciatic nerve represented the motor conduction velocity rather than motor unit potentials as measured from the innervated muscle; motor function scale: slight modification of the moto score proposed by Gale et al, open field 0.7*0.9m, observed at least 1 min, movement of hips, knees and ankle joints recorded, inclined plane test: rislin and tator's angle board test, max angle at which an animal can support its weight on an inclined plane measures in degrees from 0 to 90, animals places transversely and highest angle a rat can maintain for 5s recorded and described as capacity angle ",4h. 10h and 10 days (3 different groups),,not reported,positive effect,"MEP and CSEP: day 1- significantly longer mean latencies and lower amplitudes in the trauma group in comparison with MP, melatonin, and MP+melatonin groups, no difference in latency or amplitude between ethanol and control group, day 10- ethanol and trauma groups had significantly longer mean latencies and lower mean amplitudes of CSEP and MEP tests than those of the MP, melatonin, and MP+melatonin groups; motor function score: significant gradual recovery rate was observed in the rats treated with MP, melatonin, and MP+melatonin (P<0.05), [not clear if this is a comparison between treatment and SCI alone group]; inclined plane test: Trauma produced a highly significant decrease in angle score which, then, gradually recovered over a period of 10 days in the rats treated with MP, melatonin, and MP+melatonin (P<0.05). There was no significant increase in angle score for the rats in the trauma group (P>0.05). ",histological assessment,"ultrastructural examination: each sample evaluated according to a grading system for quantitative evaluation, MDA levels","4h, 24h or 10 days",not reported,no stats,"ultrastructural findings support that melatonin, as well as MP, protects neurons, myelin, axons, and cytoplasmic organelles such as nucleus and mitochondrion, the evaluation according to the grading system showed the neuroprotective effects of melatonin, MP, and combined treatment","anesthesia: chloral hydrate (400 mg/kg, IP); postop: All rats in the 10 days group received gentamicin twice daily during the first 3 days as prophylaxis against urinary tract infection; euthanasia: not reported","MP, melatonin, and MP and melatonin combined treatment modalities improved functional recovery at the same level. Future studies involving different doses of melatonin and different dose combinations with MP could promise better results since each drug has a different anti-oxidative mechanism of action.",tested only one dose of melatonin,"unclear to me if the motor function and inclined plane angles are actually compared between treatment and trauma only group so marked it as mixed at the moment, use chloral hydrate and gentamicin",No,
Lucie,Cayli et al,2004,Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury,10.1007/s00586-003-0550-y,English,,included,,,,,,rats,Albino,96,18,,,18,,,"6 groups, 1 sham (n=6), other 5 groups n=18",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,300,g,,"level: T7-T10; severity: severe, paraplegia",T7 - T10,severe,contusion,"laminectomy + weight drop contusion (dura left intact, impact of 50 g/cm to the dorsal surface of the spinal cord)","4h, 24h 10 days","methylprednisolone (MP), melatonin, MP+melatonin, ethanol (vehicle group)",methylprednisolone + melatonin,,"MP: 30 mg/kg, melatonin: 10 mg/kg",immediately after trauma,,single dose,-,intraperitoneally,,"neurological/behavioral assessment, electrophysiology","motor evoked potentials (MEP), cortico somatosensory evoked potentials (CSEP), motor function scale (modified Gale), inclined plane test",,"CSEP: left sciatic nerve was isolated and stimulated with a pair of hook electrodes, duration of stimuli was 0.2 ms at 3 pps and the stimulus amplitude of each test was at a threshold sufficient for moving the ipsilateral foot, tests were performed twice each time and in each test 400 CSEP were averaged in an analysis time of 50 ms, The latency of CSEP was measured from the onset of the first negative deflec tion from the baseline. The amplitudes were measured from the distance between the first negative and positive peaks; MEPs: Two silver screw electrodes were placed epidurally over the right motor cortex area and on the hard palate as active and reference electrodes, respectively, to achieve transcortical stimulation by applying square wave pulses of 0.1 ms at 3 pps, recorded from 2 pairs of electrodes on the left sciatic nerve, motor response averaged with a sweep of 50 ms, performed twice, the latency of MEP was measured from the onset of the first positive or negative deflection from the baseline and the amplitude was measured between the positive and negative peaks of averaged waveforms, the waveforms obtained from the sciatic nerve represented the motor conduction velocity rather than motor unit potentials as measured from the innervated muscle; motor function scale: slight modification of the moto score proposed by Gale et al, open field 0.7*0.9m, observed at least 1 min, movement of hips, knees and ankle joints recorded, inclined plane test: rislin and tator's angle board test, max angle at which an animal can support its weight on an inclined plane measures in degrees from 0 to 90, animals places transversely and highest angle a rat can maintain for 5s recorded and described as capacity angle ",4h. 10h and 10 days (3 different groups),,not reported,positive effect,"MEP and CSEP: day 1- significantly longer mean latencies and lower amplitudes in the trauma group in comparison with MP, melatonin, and MP+melatonin groups, no difference in latency or amplitude between ethanol and control group, day 10- ethanol and trauma groups had significantly longer mean latencies and lower mean amplitudes of CSEP and MEP tests than those of the MP, melatonin, and MP+melatonin groups; motor function score: significant gradual recovery rate was observed in the rats treated with MP, melatonin, and MP+melatonin (P<0.05), [not clear if this is a comparison between treatment and SCI alone group]; inclined plane test: Trauma produced a highly significant decrease in angle score which, then, gradually recovered over a period of 10 days in the rats treated with MP, melatonin, and MP+melatonin (P<0.05). There was no significant increase in angle score for the rats in the trauma group (P>0.05). ",histological assessment,"ultrastructural examination: each sample evaluated according to a grading system for quantitative evaluation, MDA levels","4h, 24h or 10 days",not reported,no stats,"ultrastructural findings support that melatonin, as well as MP, protects neurons, myelin, axons, and cytoplasmic organelles such as nucleus and mitochondrion, the evaluation according to the grading system showed the neuroprotective effects of melatonin, MP, and combined treatment","anesthesia: chloral hydrate (400 mg/kg, IP); postop: All rats in the 10 days group received gentamicin twice daily during the first 3 days as prophylaxis against urinary tract infection; euthanasia: not reported","MP, melatonin, and MP and melatonin combined treatment modalities improved functional recovery at the same level. Future studies involving different doses of melatonin and different dose combinations with MP could promise better results since each drug has a different anti-oxidative mechanism of action.",tested only one dose of melatonin,"unclear to me if the motor function and inclined plane angles are actually compared between treatment and trauma only group so marked it as mixed at the moment, use chloral hydrate and gentamicin",Yes (drug of interest + drug of interest),
Lucie,Cayli et al,2004,Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury,10.1007/s00586-003-0550-y,English,,included,,,,,,rats,Albino,96,18,,,18,,,"6 groups, 1 sham (n=6), other 5 groups n=18",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,300,g,,"level: T7-T10; severity: severe, paraplegia",T7 - T10,severe,contusion,"laminectomy + weight drop contusion (dura left intact, impact of 50 g/cm to the dorsal surface of the spinal cord)","4h, 24h 10 days","methylprednisolone (MP), melatonin, MP+melatonin, ethanol (vehicle group)",ethanol,,0.2 ml,immediately after trauma,,single dose,-,intraperitoneally,,"neurological/behavioral assessment, electrophysiology","motor evoked potentials (MEP), cortico somatosensory evoked potentials (CSEP), motor function scale, inclined plane test",,"CSEP: left sciatic nerve was isolated and stimulated with a pair of hook electrodes, duration of stimuli was 0.2 ms at 3 pps and the stimulus amplitude of each test was at a threshold sufficient for moving the ipsilateral foot, tests were performed twice each time and in each test 400 CSEP were averaged in an analysis time of 50 ms, The latency of CSEP was measured from the onset of the first negative deflec tion from the baseline. The amplitudes were measured from the distance between the first negative and positive peaks; MEPs: Two silver screw electrodes were placed epidurally over the right motor cortex area and on the hard palate as active and reference electrodes, respectively, to achieve transcortical stimulation by applying square wave pulses of 0.1 ms at 3 pps, recorded from 2 pairs of electrodes on the left sciatic nerve, motor response averaged with a sweep of 50 ms, performed twice, the latency of MEP was measured from the onset of the first positive or negative deflection from the baseline and the amplitude was measured between the positive and negative peaks of averaged waveforms, the waveforms obtained from the sciatic nerve represented the motor conduction velocity rather than motor unit potentials as measured from the innervated muscle; motor function scale: slight modification of the moto score proposed by Gale et al, open field 0.7*0.9m, observed at least 1 min, movement of hips, knees and ankle joints recorded, inclined plane test: rislin and tator's angle board test, max angle at which an animal can support its weight on an inclined plane measures in degrees from 0 to 90, animals places transversely and highest angle a rat can maintain for 5s recorded and described as capacity angle ",4h. 10h and 10 days (3 different groups),,not reported,no effect,"MEP and CSEP: day 1- significantly longer mean latencies and lower amplitudes in the trauma group in comparison with MP, melatonin, and MP+melatonin groups, no difference in latency or amplitude between ethanol and control group, day 10- ethanol and trauma groups had significantly longer mean latencies and lower mean amplitudes of CSEP and MEP tests than those of the MP, melatonin, and MP+melatonin groups; motor function score: significant gradual recovery rate was observed in the rats treated with MP, melatonin, and MP+melatonin (P<0.05), [not clear if this is a comparison between treatment and SCI alone group]; inclined plane test: Trauma produced a highly significant decrease in angle score which, then, gradually recovered over a period of 10 days in the rats treated with MP, melatonin, and MP+melatonin (P<0.05). There was no significant increase in angle score for the rats in the trauma group (P>0.05). ",histological assessment,"ultrastructural examination: each sample evaluated according to a grading system for quantitative evaluation, MDA levels","4h, 24h or 10 days",not reported,no stats,"ultrastructural findings support that melatonin, as well as MP, protects neurons, myelin, axons, and cytoplasmic organelles such as nucleus and mitochondrion, the evaluation according to the grading system showed the neuroprotective effects of melatonin, MP, and combined treatment","anesthesia: chloral hydrate (400 mg/kg, IP); postop: All rats in the 10 days group received gentamicin twice daily during the first 3 days as prophylaxis against urinary tract infection; euthanasia: not reported","MP, melatonin, and MP and melatonin combined treatment modalities improved functional recovery at the same level. Future studies involving different doses of melatonin and different dose combinations with MP could promise better results since each drug has a different anti-oxidative mechanism of action.",tested only one dose of melatonin,"unclear to me if the motor function and inclined plane angles are actually compared between treatment and trauma only group so marked it as mixed at the moment, use chloral hydrate and gentamicin",No,
Lucie,Cetin et al,2006,The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.,10.1007/s00586-006-0091-2,English,,included,,,,,,rats,Sprague Dawley,48,8,,,8,,,,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [200-300](g),,,300,350,g,,level: T3; severity: moderate,T3,moderate,compression,laminectomy + compression (transient extradural application of an aneurysm clip exerting a 0.6-N closing force on the spinal cord for 1 min),"24h, 72h","methylprednisolone (MP), recombinant human erythropoietin (EPO) and combination",methylprednisolone,No,"30 mg/kg, 5.4 mg/kg/h,",5 min after injury,,"infusion for 30 min, then 8h infusion started 15 min after the first one",MP: 1 bolus + 8h infusion; EPO: single bolus (1000 U group) or 1000 U/kg/day for 3 successive days for 3000 U/kg group,intraperitoneally,,neurological assessment,swimming test,,"placed in the center of a round tube of water (40-cm diameter) filled to a depth of 30 cm with a wire mesh ladder attached to the side, 0=neither hind limb was used for swimming and climbing out, 1=partial use of the hind limbs, 2=both hind limbs used normally",24 and 72h after injury,No,not reported,positive effect,"all treatment groups had significantly better neurological deficit grade at 24 and 72h compared to control group (trauma only), 2 time points not assessed separately but pulled",histological assessment,"number of ischemic neurons with histological characteristics of abnormal structures counted, presence and relative abundance of ischemic neurons in ventral gray matter area classified in 3 grouops: mild (5% of motor nuerons ischemic), moderate (5-20 %), severe (20% and more)",24 and 72h,yes,no effect,"MP alone not significantly different from control gorup, all other treatment groups were significantly better in terms of histopathological neuronal ischemic grade observed at 24 and 72h compared to control trauma only group (2 time points pooled) ","preop: imipenem (10 mg/kg of bw, IM) prophylaxis of infection; anesthesia: i.p. injection of thiopental sodium [40 mg/kg of body weight (bw)]; euthanasia: thiopental (120 mg/kg, i.p.)","The results of these experiments demonstrate a major neurological benefit associated with the systemic administration of MPSS + rHu-EPO 3,000 U after TSCI produced by transient compression.",not reported,"pooled the results of 2 time points 24 and 72h after injury, suspect that it is due to low sample size (8 per group)",No,
Lucie,Cetin et al,2006,The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.,10.1007/s00586-006-0091-2,English,,included,,,,,,rats,Sprague Dawley,48,8,,,16,,,2 groups with different dosage of EPO,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [200-300](g),,,300,350,g,,level: T3; severity: moderate,T3,moderate,compression,laminectomy + compression (transient extradural application of an aneurysm clip exerting a 0.6-N closing force on the spinal cord for 1 min),"24h, 72h","methylprednisolone (MP), recombinant human erythropoietin (EPO) and combination",epoietin,,1000 U/kg or 3000 U/kg,5 min after injury,,single dose or 3 days in the 3000 U group,MP: 1 bolus + 8h infusion; EPO: single bolus (1000 U group) or 1000 U/kg/day for 3 successive days for 3000 U/kg group,intraperitoneally,,neurological assessment,swimming test,,"placed in the center of a round tube of water (40-cm diameter) filled to a depth of 30 cm with a wire mesh ladder attached to the side, 0=neither hind limb was used for swimming and climbing out, 1=partial use of the hind limbs, 2=both hind limbs used normally",24 and 72h after injury,,not reported,positive effect,"all treatment groups had significantly better neurological deficit grade at 24 and 72h compared to control group (trauma only), 2 time points not assessed separately but pulled",histological assessment,"number of ischemic neurons with histological characteristics of abnormal structures counted, presence and relative abundance of ischemic neurons in ventral gray matter area classified in 3 grouops: mild (5% of motor nuerons ischemic), moderate (5-20 %), severe (20% and more)",24 and 72h,yes,positive effect,"MP alone not significantly different from control gorup, all other treatment groups were significantly better in terms of histopathological neuronal ischemic grade observed at 24 and 72h compared to control trauma only group (2 time points pooled) ","preop: imipenem (10 mg/kg of bw, IM) prophylaxis of infection; anesthesia: i.p. injection of thiopental sodium [40 mg/kg of body weight (bw)]; euthanasia: thiopental (120 mg/kg, i.p.)","The results of these experiments demonstrate a major neurological benefit associated with the systemic administration of MPSS + rHu-EPO 3,000 U after TSCI produced by transient compression.",not reported,"pooled the results of 2 time points 24 and 72h after injury, suspect that it is due to low sample size (8 per group)",No,
Lucie,Cetin et al,2006,The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.,10.1007/s00586-006-0091-2,English,,included,,,,,,rats,Sprague Dawley,48,8,,,16,,,2 groups with different dosage of EPO in combination with MP,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [200-300](g),,,300,350,g,,level: T3; severity: moderate,T3,moderate,compression,laminectomy + compression (transient extradural application of an aneurysm clip exerting a 0.6-N closing force on the spinal cord for 1 min),"24h, 72h","methylprednisolone (MP), recombinant human erythropoietin (EPO) and combination",methylprednisolone + epoietin,,"MP: 30 mg/kg and 5.4 mg/kg/h, EPO: 1000 U/kg or 3000 U/kg",5 min after injury,,"MP: infusion for 30 min, then 8h infusion started 15 min after the first one; EPO: 40 minutes after injury, or 3 days in the 3000 U group",MP: 1 bolus + 8h infusion; EPO: single bolus (1000 U group) or 1000 U/kg/day for 3 successive days for 3000 U/kg group,intraperitoneally,,neurological assessment,swimming test,,"placed in the center of a round tube of water (40-cm diameter) filled to a depth of 30 cm with a wire mesh ladder attached to the side, 0=neither hind limb was used for swimming and climbing out, 1=partial use of the hind limbs, 2=both hind limbs used normally",24 and 72h after injury,,not reported,positive effect,"all treatment groups had significantly better neurological deficit grade at 24 and 72h compared to control group (trauma only), 2 time points not assessed separately but pulled",histological assessment,"number of ischemic neurons with histological characteristics of abnormal structures counted, presence and relative abundance of ischemic neurons in ventral gray matter area classified in 3 grouops: mild (5% of motor nuerons ischemic), moderate (5-20 %), severe (20% and more)",24 and 72h,yes,positive effect,"MP alone not significantly different from control gorup, all other treatment groups were significantly better in terms of histopathological neuronal ischemic grade observed at 24 and 72h compared to control trauma only group (2 time points pooled) ","preop: imipenem (10 mg/kg of bw, IM) prophylaxis of infection; anesthesia: i.p. injection of thiopental sodium [40 mg/kg of body weight (bw)]; euthanasia: thiopental (120 mg/kg, i.p.)","The results of these experiments demonstrate a major neurological benefit associated with the systemic administration of MPSS + rHu-EPO 3,000 U after TSCI produced by transient compression.",not reported,"pooled the results of 2 time points 24 and 72h after injury, suspect that it is due to low sample size (8 per group)",Yes (drug of interest + drug of interest),
Lucie,Ha et al.,2008,Pregabalin as a neuroprotector after spinal cord injury in rats,10.1007/s00586-008-0653-6,English,,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,"1 control and 3 treatment groups, all n=8",male 100%,male,100,not reported (adult),,,,,,Adult,range: [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + weight drop contusion (New York University (NYU) impactor, 10 g rod dropped from a height of 2.5 cm: 25 g-cm lesion)",7 days,"Pregabalin (GP), methylprednisolone (MP), minocycline (MC)",pregabalin,,30 mg/kg,30 min after SCI,,2 days,at 30 min and every 12 h for post-operative 2 days postoperatively,intraperitoneally,,neurological/functional/behavioral assessment,"motor function score (modified Gale), inclined plane test",,"motor function socres: move freely, 1 observer, 1 min, recorded hip, knee and ankle joint movements, 0=no movement of the hindlimbs, 6=normal walking; inclined plane test: maintain its position on a board, which is raised in increments of 5°, index of hindlimb strength, max angle at which a rat was able to maintain its position for at least 5 s, was defined as the inclined plane score",motor function score: daily; inclined plane test: 7 days after SCI,,"motor function score: yes, inclined plane test: not reported",positive effect,"motor function score: mean motor function scores of the control and GP groups were also significantly different (P = 0.01), no direct comparison between MP and control and MC and control; inclined plane: Comparing the inclined plane scores between control and GP group, there was also a statistical significance (P = 0.01), no direct comparison between MP and control and MC and control",histological assessment,"cystic lesions, TUNEL assay",7 days,yes,mixed (stats/no stats),"cyst sizes were greater in the control group than in the other three groups, no statistical analysis performed (acknowledged); TUNEL positive cells were signitficantly numerous in the control group than in the other 3 groups (p<0.05)","anesthesia: ketamine (50 mg/kg) and rompun (2 mg/kg, i.p.); postop: 5 mg gentamycin IM; euthanasia: deep anesthesia by administering ketamine and rompun i.p, transcardiac perfusion was performed with 100 ml of buffered saline followed by 500 ml of 4% paraformaldehyde","This experiment demonstrates that GP can act as a neuroprotector after SCI in rats, and its anti-apoptotic and anti-inflammatory effects are related to its neuroprotective effect",not reported,"use gentamicin, ketamine",No,
Lucie,Ha et al.,2008,Pregabalin as a neuroprotector after spinal cord injury in rats,10.1007/s00586-008-0653-6,English,,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,"1 control and 3 treatment groups, all n=8",male 100%,male,100,not reported (adult),,,,,,Adult,range: [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + weight drop contusion (New York University (NYU) impactor, 10 g rod dropped from a height of 2.5 cm: 25 g-cm lesion)",7 days,"Pregabalin (GP), methylprednisolone (MP), minocycline (MC)",methylprednisolone,No,30 mg/kg,30 min after SCI,,1 day,"3 injections 30min, 12h and 24h after injury",intraperitoneally,,neurological/functional/behavioral assessment,"motor function score (modified Gale), inclined plane test",,"motor function socres: move freely, 1 observer, 1 min, recorded hip, knee and ankle joint movements, 0=no movement of the hindlimbs, 6=normal walking; inclined plane test: maintain its position on a board, which is raised in increments of 5°, index of hindlimb strength, max angle at which a rat was able to maintain its position for at least 5 s, was defined as the inclined plane score",motor function score: daily; inclined plane test: 7 days after SCI,No,"motor function score: yes, inclined plane test: not reported",not reported,"motor function score: mean motor function scores of the control and GP groups were also significantly different (P = 0.01), no direct comparison between MP and control and MC and control; inclined plane: Comparing the inclined plane scores between control and GP group, there was also a statistical significance (P = 0.01), no direct comparison between MP and control and MC and control",histological assessment,"cystic lesions, TUNEL assay",7 days,yes,mixed (stats/no stats),"cyst sizes were greater in the control group than in the other three groups, no statistical analysis performed (acknowledged); TUNEL positive cells were signitficantly numerous in the control group than in the other 3 groups (p<0.05)","anesthesia: ketamine (50 mg/kg) and rompun (2 mg/kg, i.p.); postop: 5 mg gentamycin IM; euthanasia: deep anesthesia by administering ketamine and rompun i.p, transcardiac perfusion was performed with 100 ml of buffered saline followed by 500 ml of 4% paraformaldehyde","This experiment demonstrates that GP can act as a neuroprotector after SCI in rats, and its anti-apoptotic and anti-inflammatory effects are related to its neuroprotective effect",not reported,"use gentamicin, ketamine",No,
Lucie,Ha et al.,2008,Pregabalin as a neuroprotector after spinal cord injury in rats,10.1007/s00586-008-0653-6,English,,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,"1 control and 3 treatment groups, all n=8",male 100%,male,100,not reported (adult),,,,,,Adult,range: [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + weight drop contusion (New York University (NYU) impactor, 10 g rod dropped from a height of 2.5 cm: 25 g-cm lesion)",7 days,"Pregabalin (GP), methylprednisolone (MP), minocycline (MC)",minocycline,,30 mg/kg,30 min after SCI,,2 days,at 30 min and every 12 h for post-operative 2 days postoperatively,intraperitoneally,,neurological/functional/behavioral assessment,"motor function score (modified Gale), inclined plane test",,"motor function socres: move freely, 1 observer, 1 min, recorded hip, knee and ankle joint movements, 0=no movement of the hindlimbs, 6=normal walking; inclined plane test: maintain its position on a board, which is raised in increments of 5°, index of hindlimb strength, max angle at which a rat was able to maintain its position for at least 5 s, was defined as the inclined plane score",motor function score: daily; inclined plane test: 7 days after SCI,,"motor function score: yes, inclined plane test: not reported",not reported,"motor function score: mean motor function scores of the control and GP groups were also significantly different (P = 0.01), no direct comparison between MP and control and MC and control; inclined plane: Comparing the inclined plane scores between control and GP group, there was also a statistical significance (P = 0.01), no direct comparison between MP and control and MC and control",histological assessment,"cystic lesions, TUNEL assay",7 days,yes,mixed (stats/no stats),"cyst sizes were greater in the control group than in the other three groups, no statistical analysis performed (acknowledged); TUNEL positive cells were signitficantly numerous in the control group than in the other 3 groups (p<0.05)","anesthesia: ketamine (50 mg/kg) and rompun (2 mg/kg, i.p.); postop: 5 mg gentamycin IM; euthanasia: deep anesthesia by administering ketamine and rompun i.p, transcardiac perfusion was performed with 100 ml of buffered saline followed by 500 ml of 4% paraformaldehyde","This experiment demonstrates that GP can act as a neuroprotector after SCI in rats, and its anti-apoptotic and anti-inflammatory effects are related to its neuroprotective effect",not reported,"use gentamicin, ketamine",No,
Lucie,Aslan et al,2009,Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study,10.1007/s00586-008-0872-x,English,,included,,,,,,rabbit,New Zealand ,22,8,,,8,,,sham n=6,male and female (proportions not specified),mixed,not reported,not reported,,,,,,Not reported,range: [2.4-3.0](kg),,,2.4,3,kg,,level: T10; severity: partial lesion,T10,incomplete,compression,"laminectomy + compression (balloon angioplasty catheter (2.0 mm*20 mm) placed extradurally and sublaminary, inflation, slowly until 2 atm pressure was achieved and then was waited for 5 min in 2 atm pressure)",24h,dexmedetomidine (DEX),dexmedetomidine,,1 microg/kg,after trauma,,single dose,-,intraperitoneally,,neurological/motor assessment,Tarlov scoring system,,"0=spastic paraplegia and no movement of the lower limbs, 1=spastic paraplegia and slight movement of the lower limbs, 2=good movement of the lower limbs but unable to stand, 3=able to stand but unable to walk normally, 4=complete recovery and normal gait/hopping",4 and 24h after surgery,,yes,not reported,no comparison between treatment and control group but only between treatment or control and sham group,histological assessment,number of apoptotic cell (TUNEL),24h,not reported,not reported,no comparison between treatment and control group but only between treatment or control and sham group,anesthesia: intramuscular injection of xylazine 5 mg/kg and ketamine hydrochloride 50 mg/kg; euthanasia: anesthetized with ketamine (50 mg/kg),"Therefore, it could be suggested that treatment with dexmedetomidine does not produce beneficial results in SCI.",not reported,no comparison between treatment and control group but only between treatment or control and sham group,No,
Lucie,Aslan et al,2009,Dantrolene can reduce secondary damage after spinal cord injury,10.1007/s00586-009-1033-6,English,,included,,,,,,rabbit,New Zealand ,24,8,,,8,,,sham n=8,male and female (proportions not specified),mixed,not reported,not reported,,,,,,Not reported,range: [2.5-3.0](kg),,,2.5,3,kg,,level: T10; severity: partial lesion,T10,incomplete,compression,"laminectomy + compression (balloon angioplasty catheter (2.0 mm*20 mm) placed extradurally and sublaminary, inflation, slowly until 2 atm pressure was achieved and then was waited for 5 min in 2 atm pressure)",24h ,dantrolene (DNT),dantrolene,,10 mg/kg,not reported,,single dose,-,intraperitoneally,,neurological/motor assessment,Tarlov scoring system,,"0=spastic paraplegia and no movement of the lower limbs, 1=spastic paraplegia and slight movement of the lower limbs, 2=good movement of the lower limbs but unable to stand, 3=able to stand but unable to walk normally, 4=complete recovery and normal gait/hopping",4 and 24h after surgery,,yes,positive effect,"24 h after SCI, partial improvements were observed in both control and DNT-treated groups; neurological improvements were significantly higher in DNT group when compared with control",histological assessment,number of apoptotic cell (TUNEL),24h,not reported,positive effect,"DNT treatment could attenuate the SCI-induced apoptosis, significantly less apoptotic cells identified in the DNT group compared to control group at 24h",anesthesia: intramuscular injection of xylazine 5 mg/kg and ketamine hydrochloride 50 mg/kg; euthanasia: anesthetized with ketamine (50 mg/kg),"In conclusion, experimental results observed in this study suggest that treatment with dantrolene possess potential benefits for traumatic SCI.",not reported,"very similar paper as above but different drug, same authors as above, some parts of the methods are 100% copy-pasted from one another",No,
Catherine,McKillop et al.,2016,Conditional Sox9 ablation improves locomotor recovery after spinal cord injury by increasing reactive sprouting,10.1016/j.expneurol.2016.05.028,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Takahashi et al.,2012,Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: A phase I/IIa clinical trial,10.1007/s00586-012-2213-3,English,,excluded,Out of scope,No control group,No control group,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kamiya et al. ,2015,Neuroprotective therapy with granulocyte colony-stimulating factor in acute spinal cord injury: a comparison with high-dose methylprednisolone as a historical control,10.1007/s00586-014-3373-0,English,,excluded,Out of scope,No control group,No control group,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Soy et al.,2004,Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury,10.1007/s00701-004-0343-z,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kaptanoglu et al ,2005,Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury,10.1007/s00701-004-0447-5,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Moutaery et al ,1999,Effect of acrylamide on neurological recovery following spinal cord injury in rats,10.1007/s007010050406,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Colón et al,2018,Continuous tamoxifen delivery improves locomotor recovery 6 h after spinal cord injury by neuronal and glial mechanisms in male rats,10.1016/j.expneurol.2017.10.006,English,,included,,,,,,rats,Sprague Dawley,>= 90,>= 34,,,>= 47,,,"sham >= 9 (numbers reported are from the neurological scores, unclear whether animals are the same for the histology)",male 100%,male,100,2 months old,2,,,,Months,,~ 300g,300,,,,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + weight drop contusion (MACSIS impactor, 10g rod dropped from 12.5mm height, compression held for 5s)","2, 7, 14, 28 or 35 days",tamoxifen,tamoxifen,,0.71 mg/day,"0, 6, 12 or 24 h after SCI",,21 days,continuous diffusion (pellet),subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, grid walk test",,"BBB: 2 evaluators, scored each hindlimb, both scores were averaged and total score reported for each animal; grid walk test: cross a horizontal ladder, 3ft long, bars separated by 1 or 2 in., scores assigned according to the number of correct paw positions and the number of errors (missed footsteps), avergae score (both hindlimbs) was reported","day 2, 7, 14, 21, 28, 35 after injury",,yes,mixed effects (timing),"BBB score was significantly improved in tamoxifen given at 6h and 0h after injury, compared to control, no difference between control and tamoxifen started at 12 or 24h; grid walk: reduced number of errors and  increased number of paw positions in tamoxifen at 0 and 6h compared to control, but not in tamoxifen given at 12 or 24h",histological assessment,"neuronal cell count at the dorsal and ventral horn, white matter quantification, cavity quantification, ","2, 7, 14, 28 or 35 days",yes,mixed (stats/no stats),significant increase in white matter spared tissue was observed in the SCI-TAM 0 h and SCI-TAM 6 h groups when compared to SCI-PLB (0 + 6 h) rats at 35 DPI; A significant increase in the total number of neurons at the VH and DH was found in the groups SCI-TAM (0 h) and SCI-TAM (6 h) relative to SCI-PLB; 2 time points not reported,"anesthesia: ketamine/Xylazine/Acepromazine, 87.5/4.2/0.8 mg/kg; postop: 3 mL of isotonic saline, 0.05 mg/kg/day buprenorphine for 3 days and 7 days of Cefazolin (25 mg/kg) as antibiotic treatment; euthanasia: sedated, the thoracic cavity was exposed and the animals were perfused intracardially with 250 mL of ice-cold phosphate buffered saline (PBS) followed by 250 mL of ice-cold 4% Paraformaldehyde (PFA) solution",This study supports the use of TAM in the SCI setting due to its neuroprotective effects but with a significant sexually dimorphic therapeutic window,not reported,"use ketamine, saline, buprenorphine",No,
Lucie,Yoshino et al,1998,Role of norepinephrine and excitatory amino acids in edema of the spinal cord after experimental compression injury in rats,10.1007/s007760050021,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (6-hydroxydopamine),,,rats,Wistar,,,,,,,,,male 100%,,,not reported,,,,,,,range: [400-450](g),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Jadid et al,2012,The efficacy of antioxidants in functional recovery of spinal cord injured rats: An experimental study,10.1007/s10072-011-0829-4,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wei et al,2014,"Tamoxifen reduces infiltration of inflammatory cells, apoptosis and inhibits IKK/NF-kB pathway after spinal cord injury in rats",10.1007/s10072-014-1828-z,English,,excluded,Out of scope,No assessments of interest,No assessement of interest,,,rats,"Sprague–Dawley, pathogen free",51,,,,,,,,female 100%,,,10-12 weeks,,,,,,,range: [200-220](g),,,,,,,level: T12; severity: not reported,,,,"laminectomy + weight drop contusion (NYU impactor, rod was dropped from 12.5mm height)",24h,tamoxifen,,,5 mg/kg,30 min post-injury,,single dose,-,intrathecally,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kuricova et al,2014,Oral administration of inosine promotes recovery after experimental spinal cord injury in rat,10.1007/s10072-014-1840-3,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Topsakal et al,2002,Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury,10.1007/s101430100183,English,,excluded,Out of scope,No assessments of interest,No assessement of interest,,,rats,albino Wistar,160,,,,,,,,male 100%,,,not reported,,,,,,,range: [250-340](g),,,,,,,level: T4-T5; severity: not reported,,,,laminectomy + compression (extradural compression for 30 sec using Yasargil aneurysmal clip with a closing force of 180g),"10, 30, 120min","methylprednisolone sodium succinate (MPSS), dextromethorphan (DM) and combination",,,"MPSS: 30 mg/kg, DM: 30 mg/kg",at the time of injury,,single dose,-,intraperitoneally,,,,,,,,,,,,,,,,,,,,,,
Catherine,Povysheva et al,2016,New xymedon analogues for stimulation of posttraumatic regeneration of the spinal cord in rats,10.1007/s10517-016-3580-2,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xu et al,2009,Combination of dexamethasone and aminoguanidine reduces secondary damage in compression spinal cord injury,10.1007/s10571-009-9380-8,English,,included,,,,,,rats,Sprague Dawley,25,5,,,5,,,"5 animals per group (sham, control, aminoguanidine, dexamethasone, aminoguanidine + dexamethasone) ",male 100%,male,100,not reported (adult),,,,,,Adult,range: [230-255](g),,,230,255,g,,level: T12; severity: not reported,T12,Not reported,compression,"laminectomy + compression (dura intact, T11 and T13 spinal processes were clamped in a spinal compression frame, and the compression was applied by suspending the base of the compression platform (area 2 mm*5 mm) onto the exposed T12 cord under microscopic control. A weight of 50 g was applied statically to the platform for exactly 5 min)","24h, 10 days","aminoguanidine (not of interest), dexamethasone",dexamethasone,,0.025 mg/kg,1 and 4h after SCI,,2 doses,-,intraperitoneally,,neurological/functional/behavioral assessment,modified murine BBB scale,,recovery from motor disturbance was graded,once a day for 10 days after injury,,not reported,no effect,no significant difference in dexamethasone group comapred to control in terms of BBB score,histological assessment,"spinal cord water content (Water content in spinal cord tissue was obtained by the following calculations: Hemispheric water content (%) = (wet weight - dry weight)/wet weight 9 100%), BSCB permeability, neutrophil infiltration",24 h after SCI,not reported,no effect,no significant difference in % water content or neutrohpil infiltration or BSCB permeability in dexamethasone compared to control groups,"anesthesia: not reported, euthanasia: decapitation","we have also clearly demonstrated that the combination therapy of minoguanidine (AG) and dexamethasone (DEX) significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, our results clearly indicated for the first time that strategies targeting multiple proinflammatory pathways may be more effective than a single effector molecule for the treatment of SCI.",not reported,focus on combination of minoguanidine (AG) and dexamethasone (DEX) but AG not of interest so only reported DEX group alone ,Yes (drug of interest + drug not of interest),
Lucie,Saganová et al,2009,Effects of long-term FK506 administration on functional and histopathological outcome after spinal cord injury in adult rat,10.1007/s10571-009-9395-1,English,,included,,,,,,rats,Wistar,19,9,,,10,,,,male 100%,male,100,not reported,,,,,,Not reported,range: [300-330](g),,,300,330,g,,level: T8-T9; severity: not reported,T8 - T9,Not reported,compression,"laminectomy + balloon-compression (thoracic spinal column was exposed and small opening was drilled in the Th10 vertebral arch with a dental drill. The periosteal membrane was opened and a 2-French Fogarty catheter was inserted into the epidural space and advanced cranially so that the center of the balloon rested at the Th8–Th9 segment level of the spinal cord. The balloon (connected to a 50 ll Hamilton syringe) was rapidly inflated with 12 microL of distilled water for 5 min, afterwhich the catheter was removed)",6 weeks,tacrolimus,tacrolimus,,1 mg/kg/day,15 min after SCI,,6 weeks,daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"ranging from 0 to 21, where 0 reflects complete paraplegia and 21 reflects a normal performance","first done at 24 h after injury and then, weekly throughout the 6-week survival period",,not reported,no effect,There were no significant differences in neurological scores between placebo and experimental group at any time point.,histological assessment,"Morphometric Analysis of the Lesion, sparing of the white matter, loss of gray matter, aggregates of macrophages, glial cells and vascular elements",6 weeks,not reported,no effect,no effect in spared white or gray matter ,"anesthesia: halothane (1.5–2% halothane in air delivered via face mask), euthanasia: transcardially perfused with saline followed by 4% paraformaldehyde in 0.1 M phosphate buffer","long-term FK506 treatment did not affect the parameters of outcome following balloon-compression SCI in the rat; however, multiple effects of FK506 should be taken into account when evaluating the outcomes in transplantation studies.",not reported,no effect found for tacrolimus,No,
Catherine,Hall et al,1989,Correlation Between Attenuation of Posttraumatic Spinal Cord Ischemia and Preservation of Tissue Vitamin E by the 21-Aminosteroid U74006F: Evidence for an In Vivo Antioxidant Mechanism,10.1089/neu.1989.6.169,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Seeds et al,2011,Plasminogen Activator Promotes Recovery Following Spinal Cord Injury,10.1007/s10571-011-9701-6,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al,2017,FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-kappa B in Microglia Cells,10.1007/s10571-016-0422-8,English,,excluded,Out of scope,No assessments of interest,only histology not of interest,,,rats,Sprague Dawley,24?,,,,,,,,male 100%,male,100,not reported (adult),,,,,,Adult,range: [220-250](g),,,220,250,g,,level: T9-T11; severity: not reported,T9 - T11,Not reported,contusion,laminectomy + weight drop contusion (10-g metal rod at a height of 25 mm),"3, 7, 14, and 21 days after SCI",tacrolimus,tacrolimus,,0.5 mg/kg,30 min after operation,,single dose,-,oral,,-,-,,-,-,,-,,-,histological assessment,microglia population,"3, 7, 14, 21 days",not reported,no effect,cell number has no significant difference between post-injury cords treated with or without FK506,"anesthesia: 4 % sodium pentobarbital (40 mg/kg, i.p.); postop: penicillin (intramuscularly, 100,000 unit/per animal/day) and buprenorphine (0.03 mg/kg) for 3 days to prevent post operative infection and to relieve the pain from surgery","In conclusion, we found that FK-506 prevents the activation of NF-jB in microglia, which is consistent with the results obtained from the reduced production of proinflammatory cytokines in the SCI response. Thus, FK506 treatment may be useful in the management of patients  with SCI.",not reported,"use penicillin, buprenorphin",No,
Catherine,Alvarez-Mejia et al,2015,Functional recovery in spinal cord injured rats using polypyrrole/iodine implants and treadmill training,10.1007/s10856-015-5541-0,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fabela-Sánchez et al,2018,Effect of the combined treatment of albumin with plasma synthesised pyrrole polymers on motor recovery after traumatic spinal cord injury in rats,10.1007/s10856-017-6016-2,English,,included,,,,,,rats,Long Evans,60,6,,,6,,,10 groups of 6 animals,female 100%,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T9; severity: moderate,T9,moderate,contusion,laminectomy + weight drop contusion (NYU impactor),8 weeks,"rat serum albumin (RSA), iodine-doped polypyrrole particles synthesised by plasma (PPPy/I, not of interest)",albumin,,10 microL of a solution of 14 mg/mL,2 days after,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,BBB scale,,"22 points, where zero indicates null mobility of the hind limbs and 21 a normal gait, 3 observers with kappa index of 0.7","24 h after TSCI, then once per week",,yes,no effect,no significant different in albumin vs control group in terms of BBB score,-,-,-,-,,-,"anesthesia: ketamine and xylazine (77.5 and 12.5 mg/kg of body weight, respectively) intramuscularly, followed by asepsis and antisepsis protocols; postop: antibiotic (1,200,000 IU of penicillin benzatinic) intramuscularly and an anti-inflammatory (5 mL/2 L of paracetamol in the drinking water) orally, irritations and skin ulcers due to compression by position were treated topically to avoid infections","In vivo tests showed that this interaction may be beneficial in the treatment of traumatic spinal cord injury (TSCI), depending on the surface characteristics with or without rat serum albumin (RSA). The TSCI + P1 and TSCI + P2 + RSA groups obtained significant differences in functional recovery compared with the control group according to the Basso, Beattie and Bresnahan scale (BBB)",not reported,"use ketamine, paracetamol, penicillin",Yes (drug of interest + drug not of interest),
Lucie,Darvishi et al,2014,Decreased GFAP Expression and Improved Functional Recovery in Contused Spinal Cord of Rats Following Valproic Acid Therapy,10.1007/s11064-014-1429-5,English,,included,,,,,,rats,Sprague Dawley,>= 220,10,,,200,40,,all animals with 500 mg/kg died,female 100%,female,0,not reported,,,,,,Not reported,range: [220-240](g),,,220,240,g,,level: T8; severity: moderate,T8,moderate,contusion,laminectomy + weight drop contusion (dropping the 10 g rod (2.5 mm in diameter) weight from 12.5 mm on the exposed spinal cord surface),12 weeks,valproic acid,valproic acid,,"150, 200, 300, 400 or 500 mg/kg","2, 6, 12 or 24 h",,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"BBB score, H-reflex analysis",,"BBB: 0 (complete paralysis) to 21 (normal mobility), 2 examiners, 4 min, plastic container with 110 cm diameter and 50 cm height, evaluated the rats for wounds in the hind limbs, tail and foot autophagia (autotomy) and perineal infection, measured hind limb locomotor ability of the rats and their body positions for the right side up and left side up, average score for these two positions was evaluated; H-reflex: ratio of the maximum H to maximum M reflexes (H/M ratio: Hmax and Mmax waves were recorded in order to calculate the H max /M max), recording was done at the plantar muscles of the rats under anesthesia, amplitudes of M and H-waves as determined by the maximum to maximum values of each waveform, were used for calculating the average H/M ratio.","BBB: daily for 10 days before surgery, while at post-surgery, it was at day 1, day3 and 1 week, then twice a week for 2 weeks, and finally once a week for 12 weeks; H-reflex analysis: Pre-op, and at 1, 6 and 12 weeks post-operation",,not reported,mixed (stats/no stats),"BBB: optimal dose was 300 mg/kg at 12 h post-injury, where the score was significantly higher than all of the other experimental groups at all doses used in the therapy protocol (P < 0.05) as well as the untreated controls (P < 0.05), significance between control and treated not tested (?); H-reflex: no comparison with control group, ""value of H/M ratio in 300 mg/kg was at 12 h, which was significantly lower than the other subgroups used in the study""; positive effect only refers to 300 mg/kg; there was dose dependent increase in BBB score as it reached the highest value at 300 mg/kg and then it declined at 400 mg/kg",histological assessment,"cavitation, percentage of the volume fraction was calculated by dividing the cavity area of each section to the total area of the spinal cord, total tissue of the spinal cord",12 weeks,not reported,mixed (stats/no stats),"The morphometric analysis shows that the lowest volume density of cavitation was at 300 g/kg (12 h group, the epicenter region), which was significantly lower than that of the epicenter regions at the subgroups used in the study; The regeneration rate was estimated according to Naghdi et al. [39], and the highest rate was at 300 mg/kg; ","anesthesia: ketamine (80 mg/kg) and xylazine (10 mg/kg); postop: prophylactic antibiotic was given (cefazolin: 50 mg/kg) for 3 days, in order to decrease the pain, tramadol was used every 12 h for 3 days (0.2 mg/kg); euthanasia: deeply anesthetized by intraperitoneal injection of ketamine (80 mg/kg)",We conclude that treating the contused rats with 300 mg/kg of VPA at 12 h post-injury improves the functional outcome and reduces the traumatized SC gliosis,not reported,"there was dose dependent increase in BBB score as it reached the highest value at 300 mg/kg and then it declined at 400 mg/kg; The animals treated with 500 mg/kg at all delivery times died; use tramadol, ketamine, cefazolin",No,
Lucie,Li et al,2018,Lithium Inhibits GSK3 beta Activity via Two Different Signaling Pathways in Neurons After Spinal Cord Injury,10.1007/s11064-018-2488-9,English,,excluded,Non-sci population,,Out of scope: isolated spinal cords,,,mice,C57BL/6 and B6/NTg(Thy1-YFP)14 Mes/J transgenic mice,,,,,,,,,male 100%,,,3 months old,,,,,,,~25g,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Yu et al,2014,Curcumin improves the integrity of blood-spinal cord barrier after compressive spinal cord injury in rats,10.1016/j.jns.2014.07.056,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zu et al,2014,Curcumin improves the recovery of motor function and reduces spinal cord edema in a rat acute spinal cord injury model by inhibiting the JAK/STAT signaling pathway,10.1016/j.acthis.2014.08.004,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Ni et al,2014,Curcumin inhibits the increase of labile zinc and the expression of inflammatory cytokines after traumatic spinal cord injury in rats,10.1016/j.jss.2013.12.023,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Tohda et al,2011,Current and future therapeutic strategies for functional repair of spinal cord injury.,10.1016/j.pharmthera.2011.05.006,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Qi et al,2019,Cyclic adenosine phosphate improves functional recovery after spinal cord injury via activating unfolded protein response,10.1691/ph.2019.8347,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Lau et al,2013,"Cyclic AMP promotes axon regeneration, lesion repair and neuronal survival in lampreys after spinal cord injury",10.1016/j.expneurol.2013.09.004,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Ma et al,2012,Cysteine- and glycine-rich protein 1a is involved in spinal cord regeneration in adult zebrafish,10.1111/j.1460-9568.2011.07958.x,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Pan et al,2002,Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion,10.1002/jnr.10215,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Kang et al,2007,Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury,10.1111/j.1750-3639.2007.00070.x,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Liu et al,2014,Cytosolic Phospholipase A(2) Protein as a Novel Therapeutic Target for Spinal Cord Injury,10.1002/ana.24134,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Tomás and Lucie,Torres et al,2018,Dantrolene and mesenchymal stem cells promote functional improvement in Wistar rats with spinal cord injury,10.1590/1678-5150-PVB-5165,Portuguese,,included,,,,,,rats,Wistar,60,12,,,12,,,"5 groups of 12, 1 sham, 1 control, 1 dantrolene, 2 treatment groups not of interest",male 100%,male,100,20 weeks,20,,,,Weeks,,"450(average, g)",450,,,,g,,level: T12; severity: paraplegia,T12,paraplegia,contusion,"laminectomy + weight drop contusion (stereoaxis device from EV-UFMG, weight of 70g, 5 min compression on the exposed spinal cord)",28 days,dantrolene,dantrolene,,10 mg/kg,1h post laminectomy,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"motor capacity, proprioception, tactile capacity, inclined plane, sensitivity to pain",,"based on reference Torres et al. 2010b: motor capacity assessed in open field, proprioception and tactile capacity via manual extension of limb and observation of response (return of limb, paw placement), pain sensitivity via clamp (?, likely pinch) on pelvic limb","day 0 (24h before surgery), 1, 4, 7, 10, 13, 16, 19, 22, 25, 28",,not reported,mixed effects (assessment),"motor function: dantrolene group significantly better than control starting day 22 until the end; sensitivity to pain: dantrolene significantly better than control group starting day 10 until the end of the experiment (go back to the sham group); no difference in proprioception, tactile positioning between dantrolene and control; inclined plane significantly better in dantrolene group compared to control group starting day 22 until end of the experiment",-,-,-,-,,-,"preop: tramadol (2 mg/kg, oral), anesthesia: isoflurane per mask; antibiotherapy: cefalexine (30 mg/kg, IV)",It was concluded that dantrolene and MSCs for the treatment of SCI in rats have neuroprotection effect and promote functional neurological improvement.,longer observation period might be needed to observe effects from combination of dantrolene and stem cells,"paper in Portuguese, used tramadol, isoflurane",Yes (drug of interest + drug not of interest),
Lucie,Guo et al,2018,Metformin Protects Against Spinal Cord Injury by Regulating Autophagy via the mTOR Signaling Pathway,10.1007/s11064-018-2525-8,English,,included,,,,,,rats,Sprague Dawley,60,>= 9,,,>= 9,,,5 animals per group in BBB,female 100%,female,0,not reported,,,,,,Not reported,range: [200-240](g),,,200,240,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight drop contusion (10-g weight, height of 5cm above the exposed dura, hind limbs twitching, tail swing, and spinalcord hematoma formation were used as evidence of a successful SCI model)",7 or 28 days,metformin ,metformin,,10 mg/kg ,not reported,,3 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"0=complete immobility, 21=normal function, graded according to the rat's motor motion and rating scale","1, 3, 7, 14, 21 and 28 days after SCI",,yes,positive effect,"BBB scores were significantly higher on days 14 (10.33 ± 1.53 vs. 7.00 ± 1.00, p = 0.034), 21 (15.2 ± 1.57 vs. 9.67 ± 1.60, p = 0.005) and 28 (16.00 ± 2.00 vs. 11.67 ± 1.45, p = 0.003) post injury in metformin treated animals when compared to untreated animals ",histological assessment,"tissue sparing, number of surviving neurons",7 days,not reported,positive effect,"the number of surviving neurons was higher in metformin-treated animals compared to the untreated SCI animals (22.00 ± 2.12 vs. 14.60 ± 1.82, p < 0.001) ","anesthesia: intraperitoneal injection of 10% chloral hydrate (0.3 ml/100 g), euthanasia: anesthetized and perfused with a 4% paraformaldehyde solution","taken together, these findings suggest that metformin functions as a neuroprotective agent following SCI by promoting autophagy and inhibiting apoptosis by regulating the mTOR/P70S6K signaling pathway",not reported,used chloral hydrate,No,
Catherine,Jiang et al,2007,Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury,10.1007/s11302-007-9079-6,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Reigada et al,2017,Diadenosine tetraphosphate (Ap(4)A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment,10.1007/s11302-016-9541-4,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Tang et al,2020,Deferoxamine Ameliorates Compressed Spinal Cord Injury by Promoting Neovascularization in Rats,10.1007/s12031-020-01564-1,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Liu et al,2011,Deferoxamine improves neurological function in a rat model of experimental spinal cord injury,10.3969/j.issn.1673-5374.2011.35.005,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Yao et al,2019,Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis,10.4103/1673-5374.245480,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nowicki et al,2009,Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures,10.1016/j.ejcb.2009.05.003,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hill et al,2001,Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat,10.1006/exnr.2001.7734,English,,excluded,Out of scope,No drug of interest,Out of scope (no drug tested),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Figley et al,2014,Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury,10.1371/journal.pone.0096137,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chio et al,2021,Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier,10.1016/j.nbd.2020.105187,English,,included,,,,,,rats,Wistar,173,69,,,70,,,"89 for short-term readouts and 84 for long-term tissue and neurological assessments; sham n=20, missing 14 rats in the counts",female 100%,female,0,not reported (adult),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: C7-T1; severity: moderate-severe,C7 - T1,moderate - severe,compression,"laminectomy + compression-contusion (modified aneurysm clip calibrated to deliver 35 g of compressive force, compress for 1 min before release and removal)","24h, 8 weeks",Human immunoglobulin G (hIgG),immune globulin,,100 mg/mL (2g/kg),"15 min, 1h or 4h",,single dose,-,intravenously,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, inclined plane test, grip strength meter, tail flick test, gait analysis with CatWalk XT 10.6 multivariate system, somatosensory evoked potentials (SSEPs)",,"BBB: 21-point open-field; inclined plane test:  flat plane surface with their body axis parallel to the plane and were required to maintain their body position on the plane for 5 s for 3 of 5 attempts, if a rat was able to maintain its position for 3 trials, the angle of the plane was subsequently increased at increments of 5◦ until the rat failed to maintain its position; grip strength meter: animals were held by the hindlimbs and lower abdomen and drawn backward at a consistent speed within reach of a metal rung connected to the strength apparatus, strength meter measures the maximal force achieved when the grip was broken, strength was averaged over 5 successful grasps; tail flick test: wrapped in a blanket while the tail was left exposed to a beam of light, which served as a heat source, the time elapsed before the rat ‘flicked’ its tail in response to heat was recorded; CatWalk: successful performance required three complete crossings with at least three consecutive step cycles for analysis, paw prints labeled",neurobehavioral assessments: once per week for 8 weeks post-SCI; electrophysiology and CatWalk: 8 weeks after injury,,yes,mixed effects (assessment) + mixed effects (timing),"BBB: hIgG (2 g/kg) demonstrated better hindlimb function (all groups), inclined plane test and grip strength meter: significant improvements for grip strength and trunk stability began at 4 weeks post SCI; gait analysis with CatWalk XT 10.6 multivariate system: quantifiable positive changes in gait as measured by the Noldus CatWalk system. Specifically, delayed administration of hIgG (2 g/kg) led to improvements in the regulatory index (a measure of interlimb coordination during gait), stride length (a measure of distance between two consecutive paw placements of the same paw) and swing speed (computed from stride length and swing duration), no improvements in the animal’s ability to maintain balance during movement or preferred paw usage during motion, as indicated by base of support and paw area, respectively; somatosensory evoked potentials (SSEPs) and tail flick test: no differences in pain sensation across all time points regardless of treatment groups,  delayed administration of hIgG (2 g/ kg) resulted in greater electrical activity in the brain due to tactile stimulation at the tibialis anterior. ",histological assessment,"total tissue, gray matter, white matter, lesion and cavity volumes",24h after injury,yes,mixed effects (assessment),"delayed administration of hIgG (2 g/kg) resulted in greater volumes of healthy white and gray matter, as well as a concurrent decrease in cavity and lesion tissue volume at all 3 time points, hIgG treatment increased the number of neurons (NeuN+/DAPI+ cells) in the spinal cord gray matter, Protective effects were not observed in the spinal cord gray matter from epicenter and caudal regions. Overall, tissue and neuronal preservation in animals treated with hIgG (2 g/kg) correlated with improved motor and sensory functions.",anesthesia: not reported; postop: 1 milliliter (mL) of buprenorphine (0.03 g/kg) and 5 mL of saline; euthanasia: not reported,"Overall, we demonstrate that delayed administration of hIgG (2 g/kg) at 1 and 4-h post-injury enhances short-term and long-term benefits after SCI by modulating local and systemic neuroinflammatory cascades.",not reported,use buprenorphine,No,
Lucie,Kopper et al,2019,Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury,10.3389/fncel.2019.00490,English,,included,,,,,,mice,C57BL/6,100,30,,,70,,,,female 100%,female,0,4 months old,4,,,,Months,,not reported,,,,,,Not reported,level: T9; severity: moderate-severe,T9,moderate - severe,contusion,laminectomy + contusion (IH injury device 75-kdyn),28 days,azithromycin,azithromycin,,160 mg/kg/day,"30 min, 3h or 24h after SCI",,7 days,daily,oral,,"neurological/functional/behavioral assessment, pain","BMS score, mechanical allodynia testing",,"BMS: open field for 4 min, each hindlimb was scored separately based on movement (e.g., ankle placement and stepping) and whole-body coordination and trunk stability were also scored; the average of both hindlimb scores was used to generate a single score for each animal, 0=complete paralysis, 9=normal locomotion, % of mice with plantar stepping; mechanical allodynia testing: manual up-down approach with von Frey monofilaments, monofilament was pressed perpendicularly against the plantar surface of the hindlimb until bent, beginning with the 1.4 g monofilaments and ranging from the 0.4 g to 6.0 g monofilaments. Fifty percentage withdrawal threshold was calculated and reported as the average of both hind paws at each time point, positive responses include rapid paw withdrawal, paw shaking and/or paw licking.","BMS: before surgery, 1, 3, 7, 14, 21 and 28 days after injury; mechanical pain: baseline (before surgery) and 28 days after surgery",,yes,mixed effects (assessment) + mixed effects (timing),"BMS: BMS significanlty higher in both 30 min and 3h after injury start of azytromycin compared to the vehicle group (group with start delayed by 24h discontinued because it was clear there was no effect); % mice with plantar stepping significantly higher in both treatment groups compared to vehicle group; mechanical pain threshold: SCI induced allodynia (p < 0.0001), however, azytromycin administration beginning 30 min and 3 h following injury did not significantly reduce long-term pain responses (mechanical allodynia) relative to vehicle-treated animals at 27 dpi (p = 0.89)",histological assessment,"epicenter tissue sparing (%), lesion length (mm), neuron counts",28 days after injury,yes,mixed effects (assessment) + mixed effects (timing),"tissue sparing at the lesion epicenter did not reach statistical significance for either the 30 min or 3 h treatment groups in the current studies, azythromycin administration significantly reduced the mean rostral-caudal lesion length when given 30 min after injury (p = 0.03); the 3-h delivery timepoint was not statistically significant (p=0.55) and did not affect neuron sparing throughout the rostral-caudal extent of the lesion p = 0.26 or total neuron sparing according to area under the neuron by distance curve p=0.98","anesthesia: ketamine (100 mg/kg) and xylazine (10 mg/kg), IP; postop: one injection of buprenorphine-SR (1 mg/kg, SC), one injection of antibiotic (5 mg/kg, enrofloxacin 2.27%), antibiotic continued SC in 1ml saline for 5 days; euthanasia: anesthetized then transcardially perfused with cold PBS (0.1 M, pH 7.4), followed by perfusion with cold 4% paraformaldehyde ","Collectively, these results add to a growing body of evidence supporting Azithromycin’s translational potential as a therapeutic agent for SCI and other neuroinflammatory conditions in which patients currently have very few options.",1) only one AZM dosing paradigm (160 mg/kg/day) was tested,"combined 3 studies, use buprenorphine, ketamine",No,
Catherine,Afshary et al.,2020,Therapeutic Effects of Minocycline Pretreatment in the Locomotor and Sensory Complications of Spinal Cord Injury in an Animal Model,10.1007/s12031-020-01509-8,English,,included,,,,,,rats,Sprague Dawley,40,10,,,20,,,assume equal distribtution between groups,100% male,male,100,not reported,,,,,,Not reported, 220 - 260 g ,,,220,260,g,,T9,T9,Not reported,compression,contusion injury was induced by compression ofthe cord with an aneurysmal clip ,28 days,minocycline,minocycline,,"group 1: 90 mg/kg, 45 mg/kg
group 2: 90 mg/kg, 45 mg/kg","group 1: pretreatment (90 mg/kg 48 hrs pre-injury)
group 2: 90 mg/kg immediately post-surgery",,"group 1: 3 doses, 48 hours
group 2: 3 doses, 24 hours",every 12 hours,intravenously,,locomotor function,BBB score,,"The Basso, Beattie, Bresnahan (BBB) ratingscale was used, with a scoring system ranging from 0 to 21based on weight bearing, limb and joint movements, and co-ordination of individual joints (0 indicates no motor function,while 21 represents full motor ability) ","day 0, before the surgery, and 1, 3, 5, 7, 14, 21, and 28 days after the SCI",,yes,positive effect,"Minocyclin admninistration significantly improved locomotor ability (both for treatment and pretreatment groups), however it could not restore the locomotor ability to the level of sham operated animals.",Histopathalogy,"Histopathalogical scoring, Elisa, Nitrite Assay",at study completion - 28 days,yes,positive effect,The histopathologicalscores were significantly lower in minocycline treatment,"Anesthetized with a mixture of ketamine(80 mg/kg) and xylazine (10 mg/kg) injection. A prophylaxis injection of cefazolin with a dosage of 30 mg/kg. fter the procedure, the wounds were sutured, animals received intraperitoneal injection ofbuprenorphine (0.1 mg/kg). As part of the postoperative care, the rodents received normalsaline (2 ml), cefazolin (20 mg/kg), and buprenorphine(0.1 mg/kg) for 7 consecutive days.","According to the obtained results of this study, it could beconcluded that minocycline pretreatment can show promisingtherapeutic effects similar to its post-injury administration,inhibiting inflammatory microglial activity",Long-term drug administration was not per-formed as a major scope.,,No,
Lucie,Zhang et al.,2017,Metformin Improves Functional Recovery After Spinal Cord Injury via Autophagy Flux Stimulation,10.1007/s12035-016-9895-1,English,,included,,,,,,rats,Sprague Dawley,>= 45,>= 15,,,>= 15,,,"5 rats per group per assessment (3 days, 1 week and 4 weeks after injury)",female 100%,female,0,not reported (adult),,,,,,Adult,range: [220-250](g),,,220,250,g,,level: T9; severity: not reported,T9,Not reported,compression,laminectomy + crush compression (vascular clip 30 g force for 1 min),"3 days, 7 days (histo), 28 days (neuro)",metformin,metformin,,50 mg/kg/day,after surgery,,until sacrifice,daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB score, inclined plane test",,"BBB: 2 examiners,  0 points (complete paralysis) to 21 points (normal locomotion); inclined plane test: tested in two positions (right side or left side up) on a testing apparatus (i.e., a board covered with a rubber mat containing horizontal ridges that were spaced 3 mm apart). For each position, the maximum angle at which a rat could maintain its position for 5 s without falling was recorded and averaged to obtain a single score for each animal","1, 3, 7, 14, 21 and 28 days after injury",,yes,positive effect,BBB and inclined plane scores were significantly higher in metformin treated group compared to SCI only group starting at day 14 until end of the experiment,histological assessment,"number of ventral motor neuron, cavity as percent of preserved area in relation to the total area of each section",7 days,not reported,positive effect,"% preserved tissue significantly higher in metformin group compared to SCI only group both rostral and caudal to lesion; number of ventral motoneurons: significantly higher in metformin group compared to SCI only group both rostral and caudal to lesion, no difference at epicenter","anesthesia: sodium pentobarbital (65 mg/kg IP); postop: cefazolin sodium (50 mg/kg, i.p.); euthanasia: deeply re-anesthetized with 10 % chloralic hydras (3.5 ml/kg, i.p.) and perfused with 0.9 % NaCl, followed by 4 % paraformaldehyde in 0.01 M PBS","Together, these results illustrated that metformin improved functional recovery effect through autophagy flux stimulation and implied metformin to be a potential drug for SCI therapy.","Using PC12 cells in our in vitro study is one of the limitations of our study, and this may warrant further investigations to verify these in vitro results in primary neurons","use cefazolin, pentobarbital",No,
Catherine,Huebner et al.,2019,Diltiazem Promotes Regenerative Axon Growth,10.1007/s12035-018-1349-5,English,,excluded,Non-sci population,,Cortical axon growth,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Han et al. ,2019,Descending motor circuitry required for NT-3 mediated locomotor recovery after spinal cord injury in mice,10.1038/s41467-019-13854-3,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al.,2017,Lithium Chloride Facilitates Autophagy Following Spinal Cord Injury via ERK-dependent Pathway,10.1007/s12640-017-9758-1,English,,included,,,,,,rats,Sprague Dawley,>= 36,>= 12,,,>= 12,,,,male 100%,male,100,8-10 weeks (adults),,,8,10,Weeks,Adult,~ 225g,225,,,,g,,level: T4; severity: not reported,T4,Not reported,transection,transection,25 days,lithium,lithium,,50 mg/kg/day,after surgery,,10 days,daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB score, inclined plane test",,"BBB: 0 points (complete paralysis) to 21 points (normal locomotion), paw placement, joint movements, weight bearing, and coordination among the limbs were used to evaluate the BBB locomotion scale; inclined plane test: rats were placed horizontally on a smooth tilted board, from 0 degrees, the increment of the angle was 5 degrees, max angle = rat could maintain its position for 10s without falling","1, 3, 10, 20 and 25 days after injury",,not reported,positive effect,BBB and inclined plane scores were significantly higher in lithium treated group compared to SCI only group starting at day 10 until end of the experiment,"immunofluorescence, western blotting, mRNA expression (not of interest) ",-,-,-,,-,not reported,"Taken together, our results illustrated that lithium facilitated functional recovery by enhancing autophagy flux.",not reported,,No,
Catherine,Ye et al.,2016,Regulation of Caveolin-1 and Junction Proteins by bFGF Contributes to the Integrity of Blood-Spinal Cord Barrier and Functional Recovery,10.1007/s13311-016-0437-3,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Jin et al.,2021,Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.,10.1007/s13311-020-00974-8,English,,included,,,,,,rats,Long Evans,40,5,,,5,,,11 rats removed becuase they did not learn the task prior to injury (group not specified),female 100%,female,0,2-3 months,,,2,3,Months,,not reported,,,,,,Not reported,level: C4; severity: incomplete,C4,incomplete,compression,"partial laminectomy + crush (tips of deumont #2 tweezers so that each tip was 1 mm lateral of the midline and 2mm deep into the spinal cord parenchyma, spanning the gap between the dorsal root entries and keeping them closed for 20s)",8 weeks after injury (16 weeks after start of the experiment),"buspirone, fluoxetine",buspirone,,1–2 mg/kg (increased by 0.5 at week 3 and 5 post injury),1 week post injury,,8 or 5 weeks (for 8 weeks: crossover between week 6 and 8 = buspirone-treated rats were switched to saline treatment while the saline-treated rats were switched to a buspirone treatment),daily,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","grasping test (food retrieval), horizontal ladder task, spinal motor–evoked potentials (sMEPs)",,"reaching and grasping task: grasping attempt was subdivided into seven stages (advance, digit extension, arpeggio, grasp, supination I, supination II, and release), trained to reach through the window, grasp the pellet, and retrieve the pellet to its mouth for a period of 10 min or until they achieved a maximum of 20 attempts per session, A successful trial for the reaching task was scored when the rat was able to reach, grasp, and eat the pellet. Cases in which the rat made an error in reaching, grasping, or eating were scored as failures, success rate was calculated by counting the number of successful trials per session and expressed as a percentage of total trials, success rates were normalized to pre-injury scores; horizontal ladder test: ladder (1 m long) consisted of side walls made of clear Plexiglas and fitted metal rungs (3 mm diameter) that could be irregularly spaced at distances ranging from 1 to 3 cm, two templates of irregular rung patterns were alternated every other week during testing. Steps from both forelimbs were categorized as 1=miss, in which the paw was placed in between two rungs and did not make contact with any rungs before falling between the rungs, disturbing body posture and balance, 4= correct placement, in which the mid-portion of the paw was placed on a rung with full weight support and the digits curved around the rung. Misses and slips were considered as footstep errors. Error rates were calculated by counting the number of footstep errors per category and expressed as the average rate per trial; EMG: Monophasic and bipolar epidural stimulation (2 Hz) at spinal cord levels C6 and C8 was used to evoke potentials in selected forelimb muscles of the preferred forelimb at different current intensities using a constant current stimulator, monitoring of sMEPs",once per week from week 1 to 8 post injury,,yes,mixed effects (assessment),"buspirone group performed significantly better in reaching and grasping compared to control group, fluoxetine group performed significnatly better than control as well in the fixed doses regimen; horizontal ladder walking test: not significantly different in both treatments groups compared to control group; EMGs:  By 6 wpi, there were distinct differences in EMG patterns between saline- and buspirone-treated rats, mixed results for Integrated EMG in buspirone treated animals compared to controls, amplitude and AUC of sMEPs to the same stimulation parameters were significantly reduced in saline-treated animals but more sustained in buspirone-treated animals",histological assessment,?,8 weeks after injury,not reported,not reported,?,"postop electrodes: subcutaneous injections of buprenorphine (0.05 mg/kg) for pain relief before recovering from anesthesia and every 12 h for 3 days after surgery, together with 2.5 mg/kg antibiotic Baytril and 0.6 ml of lactated Ringer’s, subcutaneously; anesthesia SCI: not reported; euthanasia: perfused with 4% paraformaldehyde in 0.1 M phosphate-buffered solution (PBS)","both serotonergic drugs, buspirone and fluoxetine, neuromodulated these networks to physiological states that enabled markedly improved forelimb function after cervical spinal cord injury",not reported,"could not find the histological results, treatment regimen not so straight forward, use buprenorphine",No,
Lucie,Jin et al.,2021,Serotonergic Facilitation of Forelimb Functional Recovery in Rats with Cervical Spinal Cord Injury.,10.1007/s13311-020-00974-8,English,,included,,,,,,rats,Long Evans,40,12,,,12,,,11 rats removed becuase they did not learn the task prior to injury (group not specified),female 100%,female,0,2-3 months,,,2,3,Months,,not reported,,,,,,Not reported,level: C4; severity: incomplete,C4,incomplete,compression,"partial laminectomy + crush (tips of deumont #2 tweezers so that each tip was 1 mm lateral of the midline and 2mm deep into the spinal cord parenchyma, spanning the gap between the dorsal root entries and keeping them closed for 20s)",8 weeks after injury (16 weeks after start of the experiment),"buspirone, fluoxetine",fluoxetine,,1–5 mg/kg,1 week post injury,,8 or 5 weeks (for 8 weeks: crossover between week 6 and 8 = buspirone-treated rats were switched to saline treatment while the saline-treated rats were switched to a buspirone treatment),daily,intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","grasping test (food retrieval), horizontal ladder task, spinal motor–evoked potentials (sMEPs)",,"reaching and grasping task: grasping attempt was subdivided into seven stages (advance, digit extension, arpeggio, grasp, supination I, supination II, and release), trained to reach through the window, grasp the pellet, and retrieve the pellet to its mouth for a period of 10 min or until they achieved a maximum of 20 attempts per session, A successful trial for the reaching task was scored when the rat was able to reach, grasp, and eat the pellet. Cases in which the rat made an error in reaching, grasping, or eating were scored as failures, success rate was calculated by counting the number of successful trials per session and expressed as a percentage of total trials, success rates were normalized to pre-injury scores; horizontal ladder test: ladder (1 m long) consisted of side walls made of clear Plexiglas and fitted metal rungs (3 mm diameter) that could be irregularly spaced at distances ranging from 1 to 3 cm, two templates of irregular rung patterns were alternated every other week during testing. Steps from both forelimbs were categorized as 1=miss, in which the paw was placed in between two rungs and did not make contact with any rungs before falling between the rungs, disturbing body posture and balance, 4= correct placement, in which the mid-portion of the paw was placed on a rung with full weight support and the digits curved around the rung. Misses and slips were considered as footstep errors. Error rates were calculated by counting the number of footstep errors per category and expressed as the average rate per trial; EMG: Monophasic and bipolar epidural stimulation (2 Hz) at spinal cord levels C6 and C8 was used to evoke potentials in selected forelimb muscles of the preferred forelimb at different current intensities using a constant current stimulator, monitoring of sMEPs",once per week from week 1 to 8 post injury,,yes,mixed effects (assessment) + mixed effects (regimen),"buspirone group performed significantly better in reaching and grasping compared to control group, fluoxetine group performed significnatly better than control as well in the fixed doses regimen; horizontal ladder walking test: not significantly different in both treatments groups compared to control group; EMGs:  By 6 wpi, there were distinct differences in EMG patterns between saline- and buspirone-treated rats, mixed results for Integrated EMG in buspirone treated animals compared to controls, amplitude and AUC of sMEPs to the same stimulation parameters were significantly reduced in saline-treated animals but more sustained in buspirone-treated animals",histological assessment,?,8 weeks after injury,not reported,not reported,?,"postop electrodes: subcutaneous injections of buprenorphine (0.05 mg/kg) for pain relief before recovering from anesthesia and every 12 h for 3 days after surgery, together with 2.5 mg/kg antibiotic Baytril and 0.6 ml of lactated Ringer’s, subcutaneously; anesthesia SCI: not reported; euthanasia: perfused with 4% paraformaldehyde in 0.1 M phosphate-buffered solution (PBS)","both serotonergic drugs, buspirone and fluoxetine, neuromodulated these networks to physiological states that enabled markedly improved forelimb function after cervical spinal cord injury",not reported,"could not find the histological results, treatment regimen not so straight forward, use buprenorphine",No,
Catherine,Lin et al.,2015,Development of telmisartan in the therapy of spinal cord injury: Pre-clinical study in rats,10.2147/DDDT.S86616,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Cooper et al.,1980,Dexamethasone and severe head injury: A prospective double-blind study, 10.3171/jns.1979.51.3.0307 ,English,,excluded,Non-sci population,,Head injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Regina et al.,2009,Dexamethasone minimizes the risk of cranial nerve injury during CEA,10.1016/j.jvs.2008.08.049,English,,excluded,Non-sci population,,Cranial nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Brandoli et al.,2001,Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord,10.1016/S0169-328X(00)00284-9,English,,excluded,Duplicate,,Duplicate of row 275,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Brandoli et al.,2001,Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord.,10.1016/s0169-328x(00)00284-9,English,,included,,,,,,rats,Sprague Dawley,36,9,,,9,,,"18 rats with SCI, 18 rats with sham operation",female 100%,female,0,not reported,,,,,,Not reported,range: [220-250](g),,,220,250,g,,level: T8; severity: incomplete,T8,incomplete,contusion,"laminectomy + contusion (weight drop, impounder tip lowered onto the dura, 10g weight dropped 2.5cm onto the impounder)",7 days,dexamethasone,dexamethasone,,"1, 8, or 20 mg/kg (in 20 mg/kg group: 20 mg/kg for 4 days then 5 mg/kg until day 7)",4h after injury,,7 days,daily,subcutaneous,,behavioral/functional test,combined behavioral score (Gale scale/CBS),,"CBS ranges from 0 to 100, 0= no functional deficit, 100=abnormal responses in all of the tests, numerically rate motor and sensory loss, including hindlimb toe spread, placing and withdrawal reflexes (to extension, pressure and brief pain), righting reflex, hot plate test, swimming test","1, 4 7 days after injury",,yes,mixed effects (dosage),"high dose of dexamethasone reduced significantly the % of deficit measured by CBS compared to vehicle group, no significant difference between the 2 other dose group and the vehicle respectively",histological assessment,"mRNA, apoptosis and immunochemistry, number of apoptotic cells (TUNEL)",7 days after injury,not reported,mixed effects (dosage),"the number of apoptotic cells was reduced throughout the cord, in both white and gray matter, by high doses of DEX when compared to vehicle-treated rats. No change in the number of apoptotic cells was observed in rats treated with lower doses of DEX","anesthesia: chloral hydrate (360 mg / kg, i.p.); pretreatment: penicillin G (40 000 U / kg) the night  before, repeated the night after surgery; euthanasia: anesthesia + intracardially perfused with saline followed by 4% paraformaldehyde in 0.1 M PBS","DEX, given at high doses (20 mg / kg, s.c.) but not at low doses (1 or 8 mg / kg) prevented the increase in p75NTR mRNA and protein in SCI rats, without affecting the expression of TrkA. High doses of DEX also reduced cellular apoptosis both in white and gray matters. This effect correlated with the ability of DEX to accelerate behavioral recovery of function measured by a combined behavioral score. These data suggest that reduction of p75NTR in SCI may be a therapeutic strategy to limit cell and tissue damage and therefore to improve recovery of function in SCI patients",not reported,"histology focuses on immunochemistry, TUNEL test and mRNA, use of chloral hyrate and penicillin",No,
Catherine,Gao et al. ,2019,Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury,10.1016/j.bja.2019.08.026,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Liu et al.,2018,Dextran-based biodegradable nanoparticles: An alternative and convenient strategy for treatment of traumatic spinal cord injury,10.2147/IJN.S171925,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hall et al.,1987,Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury.,10.1016/0006-8993(87)91599-x,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Faden et al.,1988,Structure-activity relationships of TRH analogs in rat spinal cord injury,10.1016/0006-8993(88)91265-6,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Hashimoto et al.,1991,Contribution of serotonin neurons to the functional recovery after spinal cord injury in rats,10.1016/0006-8993(91)91630-J,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al,1984,Naloxone in experimental spinal cord ischemia: Dose-response studies,10.1016/0014-2999(84)90196-1,English,,included,,,,,,rabbit,New Zealand,60,15,,,45,,,see Table 1,not reported,not reported,not reported,not reported,,,,,,Not reported,2.0 (0.25)(kg),2,0.25,,,kg,,level: not reported; severity: not reported,Not reported,Not reported,ischemia,"laparotomy + ischemic (Approximately 18 h post-surgery, when the animals were awake, the aorta was occluded for 20 rain by pulling on the snare ligature. The ligature was subsequently released and removed with the guide tube through the surgical site)",48h,naloxone,naloxone,,"2.0, 0.2 or 0.02 mg/kg/h",15 min pre-occlusion,,4h,single dose,intravenously,,neurological/functional scores,neurological scores (locomotor status),,"ordinal grading scale: 0=complete paralysis, 1=some functional movement, markedly impaired; 2=hopping, slightly impaired, 3=normal","2, 24, 48h post-occlusion",,yes,mixed effects (dosage),"Neurological differences between high-dose naloxone and control rabbits were significant at both 1 and 2 days (each P < 0.05). Differences between moderate-dose naloxone rabbits and controls were significantly different at 2 days (P < 0.05), but not at 1 day, after occlusion. Differences between low-dose naloxone-treated rabbits and control rabbits failed to reach significance at eigher 1 or 2 days following occlusion (P > 0.05)",histopathological,"0=liquefication necrosis of gray matter with craniocaudal extent of > 4mm; 1=extent of 2-4mm; 2= <2mm; 3=no liquification necrosis, some gliosis and neuronal reaction may be evident",48h after occlusion,not reported,mixed effects (dosage),"histopathologic scores were significantly higher in naloxone-treated animals (Kruskal-Wallis statistic= 9.035, P = 0.029) and appeared to be dose-related",anesthesia: ketamine hydrochloride (50 mg/kg i.m.) and sodium pentobarbital (40 mg/kg i.v.); euthanasia: sodium pentobarbital,"in this 'spinal stroke' model in the rabbit, naloxone treatment significantly reduced motor dysfunction and was associated with less spinal pathology.",not reported,"use ketamine, pentobarbital",No,
Catherine,Faden et al,1990,Effects of competetive and non-competetive NMDA receptor antagonists in spinal cord injury,10.1016/0014-2999(90)90227-W,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hashimoto et al.,1991,EFFECT OF THYROTROPIN-RELEASING-HORMONE ON THE NEUROLOGIC IMPAIRMENT IN RATS WITH SPINAL-CORD INJURY - TREATMENT STARTING 24-H AND 7 DAYS AFTER INJURY,10.1016/0014-2999(91)90786-P,English,,included,,,,,,rats,Wistar,147,20,15,,,40,,"numbers derived from the survival analysis, but no number for the treatment group (also because one drug not of interest)",male 100%,male,100,not reported,,,,,,Not reported,~300g,300,,,,g,,"level: T11; severity: severest neurological impariment (complete paraplegia, no withdrawal response upon tail pinching, urinary incontinence)",T11,complete,compression,"laminectomy + compression(small burr hole made, stainless steel screw of 2mm diameter and 2.8mm length was implanted into burr hole made just above the dura mater, rats showing no neurologic dusfunction in following days were anesthesised again and screw was inserted as far as possible (compression) and left in place for 60 min)",28 days,naloxone,naloxone,,40 mg/kg/day,24h post injury,,7 days,once daily,subcutaneous,,neurological (motor and sensory) signs and scores,neurologic scores (motor and sensory deficit),,"0-5 based on both motor and sensory deficits were defined as follows: 0, no spontaneous movement of the hindlimbs and no withdrawal response upon tail-pinching, including avoidance movement by the forelimbs, biting of clamps or vocalization; 1, no spontaneous movement of the hindlimbs but showing a withdrawal response upon tail-pinching, including avoidance movement of the forelimbs, biting of clamps or vocalization; 2, barely perceptible coordinated movement of the hindlimbs and forelimbs; 3, well coordinated movement of the hindlimbs and forelimbs but no weight bearing by the four limbs; 4, able to walk with weight bearing by all four limbs but with an ataxic gait; 5, normal walking; Urinary incontinence was judged by wetness around the external genitalia due to urine; a rat whose NS increased from the initial score of 0 to a score of more than 1 and/or whose urinary incontinence disappeared was regarded as a subject whose signs had ‘improved’.","24 h, daily from day 2 to day 8, and 10, 14 and 21 days post-injury",,yes,no effect,neurological scores: treatment with naloxone had no significant effect on the neurological score compared to control group; prevalence of urinary incontinence: treatment with naloxone did not have any significant effect on the incidence compared to control group; prevalence of improvement: the percentage with improved neurologic signs in the group treated with naloxone was 14% Q/14) on day 4 and 43% (3/7) on day 31 and there was no significant difference between the control group and the naloxone-treated group at any observation time.,-,-,-,-,,-,"anesthesia: sodium pentobarbitone (30mg/kg i.p.); postop: Rats with urinary incontinence were treated daily with a broad spectrum antibiotic, ofloxacin (10 mg/kg i.p.)","These results indicate that TRH but not naloxone treatment starting 24 h and as late as 7 days after injury is effective in rats with the severest neurologic impairment following spinal cord injury. Thus, it is suggested that the duration of the effectiveness of late treatment with TRH on the neurologic impairment in rats with spinal cord injury is more than 1 week, while the duration with naloxone is less than 24 h.",not reported,"naloxone not main drug of the study, use ofloxacin",No,
Catherine,Merry et al.,1996,Functional outcome after incomplete spinal cord injuries due to blunt injury,10.1016/0020-1383(95)00171-9,English,,excluded,Out of scope,No control group,Out of scope: no control or comparator group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nacimiento et al.,1986,Increased functional vulnerability to acute compression injury of a spinal cord segment under barbiturate anesthesia,10.1016/0090-3019(86)90056-X,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhang et al.,1993,TIME-COURSE OF ENERGY PERTURBATION AFTER COMPRESSION TRAUMA TO THE SPINAL-CORD - AN EXPERIMENTAL-STUDY IN THE RAT USING MICRODIALYSIS,10.1016/0090-3019(93)90009-P,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hirschberg et al,1994,INFLAMMATION AFTER AXONAL INJURY HAS CONFLICTING CONSEQUENCES FOR RECOVERY OF FUNCTION - RESCUE OF SPARED AXONS IS IMPAIRED BUT REGENERATION IS SUPPORTED,10.1016/0165-5728(94)90209-7,English,,excluded,Non-sci population,,"Crushed optic nerve and sciatic nerve, but not spinal cord directly",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,dexamethasone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Winkler et al,1994,OPIOID RECEPTORS INFLUENCE SPINAL-CORD ELECTRICAL-ACTIVITY AND EDEMA FORMATION FOLLOWING SPINAL-CORD INJURY - EXPERIMENTAL-OBSERVATIONS USING NALOXONE IN THE RAT,10.1016/0168-0102(94)90072-8,English,,included,,,,,,rats,Sprague Dawley,38,5,,,>= 15,,,,100% male,male,100,not reported,,,,,,Not reported,350-400 g,,,350,400,g,,T10-11,T10 - T11,incomplete,transection,unilateral incision ,5 hours,naloxone,naloxone,,"group 1: 1 mg/kg (n = 5) 
group 2: 5 mg/kg (n = 5)
group 3: 10 mg/kg (n = 17)",30 min pre-injury,,1 dose,-,intraperitoneally,,electrophysiology,spinal cord evoked potentials,,"The right tibial and sural nerves were stimulated simultaneously and supramaximally at a frequency of 10 Hz with needles (Terumo injection needles, 0.6 × 25 mm) placed behind the achilles tendon (cathode) and below the plantar surface (anode), stimulus duration 0.1 ms","30 min before (-30), 2 min before (-2), immediately after (0), and at 2, 4, 10, 30, and 60 min after injury. hereafter, recordings were made at regular intervals of 1 h until 5 h after injury",,not reported,mixed effects (dosage),High dose of naloxone (10mg/kg) completely prevented the effect of injury on SCEP amplitudes. Pretreatment with lower doses of naloxone was not protective.,histopathology,water content,5 hours post-injury,not reported,mixed effects (dosage),"high dose (10mg/kg) resulted in reduction of water content;
low doses resulted in no difference to untreated (5mg/kg) or increased water content (1mg/kg)","Urethane anaesthesia (1.5 g/kg intraperitorteal-
ly)","In summary, this study suggests that (1) opioid peptides participate in bioelectrical disturbances and edema formation after trauma, (2) these effects of peptides are mediated via opioid receptors, and (3) naloxone may be used in clinical conditions as a premedication in several forms of surgery where manipulation of spinal cord is mandatory.",not reported,,No,
Catherine,Faden et al,1983,Neuropeptides in spinal cord injury: Comparative experimental models,10.1016/0196-9781(83)90009-8,English,,included,,,,,,cats,specific-pathogen free,30,10,,,10,,,1 other group with drug not of interest: n=10,100% female,female,0,not reported,,,,,,Not reported,,3,0.25,,,kg,,C7,C7,tetraplegia,contusion,"Allen method (weight drop), 600g/cm",not reported,naloxone,naloxone,,"2 mg/kg, 2 mg/kg/h",1h after injury,,4h,continuous,intravenously,,neurological function,neurological function (walking status),,"Neurological function was graded utilizing a 3-point ordinal scale:  0=paraplegia; l=severe paraparesis; 2=mild paraparesis, with ability to walk; 3=normal.",weekly for 6 weeks,,yes,positive effect,the functional scores for naloxone-treated animals were significantly better (p<0.05) than those in the saline controls,-,,,,,,anesthesia: pentobarbital,"The high doses of naloxone required to improve neurolog- ical function in both shock and spinal cord injury suggest that naloxone's effects, if mediated by opiate receptors, may be mediated by non-p, receptors such as the 8 or K receptor",not reported,,No,
Catherine,Faden et al,1983,Neuropeptides in spinal cord injury: Comparative experimental models,10.1016/0196-9781(83)90009-8,English,,included,,,,,,rats,Sprague Dawley,26,9,,,8,,,1 other group with drug not of interest: n=9,100% male,male,100,not reported,,,,,,Not reported,,,,250,300,g,,T9 - T11,T9 - T11,Not reported,contusion,"Allen method (weight drop), 50 g/cm",not reported,naloxone,naloxone,,"2 mg/kg, 2 mg/kg/h",1h after injury,,6h,continuous,intravenously,,neurological function,neurological function (walking status),,"Neurological function was graded utilizing a 3-point ordinal scale:  0=paraplegia; l=severe paraparesis; 2=mild paraparesis, with ability to walk; 3=normal.",48h,,yes,no stats,"effects on motor score not reported, only reported effects on spinal cord blood flow",-,,,,,,not reported,"The high doses of naloxone required to improve neurolog- ical function in both shock and spinal cord injury suggest that naloxone's effects, if mediated by opiate receptors, may be mediated by non-p, receptors such as the 8 or K receptor",not reported,,No,
Catherine,Faden et al,1983,Neuropeptides in spinal cord injury: Comparative experimental models,10.1016/0196-9781(83)90009-8,English,,included,,,,,,rabbit,New Zealand,16,7,,,9,,,,not reported,not reported,,not reported,,,,,,Not reported,,2,,,,kg,,thoracic,thoracic,Not reported,ischemia,Temporary aortic occlusion using a modification of the method of Zivin et al,not reported,naloxone,naloxone,,2 mg/kg,"15 min before injury, 1, 2 and 3h after injury",,4 doses,4 doses,intravenously,,neurological function,neurological function (walking status),,"Neurological function was graded utilizing a 3-point ordinal scale:  0=paraplegia; l=severe paraparesis; 2=mild paraparesis, with ability to walk; 3=normal.","2h, 48h, 7 days",,yes,mixed (stats/no stats),"naloxone-treated animals showed even better overall improvement as ocmpared with saline-treated animals at 2h post-injury (p<0.01), no stats reported for 48h or 7 days assessments but more animals recovered in the treatemtn group compared to control group",-,,,,,,not reported,"The high doses of naloxone required to improve neurolog- ical function in both shock and spinal cord injury suggest that naloxone's effects, if mediated by opiate receptors, may be mediated by non-p, receptors such as the 8 or K receptor",not reported,,No,
Lucie,,2014,Docosahexaenoic acid attenuates the early inflammatory response following spinal cord injury in mice: In-vivo and in-vitro studies,10.1186/1742-2094-11-6,English,,excluded,Out of scope,No drug of interest,Out of scope : no drug of interest (tested the effect of docosahexaenoic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,,2013,Docosahexaenoic Acid Augments Hypothermic Neuroprotection in a Neonatal Rat Asphyxia Model,10.1159/000351011,English,,excluded,Out of scope,No drug of interest,Out of scope : no drug of interest (tested the effect of docosahexaenoic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,,2018,Docosahexaenoic acid induces changes in microglia/macrophage polarization after spinal cord injury in rats,10.1016/j.acthis.2018.08.005,English,,excluded,Out of scope,No drug of interest,Out of scope : no drug of interest (tested the effect of docosahexaenoic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,,2019,Docosahexaenoic acid reduces microglia phagocytic activity via miR-124 and induces neuroprotection in rodent models of spinal cord contusion injury,10.1093/hmg/ddz073,English,,excluded,Out of scope,No drug of interest,Out of scope : no drug of interest (tested the effect of docosahexaenoic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al. ,1985,Motor dysfunction after spinal cord injury is mediated by opiate receptors,10.1016/0196-9781(85)90006-3,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,multiple,pathogen-free cats; New Zealand albino rabbits,"cats: n=34; rabbits: n=45 (15 per group WIN(-), WIN(+) and control)",,,,,,,,cats: not reported; rabbits: 100% males,,,not reported,,,,,,,cats: 3.0(0.25)(kg); rabbits: 2.0(0.25)(kg),,,,,,,cats: traumatic cervical injuries; rabbits: ischemic lumbar injuries,,,,"cats: modified Allen method (fixed weight of 20g dropped at fixed distance of 30cm through a guide tube on an impact plate resting on the exposed dura mater); rabbits: polyethylene tubing placed around the the aorta distal to the renal arteries and threaded through plastic buttons placed dorsal and ventral to the aorta, aorta occluded for 25 min, 18h hours after surgery ",not reported,"WIN44,441-3 [WIN(-)] and WIN44,441-2 [WIN(+)] : kappa selective opiate receptor antagonist (instead of naloxone in previous studies, which is not selective)",,,cats: 2mg/kg; rabbits: 0.4mg/kg,cats: 1h and 4h after (2 bolus per animal); rabbits: 5min and 2h after (2 bolus per animal) ,,-,-,intravenously,,motor function ,hindlimb 4-point scale ,,"cats/rabbits respectively: 0=paraplegia/paraplegia; 1=severe paraparesis/some functional movement, markedly impaired; 2=mild paraparesis with ability to walk/hopping, slightly impaired; 3=normal/normal",cats: evaluated weekly over a four-week period; rabbits: 48h after occlusion,,Yes,positive effect,"WIN(+), the inactive stereoisomer, showed less motor recovery compared to WIN(-)",-,-,-,-,,-,"cats: sodium pentobarbital (30mg/kg) for anesthesia; rabbits: ketamine hydrochloride (50mg/kg, IM) and sodium pentobarbital (40 mg/kg, IV) for anesthesia",findings confirm and extend findings regarding the utility of opiate receptor antagonists following ischemic or traumatic spinal cord injury; kappa receptors may mediate the pathophysiological effects of endogenous opiods following SCI,"difference between WIN(-) and WIN(+) reached significance only in rabbit group, maybe because of smaller number in cat studies and/or too high doses in cat studies",number of animals announced and number in tables don't match: some animals died? Not explained in the text; not a drug of interest per se but close to naloxone: should we still include or exclude?,,
Lucie,Chen et al.,2020,Ezetimibe protects against spinal cord injury by regulating autophagy and apoptosis through inactivation of PI3K/AKT/mTOR signaling,PMID: 32655800,English,,included,,,,,,rats,Sprague Dawley,50,,,,,,,5 groups in total but subgroup counts not specified,100% males,male,100,not reported (adults),,,,,,Adult,range: 200-250g,,,200,250,g,,"severity: ""moderate injury""; level: exposed T6-T10, lamnectomy at T8",T8,moderate,contusion,"modified weight-drop method (25 g cm, 10g*2.5cm)",not reported,"dimethylsulfoxide, ezetimibe",ezetimibe,,5mg/kg or 10 mg/kg (two distinct groups),"1, 24 and 72h after injury",,3 doses,-,oral,,neurological/functional recovery,BBB locomoter scale,,divided into 0 to 21 representing complete paralysis to normal locomotion respectively,"before injury and 24h, 48h, 72h, 96h and 7 days after the operation",,Yes,positive effect,Ezetimibe could concentration-dependently improve the behavioral performance of SCI rats,histological assessment,"Nissel staining (neuronal survival), TUNEL staining (apoptotic cells), western blot analysis (expression of PI3K/AKT/mTOR)",not reported,not reported,mixed (stats/no stats),"enhanced the number of motor neurons in the anterior horns (significant when compared to DMSO group), H&E staining: better histologic characteristics relative to the SCI group, TUNEL: apoptosis of cells was notably reduced in ttt groups and the results shown a certain level of dose-dependent efficacy",anaesthesia: pentobarbital sodium (50 mg/kg),Ezetimibe can improve functional and tissue recovery as well as neuronal damage in rats with SCI by enhancing autophagy and decresing apoptosis through inactivation of PI3K/AKT/mTOR signaling ,lack of studies of Ezetimibe in clinical patients,"not clear if observer was blinded for the histological assessment, comparison with the DMSO and not control group?",No,
Lucie,Stys et al.,1996,Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter,10.1016/0306-4522(95)00430-0,English,,excluded,Non-sci population,,"Non-SCI population: study of optic nerve in rats, no SCI was inflicted on them",,,rats,Long-Evans rats ,,,,,,,,,,,,range 50-70 days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Oslau et al,2014,Selegiline protects motoneurons at acute phase of spinal cord injury in hemisectioned rats,https://www.acarindex.com/pdfs/712585,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Sprague Dawley,>= 65,12,,,not reported,,,"7 groups in total, MP group size not developed, sham n = 5",female 100%,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,"level:'laminectomy was cariied out on T10 (correspond to spinal segment T13)""; injury severity: not reported",T14,incomplete,transection,"laminectomy + The dura matter was perforated and the left side of the spinal cord was removed by Pasteur pipette in order to gently aspirate the spinal tissue, then the skin was sutured, referred to as an hemisection",21 days,"methylprednisolone, selegiline",methylprednisolone sodium succinate,,30 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,-,-,,-,-,,-,-,-,histological assessment,"counting of spinal motoneurons, neuronal reduction percentage according to Panahi and Al-Tiraihi, motoneuron loss ratio, morphometric neuroprotection index",21 days after injury,not reported,positive effect,mean of the total motoneurons count (TMC) in all groups are significantly higher than that of the untreated hemisectioned group.,"anesthesia: ketamine (60 mg/kg), xylazine (3 mg/kg) both IP; prophylactic penicillin (80 mg/kg)",The conclusion is that selegiline is neuroprotective to the acute spinal cord injury,not reported,"use ketamine, penicillin",No,
Lucie,Oslau et al,2014,Selegiline protects motoneurons at acute phase of spinal cord injury in hemisectioned rats,https://www.acarindex.com/pdfs/712585,English,,included,,,,,,rats,Sprague Dawley,>= 65,12,,,48,,,"7 groups in total, MP group size not developed, sham n = 5",female 100%,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,"level:'laminectomy was cariied out on T10 (correspond to spinal segment T13)""; injury severity: not reported",T13,incomplete,transection,"laminectomy + The dura matter was perforated and the left side of the spinal cord was removed by Pasteur pipette in order to gently aspirate the spinal tissue, then the skin was sutured, referred to as an hemisection",21 days,"methylprednisolone, selegiline",selegiline,,"0.1, 1, 2.5 or 5 mg/kg",immediately after injury,,single dose,-,intraperitoneally,,neurological/functional recovery,BBB locomoter scale,,"analyse according to the Gompertz model: MBS, RRC, TPIMG, and DPS are: the maximum BBB score, the recovery rate coefficient, the time of point of inflection or the time of maximum response, and the number of day's post-surgery, respectively. This model was used in order to examine the rate of recovery and the maximum recovery in BBB score",daily until day 21,,not reported,no stats,"sigmoid curve fitting using Gompertz model, no comparison of the coefficients estimated between the control and treated groups",histological assessment,"counting of spinal motoneurons, neuronal reduction percentage according to Panahi and Al-Tiraihi, motoneuron loss ratio, morphometric neuroprotection index",21 days after injury,not reported,positive effect,mean of the total motoneurons count (TMC) in all groups are significantly higher than that of the untreated hemisectioned group.,"anesthesia: ketamine (60 mg/kg), xylazine (3 mg/kg) both IP; prophylactic penicillin (80 mg/kg)",The conclusion is that selegiline is neuroprotective to the acute spinal cord injury,not reported,"use ketamine, penicillin",No,
Lucie,,2016,The effect of erythropoietin in the treatment of acute spinal cord injury,NA,English,,excluded,Out of scope,No drug of interest,Out of scope : no drug of interest (tested the recpombinant human erythropoietin treatment),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Salem et al.,2017,Does vitamin C have the ability to augment the therapeutic effect of bone marrow-derived mesenchymal stem cells on spinal cord injury?,10.4103/1673-5374.221163,English,,included,,,,,,rats,Albino,80,10,,,10,,,,100% males,male,100,not reported (adults),,,,,,Adult,180 (30)(g),180,30,,,g,,"severity: ""moderate SCI""; level: T9-10",T9 - T10,moderate,contusion,aseptic T9-10 laminectomy followed by spinal cord contusion induced using a weight-drop apparatus (10g rod dropped from height of 12.5mm on exposed dura mater),4 weeks,"depending on groups: no pharmacological treatment, 0.9% saline; 0.5mL of phosphate buffered saline; MP sodium succinate in 0.9% saline; vitamine C (vitC); bone marrow mesenchymal stem cells (BMMSCs) suspended in PBS ",methylprednisolone sodium succinate,No,30 mg/kg,1h after then 4 times at 6-hour interval,,24h,every 6h,intravenously,,behavorial/locomoter recovery,Basso Mouse Scale (BMS),,ranges from 0 (paralysis) to 9 (normal movement of the hind limbs),"1, 7, 14, 21 and 28 days after",,Yes,no effect,no significant difference compared to SCI only group,histological and immunohistochemical staining; morphometric study; RT-qPCR,"horseradish peroxidase-labeled streptavidin-biotin method (immunohistochemical staining) for nestin detection; quantification of nestion and NF-200 immunoreactive expression from image analysis; quantitative expression of transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha); matrix metalloproteinase-2 (MMP-2)",4 weeks after injury,not reported,no stats,MP and vitC in combination had some beneficial effetcs on modulating the histopathological manifestaion of rats with SCI; BMMSCs transplantation had an effective role in histological reconstruction of the spinal cord in rats after injury; BMMSCs in combination with vitC was more therapeutically effective,anesthesia by 1.9% ether presented on a cotton ball or gauze pad for 5 to 10 minutes,VitC can enhance the neruoprotective effects of BMMSCs against SCI,not reported,not clear if observer was blinded for the histological assessment  ,No,
Lucie,Salem et al.,2017,Does vitamin C have the ability to augment the therapeutic effect of bone marrow-derived mesenchymal stem cells on spinal cord injury?,10.4103/1673-5374.221163,English,,included,,,,,,rats,Albino,80,10,,,10,,,,100% males,male,100,not reported (adults),,,,,,Adult,180 (30)(g),180,30,,,g,,"severity: ""moderate SCI""; level: T9-10",T9 - T10,moderate,contusion,aseptic T9-10 laminectomy followed by spinal cord contusion induced using a weight-drop apparatus (10g rod dropped from height of 12.5mm on exposed dura mater),4 weeks,"depending on groups: no pharmacological treatment, 0.9% saline; 0.5mL of phosphate buffered saline; MP sodium succinate in 0.9% saline; vitamine C (vitC); bone marrow mesenchymal stem cells (BMMSCs) suspended in PBS ",vitamin c,,500mg then 100mg/kg,1h after then once a day for 28 days ,,28 days for vitC,once daily,intraperitoneally,,behavorial/locomoter recovery,Basso Mouse Scale (BMS),,ranges from 0 (paralysis) to 9 (normal movement of the hind limbs),"1, 7, 14, 21 and 28 days after",,Yes,no effect,no significant difference compared to SCI only group,histological and immunohistochemical staining; morphometric study; RT-qPCR,"horseradish peroxidase-labeled streptavidin-biotin method (immunohistochemical staining) for nestin detection; quantification of nestion and NF-200 immunoreactive expression from image analysis; quantitative expression of transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha); matrix metalloproteinase-2 (MMP-2)",4 weeks after injury,not reported,no stats,MP and vitC in combination had some beneficial effetcs on modulating the histopathological manifestaion of rats with SCI; BMMSCs transplantation had an effective role in histological reconstruction of the spinal cord in rats after injury; BMMSCs in combination with vitC was more therapeutically effective,anesthesia by 1.9% ether presented on a cotton ball or gauze pad for 5 to 10 minutes,VitC can enhance the neruoprotective effects of BMMSCs against SCI,not reported,not clear if observer was blinded for the histological assessment  ,No,
Lucie,Salem et al.,2017,Does vitamin C have the ability to augment the therapeutic effect of bone marrow-derived mesenchymal stem cells on spinal cord injury?,10.4103/1673-5374.221163,English,,included,,,,,,rats,Albino,80,10,,,10,,,,100% males,male,100,not reported (adults),,,,,,Adult,180 (30)(g),180,30,,,g,,"severity: ""moderate SCI""; level: T9-10",T9 - T10,moderate,contusion,aseptic T9-10 laminectomy followed by spinal cord contusion induced using a weight-drop apparatus (10g rod dropped from height of 12.5mm on exposed dura mater),4 weeks,"depending on groups: no pharmacological treatment, 0.9% saline; 0.5mL of phosphate buffered saline; MP sodium succinate in 0.9% saline; vitamine C (vitC); bone marrow mesenchymal stem cells (BMMSCs) suspended in PBS ",methylprednisolone sodium succinate + vitamin c,,MP: 30 mg/kg MP sodium succinate + vitC: 500mg then 100mg/kg,1h after then 4 times at 6-hour interval (MP sodium succinate); 1h after then once a day for 28 days (vitamine C),,24h for MP sodium succinate; 28 days for vitC,MP: every 6h; vitC: once daily,multiple,IV for MP and IP for vitC,behavorial/locomoter recovery,Basso Mouse Scale (BMS),,ranges from 0 (paralysis) to 9 (normal movement of the hind limbs),"1, 7, 14, 21 and 28 days after",,Yes,positive effect,significant difference in score at day 21 and 28 compared to SCI only group,histological and immunohistochemical staining; morphometric study; RT-qPCR,"horseradish peroxidase-labeled streptavidin-biotin method (immunohistochemical staining) for nestin detection; quantification of nestion and NF-200 immunoreactive expression from image analysis; quantitative expression of transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha (TNF-alpha); matrix metalloproteinase-2 (MMP-2)",4 weeks after injury,not reported,no stats,MP and vitC in combination had some beneficial effetcs on modulating the histopathological manifestaion of rats with SCI; BMMSCs transplantation had an effective role in histological reconstruction of the spinal cord in rats after injury; BMMSCs in combination with vitC was more therapeutically effective,anesthesia by 1.9% ether presented on a cotton ball or gauze pad for 5 to 10 minutes,VitC can enhance the neruoprotective effects of BMMSCs against SCI,not reported,not clear if observer was blinded for the histological assessment  ,Yes (drug of interest + drug of interest),
Lucie,Hou et al.,2016,Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury,10.1016/j.expneurol.2015.12.001,English,,excluded,Out of scope,No drug tested,"study the production of dopamine following SCI, but don't give dopamine",,,rats,Wistar + Sprague Dawley + Fischer 344,115,,,,,,,"Wistar rats (n=107), Sprague Dawley rats (n=4), Fischer 344 rats (n=4)","112 female, 3 not identified (""we used 104 adult female [...] and 3 postnatal day 10 (P10) Wistar rats"") (assume female from the phrasing)",female,0,"3 postnatal 10 days, 112 adults",,,,,,Adult,adult Wistar rats: range [200-250](g); Fischer 344 rats: range [150-200](g); Sprague Dawley: range [200-250](g),,,150,250,g,,"level: T4 for plasticity studies, T10 for bladder studies; severity: complete transection",T4 + T10,complete,transection,partial laminectomy at T3 or T9 followed by T4 or T10 transection,not reported,,,,,,,,,,,,,,,,,,,,,,,,,,"Lactated Ringer's solution, cefazolin (10mg/kg), buprenex (0.1 mg/kg) post-operatively",,,,,
Lucie,Jeffery et al.,2018,Pharmacokinetics and safety of oral glyburide in dogs with acute spinal cord injury,10.7717/peerj.4387,English,,excluded,Out of scope,No assessments of interest,"Out of scope: pharmacokinetic study, no information on neurological/functional recovery or histology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yao et al. ,2020,Dual-enzymatically cross-linked gelatin hydrogel enhances neural differentiation of human umbilical cord mesenchymal stem cells and functional recovery in experimental murine spinal cord injury.,10.1039/d0tb02033h,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (a dual-enzymatically cross-linked gelatin hydrogel with hydrogen horseradish peroxidase (HRP) and galactose oxidase (GalOx) and combine human umbilical cord mesenchymal stem cells (hUC-MSCs)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Vaquero et al,2004,Early administration of dexamethasone after spinal cord injury: Effects on the functional recovery and local expression of vascular permeability factors,Mapfre Medicina. 15. 258-265. ,English,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Warner et al. ,2017,Early Administration of Gabapentinoids Improves Motor Recovery after Human Spinal Cord Injury,10.1016/j.celrep.2017.01.048,English,Europe (EMSCI),excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (looking at class of anticonvulsants as an entire group),,,human,European population,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bao et al. ,2004,Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats,10.1046/j.1471-4159.2003.02240.x,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (anti-CD11d monoclonal antibody),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Matsumoto et al.,2001,Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury,10.1097/00007632-200102150-00020,English,Japan,excluded,Out of scope,No assessments of interest,Out of scope: focus on number of complications in patients with or without MPSS,,,human,Japenese population,46,,,,,,,,"42 men (91%), 4 women (9%)",,,"range [20-84], average 60.6 (years)",,,,,,,,,,,,,,"level: cervical; severity: Frankel grade A, n=15; B, n=16; C, n=7; D, n=8",,,,spinal canal narrowing without fracture n= 36,randomized within 8h of injury,methylprednisolone sodium succinate,,,bolus: 30 mg/kg; maintenance infusion: 5.4 mg/kg per hour,"start within 8h after injury; 15-minute bolus, followed by a pause of 45 minutes and then a 23-hour maintenance infusion",,24h,-,infusion?,,,,,,,,,,,,,,,,,,,,,,
Lucie,Abdanipour et al.,2012,"Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science",10.6091/ibj.1060.2012,English,,included,,,,,,rats,Sprague Dawley,30,6,,,18,,,"5 groups, 3 ttt groups (3 doses)",female 100%,female,0,not reported,,,,,,Not reported,range [250-350](g),,,250,350,g,,level: T12-L1; severity: severe contusion SCI,T12 - L1,severe,contusion,laminectomy+weight drop: 10g metal rod with a 2mm diameter dropped from 25mm,28 days,valproic acid,valproic acid,,"100, 200 or 400 mg/kg (3 distinct treatment groups)",start 3h after injury,,7 days,daily,intraperitoneally,,behavioral/locomotor assessments,Basso Beattie and Bresnahan (BBB) rating scale,,ranges from 0 (paralysis) to 21 points (normal gait),"4minutes videotaape on day 3, 7, 14, 21 and 28 post SCI",,Yes,mixed effects (dosage),"400mg/kg reduced the development of secondary damage in rat spinal cord trauma, resulting into better locomotr scores and more rapid recovery; no significant difference in 100 and 200 mg/kg in the mean of BBB score, means of delta number significantly different in 200 and 400 group but not 100 compared to contusion only group","RT-PCR, real-time PCR, histological quantitative analysis, immunochemistry","RT-PCR: expression of neurotrophins (BDNF, GDNF); real-time PCR: quantify BDNF and GDNF mRNA levels; histology: cell density per area, percentage of neural anf glial cells, cavity and remaining tissue percentage; immunochemsitry: anti-MAP2, anti- acetylated histone, anti- ED1 monoclonal mouse IgG antibodies visualised using diaminobenzidine method",28 days,not reported,mixed (stats/no stats),"mean of tissue and cavity percentage significantly different between control and 400 mg group (no results reported for the other 2 groups), results of quantification of glial and neuronal cells showed no significant difference between 400 mg/kg VPA-treated group and untreated-SCI group","anesthesia: ketamine (80 mg/kg, intraperitoneally), xylazine (5mg/kg, intraperitoneally);post-op: lactated Ringer's solution (10ml) and cefazolin (50mg/kg, intramuscular), both twice daily for one week; sacrifice: 4% paraformaldehyde in PBS (5 minutes, transcardiac perfusion)",reduction in the development of secondary damage in rat spinal cord trauma with an improvement in the open field test (BBB scale) with rapid recovery,not reported,"use ketamine, cefazolin",No,
Lucie,Teixeira et al.,2018,Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury,10.6061/clinics/2018/e235,English,,included,,,,,,rats,Wistar,40,8,,2,8,,2,"4 groups of 10 animals each, 2 groups not of interest, 2 animals excluded in each group (reasons are specified for each animal), (10 per group), 32 included in analyses",male 100%,male,100,20 to 21 weeks,,,20,21,Weeks,,range [300-340](g),,,300,340,g,,"level: T10; severity: ""moderate contusion spinal cord lesion""",T10,moderate,contusion,laminectomy+NYU-Impactor device with 10g impact rod from a 12.5mm height to compress the spinal cord for 15s,42 days,Granulocyte colony-stimulating factor (G-CSF);  Methylprednisolone; combinaison of both,methylprednisolone,No,30 mg/kg,"10min, 6h and 24h",Yes,24h (3 doses),-,intravenously,,"functional outcome, electrophysiology","BBB rating scale, motor evoked potential (MEP)",,BBB:range from complete paraplegia (0) to normal neurological function (21); MEP: method of Letaif et al.,"day 2,7,14,21,28,35 and 42 after spinal cord injury for BB: day 42 for MEP",Yes,Yes,mixed effects (assessment),BBB scores differed significantly betweem MP and control group starting day 28 after injury and until end of the experiment; MEP: no difference between groups in latency or amplitude of MEP,histological analysis,"evaluation of presence of necrosis, hemorrhage, hyperemia, neural tissue degenration and infiltrate, following: 0 (Absent), 1 (mild), 2 (moderate), and 3 (extensive)",day 42,Yes,mixed effects (assessment),"no significant difference for necrosis; significant differences for hyperemia, hemorrhage, degeneration of neural tissue and infiltration","anesthesia: pentobarbital (50mg/kg, intraperitoneally); after injury: tramadol (pain, oral, 15 mg/kg), cephalotin (antibiotic prophylaxis, oral, 25 mg/kg, immediately after lesion and once a day for 7 days); euthanasia: pentobarbital (140 mg/kg)",Methylprednisolone plus G-CSF promotes functional and histological improvements superior to those achieved by either of these drugs alone when treating spinal cord contusion injuries in rats. Combining the two drugs did have a synergistic effect.,Further experimental studies are needed to evaluate the efficacy and mechanism of action underlying the synergistic effect of G-CSF and methylprednisolone;  present study is somewhat limited by the small sample size in each group;  unable to address adverse effects or complications due to experimental intervention (excluded animals with complications) ,"use pentobarbital, tramadol, ",Yes (drug of interest + drug not of interest),
Lucie,Bai et al.,2012,"The effect of astaxanthin (AST) on Neurotrophin-3 (NT-3) expression in rats after compressive spinal cord injury (SCI)""",10.5897/AJPP12.855,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional or histological assessment,,,rats,"Sprague Dawley, healthy",48,,,,,,,,female 100%,,,2 months,,,,,,,range [180-220](g),,,,,,,level: T7; severity: ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ramos-Languren et al.,2016,Sensorimotor recovery from cortical injury is accompanied by changes on norepinephrine and serotonin levels in the dentate gyrus and pons,10.1016/j.bbr.2015.10.009,English,,excluded,Out of scope,No drug tested,Out of scope: no drug effect analysed ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tong et al.,2018,Lithium chloride contributes to blood spinal cord barrier integrity and functional recovery from spinal cord injury by stimulating autophagic flux,10.1016/j.bbrc.2017.12.119,English,,included,,,,,,rats,Sprague Dawley,>= 24,>= 8,,,>= 8,,,"numbers from the BBB assessments (8 in each group), unclear if the same animals were used for the other assessments ",female 100%,female,0,not reported (adults),,,,,,Adult,range [220-250](g),,,220,250,g,,?,Not reported,Not reported,compression,crush injury,not reported,"Lithium Chloride (LiCl), chloroquine",lithium,,20 mg/kg/day,immediately,,Not reported,Not reported,intraperitoneally,,functional locomotor recovery,"Basso-Beatie-Bresnahan (BBB) scale, inclined plane test",,,"day 1,3,7,14,21,28 after SCI",,not reported,positive effect,LiCl group significantly better in terms of BBB score and angle from the inclined plane test comapred to the SCI only group,blood-spinal cord barrier permeability,Evans Blue dye extravasation test,not reported,not reported,positive effect,LiCl significantly decreased the content of EvansBlue dye in spinal cord tissue compared with that of the SCI group,not reported,"LiCl treatment alleviates BSCB disruption andpromotes locomotor recovery after SCI, partly by stimulating autophagic flux.",not reported,"suspected reuse of data from paper 1028; methods very sparse and ""only"" referring to other papers (including paper 1028)",No,
Lucie,Aydoseli et al.,2016,Memantine and Q-VD-OPh Treatments in Experimental Spinal Cord Injury: Combined Inhibition of Necrosis and Apoptosis,10.5137/1019-5149.JTN.12999-14.1,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (memantine and Q-VD-OPh),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Karatas et al.,2015,Effect of carvedilol on secondary damage in experimental spinal cord injury in rats,10.5137/1019-5149.JTN.11749-14.1,English,,included,,,,,,rats,Wistar,24,8,,,8,,,"third group is sham (laminectomy alone, no SCI)",not reported,not reported,not reported,not reported,,,,,,Not reported,range [250-300](g),,,250,300,g,,level: T6-T10; severity not reported,T6 - T10,Not reported,contusion,"laminectomy + weight drop technique (50g/cm impact, weight stainless steel rof with rounded surface of 3mm diameter and weighing 10g dropped from 5cm)",not reported,carvedilol,carvedilol,,Not reported,Not reported,,Not reported,Not reported,not reported,,functional/neurological examination,Tarlov's scoring system,,0:paraplegic; 1:perceptible movement; 2:some functional movement; 3:hind limb movement and can support body weight; 4:normal function,1 and 24h after injury,,not reported,positive effect, The functional recovery was better in the carvedilol treatment group than the trauma group (significant),histolopathological analysis,"apoptosis in the white and gray matter, number of neurons, number of degenerated neurons, number of glial cells, number of degenerated glial cells",not reported,not reported,no effect,none of the differences between groups were significant,"anesthesia: xylazine (10mg/kg), ketamine hydrochloride (50 mg/kg)","""Carvedilol has a statistically significant therapeutic effect, especially on functional recovery, and we found that carvedilol reduced secondary damage by inhibiting apoptosis and regulating the oxidant and antioxidant status.""",number of rats,"no details on the treatment tested (dosage, timing etc), use ketamine",No,
Lucie,Papa et al.,2016,Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury,10.1016/j.biomaterials.2015.10.015,English,,included,,,,,,mice,C57BL/6 and B6.129P-Cx3cr1tm1Litt/,>= 70,>= 20,,,>= 20,,,"10 animals per group for BMS assessment, 2 control groups (saline and empty nanoparticules), and 2 treatment groups (free delivered minocycline and nanoparticules loaded with minocycline)",not reported,not reported,not reported,not reported,,,,,,Not reported,not reported,,,,,,Not reported,level: T12; severity:not reported,T12,Not reported,compression,"laminectomy of T13, mechanical trauma by aneurysm clip (closing force of 60g, left in place for 1min and then removed)",not reported,minocycline (loaded in nanoparticules),minocycline,,"nanoparticules: 0.25 mg of minocycline within 0.25 gr of polymer/mL, six injections; free: 50 mg/kg twice then 25mg/kg","minutes after, 1 day or 7 day post injury for minocycline loaded on nanoparticules; after injury in free minocycline",,minocycline loaded NPs: 6injections; only minocycline: 5 days,minocycline loaded NPs: not reported; only minocycline: once a day,multiple,minocycline loaded NPs: intraparenchymal; only minocycline: intraperitoneal,functional locomotor recovery,Basso Mouse scale (BMS),,10-points scale (9=normal locomotion; 0=complete hind limb paralysis); video acquisition for 5 min,once a week from day 7 to 63 after injury,,yes,mixed effects (timing) + mixed effects (regime),"An early, but not delayed, PCL-mino treatment is able to improve behavioral outcome in SCI mice;  mino IP treatment did not improve behavioral functions compared to the untreated INJ group",histological analysis,"immunofluoresence, flow cytometry analysis, real time RT-PCR, ELISA","""at selected time points""",not reported,mixed (stats/no stats),"An early and selective minocycline loaded NPs treatment inhibits both microglia activation and macrophages recruitment in the epicenter of the lesion, [[inhibits M1 subset and preserves M2 macrophages phenotype during the progression of SCI,  inhibits CCL2-mediated M1 macrophages migration intothe injury site promoting a regenerative environment]]; An early treatment with PCL-mino preserves white matter in the injury site of SCI mouse model (p<0.05); no results reported for late NP minocycline or free minocycline","before anesthesia: antibiotic and analgesic treatment (ampicillin SQ 50 mg/kg, buprenorphine SQ 0.15 mg/kg); anesthesia: ketamine hydrochloride (IP, 100mg/kg) and medetomidine hydrochloride (IP, 1mg/kg); euthenasia: ketamine hydrochloride (100mg/kg), medetomidine hydrochloride (1mg/kg), transcardial perfusion with PBS (0.1mol/liter, pH 7.4), sodium phosphate buffered 4% paraformaldehyde solution (50mL)","We show that a treatment with nanoparticles loaded with minocycline, the latter a well-known anti-inflammatory drug, when administered acutely in a SCI mouse model is able to efficiently modulate the resident microglial cells reducing the pro-inflammatory response, maintaining a pro-regenerative milieu and ameliorating the behavioral outcome up to 63 days post injury.",not reported,"use ketamine, buprenorphine, ampicilin, medetomidine",No,
Catherine,Pourheydar et al.,2018,"Effect of co-administration of ubiquinone and vitamin C on changes of behavioral, histological and biochemical parameters in contusion model of rat spinal cord injury",http://jmums.mazums.ac.ir/article-1-8248-en.html,Persian,,included,,,,,,rats,Wistar,40,,,,,,,,all male,male,100,not reported,,,,,,Not reported,250-300g,,,250,300,g,,level: T8-9,T8 - T9,Not reported,contusion,"laminectomy + weight drop method (10 gram, 25mm high, diameter tip 2mm)",8 weeks,ubiquinone,ubiquinone,,10 mg/kg,24hrs,,single shot,once,intraperitoneally,,functional locomotor recovery,Basso Beatie Brenahan (BBB) locomotor scale,,Test was performed in a circular enclosure with a diameter of 90 cm and a height of 24 cm. Animals could freely move.,Once a week for 8 weeks,,not reported,positive effect,BBB scores of treated rats were signifnicantly higher than in the control group,immunohistochemistry,"Measuring free radicals and antioxidant activity, glutathione reductase enzyme activity measurement",8 weeks after injury,not reported,mixed effects,"No diffference found in terms of reduction of oxidative stress between treated and untreated groups
The average number of normal motor neurons in anterior spinal horn significantly increased in treatment groups compared to that in lesion group ",anesthesia: Xylazine (10mg/kg) and ketamine (100mg/kg),"Administration of COQ10 in contusion model of SCI led to functional recovery, reduction of MDA and increase of motor neurons survival in anterior spinal horn.",not reported,,,
Catherine,Pourheydar et al.,2018,"Effect of co-administration of ubiquinone and vitamin C on changes of behavioral, histological and biochemical parameters in contusion model of rat spinal cord injury",http://jmums.mazums.ac.ir/article-1-8248-en.html,Persian,,included,,,,,,rats,Wistar,40,,,,,,,,all male,male,100,not reported,,,,,,Not reported,250-300g,,,250,300,g,,level: T8-9,T8 - T9,Not reported,contusion,"laminectomy + weight drop method (10 gram, 25mm high, diameter tip 2mm)",8 weeks,Vitamine C,vitamin c,,10 mg/kg,24hrs,,single shot,once,intraperitoneally,,functional locomotor recovery,Basso Beatie Brenahan (BBB) locomotor scale,,Test was performed in a circular enclosure with a diameter of 90 cm and a height of 24 cm. Animals could freely move.,Once a week for 8 weeks,,not reported,positive effect,BBB scores of treated rats were signifnicantly higher than in the control group,immunohistochemistry,"Measuring free radicals and antioxidant activity, glutathione reductase enzyme activity measurement",8 weeks after injury,not reported,mixed effects,"No diffference found in terms of reduction of oxidative stress between treated and untreated groups
The average number of normal motor neurons in anterior spinal horn significantly increased in treatment groups compared to that in lesion group ",anesthesia: Xylazine (10mg/kg) and ketamine (100mg/kg),"Administration of Vitamin C in contusion model of SCI led to functional recovery, reduction of MDA and increase of motor neurons survival in anterior spinal horn.",not reported,,,
Lucie,Wang et al.,2017,Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury,10.1016/j.biomaterials.2016.10.002,English,,included,,,,,,rats,Sprague Dawley,38,18,,,20,,,"2 control groups: 1 untreated injury control, control for thr MH alone treatment, 1 group with blank agarose hydrogel, control for the MH loaded in agarose hydrogel",female 100%,female,0,not reported,,,,,,Not reported,range [250-300](g),,,250,300,g,,"level: C5, severity not reported",C5,Not reported,contusion,"unilateral laminectomy and contusion + impact with a force of 200 kDyne, diameter of the impactor tip was 1.6mm",6 weeks,dextran sulfate - minocycline hydrochloride (DS-MH) complexes (self-assembled); MH alone,minocycline,,30mL agarose hydrogel loaded with DS-MH complexes; MH injection: 90mg/kg and 45mg/kg,immediately after injury,,5 days,twice daily,multiple,DS-MH complexes: Intrathecally; MH alone: intraperitoneally,behavioral/locomotor functional recovery,Forelimb locomotor scale; grid walk test,,"17-point scale that evaluates deficits based on range of joint movements, degree of weight support and forepaw placement; percentage of correct steps over total steps",prior to injury and then weekly after injury for 6 weeks,,yes,mixed effects (regime),rat with minocycline in gel were significantly better in FLS score and % of correct steps compared to group with blank gel from day 7 until week 6; rats with IP minocycline were not significantly difference from control group at week 6 (neither for FLS score nor for grid walk),histological assessment,"lesion volume, tissue sparing and inflammation",6 weeks after injury,Yes,mixed effects (assessment) + mixed effects (regimen),both IP and gel minocycline were significantly different from their respective control groups in terms of lesion volume (volume was reduced in treatment groups); MH in gel group was significantly better in number of myelinated axons from -2.88 to +2.88 mm around injury epicenter but IP minocycline was only better than control at the edges of the window (-2.88 and +2.88),"anesthesia: ketamine (60 mg/kg), xylazine (6mg/kg), acepromazine (0.5mg/kg); euthanasia: 0.9% saline followed by 4% paraformaldehyde","local delivery of MH at a safe human dose could expose the injured spinal cord tissue to high concentrations of MH that systemic administration cannot safely achieve, and was more effective in promoting neuroprotection and functional recovery than systemic injection of MH at doses that are 6-7.5 times higher than the highest tolerable human dose.",the effectiveness of MH treatment for these disorders has been compromised by the inability to locally deliver high concentrations of this medication,use ketamine,No,
Lucie,Wang et al.,2019,Combinational protective therapy for spinal cord injury medicated by sialic acid-driven and polyethylene glycol based micelles,10.1016/j.biomaterials.2019.119326,English,,included,,,,,,rats,Sprague Dawley,70,30,,,10,,,"3 control groups (1 ""normal"", 2 with 2 different types of gel free of treatment) and 3 treatment groups",female 100%,female,0,not reported (adults),,,,,,Adult,range[200-250](g),,,200,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop method (10g rod of 2.5mm diameter, dropped from 12.5mm)",12 weeks,"minocycline hydrochloride (MC.HCl), polyethyleneglycol-PLGA/minocycline micelles (PPM), sialic acid-polyethyleneglycol-PLGA/minocycline micelles (SAPPM), polyethyleneglycol-poly (lactic-co-glycolic acid) micelles (PP), sialic acid-polyethyleneglycol-poly(lactic-co-glycolic acid) micelles (SAPP)",minocycline,,10 mg/kg,6h after injury,,6 days,once daily,intravenously,,behavioral/locomotor functional recovery,Basso Beatie Brenahan (BBB) locomotor scale,,in an open and quiet container (100*100*100 cm^3),"1day, 3d, 5d, 1week, 2w, 3w, 4w, 5w, 6w, 7w, 8w, 9w, 10w, 11w, 12w, all post-injury",,not reported,positive effect,BBB scores of rats treated with SAPPM increased significant faster than those treated with PPM; all treatment groups have significantly higher BBB score compared to SCI+saline group,histopathology assessment,"intergrity and continuity of spinal cord, lesion cavities, nissl bodies, axonal myelination",12 weeks post-injury,not reported,no stats,after treatment with minocycline  more myelin sheaths and axons were preserved in caudal and rostral tissue; relative area of lesion cavity: no comparison between minocycline group and saline group,anesthesia: pentobarbital sodium; after surgery: penicillin (7 consecutive days); euthanasia: PBS and 4% paraformaldehyde,multifunctional SAPPM would be a promising delivery system for SCI treatment,not reported,developped a new treatment (minocycline-loaded nanodrug delivery system SAPPM) for systemic treatment of SCI; use pentobarbital and penicillin,Yes (drug of interest + drug not of interest),
Lucie,Khoshsirat et al.,2018,Evaluation of the effect of BMSCs condition media and methylprednisolone in TGF-Œ≤ expression and functional recovery after an acute spinal cord injury.,10.4149/BLL_2018_123,English,,included,,,,,,rats,Wistar,32,8,,,8,,,35 (32 for rat model experimental groups and 3 for cell preparation); 4 groups in total,female 100%,female,0,not reported (adults),,,,,,Adult,range [180-200](g),,,180,200,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight drop method (10g metal bar, dropped from 25mm)",13 weeks,"methylprednisolone, bone marrow stromal cells condition media (BMSCs-CM)",methylprednisolone,No,30 mg/kg,not reported,Not reported,not reported,not reported,not reported,"not reported consistently: say IP in abstract, then IV and IM in methods for MP?",behavioral/locomotor functional recovery,Basso Beatie Brenahan (BBB) locomotor scale; narrow beam test,,narrow beam scoring: trained the rats to cross a narrow wooden beam (80cm long and 4cm wide) for 5 days (5min per day),BBB: start 1 day after injury then once per week for 12 weeks; narrow beam scoring: start 1 day after SCI,Yes,yes,no effect,BBB: score of the MP+CM group was significantly higher than the scores of other experimental groups in week 8-week 12 (p<0.05); narrow beam test: narrow bean test represented a higher function recovery in the implanted group as compared to the control group at week 10 (p<0.05); not effect of MP alone in either test,H&E staiining and stereological analysis and morphometric assessment,"cavities, volume of spinal cord, number of neurons and glial cells",week 12 after injury,not reported,mixed (stats/no stats),Levels of microglial and infl ammatory cells in the control group were higher than in the other groups around the cavity. Replacement of myelin and white matter structure in the experimental group improved. Cavity size in the experimental groups decreased compared to the control group (no stats); not significant difference in terms of volume of spinal cord comapred to control group; significantly reduced number of glial cells and increased in neurons compared to control group,"anesthesia: ketamine (80 mg/kg, IP), diazepam (10mg/kg, IP)","Simultaneous use of MP and BMSC-CM will improve recovery from the spinal cord injury, reduce inflammation and improve functional recovery.",not reported,"few details about the treatment; use keatmine, diazepam",Yes (drug of interest + drug not of interest),
Lucie,Liu et al.,2015,Effect of estrogen on recovering the injured nervous system,https://pubmed.ncbi.nlm.nih.gov/26431647/,English,,excluded,Out of scope,No assessments of interest,No assessment of interest,,,rats,Sprague Dawley,72,,,,,,,,not reported,,,not reported (adults),,,,,,,range [250-310](g),,,,,,,level: T8; severity: not reported,,,,"laminectomy + contusion method (improved Allen’s impact method, 25g/cm wounding power)","1, 3, 5, 8, 14, 21 days",estrogen,,,100μg/kg,not reported,,until sacrifice ,daily,intramuscular,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fee et al.,2007,Effects of progesterone on experimental spinal cord injury,10.1016/j.brainres.2006.12.024,English,,included,,,,,,rats,Sprague Dawley,75,24 - 28,,,48 - 56,,,"19 males and 19 females in the 5-day supplementation arm but no further details on the size of rhte groups; 18 males and 19 females in the 5-day supplementation arm but no further details on the size of rhte groups; each arm has 3 groups, 1 control and 2 treatment (different dosage)","male: n=37 (49.3%), female: n=38 (50.7%)",mixed,49.3,"range: [6-8](weeks) ""adult""",,,6,8,Weeks,Adult,male: range [285-300](g); female: range [192-268](g),,,192,300,g,,"level: T10; severity: ""moderate spinal cord contusion""",T10,moderate,contusion,"laminectomy + IH impacting device (2.5 mm impactor tip, set 8mm above spinal cord)",21 days,progesterone,progesterone,,4 mg/kg and 8mg/kg for 5-day supplementation arm; 8mg/kg and 16mg/kg for 14-day supplementation arm,"30min and 6h after injury, then once daily",,5 days or 14 days,once daily,not reported,,behavioral/locomotor functional recovery,Basso Beatie Brenahan (BBB) locomotor scale,,"BBB generated for each hind limb, averages of two limbs per assessment","pre-injury and 2,7,14,21 days post-injury",,yes,no effect,5-day supplementation arm: all groups attained similar levels of recovery; 14-day supplementation arm: all groups attained a similar level of recovery in the long term,morphologic assessment,"injury length, spared tissue",day 21 after injury,not reported,mixed effects (dosage) + mixed effects (timing),"5-day supplementation arm: no significant treatment effect for length of injury or tissue sparing at the injury epicenter; 14-day supplementation arm: no significant treatment effect for length of injury, but significant treatment effect (p>0.026) with greater sparing as progesterone concentration increased","anesthesia: ketamine (80mg/kg), xylazine (10mg/kg); post-injury care: 10ml sterile saline (subcutaneously), 33.3 mg/kg cefazolin (IM), immediately post-operation and day 1 and 2 post injury + cefazolin for any evidence of hematuria/urinary tract infection",This study does not support progesterone as a potential therapeutic agent in spinalcord injury.,not reported,"use ketamine, cefazolin; use both male and female population",No,
Lucie,Ritz et al.,2008,"Effect of 17 beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats",10.1016/j.brainres.2008.01.091,English,,included,,,,,,rats,Wistar,27,18,,,36,,,"initially 9 per group (1 control, 2 treatment) + 3 animals per time point per group for cytokine assays (3 time points, so n=9 for control and 18 for treatment)",male 100%,male,100,not reported (adults),,,,,,Adult,range [250-300](g),,,250,300,g,,level: T8-T9; severity: moderate compression,T8 - T9,moderate,compression,laminectomy + moderate compression from both lateral sides using a microvessel clip with a closing force of 20g for 15s,"6h or 3,7,14 or 28 days",17beta-estradiol,estradiol,,0.1 or 4 mg/kg,immediately after clip removal,,single dose,-,intraperitoneally,,behavioral/locomotor functional recovery,Basso Beatie Brenahan (BBB) locomotor scale; narrow beam-crossing test,,"21 points scale, from 0 (no observale hind limb movements) to 21 (normal locomotion with consistent plantar stepping and coordinated gait, toe clearance, parallel paw position, trunk stability and tail consistently in an upper position), observed for 4 min in an open field; Animals were trained for 3 days before surgery to walk across an elevated narrow wood beam (starting from 5 cm to 2 cm wideover 120 cm of length) to reach their home cage, beam was divided into 24 sections of 5 cm and the number of the section at which an animal made a foot slip and fell below the beam while crossing was scored","day 3 after injury, then weekly for 4 weeks (day 7, 14, 21 and 28 post-SCI); 6 consecutive crossings on day 3 after SCI then weekly (day 7, 14, 21, 28)",,yes,mixed effects (dosage) + mixed effects (assessment),"BBB scores at day 28 of the low dose-treated rats and the controls were not significantly different, whereas the score of the 4 mg/kg 17β-estradiol-treated group was significantly better; narrow beam walking performance: although the performances of the 4 mg/kg 17β-estradiol-treated rats were higher when compared to controls at days 14 and 28, the difference did not reach statistical significance.",immunohistology,"cytokine assays, immunochemistry, quantification of maximum area of injury and inflammation, immunofluorescent staining and quantification of GFAP","cytokine: 6h, 3days and 1 week post sci; immunochemistry: day 3,7,14,28 post injury",not reported,no effect,"[[The injured spinal cord of 17β-estradiol-treated rats expressed moreI L-1α,IL-1βand IL-6 than controls 6 h after injury. Moreover, 17β-estradiol-treated rats showed reactive astrocytes as soon as 3 days following SCI, with increased GFAP expression, smaller lesion areas and more limited diffusion of CD68-positive cells after 1 week post-injury compared to controls. The number of CD68-positive cells was also reduced in 17β-estradiol-treated rats one week post-SCI. However, these differences between 17β-estradiol-treated and control rats disappeared after 4 weeks.]] no significant difference in max lesion area at week 4 after injury between control and either treatment group","anesthesia: 3% isoflurane in gas 30% O2, 70% nitrogen","These results suggest that 17β-estradiol protects the spinal cord by stimulating early cytokines release and astroglial responses. These stimulations may prevent the area of damage from expanding and inflammatory cells to spread in the surrounding tissue during the critical first week following SCI. Although transient,these effects improved the locomotor recovery that was sustained over 4 weeks after injury.",not reported,number of animals used is unclear,No,
Lucie,Espinosa-Garcia et al.,2014,Effects of progesterone on neurite growth inhibitors in the hippocampus following global cerebral ischemia,10.1016/j.brainres.2013.11.030,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology (only immunochemistry),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yang et al.,2016,Caffeine treatment aggravates secondary degeneration after spinal cord injury,10.1016/j.brainres.2015.12.053,English,,excluded,Out of scope,No drug of interest,No drug of interest (caffeine alone),,,rats,Sprague Dawley,51,>= 10,,,>= 10,,,10 per group in BBB; no numbers for the histology part,male 100%,male,100,not reported (adults),,,,,,Adult,range [250-300](g),,,250,300,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + contusion SCI (NYU impactor, 10g rod released from 25mm height)",4 weeks,caffeine,caffeine,,30 mg/kg,"""after animal awoke from anesthesia""",,1 week,daily,intraperitoneally,,functional outcome,Basso Beatie Brenahan (BBB) locomotor scale,,"scale ranged from 0 to 21, with 0 indicating no movement and 21 indicating normal movement","at the onset of SCI, at day 7 and 4 weeks after SCI",,yes,negative effect,the PBS group (control) exhibited a significantly higher BBB score than the caffeine group (treatment) 4 weeks after SCI,"activation of neural cells (microglia, astrocyte, neurofilament number)","immunofluorescence and immunohistochemistry, luxol fast blue staining, western blot; demyelination area, number of neurofilamenet, microglia activation, astrocyte activation",4 weeks after injury,not reported,negative effect,"increased the demyelination area, promoted astrocyte and microglia activa-tion and decreased the quantity of neurofilaments","anesthesia: virbac (30mg/kg, IM); following surgery: gentamycin (50mg/kg, IP); euthanasia: sodium pentobarbital (80 or 90 [discording information reported in two places in the paper] mg/kg, IP) with PBS transcardially for 6 min, 4% paraformaldehyde in PBS for 6 min","The results showed that spontaneous functional recovery was blocked after the animals were subjected caffeine daily. Moreover, caffeine administration increased the demyelination area, promoted astrocyte and microglia activation and decreased the quantity of neurofilaments. These findings suggest that the neuro-toxicity effect of caffeine may be associated with the inhibition of neural repair and the promotion of neuroinflammation",not reported,"use gentamicin, pentobarbital; drug with negative effects",No,
Lucie,Means et al.,1981,Effect of methylprednisolone in compression trauma to the feline spinal cord,10.3171/jns.1981.55.2.0200,English,,included,,,,,,cats,Mongrel,24,8,,,16,,,"Of the 24 injured animals, eight treated (experimental) and eight untreated (control) were followed as pairs. An additional eight animals (experimental) were injured and treated but were not paired.",female 100%,female,0,not reported,,,,,,Not reported,range [2.5-4.6](kg),,,2.5,4.6,kg,,level: L2; severity: not reported,L2,Not reported,compression,"laminectomy + compression (170gm-weight for 5 minutes, details in another publication: https://doi.org/10.3171/jns.1976.44.6.0715 )",at least 8 weeks,methylprednisolone sodium succinate,methylprednisolone sodium succinate,Yes,"15, 7.5 and 3.75 mg/kg/day for three days successively in this order",1h hour after injury,,9 days,3 injections per day,multiple,first 6 injections: intravenously; remainder intramuscularly,neurological function,recovery index (mobility),,A: Mobility: score from 0 (no movement of hindlimbs) to 8 (normal); B Running: score from 1 (falls frequently when running) to 3 (normal); C Climbing stairs score from 1 (use only forelimbs) to 5 (normal),"as soon as possible after injury, biweekly for 2 months",,yes,positive effect,"methylprednisolone-treated cats exhibited significantly (p<0.001) greater recovery of mobility at all time intervals, indicating that these cats recovered earlier and more completely than injured but untreated controls",histology and morphometry,"cavities (%area, %volume), degree of preservation of myelin and axons",8 weeks after injury?,yes,positive effect,The injured treated animals uniformly showed significantly smaller cavities and less tissue destruction than did the untreated animals; the steroid-treated group had greater preservation of myelin anf axons in the total white matter and separately in the lateral columns as compared with injured but untreated controls (significant),"anesthesia: pentobarbital sodium (30mg/kg, intraperitoneally), paralysis with succinylcholine chloride (1mg/kg); 1cc intramsucular procaine penicillin G (220000 units/cc) in dihydrostreptomycin solution (0.25gm/cc) daily for 5 days starting on day of injury; ringer's solution (10cc/kg) until alert and feeding after injury; euthanasia: intra-aortic perfusion fixation (ip sodium pentobarbital 30mg/kg; lactated ringer's solution 2cc, 10'000 units of sodium heparin and 1% sodium nitrate; 3L of warm 10% formalin)",strong evidence for a protective effect by pharmacological dose methylprednisolone sodium succinate on spinal cord tissue following experimental spinal cord compression injury; preliminary data suggest that protective effect of this steroid is via a machanism of enhanced microvascular perfusion,caution must be exercised in drawing firm conclusions from the data presented in these studies (other studies mentionned in discussion),"use pentobarbital, penicillin",No,
Lucie,Holtz et al.,1990,Effect of methylprednisolone on motor function and spinal cord blood flow after spinal cord compression in rats,10.1111/j.1600-0404.1990.tb01589.x,English,,included,,,,,,rats,Sprague Dawley,30,10,,,20,,,,male 100%,male,100,not reported,,,,,,Not reported,range [330-390](g),,,330,390,g,,level: T7-T8; severity: not reported,T7 - T8,Not reported,compression,"laminectomy + compression (curved rectangular plate 2.2*5.0mm, loaded with 35g applied on exposed dura for 5 minutes)",1 day (10 rats treated with methilprednisolone); 4 days (control rats and 10 rats treated with methilprednisolone),methylprednisolone,methylprednisolone,Yes,30 mg/kg,60 min after injury,,single dose,-,intravenously,,functional recovery,inclined plane test,,record the maximal angle at which the animal could maintain itself transversely for 5s,daily (also performed before injury),No,not reported,no stats,"The capacity angle in MP-treated animals was higher throughout the observation  period. ((note: no pvalues reported, but standard deviations are not overlapping between groups))",spinal cord blood flow,spinal cord blood flow,probably day 1 and day 4 but not explicit,not reported,no stats,MP increases the rate of normalization of spinal cord blood flow after spinal cord trauma. This effect is obviously still present on Day 4. ((no pvalues reported)),anesthesia: 4.25% chloral hydrate and 1% pentobarbital (1.0-1.5ml intraperitoneally); blood flow study anesthesia: 3% halothane in a 70% N2O and 30% 02 mixture,Post traumatic treatment with methylprednisolone improved both the neurologic recovery during the first 4 days and spinal cord blood flow as measured on Day 4. It is speculated that the effect of MP is at least partly exerted on the vascular bed.,not reported,"used chloral hydrate, pentobarbital; no stats reported",No,
Bobo,Wang et al.,2007,Effect of microencapsulated rabbit olfactory bulb xenotransplantation on cell apoptosis in rats with spinal cord injury,https://en.cnki.com.cn/Article_en/CJFDTotal-JXYB200702002.htm,Chinese,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Korkmaz et al.,2015,Effect of montelukast on spinal cord ischemia- Reperfusion injury,10.5137/1019-5149.JTN.11499-14.2,English,,included,,,,,,rats,Sprague Dawley,21,7,,,7,,,sham n=7,male 100%,male,100,not reported,,,,,,Not reported,range [250-350](g),,,250,350,g,,level: clamp after left renal artery and before aortic bifurcation; severity: not reported,thoracic,Not reported,ischemia,"laparotomy incision + cross-clamp after left renal artery and before aortic bifurcation, ischemic insult for 45 minutes then removed",48 hours,montelukast,montelukast,,10mg/kg,30 minutes before and during the ischemic period,,1h,-,not reported,,locomotor functional recovery,motor deficit index,,"assessment of ambulation using the hindlimbs (0:normal, symmetric and coordinated ambulation; 4: no movement of the lower extremities) and by the placing/stepping reflex (0:normal, 2:no stepping response), MDI is sum of ambulation and placing/stepping reflex score, MDI<3 =non-paraplegic, MDI>=3 considered as paraplegic",after 48h of reperfusion,,yes,positive effect,"mean MDI score of treatment group was significantly lower (=better) than in the control group (with SCI, without treatment)",histopathological and immunohistochemical evaluation,"neuronal cell degeneration, edema, inflammation, vacuolar congestion (, HSP70 staining, IL-6 receptor)",48h after injury,yes,no effect,"no treatment effect in terms of neuronal cell degeneration, edema, or inflammation or vacuolar congestion(; IL-6 receptor levels significantly lower in treatment group than the control group; no significant difference observed between the groups in terms of the degree of MPO staining)","anesthesia: ketamine (50mg/kg), xylazine (5mg/kg), intermittent delivery of ketamine (25 mg/kg), oxygen (200mL/minute); prophylactic antibiotics (procaine penicillin, 200'000 units IM twice a day) for 2 days; immediately before procedure: heparin (400 IU/kg); postoperative analgesia: tramadol (subcutaneous); euthanasia: sodium pentobarbital (100mg/kg)",The findings of the current study demonstrated that montelukast improved motor recovery and decreased IL-6 levels in spinal cord ischemia-reperfusion injury.,not reported,"study of treatment effect in ischemic SCI; use ketamine, penicillin, heparin, pentobarbital",No,
Lucie,Erman et al.,2004,"Effect of naloxone after spinal cord injury in the rat - Inducible nitric oxide synthase expression, superoxide dismutase activity, and ultrastructural changes",10.1097/00013414-200412000-00010,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Haghighi et al.,1987,Effect of naloxone in experimental acute spinal cord injury,10.1227/00006123-198703000-00005,English,,included,,,,,,cats,conditioned cats,8,4,,,4,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,range [3-4](kg),,,3,4,kg,,"level: thoracolumbar (T12-L1 laminectomy); severity: ""reversible injury""",T12 - L1,Not reported,contusion,laminectomy + weight drop method (20g weight dropped from 6cm high),4 hours,naloxone,naloxone,,"2mg/kg (initial bolus), 2mg in a 0.5ml intrathecal injection, 2mg/kg/hour",start 10 minutes after trauma,,4h (infusion),-,multiple,first bolus: IV; then intrathecal injection; then IV (infuson via pump),neuroelectrophysiological recovery ,spinal evoked potentials (SEP),,"positioned two platinum ball electrodes epidurally, one at the rostral end of T12 and on the the caudal end of L1 vertebral levels, reference electrode was attached to the spinous process of T11; SEPs to right sciatic nerve stimulation were referentially recorded; isolated stimulus of 0.1ms, repetition rate of 2.3 stimuli per second and 100 responses averaged","1 before traum, 1 immediately after trauma, then every half hour up to 4h post trauma",,not reported,no effect,"No recovery of the SEO in response to sciatic nerve stimulation occurred in either group during the 4 hours of treatment and monitoring in this study, no significant difference was found between the interpeak latencies of the naloxone and saline-treated groups",histopathological studies,microscopic examination,4h after injury,not reported,no stats,there was no qualitative or quantitative difference between the control and naloxone-treated groups,anesthesia: halothane and oxygen chamber; before recording when needed: pancuronium bromide (0.1mg/kg); euthanasia: overdose of potassium chloride solution,no recovery of the SEP response to sciatic nerve stimulation occurred in either group during the 4 hours of treatment and monitoring in this study,not reported,,No,
Lucie,Arias,1985,Effect of naloxone on functional recovery after experimental spinal cord injury in the rat,10.1016/0090-3019(85)90226-5,English,,included,,,,,,rats,Wistar,48,16,,,16,,,sham n=16,male 100%,male,100,not reported,,,,,,Not reported,range [250-300](g),,,250,300,g,,level: T3; severity: severe,T3,severe,contusion,Allen's fenestrated tube method (weight drop: 5g weight dropped 10cm onto an impounder of 1g that rests on the dorsal surface of the exposed spinal cord extradurally),6h or 10 weeks (one half of each group),naloxone,naloxone,,0.8mg bolus,45 min and 120 minutes after injury,,2 doses,-,intraperitoneally,,neurological functions,inclined plane method of Rivlin and Tator,,average maximum angle,10 week after injury,,not reported,positive effect,naloxone-treated animals showed a significantly better performance on the inclined plane than saline-treated animals,histological measures,"necrosis in the gray and white matters, hemorrhage in the gray and white matters, edema in the white matter: each feature was graded 0-3 according to severity (0: none, 3: severe), in acute animals (6h) ; cavitation in chronic animals (10 weeks)",6h and 10 weeks,not reported,no effect,the severity of the lesion in naloxone and saline groups is not significantly different; ni significant difference between the two groups of animals in the amount of spina cord cavitation in chronic animals,"anesthesia: pentobarbital (40mg/kg, IP);euthanasia: Cammermeyer method",Naloxone may be useful for the treatment of spinal cord injury although its mechanism of action remains unknown,not reported,use pentobarbital,No,
Lucie,Jia et al.,2015,Effect of nimodipine on rat spinal cord injury,10.4238/2015.February.13.5,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (nimodipine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ross et al.,1993,Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats,10.1016/0090-3019(93)90048-6,English,,included,,,,,,rats,Wistar,44,11,,,10,,,"2 treatement groups not of interest (both have nimodipine, n=10 and n=13); only 27 rats survived but no details on the deaths per group (kaplan meier plots but not possible to read numbers)",female 100%,female,0,not reported,,,,,,Not reported,range [250-315](g),,,250,315,g,,level: T1; severity: severe SCI (animals are completely paraplegic immediately after injury and then show minimal recovery of movement in the lower extremities overt the next 4 to 8 weeks),T1,severe,compression,"laminectomy of C7-T1 + acute compression of T1 (1 min, 52g curved, modified, Kerr-Lougheed aneurysm clip)",8 weeks,"nimodipine, methylprednisolone",methylprednisolone,No,"30mg/kg (bolus), 5.4 mg/kg/h (infusion)",5 minutes after injury (bolus),,8h (infusion),-,intravenously,,"functional assessment, neuroelectrophysiological assessment",inclined plane technique; somotosensory evoked potentials (SSEP) ,,"inclined plane: board covered tih rubber mat with ridges 0.6cm in height on its surface, inclined plane score was max inclination of the board in degress at which a rat could maintain its position for 5 sec; SSEP: recorded from sensorimotor cortex using a 0.8mm diameter platinum ball electrode secured in a right parietal burr hole, needles inserted into the exposed left sciatic nerve above the knee at a longitudinal separation of 1.5mm ",SSEP: 8 weeks; inclined plane: weekly from week 1 to week 7 post-injury,Yes,yes,no effect,"post hoc analyses failed to demonstrate that group A rats (nimodipine) performed significantly better than group D (placebo) rats during most weeks. MP group fared the worst ; analysis of SSEP amplitudes and latencied was not meaningful because standard error were very large because of the large number of absent responses, nimodipine group showed highest number of ""positive"" responses, but not significantly greater than in other groups, MP also not significantly different",histological measures,counts of retrogradely labeled red nucleus neurons,8 weeks + 2 days,yes,no effect,no significant difference between groups ,"anesthesia: 5% halothane, 2:1 mixture of N2O and O2; euthanasia: 65mg sodium pentobarbital (IP); cystitis treatment (hematuria): gentamicin 2mg SC QD for 7 days",statistically significant difference between treatment groups were not found for most outcome measures,not reported,"use pentobarbital, gentamicin",No,
Lucie,GOPINATHAN et al.,2008,Effect of nitric oxide synthase inhibitor and electro-acupuncture in experimentally induced acute spinal cord injury in rabbits,The Indian journal of animal sciences 78(11),English,,excluded,Out of scope,No control group,Out of scope: no control group to evaluate the effect of MPSS,,,rabbit,New Zealand White rabbits,"24 (abstract), 16 (materials and methods)",,,,,,,,of either sex,,,not reported (adults),,,,,,,not reported,,,,,,,level: L1-L2; severity: not reported,,,,A 2.5 mm diameter orthopaedic drill bit was then introduced through the incision site till the vertebral body was reached. The drill bit was then introduced through the vertebra carefully by slow rotatory movements into the spinal canal till a brisk reflex movement of the hind limbs was elicited when it· touched the dura overlying the spinal cord. The pressure applied on the spinal cord with this blunt object was such that it abolished the voluntary motor activity of hind limbs. ,2 weeks,methylprednisolone sodium succinate (MPSS),,,30 mg/kg and 15 mg/kg,immediately after trauma,,"4 doses, then at 6, 12 and 24h after trauma",-,intravenously,,neurological/functional assessement,ordinal scale from Tarlov and Klinger,,"0, complete paraplegia; 1, some minor movement of the joints; 2, major movement of the joints but inability to stand; 3, the animal can stand and possibly walk; 4, the animal can run and has a normal motor system with no obvious weakness",daily for 2 weeks,,not reported,,,histological assessment,,2 weeks,not reported,,,,,,,,
Lucie,Gerber et al.,1980,Effect of phenytoin on functional recovery after experimental spinal cord injury in dogs,10.1227/00006123-198011000-00009,English,,included,,,,,,dogs,Mongrel,26,9,3,,12,1,,2 phenytoin groups one of 7 dogs (1 died) and one of 5 dogs,not reported,not reported,not reported,not reported,,,,,,Not reported,range [9-16](kg),,,9,16,kg,,level: T9-T11; severity: not reported,T9 - T11,Not reported,contusion,"weight drop : 25g, distance of 25cm though a glass tube onto the exposed dura, weight was cylindrircal and of a diameter to drop freely trhough the glass tube, flat bottom of weight was reduced to a diameter of 6mm","killed at 6 weeks after injury, 4 dogs died between 2 and 4 weeks after injury (distemper or other systemic illness)","phenytoin, dexamethasone",phenytoin,,20mg/kg,"immediately or 30min, then at 6h",,2 doses,-,intravenously,,functional assessment,hind limb motor function (modified Tarlov),,based on scale devised by Tarlov as modified by Kajihara et al.,2 times per week,,"""single-blind"" basis",positive effect,all three treated animal groups attained final mean motor ratings superior to the ratings of untreated controls at a significance level of p < 0.01,histological assessment,"fibrosis, parenchymal loss, vacuolation, axonal dystrophy",6 weeks,not reported,no stats,"very unclear to me, no real comparison between groups, only descriptive hence classified as no stats","anesthesia: sodium pentobarbital 29mg/kg; IM penicilin immediately after wound closure, 5% dextrose in water to anorexic animals","phenytoin is at least as effective as dexamethasone, the therapeutic effectiveness of PHT treatment begun immediately after injury and begun 30 minutes after injury was evaluated. The results obtained in all three treated groups of dogs were superior to the results in untreated controls at a significant level of p<0.01",not reported,"use pentobarbital, penicillin",No,
Lucie,Gerber et al.,1980,Effect of phenytoin on functional recovery after experimental spinal cord injury in dogs,10.1227/00006123-198011000-00009,English,,included,,,,,,dogs,Mongrel,26,9,3,,5,0,,,not reported,not reported,not reported,not reported,,,,,,Not reported,range [9-16](kg),,,9,16,kg,,level: T9-T11; severity: not reported,T9 - T11,Not reported,contusion,"weight drop : 25g, distance of 25cm though a glass tube onto the exposed dura, weight was cylindrircal and of a diameter to drop freely trhough the glass tube, flat bottom of weight was reduced to a diameter of 6mm","killed at 6 weeks after injury, 4 dogs died between 2 and 4 weeks after injury (distemper or other systemic illness)","phenytoin, dexamethasone",dexamethasone,,"0.6mg/kg (immediately), 0.24mg/kg (6h after injury)","immediately, then at 6h",,2 days (total of 6 doses),twice daily,multiple,"immediately, and 6h after injury: IV; dexamethasone twice daily for four doses: IM",functional assessment,hind limb motor function (modified Tarlov),,based on scale devised by Tarlov as modified by Kajihara et al.,2 times per week,,"""single-blind"" basis",positive effect,all three treated animal groups attained final mean motor ratings superior to the ratings of untreated controls at a significance level of p < 0.01,histological assessment,"fibrosis, parenchymal loss, vacuolation, axonal dystrophy",6 weeks,not reported,no stats,"very unclear to me, no real comparison between groups, only descriptive hence classified as no stats","anesthesia: sodium pentobarbital 29mg/kg; IM penicilin immediately after wound closure, 5% dextrose in water to anorexic animals","phenytoin is at least as effective as dexamethasone, the therapeutic effectiveness of PHT treatment begun immediately after injury and begun 30 minutes after injury was evaluated. The results obtained in all three treated groups of dogs were superior to the results in untreated controls at a significant level of p<0.01",not reported,"use pentobarbital, penicillin",No,
Tomás and Lucie,Silva et al.,2008,Effect of prednisone on acute experimental spinal cord injury in rats,10.1590/S0102-09352008000300018,Portuguese,,included,,,,,,rats,Wistar,25,5,,,20,,,4 treatment groups o fn=5 each,male 100%,male,100,3 months old (adults),3,,,,Months,Adult,range: [272-377](g),,,272,377,g,,level: T12-T13; severity: moderate to severe,T12 - T13,moderate - severe,compression,"laminectomy + pressure injury (weight of 50,5g for 5 minutes on the dura)",33 days,prednisone,prednisone,,"2 (start), then 1, then 0.5 mg/kg","8, 24, 48 or 120h after injury",,5 days for each dose (15 days) + 6 days (up to 26 days),"every 12h (1 and 2 mg/kg) or 24h (0.5 mg/kg) or 48 (0.5 mg/kg, after the first 15 days) ",oral,,"behavioral/locomotor functional recovery, pain","sensitivity to pain, motor function, proprioception, localisation reflex, inclined plane test",,"motor function: higher score = closer to normal, movement of the posterior limbs, walking ability, walking on a bar of 1m with different width, sensitivity to pain, proprioception, reflex localisation, inclined plane test (1=10 degrees less than before surgery, 2=20 less, 3=30 less or 4=same angle as before surgery)",24h after surhery and then every 3 days until day 33,,not reported,no effect,Kruskal-Wallis test not significant (no group different from the others) for all assessments,histological assessment,"cavitation, axonal degeneration, area of necrosis",33 days,not reported,no stats,no differences observed between groups (no quantification possible due to technical issues in fixation),"pre-medication: tramadol hydrochloride, anesthesia: isoflurane (mask); postop: analgesia with tramadol hydrochloride for 5 days; euthanasia: sodium thiopental","The administration of high dosages of prednisone to animals with acute spinal cord injury had no deleterious effects on neurological recovery, even when used late.","problem in fixation for histology, small sample size","use tramadol, isoflurane",No,
Lucie,álvarez-Mejía et al.,2015,Effect of pyrrole implants synthesized by different methods on spinal cord injuries of rats,https://www.medigraphic.com/pdfs/inge/ib-2015/ib151c.pdf,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Polypyrrole (PPy) and polypyrrole/polyethylene glycol (PPy/PEG) implants),,,rats,Long Evans,18 (3 rats per group),,,,,,,,female 100%,,,not reported,,,,,,,range [220-260](g),,,,,,,level: T9; severity: complete spinal cord section,,,,complete transection: meninges were longitudinally cut and spinal cord tissue was completely transected by cutting transversally all fibers,30 days,Polypyrrole (PPy) synthesized by plasma or chemically or purchased and polypyrrole/polyethylene glycol (PPy/PEG) synthesized by plasma or electrochemically,,,10mg implant (all animals but controls),implant was inserted at the injured zone in the cavity between both sides of the transection ,,30 days (I guess? since I would assume the implant is staying in for the fully time),,,,motor function recovery,"Basso, Beattie and Bresnahan (BBB) scale",,22 points scale where 0 represents total absence of movement (paralysis) and 21 reprensents a normal walking,"24h after injury, then once a week during 5 weeks",,yes,positive effect,Animals with implants synthesized by plasma showed significant differences with animals from the control group; PPy (p = 0.028) and PPy / PEG (p = 0.05).,histological analysis,"integration of the implants to the spinal cord tissue, inflammatory response",4 weeks after injury,not reported,,"PPy implants synthesized by plasma polymerization were well intergated to the tissue and surrounding tissue showed little destruction, whilst chemically-synthesized implants had similar amount of tissue destruction but complete lack of implant integration; very unclear to me, no real comparison of treatment effect between groups","anesthesia: ketamine (77.5 mg/kg) and xylazine (12.5mg/kg); anti-inflammatory drug : 0.31mL/62.5mL of paracetamol into drinking water during 3 days; antibiotic: 200 microL of benzathine penicillin, in one i.m. dose; euthanasia: heparin 0.2mL IP, 200mL saline transcardially at 30mL/min, 400mL of 4% paraformaldehyde in phosphate buffer","Results showed that animals implanted with polymers synthesized by plasma had a better integration into the nerve tissue, less inflammatory response and a better functional recovery than animals implanted with polymers synthesized by chemical or electrochemical methods.",,Not sure it actually fits in the review,,
Lucie,Caglar et al.,2018,Effect of Riluzole on Spinal Cord Regeneration with Hemisection Method Before Injury,10.1016/j.wneu.2018.02.171,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (riluzole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bani et al.,2020,Effect of Selenium and Electrical Stimulation on the Expression of Cation Channel Spermia 1 and 2 Genes in Spinal Cord Injury Rat Model,https://www.cjmb.org/uploads/pdf/pdf_CJMB_392.pdf,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Xiao et al.,2016,Effect of small interferon RNA combined with electro-acupuncture on the expression of connective tissue growth factor after spinal cord injury in rats,10.16098/j.issn.0529-1356.2016.02.006,Chinese,,excluded,Out of scope,No drug of interest,"Out of scope: No drug of interest (connective tissue growth factor, electro acupuncture)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lukacova et al.,1993,EFFECT OF STOBADINE ON LIPID-PEROXIDATION AND PHOSPHOLIPIDS IN RABBIT SPINAL-CORD AFTER ISCHEMIA,10.1016/0028-3908(93)90106-D,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,rabbit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bobo,Pan et al.,2006,Effect of tacrolimus on apoptosis and expression of heat shock protein 70 after acute spinal cord injury in rats,https://pubmed.ncbi.nlm.nih.gov/17359722/,Chinese,,included,,,,,,rats,Wistar,72,30,,,30,,,sham n = 12,male 100%,male,100,not reported (adult),,,,,,Adult,range [220-270]g,,,220,270,g,,level: T10; severity: not reported,T10,Not reported,contusion,10g weight dropped from 4cm,not reported,tacrolimus,tacrolimus,No,0.3 mg/kg ,5 minutes after SCI,,single dose,single dose,intravenously,,functional assessment,BBB scoring; inclined plane test,,,"1, 3, 7, 14, 21 days post injury",No,BBB observers were not study personel,positive effect,Animals treated with FK506 had higher BBB and incline plane scale at all time points (statistically significant at all time points except 1 day post injury),histopathological and gene expression,"reverse transcription PCR detection of mRNA, immunohistochemical staining of HSP70 and Caspase 3, in situ detection of apoptic cells by TUNEL","30 mins, 6, 24, 48, 72 hrs",not reported,positive effect,"expression of HSP70 was significantly higher in the tacrolimus group than the injured group, the peak expression of HSP70 mRNA and protein was observed at 6 and 24 hours after SCI (respectively), Caspase 3 positive or TUNEL positive cells were significantly less in the tacrolimus group",anesthesia: 1% pentobarbital soodium(30mg/kg),tacrolimus may inhibit the activity of Caspase 3 which attenuates the apoptosis of neural cells and promote the recovery of spinal cord function.  The mechanism may be related to the increased expression of HSP 70,not reported,,No,
Lucie,Genovese et al.,2008,Effect of thalidomide on signal transduction pathways and secondary damage in experimental spinal cord trauma,10.1097/SHK.0b013e318162d290,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (thalidomide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Su et al.,2017,The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner,10.1016/j.brainres.2017.06.020,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (WIN55212-2, an agonist for CB1 and CB2 receptors)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ishii et al.,2018,Free radical scavenger edaravone produces robust neuroprotection in a rat model of spinal cord injury,10.1016/j.brainres.2017.12.035,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (edaravone),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al.,2017,Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury,10.4103/1673-5374.215263,English,,included,,,,,,rats,Sprague Dawley,50,10,,,10,,,sham n=10,male 100%,male,100,not reported,,,,,,Not reported,245(20)(g),245,20,,,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + impact (impact depth of 1.0mm, impact velocity of 2.0m/s, residence time of 200ms)",8 weeks,"methotrexate (MTX), methylprednisolone (MP) and combination of both",methylprednisolone,No,30 mg/kg,30 minutes after injury,,single dose,-,intravenously,,gait analysis,hind limb gait,,"hind limb swing time, stride time, minimum longitudinal deviationm instant speed, footprint area, regularity index; first ran freely for 30-45s then placed on walking table of the gait analyzer, speed of walking table increased from 7cm/s to 15 cm/s over 20 seconds; each rat was tested three times","2,4 and 8 weeks after injury",Yes,not reported,positive effect,"methylprednisolone significantly improved hind limb swing time, stride time, minimum longitudinal deviation, instant speed, footprint area and regularity index",histology,"number of neurons, vacuoles, tissue loss, cyst formation, myelin sheath swelling, losse structure of the white matter, white matter bundle, total glial cell proliferation, tissue voidsm size of cysts",8 weeks after injury,not reported,no stats,"Myelin sheath swelling and the loose structure of the white matter and the white matter bundle were improved in the MP + MTX group. Total glial cell proliferation, tissue voids, and the size of cysts at the injury cen- ter and in adjacent areas were significantly smaller in the MP + MTX group compared with those in the MP group.","anesthesia: 5% chloral hydrate, iodophor for disinfection; after surgery: 5mL Ringer's lactate solution; penicillin and gentamicin sulfate (2.5 mL/kg, IM, twice a day for 7 days after injury); if urinary tract infection: antibiotics for 10 days; euthanasia: anesthesized, perfused intracardially with saline followed by 4% paraformaldehyde solution",the combination of MP with MTX significantly improved damaged motor function caused by SCI in rats,not reported,"use chloral hydrate, gentamicin, penicillin",No,
Lucie,Liu et al.,2017,Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury,10.4103/1673-5374.215263,English,,included,,,,,,rats,Sprague Dawley,50,10,,,10,,,sham n=10,male 100%,male,100,not reported,,,,,,Not reported,245(20)(g),245,20,,,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + impact (impact depth of 1.0mm, impact velocity of 2.0m/s, residence time of 200ms)",8 weeks,"methotrexate (MTX), methylprednisolone (MP) and combination of both",methotrexate,,0.3 mg/kg,not reported,,2 weeks,once daily,subcutaneous,,gait analysis,hind limb gait,,"hind limb swing time, stride time, minimum longitudinal deviationm instant speed, footprint area, regularity index; first ran freely for 30-45s then placed on walking table of the gait analyzer, speed of walking table increased from 7cm/s to 15 cm/s over 20 seconds; each rat was tested three times","2,4 and 8 weeks after injury",,not reported,no effect,"methotrexate alone did not significantly improve hind limb swing time, stride time, minimum longitudinal deviation, instant speed, footprint area and regularity index",histology,"number of neurons, vacuoles, tissue loss, cyst formation, myelin sheath swelling, losse structure of the white matter, white matter bundle, total glial cell proliferation, tissue voidsm size of cysts",8 weeks after injury,not reported,no stats,"Myelin sheath swelling and the loose structure of the white matter and the white matter bundle were improved in the MP + MTX group. Total glial cell proliferation, tissue voids, and the size of cysts at the injury cen- ter and in adjacent areas were significantly smaller in the MP + MTX group compared with those in the MP group.","anesthesia: 5% chloral hydrate, iodophor for disinfection; after surgery: 5mL Ringer's lactate solution; penicillin and gentamicin sulfate (2.5 mL/kg, IM, twice a day for 7 days after injury); if urinary tract infection: antibiotics for 10 days; euthanasia: anesthesized, perfused intracardially with saline followed by 4% paraformaldehyde solution",the combination of MP with MTX significantly improved damaged motor function caused by SCI in rats,not reported,"use chloral hydrate, gentamicin, penicillin",No,
Lucie,Liu et al.,2017,Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury,10.4103/1673-5374.215263,English,,included,,,,,,rats,Sprague Dawley,50,10,,,10,,,sham n=10,male 100%,male,100,not reported,,,,,,Not reported,245(20)(g),245,20,,,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + impact (impact depth of 1.0mm, impact velocity of 2.0m/s, residence time of 200ms)",8 weeks,"methotrexate (MTX), methylprednisolone (MP) and combination of both",methylprednisolone + methotrexate,,MP: 30 mg/kg + MTX: 0.3 mg/kg,MP: 30 minutes before injury; MTX: 1 day after injury,,MP: single dose + MTX: 2 weeks,MTX: once daily,multiple,MP: IV + MTX: SC,gait analysis,hind limb gait,,"hind limb swing time, stride time, minimum longitudinal deviationm instant speed, footprint area, regularity index; first ran freely for 30-45s then placed on walking table of the gait analyzer, speed of walking table increased from 7cm/s to 15 cm/s over 20 seconds; each rat was tested three times","2,4 and 8 weeks after injury",,not reported,positive effect,"methotrexate combined with methylprednisolone significantly improved hind limb swing time, stride time, minimum longitudinal deviation, instant speed, footprint area and regularity index",histology,"number of neurons, vacuoles, tissue loss, cyst formation, myelin sheath swelling, losse structure of the white matter, white matter bundle, total glial cell proliferation, tissue voidsm size of cysts",8 weeks after injury,not reported,no stats,"Myelin sheath swelling and the loose structure of the white matter and the white matter bundle were improved in the MP + MTX group. Total glial cell proliferation, tissue voids, and the size of cysts at the injury cen- ter and in adjacent areas were significantly smaller in the MP + MTX group compared with those in the MP group.","anesthesia: 5% chloral hydrate, iodophor for disinfection; after surgery: 5mL Ringer's lactate solution; penicillin and gentamicin sulfate (2.5 mL/kg, IM, twice a day for 7 days after injury); if urinary tract infection: antibiotics for 10 days; euthanasia: anesthesized, perfused intracardially with saline followed by 4% paraformaldehyde solution",the combination of MP with MTX significantly improved damaged motor function caused by SCI in rats,not reported,"use chloral hydrate, gentamicin, penicillin",Yes (drug of interest + drug of interest),
Lucie,Hao et al.,2017,Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats,10.4103/1673-5374.208591,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (deferoxamine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ahmad et al.,2016,Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats,10.1016/j.pbb.2016.04.003,English,,included,,,,,,rats,Sprague Dawley,48,8,,,8,,,"sham n=8, normal group (no laminectomy) n=8",male 100%,male,100,not reported (young adults),,,,,,Adult,range [250-280](g),,,250,280,g,,level: T7-8; severity: evaluated as part of the histological assessment (evaluation a posteriori),T7 - T8,Not reported,compression,"laminectomy + compression (metallic rectangular plate 2.5*5.0mm, loaded with a total weight of 35g, for 5 min over the exposed extradural area)",29 days,minocycline; FK506; combinaison of both,minocycline,,50 mg/kg,1h after SCI,,3 weeks,daily,oral,,neurological/functional assessement,BBB scoring; Tarlov scoring; inclined plane test; functional deficits scoring,,"BBB scoring: modified version, travel through a gait performance tunnel = a narrow tunnel constructed from a wooden block (180 × 10 × 5 cm) with side wallsmade of clear Perspex glass (180 × 18 sq cm), such that animal movement was clearly visible to the observer, who assessed the movements of the animals' hindlimbsand the placement of their hind paws. Hind limb function was scored from 0 (complete paralysisor paraplegia) to 21 (complete mobility); Tarlov scoring: modified Tarlov scoring method, range from 1 (=total paraplegia of hind limbs) to 8 (=walks on ledge); inclined panel test: assess the behavioral recovery of the hind limbs from motr disturbances after SCI, measure the maximum angle at which an animal could support its body weight on an inclined board for 5 sec measures in degrees, board covered with a rubber mat having 1mm high ridges, three separate measurments per session and mean considered as a single score ","day after injury, then every other day for 29 days, 10min resting time between each test",,yes,positive effect,"the drug treated SCI groups showed better and improved recovery in all behavioral activities compared to the SCI control group, and the drugs were effective inthe order of FK506 + minocycline > minocycline > FK506",histolopathological studies; biochemical analysis,"extent of injury: 0=no evidence of injury, 3=severe injury; mild injury=no cystic necrosis, but vacuaolation focal demyelination and gliosis, dilation of central canal and infiltration with round cells or macrophages, moderate injury=cystic necrosis with loss of gray or white matter in less than one-quarter of the total surface of the transverse section of the spinal cord, severe injury=gross deformation of the spinal cord in more than one-quarter of the transverse spinal cord section",day 29 after injury,yes,no stats,"Tissue section of injured SCI control animal shows minimum recovery with deep scar. Sections from SCI animals treated with minocycline, FK506 and minocycline + FK506 show comparative recovery from SCI in the injured tissues. The drugs were effective in the order FK506<minocycline<FK506 + minocycline",anesthesia: chloral hydrate (450 mg/kg); post-op: IM gentamycin (3mg/kg) for 3 days after surgery; euthanasia: anesthesia with ether then perfused intracardially with 10% neutral buffered formalin,"Overall, the effects of the tested drugs for SCI recovery were as follows: FK506 + minocycline > minocycline > FK506 in all studied parameters. Thus, minocycline and FK506 may prove to be a potential therapy cocktail to treat acute SCI",not reported,"use chloral hydrate, gentamycin",No,
Lucie,Ahmad et al.,2016,Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats,10.1016/j.pbb.2016.04.003,English,,included,,,,,,rats,Sprague Dawley,48,8,,,8,,,"sham n=8, normal group (no laminectomy) n=8",male 100%,male,100,not reported (young adults),,,,,,Adult,range [250-280](g),,,250,280,g,,level: T7-8; severity: evaluated as part of the histological assessment (evaluation a posteriori),T7 - T8,Not reported,compression,"laminectomy + compression (metallic rectangular plate 2.5*5.0mm, loaded with a total weight of 35g, for 5 min over the exposed extradural area)",29 days,minocycline; FK506; combinaison of both,tacrolimus,,1 mg/kg,1h after SCI,,3 weeks,daily,oral,,neurological/functional assessement,BBB scoring; Tarlov scoring; inclined plane test; functional deficits scoring,,"BBB scoring: modified version, travel through a gait performance tunnel = a narrow tunnel constructed from a wooden block (180 × 10 × 5 cm) with side wallsmade of clear Perspex glass (180 × 18 sq cm), such that animal movement was clearly visible to the observer, who assessed the movements of the animals' hindlimbsand the placement of their hind paws. Hind limb function was scored from 0 (complete paralysisor paraplegia) to 21 (complete mobility); Tarlov scoring: modified Tarlov scoring method, range from 1 (=total paraplegia of hind limbs) to 8 (=walks on ledge); inclined panel test: assess the behavioral recovery of the hind limbs from motr disturbances after SCI, measure the maximum angle at which an animal could support its body weight on an inclined board for 5 sec measures in degrees, board covered with a rubber mat having 1mm high ridges, three separate measurments per session and mean considered as a single score ","day after injury, then every other day for 29 days, 10min resting time between each test",,yes,mixed effects (assessment),"the drug treated SCI groups showed better and improved recovery in all behavioral activities compared to the SCI control group, and the drugs were effective inthe order of FK506 + minocycline > minocycline > FK506; tacrolimus group no significantly different from control in tarlov's score, platform hanging score and wire mesh descent score",histolopathological studies; biochemical analysis,"extent of injury: 0=no evidence of injury, 3=severe injury; mild injury=no cystic necrosis, but vacuaolation focal demyelination and gliosis, dilation of central canal and infiltration with round cells or macrophages, moderate injury=cystic necrosis with loss of gray or white matter in less than one-quarter of the total surface of the transverse section of the spinal cord, severe injury=gross deformation of the spinal cord in more than one-quarter of the transverse spinal cord section",day 29 after injury,yes,no stats,"Tissue section of injured SCI control animal shows minimum recovery with deep scar. Sections from SCI animals treated with minocycline, FK506 and minocycline + FK506 show comparative recovery from SCI in the injured tissues. The drugs were effective in the order FK506<minocycline<FK506 + minocycline",anesthesia: chloral hydrate (450 mg/kg); post-op: IM gentamycin (3mg/kg) for 3 days after surgery; euthanasia: anesthesia with ether then perfused intracardially with 10% neutral buffered formalin,"Overall, the effects of the tested drugs for SCI recovery were as follows: FK506 + minocycline > minocycline > FK506 in all studied parameters. Thus, minocycline and FK506 may prove to be a potential therapy cocktail to treat acute SCI",not reported,"use chloral hydrate, gentamycin",No,
Lucie,Ahmad et al.,2016,Effectiveness of minocycline and FK506 alone and in combination on enhanced behavioral and biochemical recovery from spinal cord injury in rats,10.1016/j.pbb.2016.04.003,English,,included,,,,,,rats,Sprague Dawley,48,8,,,8,,,"sham n=8, normal group (no laminectomy) n=8",male 100%,male,100,not reported (young adults),,,,,,Adult,range [250-280](g),,,250,280,g,,level: T7-8; severity: evaluated as part of the histological assessment (evaluation a posteriori),T7 - T8,Not reported,compression,"laminectomy + compression (metallic rectangular plate 2.5*5.0mm, loaded with a total weight of 35g, for 5 min over the exposed extradural area)",29 days,minocycline; FK506; combinaison of both,minocycline + tacrolimus,,minocycline: 50 mg/kg + tacrolimus: 1 mg/kg,1h after SCI,,3 weeks,daily,oral,,neurological/functional assessement,BBB scoring; Tarlov scoring; inclined plane test; functional deficits scoring,,"BBB scoring: modified version, travel through a gait performance tunnel = a narrow tunnel constructed from a wooden block (180 × 10 × 5 cm) with side wallsmade of clear Perspex glass (180 × 18 sq cm), such that animal movement was clearly visible to the observer, who assessed the movements of the animals' hindlimbsand the placement of their hind paws. Hind limb function was scored from 0 (complete paralysisor paraplegia) to 21 (complete mobility); Tarlov scoring: modified Tarlov scoring method, range from 1 (=total paraplegia of hind limbs) to 8 (=walks on ledge); inclined panel test: assess the behavioral recovery of the hind limbs from motr disturbances after SCI, measure the maximum angle at which an animal could support its body weight on an inclined board for 5 sec measures in degrees, board covered with a rubber mat having 1mm high ridges, three separate measurments per session and mean considered as a single score ","day after injury, then every other day for 29 days, 10min resting time between each test",,yes,positive effect,"the drug treated SCI groups showed better and improved recovery in all behavioral activities compared to the SCI control group, and the drugs were effective inthe order of FK506 + minocycline > minocycline > FK506",histolopathological studies; biochemical analysis,"extent of injury: 0=no evidence of injury, 3=severe injury; mild injury=no cystic necrosis, but vacuaolation focal demyelination and gliosis, dilation of central canal and infiltration with round cells or macrophages, moderate injury=cystic necrosis with loss of gray or white matter in less than one-quarter of the total surface of the transverse section of the spinal cord, severe injury=gross deformation of the spinal cord in more than one-quarter of the transverse spinal cord section",day 29 after injury,yes,no stats,"Tissue section of injured SCI control animal shows minimum recovery with deep scar. Sections from SCI animals treated with minocycline, FK506 and minocycline + FK506 show comparative recovery from SCI in the injured tissues. The drugs were effective in the order FK506<minocycline<FK506 + minocycline",anesthesia: chloral hydrate (450 mg/kg); post-op: IM gentamycin (3mg/kg) for 3 days after surgery; euthanasia: anesthesia with ether then perfused intracardially with 10% neutral buffered formalin,"Overall, the effects of the tested drugs for SCI recovery were as follows: FK506 + minocycline > minocycline > FK506 in all studied parameters. Thus, minocycline and FK506 may prove to be a potential therapy cocktail to treat acute SCI",not reported,"use chloral hydrate, gentamycin",Yes (drug of interest + drug of interest),
Lucie,Genovese et al.,2009,"Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury",10.1080/10715760902954126,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (metalloporphyrinic peroxynitrite decomposition catalyst, ww-85)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Meng et al.,2011,Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury,10.1177/147323001103900313,English,,included,,,,,,rats,Sprague Dawley,>= 20,>= 5,,,>= 5,,,"2 treatment groups, 1 control, 1 sham, 5 animals per group in BBB",not reported,not reported,not reported,not reported (adult),,,,,,Adult,range [200-250](g),,,200,250,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight drop injury (10g rod, 2.5mm diameter, dropped from a height of 25mm, then spinal cord compressed for 1 min)","12, 24, 72, 144 and 168h","methylprednisolone, rosiglitazone",methylprednisolone,No,30 mg/kg,immediately after injury,Yes,1 dose,-,intraperitoneally,,neurological/functional assessement,BBB scoring,,"21-point open-field locomotor scale, based on precise observation of hind limb movements and on stepping and coordination in an open field, normal locomotion = 21, complete hin limb paralysis = 0, movements scored for 4 min, mean value for all animals in a group at the same time point were calculated","immediately after SCI, day3 after SCI, weekly for 4 weeks",Yes,yes,no stats,the rosiglitazone-treated group had a significantly higher locomotor scores than both the methylprednisolone group and the sci-only group from day 3 onwards (p<0.05 for each difference at each time point); no stats reported  comparing methylprednisolone and SCI,gene and protein expression,"(NGF and BDNF gene and protein expression, mRNA levels (real-time PCR), western blot analysis)","12, 24, 72, 144 and 168h after injury",not reported,positive effect,NGF gene significantly higher in the rosiglitazone-treated groups compared with the other groups at 72 and 168h; BDNF mRNA levels was significantly higher in the rosiglitazone-treated group than in the other groups 144h after injury; rosiglitazone treatment resulted in significantly higher levels of NGF at 72h and of BDNF at 144h (p<0.01 for both neutrophins versus all other times) ,"anesthesia: pentobarbital (50mg/kg, IP); after surgery: 1.0mL saline ",rosiglitazone enhances endogenous NGF and BDNF levels and suggest that it provides a trophic environment within the lesioned spinal cord and early functional recovery was observed in rats treated with rosiglitazone,not reported,"use saline, pentobarbital; may focus on drug not of interest in the paper so very weak results to report for MP",No,
Lucie,Hall et al.,1984,Effects of a single large dose of methylprednisolone sodium succinate on experimental postraumatic spinal cord ischemia. Dose-response and time-action analysis,10.3171/jns.1984.61.1.0124,English,,excluded,Out of scope,No assessments of interest,Out of scope: very weak information on electrophysiology ,,,cats,mongrel cats,25,,,,,,,,"""of either sex""",,,not reported (adult),,,,,,,range [2.2-3.7](kg),,,,,,,level: L3; severity: not reported,,,,laminectomy + contusion injury (500 gm-cm injury force = 50-gm weight dropped 10 cm),not reported,methylprednisolone sodium succinate,,,"15, 30 or 60 mg/kg",30 minutes after injury,,one bolus,-,intravenously,,electrophysiology,somatosensory evoked potentials,,recorded from the right somatosensory cortex via a pair of bipolar platinum-iridium electrodes with an interelectrode distance of 2mm,before injury at 30-minute intervals,,not reported,no effect,"it should be mentioned that in none of the vehicle- or MPSS-treated animals did SEP conduction, which was immediately and totally lost at the time of contusion, return over the course of the postinjury experimental period",-,-,-,-,,-,anesthesia: sodium pentobarbital (30mg/kg IV),"MPSS in a 30mg/kg dose can prevent posttraumatic spinal cord ischemia (NB: main focus of the paper is on effect of drug on ischemia of spinal cord), ability to reverse ischemia once it has developed is limited and probably lost within a few hours of onset",,main focus of the paper is on effect of drug on ischemia of spinal cord,,
Bobo,Shen et al.,2019,Effects of acetyl-L-carnitine on the recovery of hindlimb movement afterspinal cord injury in rats and its mechamism,10.12047/j.cjap.5801.2019.095,Chinese,,included,,,,,,rats,Sprague Dawley,64,14,,,36,,,sham n = 14,male 100%,male,100,8-10 weeks,,,8,10,Weeks,,range [200-240](g),,,200,240,g,,"level: T10; incomplete injury; severity: edema, paralysis of both lower limbs",T10,paraplegia,contusion,weight drop at 200kdyn,"3, 7 and 42 days",acetyl-L-carnitine,levocarnitine,,"100, 200 or 300 mg/kg","1 dose/ day for 1st week, for week 2-5: one dose a week",,5 weeks,"1 dose/ day for 1st week, for week 2-5: one dose a week",intraperitoneally,,neurological/functional assessement,BBB scoring; Rivlin inclined plane test,,none noted,"3, 7, 14, 21, 28, 35, 42 days after injury",Yes,not reported,positive effect,BBB: ALC low group had significantly higher scores at 28days onwards while ALC med/ high group had significantly higher scores starting at 7 days (with ALC high showing the most improvement in scores); inclined plane test: all ALC treated groups had significantly better results than SCI group starting at day 3 post injury with ALC high group with the highest maximum oblique angle all throughout follow-up,histopathological measures and biochemincal analysis ,"SOD and MDA detection, ALC concentration determined by high performance liquid chromatography and TUNEL and HE staining","3 days post injury for SOD/MDA/ ALC, 7 days post injury for TUNEL, 42 days post injury for HE",not reported,negative effect,SOD activities and MDA contents of the spinal cord tissue of the injured segments were significantly lower (for MDA) and higher (for SOD) in all ALC groups (with ALC high to show to most difference compared to SCI group. All ALC groups showed the same absorption spectrum for HPLC.  TUNEl staining showed that apoptosis signal was significantly decreased in the ALC high group compared to the SCI group. HE staining showed that ALC high group still showed red blood cell and inflammatory cell infiltrations,anesthesia: 2% pentobarbital sodium (40mg/kg),"ALC can promote the recovery of hindlimb motor function in rates with spinal cord injury, inhibit oxidative stress and apoptosis, and repair the damaged spinal cord.",not reported,,No,
Lucie,Anderson,1986,Effects of Acute Alcohol Intoxication on Spinal Cord Vascular Injury,10.1089/cns.1986.3.183,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (effect of alcohol [ethanol]),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Grosso et al.,2014,Effects of an immunomodulatory therapy and chondroitinase after spinal cord hemisection injury,10.1227/NEU.0000000000000447,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (clodronate, rolipram, chondroitinase ABC)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tzeng et al.,2012,"Effects of andrographolide and 14-deoxy-11,12-didehydroandrographolide on cultured primary astrocytes and PC12 cells",10.1016/j.lfs.2011.11.004,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Cristante et al.,2013,Effects of antidepressant and treadmill gait training on recovery from spinal cord injury in rats,10.1038/sc.2013.18,English,,included,,,,,,rats,Wistar,48,10,2,,10,2,,"2 other treatment group not of interest, 1 with training and 1 with drug+training; 2 rats died in each group (initially group size of 12)",male 100%,male,100,20-21 weeks,,,20,21,Weeks,,range [300-340](g),,,300,340,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,laminectomy + weight drop (10g weight dropped from 12.5 mm),"""after treatment and testing"" I guess it means 42 days, but I am not sure",fluoxetine,fluoxetine,,0.3 mL per 100g,Not reported,,42 days,once daily,intraperitoneally,,"neurological/functional, electrophysiological","BBB scale, motor evoked potentials",,"BBB: 80*80cm box, 17-cm walls, lined with blue cloth, evaluation for 4-5 min each; EPT: transcranial electrical stimulation to elicit motor-evoked potentials, responses captured at the muscular level","BBB: 2,7,14,21,28,35,42 days after injury; EP: 42 days after injury",,yes (for BBB),mixed (stats/no stats),BBB: no stats comparing treatment of interest and control groups; EP: significant improvement of treatment group in terms of latency and amplitude of evoked potentials compared to control group,histological microscopic evaluation,"necrosis, hemorrhage, hyperemia, axonal degeneration and cellular infiltration; scored as 0 (indicating absence), 1 (discrete), 2 (moderate) and 3 (severe)",42 days,not reported,no effect,HE staining showed no differences among groups for any variables; fiber counts with electron microscopy also showed no differences among groups; ANOVA confirmed that the groups were not diffferent in the number of regenerated axonal fibers,"anesthesia: 200mg/kg ketamine (IP), 5mg/kg xylzine (IP), locally lidocaine hydrochloride and epinephrine; anesthesia for evoked potential test: 55-75 mg/kg pentobarbital IP; euthanasia: thiopental (65mg per 100g), potassium chloride (both IV)","Our results indicated that a combination of antidepressant and treadmill gait training was superior to either treatment alone for improving functional deficits in rats with experimental, acute SCI.",not reported,"use lidocaine, epinephrine, thiopental, ketamine, potassium , pentobarbital",No,
Lucie,Sun et al.,2010,Effects of Axon Degeneration on Oligodendrocyte Lineage Cells: Dorsal Rhizotomy Evokes a Repair Response While Axon Degeneration Rostral to Spinal Contusion Induces Both Repair and Apoptosis,10.1002/glia.21009,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhou et al.,2016,Effects of calcitriol on experimental spinal cord injury in rats,10.1038/sc.2015.217,English,,included,,,,,,rats,Sprague Dawley,90,30,,,30,,,sham n=30,female 100%,female,0,not reported (adult),,,,,,Adult,range [220-250](g),,,220,250,g,,level: T9; severity: not reported,T9,Not reported,compression,laminectomy + vascular clip (15g force for 1 min) + crushing injury ,7 days,calcitriol,calcitriol,,3 microg/kg/day,2h after surgical procedure,,7 days (6 rats per group),once daily,intraperitoneally,,neurological/functional assessment,BBB scale; inclined plane test,,"BBB: range from 0 points, which indicates complete paralysis to 21 points, which indicates normal locomotion, 5min observation; inclined plane test: tested on two positions (right side or left side up) on board covered with a rubber mat containing horizontal ridges spaced 3mm apart, for each position, maximum angle at which a rat could maintain its position for 5s without falling was recorded and averaged to obtain a single score for each rat"," 7, 14, 21 and 28 days after SCI for both",,BBB: yes,positive effect,"BBB scores were significantly increased in calcitriol-treated rats on days 14, 21 and 28 after injury compared to SCI rats; calcitriol significantly increased the angle of incline in the inclined plane test on days 7, 14, 21 and 28 days postoperatively. There was no significant difference in the BBB score on day 3 after SCI between the SCI group and the calcitriol group (P>0.05).","histological assessment, immunohistochemistry, transmissin electron microscopy, western blot, HE staining, TUNEL staining","TUNEL (apoptosis), neuronal loss, cavity size,",7 days after injury,not reported,mixed (stats/no stats),"significantly less TUNEL positive cells in animals from treatmnet group compared to control group; significant beneficial effects, including decreased neuron loss and a smaller cavity involving the lateral funiculi, dorsal and central grey matter, in the calcitriol group compared to control (no stats); number of Nissl positive cells significantly greater in calcitirol group compared to control group","anesthesia: 2% pentobarbital sodium (40 mg/kg, IP); euthanasia: 2% (w/v) pentobarbital sodium (40mg/kg, IP), 4% (w/v) paraformaldehyde in phosphate-buffered saline","Calcitriol promotes locomotor recovery after SCI by reducing oxidative stress and inhibiting apoptosis, as well as promoting autophagy.",not reported,use pentobarbital,No,
Lucie,Bae et al.,2005,Effects of carotid body excision on recovery of respiratory function in C2 hemisected adult rats,10.1016/j.expneurol.2005.04.010,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (carotid body excision),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nantwi et al.,1998,Effects of chronic systemic theophylline injections on recovery of hemidiaphragmatic function after cervical spinal cord injury in adult rats,10.1016/S0006-8993(98)00024-9,English,,included,,,,,,rats,Not reported,62,14,,,32,,,2 other control groups: normal nonoperated n=3; hemisected but not receiving any drug-vehicle injection n=13,female 100%,female,0,not reported (adult),,,,,,Adult,not reported,,,,,,Not reported,level: left C2 hemisection; severity: not reported,C2,incomplete,transection,hemisection,not reported,theophylline,theophylline,,20 mg/kg,48h after hemisection,,"3, 7, 14 or 30 consecutive days",3 times a day,intraperitoneally,,electrophysiological assessment,activity in hemidiaphragm and phrenic nerve ipsilateral to hemisection,,,16h after last drug/drug vehicule injection,,not reported,no stats,"Theophylline-treated animals demonstrated  recovered activity in both the nerve and hemidiaphragm Fig. 2 , but control hemisected animals did not. Spontaneous recovery of  respiratory-related activity was not observed in  any of the control hemisected rats receiving either no further treatment or theophylline vehicle",-,-,-,-,,-,"anesthesia: 4% chloral hydrate (400mg/kg, IP), 10min after administration of atropine sulfate (0.1 mg/kg)","theophylline not only induces, but also maintains recovery for prolonged periods after cervical spinal cord injury",not reported,"use chloral hydrate, atropine",No,
Lucie,Cakir et al.,2005,Effects of citicoline on experimental spinal cord injury,10.1016/j.jocn.2005.03.013,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (citicoline),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ung et al.,2010,Effects of Co-administration of clenbuterol and testosterone propionate on skeletal muscle in paraplegic mice,10.1089/neu.2009.1211,English,,excluded,Out of scope,No pure effect studied,Out of scope: combination of drug with one not of interest,,,mice,CD1 mice,159,,,,,,,,male 100%,,,8 weeks old,,,,,,,range[30-35](g),,,,,,,level: T9-T10; severity: completely transected,,,,complete transection,"1, 2, 4 or 8 weeks","clenbuterol hydrochloride, testosterone propionate, combinaison",,,clenbuterol hydrochloride: 1mg/kg/day; testosterone propionate: 5mg/kg/day,first dose: 1h post surgery,,"1, 2, 4 or 8 weeks",daily,subcutaneous,,locomotor function recovery,"average combined score (ACOS); Antri, Orsal, and Barthe (AOB)",,"ACOS: composed on non-locomotor movement (number/min), locomotor-like movement (number/min), amplitude; AOB: designed for complete transected rodents, consists of 22 scores (0: no movement, 1: weak limb jerks, 2: weak rythmic movements with no bilateral alternation, 3: large rhythmic movements with no bilateral alternation, 4: weak rhythmic movements with occasional bilateral alternation, 5: large rythmic movements with occasional bilateral alternation",one day prior to sacrifice,,not reported,no effect,no significant difference was found between treatments,immunohistochemistry,"adipose tissue, muscle mass fiber CSA and fiber type distribution","upon sacrifice (1, 2, 4 or 8 weeks after surgery)",not reported,positive effect,"soleus values significantly greater in clenbuterol-treated animals at 4 and 8 weeks, comparative results in testorone-treated or clenbuterol+ testosterone, comparable effects in extensor digitorum longus (EDL); clenbuterol+testosterone induce greater effect on EDL and soleus CSA values ","preoperative care: anaelgesic (SC, buprenorphine, 0.1 mg/kg), antibiotic (enrofloxacin 5mg/kg) lactated ringer's solution (1mL); anesthesia: 2.5% isoflurane; postoperative care for 4 days: SC buprenorphine (0.2/mg/kg/day), enrofloxacin (5mg/kg/day) and lactated Ringer's solution (2 times 1mL /day)",clenbuterol alone or combined with testosterone may constitute better clinically-relevant treatments than testosterone alone to decrease muscle atrophy (mass and cross-sectional area) in SCI subjects,not reported,,,
Lucie,Genovese et al.,2007,Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma,10.1111/j.1600-079X.2007.00454.x,English,,included,,,,,,mice,Not reported,240,40,,,40,,,"6 groups in total: sham + saline, saline + dexamethasone + melatonin, control, dexamethasone, melatonin, dexamethasone + melatonin",not reported,not reported,not reported,not reported,,,,,,Not reported,not reported,,,,,,Not reported,"level: T6-T7; severity: severe trauma (edema, neutrophil infiltration, apoptosis)",T6 - T7,severe,compression,extradural compression (aneurysm clip with a closing force of 24g),"1h, 4h, 24h, 10 days (10 mice per group)","dexamethasone, melatonin  and combinaison",dexamethasone,,0.025 mg/kg,1 and 4h after injury,,2 doses,-,intraperitoneally,,neurological/functional assessment,BBB hind limb locomotor rating scale,,,10 days after injury,,not reported,no effect,"""Melatonin or the dexamethasone treatment did not attenuate the degree of score after SCI (data not shown)""",histological study,"presence of edema, alteration of the white matter, TUNEL","1h, 4h, 24h after injury",not reported,no stats,Melatonin or the dexamethasone treatment did not attenuate the development of tissue damage after SCI; Melatonin or the dexamethasone treatment did not attenuate the number of apoptotic cells or fragments after SCI (data not shown).,anesthesia: chloral hydrate (400mg/kg),"the combination therapy with melatonin and dexamethasone reduces the degree of secondary damage associated with spinal cord injury in mice, and supports the possible use of melatonin in combination with steroids to reduce the dose and the side eﬀects related with the use of steroids for the management of inﬂammatory disease.",not reported,use chloral hydrate,No,
Lucie,Genovese et al.,2007,Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma,10.1111/j.1600-079X.2007.00454.x,English,,included,,,,,,mice,Not reported,240,40,,,40,,,"6 groups in total: sham + saline, saline + dexamethasone + melatonin, control, dexamethasone, melatonin, dexamethasone + melatonin",not reported,not reported,not reported,not reported,,,,,,Not reported,not reported,,,,,,Not reported,"level: T6-T7; severity: severe trauma (edema, neutrophil infiltration, apoptosis)",T6 - T7,severe,compression,extradural compression (aneurysm clip with a closing force of 24g),"1h, 4h, 24h, 10 days (10 mice per group)","dexamethasone, melatonin  and combinaison",melatonin,,10 mg/kg,1 and 4h after injury,,2 doses,-,intraperitoneally,,neurological/functional assessment,BBB hind limb locomotor rating scale,,,10 days after injury,,not reported,no effect,"""Melatonin or the dexamethasone treatment did not attenuate the degree of score after SCI (data not shown)""",histological study,"presence of edema, alteration of the white matter, TUNEL","1h, 4h, 24h after injury",not reported,no stats,Melatonin or the dexamethasone treatment did not attenuate the development of tissue damage after SCI; Melatonin or the dexamethasone treatment did not attenuate the number of apoptotic cells or fragments after SCI (data not shown).,anesthesia: chloral hydrate (400mg/kg),"the combination therapy with melatonin and dexamethasone reduces the degree of secondary damage associated with spinal cord injury in mice, and supports the possible use of melatonin in combination with steroids to reduce the dose and the side eﬀects related with the use of steroids for the management of inﬂammatory disease.",not reported,use chloral hydrate,No,
Lucie,Genovese et al.,2007,Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma,10.1111/j.1600-079X.2007.00454.x,English,,included,,,,,,mice,Not reported,240,40,,,40,,,"6 groups in total: sham + saline, saline + dexamethasone + melatonin, control, dexamethasone, melatonin, dexamethasone + melatonin",not reported,not reported,not reported,not reported,,,,,,Not reported,not reported,,,,,,Not reported,"level: T6-T7; severity: severe trauma (edema, neutrophil infiltration, apoptosis)",T6 - T7,severe,compression,extradural compression (aneurysm clip with a closing force of 24g),"1h, 4h, 24h, 10 days (10 mice per group)","dexamethasone, melatonin  and combinaison",dexamethasone + melatonin,,dexamethasone: 0.025 mg/kg; melatonin: 10 mg/kg,1 and 4h after injury,,9 days for the motor score group (10 per group which lived for 10 days after injury),for the ones living 10 days: daily until day 9,intraperitoneally,,neurological/functional assessment,BBB hind limb locomotor rating scale,,,10 days after injury,,not reported,positive effect,"a significant amelioration of the hind limb motor disturbances was obersved in the dexamethasone + melatonin-treated mice (compared to SCI+vehicule group), fig 3 shows lower BBB scores for the treatment group compared to the control?",histological study,"presence of edema, alteration of the white matter, TUNEL","1h, 4h, 24h after injury",not reported,no stats,"development of tissue damage: a significant protection against the SCI was observed in dexamethasone + melatonin-treated mice (no stats); tissues obtained from the mice treated with dexamethasone + melatonin (TUNEL-positive cells were 0.2 ± 0.05 per field, Fig. 9C) demonstrated a small number of apoptotic cells or fragments (no stats)",anesthesia: chloral hydrate (400mg/kg),"the combination therapy with melatonin and dexamethasone reduces the degree of secondary damage associated with spinal cord injury in mice, and supports the possible use of melatonin in combination with steroids to reduce the dose and the side eﬀects related with the use of steroids for the management of inﬂammatory disease.",not reported,use chloral hydrate,Yes (drug of interest + drug of interest),
Lucie,Fang et al.,2010,Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair,10.1371/journal.pone.0015299,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (human mesenchymal stem cells and neuropeptide pituitary adenylate cyclase-activating poplypeptide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sencar et al.,2020,Effects of combined treatment of minocycline and methylprednisolone on the expression of tumor necrosis factor alpha and interleukine-6 in experimental spinal cord injury: a light and electron microscopic study,10.1080/01913123.2020.1771493,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Farsi et al.,2015,Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats,PMID: 25796020,English,,included,,,,,,rats,Not reported,48,06.Aug,,,06.Aug,,,"n=6-8 in each group, 5 groups in total, the total doesn't match ",male 100%,male,100,not reported (adults),,,,,,Adult,range [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,compression,complete laminectomy + compression (horizontally and extradurally for 1 minute with the aneurysm clips),4 weeks,"methylprednisolone, magnesium sulfate",methylprednisolone,No,30 mg/kg,30 minutes after injury,Yes,1 dose,-,intraperitoneally,,"behavioral tests, functional evaluation, pain","BBB scoring scale, neuropathic pain evaluation [acetone drop test and thermal hyperalgesia]",,"21 different levels of movements of the hind limbs, avergae BBB scores of both legs were checked, maximum was 21","days 0, 3, 5, 7, 14, 21 and 28 after injury",Yes,yes,positive effect,"on  day  28,  a  significant  difference  was  observed  between  the  mean score of BBB in SCI+veh group and other groups (P<0.05); tail flick latency: significant increase in SCI+Mg, SCI+MP and SCI+MP+Mg groups compared to control group; cold allodynia: mean acetone test score in SCI+veh group was significantly higher than other groups (P<0.05)",histological study,(was only to confirm SCI site of spinal cord is correct),28 days after injury,-,,-,"anesthesia: ketamine (50mg/kg, IP), 10% povidone iodine for disingection; postoperative care: prophylactic antibiotic (cefazolin for 7 days, 70mg/kg)","MP, MgSO4 and combining  MgSO4 and MP treatment can attenuate neuropathic pains following SCI in rats include: thermal hyperalgesia and cold allodynia. They also can yield better improvement in motor function and decrease weight loss after SCI in rats compared with the control group.",not reported,"use ketamine, povidone iodine, cefazolin",No,
Lucie,Farsi et al.,2015,Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats,PMID: 25796020,English,,included,,,,,,rats,Not reported,48,06.Aug,,,06.Aug,,,"n=6-8 in each group, 5 groups in total, the total doesn't match ",male 100%,male,100,not reported (adults),,,,,,Adult,range [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,compression,complete laminectomy + compression (horizontally and extradurally for 1 minute with the aneurysm clips),4 weeks,"methylprednisolone, magnesium sulfate",magnesium sulfate,,600 mg/kg,30 minutes after injury,,single dose,-,intraperitoneally,,"behavioral tests, functional evaluation, pain","BBB scoring scale, neuropathic pain evaluation [acetone drop test and thermal hyperalgesia]",,"21 different levels of movements of the hind limbs, avergae BBB scores of both legs were checked, maximum was 21","days 0, 3, 5, 7, 14, 21 and 28 after injury",,yes,positive effect,"on  day  28,  a  significant  difference  was  observed  between  the  mean score of BBB in SCI+veh group and other groups (P<0.05); tail flick latency: significant increase in SCI+Mg, SCI+MP and SCI+MP+Mg groups compared to control group; cold allodynia: mean acetone test score in SCI+veh group was significantly higher than other groups (P<0.05)",histological study,(was only to confirm SCI site of spinal cord is correct),28 days after injury,-,,-,"anesthesia: ketamine (50mg/kg, IP), 10% povidone iodine for disingection; postoperative care: prophylactic antibiotic (cefazolin for 7 days, 70mg/kg)","MP, MgSO4 and combining  MgSO4 and MP treatment can attenuate neuropathic pains following SCI in rats include: thermal hyperalgesia and cold allodynia. They also can yield better improvement in motor function and decrease weight loss after SCI in rats compared with the control group.",not reported,"use ketamine, povidone iodine, cefazolin",No,
Lucie,Farsi et al.,2015,Effects of combining methylprednisolone with magnesium sulfate on neuropathic pain and functional recovery following spinal cord injury in male rats,PMID: 25796020,English,,included,,,,,,rats,Not reported,48,06.Aug,,,06.Aug,,,"n=6-8 in each group, 5 groups in total, the total doesn't match ",male 100%,male,100,not reported (adults),,,,,,Adult,range [300-350](g),,,300,350,g,,level: T9; severity: not reported,T9,Not reported,compression,complete laminectomy + compression (horizontally and extradurally for 1 minute with the aneurysm clips),4 weeks,"methylprednisolone, magnesium sulfate",methylprednisolone + magnesium sulfate,,methylprednisolone: 30 mg/kg + magnesium sulfate: 600 mg/kg,30 minutes after injury,,single dose,-,intraperitoneally,,"behavioral tests, functional evaluation, pain","BBB scoring scale, neuropathic pain evaluation [acetone drop test and thermal hyperalgesia]",,"21 different levels of movements of the hind limbs, avergae BBB scores of both legs were checked, maximum was 21","days 0, 3, 5, 7, 14, 21 and 28 after injury",,yes,positive effect,"on  day  28,  a  significant  difference  was  observed  between  the  mean score of BBB in SCI+veh group and other groups (P<0.05); tail flick latency: significant increase in SCI+Mg, SCI+MP and SCI+MP+Mg groups compared to control group; cold allodynia: mean acetone test score in SCI+veh group was significantly higher than other groups (P<0.05)",histological study,(was only to confirm SCI site of spinal cord is correct),28 days after injury,-,,-,"anesthesia: ketamine (50mg/kg, IP), 10% povidone iodine for disingection; postoperative care: prophylactic antibiotic (cefazolin for 7 days, 70mg/kg)","MP, MgSO4 and combining  MgSO4 and MP treatment can attenuate neuropathic pains following SCI in rats include: thermal hyperalgesia and cold allodynia. They also can yield better improvement in motor function and decrease weight loss after SCI in rats compared with the control group.",not reported,"use ketamine, povidone iodine, cefazolin",Yes (drug of interest + drug of interest),
Lucie,Yin et al.,2013,Effects of combining methylprednisolone with rolipram on functional recovery in adult rats following spinal cord injury,10.1016/j.neuint.2013.03.005,English,,included,,,,,,rats,Sprague Dawley,72,16,,,16,,,"sham n=4, 2 other treatment groups of n=8 each, both times 2 because there are 2 types of injury",famle 100%,female,0,not reported (adults),,,,,,Adult,range [200-220](g),,,200,220,g,,level: T9-T10; severity: moderate-severe,T9 - T10,moderate - severe,multiple,"laminectomy + weight drop (10g rod, 2.5mm diameter, from 25mm height) + dorsal hemisection (depth: 1.6 mm from the dorsal surface, same level as contusion, using a pair of microscissors, to sever the dorsal corticospinal tracts)",8 weeks,"rolipram, methylprednisolone and combinaison",methylprednisolone,No,30 mg/kg,immediately after injury,Yes,1 dose,-,intravenously,,neurological/functional/behavioral assessment,BBB score; grid walking,,"BBB: open field, scale from 0 (complete paralysis) to 21 (normal locomotion), observed for 4 minutes; grid walking: irregularly horizontal wire grid, walk freely for 4 min, result expressed as percentage of missteps (hind paw of one side protruded entirely through the grid, with all toes and heel extended below the wire surface)","BBB: 24h before SCI, 24h and 3 days post-injury and once weekly thereafter up to 8 week post-injury; grid walking: allowed to walk on the grid weekly and evaluated at 8 weeks after the contusive SCI",Yes,Yes,no effect,MP alone was not significantly different from the control group in terms of both the BBB score and the percentage of missteps,histological assessment,"motoneuron survival, lesion volume, cell death, cell viability",8 weeks ,not reported,mixed effects (assessment),% of total volume significantly reduced in MP group compared to control group; significantly more neurom in the ventral horn 4mm rostral and caudal to the lesion but not closer; no differnce in axon index ,"anesthesia: pentobarbital (50 mg/kg, IP); euthanasia: sodium pentobarbital (70 mg/kg, IP)",our study strongly suggested that  the  combination treatment of MP and rolipram may represent a promising strategy for clinically applicable pharmacological therapy for rapid initiation of neuroprotection after SCI.,"further research is needed to elucidate detailed mechanisms of the effects  observed after the combined therapy for SCI. Also, as MP administration and the details surrounding its use are controversial, potential adverse effects of its application in combination with rolipram should be closely investigated",use pentobarbital,Yes (drug of interest + drug not of interest),
Lucie,Lu et al.,2016,Methylprednisolone promotes recovery of neurological function after spinal cord injury: association with Wnt/beta-catenin signaling pathway activation.,10.4103/1673-5374.194753,English,,included,,,,,,rats,Sprague Dawley,105,35,,,35,,,sham n=35,male 100%,male,100,8-12 weeks old,,,8,12,Weeks,,range [260-300](g),,,260,300,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"weight drop (impounder diameter 2.0mm, weight:10g; dropped from 25.0 mm)",7 days,methylprednisolone,methylprednisolone,Yes,30 mg/kg,immediately after injury,Yes,4 days (4 doses),once daily,intravenously,,neurological/functional assessment,BBB score,,scores ranged from 0 (complete paralysis) to 21 (unimpaired locomotion),"prior to injury and recovery at 1 and 3 days, as well as at 1, 2, 3, 4, 5, and 6 weeks post-SCI",Yes,yes,positive effect,BBB scores were significantly higher in the MP group compared with the saline group from 2 to 6 weeks post-injury (P < 0.05).,histological assessment,"number of surviving neurons, proportion of lesion size, TUNEL, ",8 weeks after injury,not reported,positive effect,"MP treatment significantly increased the number of surviving neurons comapred to control group; significantly reduced the proportion of lesion size, significantly reduced the number of TUNEL positive cells (less apoptosis)","anesthesia: 10% chloral hydrate (0.33mL/kg, IP); euthanasia: 10% chloral hydrate (0.3mL/kg, IP); 0.9% saline and 4% paraformaldehyde ",results indicate that methylprednisolone-induced neuroprotection may correlate with activation of the Wnt/β-catenin signaling pathway,not reported,use chloral hydrate,No,
Lucie,Li et al.,2016,Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury.,10.4103/1673-5374.193250,English,,included,,,,,,rats,Sprague Dawley,96,16,,,16,,,"6 groups in total, n=16 for each group",male 100%,male,100,not reported (adults),,,,,,Adult,range [200-250](g),,,200,250,g,,level: T6-T7; severity: complete and irreversible SCI with complete paralysis of the lower extremities,T6 - T7,complete,compression,"laminectomy + compressive SCI (transient extradural application of an aneurysm clip, closing force of approximatively 24g for 1 minute)",24h (10 per group) or 28 days (6 per group),"methylprednisolone, rosiglitazone and combination",methylprednisolone,No,30 mg/kg and 15 mg/kg,1h after injury,Yes,"2 days, 3 doses","1h, 24h and 48h after injury",intraperitoneally,,neurological/functional assessment,BBB score,,"based on precise observation of hindlimb movements, steppingm and coordination in an open field, 4 minutes observation, scored from 0 (no spontaneous locomotor activity) to 21 (normal movement-coordinated gait, with parallel paw placement), scores from 0 to 7 indicate return of isolated movements in the hip, knee, and ankle joints. Scores from 8 to 13 indicate return of paw placement and coordinated movements with the forelimbs. Scores from 14 to 21 show return of toe clearance during stepping, predominant paw position, trunk stability, and tail position. Scores are represented as the average score of all animals (n = 6) in each group at each time point.","days 3, 7, 14, 21, and 28 after injury",Yes,yes,positive effect,"neurological function in rats of the SCI + MP group, SCI + RSG group, and SCI + MP + RSG group improved more rapidly and showed sta- tistically significantly better scores compared with the SCI group and SCI + vehicle group (P < 0.05). However, there was a significant difference in BBB locomotor recovery scales between combined treatment group and single treatment group from 3 to 21 days after injury (P < 0.05).",histological assessment,"myeloperoxidase (MPO), enzyme linked immunosorbent assay (ELISA), terminal dexynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), and western blot assays",24h after injury,not reported,positive effect,"combined treatment with MP and rosiglitazone after spinal cord contusion significantly suppressed infiltration of neutrophils, proinflammatory cytokine expression, and occurrence of neuronal apoptosis compared with MP or rosiglitazone alone; MP, RSG, and the combination of both significantly reduced the number of TUNEL-positive cells compared with vehicle-treatment (P<0.05)","anesthesia: chloral hydrate (400mg/kg, IP); ","Our results demonstrated that a combined treatment with methylprednisolone and rosiglitazone had a more pronounced effect on attenuation of inflammation and cell apoptosis, as well as increased functional recovery, compared with either single treatment alone, indicating that a combination better promoted recovery of neurological function after injury.",,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Hou et al.,2015,Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone,10.4103/1673-5374.170314,English,,included,,,,,,rats,Sprague Dawley,40,8,,,8,,,5 groups of n=8 each,female 100%,female,0,3 months old (adult),3,,,,Months,Adult,range [280-330](g),,,280,330,g,,level: T11; severity: not reported,T11,incomplete,transection,"hemi-transection: crest of T11 was excised with a pair of nipper pliers, and a hole with a diameter of 2mm was drilled with the cusp of scissors at the center where the crest was located, then a syringe needle was gently placed into the spinal cord via the hole and the right part of the spinal cord was cut by moving the needle to the right in rats",4 weeks,"celecoxib, fasudil hydrochloride ",celecoxib,,20 mg/kg,Not reported,,2 weeks,once daily,intragastrically,,neurological/functional assessment,BBB locomotor rating scale,,"analyze individual components of limb movement, weight support, plantar and dorsal stepping, forelimb-hindlimb coordination, paw rotation, toe clear- ance, trunk stability, and tail placement. Scores from 0 to 21 were given based on these observations. The BBB scores of normal rats were 21.","preoperatively, and at 1, 7, 14, 21, and 28 days after surgery",,not reported,positive effect,"the recovery of rats in the celecoxib, fasudil or combination groups was increased com- pared to controls (P < 0.05). The recovery of rat locomotor activity was enhanced in the combination group compared with the model, celecoxib and fasudil groups --> Contradiction with the figure 1?","histological examination, western blot assay","HE staining; protein expression of COX-2, ROCK II, and COX-1;",4 weeks after injury,not reported,no stats,"Cavities were visible in the model group. The cavities were smaller in the celecoxib, fasudil and combination groups compared with the model group. Morphology in the fasudil and combination groups was similar to that in the sham surgery group.; the expression of COX-2 and ROCK II in injured spinal tissues was up-regulated in the model group, followed by the celecoxib group, fasudil group and combination group ","anesthesia: pentobarbital sodium (40 mg/kg, IP); after euthanasia: 4% paraformaldehyde (pH 7.2)",This study demonstrated that the combined use of fasudil and celecoxib synergistically enhanced the functional recovery of injured spinal cord in rats.,not reported,use pentobarbital,Yes (drug of interest + drug not of interest),
Bobo,Qinxuan et al.,2020,"Effects of dexamethasone combined with estrogen on the expression of interleukin-6, Caspase3 and Bcl-2 after spinal cord contusion in rats",10.3969/j.issn.2095-4344.2591,Chinese,,included,,,,,,rats,Sprague Dawley,48,12,,,12,,,"12 in each group: sham, normal saline, dexamethasone, combined treatment (dexamethasone & estrogen)",female 100%,female,0,4 weeks,4,,,,Weeks,,range [200-220] g,,,200,220,g,,level: T10; severity: not reported,T10,Not reported,contusion,modified ALLEN struck method (10g weight dropped from 30mm height),"3, 7 and 21 days",dexamethasone + estrogen,dexamethasone + estrogen,No,estrogen: 0.04 mg/kg + dexamethasone: 0.2 mg/kg,"30mins, 1, 2 3, 4, and 5 days post-op",,"30mins, 1, 2 3, 4, and 5 days post-op","30mins, 1, 2 3, 4, and 5 days post-op",intramuscular,,neurological/ functional assessment,BBB score,,scale from 0 to 21,"1, 3, 5, 13 and 14 days post injury",No,yes,positive effect,the motor function of combined treatment group recovered earlier than that of dexamethasone group and normal saline group.  the BBB scores in the combined treatment group were significantly higher than those in the dexamethasone group,immunohistochemistry,GENE MANIA,"3, 7 and 14 days post injury",not reported,positive effect,"Expression of interleukin-6 and casepase 3 in the combined treatment group was significantly lower than the dexamethasone group, and the expression of Bcl-2 was significantly increased in the recovery period","anesthesia: 3.6%chloral hydrate (10mL/kg); antibiotic for 3 days post op: 1mL penicillin (once a day, 2x 10^5 U/mL)","the combined treatment of dexamethasone and estrogen can effectively reduce the expression of proapoptotic factor Caspase3 and proinflammatory factor interleukin-6, and increase anti-apoptotic factor Bcl-2 to further promote functional recovery in rats after spinal cord contusion by impeding apoptosis and inflammation",,"use chloral hydrate, penicillin",Yes,
Bobo,Qinxuan et al.,2020,"Effects of dexamethasone combined with estrogen on the expression of interleukin-6, Caspase3 and Bcl-2 after spinal cord contusion in rats",10.3969/j.issn.2095-4344.2591,Chinese,,included,,,,,,rats,Sprague Dawley,48,12,,,12,,,"12 in each group: sham, normal saline, dexamethasone, combined treatment (dexamethasone & estrogen)",female 100%,female,0,4 weeks,4,,,,Weeks,,range [200-220] g,,,200,220,g,,level: T10; severity: not reported,T10,Not reported,contusion,modified ALLEN struck method (10g weight dropped from 30mm height),"3, 7 and 21 days",dexamethasone,dexamethasone,No,dexamethasone: 0.2 mg/kg,"30mins, 1, 2 3, 4, and 5 days post-op",,"30mins, 1, 2 3, 4, and 5 days post-op","30mins, 1, 2 3, 4, and 5 days post-op",intramuscular,,neurological/ functional assessment,BBB score,,scale from 0 to 21,"1, 3, 5, 13 and 14 days post injury",No,yes,no effect,"did not report on stats of effects of just dexamethasone, but from figure 2, BBB scores were higher than saline group at 13 and 14 days",immunohistochemistry,GENE MANIA,"3, 7 and 14 days post injury",not reported,positive effect,Expression of interleukin-6 was statistically higher than combined treatment at day 3; expression of BCL-2 was statistically higher at day 7 compared to saline group,"anesthesia: 3.6%chloral hydrate (10mL/kg); antibiotic for 3 days post op: 1mL penicillin (once a day, 2x 10^5 U/mL)","the combined treatment of dexamethasone and estrogen can effectively reduce the expression of proapoptotic factor Caspase3 and proinflammatory factor interleukin-6, and increase anti-apoptotic factor Bcl-2 to further promote functional recovery in rats after spinal cord contusion by impeding apoptosis and inflammation",,"use chloral hydrate, penicillin",,
Lucie,Letaif et al.,2015,Effects of estrogen on functional and neurological recovery after spinal cord injury: An experimental study with rats,10.6061/clinics/2015(10)08,English,,included,,,,,,rats,Wistar,20,10,,,10,,,,male 100%,male,100,20-21 weeks ,,,20,21,Weeks,,range [300-420](g),,,300,420,g,,level: T10; severity: moderate,T10,moderate,contusion,"weight drop: NYU Impactor (10g impact rog from a standardized height of 12.5mm, compression of the spinal cord for 15 s)",42 days,17-beta estradiol,estradiol,,4 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,"neurological/functional assessment, electroneurophysiology","BBB scale, evoked potential test (MEP)",,"BBB: rats were stimulated to move by gentle touches, 4 min evaluation per rat; MEP: transcramial electrical stimulation at the cortical level, electrodes in semitendinosus and biceps muscles of the thigh, monitores response to the stimulus for 100ms at most latency (milliseconds) and amplitude (millivolts) were recorded ","BBB: day 2, 7, 14, 21, 28, 35, 42 after SCI; MEP: day 42 after SCI",,yes,positive effect,"BBB: significantly better scores were observed in the experimental group of rats, which received the estrogen treatment; MEP: estrogen-treated rats performed significantly better than the control rats, considering both the latency (time taken from the impulse to be transmitted from the head to the limbs, p=0.000) and amplitude values (a reflection of the number of axonal fibers involved in the impulse transmission; p=0.007)",histological assessment,"HE staining: necrosis, hemorrhage, hyperemia, cellular infiltration, axonal degenration: all scored from 0 (absence) to 3 (severe)",day 42 after SCI,not reported,mixed effects (assessment),"no significant difference between groups in the histological tissue analysis for the following variables: necrosis, hemorrhage, hyperemia, axon degeneration (by HE) and cellular infiltration;  in the axon analysis with toluidine blue staining, the control group had a significantly lower neuron count than the treated group. The diameter of the axons was also significantly smaller in the control group compared to the estrogen-treated group","anesthesia: xylazine (10mg/kg, IP), ketamine (50mg/kg, IP), lidocaine hydrochloride with epinephrine (subcutaneous); after SCI: topical ointment on surgical scar (fibrinolysin, deoxyribonuclease, chloramphenicol), prophylactic cefozolin sodium (5 mg/kg, IP, immediately after SCI), in case of infection antibiotics for 10 days and excluded; pain relief: meloxicam ( 2mg/kg, IM, once daily for 7 days), tramadol hydrochloride (5mg/100g, IM, once daily for 5 days); euthnasia: transcardial perfusion of 4% paraformaldehyde solution and IV thiopental (65mg/100g) and potassium chloride","Estrogen administration provided benefits in neurological and functional motor recovery in rats with SCI beginning at the 28th day after injury. The hypothesis of a neuroprotective effect of estrogen was confirmed by the functional evaluations, but not by the tissue histological evaluations.",early VS late administration was not tested; scoring system used for the histological evaluation is subject to some bias; ,"use ketamine, lidocaine, epinephrine, cefozolin",No,
Bobo,Jiang et al.,2019,Effect of ferulate-heparin-poloxamer thermosensitive hydrogels on nerve regeneration in rats with spinal cord injury,10.3969/j.issn.1001-1978.2019.11.014,Chinese,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ferulate-heparin-poloxamer(SF-HP) ),,,rats,Sprague Dawley,50,,,,,,,,male 100%,,,not reported (adults),,,,,,,range [180-220] (g),,,,,,,level: T9; severity: not reported,,,,"laminectomy + clamping of spinal cord (The spinal cord was clamped with a vascular artery clip (30 g) for 2 min, then the artery clip was removed)",14 ays,ferulate-heparin-poloxamer(SF-HP) thermosensitive hydrogels,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hains et al.,2004,"Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI",10.1016/j.expneurol.2004.04.001,English,,included,,,,,,rats,Sprague Dawley,46,17,,,17,,,"4 groups in total, sham group with and without treatment both n = 6",male 100%,male,100,not reported (adults),,,,,,Adult,range [200-225](g),,,200,225,g,,level: T9; severity: not reported,T9,Not reported,contusion,"laminectomy + spinal contusion: MASCIS/NYU impact injury device (10g, 2.0mm diameter rod released from 25mm height, mean(SD) tissue compression: 2.11 (0.13) mm)",4 weeks or 8 weeks,phenytoin,phenytoin,,12 g/kg (fed pelleted chow incorporating phenytoin),3 days before injury,,until sacrifice,-,oral,,"neurological/functional assessment, electrophysiological assessment","BBB scale, foot print analysis (fine motor control), grid footfalls, compound action potential (CAP) recording",,"BBB: 21-point ordinal scale ranging from 0 (no discernable hindlimb movement) to 21 (consistent and coordinated gait with parallel paw placement of the hindlimb and consistent trunk stability), 0 to 7 = early phase of recovery with return of isolated movements of three joints (hip, knee, ankle), 8-13 = intermediate recovery with return of paw placement, stepping and forelimb-hindlimb coordination, 14-21 = late phase of recovery measuring toe clearance during step pahse, paw positioning, trunk stability amd tail position; footprint analysis: animal’s hindpaws were inked and the animal was placed on anarrow (13*50 cm) runway,  5 inked tracing per animal, series of 3 incremental steps to determine mean values of base of support (distance between the central pads of the hindpaw), stride length (distance between two consecutive footprints on each side of the animal) and paw offset angle (angle formed by the intersection of lines from the left and right footprints relative to the animal’s direction of travel); grid footfalls: animals placed on the runway and allowed to cross to the opposite side (1 m), error = misplacement of the animal’s paw such that it fell through the grid and consequently below the plane of the floor, rather than being placed on the grid; CAP recording: stimulation of DC axons at L1–L2 and recording of CAP at T5–T6 at the surface of the midline spinal cord, single current pulses (0.05ms) were applied in increasing increments (0.2, 0.3, 0.6, 0.8, 1.1 mA), amplitude of CAP = value between the negative deflection after the stimulus artifact and the next peak of the wave, area of the CAP = rectifying the CAP component (full-wave rectification) and measuring its area.",BBB: every 2 days following injury; footprint analysis and grid footfalls: not reported; CAP: 4 weeks after injury,,"CAP and BBB: yes, rest: not reported",mixed effects (assessment),"BBB: SCI + phenytoin group achieved significantly (P< 0.05) better performance than the SCI group; base of paw support: SCI + phenytoin group significantly (P< 0.05) less widened; stride length at 4 weeks: no significant difference between SCI and SCI + phenytoin groups, frequency distributions: SCI + phenytoin range of stride lengths was less variant when compared to SCI group; paw offset angle: SCI + phenytoin group exhibited rotation that was significantly (P< 0.05) reduced when compared to SCI; number of footfall errors: SCI + phenytoin group demonstrated fewer errors (35%), a significant (P< 0.05) difference when compared to SCI (72%);  CAP: SCI + phenytoin demonstrated significantly (P< 0.05, P< 0.01) larger CAP amplitudes at stimulation intensities greater than 0.6 mA, compared to untreated SCI. CAP area in SCI + phenytoin was significantly (P< 0.05) larger than in SCI",immunocytochemistry,"spared tissue analysis, axonal sparing",4 weeks or 8 weeks after injury,spared tissue analysis: yes,positive effect,"spared tissue analysis, SCI + phenytoin compared to SCI: less severe extent of tissue damage, white matter damage significantly reduced (epicenter and both rostral and caudal directions), gray matter significantly less damaged, total cord cross-sectional area increased, no difference in areas of cyst formation and gliosis; axonal sparing, SCI + phenytoin compared to SCI: degree of axonal loss was significantly less","anesthesia: ketamine and xylazine (80/5 mg/kg IP, respectively); postoperative treatment:  saline (2.0 cc s.c.) for hydration, Baytril (0.3 cc, 22.7 mg/ml s.c., twice daily) to prevent urinary tract infection; electrophysiological procedure: anesthetized with halothane (3% in a Plexiglas box and then by facial mask), deep anesthesia maintained with 1.2% halothane through a tracheal cannula by artificial ventilation (60–70 strokes/min, 2–2.5 cc tidal volume)","phenytoin treatment results in neuroprotection, enhanced conduction through the lesion site, and improved motor control after experimental SCI, and it merits further examination as a potential treatment strategy in human SCI",not reported,use ketamine,No,
Lucie,Mann et al.,2008,Delayed treatment of spinal cord injury with erythropoietin or darbepoetin - A lack of neuroprotective efficacy in a contusion model of cord injury,10.1016/j.expneurol.2007.12.013,English,,included,,,,,,rats,Sprague Dawley,40,11,,,12,,,sham n=6,male 100%,male,100,not reported,,,,,,Not reported,range [320-340](g),,,320,340,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + spinal contusion: half of the animal's weight suspended, Ohio State University (OSU) impactor, preload force of 0.2 kdyne onto the dura, 1.5 mm displacement injury at 300 m/s.",42 days after injury,"erythropoietin, darbepoetin",epoetin,,5000 IU/kg,1h after injury,,single dose,-,intravenously,,neurological/functional assessment,"BBB scale, hindpaw pinprick sensory threshold test, footfalls, base of support",,"footfalls: observed walking over a horizontally laid ladder with unevenly spaced rungs, and the number of times the hindlimb slipped between the rungs was recorded; base of support: width between the hindlimbs measured off of high-definition video footage of the animals walking over a transparent plexiglass surface; pinprick: evaluate whether the threshold for mechanical sharp tactile sensation changed after injury, observed for 5 to10 min, when both hindpaws evenly resting upon the rungs of the grid: monofilament pressed into the center of the volar surface of the hindpaw, mechanical force at which hindlimb with drawal occurred and time from stimulus application to hindlimb withdrawal was recorded, 3 trials performed for each hindpaw and averaged to provide the mechanical force threshold","BBB:  2, 4, 7, 14, 28, and 42 day post-injury; rest: day 42 after injury",,yes,no effect,"BBB: no significant differences between the groups; neither erythropoietin nor darbepoetin reduced the number of footfalls or reduced the hindlimb base of support as compared tothe control animals; pinprick sensory testing:  no significant differences between the erythropoietin, darbepoetin, and saline controls",anatomic outcome assessment,"Eriochrome Cyanine staining, counter-stained with Neutral Red, study of regions of spared white and grey matter",day 42 after injury,not reported,no effect,"histological analysis did not indicate any increase preservation of the contused spinal tissue by treatment of either erythropoietin or darbepoetin, compared to the saline controls; No statistical difference of spared white or grey matter was observed between animals treated with erythropoietin or darbepoetin and saline alone","anesthesia: ketamine hydro-chloride (72 mg/kg, IP), xylazinehydrochloride (9 mg/kg, IP), 20 mM phosphate buffered solution (PBS); prior to surgery and on post-operative days 1 and 2; buprenorphrine (0.02 mg/kg, SC); euthanasia: pentobarbital sodium (107 mg/kg), perfused with phosphate buffered saline followed by fixationwith cooled 4% paraformaldehyde",experimental design failed to reveal any neuroprotective benefit to either erythropoietin or darbepoetin when administered 1h after injury in this commonly utilized thoracic contusion spinal cord injury mode,not reported,"use ketamine, pentobarbital, buprenorphine",No,
Lucie,Mann et al.,2008,Delayed treatment of spinal cord injury with erythropoietin or darbepoetin - A lack of neuroprotective efficacy in a contusion model of cord injury,10.1016/j.expneurol.2007.12.013,English,,included,,,,,,rats,Sprague Dawley,40,11,,,11,,,sham n=6,male 100%,male,100,not reported,,,,,,Not reported,range [320-340](g),,,320,340,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + spinal contusion: half of the animal's weight suspended, Ohio State University (OSU) impactor, preload force of 0.2 kdyne onto the dura, 1.5 mm displacement injury at 300 m/s.",42 days after injury,"erythropoietin, darbepoetin",darbepoetin,,10 microg/kg,1h after injury,,single dose,-,intravenously,,neurological/functional assessment,"BBB scale, hindpaw pinprick sensory threshold test, footfalls, base of support",,"footfalls: observed walking over a horizontally laid ladder with unevenly spaced rungs, and the number of times the hindlimb slipped between the rungs was recorded; base of support: width between the hindlimbs measured off of high-definition video footage of the animals walking over a transparent plexiglass surface; pinprick: evaluate whether the threshold for mechanical sharp tactile sensation changed after injury, observed for 5 to10 min, when both hindpaws evenly resting upon the rungs of the grid: monofilament pressed into the center of the volar surface of the hindpaw, mechanical force at which hindlimb with drawal occurred and time from stimulus application to hindlimb withdrawal was recorded, 3 trials performed for each hindpaw and averaged to provide the mechanical force threshold","BBB:  2, 4, 7, 14, 28, and 42 day post-injury; rest: day 42 after injury",,yes,no effect,"BBB: no significant differences between the groups; neither erythropoietin nor darbepoetin reduced the number of footfalls or reduced the hindlimb base of support as compared tothe control animals; pinprick sensory testing:  no significant differences between the erythropoietin, darbepoetin, and saline controls",anatomic outcome assessment,"Eriochrome Cyanine staining, counter-stained with Neutral Red, study of regions of spared white and grey matter",day 42 after injury,not reported,no effect,"histological analysis did not indicate any increase preservation of the contused spinal tissue by treatment of either erythropoietin or darbepoetin, compared to the saline controls; No statistical difference of spared white or grey matter was observed between animals treated with erythropoietin or darbepoetin and saline alone","anesthesia: ketamine hydro-chloride (72 mg/kg, IP), xylazinehydrochloride (9 mg/kg, IP), 20 mM phosphate buffered solution (PBS); prior to surgery and on post-operative days 1 and 2; buprenorphrine (0.02 mg/kg, SC); euthanasia: pentobarbital sodium (107 mg/kg), perfused with phosphate buffered saline followed by fixationwith cooled 4% paraformaldehyde",experimental design failed to reveal any neuroprotective benefit to either erythropoietin or darbepoetin when administered 1h after injury in this commonly utilized thoracic contusion spinal cord injury mode,not reported,"use ketamine, pentobarbital, buprenorphine",No,
Lucie,Zhang et al.,2016,"Effects of Magnetically Guided, SPIO-Labeled, and Neurotrophin-3 Gene-Modified Bone Mesenchymal Stem Cells in a Rat Model of Spinal Cord Injury",10.1155/2016/2018474,English,,excluded,Out of scope,No drug of interest,Out of scope: study effect of NT3 gene-transfected bone marrow-derived mesenchymal stem cells (BMSCs),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chen et al.,2018,Therapeutic efficacy of cyclosporin a against spinal cord injury in rats with hyperglycemia,10.3892/mmr.2018.8422,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cyclosporin A),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liao et al.,2014,Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats,10.3892/mmr.2014.2352,English,,included,,,,,,rats,Sprague Dawley,48,16,,,16,,,one other treatment group n = 16 not of interest,"""both sexes""",mixed,not reported,not reported (adults),,,,,,Adult,"mean: 280 (g), range [250-310](g)",280,,250,310,g,,level: T11; severity: not reported,T11,Not reported,contusion,"laminectomy + weight drop (Allen's method: plate placed on surface of T11 dura mater, dropping 7g weight from 3cm onto the plate)","half of the animals: 7 days, other half: six weeks (?)","meglumine cyclic adenylate (MCA), methylprednisolone (MP)",methylprednisolone,No,30 mg/kg,30 minutes after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,inclined plane; gale scale,,"inclined test: highest angle of inclination maintained for 5 sec, functional motor deficits and recovery are expressed by the inclined plane (IP) maintenance ratio (post-injury/pre-injury); gale scale: observed and scored into six levels by the Gale scale",inclined plane: from week 1 to week 6 post-SCI,Yes,not reported,positive effect,Six weeks following SCI: IP maintenance ratio and Gale scale significantly higher in treatment groups A (methylprednisolone) and B (MCA) compared with the vehicle-treated group C (P<0.05); no significant different between MP and MCA group,"pathological assessment, immunohistochemistry","HE staining (only of interest), ELISA (cAMP content), AC3 and PDE4D activity",7 days after injury,not reported,no stats,"HE (only of interest): higher densities of intact neurons were observed in groups A (MCA) and B (MP) compared with those in group C (control), tissues were sparse and significantly swollen with evident hemorrhage, few neurons in control group; AC3 activity: mean density of AC3-positive cells in group C was lower than that in groups A and B (P<0.05); PDE4D activity: number of PDE-4D-positive cells was significatnly higher in group C than that in groups A and B (P<0.05); cAMP concentration: spinal cAMP levels at 7 days following injury was higher in group A and B than those in group C (P<0.05)","anesthesia: pentobarbital sodium 1% (30 mg/kg, IP); 1 to 3 minutes prior to the surgical procedure anf following surgical procedure: 2.5 mL of warm saline solution with penicillin G sodium (10'000 units/kg, BW); after surgery, for pain relief: diethyl ether (1 mL diethyl ether in 250 mL wide-mouthed bottle for 0.5-1.0 min)",MCA may serve as an effective SCI treatment by activating AC3 and suppressing PDE4D,not reported,"use pentobarbital, penicillin",No,
Lucie,Li et al.,2019,Therapeutic effect of methylprednisolone combined with high frequency electrotherapy on acute spinal cord injury in rats.,10.3892/etm.2019.8147,English,,included,,,,,,rats,Wistar,40,10,,,10,,,2 other groups: high-frequency electrotherapy and high-frequency electrotherapy + MP,male 100%,male,100,2 months old,2,,,,Months,,250 (20) (g),250,20,,,g,,level: T10; severity: not reported,T10,Not reported,contusion,modified ALLEN struck method: striker rod moved freely through the sleeve at a height of 5cm and directly hits the plastic gasket,at least 20 days ,"methylprednisolone, high-frequency electrotherapy, combination of both",methylprednisolone,No,300 mg/kg,Not reported,,Not reported,Not reported,not reported,,"neurological/functional assessment, electrophysiology","BBB scale, somatosensory evoked potential (SEP), motor evoked potential (MEP)",,"BBB: 0-21 points; 0 points indicated no visible hind limb movement, and 21 points indicated continuous palmar movement, contin- uous coordination gait, continuous toe grip, the parallel position of the active paw to the body, continued trunk stability and tail tilt; SEP and MEP:  right iliac and the Achilles tendon, wave width of 0.2 msec and a frequency of 2 Hz, test time was 20 msec, and a superposition range of ±200 msec was recorded, main electrode was placed in the muscle belly of the right gastrocnemius and the action potential was recorded using a magnetic stimulator with a test time of 0.2 msec.",day 20 after injury,No,not reported,positive effect,BBB: methylprednisolone group significantly higher scores than control group; SEPs and MEPs: All treatment groups displayed obviously improved SEPs and MEPs compared with the SCI group (P<0.05),"histological assessment, immunichemistry","ELISA, caspase 3 activity, RT-qPCR, western blotting",day 20 post injury,not reported,,"increasing the expression level of BDNF, reducing that of NF-κB, and suppressing the secretion of inflammatory factors
","anesthesia: sodium pentobarbital (30 mg/kg, IP), antibiotics: Baytril, (4mg/kg, SC); euthanasia: sodium pentobarbital, transcardially perfused with 0.1M phosphate-buffered saline (pH 7.4), 4% paraformaldehyde","methylprednisolone combined with high frequency electrotherapy may improve the symptoms of SCI by increasing the expression level of BDNF, reducing that of NF-κB, and suppressing the secretion of inflammatory factors",not reported,use pentobarbital,No,
Lucie,Wu et al.,2019,Pectolinarigenin promotes functional recovery and inhibits apoptosis in rats following spinal cord injuries.,10.3892/etm.2019.7456,English,,included,,,,,,rats,Sprague Dawley,36,6,,,6,,,"3 other treatment groups (not of interest and sham, all n = 6",male 100%,male,100,not reported (adults),,,,,,Adult,range [200-250](g),,,200,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,laminectomy + modified Allen method weight drop (10g rod dropped from 4cm height onto the dorsal surface of the spinal cord),28 days,"pectolinarigenin, methylprednisolone",methylprednisolone,No,30 mg/kg,Not reported,Not reported,28 days (14 doses),every two days,intraperitoneally,,neurological/functional assessment,BBB scale,,observed for 4 minutes by 2 examiners (average per animal calculated),"1,3,7,14,21 and 28 days following surgery",Yes,yes,positive effect,"methylprednisolone exerted protective effects on the spinal cord, significantly higher BBB Score compared to the control group",Histological assessment,"nissl staining, TUNEL staining (only of interest), western blot",day 28 post SCI,not reported,positive effect,"significantly more neurons surviving in the MP group compared to the control group, significantly less TUNEL positive cells in the MP group compared to control group (less apoptosis) ",administration of anesthetics,"Pectolinarigenin may exert a protective effect against SCI in rats, potentially by inhibiting neuronal apoptosis and Pectolinarigenin may therefore serve as a novel therapeutic agent against SCI.",not reported,MP used as positive control but not the main drug to be studied in this paper (main drug was not of interest for our review),No,
Lucie,Rong et al.,2018,Methotrexate remediates spinal cord injury in vivo and in vitro via suppression of endoplasmic reticulum stress-induced apoptosis,10.3892/etm.2018.5973,English,,included,,,,,,rats,Sprague Dawley,72,32,,,32,,,sham n=8,male 100%,male,100,6-8 weeks old,,,6,8,Weeks,,range [220-250](g),,,220,250,g,,level: T9; severity: incomplete injury,T9,incomplete,contusion,"total laminectomy + Kirschner wire (10 g) was inserted into the catheter that was inserted into the aorta with a weight, which fell freely from a 25-mm height. Following this, a semicircular slice (4x2 mm) made from thin plastic was hit, and the wire was immediately removed","1, 3, 7 or 14 days",methotrexate,methotrexate,,50 mg/kg,Not reported,,3 days,once daily,intrathecally,,neurological/functional assessment,"BBB scale, inclined plane test (modified Rivlin's method)",,"BBB: all behavioral observations were performed at the same time (8:00 p.m.); inclined plane test: moveable plate with an adjustable angle of 0‐90 ̊, rat's head placed faced forward, and angle of inclination between the inclined plane and the horizontal plane increased gradually, until the rats unable to maintain a constant position (45 ̊) for 5 sec","BBB: 1, 3, 7 or 14 day groups; incline plane test: 1, 3, 5, 7 and 14 days post injury",,not reported,positive effect,"BBB: on days 7 and 14, movement capacity was significantly improved in the MTX+SCI group compared with the SCI group (P<0.05); inclined plane test: rats from the MTX-SCI group exhibited significantly strengthened hind limb force compared with the SCI group 3 and 7 days after SCI initiation (P<0.05), and this improvement was continued 14 days after SCI induction (P<0.01)",histology,"western blot, TUNEL (only of interest), apoptosis assay, MTT colorimetric assay",day 7,not reported,positive effect,"metothrexate reduces apoptosis (TUNEL staining), inhibits the expression of GRP78 in cells in the region of SCI (wersten blotting)","anesthesia: 10% chloral hydrate (400 mg/kg, IP); no other treatments were performed (apart from object of the study); euthanasia: 10% chloral hydrate (400 mg/kg, IP) + perfusion with fixatives",MTX treatment increased neuronal survival in the region of SCI and improved the functional recovery of rats with acute SCI;  protective effect of MTX in neuronal cells may be mediated by the inhibition of ERS-induced apoptosis,not reported,use chloral hydrate,No,
Lucie,Wong et al.,2012,One day of motor training with amphetamine impairs motor recovery following spinal cord injury,10.1016/j.expneurol.2011.08.011,English,,included,,,,,,rats,Sprague Dawley,102,46,,,46,,,see table 1,female 100% for SCI lesion (male 100% for cortical lesion),female,0,male: 14 week old; female: 11-13 weeks old,,,11,13,Weeks,,male: range [310-370](g); female: range [200-250](g),,,200,250,g,,level: T9 or C5; severity: completely severed,T9 + C5,incomplete,transection,"right lateral hemisection, incision repeated 3 times",Experiment 1: 25 days post-lesion; Experiment 2: 14 days post-lesion; Experiment 3: 23 days post-lesion; Experiment 4: 78 days post-lesion (18 days following biotinylated dextran amine [BDA] injections); Experiment 5: 53 days post-lesion,amphetamine,amphetamine,,2 mg/kg or 1 mg/kg,24h after injury (groups 1 to 4) or 14 days after injury (group 5),,single dose,-,intraperitoneally,,neurological/functional assessment,"Beam walking test, straight alley BBB, grip strength task",,"Beam walking test: trained prior to injury, traverse a flat, rectangular, metal narrow beam measuring 2.5 cm×100 cm to escape bright light, 2 trials per session, 7-point scale: 1=rats unable to cross the beam or place the affected limb on the horizontal surface of the beam and 7=rats traverse the beam with 2 or fewer footslips; straight alley BBB: trained prior to injury, ambulate in a straight alley made of black plexiglass measuring 28 cm×125 cm towards a darkened goal box (28 cm×28 cm), 2 experimeters to observe both sides of the rat, 7 habituation sessions, 4 min each, 21-point scale; grip strength task: trained prior to injury, givem about 1s to establish a grip, rat pulled away until grip was released, true grip = extension of fingers gripping the bar with all fingers followed by release into a relaxed unclenched position, max force recorded by grip strength meter priori to grip release = gripping force, test stopeed after 4 true grips were recorded for each paw or until there were 10 trials without any grips","Beam walking test: every 6 h at day 1 post injury, tested again at day 2 post injury and then every other day until end of experiment; alley BBB: at day 2 post injury and then weekly until end of experiment; GSM: rats with C5 lesions were tested beginning 3 days post injury and then evry other day until the end of the experiment",,yes,mixed effects (assessment) + mixed effects (dosage),"combined data indicate that rats trained with amphetamine had greater functional deficits, negative effect reported are not consistent across all assessments and both dosage scheme and injury level",histology,"lesion volume: lesion area values were multiplied by the distance between sections to determine the lesion volume between sections, which were then summed to determine the total lesion volume",Experiment 1: 25 days post-lesion; Experiment 2: 14 days post-lesion; Experiment 3: 23 days post-lesion; Experiment 4: 78 days post-lesion (18 days following biotinylated dextran amine [BDA] injections); Experiment 5: 53 days post-lesion,not reported,mixed effects (dosage),across all experiments lesions were significantly larger in rats trained with amphetamine but in T9 lateral hemisection with 1 mg/kg amphetamine,"anesthesia: ketamine (80 mg/kg, IP), xylazine (10 mg/kg, IP); postop: buprenorphine hydrochloride for 3 days (0.03 mg/kg, SC), Baytril (2.5 mg/kg, SC) for 7 days, 10 mL lactated ringers for 7 days; euthanasia: overdose of Euthasol ( 195 mg/ml pentobarbital sodiun and 25 mg/ml phenytoin sodium), perfused transcardially with 4% paraformaldehyde in 0.1M PBS ",amphetamine/training regimen that improves recovery after cortical injury has the opposite effect of impairing recovery following spinal cord injury because early training with amphetamine increases lesion severity,not reported,"deleterious effect reported, use ketamine buprenorphine pentobarbital",No,
Lucie,Cragg et al.,2016,Effects of pain and pain management on motor recovery of spinal cord-injured patients: A longitudinal study,10.1177/1545968315624777,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ohta et al.,2008,"Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT), promoted functional recovery from spinal cord injury-induced motor dysfunction in rats",10.3727/096368908786576516,English,,excluded,Out of scope,No assessments of interest,"Out of scope: study effect of mature adipocyte-derived cells, dedifferentiated fat cells ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Aminmansour et al.,2016,"Effects of progesterone and vitamin D on outcome of patients with acute traumatic spinal cord injury; a randomized, double-blind, placebo controlled study",10.1080/10790268.2015.1114224,English,Iran,included,,,,prospective,prospective,human,acute traumatic spinal cord injury between 18 and 65 years of age who are fererred within 8h after injury,64,32,0,0,32,0,0,,male: n=35; female: n=30,mixed,53.4,progesterone + vitD: 41.88 (13.6) (years); placebo: 45.2 (13.7) (years),41.88,13.6,,,Years,,not reported,,,,,,,"levels: C4: n=3 (all ttt), C5: n=3 (all placebo), C6: n=4 (all ttt), C7: n=3 (all placebo), T1: n=3 (all placebo), T2: n=3 (all ttt), T4: n=5(2 ttt, 3 placebo), T5: n=4 (all placebo), T6: n=3 (all ttt), T11: n=9(3 ttt, 6 placebo), T12: n=11(8 ttt, 3 placebo), L1: n=10(6 ttt, 4 placebo), L2: n=3(all placebo); severity: injury severity score: ttt: 28.9 (8.9), placebo: 30.6 (9.4)","C4: n=3 (all ttt), C5: n=3 (all placebo), C6: n=4 (all ttt), C7: n=3 (all placebo), T1: n=3 (all placebo), T2: n=3 (all ttt), T4: n=5(2 ttt, 3 placebo), T5: n=4 (all placebo), T6: n=3 (all ttt), T11: n=9(3 ttt, 6 placebo), T12: n=11(8 ttt, 3 placebo), L1: n=10(6 ttt, 4 placebo), L2: n=3(all placebo)","injury severity score: ttt: 28.9 (8.9), placebo: 30.6 (9.4)",Not reported,not reported,referred within 8h after injury,progesterone and vitamin D (together),progesterone + vitamin d,,"progesterone: 0.5 mg/kg, vitamin D3: 5 microg/kg",less than 8hours after injury,,5 days,twice a day,multiple,progesterone: IM; vit D3: oral,motor and sensory scores,ASIA motor and sensory scores,neurological (motor and sensory),"report both ASIA motor and sensory scores per ""quadrant"" and ASIA classification","baseline (3 days), 6 days, 3 months, 6 months",,yes,mixed effects (assessment),"ASIA motor and sensory scores were significantly higher in study group compared to placebo after 6 months, however the ASIA classification was comparable between two study groups; ASIA motor and sensory scores for all four extremities at 6 months of treatment was significantly higher in those receiving the therapy within the first 4 hours after injury compared to those receiving it after 4 hours",-,,,,,,every patient received standard of care with methylprednisolone (30 mg/kg IV as bolus and 15 mg/kg each 3 hours till 24h),administration of progesterone and vitamin D in acute phase of traumatic SCI is associated with better functional recovery and outcome,did not measure the serum levels of sex hormones and cytokines and thus cannot comment on the mechanism of action of progesterone and vitamin D as a neuroprotective agent; not possible to know wether changes in rate of recovery over time could have been amenable to treatment effects; did not measure the baseline vitamin D level; did not include a group of progesterone or vitamin D alone,"randomized double-blind, placebo controlled study from Iran",Yes,
Lucie,Lima et al.,2020,Citalopram administration does not promote function or histological recovery after spinal cord injury,10.3390/ijms21145062,English,,included,,,,,,rats,Wistar,26,14,,,12,,,4 groups (2 controls and 2 treatment) because 2 different drug regimen tested,female 100%,female,0,14 weeks old,14,,,,Weeks,,range [210-260](g),,,210,260,g,,level: T8; severity: severe,T8,severe,contusion,"laminectomy + weight drop trauma model (10g weight rod from 20 cm height onto the exposed spinal cord, dura left intact)","7 or 8 weeks (contradictory information in the paper ""8-weeks"" treatment and ""Eight-weeks post-injury"" when describing sacrifice, but also ""ABT was performed 7 weeks post-injury and the animals sacrified"" in Fig1 with sacrifice marked at week 7)","citalopram hydrobromide, ",citalopram,,10 mg/kg for 7-day group or 8 mg/kg/day for the 8-week group,1h after injury,,7 days or 7-8 weeks (contradiction between text and figure),once daily,multiple,"first 7 days in both groups: IP, after first week and for the 7 following weeks in the 8-week group: oral in drinking water",neurological/functional assessment,"BBB scale, activity box test (ABT)",,"BBB: 0=no hindlimb movement, 1-8: joint movement but no weight support, 9-20: ability to support weight and use limb for locomotion with some degree of abnormality, 21=normal locomotion; ABT: total distance traveled, average velocity, number of rearings, freely explore arena (43.2 cm square) for 5 min","BBB: 3 days post-injury, thereafter once per week; ABT: 7 weeks post-injury",,Yes,no effect,BBB: No statistically significant differences were observed between experimental groups regarding any of the analyzed time-points; ABT: Citalopram treatment did not significantly improve any aspect of the motor recovery assessed with the ABT,histology,cavity size,8 weeks after innjury,not reported,no effect,Citolipram did not reduce the size of the cavity,"anesthesia: ketamine (100 mg/mL, IP), medetomidine hydrochloride (1 mg/mL, IP), volume ration of 1.5:1; analgesic: butorphanol (10 mg/mL), antibiotic: enrofloxacin (5 mg/mL), disinfection: ethanol 70%, chlorohexidine; anesthesia reversed: atipamezole (5 mg/mL); postoperative care: butorphanol twice per day for 5 days, vitamins, saline and enrofloxacin twice per day for 7 days, in event of weight loss of over 10% of body weight: high-calorie oral supplement, daily; euthanasia: IP injection of sodium pentobarbital (200 mg/mL), transcardially perfused with 100 mL of cold 0.9% saline followed by 300 mL of 4% paraformaldehyde in 1x PBS",results do not support citalopram treatment as a therapeutic strategy for SCI,"mainly focus on motor and histological recovery, no analysis of autonomic or sensory effects; citalopram may have a therapeutic effect on mild to moderate lesions or on different anatoic regions, different dosage might be effective, only used female because they have a higher survival rate than males subjected to this type of injury, increasing the power of our sample size the difference between groups could become significant","use ketamine, medetomidine, butorphanol",No,
Lucie,Beaumont et al.,2009,Effects of rolipram on adult rat oligodendrocytes and functional recovery after contusive cervical spinal cord injury,10.1016/j.neuroscience.2009.07.039,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al.,2014,Effects of the combination of methylprednisolone with aminoguanidine on functional recovery in rats following spinal cord injury,10.3892/etm.2014.1613,English,,included,,,,,,rats,Wistar,60,12,,,12,,,5 groups in total,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-240](g),,,200,240,g,,level: T10; severity: moderate contusion,T10,moderate,contusion,laminectomy + New York University impactor (12.5 g.cm),24h after injury or 8 weeks,"aminoguanidine (AG), methylprednisolone (MP), combination",methylprednisolone,No,0.75 mg/kg,1 and 4h after injury,Yes,2 doses,-,intraperitoneally,,neurological/functional assessment,"BBB scale, grid-walking test",,"BBB scale: open field, score form 0 (complete parlaysis) to 21 (normal locomotion), observed for 4 min by 3 observers; grid-walking test: walk freely for 4 min, counted missteps and steps taken with the hindlimb of the same side, results in percentage of missteps","24h before, 24h, 3days and once weekly for eight weeks post-injury",Yes,yes,no effect,"BBB: the scores in the AG and MP combination treatment group were consistently higher than those in the other groups and the differences between BBB scores of the AG and MP combination group and those of the other three groups were statistically significant starting from the third week and continuing until the eight week, no significant difference between the MP and control groups; grid walking test: percentage of missteps of hind paws was markedly reduced in the combination-treated rats compared with that in the other groups (singificant difference with the control group), no significant difference between the MP and control groups",immunohistochemistry,"determination of spinal cord water content (only part of interest), myeoloperoxidase (MPO) activity, TNF-alpha anf IL-1beta measurements, western blot analysis (Bax and Bcl-2)",24h after injury,not reported,no effect,combination therapy with AG and MP significantly ameliorated the increased water content of the injured spinal cords; levels of MPO activity were significantly reduced by the combination therapy compared with those of the rats in the control group;  combination therapy significantly reduced the spinal cord levels of TNF-α and IL-1β compared with those of the control group; combination therapy with MP and AG significantly reduced Bax expression levels and increased the SCI induced inhibition of Bcl-2 expression compared with those in the control group --> combination MP+AG inhibits apoptosis following SCI; no significant difference in spinal cord water content in the MP group compared to control group,"anesthesia: 40 mg/kg ketamine, 4 mg/kg xylazine and 0.9 mg/kg acepromazine IP; following surgery:  10 ml 0.9% sodium chloride and 30 mg/kg sulfadiazine and trimethoprim (SC); post-surgical care: injections of sulfadiazine and trimethoprim twice a day for up to one week",the combination therapy group treated with AG (75 mg/kg) and MP (0.75 mg/kg) exhibited significantly reduced levels of cytokine expression and cell apoptosis compared with those in the control group; the data demonstrated that the combination therapy significantly enhanced the recovery of limb function.,not reported,"use ketamine, sulfadiazine, trimethoprim",Yes (drug of interest + drug not of interest),
Lucie,Chen et al.,2014,Effects of the combined administration of vitamins C and E on the oxidative stress status and programmed cell death pathways after experimental spinal cord injury,10.1038/sc.2013.140,English,,included,,,,,,rats,Sprague Dawley,44,>= 12,,,>= 12,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range [260-320](g),,,260,320,g,,level: T10; severity: moderate,T10,moderate,contusion,laminectomy + weight drop (10g rod dropped from 12.5 mm),7 days,"VCE (combination of vitamin C (sodium ascorbic) and E, vitamin E(±)- alpha-tocopherol)",vitamin c e,,vit E : 200 mg/kg and vit C: 240 mg/kg,Not reported,,7 days,once daily,intraperitoneally,,neurological/functional assessment,BBB method,,"average between 2 investigators, open-field","before injury and at 1, 4, 7, 10, 14, 21 and 28 days postoperatively",,yes,positive effect,"At 14 and 28 days after injury, animals that underwent VCE treatment performed better than SCI animals and the difference was statistically significant (P<0.05)",immunohistochemistry,"western blot analysis, measurement of superoxide dismutase (SOD) and gluthatione peroxidase (GSH-Px) activity levels",7 days after injury,not reported,,"VCE administration increased levels of SOD in SCI rats, compared with untreated SCI rats (P<0.05), VCE treatment reduced levels of GSH-Px in SCI rats compared with those in untreated SCI rats (P<0.05), apoptosis: VCE treatment reduced the elevated levels of cleaved caspase-3 in rats with an SCI (significant), autophagy: LC3 II expression to be reduced after an SCI, and VCE treatment signifi- cantly enhanced LC3 II expression","anesthesia: xylazine (10 mg/kg, IP), tiletamine and zolasepam (40 mg/kg, IP); euthanasia: intracardiac perfusion with 0.1 mol/L PBS (pH 7.4)","The combined administration of VCE was clearly capable of modulating the antioxidant effects, and of reducing apoptosis and increasing autophagy at the lesion epicenter leading to an improved functional outcome. ",not reported,,No,
Lucie,Zhang et al.,2017,Effects of the root extract of Dipsacus asperoides (Caprifoliaceae) on locomotor function and inflammation following spinal cord injury in rats,10.4314/tjpr.v16i6.23,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (root extract of Dipsacus asperoides (Caprifoliaceae)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lu et al.,2011,Effects of transplantation of gelatin sponge cylinder scaffold containing neurotrophin-3 NT-3 gene modified bone marrow mesenchymal stem cells on promoting the recovery of partial structure and function of rats with spinal cord complete transection injury,10.3969/j.issn.1001-1242.2011.07.002,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (neurotrophin-3 NT-3 gene modified bone marrow mesenchymal stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Akdemir et al.,1993,"Effects of TRH and high-dose corticosteroid therapy on evoked potentials, and tissue Na <sup>+</sup> , K <sup>+</sup> and water content in experimental spinal injury",10.1007/BF02576237,English,,included,,,,,,rats,Albino,30,10,,,10,,,one additional treatment group n=10,male 100%,male,100,not reported,,,,,,Not reported,range: [200-275](g),,,200,275,g,,level: T1; severity: not reported,T1,paraplegia,compression,laminectomy (C6-T2) + Rivlin and Tator method (2-min extradural clip compression with a Yasargil aneursym clip exerting a force of 53g),5h,"thyrotropin-releasing hormone (TRH), methylprednisolone (MP)",methylprednisolone,No,30 mg/kg and 5.4 mg/kg/hour,1h after injury,,3h,-,intravenously,,electrophysiology,somatosensory-evoked potentials (SEPs),,"Neuromatic 2000-C evoked potential system, needle electrode under the hard palate, constant current stimuli (5 mA) of pulse duration 0.1 ms, presentation rate of 5Hz to exposed sciatic nerve, SEPs recorded via a 2mm ball platinum electrode placed epidurally over the sensorimotor cortex, analysis time of 100ms",pre- and post-injury,No,yes,positive effect,"In the MP and TRH-treated groups, all but two animals in each group showed marked or nearly complete SEPs recoveries during the time course of measurement (P< 0.001)",histology,"tissue sodium, potassium and water measurements",5h after injury,yes,positive effect,"in both treatment groups, tissue water and sodium concentration were lower (P < 0.01), potassium concentration was higher (P < 0.01)","anesthesia: ketamine (60 mg/kg), diazepam (6mg/kg) IP; sodium bicarbonate to maintain arterial pH, pO2, pCO2; euthanasia: intracardiac perfusion method",beneficial effects of high-dose corticosteroid and TRH in promoting electrophysiological recovery and preserving spinal cord tissue following experimental injury,not reported,"use ketamine, diazepam",No,
Lucie,Yang et al.,2010,Effects of vitamin E combined with monosialoganglioside on the recovery of motor function after spinal cord injury in rats,10.3969/j.issn.1001-1242.2010.06.010,Chinese,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yamamoto et al.,2010,Effects of xenon on ischemic spinal cord injury in rabbits: A comparison with propofol,10.1111/j.1399-6576.2009.02111.x,English,,excluded,Out of scope,No control group,,,,rabbit,New Zealand,32,8,,,12,,,additional treatment group n=12,male 100%,male,100,not reported,,,,,,Not reported,range: [2.6-4.1](kg),,,2.6,4.1,kg,,"level: L5 (based on level studied for hsitology), severity: not reported",L5,Not reported,ischemia,15 min aorta occlusion,48h ,"xenon, propofol",propofol,,xenon: 70%; propofol: 0.8 mg/kg/min,both: from 30 min before aortic occlusion to the end of the operation,,,,inhalation,,neurological evaluation,Tarlov scoring,,five-point grading scale: 0=paraplegic with no lower extremity function; 4=normal motor function,3 and 48h after ischemia,,yes,,"no significant differences between the neurologic scores in the xenon group and those in the propofol group (no comparison to a group with injury without any treatment, so hard to asses the treatment effect on recovery)",histology,"number of normal neuronal cells in the anterior spinal cord of L5; white matter injury (vacuolation in ventral, ventrolateral and lateral white matter)",48h after injury,not reported,,no statistically significant difference in the number of normal neurons between the xenon and the propofol groups; no statistically significant differences in the percentage areas of vacuolation among the three groups (2 treatments and sham - no ischemia),"anesthesia: 5% isoflurane in oxygen, 1% lidocaine; post-surgery: 600U IV heparin; euthanasia: 5% isoflurane (anesthesia), thiopental (50 mg/kg, IP)",70% of xenon has no additional neuroprotective efﬁcacy against ischemic spinal cord injury in rabbits compared with propofol,(i) would be better to include a control group who underwent SC ischemia without anesthesia (i.e. whithout treatment) but not possible for technical and ethical reasons; (ii) concentration of xenon might have affected the results; (iii) not known wether the doses of propofol used in study are equivalent to those of xenon,,,
Lucie,Genovese et al.,2008,Effects of zileuton and montelukast in mouse experimental spinal cord injury,10.1038/sj.bjp.0707577,English,,included,,,,,,mice,CD1,300,50,,,50,,,"6 groups in total, all of n = 50",male 100%,male,100,not reported (adults),,,,,,Adult,range: [23-30](g),,,23,30,g,,level: T6-T7; severity: not reported,T6 - T7,Not reported,compression,laminectomy + 1 min extradural compression using aneurysm clip with closing force of 24g ,"24h, 10 days","zileuton, montelukast",montelukast,,5 mg/kg,1h and 6h after injury,,2 doses or 9 days,motor function experiments: once daily,intraperitoneally,,functional assessment,modified murine BBB hindlimb locomotor-rating scale,,"0: no hindlimb movement; 21: consistent plantar steppingm coordinated gait, consistent toe clearance, predominant paw position parallel at initial contact and lift off and trunk stability (very precise description of every grade in the paper)",once a day for 10 days after injury,,not reported,positive effect,significant (P<0.001) amelioration of hindlimb motor disturbances was observed in SCI + montelukast-treated-mice,"histology, immunochemistry","oedema, alteration of the white matter ((myeloperoxidase activity, measurement of TNF-alpha, neutrophil infiltration, apoptosis levels (annexin V), Bax and Bcl-2 expressio, COX-2 expression, activation of MAPK signal transduction pathway, production of PGE2 and LTB4)), TUNEL",24h after injury ,not reported,no stats,"oedema: significant protection of the SCI was observed in the tissue collected from SCI treated mice (no stats); neutrophil infiltration: significantly attenuated MPO activity in treated mice; TNF-alpha: significantly attenuated in treated mice; apoptosis: treatment reduced the degree of positive staining for FAS Ligand, smaller number of TUNEL-positive cells, no cells in the earlier stage of apoptosis and decreased presence of cells (positive for PI) in the later stages of apoptosis (no stats); Bax and Bcl-2: treatment prevented the SCI- mediated Bax expression, and significantly increased the expression of Bcl-2; COX-2 and MAPK: treatment reduced the SCI-mediated COX-2 expression, pERK1/2 (significant); PGE2 and LTB4: significantly attenuated in treated mice",anesthesia: chloral hydrate (40 microg/kg),Zileuton and montelukast produced a substantial reduction of inflammatory events associated with experimental SCI.,not reported,neurological assessment was very limited (not main focus),No,
Lucie,Guertin et al.,2011,"Effects on locomotion, muscle, bone, and blood induced by a combination therapy eliciting weight-bearing stepping in nonassisted spinal cord-transected mice",10.1177/1545968310378753,English,,excluded,Out of scope,No drug of interest,,,,mice,CD1,21,,,,,,,,male 100%,male,100,not reported (adults),,,,,,Adult,range: [30-35](g),,,30,35,g,,level: T9-T10; severity: complete,T9 - T10,complete,transection,laminectomy + spinal transection with microscissors,30 days,combination therapy: buspirone + apomorphine + L-DOPA + benserazide,,,buspirone: 1.5mg/kg; apomorphine: 1.5mg/kg; L-DOPA: 50 mg/kg; benserazide: 12.5 mg/kg,day 3 after injury,,from day 3 to day 30 after injury,4 times per week,subcutaneous,,functional/behavioral assessment,"average combined score (ACOS); Antri, Orsal and BArthe qualitative assay (AOB); ",,"motor-driven treadmill (8-10 cm/s) used for all behavioral test; ACOS: 4-min assessment in which numbers or locomotor-like movements, non-locomotor-like movements, amplitude and incidence are quantified; AOB: also assesses weight-bearing and plantar foot placement capabilities, 22 discriminative scores (0= no movement)",weekly,,not reported,positive effect,significantly better scores in treated mice compared to placebo,histology,"bone densitometry (femoral bone), muscle (left soleus and extensor digitorum longus) and cell histology",30 days after injury,not reported,mixed effects,"bone densitometry: no significant difference; muscle size: SOL surface area significantly increased in treated mice, comparable results for EDL; cellular level: type I fiber cross-sectional area values nonsignificantly changed, type II and intermediate fiber cross-sectional area values significantly increased in treated mice","preoperative care: lactate ringer's solution (1mL SC), buprenorphine (0.1 mg/kg, SC), Baytril (5 mg/kg, SC); anesthesia: 2.5% isoflurane; postoperative care: lactate-ringer's solution (2*1mL/day, SC), buprenorphine (0.2 mg/kg/day, SC), Baytril (5mg/kg/day) for 4 consecutive days","repeated systematic administrations of a combination therapy potently induced, after each injection, weight-bearing stepping on a treadmill in previously untrained, completely paraplegic mice",cannot exclude the possibility that the effects induced by combination therapy-treated mice were in part caused by the drugs themselves and not by the activity-based training elicited by them,,,
Lucie,Chen et al.,2018,Therapeutic effect of platelet-rich plasma in rat spinal cord injuries,10.3389/fnins.2018.00252,English,,included,,,,,,rats,Wistar,>= 105,>= 27,,,>= 23,,,numbers unclear,female 100%,female,0,10 weeks old,10,,,,Weeks,,not reported,,,,,,Not reported,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop (NYU impactor, 50 mm height)","24h, 48h, 7 days, 60 days","plasma, platelet-rich plasma",plasma,,Not reported,immediately after injury,,single dose,-,intrathecally,,functional/behavioral assessment,BBB scale,,21-point scale,every 3 days after SCI,,yes,positive effect,BBB significantly higher at day 60 in plasma group compared to control group,immunofluorescence,area of spared white matter,"24h, 48h, 7 days, 60 days",not reported,positive effect,"((PRP administration significantly enhanced the GFAP IR signal, upregulated the astrocytic PDGF-B IR, enhanced PDGF- B expression in astrocytes, no significant difference in the OX-42 immunoreactivity (IR) signal or ICAM-1 IR signal; plasma treatment significantly enhanced the von Willebrand factor IR signal, singificant difference in enhanced spared white matter, enhanced neuronal regeneration)); plasma treatment enhanced spared white matter after SCI significantly","anesthesia: 2.5% isoflurane; post surgery: cephalosporin (one time per day, for at least 7 days); euthanasia: anesthesia by isoflurane, intracardially infused with ice-cold PBS with heparin (0.2 U/mL), ice-cold 4% paraformaldehyde in PBS","findings suggest by intratecal PRP stimulate angiogenesis, enhancing neuronal regeneration after SCI in rats.",not reported,"use isoflurane, cephalosporin",No,
Lucie,Chen et al.,2018,Therapeutic effect of platelet-rich plasma in rat spinal cord injuries,10.3389/fnins.2018.00252,English,,included,,,,,,rats,Wistar,>= 105,>= 27,,,>= 35,,,numbers unclear,female 100%,female,0,10 weeks old,10,,,,Weeks,,not reported,,,,,,Not reported,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop (NYU impactor, 50 mm height)","24h, 48h, 7 days, 60 days","plasma, platelet-rich plasma",platelets,,"4.8*10^6 immediately after SCI, 1.6*10^6 afterwards",immediately after injury,,single dose or 6 days,Not reported,intrathecally,,functional/behavioral assessment,BBB scale,,21-point scale,every 3 days after SCI,,yes,mixed effects (dosage),"in pilot study, high dose of platelet rich plasma was not significantly different from control, but normal dose was; in second study, PRP, and PRP-sus treatments significantly improved locomotor recovery compared with the vehicle group",immunofluorescence,area of spared white matter,"24h, 48h, 7 days, 60 days",not reported,positive effect,"((PRP administration significantly enhanced the GFAP IR signal, upregulated the astrocytic PDGF-B IR, enhanced PDGF- B expression in astrocytes, no significant difference in the OX-42 immunoreactivity (IR) signal or ICAM-1 IR signal; plasma treatment significantly enhanced the von Willebrand factor IR signal, singificant difference in enhanced spared white matter, enhanced neuronal regeneration)); PRP treatment enhanced spared white matter after SCI significantly","anesthesia: 2.5% isoflurane; post surgery: cephalosporin (one time per day, for at least 7 days); euthanasia: anesthesia by isoflurane, intracardially infused with ice-cold PBS with heparin (0.2 U/mL), ice-cold 4% paraformaldehyde in PBS","findings suggest by intratecal PRP stimulate angiogenesis, enhancing neuronal regeneration after SCI in rats.",not reported,"use isoflurane, cephalosporin",No,
Lucie,Majczynski et al.,2020,Contribution of 5-HT2 Receptors to the Control of the Spinal Locomotor System in Intact Rats,10.3389/fncir.2020.00014,English,,excluded,Non-sci population,,"OUt fo scope: study on ""intact rats"" i.e. no spinal cord injury",,,rats,Wistar rats,17,,,,,,,,female 100%,,,3 months,,,,,,,range [250-300](g),,,,,,,level: ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tang et al.,2011,Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: Roles of Bcl-2 and thioredoxin,10.1016/j.freeradbiomed.2010.12.024,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al.,2019,Berberine enhances survival and axonal regeneration of motoneurons following spinal root avulsion and re-implantation in rats,10.1016/j.freeradbiomed.2019.08.029,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (berberine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al.,2011,Protective effect of deferoxamine on experimental spinal cord injury in rat,10.1016/j.injury.2010.08.028,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (deferoxamine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Aras et al.,2015,Protective effects of minocycline on experimental spinal cord injury in rats,10.1016/j.injury.2015.05.018,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yoon et al.,1999,Therapeutic time window for methylprednisolone in spinal cord injured rat,10.3349/ymj.1999.40.4.313,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Long Evans,193 - 289,34,,,159,,,contradiction between table 1 and 2,male 100%,male,100,not reported (adults),,,,,,Adult,range [400-500](gm),,,400,500,g,,level: not reported; severity: not reported,Not reported,mixed,contusion,"NYU impactor system, 12.5 or 25.0 or 50.0 gcm dropped",24h ,methylprednisolone,methylprednisolone,,30 mg/kg,5 groups: 10min or 30min or 30+120min or 120min or 120+240min after injury,,single or 2 doses,-,intravenously,,-,-,,-,-,,-,,-,histology,"lesion volume assessment, tissue water concentration",24h after injury,not reported,mixed effects (timing) + mixed effects (regimen),lesion volumes in group A (1o min after injury) were significantly smaller than those in all other groups; two bolus injection of methylprednisolone did not provide significantly better protection againt injury-induced 24-hour lesion volumes; delayed administration of a 30 mg/kg single dose of MP at 2h after injury (group D) slightly increased lesion volumes compared to control (p=0.04); treatment had no effect on overall spinal cord water concentration,"anesthesia: pentobarbital (60 mg/kg, IP)",NYU SCI models has a very short therapeutic window,not reported,"histology includes only lesion volume, no neurological assessment",No,
Lucie,Hong et al.,2019,Elevated Serum Melatonin under Constant Darkness Enhances Neural Repair in Spinal Cord Injury through Regulation of Circadian Clock Proteins Expression,10.3390/jcm8020135,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested per se (intervention is on the light/dark pattern),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kim et al.,2004,Continuous Brain-derived Neurotrophic Factor (BDNF) Infusion after Methylprednisolone Treatment in Severe Spinal Cord Injury,10.3346/jkms.2004.19.1.113,English,,included,,,,,,rats,Sprague Dawley,45,13,2,,14,1,,one other treatment group not of interest n=15,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T10; severity: severe (based on abstract),T10,severe,contusion,"laminectomy + weight drop (10g-weight device - Teflon impounder attochedt to 3D stereotaxic frame, dropped by 5 cm, 5 sec on the spinal cord)","1, 3, 7 days or 10 weeks (functional assessment)",brain-derived neurotrophic factors (BDNF) + methylprednisolone (MP),methylprednisolone,No,60 mg/kg and 30 mg/kg,immediately after SCI and 4h later (respectively),Yes,2 doses,-,intravenously,,functional/behavioral assessment,BBB scale,,rats were trained preoperatively each week in an open field (plywood circular enclosure with a smooth non-slip floor),every week following injury and treatment,Yes,yes,no effect,Rats in the MP-only group were not significantly different from the control group,immunohistochemical analysis,"hematogenous cell infiltration, axonal survival and regeneration, motor axonal regeneration, GAP-43 gene expression","1, 3, and 7 days post injury",not reported,positive effect,"hematogenous cell infiltration: singificantly fewer ED-1-positive cells in MP-only and MP+BDNF-infused animals, axonal survival and regeneration: singificantly more NF-positive axons and GAP-43-positive neurites in MP+BDNF rats, motor axonal regeneration: MP+BDNF regenerated many more motor axons than did MP-only and control groups (p<0.05), GAP-43 gene expression: no significant difference between MP+BDNF and MP-only but GAP-43 gene expression in both groupa was still higher than it was in the control group","anesthesia: ketamine (60 mg/kg, I{0, xylazine (10 mg/kg, IP); postoperative care: gentocin (2.5 mg, daily, IM), 5mL SC saline; euthanasia: 0.1M, pH 7.2 PBS containing heparin, 4% bufered paraformaldehyde",continuous infusion of BDNF after initial MP treatment improved functional recovery after severe spinal cord injury without dampening the acute effect of MP,"(i) necessary to identify whether chronic BDNF infusion without initial MP treatment can evoke similar outcome compared to MP+BDNF infusion; (ii) imprevode fucntional recovery was not enough to walk, might reflect an increase in reflexive movements that may not associated with motor axon regeneration because BDNF alone can also cause reflexive air walking in transection models; (iii) Immunohistopathologic technique in this study is semi-quantitative, would need further precise quantitative techniques ","use heparin, ketamin, gentocin",Yes (drug of interest + drug not of interest),
Lucie,Mbori et al.,2016,Evaluation of the combination of methylprednisolone and tranilast after spinal cord injury in rat models,10.3340/jkns.2016.59.4.334,English,,included,,,,,,rats,Wistar,48,,,,,,,no details on the numbers per group,female 100%,female,0,10-12 weeks,,,10,12,Weeks,,range: [230-250](g),,,230,250,g,,level: T10; severity: not reproted,T10,Not reported,compression,"laminectomy + compression using an aneurysm clip (Yasargil aneurysm clips FE716K) as previously by Jazayeri et al., held vertically for 30 sec",7 or 14 days,"methylprednisolone (MP), tranilast (TR)",methylprednisolone,No,0.75 mg/kg,1 and 4h after injury,,2 doses,-,intraperitoneally,,functional/behavioral assessment,BBB scale,,"4 min in open field, 2 observers, 21-point system based (0=complete hind limb paralysis; 21=complete normal locomation function)","prior to injury and 1, 3, 7, 10, 14 days after injury",No,yes,positive effect,"Individual therapies MP indicated significant improvement in hind limb function at day 7, 10, and 14 p<0.05 vs. the control.","histopathology, immunochemistry","spinal cord water content, neutrophil infiltration, HE staining (neural damage, cystic spaces, neuronal apoptosis, number of gliocytes, GFAP expression)",24h 7 days and 14 days,not reported,mixed (stats/no stats),"water content (24h): MP alone showed significant reduction in spinal cord water content p<0.05, not TR alone, combined therapy MP and TR had better results and significantly ameliorated the increase in spinal water content after SCI and showed reduction in spinal cord water; p<0.05 vs. the control, p<0.05 vs. MP and TR; neutrophil infiltration (24h): independent therapies MP and TR exhibited significant reduction in the MPO activity compared to the control p<0.05. The combined therapy using MPand TR significantly reduced neutrophil infiltration better than the individual therapies; p<0.05 vs. the control, p<0.05 vs. MP and TR; HE staining (14 days): no group comaprison reported; GFAP (7 days): individual therapies of MP and TR showed a less dense staining compared to the control group and the GFAP expression was significantly less, p<0.05 vs. the control group, no significant difference between GFAP expression of the individual therapies and the combined therapy of MP and TR p>0.05, difference in the mean GFAP expression between the groups was not statistically significant p>0.05","anesthesia: 10% chloral hydrate (350 mg/kg, IP); surgery: 1 mL of NS with crystalline penicillin (80000 units diluted in 5 mL NS, SC) and then for 7 days after injury to prevent infection ","Combining MP and TR is therapeutically more effective in improving functional recovery, inhibiting inflammation and glial scar formation after acute SCI.",not reported,"use chloral hydrate, penicillin",Yes (drug of interest + drug not of interest),
Lucie,Wiseman et al.,2009,Magnesium efficacy in a rat spinal cord injury model: Laboratory investigation,10.3171/spi.2009.10.4.308,English,,included,,,,,,rats,Sprague Dawley,122,12,1,,4,13,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,"level: T9-T10; severity: moderate-to-severe (experiment 1), less severe inury (experiment 2)",T9 - T10,moderate - severe,contusion,laminectomy + weight drop (10-g weight dropped from 25 mm (experiment 1) or 12.5 mm (experiment 2)),4 weeks ,"magnesium, methylprednisolone, combination",methylprednisolone,No,30 mg/kg,10 minutes after injury,Yes,1 dose,-,intraperitoneally,,functional/behavioral assessment,BBB scale,,2 observers,day 1 after injury and then each week for 4 weeks ,Yes,yes,no stats,MP and combination groups did not have sufficient number of animals to perform statistical analysis of BBB outcomes at 4 weeks postinjury,histological measures,"areas of myelinated tissure, area of preserved white matter, lesion length",4 weeks after injury,not reported,mixed effects (assessment),"no differences in mean lesion length, all treatment groups had significantly greater volume of white matter spared after injury than did the control group","enrofloxacin as prophylaxis immediately abefore procedure and each day for 7 days afterwards; anesthesia: 29 mg/kg IP pentobarbital; postop pain managed with buprenorphine hydrochloride (0.3 mg/kg); euthanasia: 50 mg/kg pentobarbital intraperitoneally, and then intracardiac perfusion was performed with 4% paraformaldehyde",the rats receiving magnesium had significantly better BBB motor scores and white matter sparing 4 weeks after moderate-to-severe SCI than the control animal; the optimal timing of magnesium administration appears to be within 8h of injury; MP use was associated with severe weight loss in rat model (which led to early euthanasia and so less specimens at 4 weeks post injury to be studied),"histology: small number (n=4 in each group) of specimens and the cariance in the control groupe were potential limitations; histological analysis was limited to a quantification of white amtter preservation, difficult to determine the extent of injury in the gray matter; limited number of specimens in the steroid groups (killed due to important weight loss)",lots of deaths,No,
Lucie,Wiseman et al.,2009,Magnesium efficacy in a rat spinal cord injury model: Laboratory investigation,10.3171/spi.2009.10.4.308,English,,included,,,,,,rats,Sprague Dawley,122,25,1,,54,5,,experiment 2 only for magnesium treatment,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,"level: T9-T10; severity: moderate-to-severe (experiment 1), less severe inury (experiment 2)",T9 - T10,multiple,contusion,laminectomy + weight drop (10-g weight dropped from 25 mm (experiment 1) or 12.5 mm (experiment 2)),4 weeks ,"magnesium, methylprednisolone, combination",magnesium,,600 mg/kg,"10 minutes after injury (experiment 1), or at 8, 12, or 24 hours after injury (experiment 2)",,single dose,-,intraperitoneally,,functional/behavioral assessment,BBB scale,,2 observers,day 1 after injury and then each week for 4 weeks ,,yes,mixed effects (timing),"mean BBB scores were significantly better for the magnesium group than ofr the control group at 4 weeks (experiment 1); the mean BBB data at 4 weeks revealed that the animals in which magnesium was administered within 8 hours (BBB Score 13.8 ± 3.7) had significantly better function than animals in the control (8.6 ± 5.1), 12-hour (8.1 ± 3.1), or 24-hour (7.9 ± 2.8) groups (p < 0.01, unpaired t-tests), no difference with control when magnesium administered later",histological measures,"areas of myelinated tissure, area of preserved white matter, lesion length",4 weeks after injury,not reported,mixed effects (assessment),"no differences in mean lesion length, all treatment groups had significantly greater volume of white matter spared after injury than did the control group","enrofloxacin as prophylaxis immediately abefore procedure and each day for 7 days afterwards; anesthesia: 29 mg/kg IP pentobarbital; postop pain managed with buprenorphine hydrochloride (0.3 mg/kg); euthanasia: 50 mg/kg pentobarbital intraperitoneally, and then intracardiac perfusion was performed with 4% paraformaldehyde",the rats receiving magnesium had significantly better BBB motor scores and white matter sparing 4 weeks after moderate-to-severe SCI than the control animal; the optimal timing of magnesium administration appears to be within 8h of injury; MP use was associated with severe weight loss in rat model (which led to early euthanasia and so less specimens at 4 weeks post injury to be studied),"histology: small number (n=4 in each group) of specimens and the cariance in the control groupe were potential limitations; histological analysis was limited to a quantification of white amtter preservation, difficult to determine the extent of injury in the gray matter; limited number of specimens in the steroid groups (killed due to important weight loss)",lots of deaths,No,
Lucie,Wiseman et al.,2009,Magnesium efficacy in a rat spinal cord injury model: Laboratory investigation,10.3171/spi.2009.10.4.308,English,,included,,,,,,rats,Sprague Dawley,122,12,1,,6,14,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,"level: T9-T10; severity: moderate-to-severe (experiment 1), less severe inury (experiment 2)",T9 - T10,moderate - severe,contusion,laminectomy + weight drop (10-g weight dropped from 25 mm (experiment 1) or 12.5 mm (experiment 2)),4 weeks ,"magnesium, methylprednisolone, combination",magnesium + methylprednisolone,,magnesium: 600 mg/kg + MP: 30 mg/kg,10 minutes after injury,,single dose,-,intraperitoneally,,functional/behavioral assessment,BBB scale,,2 observers,day 1 after injury and then each week for 4 weeks ,,yes,no stats,MP and combination groups did not have sufficient number of animals to perform statistical analysis of BBB outcomes at 4 weeks postinjury,histological measures,"areas of myelinated tissure, area of preserved white matter, lesion length",4 weeks after injury,not reported,mixed effects (assessment),"no differences in mean lesion length, all treatment groups had significantly greater volume of white matter spared after injury than did the control group","enrofloxacin as prophylaxis immediately abefore procedure and each day for 7 days afterwards; anesthesia: 29 mg/kg IP pentobarbital; postop pain managed with buprenorphine hydrochloride (0.3 mg/kg); euthanasia: 50 mg/kg pentobarbital intraperitoneally, and then intracardiac perfusion was performed with 4% paraformaldehyde",the rats receiving magnesium had significantly better BBB motor scores and white matter sparing 4 weeks after moderate-to-severe SCI than the control animal; the optimal timing of magnesium administration appears to be within 8h of injury; MP use was associated with severe weight loss in rat model (which led to early euthanasia and so less specimens at 4 weeks post injury to be studied),"histology: small number (n=4 in each group) of specimens and the cariance in the control groupe were potential limitations; histological analysis was limited to a quantification of white amtter preservation, difficult to determine the extent of injury in the gray matter; limited number of specimens in the steroid groups (killed due to important weight loss)",lots of deaths,Yes (drug of interest + drug of interest),
Lucie,Ates et al.,2007,Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury,10.1016/j.jocn.2006.03.023,English,,included,,,,,,rats,Wistar,90,18,,,18,,,"5 groups in total (one treatment not of interest and one sham), all n=18",male 100%,male,100,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T7-T10; severity: not reported,T7 - T10,Not reported,contusion,"laminectomy + weight-drop (10cm guide tube positioned perpendicular to the center of the spinal cord with an inner stainless steel rod, weight 5g, impact of 50 g/cm to the dorsal surface of the spinal cord)",24h (n=12 per group) or 6 weeks (n=6 per group),"mexiletine, phenytoin, riluzole",mexiletine,,80 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,functional/behavioral assessment,"motor function scale (modified Gale), inclined plane technique",,"motor function scale: slight modification of motor score of Gale et al, move freely in open field (0.7*0.9m), observed for 1 min at least, movements in hip, knee and ankle joints recorded; inclined plane technique: Rivlin and Tator's angle board test, measure the max angle at which an animal can support its weight for 5 sec in degrees, animals transversely on inclined plane",weekly from week 1 to week 6,,not reported,no stats,motor function scale: no significant difference in the motor function score at the end of the study between the treatment groups (no statement on the statistics when compared to the control group); inclined plane: phenytoin-treated rats revealed significantly lower improvements rates than mexiletine and riluzole-treated rats (p<0.05),histopathological assessment,"quantitative histopathological evaluation (percentage of lesion areas), lipid peroxidation levels, spinal cord water content",lipid peroxidation levels and spinal cord water content: 24h after injury; histology: 6 weeks after injury,not reported,positive effect,"histology: more myelin tissue and neurons in gray matter than those in the trauma group, treatment goups revealed significantly smaller lesion areas in the contused spina than trauma groups, no difference between treatment groups ; lipid peroxidation levels: treatment groups significantly lower MDA levels than the trauma group, levels higher in phenytoin than other two treatments; spinal cord water content: treatment groups had significantly lower water content than the trauma group, no significant difference between treatments","anesthesia: xylasine (10 mg/kg, IP), ketamine hydrochloride (50 mg/kg, IP); for 6 weeks-group: gentamycin twice daily during first 3 days as prophylaxis against urinary tract infection; euthanasia: anesthesia with sodium pentobarbital, intracardiac perfusion with isotonic saline (5min), then 10% formaldehyde (5min)","all tested Na+ blockers had a neuroprotective effect after SCI, riluzole and mexiletine were superior to phenytoin",not reported,"use ketamine, gentamycin",No,
Lucie,Ates et al.,2007,Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury,10.1016/j.jocn.2006.03.023,English,,included,,,,,,rats,Wistar,90,18,,,18,,,"5 groups in total (one treatment not of interest and one sham), all n=18",male 100%,male,100,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T7-T10; severity: not reported,T7 - T10,Not reported,contusion,"laminectomy + weight-drop (10cm guide tube positioned perpendicular to the center of the spinal cord with an inner stainless steel rod, weight 5g, impact of 50 g/cm to the dorsal surface of the spinal cord)",24h (n=12 per group) or 6 weeks (n=6 per group),"mexiletine, phenytoin, riluzole",phenytoin,,200 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,functional/behavioral assessment,"motor function scale (modified Gale), inclined plane technique",,"motor function scale: slight modification of motor score of Gale et al, move freely in open field (0.7*0.9m), observed for 1 min at least, movements in hip, knee and ankle joints recorded; inclined plane technique: Rivlin and Tator's angle board test, measure the max angle at which an animal can support its weight for 5 sec in degrees, animals transversely on inclined plane",weekly from week 1 to week 6,,not reported,no stats,motor function scale: no significant difference in the motor function score at the end of the study between the treatment groups (no statement on the statistics when compared to the control group); inclined plane: phenytoin-treated rats revealed significantly lower improvements rates than mexiletine and riluzole-treated rats (p<0.05),histopathological assessment,"quantitative histopathological evaluation (percentage of lesion areas), lipid peroxidation levels, spinal cord water content",lipid peroxidation levels and spinal cord water content: 24h after injury; histology: 6 weeks after injury,not reported,positive effect,"histology: more myelin tissue and neurons in gray matter than those in the trauma group, treatment goups revealed significantly smaller lesion areas in the contused spina than trauma groups, no difference between treatment groups ; lipid peroxidation levels: treatment groups significantly lower MDA levels than the trauma group, levels higher in phenytoin than other two treatments; spinal cord water content: treatment groups had significantly lower water content than the trauma group, no significant difference between treatments","anesthesia: xylasine (10 mg/kg, IP), ketamine hydrochloride (50 mg/kg, IP); for 6 weeks-group: gentamycin twice daily during first 3 days as prophylaxis against urinary tract infection; euthanasia: anesthesia with sodium pentobarbital, intracardiac perfusion with isotonic saline (5min), then 10% formaldehyde (5min)","all tested Na+ blockers had a neuroprotective effect after SCI, riluzole and mexiletine were superior to phenytoin",not reported,"use ketamine, gentamycin",No,
Lucie,Erol et al.,2008,Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury,10.1016/j.jocn.2007.06.009,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Wistar,42,7,,,14,,,"4 groups, sham n = 7",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T4-5; severity: not reported,T4 - T5,Not reported,compression,"total laminectomy from T3-T6, extradural compression of the exposed spinal cord for 30s using an aneurysmal clip with a closing force of 180g on the cord",1 or 10 days,"melatonin, octreotide",melatonin,,7.5 mg/kg twice or three equal doses to achieve total dose of 7.5 mg/kg/day,immediately after + 1 day after OR 3 doses over 10 days,,1 day or 10 days,Not reported,intraperitoneally,,-,-,,-,-,,-,,-,histopathological investigation,"congestion, edema, axonal degenration, necrosis",1 or 10 days,not reported,positive effect,"necrosis was significantly prevented in melatonin groups, melatonin was significantly more effective than octreotide in reducin necrosis; degeneration was found to be significantly prevented in all treatment groups, in melatonin-10 day group, levels of degenration, necrosis and edema were very similar to control levels (control=no injury); edema was significantly less severe in treatment groups; in terms of prevention of degenration and edema, melatonin was found to be significantly more effective than octreotide in early stages after injury but no significant difference between melatonin anc octreotidde in the late stages after injury; congestion was minimal in treatment groups, no statistically difference was observed between the melatonin and octreotide groups","anesthesia: ketamine hydrochloride (50 mg/kg, xylazine hydrochloride (5 mg/kg) both IM, one-third of the initila dose was repeated every hour as required","both melatonin and octreotide had biochemical and histopathological benefits in an SCI models; melatonin produced a more pronounced beneficial effect; melatonin and octreotide, which have potential to upregulate antioxidant defense systems, may be beneficial in patients who sustain SCI",not reported,"no neurological assessment, only histology",No,
Lucie,Erol et al.,2008,Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury,10.1016/j.jocn.2007.06.009,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Wistar,42,7,,,14,,,"4 groups, sham n = 7",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T4-5; severity: not reported,T4 - T5,Not reported,compression,"total laminectomy from T3-T6, extradural compression of the exposed spinal cord for 30s using an aneurysmal clip with a closing force of 180g on the cord",1 or 10 days,"melatonin, octreotide",octreotide,,30 microg/kg twice or three equal doses to achieve total dose of 30 microg/kg,immediately after + 1 day after OR 3 doses over 10 days,,1 day or 10 days,Not reported,intraperitoneally,,-,-,,-,-,,-,,-,histopathological investigation,"congestion, edema, axonal degenration, necrosis",1 or 10 days,not reported,positive effect,"necrosis was significantly prevented in melatonin groups, melatonin was significantly more effective than octreotide in reducin necrosis; degeneration was found to be significantly prevented in all treatment groups, in melatonin-10 day group, levels of degenration, necrosis and edema were very similar to control levels (control=no injury); edema was significantly less severe in treatment groups; in terms of prevention of degenration and edema, melatonin was found to be significantly more effective than octreotide in early stages after injury but no significant difference between melatonin anc octreotidde in the late stages after injury; congestion was minimal in treatment groups, no statistically difference was observed between the melatonin and octreotide groups","anesthesia: ketamine hydrochloride (50 mg/kg, xylazine hydrochloride (5 mg/kg) both IM, one-third of the initila dose was repeated every hour as required","both melatonin and octreotide had biochemical and histopathological benefits in an SCI models; melatonin produced a more pronounced beneficial effect; melatonin and octreotide, which have potential to upregulate antioxidant defense systems, may be beneficial in patients who sustain SCI",not reported,"no neurological assessment, only histology",No,
Lucie,Casas et al.,2005,Effects of epidural hypothermic saline infusion on locomotor outcome and tissue preservation after moderate thoracic spinal cord contusion in rats.,10.3171/spi.2005.2.3.0308,English,,excluded,Out of scope,No drug of interest,Out of scope: not drug of interest,,,rats,Sprague Dawley,56,,,,,,,,female 100%,,,not reported,,,,,,,267(18) (g),,,,,,,level: T10; severity: moderate,,,,laminectomy + weight drop with NYU impactor (12.5 g/cm contusion),45 days,"saline at different temperatures (24 (2.3), 30 (2.4), 35 (0.9), all in celsius degrees)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Serarslan et al.,2010,Protective effects of tadalafil on experimental spinal cord injury in rats,10.1016/j.jocn.2009.03.036,English,,included,,,,,,rats,Wistar,28,7,,,7,,,"4 groups, sham n = 7",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy + weight drop (10g rod from 5.0cm),24h,"tadalafil, methylprednisolone",methylprednisolone,No,30 mg/kg,"""after SCI"" (=immediately after?)",,single dose,-,intramuscular,,neurological assessment,hind-limb motor-function according to Tarlov,,"0= no voluntary hind-limb movement, 4=complete recovery; paraplegia=absence of muscle tonus and contractions",24h after injury,No,not reported,no effect,difference between groups were not significant except for between the sham group and all other groups,biochemical analysis,"serum levelsf of superoxide dismutase (SOD), nitric oxide (NO), malondialdehyde (MDA); ",24h after injury,not reported,mixed effects,"MDA serum: significantly higher in non-treated group compared to treated groups; tissue levels of MDA: lower in treated groups than in non-treatment but not significant, higher in treated groups than in sham group but not significant; serum SOD: lower in MP group than in non-treated and tadalafil groups (significant); serum NO: higher in tadalafil and sham than in non-treated and MP groups; MDA levels in spinal cord: no difference between groups; NO in spinal cord: lower in non-treated group compared to sham group, higher in taladafil compared to non-treated and MP groups (significant)","anesthesia: xylaine hydrochloride (2-5mg/kg), ketamine hydrochloride (40-50 mg/kg)",tadalafil appears to be beneficial in reducing the effects of injury to the spinal cord by increasing tissue levels of NO and serum activity of SOD,not reported,use ketamine,No,
Lucie,Serarslan et al.,2010,Protective effects of tadalafil on experimental spinal cord injury in rats,10.1016/j.jocn.2009.03.036,English,,included,,,,,,rats,Wistar,28,7,,,7,,,"4 groups, sham n = 7",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy + weight drop (10g rod from 5.0cm),24h,"tadalafil, methylprednisolone",tadalafil,,2 mg/kg,"""after SCI"" (=immediately after?)",,single dose,-,intragastrically,"nasogastric tube, would be enteral but not part of the list, should we add it?",neurological assessment,hind-limb motor-function according to Tarlov,,"0= no voluntary hind-limb movement, 4=complete recovery; paraplegia=absence of muscle tonus and contractions",24h after injury,,not reported,no effect,difference between groups were not significant except for between the sham group and all other groups,biochemical analysis,"serum levelsf of superoxide dismutase (SOD), nitric oxide (NO), malondialdehyde (MDA); ",24h after injury,not reported,mixed effects,"MDA serum: significantly higher in non-treated group compared to treated groups; tissue levels of MDA: lower in treated groups than in non-treatment but not significant, higher in treated groups than in sham group but not significant; serum SOD: lower in MP group than in non-treated and tadalafil groups (significant); serum NO: higher in tadalafil and sham than in non-treated and MP groups; MDA levels in spinal cord: no difference between groups; NO in spinal cord: lower in non-treated group compared to sham group, higher in taladafil compared to non-treated and MP groups (significant)","anesthesia: xylaine hydrochloride (2-5mg/kg), ketamine hydrochloride (40-50 mg/kg)",tadalafil appears to be beneficial in reducing the effects of injury to the spinal cord by increasing tissue levels of NO and serum activity of SOD,not reported,use ketamine,No,
Lucie,Bracken et al.,2002,Neurological and functional status 1 year after acute spinal cord injury: Estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III,10.3171/spi.2002.96.3.0259,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Pirbudack et al.,2003,Epidural corticosteroid injection and amitriptyline for the treatment of chronic low back pain associated with radiculopathy,10.1163/156856903767650763,English,,excluded,Non-sci population,,Out of scope: no SCI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hara et al.,2000,Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats,10.3171/spi.2000.93.1.0094,English,,included,,,,,,rats,Sprague Dawley,21,7,,,7,,,other treatment group not of interest n = 7,female 100%,female,0,not reported,,,,,,Not reported,"210 (g) (mean), range: [195-239](g)",210,,195,230,g,,level: T3; severity: not reported,T3,Not reported,compression,laminectomy + extradural application of aneurysm clip (40g force for 1 minute),4 weeks,"fasudil hydrochloride (FH), methylprednisolone sodium succinate (MP)",methylprednisolone sodium succinate,No,30 mg/kg,"5 min, 2, 4 and 6h after injury",,"4 doses, 6h",,intravenously,,functional/behavioral assessment,overall hindlimb impairment (modified CBS),,"reflex responses: toe spread, placing, withdrawal in response to extension, pressure, or brief noxious stimulus; motor acitivity: open-field locomotion, swimming and ability to maintain position on inclined plane","1 day, 1, 2, 3 and 4 weeks post-injury",,yes,no effect,mean CBS was significantly better in the fasudil-treated group than in controls at all time points following SCI (p <0.05); all other responses also better in fasudil compared to control; MP treated rats not shown to improce recovery of any function beyond that seen in controls,histopathological assessment,"myeloperoxidase activty, spinal cord blood flow, total cross-sectional area of spinal cord, area of the lesion, remaining gray and white matter, cavitation, collagenous scarring, loss of myelin staining","4 weeks after injury, 3h after injury (spinal cord blood flow), 24h (myeloperoxidase activity)",not reported,mixed (stats/no stats),"cross-sectional area: no difference between groups (no stats); relative area spared at 2 mm caudal to the center: significantly greater in the fasudil-treated group than in the control, no effect of MP; spinal cord blood flow: no significant difference in spinal cord blood flow between FH and control at 180 minutes after injury; myeloperoxidase activity: increase in MPO activity was significantly inhibited in fasudil-treated rats caudal to the lesion center compared with control rats, but not rostral to the center","anesthesia: sodium pentobarbital (50 mg/kg, IP); no prophylactuc antibiotics; euthanasia: anesthesia with sodium pentobarbital (60 mg/kg, IP), perfused transcardially with saline followed by 10% formaldehyde in a PBS",Fasudil hydrochloride showed promise of effectiveness in promoting neurological recovery after traumatic SCI. Possible mechanisms of this effect include protein kinase inhibition and decreased infiltration by neutrophils,"the use of a laser Doppler flowmeter to measure SCBF in SCI had significant limitation, because the blood flow was measured only on the dorsal surface of the spinal cord, whereas tissue injury was heterogeneous and much of it occurred centrally and in the area away from the dorsal side",use pentobarbital,No,
Lucie,Li et al.,2017,Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury,10.3892/etm.2017.4182,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (erythropoietin),,,rats,Sprague Dawley pathogen-free,"60 (45 for SCI model, 15 for BMSCs for culture)",,,,,,,,female 100%,,,8 weeks old,,,,,,,range: [200-250](g),,,,,,,level: T9; severity: moderate,,,,"dorsal laminectomy + compression SCI by perpendicularly descending a spinal cord impactor (10g impact rod from a height of 5 cm, compress for 10s)",4 weeks,"bone marrow mesenchymal stem cell (BMCS), BMSC+EPO (erythropoeitin)",,,BMSC: 10 microL of BMSC suspension containing 3*10^5; BMSC+EPO: 10 microL of BMSC suspension containing 3*10^5 + 5*10^3 IU/kg ,not reported,,single dose,,multiple,,neurological assessment,"BBB scale, grid walk test",,"BBB: 0=complete loss of locomotive function, 21=normal locomotive function, 120*30cm foam-padded box with a flat bottom; grid walk test: crawl freely in 120*120cm grid structure, divided into 10mm squares, missteps tracked, test terminted when a max of 20 misstpes achieved, if failed to coherent gait in BBB then not put through the grid walk test and instead assigned the maximum score","1, 7, 14, 21 and 28 days after injury",,yes,positive effect,BBB: BMSC+EPO significantly higher scores compared to control (P<0.01) and BMSC alone (P<0.05); grid walk test: BMSC+EPO significantly less missteps from 7-days post-SCI compared with control (p<0.01) and BMSC alone (p<0.05),"histology, western blotting, immunofluorescence","apoptosis (TUNEL assay), expression of vascular endothelial growth factor (VEGF) and brain derived neurotrophic factor (BDNF)",4 weeks after injury,not reported,positive effect,"apoptotic index: BMSC group apaptotic index significantly decreased compared to control (p<0.05), BMSC+EPO significantly decreased compared with control (p<0.01) and BMSC alone (p<0.05); recruitment of BMSCs: stronger signal in BMSC+EPO group; VEGF and BDNF expression: significantly increased in BMSC compared with control (P<0.05), significantly higher in BMSC+EPO compared with control (p<0.01) and BMSC group (0<0.05)",,"EPO can facilitate the recruitment of BMSCs to sites of SCI, increase expression of BDNF and VEGF, and accelerate recovery of neurological function following SCI",not reported,stem cell treatment,,
Lucie,Bracken et al.,1998,Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up - Results of the third National Acute Spinal Cord Injury randomized controlled trial,10.3171/jns.1998.89.5.0699,English,USA,excluded,Out of scope,No control group,,,prospective,human,,499,,,,,,,,not reported,not reported,not reported,not reported,,,,,,,not reported,,,,,,,not reported,,,Not reported,not reported,1 year follow-up,"methylprednisolone (MP), tirilazad mesylate (TM)",methylprednisolone,,"48MP group: 5.4 mg/kg/hour, 24MP group: 5.4 mg/kg/hour; 48TM group: 2.5 mg/kg; all groups: 30 mg/kg bolus of MP","before randomization: all groups got bolus of MP, treatement initiation either before or after 3h post-injury (2 groups compared in analyses)",,"48MP: 48h, 24MP: 24h of MP + 24h of placebo, 48TM: 48h",48MP and 24MP: continuous for 48h; 48TM: bolus infusion for 15-20 minutes every 6h,intravenously,,neurological and functional assessment,"motor assessment, sensory assessment, functional independence measurement","neurological (motor and sensory), functional (general)","motor assessment: 14 muscle roots bilaterally, 0=no contraction, 5=normal, sum ranges from 0=no motor activity, to 70=normal motor function; sensory assessment: 29 spinal cord segments evaluated with pinprick and light touch, 1=sensation absent, 2=dysfunctional (including hyperesthesia), 3=normal, responses ranged from 29=no response in any segment, to 87=all segments were normal; functional independence measure examination","72h (+/- 1h), 6 weeks (42-49 days), 6 months (180-210 days), and 1 year (365-425 days) postinjury",,not reported,mixed effects,"motor: overall, patients treated with 48MP attained better motor recovery than those given 24MP, but the difference was modest (p=0.232), not as strong results for sensory measures, corresponding improvements for patients receiving TM fell between those observed for the two MP-treated groups; FIM scores at 1-year: patients treated with 48MP experienced better functional recovery than those receiving 24MP, higher total and component FIM scores were seen in patients treated with 48MO who had either complete or incomplete injuries, stronger associations in patients treated after 3hours, but none of these associations reached nominal statistical significance",,,,,,,,"for patients in whom MP therapy in initiated within 3h of injury, 24h maintenance is appropriate. Patients starting therapy 3 to 8 hours after injury should be maintained on the regimen for 48h unless there are complicating medical factors","""despite randomization, patients in the 48TM group were more severely injured than those in the MP groups""","no description of population characteristics, described in other NASCIS papers?",,
Lucie,Beckmann et al.,2014,Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide,10.1016/j.lfs.2014.03.033,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury (demyelintaion with ethidium bromide instead),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yanase et al.,1995,Role of N-methyl-D-aspartate receptor in acute spinal cord injury,10.3171/jns.1995.83.5.0884,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (MK-801, a.k.a dizocilpine used, an NMDA receptor antagonist)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Constantini et al.,1994,The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats,10.3171/jns.1994.80.1.0097,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Long Evans,190,29,,,30,,,other groups include GM1 which is not of interest,male 100%,male,100,not reported (adults),,,,,,Adult,range [450-550](gm),,,450,500,g,,level: T10; severity: not reported,T10,multiple,contusion,"laminectomy + weight drop contusion (10g rod dropped from a height of 1.25, 2.50 or 5.00 cm directly onto the cord)",24h,"methylprednisolone sodium succinate (MP), monosialic ganglioside GM1",methylprednisolone sodium succinate,,30 mg/kg,5 min after injury,,single dose,- ,intravenously,,-,-,,-,-,,-,,-,histological assessment (in 25 rats injured with 25.0 gm-cm),"hemorrhage, necrosis, white matter preservation at the lesion center; each section was scored from 0 (none) to 4 (gross or no rim), confluent denotes large ares of hemorrhage or necrosis that occupy less than 50% of the impact site, gross indicates involvement of more than 50%; scores were summed for a total possible histological score of 0 to 12, with higher numbers indicating more severe lesions",24h after injury,not reported,mixed effects (assessment),"MP1 group had histological appearance of the spinal cords was improved compared to those with vehicle and MG30 treatments, MP1 treated rats had a significanlty better histological rank than the MG30-treated rats but did not have a significantly better mean histological rank compared to vehicle-treated rats; mean rank of MG30 group was significantly worse than the vehicle control group; MP1 treated rats had less hemorrhage than the vehicle-treated rats, but their necrosis and white matter scores did not differ significantly; MG20-treated animals had worst lesions, with most cords showing gross hemorrhage , necrosis involving more than 50% of the impact site, and thin rims of preserved white matter","anesthesia: pentobarbital (40 mg/kg IP), euthanasia: pentobarbital (40 mg/kg, IP)",observation that GM1 blocks the neuroprotective effects of MP in SCI offers interesting and new therapeutic opportunities,not reported,"interesting paper looking at interaction between GM1 and MP, use pentobarbital",Yes (drug of interest + drug not of interest),
Lucie,Zendedel et al.,2018,Estrogen Attenuates Local Inflammasome Expression and Activation after Spinal Cord Injury,10.1007/s12035-017-0400-2,English,,included,,,,,,rats,Wistar,>= 66,>= 19,,,>= 19,,,"""For immunohistochemistry staining, 12 animals were assigned randomly to experimental groups with a size of four animals per group. For molecular and biochemical studies, the numbers of animals in the experimental groups were as follows: sham (n=5), SCI 12h (n=5), SCI 24 h (n = 6), SCI 72 h (n = 7), and SCI 72 h plus E2 (n = 7)."", no number for the locomotion assessment",male 100%,male,100,14 weeks old,14,,,,Weeks,,range: [350-400](g),,,350,400,g,,level: T9; severity: not reported,T9,Not reported,compression,"laminectomy + compression (50g weight on exposed spinal cord for 5 min using a rectangular plate longitudinally oriented over the spinal cord, plate had an area of 11.0 mm^2 (2.2*5.0mm)and a concave shape to ensure equal distribution of the pressur eon the exposed tissue)","12, 24 or 72h ",17beta-estradiol (E2),estradiol,,25 microg/kg,immediately after SCI,,up to 72h (depending on when the animal is sacrified),twice daily (every 12h),subcutaneous,,neurological and functional assessment,BBB scale,,"21 levels (0 complete paralysis to 21 normal), scale assesses hind limb movements, body weight support, forelimb to hind limb coordination and whole body movements","before surgery, 12, 24 and 72h after injury",,yes,positive effect,BBB in the SCI+E2 group recovered significantly better compared to SCI vehicle,cell count from staining,"number of of Iba-1-positive (microglia/macrophage), APC-positive (mature oligodendrocyte), Olig2-positive (pan-oligodendrocyte)",72h after injury,not reported,positive effect,"significantly less microglia/macrophages, more pan-oligodendrocytes, more mature oligodendrocytes, in treatment group compared to control group (all closer to the sham group in the treatment group)","anesthesia: isoflurane in O2 (2.o%); postoperative aftercare: saline rehydration (2mL) and Baytril (0.3 mL, SC, twice daily) to prevent urinary infection; euthanasia: transcardially perfused with 4% formaldehyde ",findings support and extend the knowledge of the E2-mediated neuroprotective function during SCI,not reported,use isoflurane,No,
Lucie,Xia et al.,2020,Estrogen improved the regeneration of axons after subcortical axon injury via regulation of PI3K/Akt/CDK5/Tau pathway,10.1002/brb3.1777,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury but subcortical axonal injury instead,,,rats,Sprague Dawley,50,,,,,,,,female 100%,,,not reported ,,,,,,,range: [220-250](g),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yune et al.,2008,Estrogen-Induced Bcl-2 Expression after Spinal Cord Injury Is Mediated through Phosphoinositide-3-Kinase/Akt-Dependent CREB Activation,10.1089/neu.2008.0544,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional/behavioral assessment or histology,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al.,2017,Estrogen-like neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ER alpha,10.1007/s11011-016-9913-z,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (isopsoralen),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pencalet et al.,1993,Thienylphencyclidine protection for the spinal cord of adult rats against extension of lesions secondary to a photochemical injury,10.3171/jns.1993.78.4.0603,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (thienylphencyclidine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al.,2020,"Injectable, anti-inflammatory and conductive hydrogels based on graphene oxide and diacerein-terminated four-armed polyethylene glycol for spinal cord injury repair",10.1016/j.matdes.2020.109092,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Braughler et al.,1987,Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury,10.3171/jns.1987.67.1.0102,English,,included,,,,,,cats,Mongrel,20,7,,3,10,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,range: [2-4](kg),,,2,4,kg,,level: L2; severity: not reported,L2,Not reported,compression,laminectomy + compression (170-gm weight placed extradurally for 5 minutes),30 days,methylprednisolone (MP) administered as the sodium salt of the 21-succinate ester (MPSS),methylprednisolone sodium succinate,Yes,"first bolus: 30 mg/kg, second and third bolus: 15 mg/kg, continuous infusion: 2.5 mg/kg/h; total dose: 165 mg/kg","first bolus: 30 minutes after injury, second bolus: 2h hours later, third bolus: 4h later; then: continuous infusion for the remaining 42h",,48h,-,intravenously,,functional assessment,recovery index (mobility),,"observed and rated the mobility of a freely moving animal in various controlled situations; rating according to 3 categories: mobility (1=walks, very unstable; 4=normal); running (1=falls frequently when running, 3=normal); climbing stairs (1=uses only forelimbs; 5=normal); total score was used as an index of the degree of neurological functional recovery, i.e. recovery index; 12 is the highest obtainable score and denotes normalcy (preinjury function)",weekly for 4 weeks,,yes,positive effect,MPSS-treated cats exhibited a significantly earlier and more complete recovery than the vehicle-treated cats,cavities,maximum cross-sectional area of the cavities (% area = area cavity/area cord *100),30 days after injury,yes,no stats,"(I put positive but it is not explicit): ""correlation coefficient between the recovery index and the size of the cavity in the spinal cord at 4 weeks after injury was -0.88, indicates a strong negative relationship between the degree of recovery and the size of the cavity in the spinal cord (that is, the greater the recovery the smaller the cavity size and vice versa)","anesthesia: pentobarbital sodium (30 mg/kg, IP); muscle paralysis: succinylcholine chloride (1 mg/kg, IV); ventilation: mixture of room air, 95% O2 and 5% CO2; postop: 100'000 U IM doses of procaine penicillin G in dihydrostreptomycin solution; euthanasia: IP sodium pentobarbital (30 mg/kg), warm lactated Ringer's solution with 2cc (10'000 U) sodium heparin and 1% sodium nitrate",resultas demonstrate the therapeutic effectiveness and low incidence of side effects associated with an intensive MP dose regimen for treatment of experimental spinal cord injury,"under the best of circumstances treatment in clinical situation, treatment may be delayed for 1 ot 2 hours following injury; difficult to compare the efficacy of MP regimen reported here with the results from previously reported studies of MP in chronic experimental spinal cord injury studies",3 vehicule-treated cats became critically ill and were excluded from study; use pentobarbital sodium,No,
Lucie,Robertson et al.,1986,Protection against experimental ischemic spinal cord injury,10.3171/jns.1986.64.4.0633,English,,included,,,,,,rabbit,New Zealand,133,31,,,22,,,other groups not of interest and subgroups in the time of aortic occlusion,not reported,not reported,not reported,not reported,,,,,,Not reported,mean: 4.0 (kg); range: [3.5-4.5](kg),4,,3.5,4.5,kg,,level: not reported (occlusion of vessel below the origin of the eft renal artery); severity: not reported,thoracic,multiple,ischemia,"modified no 5 French pediatric Swan-Ganz catheter with pressure-monitoring ports proximal and distal to the baloon was inserted through the right femoral artery into the abdominal aorta, catheter was positioned so taht the tip was below the origin of the left renal artery, ischemia produced by inflation of baloon with 0.4 mL of air ""for desired period"" for 15, 25, 40, 50 or 60 minutes depending on the groups",48h,thiopental; magnesium sulfate; lidocaine; naloxone; thiopental+naloxone,thiopental,,30 mg/kg OR 30 mg diluted to 20 mL with saline OR both,30 minutes before injury and during occlusion respectively,,single dose or duration of occlusion,-,intravenously,,electrophysiology and functional assessment,somatosensory evoked potentials (SSEP); motor function,,"SSEPs: left sciatic nerve exposed, cuff bipolar stimulating electrode placed around; leg-muscle twitch threshold was less than 0.05 mA with pulse duration of 0.1 msec; 2 0.01-in diameter Teflon-coated silver wire recording electrodes inserted lateral to spinous processes of L5 and L6 vertebrae so that tips of wires rested on the laminae; stimuli were square-wave pulses of 0.1 msec duration and 0.5 mA intensity delivered at 3.1 Hz; potentials recorded in a bipolar fashion from L6 to L5 and displayed so that negative potential at L6 with respect to L5 was an upgoing deflection; motor function: function of hindlimbs was graded using the scale: normal (able to hop normally), weak (paretic, spastic hindlimbs, usually abnormal sensation, variable bladder and bowel function), and paralyzed (flaccid paraplegia with absence of sensation and bowel and bladder function).","SSEPs: prior to ischemia, at intervals during ischemia and reperfusion, at 48h after ischemia; motor function: 24h and 48h after injury",,not reported,mixed effects (assessment) + mixed effects (regime),"Pretreatment with lidocaine or magnesium did not result in a signifi- cant improvement in the recovery of the SSEP following ischemia;  Pretreatment with thiopental, and/or naloxone prolonged the period during which failure of the late waves was tolerated by all animals without the development of neurological deficits; thiopental increased the average recovery of N3 and N4 after 25 minutes of ischemia and of N3 and P2 after 40 minutes of ischemia; combination of thiopental and naloxone resulted in no significant improvement over intravenous thiopental alone after 40 and 50 minutes of ischemia;  intravenous thiopental, and naloxone produced no significant change in the length of time during ischemia that the later waves were present nor in the sequence of disappearance of the waves","histology, cavities",neuronal damage; rarefaction; cavitation; total area; gray matter area; lesion area,48h after injury,yes,not reported,no treatment effect reported,"anesthesia: methohexital sodium (IV, up to 10 mg/kg total dose), ketamine (initial dose of 44 mg/kg, followed by 20 mg/kg/h); postop care: saline IP until able to drink, cephalothin (25 mg/kg IM every 12h); euthanasia: anesthesia+left cardiac perfusion with buffered solution of 4% paraformaldehyde and 0.5% glutaraldehyde","thiopental had beneficial effects;  Naloxone increased the duration of ischemia required to produce neurological deficits;  Magnesium pretreatment improved neurological outcome, possibly by improving collateral circulation as the SSEP did not fail completely during aortic occlusion in all animals; Lidocaine was not beneficial",not reported,the different groups are very confusing,No,
Lucie,Robertson et al.,1986,Protection against experimental ischemic spinal cord injury,10.3171/jns.1986.64.4.0633,English,,included,,,,,,rabbit,New Zealand,133,31,,,14,,,other groups not of interest and subgroups in the time of aortic occlusion,not reported,not reported,not reported,not reported,,,,,,Not reported,mean: 4.0 (kg); range: [3.5-4.5](kg),4,,3.5,4.5,kg,,level: not reported (occlusion of vessel below the origin of the eft renal artery); severity: not reported,thoracic,multiple,ischemia,"modified no 5 French pediatric Swan-Ganz catheter with pressure-monitoring ports proximal and distal to the baloon was inserted through the right femoral artery into the abdominal aorta, catheter was positioned so taht the tip was below the origin of the left renal artery, ischemia produced by inflation of baloon with 0.4 mL of air ""for desired period"" for 15, 25, 40, 50 or 60 minutes depending on the groups",48h,thiopental; magnesium sulfate; lidocaine; naloxone; thiopental+naloxone,magnesium sulfate,,100 mg/kg,15 minutes before injury,,single dose,-,intravenously,,electrophysiology and functional assessment,somatosensory evoked potentials (SSEP); motor function,,"SSEPs: left sciatic nerve exposed, cuff bipolar stimulating electrode placed around; leg-muscle twitch threshold was less than 0.05 mA with pulse duration of 0.1 msec; 2 0.01-in diameter Teflon-coated silver wire recording electrodes inserted lateral to spinous processes of L5 and L6 vertebrae so that tips of wires rested on the laminae; stimuli were square-wave pulses of 0.1 msec duration and 0.5 mA intensity delivered at 3.1 Hz; potentials recorded in a bipolar fashion from L6 to L5 and displayed so that negative potential at L6 with respect to L5 was an upgoing deflection; motor function: function of hindlimbs was graded using the scale: normal (able to hop normally), weak (paretic, spastic hindlimbs, usually abnormal sensation, variable bladder and bowel function), and paralyzed (flaccid paraplegia with absence of sensation and bowel and bladder function).","SSEPs: prior to ischemia, at intervals during ischemia and reperfusion, at 48h after ischemia; motor function: 24h and 48h after injury",,not reported,no effect,"Pretreatment with lidocaine or magnesium did not result in a signifi- cant improvement in the recovery of the SSEP following ischemia;  Pretreatment with thiopental, and/or naloxone prolonged the period during which failure of the late waves was tolerated by all animals without the development of neurological deficits; thiopental increased the average recovery of N3 and N4 after 25 minutes of ischemia and of N3 and P2 after 40 minutes of ischemia; combination of thiopental and naloxone resulted in no significant improvement over intravenous thiopental alone after 40 and 50 minutes of ischemia;  intravenous thiopental, and naloxone produced no significant change in the length of time during ischemia that the later waves were present nor in the sequence of disappearance of the waves","histology, cavities",neuronal damage; rarefaction; cavitation; total area; gray matter area; lesion area,48h after injury,yes,not reported,no treatment effect reported,"anesthesia: methohexital sodium (IV, up to 10 mg/kg total dose), ketamine (initial dose of 44 mg/kg, followed by 20 mg/kg/h); postop care: saline IP until able to drink, cephalothin (25 mg/kg IM every 12h); euthanasia: anesthesia+left cardiac perfusion with buffered solution of 4% paraformaldehyde and 0.5% glutaraldehyde","thiopental had beneficial effects;  Naloxone increased the duration of ischemia required to produce neurological deficits;  Magnesium pretreatment improved neurological outcome, possibly by improving collateral circulation as the SSEP did not fail completely during aortic occlusion in all animals; Lidocaine was not beneficial",not reported,the different groups are very confusing,No,
Lucie,Robertson et al.,1986,Protection against experimental ischemic spinal cord injury,10.3171/jns.1986.64.4.0633,English,,included,,,,,,rabbit,New Zealand,133,31,,,5,,,other groups not of interest and subgroups in the time of aortic occlusion,not reported,not reported,not reported,not reported,,,,,,Not reported,mean: 4.0 (kg); range: [3.5-4.5](kg),4,,3.5,4.5,kg,,level: not reported (occlusion of vessel below the origin of the eft renal artery); severity: not reported,thoracic,multiple,ischemia,"modified no 5 French pediatric Swan-Ganz catheter with pressure-monitoring ports proximal and distal to the baloon was inserted through the right femoral artery into the abdominal aorta, catheter was positioned so taht the tip was below the origin of the left renal artery, ischemia produced by inflation of baloon with 0.4 mL of air ""for desired period"" for 15, 25, 40, 50 or 60 minutes depending on the groups",48h,thiopental; magnesium sulfate; lidocaine; naloxone; thiopental+naloxone,lidocaine,,160 mg/kg,"5 minutes before injury and, during occlusion and for 1h after deflation of the balloon respectively",,single dose,-,intravenously,,electrophysiology and functional assessment,somatosensory evoked potentials (SSEP); motor function,,"SSEPs: left sciatic nerve exposed, cuff bipolar stimulating electrode placed around; leg-muscle twitch threshold was less than 0.05 mA with pulse duration of 0.1 msec; 2 0.01-in diameter Teflon-coated silver wire recording electrodes inserted lateral to spinous processes of L5 and L6 vertebrae so that tips of wires rested on the laminae; stimuli were square-wave pulses of 0.1 msec duration and 0.5 mA intensity delivered at 3.1 Hz; potentials recorded in a bipolar fashion from L6 to L5 and displayed so that negative potential at L6 with respect to L5 was an upgoing deflection; motor function: function of hindlimbs was graded using the scale: normal (able to hop normally), weak (paretic, spastic hindlimbs, usually abnormal sensation, variable bladder and bowel function), and paralyzed (flaccid paraplegia with absence of sensation and bowel and bladder function).","SSEPs: prior to ischemia, at intervals during ischemia and reperfusion, at 48h after ischemia; motor function: 24h and 48h after injury",,not reported,no effect,"Pretreatment with lidocaine or magnesium did not result in a signifi- cant improvement in the recovery of the SSEP following ischemia;  Pretreatment with thiopental, and/or naloxone prolonged the period during which failure of the late waves was tolerated by all animals without the development of neurological deficits; thiopental increased the average recovery of N3 and N4 after 25 minutes of ischemia and of N3 and P2 after 40 minutes of ischemia; combination of thiopental and naloxone resulted in no significant improvement over intravenous thiopental alone after 40 and 50 minutes of ischemia;  intravenous thiopental, and naloxone produced no significant change in the length of time during ischemia that the later waves were present nor in the sequence of disappearance of the waves","histology, cavities",neuronal damage; rarefaction; cavitation; total area; gray matter area; lesion area,48h after injury,yes,not reported,no treatment effect reported,"anesthesia: methohexital sodium (IV, up to 10 mg/kg total dose), ketamine (initial dose of 44 mg/kg, followed by 20 mg/kg/h); postop care: saline IP until able to drink, cephalothin (25 mg/kg IM every 12h); euthanasia: anesthesia+left cardiac perfusion with buffered solution of 4% paraformaldehyde and 0.5% glutaraldehyde","thiopental had beneficial effects;  Naloxone increased the duration of ischemia required to produce neurological deficits;  Magnesium pretreatment improved neurological outcome, possibly by improving collateral circulation as the SSEP did not fail completely during aortic occlusion in all animals; Lidocaine was not beneficial",not reported,the different groups are very confusing,No,
Lucie,Robertson et al.,1986,Protection against experimental ischemic spinal cord injury,10.3171/jns.1986.64.4.0633,English,,included,,,,,,rabbit,New Zealand,133,31,,,9,,,other groups not of interest and subgroups in the time of aortic occlusion,not reported,not reported,not reported,not reported,,,,,,Not reported,mean: 4.0 (kg); range: [3.5-4.5](kg),4,,3.5,4.5,kg,,level: not reported (occlusion of vessel below the origin of the eft renal artery); severity: not reported,thoracic,multiple,ischemia,"modified no 5 French pediatric Swan-Ganz catheter with pressure-monitoring ports proximal and distal to the baloon was inserted through the right femoral artery into the abdominal aorta, catheter was positioned so taht the tip was below the origin of the left renal artery, ischemia produced by inflation of baloon with 0.4 mL of air ""for desired period"" for 15, 25, 40, 50 or 60 minutes depending on the groups",48h,thiopental; magnesium sulfate; lidocaine; naloxone; thiopental+naloxone,naloxone,,2.5 mg/kg and 0.25 mg/kg/min,"thiopental: 30 minutes before injury and during occlusion respectively; magnesium sulfate: 15 minutes before injury; lidocaine: 15 min before injury; naloxone: 5 minutes before injury and, during occlusion and for 1h after deflation of the balloon respectively; thiopental+naloxone: 30 minutes before injury and 5 minutes before injury and, during occlusion and for 1h after deflation of the balloon respectively",,single dose + during occlusion + 1h after deflation of balloon,-,intravenously,,electrophysiology and functional assessment,somatosensory evoked potentials (SSEP); motor function,,"SSEPs: left sciatic nerve exposed, cuff bipolar stimulating electrode placed around; leg-muscle twitch threshold was less than 0.05 mA with pulse duration of 0.1 msec; 2 0.01-in diameter Teflon-coated silver wire recording electrodes inserted lateral to spinous processes of L5 and L6 vertebrae so that tips of wires rested on the laminae; stimuli were square-wave pulses of 0.1 msec duration and 0.5 mA intensity delivered at 3.1 Hz; potentials recorded in a bipolar fashion from L6 to L5 and displayed so that negative potential at L6 with respect to L5 was an upgoing deflection; motor function: function of hindlimbs was graded using the scale: normal (able to hop normally), weak (paretic, spastic hindlimbs, usually abnormal sensation, variable bladder and bowel function), and paralyzed (flaccid paraplegia with absence of sensation and bowel and bladder function).","SSEPs: prior to ischemia, at intervals during ischemia and reperfusion, at 48h after ischemia; motor function: 24h and 48h after injury",,not reported,mixed effects (assessment),"Pretreatment with lidocaine or magnesium did not result in a signifi- cant improvement in the recovery of the SSEP following ischemia;  Pretreatment with thiopental, and/or naloxone prolonged the period during which failure of the late waves was tolerated by all animals without the development of neurological deficits; thiopental increased the average recovery of N3 and N4 after 25 minutes of ischemia and of N3 and P2 after 40 minutes of ischemia; combination of thiopental and naloxone resulted in no significant improvement over intravenous thiopental alone after 40 and 50 minutes of ischemia;  intravenous thiopental, and naloxone produced no significant change in the length of time during ischemia that the later waves were present nor in the sequence of disappearance of the waves","histology, cavities",neuronal damage; rarefaction; cavitation; total area; gray matter area; lesion area,48h after injury,yes,not reported,no treatment effect reported,"anesthesia: methohexital sodium (IV, up to 10 mg/kg total dose), ketamine (initial dose of 44 mg/kg, followed by 20 mg/kg/h); postop care: saline IP until able to drink, cephalothin (25 mg/kg IM every 12h); euthanasia: anesthesia+left cardiac perfusion with buffered solution of 4% paraformaldehyde and 0.5% glutaraldehyde","thiopental had beneficial effects;  Naloxone increased the duration of ischemia required to produce neurological deficits;  Magnesium pretreatment improved neurological outcome, possibly by improving collateral circulation as the SSEP did not fail completely during aortic occlusion in all animals; Lidocaine was not beneficial",not reported,the different groups are very confusing,No,
Lucie,Robertson et al.,1986,Protection against experimental ischemic spinal cord injury,10.3171/jns.1986.64.4.0633,English,,included,,,,,,rabbit,New Zealand,133,31,,,8,,,other groups not of interest and subgroups in the time of aortic occlusion,not reported,not reported,not reported,not reported,,,,,,Not reported,mean: 4.0 (kg); range: [3.5-4.5](kg),4,,3.5,4.5,kg,,level: not reported (occlusion of vessel below the origin of the eft renal artery); severity: not reported,thoracic,multiple,ischemia,"modified no 5 French pediatric Swan-Ganz catheter with pressure-monitoring ports proximal and distal to the baloon was inserted through the right femoral artery into the abdominal aorta, catheter was positioned so taht the tip was below the origin of the left renal artery, ischemia produced by inflation of baloon with 0.4 mL of air ""for desired period"" for 15, 25, 40, 50 or 60 minutes depending on the groups",48h,thiopental; magnesium sulfate; lidocaine; naloxone; thiopental+naloxone,thiopental + naloxone,,30 mg/kg (thiopental) + 2.5 mg/kg and 0.25 mg/kg/min (naloxone),"30 minutes before injury and 5 minutes before injury and, during occlusion and for 1h after deflation of the balloon respectively",,"single dose (thiopental), naloxone similar as when taken alone",-,intravenously,,electrophysiology and functional assessment,somatosensory evoked potentials (SSEP); motor function,,"SSEPs: left sciatic nerve exposed, cuff bipolar stimulating electrode placed around; leg-muscle twitch threshold was less than 0.05 mA with pulse duration of 0.1 msec; 2 0.01-in diameter Teflon-coated silver wire recording electrodes inserted lateral to spinous processes of L5 and L6 vertebrae so that tips of wires rested on the laminae; stimuli were square-wave pulses of 0.1 msec duration and 0.5 mA intensity delivered at 3.1 Hz; potentials recorded in a bipolar fashion from L6 to L5 and displayed so that negative potential at L6 with respect to L5 was an upgoing deflection; motor function: function of hindlimbs was graded using the scale: normal (able to hop normally), weak (paretic, spastic hindlimbs, usually abnormal sensation, variable bladder and bowel function), and paralyzed (flaccid paraplegia with absence of sensation and bowel and bladder function).","SSEPs: prior to ischemia, at intervals during ischemia and reperfusion, at 48h after ischemia; motor function: 24h and 48h after injury",,not reported,no effect,"Pretreatment with lidocaine or magnesium did not result in a signifi- cant improvement in the recovery of the SSEP following ischemia;  Pretreatment with thiopental, and/or naloxone prolonged the period during which failure of the late waves was tolerated by all animals without the development of neurological deficits; thiopental increased the average recovery of N3 and N4 after 25 minutes of ischemia and of N3 and P2 after 40 minutes of ischemia; combination of thiopental and naloxone resulted in no significant improvement over intravenous thiopental alone after 40 and 50 minutes of ischemia;  intravenous thiopental, and naloxone produced no significant change in the length of time during ischemia that the later waves were present nor in the sequence of disappearance of the waves","histology, cavities",neuronal damage; rarefaction; cavitation; total area; gray matter area; lesion area,48h after injury,yes,not reported,no treatment effect reported,"anesthesia: methohexital sodium (IV, up to 10 mg/kg total dose), ketamine (initial dose of 44 mg/kg, followed by 20 mg/kg/h); postop care: saline IP until able to drink, cephalothin (25 mg/kg IM every 12h); euthanasia: anesthesia+left cardiac perfusion with buffered solution of 4% paraformaldehyde and 0.5% glutaraldehyde","thiopental had beneficial effects;  Naloxone increased the duration of ischemia required to produce neurological deficits;  Magnesium pretreatment improved neurological outcome, possibly by improving collateral circulation as the SSEP did not fail completely during aortic occlusion in all animals; Lidocaine was not beneficial",not reported,the different groups are very confusing,Yes (drug of interest + drug of interest),
Lucie,Kumar et al.,2014,Cur(Que)min: A neuroactive permutation of Curcumin and Quercetin for treating spinal cord injury,10.1016/j.mehy.2014.01.019,English,,excluded,Non-sci population,,"Out of scope: no SCI, no drug of interest",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ravikumar et al.,2004,"Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma",10.1016/j.molbrainres.2004.02.018,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/histological assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bracken et al.,1985,Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury study,10.3171/jns.1985.63.5.0704,English,USA,excluded,Out of scope,No control group,,,prospective,human,,256,,,,,,,,not reported,not reported,not reported,not reported,,,,,,,not reported,,,,,,,,,,,,not reported,methylprednisolone,methylprednisolone,Yes,100 or 1000 mg for bolus; 25 or 250 mg for maintenance,bolus immediately after randomisation over 10-minute period,,10 days,"every 6h, over 1 minute using a buretrol",intravenously,,neurologoical parameters,"motor function, response to pinprick, light touch sensation",neurological (motor and sensory),"motor function: 14 muscles evaluated from 1=normal function to 6=no contraction, derived bilaterally for each patient + five-point scale 1=quadriplegic if most cephalad muscle with no contraction was the first dorsal interosseus representing spinal segements C8 and T1 or higher and no distal muscles showed contraction to 5=minimal function; PP and LT: bilaterally, 1=normal to 3=absent + 5-point scale: 1=analgesic >= T1 and anesthetic>= T1 if PP and LT  were absent at T1 or above and ina ll distal segment to 5= normal; completeness of neurological deficit: 1=quadriplegic with total sensory loss; 5=paretic with variable sensory loss; changes in neurological status: substraction of the expanded neurological scores at admission from 1year scores","at admission, 6 weeks (30-90 days), 6 months (170-240 days), 1 year (365-425 days)",,yes,no effect,"No significant difference was observed in neurological recovery of motor function, PP response or touch sensation 1 year after injurybetween the 2 treatment groups, after adjustement for other potentially confounding factors",-,-,-,-,,-,exclusion if patients had received more than 100 mg MPSS or its equivalent prior to admission,"No significant difference was observed in neurological recovery of motor function, PP response or touch sensation 1 year after injurybetween the 2 treatment groups, after adjustement for other potentially confounding factors",not reported,"one exclusion criterion was ""the decision of partipating physicians, at their discretion, to exclude certain patients; methylprednisolone study",,
Lucie,Ford et al.,1984,Failure of tetracaine to reverse spinal cord injury in the cat,10.3171/jns.1984.60.6.1269,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kobrine et al.,1984,Effect of intravenous lidocaine on experimental spinal cord injury,10.3171/jns.1984.60.3.0595,English,,included,,,,,,cats,Not reported,10,5,,,5,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,"mean: 3.8 (0.87, kg), range: [2.85-5.9](kg)",3.8,0.87,2.85,5.9,kg,,level: T6; severity: not reported,T6,Not reported,compression,"laminectomy + compression (No. 3 French Fogarty catheter inserted into epidural space, with tip resting on right side of T6; quick inflation of water-filled balloon catheter to a volume of 0.25cc for 15 sec; then balloon quickly deflated and catheter removed)",4h,lidocaine,lidocaine,,"1.5 mg/kg, 3 mg/kg, 1 mg/kg (sequentially)",15 minutes after injury,,63 minutes infusion,"dose 1 for 3 minutes, dose 2 for 30 minutes, dose 3 for 30 minutes",intravenously,,electrophysiology,somatosensory evoked responses (SER),,stimulus (8 V for 1msec at 1Hz) to left sciatic nerve; recording from temporal and indifferent (frontal) screw electrodes; ,"immediately before injury, at 1 to 3 seconds during the 15-sec balloon compression, and at 5 to 15 minute intervals for 4h thereafter",,not reported,no stats,"one lidocaine-treated animal had significant return of SER, one lidocaine-treated animal had significant transient return of the SER at 60 and 90 minutes, the remaining two lidocaine-treated animals demonstrated no significant return of the SER; no stats reported comparing the control and treatment groups, only compare the pre and post injury",histology (qualitative),"degree of hemorrhage, graded as mild, moderate and severe",4h atfer injury,yes,no stats,lidocaine-treated had significantly less hemorrhage than untreated controls; number of petechial hemorrhages and the extent of central hemorrhage throughout the region of compression was reduced in lidocaine-treated animals,"anesthesia: ketamine HCl (0.15 mg/kg, IM), alpha-chloralose (80 to 100 mg/kg, IV) dissolved in warm saline, chloralose anesthesia supplemented with nitrous oxide and/or halothane; pancuronium bromide (0.1 mg/kg, IV) to control ventilation and movement artifast during surgery; euthanasia: somlethal (IV)",results suggest that systemic lidocaine administration has a significant beneficial effect in the treatment of acute spinal cord injury,not reported,personal limitation: very low sample size; use ketamine,No,
Lucie,Hallenbeck et al.,1983,"Combined PGI<inf>2</inf>, indomethacin, and heparin improves neurological recovery after spinal trauma in cats",10.3171/jns.1983.58.5.0749,English,,included,,,,,,cats,Conditioned,18,6,,,6,,,other group not of interest n = 6,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [2.5-3.5](kg),,,2.5,3.5,kg,,level: C7; severity: moderately severe spastic quadriparesis (incomplete),C7,moderate - severe,contusion,laminectomy + modified allen method (weight 20gm dropped from 30cm through guide tube onto 10sq mm impact plate that rests on the exposed dura),6 weeks,"naloxone, indomethacin+heparin+PGI2",naloxone,,2 mg/kg,1h after injury,,4h,continuous,intravenously,,neurological functions,modified five-point scale developed by Tarlov,,forelimb and hindlimb rated separately as follows: 0=absence of voluntary movement; 1=spontaneous movement but inbaility to suuport weight; 2=ability to support weight but not able to walk; 3=ability to walk but with marked spasticity or ataxia or both; 4=ability to run but with mild spaticity or ataxia; 5=normal motor function; score considered as total sum,weekly,,yes,no effect,"naloxone: no significantly different from control (p=0.06), indomethacin+heparin+PIG2: significantly different from control (p<0.05)","histology, cavities","degree of hemorrhage, cavity formation, demyelination",6 weeks,not reported,no stats,"no significant difference between treatment groups, no significant correlation between hitological and neurological scores; no comparison between the treatment and control groups","anesthesia: pentobarbital (30 mg/kg), paralyzed gallamine triethiodide; euthanasia: pentobarbital, 4% glutaraldehyde and cacodylate buffer ","combination of PGI2, indomethacin and heparin improved neurological outcome to the same general degree as naloxone",different design compared to previous studies: cervical injuries and incomplete,histology: no comparison between treatment and control groups; use pentobarbital,Yes (drug of interest + drug not of interest),
Lucie,Kandhare et al,2014,Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury,10.1007/s11418-014-0840-1,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (chrysin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Watanabe et al.,2012,Evaluation of the Neuroprotective Effect of Minocycline in a Rabbit Spinal Cord Ischemia Model,10.1053/j.jvca.2012.05.003,English,,included,,,,,,rabbit,New Zealand,28,8,,,16,,,sham n = 4,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [2.7-3.0](kg),,,2.7,3,kg,,level: not reported (occlusion immediately distal to the left renal artery); severity: not reported,thoracic,Not reported,ischemia,ischemia (occlusion of the infrarenal aorta for 15 minutes),72h,minocycline,minocycline,,10 mg/kg,1h or 3h after injury,,60h,every 12h,intravenously,,neurological,Tarlov scoring,,"5-point grading scale (0, paraplegic with no lower extremity function; 4, normal motor function)","24, 48 and 72h after reperfusion",,yes,mixed effects (timing),"score significantly higher in M1 group (onset of treatment 1h after injury) compared with those in the control group, no significant differences in Tarlov score between the control and M3 group (onset 3h after injury)",histology and vacuoles,gray matter injury: number of normal neurons; white matter injury: percentage of areas of vacuolation,72h,yes,mixed effects (assessment) + mixed effects (timing),"number of normal neuros in M1 significantly larger then in the control group, no significant difference between M1 and M3 groups; percentages of areas of vacuolation no significantly different between the 3 injures groups (control and 2 treatment schemes)","anesthesia: 5% isoflurane, ringer's solution (10 ml/kg/h), fentanyl (50 microg/kg, IV); euthanasia: thiopental (50 mg/kg, IP), 5% isoflurane, cold heparinised physiologic saline transcardially (1000 mL), 500 mL 4% paraformaldehyde",minocycline administration beginning at 1h after reperfusion improved hind-limb motor dysfunction and attenuated gray matter injury in a rabbit spinal cord ischemia model,"dose: minocycline might have been effective in the M3 group if it had been administered at a higher dose or in a different regimen for administration; severity: resultas may have changed depending on the severity of SCI; unckear wether the administration of minocycline before ischemia would be more effective than after reperfusion (not tested); evaluation of white matter at > 4 days but not at 72h after reperfusion might be appropriate; demonstration of neuroprotection in animal species does not necessarily translate to humans; concerning the long-term outcome, evaluation of motor function and histologic changes after a long-term interval after reperfusion would be necessary","use isoflurane, thiopental, fentanyl, heparin, saline",No,
Lucie,Yücel et al.,2006,Evaluation of the neuroprotective effects of citicoline after experimental spinal cord injury: Improved behavioral and neuroanatomical recovery,10.1007/s11064-006-9075-1,English,,included,,,,,,rats,Wistar,60,12,,,12,,,"2 groups not of interest n = 12 each, sham n = 12",male 100%,male,100,not reported (adults),,,,,,Adult,range: [210-270](g),,,210,270,g,,level: T7-10; severity: not reported,T7 - T10,Not reported,contusion,"laminectomy + weight-drop (50g/cm impact to the doral surface of the spinal cord, stainless steel rod 3mm diameter tip weighing 5g, dropped vertical though 10cm guided tube)","24h (biochemical analysis), 6 weeks (neurobehavioral and histopathological analyses)","citicoline, methylprednisolone and combination of both",methylprednisolone,No,30 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological and functional assessment,"motor function score (modified Gale), inclined plane score",,"motor function score: slight modification of motor score by Gale et al, move freely in open field 0.7*0.9m, observed at least one minute by 2, movements in hip, knee and ankle joints were recorded, 0=no movement of hind linm to 6=normal walking; inclined plane score: measure the max angle at which the animal can support its weight on an inclined plane were measured raging from 0 to 90 degrees, animals placed transversely on the inclined plane, highest angle that rats could maintain their position for 5 seconds were recorded",weekly,Yes,yes,positive effect,"significant recovery in treatment groups compared to control group (P<0.002 in all 3 cases), no difference between treatment (citicoline, methylprednisolone and combination)",histopathological evaluation,injured area: percentage of the whole cross-sectional spinal cord area,6 weeks,not reported,positive effect,treatment groups had significantly reduced contused areas when compared to control group (p < 0.002 in all 3 cases); no significant difference between the 3 treatment groups ,"anesthesia: xylasine (10 mg/kg, IP), ketamine hydrochloride (50 mg/kg); suture : 6-0 vicryl; early postop: 3 mL saline IP; euthanasia: propofol (50 mg/kg IP), intracardiac perfusion with isotonic saline for 5 min followed by 10% formaldehyde for 5 min",this study demonstrates that citicoline is as effective as methylprednisolone. The efficacy of citicoline combined with methylprednisolone is not superior to either citicoline or methylprednisolone alone.,not reported,use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Gürkan et al.,2020,Evaluation of the neuroprotective effects of ozone in an experimental spine injury model.,10.3171/2020.2.SPINE191439,English,,included,,,,,,rats,Wistar,31,7,,,7,,,"sham n = 3, 2 groups not of interest n = 7 each ",female 100%,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T7-10; severity: not reported,T7 - T10,Not reported,compression,"laminectomy + aneurysm clip (1 min, 70g force in accordance with the model developed by Tator and Rivlin)",1 week,"ozone, methylprednisolone and combination of both",methylprednisolone,No,30 mg/kg,1h after injury,,single dose,-,intraperitoneally,,"behavioral, functional, neurological","inclined plane test, BBB scale, modified Tarlov scale, Drummond and Moore criteria",,"inclined plane test: highest angle at which the subject can stand on the table without falling for 5 seconds is considered the inclined plane angle, BBB scale: from 0 to 21 points, since follow-up was performed only during the acute period after SCI, only point scores from 0 to 7, which are used in the BBB scale to evaluate the early phase of recovery, were taken into consideration; modified Tarlov scale: open field behaviors, 1=no movement, 5=normal motor movement; Drummond and Moore criteria: functional improvements, 0=paraplegia no motor function in the lower extremities, 4=normal motor function","days 1, 3, 5 and 7 after injury",No,not reported,no stats,"compared different days assessed within each group but not comparison between groups (e.g. no comparison between control and treatment groups); combination of treatment, significant differences were found between days 1 and 7 for all of the tests",histopathological evaluation,"semi quantitative rating scale for edema, tisuse necrosis, hemorrhage and inflammation, without lower score being better",7 days,not reported,no stats,"combination of treatment had significantly lower scores than treatment taken alone, no comparison between treatment with control groups","anesthesia: ketamine HCl (50 mg/kg, IP), xylazine (5 mg/kg, IP); postop care: cefazolin sodium (40 mg/kg/day, IP) to prevent surgical field and urinary tract infection during the first 3 days after surgery","combined application of methylprednisolone and ozone was found to have a greater antiinflammatory effect, hasten clinical recovery, and increase histological recovery compared with methyl- prednisolone therapy alone","number and types of animal used were determined by ethics committee, result might have had more variability if more or different types of animals were used, medicine administered IP and spinal trauma might have cuased minor hemorrahge and cannot determine if these minor hemorrhages altered the results of the study","explicit limitation section, no proper comparison between treatment and control groups; use ketamine",Yes (drug of interest + drug not of interest),
Lucie,Schwartz et al.,2001,Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: Improved behavioral and neuroanatomical recovery with riluzole,10.3171/spi.2001.94.2.0245,English,,included,,,,,,rats,Wistar,60,15,,,15,,,2 other groups n = 15 each not of interest,female 100%,female,0,not reported (adults),,,,,,Adult,range: [225-280](g),,,225,280,g,,level: C7-T1; severity: severe,C7 - T1,severe,compression,laminectomy + extradurally compressed for 1 minute with aneurysm clip with closing force of 53g,7 weeks,"riluzole, phenytoin, CNS5546A (novel Na+ channel blocker)",phenytoin,,30 mg/kg,15 minutes after injury,,single dose,-,intraperitoneally,,"behavioral, functional, neurological","BBB locomotor rating scale, inclined plane test",,"BBB: open-fiel, quantify hindlimb joint movement and motor coordination, from 0=no movement to 21=normal locomotion performance, scores averaged across right and left; inclined plane test: maximal angle at which the animal could maintain its position for 5 sec",weekly for 7 weeks,,not reported,no effect,"riluzole group performed significantly better for BBB and inclined test compared to control and other treatment groups, other treatment groups were not significantly different from the control group",histopathological and lesion site analysis,"morphometrical and volumetrical assessements: area of the cavity and residual tissue, volumetric proportion for white matter, gray matter and cavity",7 weeks,not reported,positive effect,"all treatments significantly increased residual tissue (only at epicenter) and decreased caivty ares compared with the control (p < 0.05), greater gray matter and reduced cavity volumes emerged with riluzole having the greatest effect on both volumes over all other treatments",anesthesia: halothane 1.5%,"Systemic Na+ channel blockers, in particular riluzole, can confer significant neuroprotection after in vivo SCI and result in behavioral recovery and sparing of both gray and white matter",not reported,,No,
Lucie,Tator et al.,1983,Effect of triiodo-L-thyronine on axonal regeneration in the rat spinal cord after acute compression injury,10.3171/jns.1983.58.3.0406,English,,included,,,,,,rats,Wistar,56,18,10,,19,9,,,female 100%,female,0,not reported,,,,,,Not reported,not reported,,,,,,Not reported,level: T7; severity: not reported,T7,Not reported,compression,modified aneurysm clip for 1 min with force of 174g,4 weeks or 12 weeks,triiodo-L-thyronine (T3),liothyronine,,5 microg/kg,not reported,,4 weeks,daily,intraperitoneally,,functional,inclined plane test,,"record highest angle from the horizontal at which an animal can maintain its position on an inclined plane for 5 sec, normal animal score better than 80 degrees on the plane",weekly,,yes,no effect,no significant differences in recovery between the treamtent and control group (p>0.05) as determined by the performance of the animals on the inclined plane,histopathological assessment,"axon count, axon degeneration, necrosis, cavities",4 weeks and 12 weeks,yes,no effect,at neither 4 nor 12 weeks was there any significant difference between the treamtent and control groups in axon counts; the pathological changes were similar in the treatment and control groups,any urinary tract infections were treated with IM gentamicin,present experiment showed no beneficial effect from IP administered T3 on functional or histological recoveryof rats after SCI,not reported,use gentamicin,No,
Lucie,Young et al.,1982,"Effect of high-dose corticosteroid therapy on blood flow, evoked potentials, and extracellular calcium in experimental spinal injury",10.3171/jns.1982.57.5.0667,English,,included,,,,,,cats,Not reported,15,5,,,10,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,not reported,,,,,,Not reported,"level: T9, severity: severe",T9,severe,contusion,laminectomy + 400 gm-cm contusion,not reported,methylprednisolone sodium succinate,methylprednisolone sodium succinate,Yes,15 mg/kg or 30 mg/kg,45 minutes after injury,,single dose,-,intravenously,,electrophysiology,somatosensory evoked potentials,,"sciatic nerve stimulation, recorded bipolarly from epidural elctrodes placed over somatosensory cortex; evoked potential was judged on the basis of absence or presence of an early positive peak with latency of 13 to 15 msec","pre-injury, then assessed hourly after injury for 4h",,not reported,no stats,"group with 15 mg/kg: mean blood flows were significantly higher by 3 hours compared to control, 80% of cats had evoked potentials at 4h after injury, compared to none of the controls; group with 30 mg/kg: 60% of the cats had evoked potentials by 2h, 80% by 3h and 100% by 4h",-,-,-,-,,-,not reported,"large doses of MP given 45 minutes after spinal contusion, improved lateral column blood flow and preserved evoked-potentials that were lsot in control untreated cats",not reported,,No,
Lucie,Kaya et al.,2020,Examination of neuroprotective effects of levetiracetam in the model with experimental brain and cervical spinal cord trauma,10.19193/0393-6384_2020_1_115,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Sprague Dawley,24,6,,,6,,,sham n = 6,female 100%,female,0,6 to 8 weeks,,,6,8,Weeks,,range: [250-320](g),,,250,320,g,,level: T6-T10; severity: not reported,T6 - T10,Not reported,compression,laminectomy + aneurysm clip (dura and spinal cord were completely clipped),24h,"methylprednisolone, levetiracetam",methylprednisolone,,30 mg/kg,not reported,,single dose,-,intraperitoneally,,-,-,,-,-,,-,,-,histopathological evaluation,"HE preparation: necrosis, spread hemorrhage, glial cell reaction and inflammation of inflammatory cells; TUNEL assay",24h after injury,not reported,mixed (stats/no stats),"minimal edema, gray and white substance findings close to normal which were limited with some areas in both treatment groups; significantly fewer TUNEL positive cells in treatment group compared to control","surgery: local antispepsis with polyninyl pyrrolidone iodine, euthanasia: high dose of IP anesthetic","In spinal cord trauma formed rats, it was detected that Levetiracetam application increased histopathological recovery.",not reported,"no functional assesmsnet, minimal info on histopathology",No,
Lucie,Kaya et al.,2020,Examination of neuroprotective effects of levetiracetam in the model with experimental brain and cervical spinal cord trauma,10.19193/0393-6384_2020_1_115,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Sprague Dawley,24,6,,,6,,,sham n = 6,female 100%,female,0,6 to 8 weeks,,,6,8,Weeks,,range: [250-320](g),,,250,320,g,,level: T6-T10; severity: not reported,T6 - T10,Not reported,compression,laminectomy + aneurysm clip (dura and spinal cord were completely clipped),24h,"methylprednisolone, levetiracetam",levetiracetam,,50 mg/kg,not reported,,single dose,-,intraperitoneally,,-,-,,-,-,,-,,-,histopathological evaluation,"HE preparation: necrosis, spread hemorrhage, glial cell reaction and inflammation of inflammatory cells; TUNEL assay",24h after injury,not reported,mixed (stats/no stats),"minimal edema, gray and white substance findings close to normal which were limited with some areas in both treatment groups; significantly fewer TUNEL positive cells in treatment group compared to control","surgery: local antispepsis with polyninyl pyrrolidone iodine, euthanasia: high dose of IP anesthetic","In spinal cord trauma formed rats, it was detected that Levetiracetam application increased histopathological recovery.",not reported,"no functional assesmsnet, minimal info on histopathology",No,
Lucie,Luo et al.,2004,Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol,10.1016/j.neulet.2004.02.027,English,,excluded,Out of scope,No assessments of interest,"Out of scope: no outcome of interest (functional or histopathology, focus is on study of oxidative stress response)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Agari et al.,2010,Exercise exerts neuroprotective effects on Parkinson's disease model of rats,10.1016/j.brainres.2009.10.075,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Saganova et al.,2008,Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat,10.1016/j.neulet.2008.01.041,English,,included,,,,,,rats,Wistar,35,11,,,24,,,,male 100%,male,100,not reported,,,,,,Not reported,not reported,,,,,,Not reported,level: T8-T9; severity: not reported,T8 - T9,Not reported,compression,"small hole (1.5 mm diameter) drilled in the T10 vertebral arch with a dental drill, fogarty catheter connected to a 50 microL Hamilton syringe rapidly inflated with 12.5 microL of distilled water for 5 min",28 days,monocycline hydrochloride,minocycline,,90 mg/kg then 45 mg/kg,1h after injury,,"group1: 1 day, group2 : 5 days",every 12h,intraperitoneally,,"behavioral, functional, neurological",BBB scale,,"range from 0 to 21, 0 = no locomotors activity and 21 = normal performance","24h after injury, then weekly for 4 weeks",,not reported,no effect,"no statistical difference between group with 1 day tretament and placebo; 5day treamtent group worse than placebo at day 14 and 21, but no significant difference betwenn 5day treatment group and placebo at day 28",morphometric analysis,distribution of spared tissue,28 days after injury,not reported,mixed effects,"1 and 5 day treatment increased sparing of the spianl cord gray and white matter, which was significant in rostral direction beginning 2mm from the lesion epicenter; both short and long-term minocycline administration did not reduce spinal cord white and gray matter damage caudal to the lesion epicenter",anesthesia: halothane 1.5-2% in air delivered via face mask,data suggest that minocycline has limited neuroprotective effects on reduction of damaged spinal cord parenchyma following balloon-compression SCI,not reported,"unstructured paper, no intro/methods/results/discussion separations, use halothane",No,
Lucie,Rivlin et al.,1979,Effect of vasodilators and myelotomy on recovery after acute spinal cord injury in rats,10.3171/jns.1979.50.3.0349,English,,included,,,,,,rats,Wistar,90,10,,,10,,,other groups not of interest ,female 100 %,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T1; severity: not reported,T1,Not reported,compression,"laminectomy + acute extradural compression (modified Kerr-Lougheed aneurysm clip, 1 min compression with force of 180 gm, clip was released as rapidly as possible from a Heifetz clip applicator to produce sudden cord compression)",8 weeks,"papaverine, nitroprusside+/-epinephrine, myelotomy (only report nitropusside+/-epinephrine in the following parts as it is the only drug of interest)",epinephrine,,3.3 microg/min,immediately after injury,,1h,continuous,intravenously,,functional,inclined plane test,,maximum angle of the plane at which a rat could maintain its position without falling was determined,day 4 after injury then weekly for 8 weeks,,yes,no effect,neither nitroprusside plus epinephrine nor epinephrine alone produced better recovery than in the control group (p>0.05),-,-,-,-,,-,"anesthesia: pentobarbital sodium (5 mg/100 gm, IP)",nitroprusside did not improve recovery of cord function,not reported,multiple drugs + myelotomy procedure tested but only reported the drug part of list of drugs of interest (nitroprusside); no histopathological assessment; use pentobarbital,No,
Lucie,Rivlin et al.,1979,Effect of vasodilators and myelotomy on recovery after acute spinal cord injury in rats,10.3171/jns.1979.50.3.0349,English,,included,,,,,,rats,Wistar,90,10,,,10,,,other groups not of interest ,female 100 %,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T1; severity: not reported,T1,Not reported,compression,"laminectomy + acute extradural compression (modified Kerr-Lougheed aneurysm clip, 1 min compression with force of 180 gm, clip was released as rapidly as possible from a Heifetz clip applicator to produce sudden cord compression)",8 weeks,"papaverine, nitroprusside+/-epinephrine, myelotomy (only report nitropusside+/-epinephrine in the following parts as it is the only drug of interest)",epinephrine + nitroprusside,,"nitropusside: 40 microg/kg/min, epinephrine: 3.3 microg/min",immediately after injury,,1h,continuous,intravenously,,functional,inclined plane test,,maximum angle of the plane at which a rat could maintain its position without falling was determined,day 4 after injury then weekly for 8 weeks,,yes,no effect,neither nitroprusside plus epinephrine nor epinephrine alone produced better recovery than in the control group (p>0.05),-,-,-,-,,-,"anesthesia: pentobarbital sodium (5 mg/100 gm, IP)",nitroprusside did not improve recovery of cord function,not reported,multiple drugs + myelotomy procedure tested but only reported the drug part of list of drugs of interest (nitroprusside); no histopathological assessment; use pentobarbital,Yes (drug of interest + drug of interest),
Lucie,Zhang et al.,2020,Liraglutide provides neuroprotection by regulating autophagy through the AMPK-FOXO3 signaling pathway in a spinal contusion injury rat model,10.1016/j.neulet.2020.134747,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (liraglutide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al.,2020,Therapeutic effect of metformin on inflammation and apoptosis after spinal cord injury in rats through the Wnt/beta-catenin signaling pathway,10.1016/j.neulet.2020.135440,English,,included,,,,,,rats,Sprague Dawley,90,18,,,18,,,"sham n = 18, one group not of interest n = 18",male 100%,male,100,8 to 12 weeks (adults),,,8,12,Weeks,,range: [180-200](g),,,180,200,g,,level: T9-10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight drop (modified Allen procedure: a striker [weight: 10g, diameter: 2mm] dropped from height of 30 mm)",14 days or 28 days,"metformin, metformin+XAV939 (inhibitor of the Wnt/beta-catenin signaling pathway), methylprednisolone",methylprednisolone,No,30 mg/kg,not reported,Not reported,14 days (14 doses),daily,intraperitoneally,,"functional, behavioral assessment",BBB scale,,"range 0-21: the lowest score of 0 was complete paralysis, and the highest score of 21 was normal; avergae was used to reflect the progress of motor function recovery in each group","1, 3, 7, 14, 21 and 28 days after injury",Yes,yes,positive effect,BBB scores of the rats in the metformin and methylprednisolone groups were evidently higher than those of the rats in the SCI group after 14 days (p<0.05);  not statistically significant between metformin group and methylprednisolone group at each time points (p＞0.05); scores in the metformin +XAV939 group were obviously lower than those in the metformin group (p<0.05),histological,"proportion of lesion size, number of surviving neurons, TUNEL assay",14 days,not reported,positive effect,the proportion of lesion size was smaller in the metformin groups than that in the SCI group; the proportion of lesion size in the metformin +XAV939 group was larger than that in the metformin and methylprednisolone groups; there is no statistically significant between metformin group and methylprednisolone group; signigicnatly higher number of surviving neurons both in MP and metformin compared to control; significantly less TUNEL positive cells in metformin and MP groups compared to control group,"anesthesia: 10% chloral hydrate (0.33 mg/kg, IP); incision was disinfected twice a day after surgery to avoid infection; euthanasia: severally narcotized with 10% chloral hydrate (0.33 mg/kg, IP), perfused with 4% paraformaldehyde","found a possible mechanism that metformin could reduce inflammation and  apoptosis, and promote functional recovery of SCI rats through activating Wnt/β-catenin signaling pathway",not reported,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Zhang et al.,2020,Therapeutic effect of metformin on inflammation and apoptosis after spinal cord injury in rats through the Wnt/beta-catenin signaling pathway,10.1016/j.neulet.2020.135440,English,,included,,,,,,rats,Sprague Dawley,90,18,,,18,,,"sham n = 18, one group not of interest n = 18",male 100%,male,100,8 to 12 weeks (adults),,,8,12,Weeks,,range: [180-200](g),,,180,200,g,,level: T9-10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight drop (modified Allen procedure: a striker [weight: 10g, diameter: 2mm] dropped from height of 30 mm)",14 days or 28 days,"metformin, metformin+XAV939 (inhibitor of the Wnt/beta-catenin signaling pathway), methylprednisolone",metformin,,50 mg/kg,not reported,,14 days,daily,intraperitoneally,,"functional, behavioral assessment",BBB scale,,"range 0-21: the lowest score of 0 was complete paralysis, and the highest score of 21 was normal; avergae was used to reflect the progress of motor function recovery in each group","1, 3, 7, 14, 21 and 28 days after injury",,yes,positive effect,BBB scores of the rats in the metformin and methylprednisolone groups were evidently higher than those of the rats in the SCI group after 14 days (p<0.05);  not statistically significant between metformin group and methylprednisolone group at each time points (p＞0.05); scores in the metformin +XAV939 group were obviously lower than those in the metformin group (p<0.05),histological,"proportion of lesion size, number of surviving neurons, TUNEL assay",14 days,not reported,positive effect,the proportion of lesion size was smaller in the metformin groups than that in the SCI group; the proportion of lesion size in the metformin +XAV939 group was larger than that in the metformin and methylprednisolone groups; there is no statistically significant between metformin group and methylprednisolone group; signigicnatly higher number of surviving neurons both in MP and metformin compared to control; significantly less TUNEL positive cells in metformin and MP groups compared to control group,"anesthesia: 10% chloral hydrate (0.33 mg/kg, IP); incision was disinfected twice a day after surgery to avoid infection; euthanasia: severally narcotized with 10% chloral hydrate (0.33 mg/kg, IP), perfused with 4% paraformaldehyde","found a possible mechanism that metformin could reduce inflammation and  apoptosis, and promote functional recovery of SCI rats through activating Wnt/β-catenin signaling pathway",not reported,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Li et al.,2019,Expression of miR-210 mediated by adeno-associated virus performed neuroprotective effects on a rat model of acute spinal cord injury,10.1016/j.tice.2019.02.004,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (adeno-associated virus-expressing miR-210),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sakamoto et al.,2020,The protective effect and mechanism of COA-Cl in acute phase after spinal cord injury,10.1016/j.neures.2020.10.003,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (COA-Cl, a novel synthesized adenosine analog)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Impellizzeri et al.,2011,"Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury.",10.3109/10715762.2010.526604,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (apocynin, a NADPH-oxidase inhibitor)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Paterniti et al.,2010,"Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator",10.3109/10715761003742993,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (deferoxamine, an iron-chelator)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Filippone et al.,2020,Protective effect of sodium propionate in AŒ≤1-42 -induced neurotoxicity and spinal cord trauma.,10.1016/j.neuropharm.2020.107977,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (sodium propionate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Risterucci et al.,2006,The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions,10.1016/j.neuroscience.2005.08.054,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Vitellaro-Zuccarello et al.,2007,Erythropoietin-mediated preservation of the white matter in rat spinal cord injury,10.1016/j.neuroscience.2006.10.023,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (recombinant human erythropoietin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Genovese et al.,2007,Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma,10.1016/j.neuroscience.2007.06.059,English,,included,,,,,,mice,CD1,240,30,,,30,,,"2 groups not of interest n = 30 each, 4 sham groups n = 30 each",male 100%,male,100,not reported (adults),,,,,,Adult,range: [25-30](g),,,25,30,g,,level: T6-T7; severity: severe,T6 - T7,severe,compression,laminectomy + aneurysm clip (24g closing force for 1 min),24h or 10 days,"etanercept, dexamethasone, combination",dexamethasone,,0.025 mg/kg,1h after injury,,10 days,daily,intraperitoneally,,motor function,modified murine BBB hindlimb locomotor rating scale,,,day 10 after injury,,not reported,no effect,combination therapy significant ameliorated the hindlimb motor disturbances; etanercept and dexamethasone when administered as a single treatment did not reduce the hindlimb motor distrubances,histopathology,"HE staining: neutrophil infiltration, edema, alteration of the white matter",24h,yes,no stats,no significant protection was observed with etanercept and dexamethasone when administered as a single treatment; combination therapy (etanercept + dexamethasone) significatnly reduced the SCI,anesthesia: chloral hydrate (40 microg/kg); post surgery: 1.0 cc of saline to replace blood volume lost during surgery,results demonstrate for the first time that strategies targeting multiple proinflammatory pathways may be more effective than a single effector molecule for the treatment of a spinal cord trauma,not reported,"looking at effect of combination of therapy: positive effect when taken together but no effect when taken alone; use chloral hydrate, saline",Yes (drug of interest + drug not of interest),
Lucie,Wizenmann et al.,2019,Evaluation of the effect of nandrolone decanoate on experimental spinal cord injury in rats,10.22456/1679-9216.98190,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Nandrolone decanoate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Guertin et al.,2009,Recovery of locomotor function with combinatory drug treatments designed to synergistically activate specific neuronal networks.,10.2174/092986709787846541,English,,excluded,Review,,Review/commentary/opinion paper,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhao et al.,2017,Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway,10.1016/j.neuroscience.2017.02.027,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (resveratrol),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wu et al.,2017,Sevoflurane preconditioning ameliorates traumatic spinal cord injury through caveolin-3-dependent cyclooxygenase-2 inhibition,10.18632/oncotarget.21142,English,,included,,,,,,rats,Sprague Dawley,>= 15,5,,,>= 5,,,sham n = 5,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T8; severity: moderate,T8,moderate,contusion,laminectomy + weight dropp (10g weight dropped 2.5 cm),>= 1 week,sevoflurane preconditioning,sevoflurane,,"0.5 minimim alveolar concentration (MAC), 1.0 MAC and 1.5 MAC",before injury,,3 cycles of 10-minute exposure interspersed with 15 minutes of washout,3 cycles of 10-minute exposure interspersed with 15 minutes of washout,inhalation,,neurological scoring,"modified Tarlov method, combined behavioral score (Gale scale/CBS)",,,1 week after surgery,,not reported,positive effect,"average combined behavioral scores after SCI were improved in rats preconditioned with sevoflurane (p<0.05) compared to vehicule group at the 3 doses (0.5, 1.0 and 1.5 MAC), 1.0 MAC showed the highest CBS score",histopathological assessment,TUNEL assay,>= 1 week,not reported,positive effect,"percentage of TUNEL-positive cells was obviously increased after tSCI, and this increase was significantly compromised by SF-PreCon","anesthesia: ketamine (0.25 mL/kg, 100 mg/mL)","results suggest that sevoflurane preconditioning attenuated the apoptosis, reduced the expression of inflammatory cytokines in the injured spinal cord tissues and therefore enhanced the recovery after traumatic SCI",not reported,very limited information on the methods for assessment neurological effect and no histopathological assessment; use ketamine,No,
Lucie,Lu et al.,2014,Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage,10.1016/j.brainres.2014.01.048,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (fingolimod), no spinal cord injury (effect evaluated on intracerebral hemorrhage)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chen et al.,2017,Liraglutide activates autophagy via GLP-1R to improve functional recovery after spinal cord injury,10.18632/oncotarget.20791,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (liraglutide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ledecky et al.,2015,The effects of inosine on clinical and histological findings after experimental spinal cord injury in rats,10.17221/8106-VETMED,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (inosine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al.,2018,Telmisartan regulates the development of cerebral ischemia by alleviating endoplasmic reticulum stress,10.1691/ph.2018.8592,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury (perform cerebral ischamia instead),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al.,2017,Effect of curcumin on acute spinal cord injury in mice via inhibition of inflammation and TAK1 pathway,10.1016/j.pharep.2017.02.012,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (curcumin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lim et al. ,2010,The acute administration of eicosapentaenoic acid is neuroprotective after spinal cord compression injury in rats,10.1016/j.plefa.2010.08.003,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (eicosapentaenoic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lee et al.,2016,Fluoxetine and vitamin C synergistically inhibits blood-spinal cord barrier disruption and improves functional recovery after spinal cord injury,10.1016/j.neuropharm.2016.05.018,English,,included,,,,,,rats,Sprague Dawley,>= 65,>= 15,,,>= 15,,,numbers unclear and reported according to figure legend for BBB assessment and figure 1,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + contusion injury (NYU impactor, 10g * 25mm)","4h, 24h, 5 days, 35 days","fluoxetine, ascorbic acid (vit C), and combination of both",fluoxetine + vitamin c,,"fluoxetine: 1 mg/kg, vitC: 100 mg/kg",immediately after injury,,"until death, or 14 days for behavioral analysis",once daily,intraperitoneally,,functional/behavioral test,BBB scale,,"22-point scale systematically and logically follows recovery of hindlimb function from a score of 0, indicative of no observed hindlimb movements, to a score of 21, representative of anormal ambulating rodent; rats used for behavioral studies were not used in the other assay","1, 7, 14, 28 and 35 days after injury",,yes,positive effect,co-treatment with vitamin C andfluoxetine significantly increased the hindlimb locomotor function from 28 d to 35 d after injury as compared to that observed in vehicle-treated control (p<0.05); no information on effect of each drug taken alone ,histological measure,"lesion volume: areas at each longitudinal level were determined, and the total lesion volume was derived by means of numerical integration of sequential areas",35 days,yes,positive effect,total lesion volume was significantly decreased upon co-treatment with vitamin C and fluoxetine as compared with that of vehicle treatment (p<0.05); no info on effect of each treatment taken alone,"anesthesia: chloral hydrate (500 mg/kg, IP); postop care: performed in accordance with the Guidelines and POlices for Rodent Survival Surgery provided by the Animal Care Committee of the Kyung Hee University; euthanasia: chloral hydrate (500 mg/kg), perfused via cardia puncture with 0.1 M PBS and 4% paraformaldehyde in 0.1 M PBS",low-dose combination of fluoxetine (1 mg/kg) and vitamin C (100 mg/kg) synergistically exerts neuroprotective effects by inhibiting MMP-9 activation and thereby preventing blood spinal cord barrier disruption after SCI,not reported,BBB score only assessed for combination of treatment (fluoxetine and vitamin C) but not for each treatment individually; use chloral hydrate,Yes (drug of interest + drug of interest),
Lucie,de Figueiredo et al.,2018,Influence of tramadol on functional recovery of acute spinal cord injury in rats,10.1590/s0102-865020180120000006,English,,included,,,,,,rats,Wistar,10,5,,,5,,,,male 100%,male,100,between 90-120 days,,,90,120,Days,,range: [250-350](g),,,250,350,g,,level: T8; severity: complete right hemisection,T8,incomplete,transection,"laminectomy + complete right hemisection based on posterior spinal vein, with total depth",14 days,tramadol hydrochloride,tramadol,,4 mg/kg,not reported,,5 days,every 12h,subcutaneous,,functional/behavioral test,"BBB scale, Rat Grimace Scale",,"BBB: filming of the motricity of each rat during five minutes, three times at least, 50*20cm open field cage lined with ethylene vinyl acetate to avoid slip action, 0=no observable movement of the hindlimbs to 21=consistent plantar stepping and coordinated gat consistent movement of the toes, paw position is predominantly parallel to the body during the whole support stage, consistent trunk stability, consistent tail elevation; rat grimace scale: consists of four facial action units (orbital tightening, nose/cheek flattening, ear changes, whisker change) scored on a 0-2 scale (from photos)","1, 3, 7, 14 days after injury",,yes,no effect,BBB: no significant differences between the groups at the four analyzed periods p<0.05; rat grimace scale: no significant differences in the tramadol group at the four analyzed periods (p>0.05),-,-,-,-,,-,"anesthesia: ketamine (60 mg/kg, IP), xylazine (8 mg/kg, IP), fentanyl (0.03 mg/kg, IP) repeated for each 30 minutes until the end of the surgery, antisepsis with povidone-iodine; postop: enrofloxacin (SC, 10 mg/kg, once a day until 7 days), lidocaine topical (used in the incision at 12/12h until 5 days)",tramadol as an analgesic agent don't influence on functional recovery of acute spinal cord injury in rats,don't evaluate the effect of tramadol on chronic stage of spinal cord injury,"this study seems a bit weak both on the method and the way it is presented; use fentanyl, ketamine, povidone iodine, lidocaine",No,
Lucie,Vasconcelos et al.,2016,Combining neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury,10.1016/j.spinee.2016.04.013,English,,included,,,,,,rats,Wistar,19,5,,,5,,,riluzole group n = 4; riluzole + magnesium chloride n = 5,female 100%,female,0,14 weeks,14,,,,Weeks,,range: [210-260](g),,,210,260,g,,level: T8; severity: not reported,T8,Not reported,contusion,"laminectomy + weight drop trauma (dura left intact, 10g weight rod from 20cm height on to the exposed spinal cord)",5 weeks,"riluzole, magnesium chloride in polyethylene glycol formulation, combined treatment",magnesium chloride + polyethylene glycol,,24.18 mg/kg,1h after injury,,"49h, 5 doses",every 12h,intraperitoneally,,functional/behavioral/motor assessment,"BBB scale, activity box, swimming test",,"BBB: open field for 4 mintues, 2 examiners, 21 point scale, 0=no hind limb movement, 1-8: joint movement but no weight support, 9-20: support weight and use limb for locomotion with some degree of abnormlaity, 21 =normal; activity box: total distance traveled used as measure of locomotor activity, open arena 43.2cm*43.2cm with transparent acrylic walls, 5 mins; swimming test: swim freely in circular pool with diameter 170cm , 50cm depth for 2 min, three trials",BBB: day3 then weekly for 4 weeks; activity box: 29 day after injury; swimming test: 31 days post injury,,yes,no effect,"BBB: riluzole group significantly better than control at week 1 and 2 but not after, no significant difference between control and magnesium or magnesium + riluzole; activity box: riluzole group traveled significantly more distance than in control group, trend toward positive effect in magnesium and combination group but not significantly different from control; swimming test: no significant difference between any group (trend towards combination group having higher swimming velocity)",histologic assessment,"lesion volume: sum of total lesion area multiplied by distance between sections; number of neuronal nuclei, percentage of neurofilament, percentage of injury tissue",5 weeks after injury,yes,no effect,"riluzole group presented a significantly smaller lesion when compared iwth the saline-group, no significant difference between other treatment groups and control","anesthesia: ketamine (100 mg/mL, IP), medetomidine hydrochloride (1 mg/mL, IP); during surgery: analgesic butorphanol (10 mg/mL, SC), antibiotic enrofloxacin (5 mg/mL, SC), disinfection with chlorhexidine; anesthesia reversed: atipamezole (5 mg/mL), vitamins, 0.9% NaCl (SC); postop: butorphanol (twice a day for 5 days), vitamins, saline, enrofloxacin twice a day for 7 day period; if weight loss of more than 10% of body weight: high-calorie oral supplement (nutri-Cal) daily; euthanasia: anesthesia with IP sodium pentobarbital (200 mg/kg), transcardially perfused with 100 mL of cold 0.9% saline followed by 300 mL of 4% paraformaldehyde in 1* PBS","combined treatment, although simultaneously targeting two excitotoxic-related mechanisms, did not further improve behavioral and histologic outcome when compared with riluzole given alone",not reported,"personal limitation: small sample size, they have only 4 rats in one group and 5 rats in the others, difficult to see how to perform some robust statistics with such low numbers; use butorphanol, ketamine, vitamins",Yes (drug of interest + drug of interest),
Lucie,Miranpuri et al.,2017,"Folic acid modulates matrix metalloproteinase-2 expression, alleviates neuropathic pain, and improves functional recovery in spinal cord-injured rats",10.1159/000475896,English,,included,,,,,,rats,Sprague Dawley,>= 15,>= 8,,,>= 7,,,numbers unclear,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-270](g),,,250,270,g,,level: T9; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + contusion (custom spinal cord impactor device, drop 10g from height of 12.5mm)",18 or 42 days,folic acid,folic acid,,80 microg/kg,3 days before injury,,20 days,14 days after injury ending on the 17th day (mid phase) or 42nd day of cSCI (late phase),intraperitoneally,,functional/behavioral test,"BBB scale, thermal hyperalgesia",,"BBB: observed individually in an open field testing area consisting of an unfilled plastic wading pool; thermal hyperalgesia: method from Hargreaves et al. withdrawal of hind paw to a thermal noxious stimulus, placed in Ugo Basile Plantar Test apparatus, focus beam of radiant heat underneath paws, when each animal moved its paw, a photocell turnedd off the heat and the latency to withdraw the paw was recorded","BBB: either on post-impaction days 0 through 18 post-cSCI (mid phase) or on days 0, 2, 7, 14, 21, 28, 35, and 42 (late phase); thermal hyperalgesia: day prior to injury and then again on post-injury days 18, 21, 28, 35, and 42",,yes,mixed effects (assessment),"BBB: significant differences between the mid phase FA and the water groups, and between the late phase FA and water groups; thermal hyperalgesia: significant differences between FA and control (water) groups, indicating that FA ameliorates NP after SCI, no statistical difference between the FA- and water-treated groups on day 42 ( Fig. 2 c) owing to the recovery during that time period",-,-,-,-,,-,"anesthesia: isoflurane with oxygen (inhalation, induction 5%, maintenance 2,5%)","Folic acid could alleviate neuropathic pain and improve functional recovery post-SCI, possibly by reducing the expression of MMP2",not reported,treatment regimen is wuite unclear to me; use isoflurane,No,
Lucie,Lee et al.,2019,Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model,10.1016/j.spinee.2019.07.013,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (streptozotocin and curcumin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lopèz-Vales et al.,2010,Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice,10.1523/JNEUROSCI.5770-09.2010,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (fenretinide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gül et al.,2005,Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats,10.1016/j.surneu.2005.03.036,English,,included,,,,,,rats,Wistar,60,10,,,10,,,"sham n = 10, SCI group with no treatment n = 10 (control is considered for the group with SCI and saline)",not reported,not reported,not reported,not reported,,,,,,Not reported,range: [230-300](g),,,230,300,g,,level: T10; severity: not reported,T10,paraplegia,compression,laminectomy + aneurysm clip applied extradurally for 5 minutes),24h,"melatonin, methylprednisolone",methylprednisolone,No,30 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological evaluation,"painful stimulus by pinching of rat tail, inclined plane test",,"inclined plane test: placed on a flat platform at prone position, the angle of the inclined plane is maximum angle of the platform at which the rat could keep itself for at least 5 minutes",12 and 24h after SCI,No,not reported,mixed (stats/no stats),"Statistically inclined plane tests at 12 and 24 hours were not different among groups 2 to 6 (control, placebo and 3 treatment groups); Pure injury groups (control and placebo) have significantly lower scores than treated groups; tail pinch test missing",histological assessment,"intracellular edema, nuclear damage, axonal degeneration, axon-myelin splitting, mitochondiral damage",24h after injury,yes,positive effect,"Group 4 (methylprednisolone-treated) rats were significantly different from the previous 2 trauma groups (controls); Groups 5 and 6 (melatonin-treated) rats showed intermediate results between trauma groups (groups 2 and 3) and methylprednisolone-treated rats; Statistical results yielded significantly better difference in group 1 (only laminectomy), group 4 (methylprednisolone-treated), and group 6 (melatonin 100 mg/kg) than others in ultrastructural investigation","anesthesia: sodium pentobarbital (20 mg/kg, IP); euthanasia: sodium pentobarbital ","melatonin has neuroprotective effects on secondary pathochemical events after SCI in rats, particularly on axonal myelin fibers of white matter increasing with dose",not reported,"comparison to ""other trauma groups"" rather than only control group?; use pentobarbital",No,
Lucie,Gül et al.,2005,Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats,10.1016/j.surneu.2005.03.036,English,,included,,,,,,rats,Wistar,60,10,,,20,,,"sham n = 10, SCI group with no treatment n = 10 (control is considered for the group with SCI and saline)",not reported,not reported,not reported,not reported,,,,,,Not reported,range: [230-300](g),,,230,300,g,,level: T10; severity: not reported,T10,paraplegia,compression,laminectomy + aneurysm clip applied extradurally for 5 minutes),24h,"melatonin, methylprednisolone",melatonin,,50 or 100 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological evaluation,"painful stimulus by pinching of rat tail, inclined plane test",,"inclined plane test: placed on a flat platform at prone position, the angle of the inclined plane is maximum angle of the platform at which the rat could keep itself for at least 5 minutes",12 and 24h after SCI,,not reported,mixed (stats/no stats),"Statistically inclined plane tests at 12 and 24 hours were not different among groups 2 to 6 (control, placebo and 3 treatment groups); Pure injury groups (control and placebo) have significantly lower scores than treated groups; tail pinch test missing",histological assessment,"intracellular edema, nuclear damage, axonal degeneration, axon-myelin splitting, mitochondiral damage",24h after injury,yes,mixed effects (dosage),"Group 4 (methylprednisolone-treated) rats were significantly different from the previous 2 trauma groups (controls); Groups 5 and 6 (melatonin-treated) rats showed intermediate results between trauma groups (groups 2 and 3) and methylprednisolone-treated rats; Statistical results yielded significantly better difference in group 1 (only laminectomy), group 4 (methylprednisolone-treated), and group 6 (melatonin 100 mg/kg) than others in ultrastructural investigation","anesthesia: sodium pentobarbital (20 mg/kg, IP); euthanasia: sodium pentobarbital ","melatonin has neuroprotective effects on secondary pathochemical events after SCI in rats, particularly on axonal myelin fibers of white matter increasing with dose",not reported,"comparison to ""other trauma groups"" rather than only control group?; use pentobarbital",No,
Lucie,Imagama et al.,2011,Keratan sulfate restricts neural plasticity after spinal cord injury,10.1523/JNEUROSCI.5120-10.2011,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (keratanase-II and CS-degrading enzyme chondroitinase),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fu et al.,2007,Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition,10.1523/JNEUROSCI.4353-06.2007,English,,included,,,,,,rats,Sprague Dawley,62,7,4,4,7,6,2,very detailed description,female 100%,female,0,not reported,,,,,,Not reported,range: [180-250](g),,,180,250,g,,"level: T6-7 (dorsal over-transection), T8-9 (contusion) ; severity: severe (dorsal over-transection), moderate (contusion)",T6 - T7,multiple,multiple,"laminectomy + transection injury procedure (dorsal part of the cord was cut with a pair of microscissors to sever the dorsal parts of corticospinal tracts, depth of lesion=1.9mm) or contusion SCI (NYU impactor)",5-7 days (some in contusion group for the Rho-GTP assay) or 6 weeks after injury,"naproxen (n=7 with transection), ibuprofen (n=12 with transection, n=6 with contusion), vehicule (n=7 with transection, n=6 with contusion)",naproxen,,50 mg/kg/d,immediately after injury,,28 days,continuous,subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, grid walking, footprint analysis",,"BBB scale: no details; grid walking: trained to walk on a wire grid (90cm long, 25mm between grids) before surgery, number of instances in which the hindpaw dropped below the grid plane was counted; footprint analysis: walking patterns of hindpaws recorded with ink during a continuous locomotion across a 90cm runway, stride length on each side and stride width between two sides were calculated","BBB scale: day 2, 7, 14, 21, 28, 35, 42 after injury (from figure 7), grid walking: 6 weeks after injury and footprint analysis: 6 weeks after injury",,yes,no effect,"transection injury: Ibuprofen group had significantly better BBB scores at day 42 after injury compared to control, no significant effect on BBB of naproxen compared to control, Ibu significantly less grid walk failure compared to control (no effect of naproxen), length of stride distance significanlty longer and significantly less wide in Ibuprofen group compared to control (no effect of naproxen); contusion injury: Ibuprofen group significantly better in BBB score and significantly less failure in grid walk compared to controls",histological assessment,"serotonergic fibers and lesion area, CST fiber quantification",6 weeks after injury,yes,mixed effects,"hemisection: more CST sprouts in ibuprofen group than control, more 5-HT fiber length per section for ibuprofen group compared to control; contusion: more CST fibers in gray and white matter when ibuprofen treated, more 5-HT fiber length in ibuprofen treated compared to control",anesthesia: ketamine (70 mg/kg) and xylazine (8 mg/kg); euthanasia: perfusion of cold PBS followed by 4% paraformaldehyde ,These studies demonstrate the therapeutic potential of RhoA-inhibiting NSAIDs in treating CNS injuries characterized by axonal disconnection including spinal cord injury.,not reported,indomethacin treatment tested in vitro but not in vivo; used ketamine,No,
Lucie,Fu et al.,2007,Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition,10.1523/JNEUROSCI.4353-06.2007,English,,included,,,,,,rats,Sprague Dawley,62,13,5,5,18,3,3,very detailed description,female 100%,female,0,not reported,,,,,,Not reported,range: [180-250](g),,,180,250,g,,"level: T6-7 (dorsal over-transection), T8-9 (contusion) ; severity: severe (dorsal over-transection), moderate (contusion)",T6 - T9,moderate + incomplete,multiple,"laminectomy + transection injury procedure (dorsal part of the cord was cut with a pair of microscissors to sever the dorsal parts of corticospinal tracts, depth of lesion=1.9mm) or contusion SCI (NYU impactor)",5-7 days (some in contusion group for the Rho-GTP assay) or 6 weeks after injury,"naproxen (n=7 with transection), ibuprofen (n=12 with transection, n=6 with contusion), vehicule (n=7 with transection, n=6 with contusion)",ibuprofen,,60 mg/kg/d,immediately after injury (transection) or 7 days after injury (contusion),,28 days,continuous,subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, grid walking, footprint analysis",,"BBB scale: no details; grid walking: trained to walk on a wire grid (90cm long, 25mm between grids) before surgery, number of instances in which the hindpaw dropped below the grid plane was counted; footprint analysis: walking patterns of hindpaws recorded with ink during a continuous locomotion across a 90cm runway, stride length on each side and stride width between two sides were calculated","BBB scale: day 2, 7, 14, 21, 28, 35, 42 after injury (from figure 7), grid walking: 6 weeks after injury and footprint analysis: 6 weeks after injury",,yes,positive effect,"transection injury: Ibuprofen group had significantly better BBB scores at day 42 after injury compared to control, no significant effect on BBB of naproxen compared to control, Ibu significantly less grid walk failure compared to control (no effect of naproxen), length of stride distance significanlty longer and significantly less wide in Ibuprofen group compared to control (no effect of naproxen); contusion injury: Ibuprofen group significantly better in BBB score and significantly less failure in grid walk compared to controls",histological assessment,"serotonergic fibers and lesion area, CST fiber quantification",6 weeks after injury,yes,mixed effects,"hemisection: more CST sprouts in ibuprofen group than control, more 5-HT fiber length per section for ibuprofen group compared to control; contusion: more CST fibers in gray and white matter when ibuprofen treated, more 5-HT fiber length in ibuprofen treated compared to control",anesthesia: ketamine (70 mg/kg) and xylazine (8 mg/kg); euthanasia: perfusion of cold PBS followed by 4% paraformaldehyde ,These studies demonstrate the therapeutic potential of RhoA-inhibiting NSAIDs in treating CNS injuries characterized by axonal disconnection including spinal cord injury.,not reported,indomethacin treatment tested in vitro but not in vivo; used ketamine,No,
Lucie,De Nicola et al.,2009,Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration.,10.1016/j.yfrne.2009.03.001,English,,excluded,Review,,Review paper on progesterone,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Park et al.,2012,Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal Stem cells,10.3109/14653249.2012.658913,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (matrigel and neural-induced mesenchymal stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Parker et al.,1976,Functional recovery from spinal cord trauma following dexamethazone and chlorpromazine therapy in dogs,10.1016/s0034-5288(18)33383-6,English,,excluded,Out of scope,No control group,,,,dogs,Beagle,20,,,,,,,,female: n=8 (40%); male: n=12 (60%),mixed,60,1 to 2 years old,,,1,2,Years,,"11 (0.65), range: [10-12](kg)",11,0.65,10,12,kg,,level: not reported; severity: not reported,Not reported,Not reported,contusion,"surgical exposure of the spinal cord + impact trauma (440 g/cm), durotomy",not reported,"dexamethasone, chlorpromazine",,,"dexamethasone: 1mg/kg, chlorpromazine: 5 mg/kg",first dose 45 min after trauma,,5 days,every 12h (i.e. twice a day),intramuscular,,neurological signs,posstsurgical spinal cord tract function in the hind limbs,,"scale from N= normal voluntary motor and normal conscious proprioception functions, 1=normal voluntary motor with a moderate deficit in conscious proprioception function to 8=flaccid or spastic paralysis without deep pain function","not reported, at most 30 assessments ",,not reported,no effect,there was an apparent tendency for dogs of dexamethasone group to recover faster than chlorpromazine group but the difference was not significant when analysed by a parametric randomisation test; no significant difference between the recovery times of either treatment group compared to previously reported control group,-,-,-,-,,-,-,"results showed that neither drug had a significantly beneficial effect on the functional recovery of the spinal cords, when compared to a control group of similarly traumatised dogs",not reported,very very short paper,,
Lucie,Teng et al.,1997,Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury,10.1523/jneurosci.17-11-04359.1997,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (tetrodotoxin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hansen et al.,2013,Elevated MMP-9 in the lumbar cord early after thoracic spinal cord injury impedes motor relearning in mice,10.1523/JNEUROSCI.1576-13.2013,English,,excluded,Out of scope,No drug tested,Out of scope: no treatment but comparison of wild type mice and MMP-9-null (i.e. knocked-out) mice (MMP = matrix metalloproteinase),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Cheng et al.,2016,G-1 exerts neuroprotective effects through G protein-coupled estrogen receptor 1 following spinal cord injury in mice,10.1042/BSR20160134,English,,included,,,,,,mice,C57BL/6J,40,8,,8,,,,other groups not of interest,female 100%,female,0,not reported,,,,,,Not reported,range: [22-25](g),,,22,25,g,,level: T7-T9; severity: moderate,T7 - T9,moderate,compression,laminectomy + clip for 20s using a modified micro-ophtalmic forcep,14 days,"G protein-coupled estrogen receptor 1 antagonist (G15), specific GPR30 agonist (G1), estradiol (E2), E2+G15, G1+G15",estradiol,,1 microg,not reported,,14 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,"Basso mouse scale (BMS), inclined plane test",,"BMS: subscores reflects specific changes such as stepping frequency coordination, paw position, trunk stability and tail position, test performed in a box 150cm long*120cm wide*30cm high; inclined plane test (IPT): placed on an inclined board to assess its abil- ity to maintain position for at least 5 s without falling. The board is raised in 5 degrees increments during the process, and the maximum angle at which the mouse can maintain position is recorded","BMS: before SCI, 1 and 14 days after injury; IPT: before surgery and 14 days after SCI",,yes,positive effect,BMS scores and subscore and IPT angles were significantly higher in E2 compared with the control,histological assessment,"myelinated area of spinal white matter, cross-sectional cavity area, cavity area/total cross-sectional area, myelinated white matter area/total cross-sectional area and counting of caspase-3 positive cells were well-accepted quantitative techniques to assess lesion size and were used to evaluate biological differences between different treatment groups",14 days,not reported,positive effect,cavity area/total area and myelinated/total area were significantly higher in E2 group compared with the control,"anesthesia: chloral hydrate (5%, 0.2 mL/30g body weight, IP); postop: ampicilin (10 mg/kg, once daily for 3 days) to prevent infection; euthanasia: chloral hydrate overdose (5% 0.5 mL/30g)","The intraperitoneal injection of the GPR30 agonist G1 for 14 days induces neuroprotective effects similar with the same dose of E2. We infer that E2 exert neuroprotection probably by the nonclassic ER, GPR30, because the effects of E2 could be blocked by G-15.",not reported,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Hu et al.,2012,G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury,10.1097/CCM.0b013e3182657560,English,,included,,,,,,rats,Sprague Dawley,>= 65,>= 10,,>= 10,,,,based on figure 4,male 100%,male,100,not reported,,,,,,Not reported,"""~250g""",250,,,,g,,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy + contusion spinal injury (10-g weight rod of diameter 2.5mm was dropped from a height of 12.5mm onto the exposed dura),not reported,"17beta-estradiol (E2), nuclear estrogen receptor antagonist ICI 182 780, selective GPER1-agonist G-1 (G1)",estradiol,,100 microg/kg,15 mins after injury,,"2 doses, 24h","first dose 15 mins after injury, second dose 24h after injury",intravenously,,neurological/functional/behavioral assessment,BBB locomotor rating scale,,"ranges from 0 to 21, 0=locomotor function and 21=normal performance, walk freely in 90 cm^2 field 5 mins while movements of the hind limb were observed closely",every 3 days following SCI,,yes,positive effect,"E2 significantly improved the functional recvoery from SCI compared with vehicle control. G1 produced similar effects as E2, G1 antisense reduced the functional protection of estrogen; nuclear ER antagonist ICI 182 780 had no influence on the protective effect of E2 on locomotion",histological assessment,TUNEL assay,not reported,not reported,positive effect,significantly less TUNEL positive cells in the estradiol group compared to control group,"anesthesia: chloral hydrate (50 mg/kg, IP); euthanasia: chloral hydrate (50 mg/kg, IP), 100mL physiological saline followed by 200mL of 4% paraformaldehyde in PBS","G-protein coupled estrogen receptor 1 may mediate estrogenic neuroprotection against spinal cord injury, and underline the promising potential of estrogen with its new target G-protein coupled estrogen receptor 1 for the treatment of spinal cord injury patients",not reported,"main focus on protein expression, very few info on locomotion and only TUNEL for histology; use chloral hydrate",Yes (drug of interest + drug not of interest),
Lucie,Tanabe et al.,2009,Gabapentin and pregabalin ameliorate mechanical hypersensitivity after spinal cord injury in mice,10.1016/j.ejphar.2009.03.020,English,,excluded,Out of scope,No assessments of interest,Out of scope: no sufficient details on neurological assessment,,,mice,ddY-strain mice,46,,,,,,,,female 100%,,,4 week old,,,,,,,not reported,,,,,,,level: T8; severity: not reported,,,,laminectomy + weight drop (2.5 g dropped from a height of 5cm onto the exposed dura),28 days,"gabapentin, pregabalin",,,"gabapentin: 30 or 100 mg/kg, pregabalin: 10 or 30 mg/kg",,,,,intraperitoneally,,neurological/functional/behavioral assessment,BBB locomotor rating scale,,"open field, 5min, 22point scale where 0 is complete paralysis and 21 is normal movement",daily for 4 weeks,,not reported,,"results are unclear, no numbers, no statistics, no comparison to control group ?",-,-,-,-,,-,"anesthesia: pentobarbital sodium (50 mg/kg, IP), Baytril (10 mg/kg, IP), atropine sulfate (0.01 mg/kg, IP)",gabapentin and pregabalin could be useful therapeutic tools for patinets with neutopathic pain after spinal cord injury,not reported,,,
Lucie,Sun et al.,2020,Gabapentinoid treatment promotes corticospinal plasticity and regeneration following murine spinal cord injury,10.1172/JCI130391,English,,included,,,,,,mice,C57BL/6J and GFP-M,>= 25,>= 14,,>= 11,,,,,female and male,mixed,not reported,7- to 8-week-old,,,7,8,Weeks,,not reported,,,,,,Not reported,level: C5; severity: complete hemisection,C5,complete,compression,laminectomy + corticospinal transduction (spinal cord was crushed with no.5 modified forceps positioned to completely sever half of the spinal cord),day 131 after injury,gabapentin (GBP),gabapentin,,46 mg/kg,1h after injury,,until end of the study (day 131 after injury),"3 times/day during the first week, 2 times/day until the end of the study",intraperitoneally,,neurological/functional/behavioral assessment,"horizontal ladder, toe spread index, cylinder test (forelimb assymetry), Von Frey test, activity box",,"horizontal ladder: placed at one end of the ladder and video recorded while moving across to the other end where the enriched cage was located, percentage of correct steps was calculated, toe spread index: controlateral and ipsilateral forepaws photographed and images taken when the mosue was bearing weight, intermediary toe spread was established from the images by measuring the distance between the first and fourth toe, cylinder test: placed in 500 ml clear beaker with a small amout of bedding at the bottom, proportion of right versus left both paw placements on the side of the beaker was noted fro 10 attempts and used to calculate the percentage of forelimb asymmetry, Von Frey test: plantar threshold was measured using retractable monofilaments and the up-down method, quick withdrawal of the left hindpaw was considered as a positive respoinse, response threshold calculated as the lowest force (in grams) that produced a retraction at least 50% of the time, activity box: in activity boxes for 10 min, spontaneous activity in horizontal and vertical planes recorded","training before SCI (~2 weeks) and then tested from day 7 to 131 (horizontal ladder: day 7, 14, 26, 39, 50, 65, 92, 103, 131; repetition: day 7, 14, 28, 41, 50, 65, 92, 105, 114)",,yes,mixed effects (assessment),"GBP increased the proportion of correct forelimb placement compared to control, GBP ameliorated mechanical hypersensitivity and partiall restored forelimb symmetry in rearing after SCI, no difference was found in hindlimb correct placement, increased toe spred on the ipsilateral forepaw in mice with GBP, no differences in total distance traveled and vertical episode counts between GBP and control mice, GBP mice spent more time resting",-,-,-,-,,-,"anesthesia: ketamine (100 mg/kg), xylazine (10 mg/kg)","Mice administered gabapentin recovered upper extremity function after cervical SCI, such recovery relies on reorganization of the corticospinal pathway, as chemogenetic silencing of injured corticospinal neurons transiently abrogated recovery, thus, targeting α2δ2 with a clinically relevant treatment strategy aids repair of motor circuits after SCI",not reported,very dense study,No,
Lucie,Agrawal et al.,2000,Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury,10.1016/S0306-4522(00)00165-2,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury but isolated spinal cord instead,,,rats,Wistar,44,,,,,,,,male 100%,,,not reported (adults),,,,,,,range: [250-350](g),,,,,,,level: T3-T10; severity: ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Deniselle et al.,2002,Basis of progesterone protection in spinal cord neurodegeneration.,10.1016/s0960-0760(02)00262-5,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury but genetic mouse model of spinal cord neurodegeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Isbir et al.,2003,Ischemic preconditioning and nicotinamide in spinal cord protection in an experimental model of transient aortic occlusion,10.1016/S1010-7940(03)00110-6,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (nicotinamide),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Mobley et al.,2003,Role of calcineurin in calcium-mediated hypoxic injury to white matter,10.1016/S1529-9430(02)00442-4,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (cyclosporin A, FK-506, rapamycin)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,McCreedy et al.,2018,"Early targeting of L-selectin on leukocytes promotes recovery after spinal cord injury, implicating novel mechanisms of pathogenesis",10.1523/ENEURO.0101-18.2018,English,,included,,,,,,mice,C57BL/6,>= 201,>= 79,>= 2,,>= 122,>= 18,,"numbers taken from table 1, unclear",male 100%,male,100,3-5 months of age (adults),,,3,5,Months,Adult,not reported,,,,,,Not reported,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy + weight drop (3g weight dropped from 5-7.5cm onto the exposed dura),35 or 42 days after injury,diclofenac,diclofenac,,"20, 30 or 40 mg/kg","immediately, 3h or 8h after SCI",,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"Basso Mouse scale (BMS), grid walking",,"BMS: 9-point scale, in open-field (53*108*5.5cm), takes into account limb movement, stepping, coordination and trunk stability; grid walking: only for mice with BMS of 4 or greater, positioned on a grid divided into 0.5cm squares, number of foot faults was recorded over a period of 3 min, foot fault = paw fully extended trhough a space in the grid","BMS: 1, 3, 7 days after SCI and then weekly until euthanasia; grid walking: over 3 days at approximately five weeks post-SCI with 3 trials per day",,yes,mixed effects (dosage) + mixed effects (timing),"higher dose of diclofenac significantly improved the locomotor recovery compared to control group, both in BMS and grid walk test; but not lower doses; diclofenac treatment improves BMS when delayed for 3h but not 8h",histology,white matter sparring,35 or 42 days after injury,yes,mixed (stats/no stats),Diclofenac-treated WT mice (40 mg/kg) showed 5-fold greater white matter sparing compared to PBS-treated WT mice (p 􏰃 0.030); no ifnormation about lower doses and when treatment in delayed,"anesthesia: 2.5% avertin (0.02 ml/g, IP, tribromoethanol) or 2% isoflurane; postop: SC saline and antibiotics daily for 10days; euthanasia: 50 mL of PBS followed by 50 mL of 4% paraformaldehyde","findings demonstrate a critical time-period for anti-inflammatory intervention in a murine model of SCI and suggest that diclofenac be tested as an acute therapy for attenuating neurologic deficits following SCI in humans; establish a therapeutic window for diclofenac administration with efficacy observed up to at least 3 h, but 􏰅8 h, after SCI",not reported,"""Data availability: All data are available from the authors""",No,
Lucie,Tajkey et al.,2015,Comparative study on the effects of ceftriaxone and monocytes on recovery after spinal cord injury in rat,10.15171/apb.2015.026,English,,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,other group not of interest n = 10,female 100%,female,0,10 weeks,10,,,,Weeks,,range: [200-245](g),,,200,245,g,,level: not reported; severity: not reported,Not reported,Not reported,contusion,laminectomy + weight drop (10g metal rod dropped from a height of 5 cm),6 weeks,ceftriaxone,ceftriaxone,,200 mg/kg/day,not reported,,not reported,not reported,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,no details,weekly,,not reported,positive effect,significantly higher BBB scores in the ceftriaxone group from week 1 to week 6,histology,axonal regeneration,6 weeks,not reported,positive effect,significant increase in axon number in the ceftriaxone group compared to control group,"anesthesia: ketamine (80 mg/kg, IP), xylazine (10 mg/kg, IP); biotin dextran amine injected intracerebrally at week 4 after injury",ceftriaxone improves functional recovery more effectively than monocytes in rats after SCI,not reported,"also looked at the effect of monocytes in the study (not significantly different from control in BBB, same as drug of interest for axonal regeneration), but not extracted here since it is not a drug of interest; use ketamine",No,
Lucie,Lv et al.,2017,Geraniol promotes functional recovery and attenuates neuropathic pain in rats with spinal cord injury,10.1139/cjpp-2016-0528,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (geraniol),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Park et al.,2013,The Multifaceted Effects of Agmatine on Functional Recovery after Spinal Cord Injury through Modulations of BMP-2/4/7 Expressions in Neurons and Glial Cells,10.1371/journal.pone.0053911,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (agmatine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xu et al.,2008,Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord,10.1016/j.neuroscience.2008.02.065,English,,excluded,Non-sci population,,"Out of scope: no spinal cord injuery induced, no drug of interest (glutamate)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Schaal et al.,2012,"The Therapeutic Profile of Rolipram, PDE Target and Mechanism of Action as a Neuroprotectant following Spinal Cord Injury",10.1371/journal.pone.0043634,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Stys et al.,1995,PROTECTIVE EFFECTS OF ANTIARRHYTHMIC AGENTS AGAINST ANOXIC INJURY IN CNS WHITE-MATTER,10.1038/jcbfm.1995.53,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury (optic nerves),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fehlings et al.,2012,Early versus Delayed Decompression for Traumatic Cervical Spinal Cord Injury: Results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS),10.1371/journal.pone.0032037,English,,excluded,Out of scope,No drug tested,"Out of scope: STASCIS study, looking at effect of surgery not of a drug per se",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Choi et al.,2020,Incidence of acute spinal cord injury and associated complications of methylprednisolone therapy: a national population-based study in South Korea,10.1038/s41393-019-0357-2,English,,excluded,Out of scope,No assessments of interest,"Out of scope: looking at prescription rates and complications related to high dose methylprednisolone therapy, not looking at treatment effect",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Esposito et al.,2010,Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice,10.1371/journal.pone.0012170,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Olprinone),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yu et al.,2020,"Dihydrotanshinone I alleviates spinal cord injury via suppressing inflammatory response, oxidative stress and apoptosis in rats",10.12659/MSM.920738,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (dihydrotanshinone I, chinese medicine)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Bellver-Landete et al.,2019,Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury,10.1038/s41467-019-08446-0,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (looking at the importance of microglia),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Suzuki et al.,1995,Effects of GABAergic Drugs on the Recovery of Reflex Potentials after Spinal Cord Ischemia in Cats,10.1254/jjp.68.423,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (bicuculline, semicarbazide, aminooxyacetic acid)",,,cats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sobrido-Cameán et al.,2019,Serotonin inhibits axonal regeneration of identifiable descending neurons after a complete spinal cord injury in lampreys,10.1242/dmm.037085,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (5-HT-hydrochloride, WAY-100135, db-cAMP)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zheng et al.,2011,Effect of heparin following cervical spinal cord injuries in rats,10.1227/NEU.0b013e3182241f3b,English,,included,,,,,,rats,Sprague Dawley,62,>= 12,,,>= 12,,,"numbers unclear, 3 treatment and 3 control groups (one for each severity of injury)",female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-230](g),,,200,230,g,,"level: C7; severity: mild (0.6mm), moderate (0.9mm), severe (1.2mm) (3 groups)",C7,multiple,contusion,"laminectomy + contusion SCI (Louisville Injury System Apparatus, plunger velocity of 1.8 m/s, plunger-cord contact duration of 20 ms, 3 severity groups: 0.6, 0.9 and 1.2mm tissue displacement",72h or 7 weeks,heparin,heparin,,loading dose: 100 IU/kg; afterwards: 250 IU/kg,immediately after injury,,72h,"second dose 2h after injury, then every 4h for the first 24h, then every 5h for until 72h",multiple,loading dose: IV; maintenance: SC,neurological/functional/behavioral assessment,"BBB scale, Hargreave's test",,"BBB scale: 2 independent evaluators, Hargreave's test: evalutes sensory changes in the hindpaw with noxious stimuli, hindpaw on prewarmed Plexiglas floor at 32 degrees celsius, paw withdrawal latency averaged for 5 trials at 5-minutes intervals",BBB: weekly from week 1 to 6; Hargreave's test: baseline 1 day before SCI,,not reported,no effect,no significant difference for any of the test or severity category when comparing heparin treated animals to control animals,histology,"area of hemorrhage on pial surface, hemorrhagic volume, non perfused colume, lesion volume",72h or 7 weeks,not reported,mixed effects (assessment) + mixed effects (regimen),"increased the magnitude of subpial hemorrhage following SCI at all injury severities in heparing group compared to control; mild SCI group: heparin grouped significanlty decreased volume of blood extravasation, improved microvascular patency, smaller volume of nonperfused spinal cord, similar level of white matter sparing, all compared to control group; moderate and severe SCI: no difference in hemorrhagic volume, no difference in size of posttraumatic cyst compared to control","anesthesia: Nembutal (50 mg/kg, IP); prophylactuc gentamicin (0.01 mL/100g SC); euthanasia: anesthesia and transcardially perfused with 0.01M PBS followed by 4% prarformaldehyde (400mL/rat)","Heparin treatment following SCI is safe at all degrees of injury. Heparin decreases platelet aggregation and microvascular occlusion, providing a potential neuroprotective effect following mild SCI.",not reported,no severely injured rat survived for more than 3 days; use gentamicin,No,
Lucie,Black et al.,1988,Experimental spinal cord injury: effect of a calcium channel antagonist (nicardipine).,10.1227/00006123-198801010-00009,English,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Torres et al.,2009,Deleterious versus neuroprotective effect of metabolic inhibition after traumatic spinal cord injury,10.1038/sc.2009.27,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (pyrophosphate of thiamine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sunshine et al.,2017,Methylprednisolone Therapy in Acute Traumatic Spinal Cord Injury: Analysis of a Regional Spinal Cord Model Systems Database.,10.1213/ANE.0000000000001906,English,USA,included,,,,prospective,retrospective,human,traumatic spinal cord injury,311,151,,,160,,,,male: n=231 (74.3%),mixed,74.3,no MP: 44.8(1.3); MP: 42(1.2) (years),42,1.2,,,Years,,no MP: 187.1 (4.5); MP: 185 (3.0) (pounds),185,3,,,pounds,,"level n (%) no MP: cervical 82(54.3), thoracic 52(34.4), lumbar 13(8.7), sacral 2(1.3), unknown 2(1.3); level n (%) MP: cervical 103(83.1), thoracic 42(26.2), lumbar 12(7.5), sacral 0(0), unknown 3(1.9); severity n(%) no MP: AIS A 40(26.5), B 11 (7.3), C 24(15.9), D 73(48.3), unknown 2 (1.3); severity n(%) MP: AIS A 72(45.0), B 16 (10.0), C 31(19.3), D 35(22.0), unknown 6(3.7)","no MP: cervical 82(54.3), thoracic 52(34.4), lumbar 13(8.7), sacral 2(1.3), unknown 2(1.3); MP: cervical 103(83.1), thoracic 42(26.2), lumbar 12(7.5), sacral 0(0), unknown 3(1.9)","no MP: AIS A 40(26.5), B 11 (7.3), C 24(15.9), D 73(48.3), unknown 2 (1.3); MP: AIS A 72(45.0), B 16 (10.0), C 31(19.3), D 35(22.0), unknown 6(3.7)",trauma,"no MP n(%): automobile 22(14.6), motorcycle 17(11.3), fall 52(34.4), bicycle 11(7.3), water related 2(1.3), other 47(31.1); MP n(%): automobile 33(20.6), motorcycle 13(8.1), fall 60(37.5), bicycle 14(8.7), water related 7(4.3), other 33(20.6)","Days from hospital admission to rehabilitation admission: no MP 21.9(2.0), MP 17.8(1.8);  Days on rehabilitation unit: no MP 34(2.4), MP 39.8(2.2)",methylprednisolone,methylprednisolone,Yes,not reported,MP recipients if they had received MP within 72h of admission (usually in the first 8h),,both as a bolus and an infusion that completed 23 hours later,-,not reported,,motor scores,"ASIA motor score, FIM motor score","neurological (motor), functional (mobility)","The first primary outcome was the discharge ASIA motor score. The ASIA motor score is a standardized examination based on a meticulously performed strength assessment, as defined by ISNCSCI. It is calculated by summating motor grades (0–5 scale) recorded for 5 upper limb and 5 lower limb muscles bilaterally. The ASIA motor score ranges from 0 to 100. The second primary outcome was discharge FIM motor score. The FIM assessment measures motor and non-motor domains of function: social cognition, communication, mobility, sphincter control, self-care, and locomotion. The FIM motor score component represents the sum of the 13 specific motor items of the FIM assessment. Each motor item has a maximal level score of 7. Total scores range from a minimum of 13 to a maximum of 91.","at the time of hospital admission (for 75% of the patients), at rehabilitation admission (rehabilitation baseline scores), at discharge",,not reported (retrospective cohort study),no effect,"Adjusting for age, sex, weight, race, respective baseline motor score, surgical intervention, injury level, ASIA Impairment Scale (AIS) grade, education, and insurance status, there was no association with improvement in dis- charge ASIA motor function or FIM motor score among MP recipients: −0.34 (95% CI, −2.8, 2.1) and 0.75 (95% CI, −2.8, 4.3), respectively. Adjusting for age, sex, race, weight, injury level, and receipt of surgery, no association with increased risk of infection or GI complications was observed.",-,-,-,-,,-,no other drug reported,This retrospective cohort study involving patients with acute TSCI observed no short-term improvements in motor function among MP recipients compared with nonrecipients. Our findings support current recommendations that MP use in this population should be limited.,"(i) this study is unable to control completely for potential confounders; (ii) absence of detailed ASIA motor scores before rehabilitation admission (ie, at hospital admission) for approximately 25% of patients; (iii) FIM motor score was used to measure changes in function (not as sensitive as SCIM, ceiling effect)","MP retrospective study in human population showing no effect on recovery but also no increase in risk of pneumonia, UTI or any other infection",No,
Lucie,Faden et al.,1985,"Opiate antagonist WIN44,441-3 stereospecifically improves neurologic recovery after ischemic spinal injury",10.1212/wnl.35.9.1311,English,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kumar et al.,2018,Neutrophil elastase inhibition effectively rescued angiopoietin-1 decrease and inhibits glial scar after spinal cord injury,10.1186/s40478-018-0576-3,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Sivelestat sodium),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fan et al.,2016,Beneficial effects of early hemostasis on spinal cord injury in the rat,10.1038/sc.2016.58,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Szepanowski et al.,2016,Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling,10.1186/s12974-016-0612-9,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury (sciatic nerve crush instead),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lafci et al.,2013,Efficacy of iloprost and montelukast combination on spinal cord ischemia/reperfusion injury in a rat model,10.1186/1749-8090-8-64,English,,excluded,Out of scope,No drug of interest,combination of drug of interest + drug not of interest but no group assessing the drug of interest alone,,,rats,Sprague Dawley,21,7,,,7,,,sham n = 7,male 100%,male,100,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,level: below the left renal artery and above the aortic bifurcation; severity: not reported,thoracic,Not reported,ischemia,"laparotomy + ischemia (aortic occlusion) operation with cross clamping for 45 minutes: one proximal, just below the left renal artery and one distal, just above the aortic bifurcation",48 hours,"iloprost, montelukast",,,"iloprost: 25 ng/kg, montelukast: 1 mg/kg",both 30 minutes before and during the clamping procedure,,single dose,,intraperitoneally,,neurological/functional/behavioral assessment,motor deficit index (MDI): ambulation and placing/stepping reflex,,"two osbervers; ambulation: 0=normal (symmetrical and coordinated ambulation), 4=no movement or drags lower extrimities; placing/stepping reflex: 0=normal (coordinating lifting, placing and stepping responses observed when touching the hindpaw), 2=no response to pinch; max score was 6, motor deficit index calculated for each rat at each time interval","6, 12, 24, 48h after injury",,yes,negative effect,Motor deficit index scores at 24 and 48 hours after ischemia were significantly lower in the study group than in the control group,histopathological assessment,"neuronal cell degeneration, edema, inflammation, vascular congestion",48h after injury,yes,mixed effects,"no significant difference among the groups with respect to the neuronal cell degeneration, edema, or inflammation, but vascular congestion was found to be significantly more prominent in the control group than in the sham or in the study group (p = 0.05) [personal comment: borderline significant]","anesthesia: ketamine (50 mg/kg, IP), xylazine (5 mg/kg, IP), maintenance of anesthesia via intermittent delivery of ketamine; before incision: cephalosporine (10 mg/kg, IP); postop analgesia: tramadol per 12h; euthanasia: penthobarbital (20 mmg/kg); 400 IU/kg of heparin was administered IP to all animals immediately before the surgery procedure",This study suggests that in rat model of spinal cord injury prophylactic use of iloprost-montelukast combination may reduce ischemic damage of spinal cord via anti-inflammatory effects and may provide better neurological outcome.,preparation of the parenteral form of montelukast from oral tablets due to the absence of commercial parenteral form of this drug in our country,"I don't understand the positive conclusion while reporting significantly lower motor score in treated group compared to control, unless I missunderstood the results or the conclusion; potential bias in the conclusion since all animals were treated with heparin as well as the treatment to be tested (read some previous studies which were specifically looking at the effect of heparin)",,
Lucie,Nguyen et al.,2012,Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury,10.1186/1742-2094-9-224,English,,included,,,,,,rats,Wistar,135,>= 29,,,>= 27,,,sham >= 12,female 100%,female,0,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: C7-T1; severity: moderate-severe,C7 - T1,moderate - severe,compression,laminectomy + clip compression injury (35g modified aneurysm clip extradurally for 60s),"4h (biochemical analyses), 24h (immunohistochemical analysis), 6 weeks (histological analysis) after injury",IgG from pooled human serum,immune globulin,,0.4 g/kg,15 min after injury,,single dose,-,intravenously,,"neurobehavioal assessment, electrophysiology","inclined test, BBB, motor-evoked potentials (MEPs)",,"inclined test: evaluates forelimg, hind-limb and trunk control; BBB: 4 consecutive minutes, 2 observers, 21-point locomotor rating system; MEPs: electrodes positioned extradurally over the spinal cord under the vertebral arch of C3, constant current stimulus of 0.1ms in duration and 2.0 mA in intensity applied at a rate of 0.13Hz to the dorsum of either C1 or C3, 500 MEPs averaged, spinal axonal conduction velocity calculated by dividing the distanc ebetween the stimulating electrodes by the difference between the peak latencies of distal and proximal stimuli","weekly for inclined test and BBB, week6 after SCI for MEPs",,yes,positive effect,BBB and inclined test significantly greater in IgG-treated animals compared to the saline control group; IgG-treated animals had significantly faster conduction velocity compared to saline control animals,histological assessment,"area of scar and cavity, white matter area, grey matter, preserved tissue area",6 weeks,yes,positive effect,"IgG-treated animals had significantly less scaring at the injury epicenter, more preserved tissue compared to the saline-treated animals at the injury epicenter; overall treatment effect in the scar/caviation size and amount of tissue sparing in the IgG-treated animals; no effect caudal to the lesion?","postop: 1 mL buprenorphine (0.05 mg/kg), 5 mL saline immediately after SCI and subsequently every 12h for 3 days after surgery; euthanasia: overdose with pentobarbital, 180 mL of iced-cold Ringer's solution (biochemical analysis), overdosed with pentobarbital then perfused with 60 mL of ice-cold PBS and 180 mL of paraformaldehyde",IgG is a novel immuno-modulatory therapy which shows promise as a potential treatment for SCI.,not reported,"use buprenorphine, saline, pentobarbital",No,
Lucie,Zhang et al.,2014,Nerve growth factor improves functional recovery by inhibiting endoplasmic reticulum stress-induced neuronal apoptosis in rats with spinal cord injury,10.1186/1479-5876-12-130,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (nerve growth factor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kushchayev et al.,2016,Hyaluronic acid scaffold has a neuroprotective effect in hemisection spinal cord injury,10.3171/2015.9.SPINE15628,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (hyaluronan or hyaluronic acid gel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chen et al.,2019,"Hyperglycemia aggravates spinal cord injury through endoplasmic reticulum stress mediated neuronal apoptosis, gliosis and activation",10.1016/j.biopha.2019.108672,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (strptozotocin and 4-PBA (4-phenylbutyric acid for endoplasmic reticulum stress inhibition)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ueno et al.,2011,Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury,10.1038/sc.2010.116,English,,included,,,,,,rats,Sprague Dawley,8,4,,,4,,,,not reported,not reported,not reported,adults 10- to 12-week-old,,,10,12,Weeks,Adult,range: [280-320](g),,,280,320,g,,level: T10; severity: moderate incomplete,T10,moderate,contusion,"laminectomy + contusion injury: infinite horizon SCI device (1.5 N, 150 kdyn)",28 days,minocycline ,minocycline,,"90 mg/kg, then 45 mg/kg",immediately after injury,,3 days post injury,twice a day,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,one individual assessed BBB,"1, 3, 7, 14, 21, 28 days",,yes,positive effect,Behavioral assessments at 28 days post injury revealed that minocycline-treated rats had better hind limb motor function than did the control rats (p<0.05),-,-,-,-,,-,anestesia: barbiturate IP,pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI,not reported,paper focusing on evaluation of pNF-H as a biomarker rather than on treatment effect,No,
Lucie,Wang et al.,2009,Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth,10.1089/neu.2007.0464,English,,included,,,,,,rats,Sprague Dawley,47,22,,,25,,,control group shared with paper below,female 100%,female,0,11-12 weeks old (rats); 8-9 weeks old (mice),,,11,12,Weeks,,range: [250-270](g) (rats); 20g (mice),,,250,270,g,,"level: T7 (rats), T8 (mice); severity: moderate (rats), complete (mice)",T7,moderate,contusion,"laminectomy + rat: contusion injury (10g, 25mm, MASCIS impactor) or mice: complete transection (cutting spinal cord with microscissors, then cutting twice with a no11 blade scalpel)",either 2 weeks or 6.5 weeks after treatment initiation,"ibuprofen, naproxen (rats only)",ibuprofen,,500mg (70 mg/kg/day),3 days after injury,,28 days,"2.5 microL/hour, continuous",subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,BMS performed by 2 observers,"10, 20, 30, 50 days after injury",,yes,positive effect,BBB significantly improved for ibuprofen-treated group after 3 weeks compared to control PBS group (p <0.01); BMS with complete transection: trend towards higher scores in treated group with ibuprofen but not significant,histological assessment (rats only),area of spared tissue at the injury epicenter,2 and 6.5 weeks after injury,not reported,positive effect,"degree of sparing was greater in ibuprofen-treated group compared to control, both at 2 and 6.5 weeks (no statement on whether it is significant or not), attributable to neuronal protection","anesthesia: rats: ketamine (60 mg/kg), xylazine (10 mg/kg), mice: ketamine and xylazine IP; euthanasia: (rats) anesthesized and perfused transcardially with PBS followed by 4% paraformaldehyde/PBS solution ","administration of ibuprofen improves the recovery of rats from a clinically relevant spinal cord trauma by protecting tissue, stimulating axonal sprouting, and allowing a minor degree of raphespinal regeneration",not reported,,No,
Lucie,Wang et al.,2009,Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth,10.1089/neu.2007.0464,English,,included,,,,,,rats,Sprague Dawley,28,22,,,6,,,control group shared with paper above,female 100%,female,0,11-12 weeks old (rats); 8-9 weeks old (mice),,,11,12,Weeks,,range: [250-270](g) (rats); 20g (mice),,,250,270,g,,"level: T7 (rats), T8 (mice); severity: moderate (rats), complete (mice)",T7,moderate,contusion,"laminectomy + rat: contusion injury (10g, 25mm, MASCIS impactor) or mice: complete transection (cutting spinal cord with microscissors, then cutting twice with a no11 blade scalpel)",either 2 weeks or 6.5 weeks after treatment initiation,"ibuprofen, naproxen (rats only)",naproxen,,25 mg/kg/day,3 days after injury,,28 days,"2.5 microL/hour, continuous",subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,BMS performed by 2 observers,"10, 20, 30, 50 days after injury",,yes,no effect,BBB significantly improved for ibuprofen-treated group after 3 weeks compared to control PBS group (p <0.01); BMS with complete transection: trend towards higher scores in treated group with ibuprofen but not significant,histological assessment (rats only),area of spared tissue at the injury epicenter,2 and 6.5 weeks after injury,not reported,positive effect,"degree of sparing was greater in ibuprofen-treated group compared to control, both at 2 and 6.5 weeks (no statement on whether it is significant or not), attributable to neuronal protection","anesthesia: rats: ketamine (60 mg/kg), xylazine (10 mg/kg), mice: ketamine and xylazine IP; euthanasia: (rats) anesthesized and perfused transcardially with PBS followed by 4% paraformaldehyde/PBS solution ","administration of ibuprofen improves the recovery of rats from a clinically relevant spinal cord trauma by protecting tissue, stimulating axonal sprouting, and allowing a minor degree of raphespinal regeneration",not reported,,No,
Lucie,Wang et al.,2009,Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth,10.1089/neu.2007.0464,English,,included,,,,,,mice,C57/B16,47,11,,1,35,,,"2 treatment groups, n = 13 for 35 mg/kg/d and n = 22 for 70 mg/kg/d",female 100%,female,0,11-12 weeks old (rats); 8-9 weeks old (mice),,,8,9,Weeks,,range: [250-270](g) (rats); 20g (mice),20,,,,g,,"level: T7 (rats), T8 (mice); severity: moderate (rats), complete (mice)",T8,complete,transection,"laminectomy + rat: contusion injury (10g, 25mm, MASCIS impactor) or mice: complete transection (cutting spinal cord with microscissors, then cutting twice with a no11 blade scalpel)",at least 35 days (based on last measurement for BMS),"ibuprofen, naproxen (rats only)",ibuprofen,,20 mg (35 mg/kg/day) or 40 mg (70mg/kg/day),"""in the same surgery""",,28 days,"0.25 microL/hour, continuous",subcutaneous,,neurological/functional/behavioral assessment,Basso Mouse Scale (BMS),,BMS performed by 2 observers,"7, 14, 21, 28 and 35 days after injury",,yes,no effect,BBB significantly improved for ibuprofen-treated group after 3 weeks compared to control PBS group (p <0.01); BMS with complete transection: trend towards higher scores in treated group with ibuprofen but not significant,histological assessment (rats only),area of spared tissue at the injury epicenter,2 and 6.5 weeks after injury,not reported,positive effect,"degree of sparing was greater in ibuprofen-treated group compared to control, both at 2 and 6.5 weeks (no statement on whether it is significant or not), attributable to neuronal protection","anesthesia: rats: ketamine (60 mg/kg), xylazine (10 mg/kg), mice: ketamine and xylazine IP; euthanasia: (rats) anesthesized and perfused transcardially with PBS followed by 4% paraformaldehyde/PBS solution ","administration of ibuprofen improves the recovery of rats from a clinically relevant spinal cord trauma by protecting tissue, stimulating axonal sprouting, and allowing a minor degree of raphespinal regeneration",not reported,,No,
Lucie,Luo et al.,2002,Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury,10.1046/j.1471-4159.2002.01160.x,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury but isolated spinal cords instead,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ozkunt et al.,2017,Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.,10.1177/2309499017739481,English,,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-220](g) ,,,200,220,g,,level: T9; severity: not reported,T9,Not reported,contusion,bilateral laminectomy + contusion injury (extradural application of an aneurysm clip for 1 min),30 days,"methylprednisolone (MP), erythropoietin (EPO)",methylprednisolone,No,3 mg/kg,immediately after injury,Yes,single dose,-,intrathecally,,neurological/functional/behavioral assessment,BBB,,"1 observer, always the same","1, 24, 48 and 72h, then 1, 2, 3 and 4 weeks after injury",Yes,yes,no stats,"BBB at day 30 in EPO group increased from 1 to 12 on average (p<0.05), whilst the increases in BBB scores for control and MP were not significant (comparison within group at different time points but no comparison between control and EPO)",only immunohistochemistry,-,-,-,,-,"anesthesia: ketamine-xylazine (0.9cc/kg, IM) and penicillin for prophylaxis of infections (10'000 U/kg); euthanasia: lethal dose of sodium pentothal","EPO seems to better increase the expression of PDGF-beta, thus produce better results in locomotor functions when compared to MP",not reported,"comparison within group at different time points but no comparison between control and EPO; use keatmine, penicillin",No,
Lucie,Ozkunt et al.,2017,Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.,10.1177/2309499017739481,English,,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-220](g) ,,,200,220,g,,level: T9; severity: not reported,T9,Not reported,contusion,bilateral laminectomy + contusion injury (extradural application of an aneurysm clip for 1 min),30 days,"methylprednisolone (MP), erythropoietin (EPO)",epoetin,,5000 IU/kg,immediately after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,BBB,,"1 observer, always the same","1, 24, 48 and 72h, then 1, 2, 3 and 4 weeks after injury",,yes,no stats,"BBB at day 30 in EPO group increased from 1 to 12 on average (p<0.05), whilst the increases in BBB scores for control and MP were not significant (comparison within group at different time points but no comparison between control and EPO)",only immunohistochemistry,-,-,-,,-,"anesthesia: ketamine-xylazine (0.9cc/kg, IM) and penicillin for prophylaxis of infections (10'000 U/kg); euthanasia: lethal dose of sodium pentothal","EPO seems to better increase the expression of PDGF-beta, thus produce better results in locomotor functions when compared to MP",not reported,"comparison within group at different time points but no comparison between control and EPO; use keatmine, penicillin",No,
Lucie,Zakeri et al.,2014,Lithium Protects Against Spinal Cord Injury in Rats: Role of Nitric Oxide,10.1055/s-0033-1345098,English,,included,,,,,,rats,Sprague Dawley,72 - 90,08.Oct,,,32 - 40,,,other groups not of interest,male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g) ,,,200,250,g,,level: T9; severity: not reported,T9,Not reported,compression,"complete laminectomy + spinal compression with aneurysmal clip (60 sec, closing force of 113g - 1.17N, range: 1.15-1.41N; 5.0mm length, 3.5mm diameter (max opening))",30 days,"lithium, N^omega-nitro-L-arginine (not reported in the following columns)",lithium,,"1, 4, 10 or 20 mg/kg",1h before injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"score from 0 to 21 on weight baring, coordination of limb movements, use of individual joints, and coordination of joint movements (0 indicates no motor function, and 21 indicates full motor function), open field, 1 investigator, observation for 10 minutes, scoring for each leg and mean taken for each rat during every session","1, 3, 5, 7, 14, 21, and 28 days after SCI",,yes,mixed effects (dosage),"lithium 20 mgkg significantly improved locomotor score of rats with SCI, effect reversed when taken with L-NAME (N-nitro-L-arginine methyl ester hydrochloride)",histopathologic examination,"degree of neuronal loss and demyelination: 0=no change observable, 1+= mild changes, 2+=moderate changes, 3+= severe changes, 4+= very severe changes",30 days after injury,yes,mixed (stats/no stats),"lithium 20 mg/kg significantly reduced histopathologic scores when administered before SCI, effect reversed when taken with L-NAME (N-nitro-L-arginine methyl ester hydrochloride); lower dose not reported ","anesthesia: ketamine (100 mg/kg, IP), xylazine (10 mg/kg, IP); euthanasia: same anesthesia + right atrium cut and exsanguination, 100mL of soluation containing 4% paraformaldehyde in 0.1M PBS gradually injected into the aorta via the left ventricule",Lithium exerts a beneficial effect on locomotor scores and spinal histopathological changes after SCI through an NO-dependent mechanism,not reported,use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Teng et al.,2004,Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury,10.1073/pnas.0306239101,English,,included,,,,,,rats,Sprague Dawley,>= 40,>= 20,,,>= 20,,,numbers unclear,female 100%,female,0,not reported,,,,,,Not reported,range: [280-330](g),,,280,330,g,,level: T10; severity: not reported,T10,Not reported,contusion,contusion injury (10g * 12.5mm) using NYU impactor (they refer to another paper for more details),4 weeks,minocycline,minocycline,,90 mg/kg then 45 mg/kg,1h after injury ,,5 days,every 12h,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, inclined plane test, test of hind limb reflexes, toe spread reflex",,"reflexes: withdrawal reflex tested, toe-spread reflex; inclined plane test: downward and upward; BBB: open-field locomotion","1, 7, 14, 21, 28 days post injury",,"""randomized block design"" ?",mixed effects (assessment),"Greater return to a normal withdrawal reflex to an extension stimulus was noted in minocycline-treated rats vs. controls (70% vs. 25% of hind limbs; P =􏰉 0.010, Fisher’s exact test) at 4 weeks p.i; toe-spread reflex: no significant difference; inclined test:  In the upward-facing orientation, the performances of the two groups were not statistically different (P >􏰊 0.05). However, the minocycline-treated group showed a statistically significant improvement compared with controls in the downward-facing orientation (P = 􏰉 0.040) beginning on day 7 p.i. and persisting through the duration of the study; BBB: significantly improved in an overall statistical comparison (P 􏰉 = 0.033, repeated-measures ANOVA) and at days 21 and 28 p.i. of the post hoc analysis (P <􏰈 0.05, unpaired Student’s t test)",histopathologic examination,"lesion volume, spared white matter, gray matter sparring",4 weeks,yes,mixed effects (assessment),"no significant effect of minocycline on lesion area size or length of lesion; overall significant difference between the two groups in the average area of residual total white matter (P = 0.014, repeated-measures ANOVA) as well as at 2, 3, and 4 mm rostral and 3 and 4 mm caudal to the lesion epicenter on post hoc tests (P 􏰈= 0.03, unpaired Student’s t test); gray matter-sparing effect of minocycline and found no significant difference be- tween the two experimental groups (data not shown); Minocycline treatment significantly protected ventral horn neurons in the overall analysis (P 􏰈< 0.03, repeated-measures ANOVA) and 3 and 4 mm rostral to the epicenter, as well as 2, 3, and 4 mm caudal to the epicenter in post hoc analyses (P <􏰈 0.05, unpaired Student’s t tests)","anesthesia: ketamine (75 mg/kg, IP), xylazine (20 mg/kg, IP); euthanasia: deeply anesthetized and perfused intracardially with 0.1 M PBS followed by 4% paraformaldehyde in PBS",Our results demonstrate that minocycline administered systemically 1h after SCI significantly diminishes mitochondrial cytochrome c release resulting from SCI and reduces functional deficits starting 7 days p.i.,not reported,use ketamine,No,
Lucie,Wu et al.,2010,Effect of combined treatment with methylprednisolone and Nogo-A monoclonal antibody after rat spinal cord injury.,10.1177/147323001003800219,English,,included,,,,,,rats,Wistar,Not reported,Not reported,,,Not reported,,,nothing reported,female 100%,female,0,12 weeks old,12,,,,Weeks,,range: [250-300](g),,,250,300,g,,level: T8; severity: not reported,T8,Not reported,contusion,laminectomy + weight drop trauma,4 weeks,"methylprednisolone (MP), Nogo-66 antagnonist peptide (NEP1-40)",methylprednisolone,No,"60 mg/kg (first dose), 30 mg/kg (second dose)",immediately after injury,Yes,2 doses,immediately and after 4h,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"open field, from 0=complete paralysis to 21=normal locomotion, done in the morning between 9am and 12pm, observed for 5 min by 2 observers","1 and 3 days, 1, 2, 3, 4 weeks post-injury",Yes,yes,positive effect,MP and NEP1-40 groups significantly higher scores compared to trauma only group; combination group significantly higher than control and than MP or NEP1-40 only groups,histopathologic examination (electron microscopy technique),"cross-sectional grey and white matter, quantitative grading system",4 weeks,not reported,mixed effects (assessment),"fewer ED1-positive cells seen at the contusion site in both the MP-only and combined ttt groups compared to trauma control and NEP1-40-only ttt groups (statistically diifferent, p<0.05); grading scores for mitochondria, small- medium- large-sized myelinated axons all not significantly different between MP alone group and control group","anesthesia: 10% chloral hydrate (400 mg/kg, IP)","Taken together, combined treatment with NEP1-40 and MP tended to have a greater effect on functional and histological recovery than either treatment administered alone. These findings suggest an additive effect of administration of MP when combined with NEP1-40; combination treatment with MP plus NEP1-40 not only attenuated haematogenous inflammatory cell infiltration but also enhanced neuronal and oligodendrocyte survival following SCI",not reported,"not sure about the histological part, I don't know if this should be reported; Nogo test in animal model; use chloral hydrate",Yes (drug of interest + drug not of interest),
Lucie,Huang et al.,2009,Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK,10.1177/147323000903700227,English,,included,,,,,,rats,Sprague Dawley,60,20,,,20,,,sham n = 20,male 100%,male,100,not reported,,,,,,Not reported,"""weight of approximately 210 g""",210,,,,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + contusion injury (weight-drop, 10g weight from height of 50mm onto the exposed spinal cord and the impounder was left for 20s before being withdrawn)","1 day (histological), 7 days (immunohistochemical examinations)",erythropoietin,epoetin,,1000 IU/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB locomotor rating scale,,"circular enclosure, 5 min, 2 observers",1 day and 7 days,,not reported,positive effect,"erythropoietin-treated SCI group exhibited comparable yet significantly improved neurological function when compared with the saline group (P < 0.01), with a BBB score above 10 at 7 days after SCI",histopathologic/morphological changes,"cavities, haemorrhage, architecture of dorsal white and central grey matter, neuronal regeneration",1 and 7 days,not reported,no stats,"7 days after injury the architecture of the dorsal white and central grey matter had become more disrupted, and gliocytes filled the injury area in the saline-treated SCI group; in erythropoietin-treated SCI rats there was a smaller cavity volume compared with the saline-treated SCI group;  some neuronal regeneration in the erythropoietin-treated rats but little regeneration was seen in the saline-treated SCI group 7 days after injury and, moreover, lesions in the saline-treated SCI group were more severe than in the erythropoietin- treated SCI group","anesthesia: sodium pentobarbital (40 mg/kg, IP); euthanasia: lethal dose of sodium pentobarbital, saline perfusion, 300-400mL of fixative containing 4% paraformaldehyde in 0.1M PBS",erythropoietin reduces pathological changes and SCI severity via down- regulation of p-ERK and up-regulation of MKP-1,not reported,use pentobarbital,No,
Lucie,Lan et al.,2017,Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury,10.1371/journal.pone.0173814,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (basic fibroblast growth factor), gelatin only vehicule",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Johnson et al,1993,Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in rabbits.,10.1161/01.str.24.10.1547,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (flunarizine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lafci et al.,2008,Protection of the spinal cord from ischemia: Comparative effects of levosimendan and iloprost,10.1159/000121394,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (levosimendan, iloprost)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yeo et al.,2008,Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study,10.1159/000113764,English,,excluded,Out of scope,No control group,look at selenite+matrigel whilst we are only interest in selenite,,,rats,Wistar,40,10,,,30,,,,female 100%,female,0,"""260g or 6 weeks old rats""",6,,,,Weeks,,"""260g or 6 weeks old rats""",260,,,,g,,level: T9-T10; severity: total transection,T9 - T10,complete,transection,laminectomy + total transection (dorsal and ventral columns were cut by lowering microscissors attached to a sterotaxic arm to a depth of 3.5mm below the dorsal surface of the spinal cord and cutting twice),30 days,selenite,selenium,,"0, 10, 30, 50 mg/kg",immediately after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,BBB scale,,"21 different criteria of the movementof the hind limb from complete paralysis to complete mobility, 0=no hindlimb movement and 20=normal mobility","0, 7, 14, 21, 30 days (from the figure 5C)",,not reported,positive effect,"by the fifth day post-injury, motor recovery was significantly improved in the selenite-treated animals, and they continued to regain motor function, whereas no such effects were observed in the SCI control group; not significant at day 30? based on figure 5C",histopathologic examination,macrophage and microglia infiltration and activation,1 week,not reported,no effect,selenite treatment exerted no direct effects on macrophage invasio,"anesthesia: ketamine (75 mg/kg) and xylazine (10 mg/kg); euthanasia: anesthesia with sodium pentobarbital (60 mg/kg, IP), transcardial perfusion with 0.2M PBS followed by 4% paraformaldehyde in 0.1M phosphate buffer","administration of selenite prevents secondary pathological events in traumatic spinal cord injuries, and promotes the recovery of motor function in an animal model",not reported,"unclear report of BBB results, the different doses are not distinguished + histopatho reporting is looking at macrophages and microglia more than lesion characteristics and cavities",,
Lucie,Giroux et al.,2001,Comparison of the effect of intrathecal administration of clonidine and yohimbine on the locomotion of intact and spinal cats,10.1152/jn.2001.85.6.2516,English,,excluded,Out of scope,No control group,no control group,,,cats,not reported,3,,,,,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,not reported,,,,,,Not reported,level: T13; severity: complete injury,T13,,transection,laminectomy + complete transection using micro scissors,at least 3-4 weeks,"clonidine, yohimbine (reported only clonidine in the following as it is the only drug of interest)",,,"1.9-5.6 mM dissolved in saline solution (0.9%), not standardised","drug injected a first time after 3-4 week of training but before injury, then injury, then 3-4 weeks training and then re injection of the drug, not standardised",,"""drugs were injected several times on different days and at different concentrations"" (see figure 2: schedule and doses are all over the place), not standardised",-,intrathecally,,"electrophysiology, locomotion","kinematic analysis, reflex testing (electrical stimulation, fast paw shake)",,"locomotion: different speeds (0.2-0.8 m/s) and tilts (15 degree up or 15 degrees down) on a treadmill belt, walk on horizontal ladder with eight round rungs (3cm of diameter) spaced by about 20cm, recodrings on video tape, kinematic analysis with @d pwak performance system looking at x-y coordinated of different joint markers (iliac crest, femoral head, knee joint, lateral malleolus, metatarso-phalangeal or MTP joint and tip of the 4th toe) obtaines at a frequency of 60 fields/s, angular joint movements; reflex testing: electrical stimulation of superficial peroneal nerve by a signle pulse of 250 micros at 0.45 Hz, EMGs analysed and threshold of stimulation was set at the current value required to evoke a small short-latency (10 ms)response in the semitendinosus muscle in 50% of the trials, fast paw shake elicited by holding the cat in the aire and dipping the paw into a bowl of warm water, EMG signals recorded and analysed","locomotion: after implantation and before any drug injections, during each drug-injection trial, similar recording were done before and at different times after the drug injection",,not reported,mixed effects,"clonidine: cats were able to walk either on 15 degrees slopes or on a horizontal ladder, but decrese in cutaneous excitability; yohimbine: could not place correctly their hindfeet on the rungs and had major difficulty walking on slopes despite normal cutaneous excitability",histopathologic examination,-,-,-,,-,"surgery: 2% xylocaine, anesthesia with no further details; post op: 0.005-0.01 mg/kg SC og Buprenorphine (every 6h) for analgesia; euthanasia: overdose of pentobarbital sodium","although nordrenergic are still present and functional after spinal cord injury, they are seemingly not critical for the spontaneous expression of spinal locomotoin since their blockade by yohimbine does not impair spinal locomotion. It is postulated therefors that the expression of spinal locomotion must depedn on the activation of other types of receptors, probably related to excitatory amino acids",not reported,experimental protocol hard to follow for me,,
Lucie,Brustein et al.,1999,Recovery of locomotion after ventral and ventrolateral spinal lesions in the cat. II. Effects of noradrenergic and serotoninergic drugs,10.1152/jn.1999.81.4.1513,English,,excluded,Case report,,2 cats only with many drugs and no pre-defined timing --> not possible to disentagle a treatment effect from it,,,cats,not reported,2,,,,,,,,not reported,,,not reported (adults),,,,,,,4.1 and 2.8 kg,,,,,,,level: T13; severity: not reported,,,,ventral and ventrolateral spinal lesion,343 and 283 days after injury,"norepinephrine, clonidine, methoxamine, yohimbine, serotonin quipazine, DPAT, 5HTP",,," all in mM/100 microL, cat 1: norepinephrine: 0.8-4.7, clonidine: 0.6-5.6, methoxamine: 2-4, yohimbine: 12.8-20.5, serotonin: 2.4-7.1, quipazine: 0.6-2.2, DPAT: 1.5, 5HTP: 1.1-2.3; cat2: norepinephrine: 1.6-6.3, clonidine: 1.9-5.6, methoxamine: 4-6, yohimbine:12.8-20.5, serotonin: 1.2-2.3, quipazine: 1.2-3.4, DPAT: 1.5, 5HTP: 2.3-4.5","in days after injury, cat1: norepinephrine: 9,14,17,34,49,104,107,147,182, clonidine: 16,33,128,169,190,205,210, methoxamine: 196,198,203,239, yohimbine:205,210,212, serotonin: 42,44,120,126,175,177, quipazine: 224,227,231,234, DPAT:266,268, 5HTP: 280,282,287,289, cat2: norepinephrine: 6,8,21,23,70,135, clonidine: 14,65,76,84,86,91,98, methoxamine: 104,107, yohimbine: 84,86,91,98,100, serotonin: 16,35,63, quipazine: 112,119,127, DPAT: 154,156, 5HTP: 168, 170, 175",,single doses,,intrathecally,,"electrophysiology, locomotion",EMG activity,,,,,,,,histological assessment (mainly described in another paper),,,not reported,,major increase was observed in the number of HRP-labeled cells in the motor cortex controlateral to the less affected DLF as well as by changes in the distribution of the cells,,,,,,
Lucie,Benes et al.,2017,Regulation of axonal regeneration following spinal cord injury in the lamprey,10.1152/jn.00986.2016,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Shen et al.,2018,Induction of innervation by encapsulated adipocytes with engineered vitamin A metabolism,10.1016/j.trsl.2017.10.005,English,,excluded,Non-sci population,,Out of scope: no spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Labombarda et al.,2002,Cellular basis for progesterone neuroprotection in the injured spinal cord,10.1089/089771502753594918,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neuro or histo assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Puri et al.,1998,The human motor cortex after incomplete spinal cord injury: An investigation using proton magnetic resonance spectroscopy,10.1136/jnnp.65.5.748,English,,excluded,Out of scope,No assessments of interest,Out of scope: no treatment effect tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lee et al.,2003,Minocycline Reduces Cell Death and Improves Functional Recovery after Traumatic Spinal Cord Injury in the Rat,10.1089/089771503770195867,English,,included,,,,,,rats,Sprague Dawley,>= 65,31,,,31,,,"sham >= 3, unsure about the exact numbers",male 100%,male,100,not reported,,,,,,Not reported,range: [230-250](g) ,,,230,250,g,,level: T8-T11; severity: mild,T8 - T11,mild,contusion,"laminectomy + weight-drop contusion (10g rod, 2.5mm diameter dropped from a height of 12.5mm)","14, 21, 28 and 38 days",minocycline,minocycline,,"90 mg/kg (single bolus), 45 mg/kg afterwards",immediately after injury,,3 doses,every 12h,intraperitoneally,,neurological/functional/behavioral assessment,BBB locomotor rating scale,,,"before injury, day 1, and then twice weekly for up to 38 days",,yes,positive effect,BBB scores were significantly higher in minocycline-treated rats 24-38 days after SCI as compared to those in vehicule-treated rats (p<0.01),histopathologic examination,lesion area analysis: area of cavitation at the epicenter of the injury; TUNEL assay,"14, 21, 28, 38 days after injury",not reported,positive effect,"the lesion size in minocycline treated rats, when compared to that of vehicule control, was significantly reduced at both 28 and 38 days after SCI; number of TUNEL positive cells was significantly reduced in the treatment group comapred to control","anesthesia: chloral hydrate (50 mg/kg, IP); euthanasia: anesthesia and perfused intracardially with 0.1 M PBS pH 7.4 followed by 4% paraformaldehyde in PBS, pH 7.4","These data suggest that, after SCI, minocycline treatment modulated expression of cytokines, attenuated cell death and the size of lesions, and improved functional recovery in the injured rats.",not reported,use chloral hydrate,No,
Lucie,Taoka et al.,1990,Influence of Dietary Vitamin E Deficiency on Compression Injury of Rat Spinal Cord,10.3177/jnsv.36.217,English,,excluded,Out of scope,No drug of interest,"look at the effect of vit E but by giving either normal dosage of requirement of vit E (control) or deficit of vit E, so I am not sure how to report it because technically they are looking at the effect of deficiency of vit E, not treatment of vit E",,,rats,Wistar,>= 70,>= 11,,,>= 11,,,number very unclear,male 100%,male,100,not reported,,,,,,Not reported,"range: [120-140](g) at start of experiement, [280-320](g) requirement for performing the SCI",,,280,320,g,,level: T12; severity: not fixed (multiple weights used forthe different traumas),T12,multiple,compression,"laminectomy (C2, C3, T12, L1) + compression at T12 (10, 20 or 40g weight placed extradurally on spinal cord for 5 min, weight had a round concase lower surface of 6mm diameter and a square top of 2mm^2 area, which exactly fitted the spinal cord)","6h (histology), 1 week (motor function)",alpha-tocopherol acetate,vitamin e,,"2 IU (control), less than 0.1IU (vitamin E-deficient group) per 100g of diet",before injury,,6-8 weeks before injury,in food,oral,,"electrophysiology, motor assessment","spinal cord evoked potentials (SCEP), motor disturbance ",,"SCEP: method of Inoue: electrode for recording (distance of 0.3mm) placed on the posteromedial surface of the dural tube at C2, reference electrode placed at the same level as the recording electrode but in the paravertebrak muscle; SCEP were evoked by bipolar supramaximal stimulation (about 0.3 mA, 6Hz, 0.1ms duration) of the posteromedial dural tube at L1; motor function: Tarlov's criteria, 0=no voluntary movement, 1=perceptible movements at joints, 2=good movement at joints but inability to stand, 3=ability to stand and walk, 4=complete recovery","SCEP: before, during and after compression; motor grading: daily for 1 week after injury",,not reported,negative effect,motor grading: degree of motor disturbance was higher in group deficient in vitE than in control and proportional to the compression weight; SCEP: significantly lower amplitude and latency both with 10g and 20g compression in the group deficient in vitE compared to control ,histopathologic assessment,bleeding index = (area of bleeding/area of spinal cord in saggital section)*100,6h after injury,not reported,negative effect,areas of hemorrhage were significantly different in the two groups with the extent of hemorrahge being greater in vitamin E deficiency,"anesthesia: sodium pentobarbital (2.1mg/100g, IP)",These results suggest that vitamin E may have a protective effects against ischemic spinal cord injury by its antioxidant effect,not reported,careful in interpretation of result (double negation): negative effect in case of deficiency in vitE,,
Lucie,Luo et al.,2004,Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury,10.1089/0897715041651097,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neuro or histo assessment,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ridella et al.,1986,Compression of Rat Spinal Cord in Vitro: Effects of Ethanol on Recovery of Axonal Conduction,10.1089/cns.1986.3.193,English,,excluded,Out of scope,Ex-vivo,Out of scope: spinal cord compression but isolated spinal cords (outside the animal),,,rats,Fischer,65,,,,,,,,male 100%,,,not reported (adults),,,,,,,range: [200-300](g) ,,,,,,,level: ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chiduka et al.,2014,Mortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative database,10.1136/emermed-2012-202058,English,Japan,excluded,Out of scope,No assessments of interest,Out of scope: human recovery not looking at motor recovery but specifically looking at adverse events,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kopp et al.,2016,SCISSOR - Spinal Cord Injury Study on Small molecule-derived Rho inhibition: A clinical study protocol,10.1136/bmjopen-2015-010651,English,,excluded,Out of scope,Other,"Out of scope: clinical study protocol, no data reported in it",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lin et al.,2016,Inhibition of Autophagy by Estradiol Promotes Locomotor Recovery after Spinal Cord Injury in Rats,10.1007/s12264-016-0017-x,English,,included,,,,,,rats,Sprague Dawley,120,>= 24,,,>= 24,,,sham >= 48; very little details on the group sizes,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-220](g) ,,,200,220,g,,level: T9; severity: not reported,T9,Not reported,compression,"ovariectomy (7 days before SCI) + laminectomy + crush injury by compression with a vascular clip (15g force, 1 min)","1, 3, 7 and 28 days after injury",estradiol benzoate (E2),estradiol,,"20 nmol/L (high dose), 0.5 mg/kg",7 days before injury,,until sacrifice,every other day,intramuscular,,neurological/functional/behavioral assessment,"BBB scale, inclined plane test",,BBB: open field; both: 2 investigators,"before injury, 7, 14, 21 and 28 days after injury",,yes,positive effect,Both the BBB locomotor score test and the inclined plane test showed functional improvement in locomotor activity on day 28 after SCI (p<0.01),histopathologic examination,"necrosis, area of defect","day 1, 3, 7 and 28 after injury",not reported,no stats,"Compared with the vehicle group, E2-treated rats showed a significant protective effect of treatment via reducing necrosis and area of defect; motor neurons were significantly retained in the spinal cord of rats treated with E2 compared to the vehicle group following SCI","ovariectomy: 10% chloral hydrate anesthesia (4 mL/kg, IP); SCI: disinfected with iodine and alcohol; euthanasia: 10 % chloral hydrate IP, transcardially perfused with normal saline followed by 4% paraformaldehyde in 0.1 mol/L PBS overnight","E2 distinctly reduced the extent of dam- age after SCI, minimizing the loss of motor neurons and promoting locomotor recovery. We report for the first time that the neuroprotective action of E2 in SCI is related to the restraint of excessive autophagy. Our current study sug- gests that a therapeutic strategy applying E2 may be a promising treatment for recovery from central nervous system injury.",not reported,use chloral hydrate,No,
Lucie,Faden et al.,1981,Opiate antagonist improves neurologic recovery after spinal injury,10.1126/science.7455690,English,,included,,,,,,cats,Not reported,22,13,,,9,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,range: [2-3](kg) ,,,2,3,kg,,level: C7; severity: moderate,C7,moderate,contusion,"laminectomy + dura intact, weight drop (allen's method, 20g lead weight, distance of 25 cm, i.e. 500 g.cm, onto a 10 mm^2 plastic impact plate contoured to matched the curve of the spinal cord)",3 weeks,noloxone hydrochloride,naloxone,,2mg/kg/h,45 minutes after injury,,4h,continuous,intravenously,,neurological/functional/behavioral assessment,Tarlov scale,,"2 investigators; 5-point scale: 0=absence of voluntary movement, 1=minimal voluntary movement, 2=good voluntary movement but inability to support, 3=ability to support weight, but unable to walk, 4=ability to walk, but with substantial spasticity, ataxia or both, 5=normal function; scale was modified to allow for half-point scoring in order to describe neurologic function falling between points; based on reference 10, this should be (modified) Tarlov scale","24h, 1, 2 and 3 weeks",,yes,positive effect,"neurological recovery was significantly better in naloxone-treated animals than in saline-treated controls at 1,2 and 3 weeks (p<0.05)",-,-,-,-,,-,"anesthesia: pentobarbital (30 mg/kg, IV), paralyzed with gallamine trietiodide; euthanasia: IV pentobarbital",naloxone treatment can significantly improve functional neurologic recovery after cervical spinal injury,not reported,use pentobarbital,No,
Lucie,Holtz et al.,1991,Blocking Weight-Induced Spinal Cord Injury in Rats: Therapeutic Effect of the 21-Aminosteroid U74006F,10.1089/neu.1991.8.239,English,,included,,,,,,rats,Sprague Dawley,44,8,,,8,,,"3 groups not of interest, see table 1",male 100%,male,100,not reported,,,,,,Not reported,range: [320-390](g),,,320,390,g,,level: T7-T8; severity: moderate and severe (MP is only severe),T7 - T8,severe,compression,laminectomy + load application (35g or 50g for 5 minutes with aid of a slightly curved rectangular plate 2.2*5.0mm),4 days,"methylprednisolone (MP), 21-aminosteroidU74006F(21-AS, not reported afterwards as it is not a drug of interest), MP administered only in a group injured with 50g load",methylprednisolone,No,30 mg/kg,1h after injury,,single dose,-,not reported,,neurological/functional/behavioral assessment,inclined plane technique,,capacity angle = maximum inclination at which the rats could maintain themselves perpendicular for 5 seconds,daily for 4 days,No,not reported,no effect,"all three groups loaded with 50g (MP, other treatment and control) exhibited equal impariment of motor function, no restoration of function was observed in these three groups over the 4 day period before they were killed",-,-,-,-,,-,"anesthesia: 4.25% chloral hydrate and 1% pentobarbital (1.2-1.5 ml, IP)","results suggest that after weight-induced spinal cord trauma,U74006F is associated with improved neurologic function in moderately injured, but not severely injured animals",not reported,"few data on MP, which is there in only severely injured rats and not the main object of study; use chloral hydrate, pentobarbital",No,
Lucie,Nie et al.,2018,Inhibition of mammalian target of rapamycin complex 1 signaling by n-3 polyunsaturated fatty acids promotes locomotor recovery after spinal cord injury,10.3892/mmr.2018.8583,English,,excluded,Out of scope,No drug of interest,"combination of omega 3 and 6 tested, but omega 6 is not of interest and no group with omega 3 alone",,,rats,Sprague Dawley,90,30,,,60,,,,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-250](g) ,,,200,250,g,,"level: T10; severity: ""paralysis of both hind limb""",T10,paraplegia,contusion,laminectomy + Allen's method,"8 weeks (behovioral), 12h (immunofluoresence), 2 weeks (western blotting)",n-3/n-6 polyunsaturated fatty acids (omega3/6),,,"low omega3/6 diet: 9.5g/kg diet of omega3, 10.29 g/kg diet of omega 6, n3/n6: 0.923; high omega3 diet: 48.18g/kg diet of omega3, 6.82g/kg diet of omega 6, n3/n6: 7.04; control: 6.41g/kg diet of omega3, 54.01g/kg diet of omega 6, n3/n6(ratio): 0.118",start feeding one week before injury,,until end of experiment,,oral,,"motor function, electrophysiological assessment","BBB scale, motor-evoked potential (MEP)",,"BBB: open-field, score rangin from 0 to 21, two observers; MEP: 5 rats from each group, head of electrodes inserted into the scalp at the motor cortex and the end into the quadriceps muscle, latency and amplitude were detected according to manufacturer's instructions, measruements performed three times for each rat",BBB: day 1 and then weekly upt o 8 weeks post op; MEP: week 8 post injury,,not reported,positive effect,"Compared with the group fed a low-n-3 PUFA diet and the control group at each time-point, BBB scores of the rats in the high-n-3 PUFA diet group were higher, but the group that received n-3 PUFA lavage had much higher scores (P<0.05. Rats in the high-n-3 PUFA diet group showed shorter latency times of motor evoked potential (5.3±0.32 msec) and higher amplitude (60.30±4.72 msec) than those in the low-n-3 PUFA diet group (6.19±0.42 and 33.19±4.49 msec, respectively) or the control group (9.51±0.39 and 31.61±4.22 msec, respectively), and all differences were statistically significant (P<0.05). These results indicate that the high-n-3/n-6 PUFA diet was more effective in promoting functional recovery.",-,-,-,-,,-,"anesthesia: 10% chloral hydrate, 40 mg/kg; wound sterilized; post op: saline for rehydratation (5 ml, IP), prevention of infection via penicillin (100 mg/kg) for 3 days","results suggest that exogenous dietary n-3 PUFAs can inhibit mTORC1 signaling and enhance autophagy, promoting functional recovery of rats with SCI",not reported,,,
Lucie,Impellizzeri et al.,2012,"Effect of fasudil, a selective inhibitor of rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma",10.1124/jpet.111.191239,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (fasudil),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gorio et al.,2007,"Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord",10.1124/jpet.107.123679,English,,included,,,,,,rats,Sprague Dawley,>= 72,>= 18,,,>= 18,,,"sham >= 18, one other group not of interest >= 18",not reported,not reported,not reported,not reported (adults),,,,,,Adult,range: [240-260](g) ,,,240,260,g,,"level: T9, severity: not reported",T9,Not reported,contusion,"laminectomy + UTS impactor (metallic rod with flat end of 2-3mm diameter, force of 1 Newton for 1s applied)",5 weeks (last behavioral assesment),"methylprednisolone sodium succinate (MP), reparixin (not reported afterwards since it is not a drug of interest)",methylprednisolone sodium succinate,No,30 mg/kg,30 min after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"BBB, ladder walk test, sensory function (hot plate/cold stimulation)",,"BBB scale: open field, standard hot-plate test and cold stimulation: placed on hot-plate and laatency to licking was measured, cold stimulation tested by the application of ethyl chloride spray on the palmar surface, response rated as 1=no response, 2=brief withdrawal with licking, 3=vocalisation withdrawal with licking and aversion; walk on ladder: 1m long horizontal ladder with metal rungs elevated 30 cm from the ground, counted the number of errors in placing of the right hind limb and averaging errors from the three passes for each animal","BBB scale and standard hot-plate test and cold stimulation: evaluated at the first 24h after injury and then twice a week, walk on ladder: one week before the lesion, weekly from the 14th day until up to 5 weeks after surgery",,yes,no effect,"BBB : Methylprednisolone treatment resulted in an early transient improvement of locomotor recovery; after 10 days, no difference with saline treat ment was observed; MPSS Administration Did Not Affect the Rate of Hind Limb Recovery and Was Identical to Saline (Data Not Shown).","histology, cavities","lesion epicenter and total T9 segment cavitation, percent cavitation was calculated as the area of cavitated tissue divided by the area of the total cross-section at the level of the injury",4 weeks after injury,not reported,no effect,tissue degeneration (cavity size) was unaffected when 30 mg/kg MP was applied compared to saline control; percentage of spared tissue was not significantly different in MPSS group compared to control both at the lesion epicenter at throughout T9,"anesthesia: 4% chloral hydrate (10 ml/kg, IP); postop: buprenorphine (0.03 mg/kg) for pain and penicillin G (10'000 U/kg) as antimicrobial agent; euthanasia: inhalation of halothane and fixed by a 4% paraformaldehyde in isotonic PBS at pH 7.4 via transcardial perfusion",Methylprednisolone was used as a reference drug; such treatment reduced cytokine production but failed to affect the rate of hind limb recovery.,not reported,"use buprenorphine, chloral hydrate, penicillin",No,
Lucie,Züchner et al.,2018,Rapid recovery and altered neurochemical dependence of locomotor central pattern generation following lumbar neonatal spinal cord injury,10.1113/JP274484,English,,excluded,Out of scope,No drug tested,Out of scope: no treatment tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ravikumar et al.,2005,Nicotine attenuates morphological deficits in a contusion model of spinal cord injury,10.1089/neu.2005.22.240,English,,included,,,,,,rats,Long Evans,34,10,,,20,,,sham n = 4,male 100%,male,100,9-10 weeks old,,,9,10,Weeks,,range: [225-275](g) ,,,225,275,g,,level: T10; severity: moderate SCI,T10,moderate,contusion,"laminectomy + weight drop (10g from 12.5mm, impact rod removed immediately following the injury)",42 days,nicotine,nicotine,,0.35 or 7 mg/kg,2 h after injury,,14 days,"daily, (7 mg/kg dose was administered in four injections of 1.75 mg each, 30min apart)",subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,"black molded-plastic open field (120cm diameter, 25cm wall height) for 4 min, 2 observers, 21-point ordinal scale ranging from0 (which is no distinct hindlimb movement) to 21 (whichis consistent and coordinated gait with parallel paw place-ment  of  the  hindlimb  and  consistent  trunk  stability), the functional locomotor scores of left and right hindlimb movements were averaged.",day2 post injury and then once a week for a period of 6 weeks,,yes,no effect,The  general  profile  of  behavioral  recovery  was  similar  in  all  rats  with  SCI;  however  the  animals  which  received  injections  with  nicotine  exhibited  a  trend  of  better recovery as compared to untreated rats with SCI (not significant),histopmorphometry,"tissue destruction, cavitation, volume of gray and white spared tissue, vacuolization, volume of central cavity, cavity volume",42 days after injury,not reported,mixed effects (assessment) + mixed effects (dosage),"central cavity volume significantly lower in 7mg group compared to control, spared tissue and spared white amtter significantly higher in 0.35mg compared to control, spare tissue epicenter significantly higher in both treatment groups compared to control; all other comparisons between treatment and control groups were not significant","anesthesia: pentobarbital (40 mg/kg); postop: analgesia: buprenorphine hydrochloride (buprenex, 0.3 mg/kg, SC) twice daily for 2 days; euthanasia: sodium pentobarbital and transcardially perfused with 100 mL of cold 0.1 M PBS followed by 400 mL of 4% paraformaldehyde in PBS","the  present  study  is  the  first  research  report  which  demonstrates  that  chronic  nicotine  administration  can  promote  sparing  of  spinal  cord  tissue  fol-lowing contusion injury to the thoracic spinal cord. In addition, these effects were correlated with a general trendin  recovery  of  hindlimb  locomotor  functions  in  animalstreated with nicotine. Thus, these experimental results indicate that administration of nicotine may decrease neurodegeneration in SCI and enhance the repairing mechanisms in injured spinal cord tissue.",not reported,"use buprenorphine, pentobarbital",No,
Lucie,Ma et al.,2019,Insulin-like growth factor-1 enhances neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism,10.18632/aging.102568,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (miRNAs isolated from exosomes, insulin growth factor-1)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Chen et al.,2016,Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury,10.1111/jnc.13639,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest with reported outcomes and comparison to control group,,,rats,Sprague Dawley,,,,,,,,,male 100%,,,not reported,,,,,,,range: [200-250](g) ,,,,,,,level: T10; severity: moderate SCI,,,,"laminectomy + weight drop contusion (NYU impactor, 10-g rod dropped from 25 mm)",4 weeks,"phenelzine sulfate salt (not reported afterwards as it is not a drug of interest), hydralazine hydrochloride (drug of interest is hydralazine)",,,5 or 25 mg/kg,2 injections: 3 min after injury and 24h after injury,,2 injections,-,intraperitoneally,,neurological/functional/behavioral assessment,"mechanical allodynia, locomotion function (BBB scale)",,paw withdrawal threshold in response to mechanical stimuli,,,,,,,,,,,,"anesthesia: ketamine (80 mg/kg, IP), xylazine (10 mg/kg, IP); postop: 3 mL saline SC to prevent dehydratation",,,,,
Lucie,Hill et al.,2011,Interleukin-17 deficiency improves locomotor recovery and tissue sparing after spinal cord contusion injury in mice,10.1016/j.neulet.2010.10.057,English,,excluded,Out of scope,No drug tested,Out of scope: no treated study but comparison between wild type and IL-17 knock out mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al.,2018,Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation,10.1111/jcmm.13368,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (salidroside),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Grasmueck et al.,2004,Survival rates and outcomes in cats with thoracic and lumbar spinal cord injuries due to external trauma,10.1111/j.1748-5827.2004.tb00236.x,English,,excluded,Out of scope,No drug tested,Out of scope: no treatment examined,,,cats,,30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lombardi et al.,2009,Ten years of phosphodiesterase type 5 inhibitors in spinal cord injured patients.,10.1111/j.1743-6109.2008.01205.x,English,,excluded,Review,,Out of scope: review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,10,,,15,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",methylprednisolone,No,30 mg/kg,15 min or 2h after injury,Yes,2 or 5 shots,6h interval,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",Yes,yes,no effect,BBB in MP alone group not significantly different compared to control group,histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,positive effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",No,
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,10,,,10,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",polyethylene glycol,,1 g/kg,15 min after injury,,2 shots,6h interval,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",,yes,no effect,BBB in PEG alone group not significantly different compared to control group,histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,no effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",No,
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,10,,,10,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",magnesium sulfate,,500 micromol/kg,15 min after injury,,2 shots,6h interval,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",,yes,no effect,BBB in MgSO4 alone group not significantly different compared to control group,histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,positive effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",No,
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,10,,,5,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",magnesium sulfate + polyethylene glycol,,MgSO4: 500 micromol/kg + PEG: 1g/kg,15 min after injury,,2 shots,6h interval,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",,yes,positive effect,BBB significantly better in MgSO4+PEG compared to control,histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,positive effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",Yes (drug of interest + drug of interest),
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,20,,,75,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",magnesium chloride + polyethylene glycol,,MgCl2: 127 or 190 or 254 micromol/kg + PEG: 1 or 1.65 or 2 g/kg,15 min or 2h or 4h or 8h after injury,,2 or 5 shots,infusion duration of 10 or 30 minutes,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",,yes,mixed effects (dosage) + mixed effects (timing) + mixed effects (regime),"ttt with MgSO4 or pEG alone resulted in scored which were not significantly improved over the saline controls, however in the gorup of MgSo4+PEG formulation, locomotor scored was singificanlty improved upon the saline control (p=0.0501); an incresing number of infusions of MgCl2 in PEG promoted a significantly improved locomotor scores compared to saline, doubling bolus of MgCL2 improved locomotor scores signficantly; MP alone not significant, MgCl2 and MgCl2+MP significantly better than saline",histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,positive effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",Yes (drug of interest + drug of interest),
Lucie,Know et al.,2009,Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: Preclinical refinement and optimization,10.1089/neu.2009.0884,English,,included,,,,,,rats,Sprague Dawley,125,10,,,10,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [200-225](g),,,200,225,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion injury (impactor Infinite Horizon with force of 150 kdyn, impactor tip of diameter of 2mm was positioned over the exposed dura)",6 weeks,"MgSO4, PEG and combination of both, MgCl2, methylprednisolone",methylprednisolone + magnesium chloride + polyethylene glycol,,"MgSO4: 244 micromol/kg or 60 mg/kg, PEG: 1g/kg; MgCl2: 127 micromol/kg or 254 micromol/kg; MP: not reported?",2h after injury,,5 shots,infusion duration of 10 minutes,intravenously,,neurological/functional/behavioral assessment,BBB locomotor test,,"21point scale, 12 point Ferguson transformation was applied given locomotor recovery in the middle levels of the BBB scale","prior to surgery, day 3 and 7 post injury and then once per week over 6 weeks",,yes,positive effect,BBB significantly better in MgCl2+PEG+MP compared to control,histological assessment,"lesion size, tissue loss, lesion volume",6 weeks after injury,yes,positive effect,"when compared to saline controls, the lesion volumes were significantly less for MgSO4 (p=0.03) and for MGSO4+PEG (p=0.0012) but the effect of PEG alone was not significant (p=0.1625); significant decresed in volume lesion with incresing number of shot of MgCl2, decresed lesion volume with single and double dose of MgCl2 compared to saline, more significant for double dose, no difference in lesion volume between MgCl2 and MgSO4, lesion volume significantly decresed in MgCl2 and MgCl2+MP compared to saline and MP alone, decrese in lesion volume more important the earlier the MgCl2 was given (but lesion volume still significantly reduced if treatment at 8h post injury)","anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: IP sodium pentobarbital","series of experiments performed to chracterise, refine and optimise a magnesium treatment regimen for acute SCI, protective effect for secondary damage with a delay of drug administration up to 8h post-injury",not reported,"BBB barely significantly improved (p=0.0501); weird study design: look at the optimisation of number of shots, dose and effect with MP etc using MGCl2 but then use MgSO4 in the other experiments?; use ketamine, pentobarbital",Yes (drug of interest + drug of interest),
Lucie,Nehrt et al.,2010,Polyethylene glycol enhances axolemmal resealing following transection in cultured cells and in Ex vivo spinal cord,10.1089/neu.2009.0993,English,,excluded,Non-sci population,,Out of scope: isolated spinal cords,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kachadroka et al.,2010,Effect of Endogenous Androgens on 17 beta-Estradiol-Mediated Protection after Spinal Cord Injury in Male Rats,10.1089/neu.2009.1069,English,,included,,,,,,rats,Sprague Dawley,250,>= 81,,,>= 81,,,"sham group, numbers recalculated based on number provided for each assessment",male 100%,male,100,2 months old,2,,,,Months,,range: [250-300](g),,,250,300,g,,level: T8-T9; severity: moderate to severe,T8 - T9,moderate - severe,compression,gonadectomy + laminectomy + compression (extradurally for 3 s),4 and 28 days,17b-estradiol,estradiol,,"0.0, 0.05, 0.5, or 5.0 mg",30 min after injury,,21 days,continuous,subcutaneous,,neurological/functional/behavioral assessment,BBB locomotor test,,"1.2m diameter metal smooth-surfaced activity chamber, 4 min, two investigators, discrepancy discussed and scored to the deficit, score for each hindlimb and averaged, range from no movement (0) to normal walking with coordinated fore-hindlimb stepping and normal paw placement (21), used a transformation of the BBB scale developed specifically to improve the metric propertied in evaluation of animals with moderate to severe SCI","3, 7, 14, 21 and 28 days after injury",,yes,mixed effects (dosage),"In rats that received a gonadectomy prior to injury, post-SCI administration of either the 0.5- or 5.0-mg pellet of E2 significantly improved the BBB open-field scores on days 14, 21, and 28 compared to the group receiving the placebo (0.0 mg) pellet;  Similarly, in gonad-intact male rats, administration of the 0.5- or 5.0-mg pellet of E2 significantly improved the BBB open-field locomotor score compared to the placebo group on post-SCI days 7, 14, 21, and 28, and days 14, 21, and 28 respectively; no effect when 0.05-mg",histological assessment,"quantification of cell number, quantitative analysis of spare myelin, TUNEL assay",4 and 28 days after injury,yes,mixed effects (dosage),"post-SCI administration of either the 0.5- or 5.0-mg E2 pellet causes significant preservation of white matter, and that levels of gonad-derived testosterone did not alter estrogen-induced white-matter sparing;  in the gonadectomized rats, significantly more neurons were present in either the 0.5- or 5.0-mg E2 pellet groups than in the placebo (0.0 mg) group . A similar trend was seen in gonad-intact rats in that more neurons were visualized in the 0.5- and 5.0-mg treatment groups than in the placebo (0.0 mg) or 0.05-mg treatment groups; TUNEL positive significantly reduced with 0.5mg and 5.0mg treatment but not 0.05mg","anesthesia: ketamine/xylazine mixture (70/30 mg/kg, IP); post op: Ringer's solution for fluid replacement and hydratation, 5 mg/kg carprofen and 0.1 mg/kg enrofloxacin SC for fluid replacemnt and presention of pain and infection respectively; euthanasia: deeply anesthetised with Fatal Plus (100 mg/kg) and perfused intracardially with cold 0.1M PBS followed by 4% paraformaldehyde for 20 min","17b-estradiol is an effective therapeutic intervention for reducing secondary damage after SCI in males, which could be readily translated to clinical trial",not reported,use ketamine,No,
Lucie,Holtz et al.,1991,"MK 801, an OBS N-methyl-D-aspartate channel blocker, does not improve the functional recovery nor spinal cord blood flow after spinal cord compression in rats.",10.1111/j.1600-0404.1991.tb04964.x,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (MK 801 aka Dizocilpine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Roman et al.,2011,Single-walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury,10.1089/neu.2010.1409,English,,included,,,,,,rats,Sprague Dawley,58,16,,,36,,,sham n = 6,female 100%,female,0,2 months old,2,,,,Months,,range: [250-300](g),,,250,300,g,,level: T9; severity: complete,T9,complete,transection,laminectomy + complete transection SCI induced by severing the spinal cord with a MicroFeather ophthalmic scalpel,35 days,SWNT-PEG (single-walled carbon nanotubes with polyethylene glycol),polyethylene glycol,,"acute administration: 10 microg/mL in 25 microL, 10 microg/mL in 50 microL; delayed administration: 25 microL with 1 microg/mL, 10 microg/mL or 100 microg/mL",acute: 5 min after injury; delayed: 1 week after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"BBB test, kinematic analysis with the CatWalk gait analysis system, hindpaw withdrawal threshold for mechanical allodynia, tail-flick test",,"BBB: range from 0 (no hindlimb movement) to 21 (no impairment in walking or gait), 1.2m-diameter metal smooth-surfaced activity chamber for 4 min, two investigators, discrepancies in scores were discussed and scored to the deficit, score for each hindlimb and averaged; kinematic analysis: glass walkway and a 60 Hz. camera digitally records the pawprints, gait analysed frame by frame; mechanical allodynia: stimulation with a series of calibrated von Frey filaments, stimulus of 2g, 4g, 6g, 8g, 15g, 26g, 60g to the plantar surface of the hindpaw while the animal stood on a wire grid, the lowest filaments receiving at least 50% positive response of 5 trials (at least 3 positive responses) was recorded as the conclusive sensitivity level using the up-down method, only animals with plantar placement evaluated; tail-flick test: radiant heat source of a tail-flick unit focused on the rat's tail 3-5cm from the tip, tail-flick latency measured in seconds by a timer connected to a photoelectric cell that upon movement of the tail stopped the timer and the heat, two trials and latencies were averaged","BBB: pre-injury, once each week for the following 35 days; kinematic analysis: one day pre-injury, once every week for 35 days; mechanical alllodynia: not reported; tail-flick test: weekly evaluation",,"BBB yes, others not reported",mixed (stats/no stats),"delayed treatment: BBB: 100 microg/mL group had significantly higher BBB score ath day 35 compared to control; max hindpaw print area catwalk kinematic: 100 microg/mL group had trend toward increased max hindpaw print area but not significant, allodynia: no significant differences in tail-flick latency were observed between for any treatment (no increased sensibility to heat induced by high dose of treatment)",histological assessment,"quantification of lesion volume, cystic cavities, corticospinal tract (CST) axonal counting",35 days,"lession volume and corticospinal tract axonal count: yes, others not reported",mixed effects (assessment) + mixed effects (dosage) + mixed effects (timing),"delayed treatment: group with 10 microg/mL and 100 microg/mL had significantly more CST axons than control group, group with 100 microg/mL had significantly smaller lesion volume compared to the control group; early treatment: both 25 microL and 50 microL groups had more CST axons than control group","postop care twice daily: isotonic saline (5 ml SC BID), enrofloxacin (5 mg/kg SC QD), carprofen (1 mg/kg SC BID) for 7 days post-op; euthanasia: overdose of pentobarbital and perfused with 4% paraformaldehyde","post-SCI administration of SWNT-PEG decreased lesion volume, increased neurofilament-positive fibers and corticospinal tract fibers in the lesion, and did not increase reactive gliosis; post-SCI administration of SWNT-PEG induced a modest improvement in hindlimb locomotor recovery without inducing hyperalgesia; suggest that SWNT-PEG may be an effective material to promote axonal repair and regeneration after SCI",not reported,use saline,No,
Bobo,Bu et al.,2018,Intramuscular injection of estradiol combined with bone marrow mesenchymal stem cell transplantation for spinal cord injury,10.3969/j.issn.2095-4344.0410,Chinese,,included,,,,,,rats,Sprague Dawley,144,36,,,36,,,"rats were randomly divided into 4 groups: combined group, BMSC group, estradiol group and control group",not reported,not reported,Not reported,3-4 weeks old,,,3,4,Weeks,,range: [250-350](g),,,250,350,g,,level: T7; severity: not reported,T7,Not reported,contusion,laminectomy + weight drop (Allen tool 10g x 5cm),"3, 7 days and 4 weeks",estradiol,estradiol,No,250 microg/kg,not reported,,single dose,-,intramuscular,,neurological/functional/behavioral assessment,BBB locomotor test,,21 point scale,"1, 4 weeks post injury",,not reported,no stats,"BBB scores were higher at 1 and 4 weeks post injury for estradiol group compared to control (saline group), but statistics were calculated based on bone marrow transplant + estradiol ",immunohistochemistry,"superoxide dismutase levels, malondialhyde levels, cell apoptosis",3 and 7 days after injury,not noted,no stats,level of superoxide dismutase is higher and malondialdehyde levels are lower in estradiol group compared to control group; apoptotic rates of spinal cord cells are lower in the estradiol group compared to control (stats were conducted only on combined theray group),,conclusions were not drawn on estradiol group ,not reported,,,
Lucie,Loske et al.,2012,Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode,10.1111/j.1471-4159.2012.07657.x,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (26mer peptide, derived from C3 ADP-ribosyltransferase)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fakhri et al.,2020,Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation-mediated Sensory and Motor Dysfunction in a rat Model of Compression Spinal Cord Injury.,10.2174/1874467213666201230101811,English,,included,,,,,,rats,Wistar,45,15,,,15,,,sham n = 15,male 100%,male,100,not reported (adults),,,,,,Adult,range: [230-270](g),,,230,270,g,,level: T8-T9; severity: severe,T8 - T9,severe,compression,laminectomy + aneurysm clip with a 90 g force for 60s,"14, 21, 28 days",melatonin,melatonin,,"10 microL, 0.004M",30 min after injury,,single dose,- ,intrathecally,,"neurological/functional/behavioral assessment, pain","BBB test, Von Frey test, acetone drop test, inclined plane test",,"Von Frey test: increasing forces (10, 15, 26, 60 and 100 gram-forces), each filament was used five times on the palmar surface of the claw with 5 s intervals. The filament-induced paw withdrawal, flinching, biting, and licking were defined as positive responses. Three out of five stimuli were considered the threshold of allodynia as a positive response, both left and right paws were evaluated in response to the stimulation of filaments; acetone drop test: wire mesh network on an acrylic cage, 100 μL of acetone from a 2 cm distance, according to the drawback of the hind claw, responses were categorized and scored as (0) no paw withdrawal, (1) startle response without paw withdrawal, (2) slight paw withdrawal, (3) prolonged paw withdrawal (5-30 s), (4) repetitive and prolonged paw withdrawal (30 s) and (5) licking and flinching; BBB score: box with 90 cm2 surface and 10 cm surrounding walls for 5 min, scored in the range of 0 (hind limbs full paralysis) to 21 (normal walking), average scores of both left and right hind paws were determined per time point to obtain the average; inclined plane test: wood plane (60×40cm) capable of being inclined at the angles of 0° (horizontal) to 70°, biggest angle in which rats could stay for 5 s, was analyzed by two blinded observers, the mean angle was determined at the same time points.",von frey: weekly till day 28; acetome drop test: not reported; BBB: before surgery and weekly till 28 days; inclined plane test: not reported,,yes,positive effect,"von frey, BBB test, acetone drop test, inclined test all significantly better in the treatment group compared to control",histological assessment,"extent of spared myelin, mean of number of dorsal horn sensory neurons, spared myelin percentage (normal-myelinated tissue area  divided by the whole spinal cord area), mean survived sensory neurons on the gray matter of both dorsal horns","day 14, 21 or 28 after injury",not reported,positive effect,MEL treatment significantly preserved the white matter normal staining and reduced myelin loss at different time points post-SCI (p < 0.05); MEL significantly improved the neuronal survival (p < 0.05 and p <0.01),"anesthesia: keatmine (80 mg/kg), xylazine (10 mg/kg), ethanol 70% to disinfect instruments; postop: twice a day normal SC saline (2mL) to prevent dehydration, IP cefazolin to prevent infections (40 mg/kg)","The results suggest melatonin as a promising candidate for medical therapies with advantageous effects on improving functional recovery through suppressing inflammatory mediators, and attenuating spinal tissue damages","As no FDA approved drug has been so far introduced to be used as a positive control in such studies, our study has a minor limitation in this regard","use ketamine, cefazolin, saline",No,
Lucie,Wu et al.,2013,Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury,10.1089/neu.2012.2622,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (riluzole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Saunders et al.,1987,Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue.,10.1111/j.1471-4159.1987.tb03388.x,English,,excluded,Out of scope,No assessments of interest,Out of scope: no histological or functional assessment,,,cats,Mongrel,,,,,,,,,not reported,,,not reported,,,,,,,range: [2-4](kg),,,,,,,level: L2; severity: not reported,,,,laminectomy + compression (place tip of rod extradurally and compress the spinal cord with a 170-g weight for 5 min),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,McMahon et al.,2009,Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury,10.1111/j.1469-7580.2009.01107.x,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cyclosporin A),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hook et al.,2009,Intrathecal morphine attenuates recovery of function after a spinal cord injury,s,English,,included,,,,,,rats,Sprague Dawley,24,8,1,,16,7,,unclear if the dead animals were replaced to reach n = 8 and n = 16 or if control = 7 and treatment = 9,male 100%,male,100,90-110 days old,,,90,110,Days,,range: [300-350](g),,,300,350,g,,level: T12-T13; severity: moderate,T12 - T13,moderate,contusion,"laminectomy + weight drop (onto intact dura, MASCIS device, 10g impactor outfitted with a 2.5mm tip to drop 12.5mm)",21 days,morphine sulfate,morphine sulfate,,"0, 30 or 90 microg dissolved in 2 microL of distilled water followed by 20 microL of saline to flush the catheter",24h after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"BBB scale, ladder walk test, beam walk test, sensory function (paw withdrawal), nociceptive reactivity (thermal shock threshold tested through tail-flick test)",,"BBB: open field, acclimated 5 min per day for 3 days prior to surgery, observed for 4 min, locomotor scores transformed to be amendable to parametric analyses (pooling of 2-4 and 14-21); ladder walk test: habituation 8 min per day for 3 days, cross a horizontal ladder (20cm wide, 37 rungs at 2.5cm spacing) to reach a black box, counted number of foot slips; beam walk: same habituation as ladder test, traverse a tapered beam (0.375-6.75 in wide), average width across the 2 legs was used as an index of beam walk performance; sensory/noiciception: incremented shock and radiant heat, time to paw withdrawal","BBB: once per day for 1 week (days 2-7), every other day (days 9-15), every third day (18-21); ladder and beam test: end of 3-week after injury; sensory: day 21",,"BBB: yes, rest: not reported",mixed effects (dosage) + mixed effects (assessment),"motor response to heat at acute stage: tail-flick lattency significantly increased in both treatment groups compared to control (negative effect); voice response to heat at acute stage: no significant difference between groups (no effect); motor response to shock at acute stage: no significant difference between groups (no effect); voice response to shock at acute stage: lattency to vocalize significantly increased in both treatment groups compared to control (negative effect); BBB: dose-dependant attenuation of locomotor recovery, high dose treatment group recovered significantly less motor function than control (negative effect); tapered beam and ladder walk tests: no significant difference between groups on beam walk (no effect), 30microg and 90microg group significantly different in ladder walk (more missteps for higher dose), but no comparison with control (difference seems not significant from plot) (no effect to negative effect?); no effect of morphine on either motor or vocal reactivity to mechanical stimuli, heat or shock stimuli assessed at 21 days (chronic stage)",histological assessment,"total cross-sectional area, spared tissue",21 days after injury,yes,mixed effects (assessment),"no effect of morphine at the lesion center, for any histological indice. The relative lesion (damage + missing), and areas of remaining gray and white matter were comparable across groups, no significant effects of drug dose were found caudal to the injury site; Morphine significantly affected the relative lesion area and the area of gray matter remaining rostral to the injury site. Although there was no main effect of dose on the relative lesion, there was a significant Dose􏰀*Section Level interaction (p < 0.05)","anesthesia: isoflurane (5% gas), maintained with 2-3% isoflurane; infection prevention: penicillin G potassium (100'000 units/kg) immediately after surgery and again 2 days later; euthanasia: deep anesthesia (100 mg/kg pentobarbital, IP), perfused intracardially with 4% paraformaldehyde","data presented here suggest that morphine given in the acute phase of a contusion injury, and particularly i.t. mor- phine, can severely compromise recovery of function at multiple levels",not reported,higher mortality and autophagia with increasing doses of morphine ,No,
Lucie,Garcia-Ovejero et al.,2014,"Progesterone reduces secondary damage, preserves white matter, and improves locomotor outcome after spinal cord contusion",10.1089/neu.2013.3162,English,,included,,,,,,rats,Wistar,24,8,,,8,,,sham n= 8,male 100%,male,100,12 weeks old (young adults),12,,,,Weeks,Adult,range: [300-335](g),,,300,335,g,,level: T8; severity: moderate to severe contusion,T8,moderate - severe,contusion,"laminectomy + contusion (Infinite Horizon device, force of 200 Kdyn with no additional dwell time)",60 days,progesterone,progesterone,,16 mg/kg/day,1h after injury,,until sacrifice (60 days),daily,subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, Catwalk-automated quantitative gait analysis, mechanical sensitivity, thermal sensitivity",,"BBB: 2 trained observers, 4 min, movement elicited by the touch of an examiner were not scored, 0=nomovement of the hindlimb, 21=normal locomotion as observed in unlesioned rats, score includes criteria such as joint movements, weight support, forelimb-hindlimb coordination and tail position, corrected open field BBB using objective assessments of coordination with the CatWalk system, CatWalk: 5 uninterrupted runs considering ""consistent coordination"" when regularity index scored 100% in 5/5 runs, to ""no coordintation"" when RI scored 100% in 0/5 runs, also sued the BBB subscoring scale to improve the sensitivity of the BBB by scoring the higher motor functions (toe clerance, predominant paw position, trunk stability andd tail position) regardless of the other BBB parameters, adding them together to yield a single score (max score of 13); CatWalk measures a large number of both static and dynamic gait parameters and enables quantitative assessment of locomotion, following criteria had to be met for walkway crossing: 1) rat crossed the walkway without any interruption or hesitation with a cosistent pace, 2) a minimum of five correct crossings with about four step cycle, 3) only runs with stable crossing time of the runway between3 nd 4 seconds were included, left and right gait parameters were averaged; sensory function: sugared cereal reward, average value of three readings was used as the tolerance trheshold for each hindpaw, mechanical sensitivity: dynamic plantar aesthesiometer, wire mesh floor over the stimulator unit, metal filament applied to the center of the palmar surface of the hindpaw, and upward force was increased from 1 to 50g over 15sec, force at withdrawal was recorded for both hindpaws, themarl sensitivity: plantar test according to Hargreaves method, light source positioned under center of palmar hindpaw, turn off when rat lift paw, 20-sec cutoff to prevent tissue damage, thermal withdrawal latency was recorded for both hindpaws","BBB: 3,7,14,30 and 60 days after SCI (with CatWalk); CatWalk for gait analysis: before surgery, day 14, 30 and 60 after injury; sensory (mechanical reactivity, thermal sensitivity): 60 days after injury",,"BBB: yes, rest: not reported",positive effect,"CatWalk-modified BBB and BBB subscores significantly better in treatment group compared to control, gait analysis: base support, stride length, duty cycle, swing significantly better in treatment group compared to group with SCI without treatment; coordination (regulatiry index, diagonal pairs, ipsilateral pairs, pelvic girdle) significantly better in treatment group compared to non treatment after SCI; neither progesterone nor SCI induced mechanical or thermal allodynia after 60 days of SCI",histological assessment,quantification of axonal profiles: axonal preservation expressed as percentage of total axonal profile in white matter with respect to sham animals; tissue sparing; edema volume; total volume of spinal cord at the epicenter region,60 days after injury,not reported,mixed effects (assessment),"increase in spred white matter preservation in treatment gorup compared to non treatment, progesterone increased the oligodendrocytes number and reduced myelin damage, improved axonal preservation compared to no treatment; no difference in spared grey matter, ","anesthesia: sodium pentobarbital (IP, 45 mg/kg) and xilagesic (2% xylazine, 10 mg/kg), atropine (50 microg/kg, low dose) to reduce salivary and bronchial secretions and to avoid the induction of bradycardia and possible acrdiac arrest by the surgery or xylazine, artifical tears to present corneal abrasion and infection ; postop: SC buprex (buprenorphine, 0.05 mg/kg) and proophylactic SC antibiotic injection 1h after lesion and on the following day (baytril, enrofloxacine, 1 mg/kg); euthanasia: anesthesized andthranscardially perfused with 4% paraformaldehyde in 0.1M PB)",progesterone treatment significantly improved motor outcome as assessed using the Basso-Bresnahan-Beattie scale for locomotion and CatWalk gait analysis,not reported,"use pentobarbital, atropine",No,
Catherine,Erol et al.,2016,Investigation of neuroprotective effects of topiramate as an antiepileptic agent in experimental spinal cord injury model,10.5606/tftrd.2016.67760,Turkish,,included,,,,,,rats,Wistar,40,,,,,,,8 per group,male 100%,male,100,not reported,,,,,,Not reported,280g (range: 250-320g),280,,250,320,g,,level: T7-T10; severity: not reported ,T7 - T10,Not reported,compression,laminectomy+clipping method (aneurysm clip),24 hrs,methylprednisolone,methylprednisolone,,30mg/Kg,3h after injury,,single dose,single dose,intraperitoneally,,neurological/functional/behavioral assessment,"Tarlow scale, incline plane test method",,"Tarlow scale: Grade I - flat paralysis, Grade II - Minimal voluntary movemen of the hind limbs, Grade III - Able to stand, active to support the trunk, but unable to walk, Grade IV - Gait is present, but there is incoordination and spasticity, Gade V - normal gait;

The subject is placed on a platform that was placed parallel to the ground on a smooth surface and could be opened up to 60 degrees
when necessary. Then, the inclination of the platform is increased by 10 degrees and the highest angle at which the subject could stand without falling for 5 seconds is accepted as the inclined plane angle.","Tarlow scale: first day after injury
Incline plane test: first day after injury",No,Not reported,positive effect,"Tarlow scale: not reported
Incline plane test: treated group performed significantly better than the untreated control group",histological assessment,quantification of lesion volume,24hrs after injury,not reported,positive effect,minimal edema and near-normal gray and white matter findings in treated group when compared to untreated group,not reported,"Based on biochemical markers, histological examination, and motor function evaluation data in the acute spinal cord trauma model created in rats, 
topiramate possess neuroprotective effect and can be used in the acute treatment of spinal cord traumas, but more studies are needed on this subject",none reported,,,
Catherine,Erol et al.,2016,Investigation of neuroprotective effects of topiramate as an antiepileptic agent in experimental spinal cord injury model,10.5606/tftrd.2016.67760,Turkish,,included,,,,,,rats,Wistar,40,,,,,,,8 per group,male 100%,male,100,not reported,,,,,,Not reported,280g (range: 250-320g),280,,250,320,g,,level: T7-T10; severity: not reported ,T7 - T10,Not reported,compression,laminectomy+clipping method (aneurysm clip),24 hrs,topiramate,topiramate,,30mg/Kg,3h after injury,,single dose,single dose,intraperitoneally,,neurological/functional/behavioral assessment,"Tarlow scale, incline plane test method",,"Tarlow scale: Grade I - flat paralysis, Grade II - Minimal voluntary movemen of the hind limbs, Grade III - Able to stand, active to support the trunk, but unable to walk, Grade IV - Gait is present, but there is incoordination and spasticity, Gade V - normal gait;

The subject is placed on a platform that was placed parallel to the ground on a smooth surface and could be opened up to 60 degrees
when necessary. Then, the inclination of the platform is increased by 10 degrees and the highest angle at which the subject could stand without falling for 5 seconds is accepted as the inclined plane angle.","Tarlow scale: first day after injury
Incline plane test: first day after injury",,Not reported,positive effect,"Tarlow scale: not reported
Incline plane test: treated group performed significantly better than the untreated control group",histological assessment,quantification of lesion volume,24hrs after injury,not reported,positive effect,minimal edema and near-normal gray and white matter findings in treated group when compared to untreated group,not reported,"Based on biochemical markers, histological examination, and motor function evaluation data in the acute spinal cord trauma model created in rats, methylprednisolone possess neuroprotective effect and can be used in the acute treatment of spinal cord traumas, but more studies are needed on this subject",none reported,,,
Lucie,Kotil et al.,2006,Investigation of the dose-dependent neuroprotective effects of agmatine in experimental spinal cord injury: A prospective randomized and placebo-control trial,10.3171/spi.2006.4.5.392,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (agmatine aka guanidine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Streijger et al.,2016,The Evaluation of Magnesium Chloride within a Polyethylene Glycol Formulation in a Porcine Model of Acute Spinal Cord Injury,10.1089/neu.2016.4439,English,,included,,,,,,other,Yucatan miniature pigs,22,6,,,6,,,sham n = 4,female 100%,female,0,not reported,,,,,,Not reported,22.19 (0.28)(kg),22.19,0.28,,,kg,,level: T10; severity: not reported,T10,Not reported,contusion,laminectomy + weight drop (50g weight dropped from 20 cm and an additional 100g was added for 5 min to provide sustained extradural compression),12 weeks,"magnesium chlroide within a polyethylene glycol (AC105), magnesium sulfate (MgSO4)",magnesium chloride + polyethylene glycol,,"5 mL/kg, 39.1 mg/mL of MgCl2",4h after injury,,"28h, 5 doses",every 6h,intravenously,,neurological/functional/behavioral assessment,"porcine thoracic behavior scale, 2D hindlimb kinematics during weight-supported treadmill locomotion",,"behavior scale: videotape, 10 different stages ranging from no active hindlimb movements (score 1) to normal ambulation (score of 10), score of 1-3 = ""hindlimb dragging"", scores 4-6= varying degrees of steeping ability, scores 7-10 reflect varying walking ability; 2d kinematic: 6min walking at 1.5 mph without interruption, sampling rate of 60 frames per second, reflective markers on each animal's four hindlimb joints inclusing fetlock joints, hock joint, stigle joint and hip joint, camera based assessment, looked at joint angle trajectories, gait cycle, swing phase, mean trajectories of joints","behavior scale: before injury, 1 week psot-injury and then weekly for 12 weeks in total; 2D kinematic: preop, 2 weeks postop and then weekly until the end of the experiement (week12)",,not reported,no effect,behavior scale: no significant differences between treatment groups (including control); 2d kinematic: SCi animals treated with MgSO4 and AC105 showed similar ability to perform stepping on the tredmill compared to the saline-treated group,histological assessment,quantification of tissue sparing (distribution of spared white and gray matter): calculated as the percentage of total area of the spinal cord with lesion epicenter located centrally,12 weeks after injury,yes,no effect,quantification of spared white and gray matter area showed no difference between saline- and MgSO4-treated animals; no significant difference was observed between treatment groups,,did not observe a neuroprotective effect with administration of AC105 in the large animal model of SCI,not reported,"larger animals, very detailles",Yes (drug of interest + drug of interest),
Lucie,Streijger et al.,2016,The Evaluation of Magnesium Chloride within a Polyethylene Glycol Formulation in a Porcine Model of Acute Spinal Cord Injury,10.1089/neu.2016.4439,English,,included,,,,,,other,Yucatan miniature pigs,22,6,,,6,,,sham n = 4,female 100%,female,0,not reported,,,,,,Not reported,22.19 (0.28)(kg),22.19,0.28,,,kg,,level: T10; severity: not reported,T10,Not reported,contusion,laminectomy + weight drop (50g weight dropped from 20 cm and an additional 100g was added for 5 min to provide sustained extradural compression),12 weeks,"magnesium chlroide within a polyethylene glycol (AC105), magnesium sulfate (MgSO4)",magnesium sulfate,,47.4 mg/kg,4h after injury,,"28h, 5 doses",every 6h,intravenously,,neurological/functional/behavioral assessment,"porcine thoracic behavior scale, 2D hindlimb kinematics during weight-supported treadmill locomotion",,"behavior scale: videotape, 10 different stages ranging from no active hindlimb movements (score 1) to normal ambulation (score of 10), score of 1-3 = ""hindlimb dragging"", scores 4-6= varying degrees of steeping ability, scores 7-10 reflect varying walking ability; 2d kinematic: 6min walking at 1.5 mph without interruption, sampling rate of 60 frames per second, reflective markers on each animal's four hindlimb joints inclusing fetlock joints, hock joint, stigle joint and hip joint, camera based assessment, looked at joint angle trajectories, gait cycle, swing phase, mean trajectories of joints","behavior scale: before injury, 1 week psot-injury and then weekly for 12 weeks in total; 2D kinematic: preop, 2 weeks postop and then weekly until the end of the experiement (week12)",,not reported,no effect,behavior scale: no significant differences between treatment groups (including control); 2d kinematic: SCi animals treated with MgSO4 and AC105 showed similar ability to perform stepping on the tredmill compared to the saline-treated group,histological assessment,quantification of tissue sparing (distribution of spared white and gray matter): calculated as the percentage of total area of the spinal cord with lesion epicenter located centrally,12 weeks after injury,yes,no effect,quantification of spared white and gray matter area showed no difference between saline- and MgSO4-treated animals; no significant difference was observed between treatment groups,,did not observe a neuroprotective effect with administration of AC105 in the large animal model of SCI,not reported,"larger animals, very detailles",No,
Lucie,Ji et al.,2005,Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury,10.1111/j.1460-9568.2005.04241.x,English,,included,,,,,,rats,Long Evans,>= 35,8,,,not reported,,,"2 other treatment groups not of interest, n = 19 amd n = 8",female 100%,female,0,7 weeks old,7,,,,Weeks,,not reported,,,,,,Not reported,"level: T6-7; severity: complete? ""hemisection completely interrupting the main dorsomedial and minor dorsolateral corticospinal tract)",T6 - T7,incomplete,transection,laminectomy + CST transection (dorsal hemisection was performed completely interrupting the main dorsomedial and the minor dorsolateral corticospinal tract (CST) components. A micro-scalpel was used to stereotaxically transect the cord at a depth of 1.8 mm from the surface of the cord),4 weeks,"methylprednisolone, soluble Nogo-66 receptor (NgR(310)ecto-Fc)",methylprednisolone,No,30 mg/kg,immediately after injury,Yes,3 doses,"immediately, 4h and 6h after injury",intravenously,,neurological/functional/behavioral assessment,"BBB, footprint analysis",,"BBB: open field; footprint analysis: plantar surface of the paws painted with nontoxic dye and footprints marked over consecutive steps, stride length was quantified as the mean distance between hindlimb print for at least three strides per animal","BBB: day2 after injury and weekly thereafter for 4 weeks, footprint analysis: 4 weeks after injury",Yes,"BBB: yes, footprint analysis: not reported",mixed effects (assessment),"BBB: A statistically significant increase in BBB score was observed in MP- and MP plus Nogo-treated rats the day after surgery compared with control animals or animals treated with Nogo-Fc alone,aAll rats (100%) treated with Nogo or MP or combined therapy demonstrated consistent plantar stepping and coordinated movement by 4 week (BBB>14); footprint analysis: Improved functional recovery was also demonstrated as significantly improved mean stride length in Nogo- and Nogo+MP-treated groups compared with controls. MP treatment alone did not significantly improve stride length measured 4 weeks after SCI",histological assessment,axon counts,28 days (4 weeks) after injury,yes,mixed effects (assessment),"The number of axons contacting α- and/or γ-motor neurons was significantly increased inMP group compared to control overall, but not when looking at gray matter, ventral white matter and forsal white matter separately","anesthesia: Midazolam (2.5 mg/kg, IP), 2-3% fluothane in O2, general anesthesia maintained at 1.55-2% Fluothane in O2; postop care: analgesia with buprenorphine/buprenex (0.05 mg/kg SC) every 8-12h for 3 days, antibiotic treatment (ampicillin, 100 mg/kg, SC twice daily) for 7 days after surgery; euthanasia: anesthesia with Inactin (100-110 mg/kg, IP), transcardially perfused with heparinized saline (100 mL, 10 iu heparin) followed by 4% paraformaldehyde (150 mL)",Combined treatment with Nogo and MP had a more pronounced effect on recovery of function and axonal growth compared with either treatment alone. The data demonstrate that Nogo and MP act in a temporally and mechanistically distinct manner and suggest that they may have complementary effects.,not reported,"looking at the combined effect of Nogo and MP; use buprenorphine, ampicillin",Yes (drug of interest + drug not of interest),
Lucie,Doyle et al.,2004,Functional recovery and axonal growth following spinal cord transection is accelerated by sustained L-DOPA administration,10.1111/j.1460-9568.2004.03658.x,English,,included,,,,,,other,yellow eel Anguilla anguilla L.,50,15,,,20,,,sham n = 15,not reported,not reported,not reported,not reported,,,,,,Not reported,64.4(6.2)(g) [length: 245-400mm],64.4,6.2,,,g,,level: level of 13 segments caudal to the anus (about 60% of the total body length); severity: clear cut,level of 13 segments caudal to the anus (about 60% of the total body length),incomplete,transection,"spinal cord carefully approched through the dorsal epaxial musculature, exposed by removing a small dorsal part of three vertegrae and cut with microscissors",7 to 128 days,L-DOPA,levodopa,,50 mg/kg,one injection once a day for 5 days each week until they were killed,,until death,once a day for 5 days per week,intraperitoneally,,functional recovery,swimming performance,,"swimming performance in swim tunnel, swam against water pumped through a transparent tube at varying rates, recorded onto tape; looked at tail beat frequency (tail beat/s), caudal amplitude (mean amplitude of the beat measured at the tail) vs the water velocity = swimming speed of the fish (expressed as body lengths/s)","once before surgery, and at several stages throughout the recovery period (as per Doyle et al, 2001), seems to be day 8, 20 37 after injury",,not reported,mixed (stats/no stats),"when stationary in the tunnel, spinal swimming was noticeably faster in L-DOPA-treated fish and were moved active and for longer compared to control; when placed in swim tunnel: linear relationship between beat frequency and swimming speed was still evident, max values of slope from this relationship were smaller in L-DOPA treated animals (compared to ?); The statistical tests revealed that l-DOPA-treated eels displayed a different pattern of recovery of tail beat frequency overall when contrasted with the untreated controls (?); caudal amplitudes no longer different from presurgery levels for control eels after 30 days, but full recovery never witnessed in L-DOPA-treated fish",histology,axonal growth,"7, 20 and 40 days after injury",not reported,mixed (stats/no stats),"L-DOPA-treated eels at day 7 were not different in distribution of axons from the controls; at 20 days, significiantly more axons had extended between 2 and 4 mm than in the controls but max limit of growth cones was similar and overall distribution did not differ between treated and untreated fish; at day 40: treated fish had greater distances attained by the advancing neurites, more had traversed the bridge, max caudal extent for axonal growth cone in treated fish was not seen in control until day 77","anesthesia: MS 222, 0.4g/L water, pH 7.4; euthanasia: anesthesized as for surgery and perfused transcardially with a RInger's solution containing procaine (1g/L) followed by fixative (4% paraformaldehyde in 0.1 M phosphate buffer)","administration of L-DOPA enhances the locomotory activity of an eel for up to 8 h and, when such treatment is sustained, also accelerates some aspects of the recovery of coordinated locomotory function that are lost following spinal cord transection",not reported,"used eel fish? + not sure how to interpret the results, it is a bit confusing to me how they are reported and interpreted and how they make it sound like a positive treatment effect, whilst I feel like there are mixed results",No,
Lucie,Goldshmit et al.,2018,Blood Glutamate Scavenger as a Novel Neuroprotective Treatment in Spinal Cord Injury,10.1089/neu.2017.5524,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (enzyme recombinant glutamate-oxaloacetate transaminase 1 and its co-substrate = blood glutamate scavengers),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Torres et al.,2010,Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats,10.1111/j.1365-2613.2010.00738.x,English,,excluded,Out of scope,No assessments of interest,Out of scope: no outcome of interest,,,rats,Wistar,46,,,,,,,,male 100%,,,12 weeks,,,,,,,range: [320-350](g),,,,,,,level: T13; severity: not reported,,,,laminectomy + compressive SCI (Allen's method: weigh of 70 g/cm loading to the dorsal surface of the spinal cord),32h or 8 days,dantrolene,,,10 mg/kg,1h after laminectomy,,single shot,,intraperitoneally,,no neurological/functional/behavioral assessment,-,,-,-,,-,,-,histological assessment,"haemorrhage, necrosis",32h or 8 days,not reported,,,"anesthesia: tramadol (2 mg/kg, orally), isoflurane inhaled; prophylactic antibiotherapy: cephalothin (30 mg/kg, IV); tramadol (2 mg/kg, orally) every 8h for 3 days after injury; euthanasia: overodse of thiopental IP","dantrolene has neuroprotective effects in rats suffering from traumatic SCI. Systemically injected, this drug decreases apoptotic cell death and preserves neuronal viability following SCI.",not reported,,,
Lucie,Scholpa et al.,2019,Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved beta(2)-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury,10.1089/neu.2018.5669,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (formoterol),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Casha et al.,2018,Cerebrospinal Fluid Biomarkers in Human Spinal Cord Injury from a Phase II Minocycline Trial,10.1089/neu.2018.5899,English,Canada,excluded,Out of scope,No assessments of interest,Out of scope: does not report treatment effect on recovery,,,human,,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ibarra et al.,2004,The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats,10.1111/j.0953-816X.2004.03402.x,English,,included,,,,,,rats,Lewis and Sprague Dawley,Not reported,Not reported,,,Not reported,,,Not reported,female 100%,female,0,13-14 weeks (adults),,,13,14,Weeks,Adult,range: [180-220](g),,,180,220,g,,level: T9; severity: not reported,T9,Not reported,contusion,laminectomy + weight drop (10-g rod from 50 mm using NYU impactor),7 days,"sodium succinate methylprednisolone (MP) and cyclosporin-A (CsA), non-encepphalitogenic MBP peptide (A91, for active immunization)",methylprednisolone sodium succinate,No,30 mg/kg,immediately after injury,,3 doses,"immediately after, then twice more at 12h intervals (total 24h) when early immunization, 5 min, 2h and 4h after injury for late immunization",intravenously,,neurological/functional/behavioral assessment,BBB scale,,"open-field, rated from 0 (complete paralysis) to 21 (complete mobility)","unclear: goes up to 80 days post-injury, probably 7, 14, 28, 32, 40, 55, 65 and 80 days? based on figure 3",,yes,no effect,immunization 1h after contusion: A91+CFA significantly better motor recovery than in controls treated with PBS+CFA; MP alone no different from PBS+CFA; A91+CFA+MP beneficial effect of vaccination was eliminated in both Lewis and Sprague Dawley rats; CsA eliminated the protective effect induced by immunization with A91: A91+CsA was significantly poorer than A91+CFA without CsA; immunization 48h after MP administration: A91 appeared to circumvent the inhibitory effect of MP on the effects of the vaccination; no effect of MP alone,-,-,-,-,,-,"anesthesia: IM xylazine 10 mg/kg, and ketamine 50 mg/kg; postop: during the first week after contusion and in any case of hematuria after this period: sulphamethoxazole (400 mg/mL) and trimethoprim (8 mg/mL), 0.3 mL of solution per day; euthanasia: perfused intracardially","We show, using rats of two different strains, that if MP is injected concomitantly with the therapeutic vaccination, the beneficial effect of the vaccination is diminished. However, if MP is given immediately after the insult and the vaccination 48 h later, MP does not detract from the beneficial effect of the vaccination",not reported,"used two strains of rat: ""The two strains differ in their susceptibility to experimental autoimmune encephalomyelitis, the Lewis rats being relatively susceptible and the SPD rats relatively resistant.""",Yes (drug of interest + drug not of interest),
Lucie,Kuroiwa et al.,2014,Effect of amiloride on endoplasmic reticulum stress response in the injured spinal cord of rats,10.1111/ejn.12647,English,,included,,,,,,rats,Sprague Dawley,>= 54,>= 24,,,>= 24,,,sham >= 6,female 100%,female,0,10 weeks old,10,,,,Weeks,,range: [280-320](g),,,280,320,g,,level: T10; severity: not reported,T10,Not reported,contusion,laminectomy + contusion with IH impactor device with force of 200 Kdyne (2mN),"3, 7, 14, 28 days","amiloride (amiloride hydrochloride hydrate), PBS for control group",amiloride,,10 mg/kg,24h after injury,,28 days,every 24h,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"open-field, mean score calculated from 3 observers for 5 min","immediately before injury, and each following day at approximately the same time for 28 days",,yes,positive effect,significantly better BBB score in treatment group from day 12 post injury onwards compared to control,histological analysis,TUNEL assay,"3, 7, 14 days after injury",not reported,no effect,no significant difference in number of tunel positive cells between treatment and control group,anesthesia: inhaled 4% isoflurane; euthanasia: 4% isoflurane,"amiloride ameliorates endoplasmic reticulum stress in the injured spinal cord and improves hindlimb function after SCI by inhibiting cell death, leading to oligodendrocytes precursor cell survival",not reported,use isoflurane,No,
Lucie,Zhao et al.,2015,Histamine Promotes Locomotion Recovery After Spinal Cord Hemisection via Inhibiting Astrocytic Scar Formation,10.1111/cns.12379,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (histamine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Alluin et al.,2011,Kinematic study of locomotor recovery after spinal cord clip compression injury in rats,10.1089/neu.2011.1840,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested (treadmill training program tested instead),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wells et al.,2003,Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice,10.1093/brain/awg178,English,,included,,,,,,mice,CD1,124,51,,,10,,,"not sure where the other 10 animals are coming from; (51 in non-temperature controlled environment, 73 in temperature controlled environment)",male 100%,male,100,approximatley 3 months of age,3,,,,Months,,not reported,,,,,,Not reported,level: T3-T4; severity: not reported,T3 - T4,Not reported,compression,"laminectomy + extradural compression with modified aneurysm clip with a closing force of 8g producing mechanical trauma, clip left in place for 1 min",28 days,"minocycline, methylprednisolone (MP)",methylprednisolone,No,30 mg/kg,1h after injury,,24h,every 6h,intramuscular,,neurological/functional/behavioral assessment,BBB,,"BBB: beginning 5 days prior to SCI, acclimated in an open field arena every day for 5 days, 5 min, 22-point scale detailing hindlimb function of joint movements, stepping ability, the degree of fine control of coordinated stepping and trunk stability, test sessions were 4 min in duration; inclined plane task: assesses an animal's ability to maintain its position on a board which is raised by 5 degrees increments and thus can be used as an index of hindlimb strength, max angle at which a mouse is able to maintain its position for at least 5s constitutes the inclined plane score",BBB: day3 post injury then twice weekly from day 3 to 28 post-injury; inclined plane task: once a week beginning at day 7 post-surgery,,not reported,no effect,"BBB: minocycline has a significant treatment effect (F = 18.283, P = 0.0002), with significant recovery in hindlimb function compared with control, MP no significant effect compared to control, minocycline significantly better than MP; inclined plane test: significant treatment effect of minocycline compared to control at day 21 and 28 post injury",histological analysis,-,-,-,,-,"anesthesia: ketamine (200 mg/kg) and xylazine (10 mg/kg) both IP, postop: SC injection of 0.5mL saline to compensate for any blood loss during surgery; euthanasia: 10% neutral buffered formalin","use of minocycline in a mouse model of SCI significantly preserves axonal integrity, prevents tissue loss and leads to behavioural improvements",not reported,"MP group not tested for incline plane test and histology, but also not the treatment studied in the paper; use keatmine, saline",No,
Lucie,Wells et al.,2003,Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice,10.1093/brain/awg178,English,,included,,,,,,mice,CD1,124,51,,,53,,,"not sure where the other 10 animals are coming from; (51 in non-temperature controlled environment, 73 in temperature controlled environment)",male 100%,male,100,approximatley 3 months of age,3,,,,Months,,not reported,,,,,,Not reported,level: T3-T4; severity: not reported,T3 - T4,Not reported,compression,"laminectomy + extradural compression with modified aneurysm clip with a closing force of 8g producing mechanical trauma, clip left in place for 1 min",28 days,"minocycline, methylprednisolone (MP)",minocycline,,50 mg/kg then 25 mg/kg,1h after injury,,5 days,every 24h,intraperitoneally,,neurological/functional/behavioral assessment,"BBB, inclined plane task",,"BBB: beginning 5 days prior to SCI, acclimated in an open field arena every day for 5 days, 5 min, 22-point scale detailing hindlimb function of joint movements, stepping ability, the degree of fine control of coordinated stepping and trunk stability, test sessions were 4 min in duration; inclined plane task: assesses an animal's ability to maintain its position on a board which is raised by 5 degrees increments and thus can be used as an index of hindlimb strength, max angle at which a mouse is able to maintain its position for at least 5s constitutes the inclined plane score",BBB: day3 post injury then twice weekly from day 3 to 28 post-injury; inclined plane task: once a week beginning at day 7 post-surgery,,not reported,positive effect,"BBB: minocycline has a significant treatment effect (F = 18.283, P = 0.0002), with significant recovery in hindlimb function compared with control, MP no significant effect compared to control, minocycline significantly better than MP; inclined plane test: significant treatment effect of minocycline compared to control at day 21 and 28 post injury",histological analysis,"degree of axonal integrity, lesion areas",28 days,"not sure how to interpret this: ""Sections (6 mm) were cut and  ̄uorogold-positive cells in both red nuclei were counted blind""",mixed effects (assessment),"qualitatively more intact axons in minocycline-treated animals compared with vehicle-treated controls, significant reduction in lesion size in minocycline-treated mice compared with vehicle-treated controls; number of cells higher in minocycline group compared to vehicle but not significant","anesthesia: ketamine (200 mg/kg) and xylazine (10 mg/kg) both IP, postop: SC injection of 0.5mL saline to compensate for any blood loss during surgery; euthanasia: 10% neutral buffered formalin","use of minocycline in a mouse model of SCI significantly preserves axonal integrity, prevents tissue loss and leads to behavioural improvements",not reported,"MP group not tested for incline plane test and histology, but also not the treatment studied in the paper; use keatmine, saline",No,
Louis,Casha et al.,2012,Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury,10.1093/brain/aws072,English,Canada,included,,,,prospective,prospective,human,,71,25,,4,27,,5,19 patients did not meet inclusio criteria,female: 13 (25%),mixed,75,36,36,,,,Years,,not reported,,,,,,,"Motor-complete (20), Motor-incomplete (9), Central cord injury (6),
ASIA A (34), ASIA B (2), ASIA C (10), ASIA D (6),","Cervical: 20 + 9  + 6;
Thoracic: 16 + 1",mixed,trauma,"Vehicle collision (30), Work accident (9), 
Sport  injury (9),  Fall (4) ",-,Minocycline,minocycline,,"200mg (first five subjects);
800mg loading dose, tapering by 100 mg to 400mg (remaining subjects)",treatment started on average at 10.2hrs post-injury,,14 doses in total / 7 days,every 12hrs/twice daily,intravenously,,"neurological;
functional","ASIA scale: motor and sensory composites;
Spinal Cord Independence Measure, Functional Independence Measure, London Handicap scale, Short Form 36 Questionnaire","neurological (motor and sensory), functional (general)",,"neurological: Days 1 (enrolment), 4, 5, 7; Weeks 3, 6,  12; Months 6, 12
functional: Weeks 6, 12, 26, 52",,Yes,no effect,"In general no statistically significant effect of minocycline treatment on recovery. 
Useful observations might be that clinical safety was established also for higher dosing scheme
and that higher dosing scheme corresponds to larger improvements in assessment scores (still not statistically significant).",,,,,,,"no additional medication reported; 
emphasis on short and standardised time to 
surgical decompression to avoid confounding ","steady state concentration comparable to animal studies requires higher doses than previously used;
no adverse events despite higher doses administered;
treatment associated with apparent improvement in neurological and functional outcomes",,,No,
Louis,Guizar-Sahagun et al.,2009,Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions,10.1038/sc.2008.85,English,Mexico,included,,,,,,rats,Long Evans,35,7,,,7,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,not reported,,,,,,,contusion injury at T9,T9,mild,contusion,10g steel rod dropped from 12.5mm,6 weeks,methylprednisolone sodium succinate,methylprednisolone sodium succinate,,30mg/kg,"2h pre-injury, intraoperatively, 2h post-injury",,3 doses,,intraperitoneally,,functional,BBB locomotor scale; BBB subscoring; spontaneous activity (rearing and trunk muscle activity),,individual assessment for 4min in an open field,"BBB locomotor: day 1 post-injury, then weekly for 6 weeks;
BBB subscoring: weeks 5 and 6 post-injury;
spontaneous activity: weeks 5 and 6 post-injury",,not reported,no effect,"no statistically significant differences between treatment and control groups for BBB, BBB subscoring, or spontaneous activity",histopathology,"morphology and morphometry 
(masson stain) of spared parenchyma
based on presence of ependyma",6 weeks post-injury (samples taken),Yes,no effect,amount of spared tissue did not vary between groups,"ciprofloxacin lactate (8mg/kg, subcutaneously, every 12hrs for 7 days post-injury);
acetaminophen (64mg/kg, by drinking water, daily for 3 weeks post-injury)","No detectable neuroprotective benefit from drug tested
",,"administration of drugs pre-operatively, intraoperatively motivated by accidental damage during elective spine surgery",No,
Louis,Guizar-Sahagun et al.,2009,Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions,10.1038/sc.2008.85,English,Mexico,included,,,,,,rats,Long Evans,35,7,,,7,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,not reported,,,,,,,contusion injury at T9,T9,mild,contusion,10g steel rod dropped from 12.5mm,6 weeks,melatonin,melatonin,,10mg/kg,"20min pre-injury, intraoperatively, 1h post-injury",,3 doses,,intraperitoneally,,functional,BBB locomotor scale; BBB subscoring; spontaneous activity (rearing and trunk muscle activity),,individual assessment for 4min in an open field,"BBB locomotor: day 1 post-injury, then weekly for 6 weeks;
BBB subscoring: weeks 5 and 6 post-injury;
spontaneous activity: weeks 5 and 6 post-injury",,not reported,mixed effects (assessment),"no statistically significant differences between treatment and control groups for BBB or spontaneous activity, 
worse results for BBB subscoring",histopathology,"morphology and morphometry 
(masson stain) of spared parenchyma
based on presence of ependyma",6 weeks post-injury (samples taken),Yes,no effect,amount of spared tissue did not vary between groups,"ciprofloxacin lactate (8mg/kg, subcutaneously, every 12hrs for 7 days post-injury);
acetaminophen (64mg/kg, by drinking water, daily for 3 weeks post-injury)","No detectable neuroprotective benefit from drug tested
",,"administration of drugs pre-operatively, intraoperatively motivated by accidental damage during elective spine surgery",No,
Louis,Lee et al.,2010,Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury,10.1016/j.expneurol.2010.06.018,English,Canada,included,,,,,,rats,Sprague Dawley,43,10,,,9,,,4 animals excluded due to too high injury forces,not reported,not reported,not reported,not reported,,,,,,Not reported,300g to 350g,,,300,350,g,,contusion injury at C5 (unilateral),C5,Not reported,contusion,"impactor tip w/ 1.5mm diameter,
force delivered 150kdyn at 100mm/s",6 weeks,minocycline,minocycline,,90mg/kg,"1hr post-surgery, days 2, 3 post-injury",,3 days,daily,intraperitoneally,,functional,"horizontal ladder test;
cylinder rearing test;
modified Montoya's staircase test;
grooming test (Gensel);
mechanical reactivity (von Frey)",,"horizontal ladder test: 5 runs recorded per assessment, no. of steps and missteps counted;
cylinder rearing test: 20 rears recorded per assessment, use of different forelimbs (or both) counted;
Montoya's staircase test: pellets placed in wells of different depth, animals introduced to apparatus before injury, fasted for 20hrs before assessment, no. of pellets retrieved counted;
grooming test: animals placed in cylinder, sterile saline applied between ears and grooming response monitored for 15min, grooming score according to Gensel et al. (2006);
sensory test: animals placed in cylinder, withdrawal of forelimb(s) under varying mechanical forces (0 to 50g), each forelimb assessed three times","horizontal ladder test: day 6 pre-injury, days 14, 28, 41 post-injury;
cylinder rearing test: day 7 pre-injury, days 13, 27, 40 post-injury;
Montoya's staircase test: day 5 pre-injury, days 15, 29, 42 post-injury;
grooming test: day 6 pre-injury, days 14, 28, 41 post-injury;
sensory test: day 6 pre-injury, days 14, 28, 41 post-injury",,Yes,no effect,no effect for treatment with minocycline,histopathology,"white and gray matter sparing;
axonal sprouting (anterograde tracing of corticospinal and rubrospinal tracts)",6 weeks post-injury,Yes,no effect,"white and gray matter sparing: no statistically significant difference between treatment and control groups for overal tissue sparing, statistically significant difference (negative) in section 400um to 800um caudally to injury in minocycline group;
axonal sprotuing: no statistically significant differences between treatment and control groups","buprenorphine (0.02mg/kg, subcutaneously, pre-operatively and on days 1 and 2 post-operatively)",No detectbale effects of any treatment on functional or histological outcomes. ,"Complete absence of (positive) effects due to simvastatin might indicate that drug was not entering systemic circulation -- assessed by measuring HDL/LDL ratio, which was persistently changed (stat. significant) for treatment groups receiving simvastatin. ",Note that unilateral injury means that functional deficits were limited to injured site.,No,
Louis,Lee et al.,2010,Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury,10.1016/j.expneurol.2010.06.018,English,Canada,included,,,,,,rats,Sprague Dawley,43,10,,,20,,,4 animals excluded due to too high injury forces,not reported,not reported,not reported,not reported,,,,,,Not reported,300g to 350g,,,300,350,g,,contusion injury at C5 (unilateral),C5,Not reported,contusion,"impactor tip w/ 1.5mm diameter,
force delivered 150kdyn at 100mm/s",6 weeks,simvastatin,simvastatin,,"group 1: 20mg/kg, 
group 2: 5mg/kg","group 1: 20mg/kg for 1hr post-surgery, days 2, 3 post-injury and 5mg/kg for days 4, 5, 6, 7 post-injury
group 2: 20mg/kg for 1hr post-surgery, days 2, 3 post-injury and 5mg/kg for days 4 to 42 post-injury",,"group 1: 7 days
group 2: 42 days",daily,subcutaneous,,functional,"horizontal ladder test;
cylinder rearing test;
modified Montoya's staircase test;
grooming test (Gensel);
mechanical reactivity (von Frey)",,"horizontal ladder test: 5 runs recorded per assessment, no. of steps and missteps counted;
cylinder rearing test: 20 rears recorded per assessment, use of different forelimbs (or both) counted;
Montoya's staircase test: pellets placed in wells of different depth, animals introduced to apparatus before injury, fasted for 20hrs before assessment, no. of pellets retrieved counted;
grooming test: animals placed in cylinder, sterile saline applied between ears and grooming response monitored for 15min, grooming score according to Gensel et al. (2006);
sensory test: animals placed in cylinder, withdrawal of forelimb(s) under varying mechanical forces (0 to 50g), each forelimb assessed three times","horizontal ladder test: day 6 pre-injury, days 14, 28, 41 post-injury;
cylinder rearing test: day 7 pre-injury, days 13, 27, 40 post-injury;
Montoya's staircase test: day 5 pre-injury, days 15, 29, 42 post-injury;
grooming test: day 6 pre-injury, days 14, 28, 41 post-injury;
sensory test: day 6 pre-injury, days 14, 28, 41 post-injury",,Yes,mixed effects (assessment) + mixed effects (regimen),"horizontal ladder test: no significant difference between treatment groups and control;
cylinder rearing test: no significant difference between treatment groups and control;
Montoya's staircase test: significantly worse performance for animals treated w/ simvastatin for 42 days at week 6;
grooming test: significantly higher score for animals treated w/ simvastatin for 42 days at all time points;
sensory test: no difference in sensitivity to force between groups",,"white and gray matter sparing;
axonal sprouting (anterograde tracing of corticospinal and rubrospinal tracts)",6 weeks post-injury,Yes,no effect,"white and gray matter sparing: no statistically significant difference between treatment and control groups for overal tissue sparing, statistically significant difference (negative) in section 400um to 800um caudally to injury in minocycline group;
axonal sprotuing: no statistically significant differences between treatment and control groups","buprenorphine (0.02mg/kg, subcutaneously, pre-operatively and on days 1 and 2 post-operatively)",No detectbale effects of any treatment on functional or histological outcomes for cervical SCI model. ,"Complete absence of (positive) effects due to simvastatin might indicate that drug was not entering systemic circulation -- assessed by measuring HDL/LDL ratio, which was persistently changed (stat. significant) for treatment groups receiving simvastatin. ",Note that unilateral injury means that functional deficits were limited to injured site.,No,
Louis,Kotaka et al.,2017,Lanthionine ketimine ester promotes locomotor recovery after spinal cord injury by reducing neuroinflammation and promoting axon growth,10.1016/j.bbrc.2016.12.069,English,Japan,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Borgens, Shi",2000,Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol,10.1096/fasebj.14.1.27,English,United States,excluded,Out of scope,No assessments of interest,No functional outcomes assessed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zeman et al.,2009,Improved functional recovery with oxandrolone after spinal cord injury in rats,10.1097/WNR.0b013e32832c5cc2,English,United States,included,,,,,,rats,Wistar,48 - 78,06.Dec,,,42 - 72,,,"no counts per group reported; 
counts only derived from figure captions which include ranges;
assume single control group",all male,male,100,adult (no precise age reported),,,,,,Adult,approx. 240g,~240,,,,g,,contusion injury at T10,T10,Not reported,contusion,10g rod w/ 2.5mm diameter dropped from 25mm,6 weeks,oxandrolone,oxandrolone,,"group 1: 0.1mg/kg
group 2: 1mg/kg
group 3: 4mg/kg",initial dose 20min post-injury,,"group 1, 2, 3 short: 5 days;
group 1, 2, 3 long: 6 weeks",daily,oral,drug dissolved in peanut oil,functional,BBB locomotor scale,,"open field testing, 4min per session","days 1, 2, 3 post-injury;
weeks 1 to 6",,Yes,mixed effects (dosage) + mixed effects (timing),"short: significant improvement in BBB scores for 0.1mg/kg and 4mg/kg;
long: no statistically significant effect for any dosing regime",histopathology,"white and gray matter sparing;
axonal sprouting",6 weeks post-injury (sample taken),Yes,mixed (stats/no stats),"short: significantly increased white matter sparing in all dosing regimes across epicenter of injury and rostrally & caudally, significantly increased gray matter sparing rostrally & caudally; axonal sprouting caudally to inury site significantly increased for high dose (4mg/kg);
long: not discussed",,Short treatment (5 consecutive days post-injury) can improve locomotor recovery as well as tissue sparing and axonal sprouting. Longer treatment (6 weeks post-injury) is ineffective. ,,"Number of animals (per group or total) NOT reported! 
Some dose dependence observed (larger positive effect for higher dose) but it seems like this was not assessed further.",No,
Louis,Cole et al.,1989,The Effect of Fentanyl Anesthesia and Intrathecal Naloxone on Neurologic Outcome Following Spinal Cord Injury in the Rat,10.1097/00000542-198909000-00019,English,United States,included,,,,,,rats,Sprague Dawley,77,22,2,,22,2,,4 animals excluded due to neurologic deficit after catheter inseration (i.e. pre-injury),all male,male,100,not reported,,,,,,Not reported,300g to 350g,,,300,350,g,,compression injury at L3/L4,L3 - L4,Not reported,compression,"balloon inflated, inflated state maintained for 0, 6, 12, 24, 42 minutes in subset of animals fom each group",,fentanyl + nitrous oxide ,fentanyl + nitrous oxide ,,"fentanyl: 57microgram/kg;
nitrous oxide: 65%;
naloxone: 1mg/kg","fentanyl, nitrous oxide: started 15min pre-injury, during balloon inflation;
naloxone: 10min post-injury",,-,-,multiple,"fentanyl, nitrous oxide: inhalation (oral?)",functional,"presence/absence of hindlimb paralysis,
purposeful response to paw pinch",,"presence/absence of hindlimb paralysis: lack of spontaneous or purposeful movement of hindlimbs,",daily for 7 days post-injury,,Yes,no stats,"significant reduction in probability of neurologic deficit
for anaesthesia groups compared to awake control group;
no difference between fentanyl + naloxone and fentanyl + saline groups",,,,,,,"bupivacaine (0.25% at site of incision for balloon catheter placement);
nitrous oxide (65%)/isoflurane (1%) anesthetic during catheter removal
","Opioid-based anaesthetic during SCI does not have
detrimental effect on neurological outcome. 
Naloxone (opioid antagonist) does not influence 
neurologic outcome. 
","Removal of catheters immediately post-injury required brief period of anaesthesia for all groups (including awake control group). 
Intrathecal administration of naloxone (compared to systemic route in other studies).
Relatively low dose of naloxone (1mg/kg) compared to studies finding benefit (2 to 10mg/kg).
",,Yes (drug of interest + drug of interest),
Louis,Cole et al.,1989,The Effect of Fentanyl Anesthesia and Intrathecal Naloxone on Neurologic Outcome Following Spinal Cord Injury in the Rat,10.1097/00000542-198909000-00019,English,United States,included,,,,,,rats,Sprague Dawley,77,22,2,,22,3,,4 animals excluded due to neurologic deficit after catheter inseration (i.e. pre-injury),all male,male,100,not reported,,,,,,Not reported,300g to 350g,,,300,350,g,,compression injury at L3/L4,L3 - L4,Not reported,compression,"balloon inflated, inflated state maintained for 0, 6, 12, 24, 42 minutes in subset of animals fom each group",,fentanyl + nitrous oxide + naloxone,fentanyl + nitrous oxide + naloxone,,"fentanyl: 57microgram/kg;
nitrous oxide: 65%;
naloxone: 1mg/kg","fentanyl, nitrous oxide: started 15min pre-injury, during balloon inflation;
naloxone: 10min post-injury
",,-,-,multiple,"fentanyl, nitrous oxide: inhalation (oral?);
naloxone:intrathecal",functional,"presence/absence of hindlimb paralysis,
purposeful response to paw pinch",,"presence/absence of hindlimb paralysis: lack of spontaneous or purposeful movement of hindlimbs,",daily for 7 days post-injury,,Yes,no stats,"significant reduction in probability of neurologic deficit
for anaesthesia groups compared to awake control group;
no difference between fentanyl + naloxone and fentanyl + saline groups",,,,,,,"""bupivacaine (0.25% at site of incision for balloon catheter placement);
nitrous oxide (65%)/isoflurane (1%) anesthetic during catheter removal
""","Opioid-based anaesthetic during SCI does not have
detrimental effect on neurological outcome. 
Naloxone (opioid antagonist) does not influence 
neurologic outcome. 
","Removal of catheters immediately post-injury required brief period of anaesthesia for all groups (including awake control group). 
Intrathecal administration of naloxone (compared to systemic route in other studies).
Relatively low dose of naloxone (1mg/kg) compared to studies finding benefit (2 to 10mg/kg).
",,Yes (drug of interest + drug of interest),
Louis,Genovese et al.,2009,Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice,10.1097/SHK.0b013e3181833b08,English,Italy,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Yu et al.,2004,Effects of MPSS and a potent iNOS inhibitor on traumatic spinal cord injury,10.1097/00001756-200409150-00021,English,Japan,excluded,Out of scope,No assessments of interest,No functional outcomes of interest assessed (bladder function),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Nakashima et al.,2004,Suppression of GDNF production by MPSS treatment following spinal cord injury in the rat,10.1097/00001756-200410250-00007,English,Japan,excluded,Out of scope,No assessments of interest,No functional outcomes assessed (gene expression),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kuchner et al.,2000,Effects of Dexamethasone and of Local Hypothermia on Early and Late Tissue Electrolyte Changes in Experimental Spinal Cord Injury,10.1097/00002517-200010000-00004,English,"United States, Canada",included,,,,,,dogs,Mongrel,88,24,,,16,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,20.4kg to 27.2kg,,,20.4,27.2,kg,,compression injury at T13,T13,Not reported,compression,"epidural balloon (10mm diameter), intra-balloon pressure 160mm Hg achieved within 1s and maintained for 1h",6 days or 49 days,dexamethasone,dexamethasone,,"group 1: 0.24mg/kg/day (days 1 to 11 post-injury);
group 2: 0.24mg/kg/day (days 1 to 11 post-injury), dose halved every second day (beyond day 11)",15min post-injury (deflation of balloon),,"group 1: 6 days post-injury;
group 2: 18 days post-injury","twice daily (morning, afternoon/
start and end of working day)",intramuscular,,functional,modified Tarlov rating system,,two independent examiners,every three days starting on day 2 post-injury,,Yes,positive effect,improved functional score in both dexamethasone treatment groups,presence/level of edema,"dry weight of tissue sample 
(as percentage of wet weight)",6 days or 7 weeks post-injury,Not reported,mixed effects (timing),"dexamethasone is only treatment which prevents reduction in dry weight (large change in dry weight corresponds to more edema/higher water content) at one week post-injury in region adjacent to injury (L1);
no protective effect at level of injury (T13) or at later time point (7 weeks post-injury)",,"Dexamethasone can provide short-term (6 days) advantages (reduction in edema, earlier improvement in motor score) but this is advantage is not maintained in the long-term (7 weeks).",,reduced mortality in dexamethasone treatment group,No,
Louis,Luo et al.,2013,"Effect of Infliximab Combined With Methylprednisolone on Expressions of NF-kappa B, TRADD, and FADD in Rat Acute Spinal Cord Injury",10.1097/BRS.0b013e318294892c,English,China,included,,,,,,rats,Sprague Dawley,180,30,,,30,,,only counted SCI + placebo as control,all male,male,100,10 months,10,,,,Months,,280g to 300g,,,280,300,g,,contusion injury at T10,T10,Not reported,contusion,5g rod dropped from 5cm,21 days,methylprednisolone,methylprednisolone,No,30mg/kg,immediately after SCI,,one dose,,intraperitoneally,,functional,BBB locomotor scale,,assessed on 10 rats for each treatment and control group,"days 1, 3, 5, 14, 21 post-injury",No,Not reported,positive effect,average BBB score for methylprednisolone treated group significantly higher than for SCI control group,"histopathology;
immunohistochemistry","tissue composition (hematoxylin and eosin stains) assessed by light microscopy;
staining for anti-NF-kB, anti-TRADD, anti-FADD",24hrs post-injury,Not reported,positive effect,"tissue composition: improvement in methylpredinosolone treatment group compared to SCI control but still neurons in necrotic state, presence of inflammatory cells;
immunohistochemistry stain: possibly statistically significant reduction in NF-kB/TRADD/FADD positive cells in methylprednisolone group","penicillin (80'000 units/kg, daily post-injury until wound healed, exact duration not further specified)",Methylprednisolone and infliximab individually as well as combined can have positive effect on outcome(s) after SCI.,,tissue composition only assessed qualitatively,Yes (drug of interest + drug not of interest),
Louis,Felleiter et al.,2012,Changes in the Use of the Methylprednisolone Protocol for Traumatic Spinal Cord Injury in Switzerland,10.1097/BRS.0b013e31823a07a2,English,Switzerland,included,,,,retrospective,retrospective,human,,226,128,,,98,,,,female: 66 (31%),mixed,69,41.1 years (mean),41.1,,,,Years,,not reported,,,,,,,not reported,,Not reported,,not reported,,methylprednisolone,methylprednisolone,,"bolus: 30mg/kg;
infusion: 5.4mg/kg ",within 8hrs post-injury,,"bolus dose; 
infusion from 23hrs to 47hrs after initial dose",,not reported,,neurological,"improvement to level of injury (improvement equivalent to a change in segment to a more caudal location);
improvement in ASIA scale","neurological (other), injury severity",-,not precisely reported; presumably as soon after admission as possible and average interval between examinations of 178 days,,Not reported,no effect,no statistically significant difference in number of patients showing neurological improvement between groups treated w/ methyprednisolone and w/o treatment w/ methylprednisolone.,,,,,,,,"No benefit in neurological outcomes derived from administration of methylprednisolone. 
Change in clinical guidelines (use of methylprednisolone from standard to facultative) did not affect no. of patients showing improvements.","Single-center study (relatively homogeneous patient population, relatively small variability in treatment); 
larger no. of patients w/o initial neurological deficit referred in one period under study",,No,
Louis,Park et  al.,2011,The effect of irradiation and methylprednisolone in spinal cord injured rats.,10.1097/BRS.0b013e3181d3cf82,English,South Korea,excluded,Out of scope,No pure effect studied,Methylprednisolone only assessed in combination with irradiation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ito et al.,2009,Does High Dose Methylprednisolone Sodium Succinate Really Improve Neurological Status in Patient With Acute Cervical Cord Injury? A Prospective Study About Neurological Recovery and Early Complications,10.1097/BRS.0b013e3181b613c7,English,Japan,included,,,,prospective,not reported,human,,79,41,,,38,,,,female: 16 (20%),mixed,80,57.6 years (mean),57.6,,,,Years,,not reported,,,,,,,"cervical cord injury;
ASIA A: 21, ASIA B: 15, ASIA C: 23, ASIA D: 20",not reported,mixed,,"major cause (56 patients) high energy trauma (traffic accident, fall)",,methylprednisolone,methylprednisolone,,NASCIS-2 protocol,within 8hrs post-injury,,,,,,neurological,"ASIA impairment score and grade, 
ASIA motor score","neurological (motor), injury severity",,"at admission,
3 months post-injury",,Not reported,no effect,no statistically significant difference between groups in number of patients showing neurological improvement (ASIA grade) or increase of total motor score.,,,,,,,,"No evidence for benefit from methylprednisolone treatment w.r.t. neurologic recovery.
Statistically significant increase in complications (infections, in particular pneumonia) in methyprednisolone treatment group.",,,No,
Louis,van de Meent et al.,1997,Beneficial effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury,10.1097/00006123-199701000-00028,English,The Netherlands,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Donaldson et al.,2002,Polyethylene glycol rapidly in damaged sciatic restores physiological functions nerves of guinea pigs,10.1097/00006123-200201000-00023,English,United States,excluded,Non-sci population,,Sciatic nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Thomas et al.,1999,Progesterone is neuroprotective after acute experimental spinal cord trauma in rats.,10.1097/00007632-199910150-00013,English,United States,included,,,,,,rats,Sprague Dawley,40,10,,,10,,,only counted SCI + vehicle as control,all male,male,100,mature (no precise age reported),,,,,,Adult,295g to 305g,,,295,305,g,,contusion injury at T7/T8,T7 - T8,moderate - severe,contusion,10g impactor dropped from 25mm height,42 days,progesterone,progesterone,,4mg/kg,"30min, 6hrs and days 1 to 5 post-injury",,5 days,daily,intraperitoneally,,functional,BBB lcoomotor score,,"open field (1.5m x 1.5m tub), 
two observers (avg. score in case of disagreement)","6hrs, 24hrs, 3 days post-injury;
thereafter weekly ",,Not reported,positive effect,statistically significant difference in BBB score for treatment group compared to control group  ,histopathology,"tissue composition 
(hematoxylin and eosin stain, 
Klüver-Barrera Luxol stain)",42 days post-injury,Not reported,positive effect,larger percentage of white matter intact in progesterone treatment group compared to control groups,"cefazolin (50mg/kg, pre-operatively);
buprenorphine (twice daily post-operatively for two days, subcutaneously);
cefazolin (twice daily post-operatively for three days, subcutaneously) ","Significant improvement in functional recovery and tissue
sparing achieved by progesterone treatment if started within
30 minutes of injury and administered for 5 days.",,"Progesterone was dissolved in DMSO, which itself is thought to have neuroprotective effect. Accordingly, one control group received only DMSO and showed recovery similar to untreated control (and statistically significant worse recovery compared to progesterone treatment).",No,
Louis,Schroeder et al.,2014,Survey of cervical spine research society members on the use of high-dose steroids for acute spinal cord injuries,10.1097/BRS.0000000000000297,English,,excluded,Out of scope,No assessments of interest,Survey results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Inada et al.,2014,Multicenter Prospective Nonrandomized Controlled Clinical Trial to Prove Neurotherapeutic Effects of Granulocyte Colony-Stimulating Factor for Acute Spinal Cord Injury,10.1097/BRS.0000000000000121,English,Japan,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Stewart et al.,2019,Nitrous oxide impairs axon regeneration after nervous system injury in male rats,10.1097/ALN.0000000000002906,English,United States,included,,,,,,rats,Sprague Dawley,116,9,,,9,,,"only counted animals subjected to SCI (animals for cell harvest, animals with optical nerve injury (non-SCI) excluded)",all male,male,100,4 to 8 weeks,,,4,8,Weeks,,200g to 250g,,,200,250,g,,contusion injury at T9,T9,Not reported,contusion,"NYU impactor, 12.5gm/cm force",5 weeks,folic acid,folic acid,,80microgram/kg,"beginning three days pre-injury, continuing 17 days post-injury",,,daily,intraperitoneally,,functional,BBB locomotor score,,"videotaped 4min, open field,
two independent observers (scores averaged)","beginning on day 3 pre-injury,
then weekly for 5 weeks post-injury",,Yes,positive effect,"serial folic acid administration results in statistically significant increase
in BBB score compared to control",,,,,,,,Folic acid can have benefitial effect on functional recovery after SCI. ,"Potential inter-sex and inter-species differences;
first study on this specific drug/drug interaction (replication required).",Study focuses on the potentially negative effect of nitrous oxide but impact of folic acid on functional recovery is assessed as part of this.,No,
Louis,Stewart et al.,2019,Nitrous oxide impairs axon regeneration after nervous system injury in male rats,10.1097/ALN.0000000000002906,English,United States,included,,,,,,rats,Sprague Dawley,116,9,,,8,,,"only counted animals subjected to SCI (animals for cell harvest, animals with optical nerve injury (non-SCI) excluded)",all male,male,100,4 to 8 weeks,,,4,8,Weeks,,200g to 250g,,,200,250,g,,contusion injury at T9,T9,Not reported,contusion,"NYU impactor, 12.5gm/cm force",5 weeks,nitrous oxide,nitrous oxide,,"
80% in 20% oxygen","beginning three days pre-injury, continuing 17 days post-injury",,"4hrs day 3 pre-injury, 2hrs days 2 and 1 pre-injury, 2hrs post-injury","daily pre-injury, every other day post-injury",oral,presumably inhalation (cage placed in fume hood),functional,BBB locomotor score,,"videotaped 4min, open field,
two independent observers (scores averaged)","beginning on day 3 pre-injury,
then weekly for 5 weeks post-injury",,,no effect,,,,,,,,,Folic acid can have benefitial effect on functional recovery after SCI. ,"Potential inter-sex and inter-species differences;
first study on this specific drug/drug interaction (replication required).",,No,
Louis,Stewart et al.,2019,Nitrous oxide impairs axon regeneration after nervous system injury in male rats,10.1097/ALN.0000000000002906,English,United States,included,,,,,,rats,Sprague Dawley,116,9,,,7,,,"only counted animals subjected to SCI (animals for cell harvest, animals with optical nerve injury (non-SCI) excluded)",all male,male,100,4 to 8 weeks,,,4,8,Weeks,,200g to 250g,,,200,250,g,,contusion injury at T9,T9,Not reported,contusion,"NYU impactor, 12.5gm/cm force",5 weeks,folic acid + nitrous oxide,folic acid + nitrous oxide,,"folic acid: 80microgram/kg
nitrous oxide: 80% in 20% oxygen","folic acid: beginning three days pre-injury, continuing 17 days post-injury;
nitrous oxide: beginning three days pre-injury, continuing 17 days post-injury",,"nitrous oxide: 4hrs day 3 pre-injury, 2hrs days 2 and 1 pre-injury, 2hrs post-injury","folic acid: daily;
nitrous oxide: daily pre-injury, every other day post-injury",multiple,"folic acid: intraperitoneally;
nitrous oxide: presuambly oral (inhalation)",functional,BBB locomotor score,,"videotaped 4min, open field,
two independent observers (scores averaged)","beginning on day 3 pre-injury,
then weekly for 5 weeks post-injury",,,no effect,,,,,,,,,Folic acid can have benefitial effect on functional recovery after SCI. ,"Potential inter-sex and inter-species differences;
first study on this specific drug/drug interaction (replication required).",,Yes (drug of interest + drug of interest),
Louis,Severino et al.,2018,Plasticity and function of spinal oxytocin and vasopressin signaling during recovery from surgery with nerve injury,10.1097/ALN.0000000000002290,English,United States,excluded,Out of scope,No assessments of interest,No functional outcomes assessed (mechanical hypersensitivity),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Rice et al.,2007,Characterization of the early neuroinflammation after spinal cord injury in mice,10.1097/01.jnen.0000248552.07338.7f,English,Canada,excluded,Out of scope,No assessments of interest,No functional outcomes assessed (neuroinflammatory response),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gok et al.,2007,Effect of immunomodulation with human interferon-beta on early functional recovery from experimental spinal cord injury,10.1097/01.brs.0000259841.40358.8f,English,Turkey,included,,,,,,rats,Wistar,40,8,,,8,,,only counted SCI + vehicle as control,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 250g,,,210,250,g,,contusion injury between T7 and T10,T7 - T10,Not reported,contusion,"Allen's method, 50g/cm force",1 day,methylprednisolone,methylprednisolone,No,30mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,functional,"inclined plane test;
BBB locomotor scale",,inclined plane: max. degree at which animal could maintain position for at least 5 seconds,24hrs post-injury,No,Yes,mixed effects (assessment),Statistically significant improvement in results of inclined plane test compared to trauma and vehicle groups; no statistically significant difference for BBB score,histopathology,tissue composition (methylene blue stain and light microscopy; transmission electron microscopy combined with grading system for quantitative assessment),24hrs post-injury (samples taken),Yes,no effect,,,"Methylprednisolone treatment shows some beneficial effects (inclined plane test) but otherwise no effect (BBB score, histopathology) when compared to trauma or vehicle groups.",,Study's focus on assessment of effect of interferon-beta on outcomes after SCI; methylprednisolone seems to have been used as a comparison (only).,No,
Louis,Leypold et al.,2007,The impact of methylprednisolone on lesion severity following spinal cord injury,10.1097/01.brs.0000253964.10701.00,English,United States,excluded,Out of scope,No assessments of interest,No functional outcomes assessed (MRI),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Tsutsumi et al.,2006,Effects of the second national acute spinal cord injury study of high-dose methylprednisolone therapy on acute cervical spinal cord injury - Results in spinal injuries center,10.1097/01.brs.0000250273.28483.5c,English,Japan,included,,,,not reported,retrospective,human,,70,33,,,37,,,,female: 8 (11%),mixed,89,50.8 yrs,50.8,,,,Years,,not reported,,,,,,,"ASIA A (43), ASIA B (5), ASIA C (10), ASIA D (12)",,Not reported,,Not reported,,methylprednisolone,methylprednisolone,,"NASCIS-2 protocol: initial dose 30mg/kg, followed by infusion of 5.4mg/kg",treatment started within 8hrs post-injury,,"initial dose for 15min, infusion for 23hrs following the initial dose",,not reported,,neurological,ASIA motor score,neurological (motor),,"time of admission, six weeks post-injury, six months post-injury",,Not reported,mixed effects (subgroup),"Improved motor score for patients treated with methylprednisolone;
stratificiation by complete/incomplete injury shows significant improvement for patients with incomplete injuries but not for patients with complete injuries",,,,,,,,,,,No,
Louis,,2006,Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury,10.1097/01.brs.0000214886.21265.8c,English,United States,excluded,Out of scope,No assessments of interest,Survey results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Pollard, Apple",2003,Factors associated with improved neurologic outcomes in patients with incomplete tetraplegia,10.1097/00007632-200301010-00009,English,United States,included,,,,retrospective,retrospective,human,,412,unclear,,,unclear,,,separate counts for each assessments (motor versus sensory) and different time points (see table 3),"not reported; presumably more
male participants (Results, paragraph 1)",not reported,not reported,not reported,,,,,,Not reported,not reported,,,,,,,"incomplete injury; 
47% anterior cord syndrome, 24% central cord syndrome, 16% Brown-Sequard syndrome",,,,not reported,-,Methylprednisolone,methylprednisolone,,NASCIS-2 protocol,not reported,,not reported,not reported,not reported,,neurological,"ASIA motor score;
ASIA sensory score",neurological (motor and sensory),"for both scores, improvement (final score - earliest available score; earliest available either at admission to hospital or admission to rehabilitation) and final/total score","at admission (if possible), at admission to rehab,
at discharge from rehab, at years 1 and 2 (if possible)",,Not reported,no effect,"Final motor and sensory scores did not vary between treated vs. untreated group. 
Avg. improvement in sensory scores might be considered statistically significant (which might indicate lower starting point/indication bias).",,,,,,,,No association between administration of methylprednisolone and improved recovery could be detected. ,"Retrospective data collection and assessment of patients. No randomising or matching between treatment/control groups. Partially different demographics between groups (avg. length of hospital stay, share of patients w/ anterior cord syndrome).",,No,
Louis,,2006,Neuroprotection and enhanced recovery with Hypericum perforatum extract after experimental spinal cord injury in mice,10.1097/01.shk.0000209560.54328.69,English,Italy,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Ishida, Tominaga",2002,Predictors of neurologic recovery in acute central cervical cord injury with only upper extremity impairment,10.1097/00007632-200208010-00011,English,Japan,excluded,Out of scope,No control group,No control group; time course of recovery studied,,,human,,22,,,,,,,,female: 7 (32%),,,45.9 years (mean),,,,,,,-,,,,,,,,,,,"Motor vehicle accident (50%), fall (36.4%), diving accident (4.5%), othher (9.1%)",-,Methylprednisolone,,,"NASCIS-2 protocol: initial dose 30mg/kg, followed by infusion of 5.4mg/kg","Not reported explicitly, can potentially be inferred from NASCIS-2 protocol?",,"initial dose for 15min, infusion for 23hrs following the initial dose",-,intravenously,,neurological,"ASIA motor score, ASIA sensory score",,,"time of admission, one day, 3 days, one week, 3 weeks, 6 weeks, 3 months, 6 months, one year, two years post-injury",,Not clear but unlikely,,,,,,,,,,,,,,
Louis,Dinc et al.,2013,Comparison of Deferoxamine and Methylprednisolone Protective Effect of Pharmacological Agents on Lipid Peroxidation in Spinal Cord Injury in Rats,10.1097/BRS.0000000000000055,English,Turkey,included,,,,,,rats,Wistar,40,8,,,8,,,only counted SCI + vehicle as control,all male,male,100,not reported,,,,,,Not reported,250g to 320g,,,250,320,g,,compression injury between T7 and T10,T7 - T10,Not reported,compression,"aneurysm clip (closure force 70g), applied for 1min",,methylprednisolone,methylprednisolone,No,30mg/kg,"not reported explicitly, presumably post-injury",,not reported,not reported,intraperitoneally,,functional,inclined plane test,,,within 24hrs post-injury,No,Not reported,no stats,,histopathology,"tissue composition (hematoxylin-eosin stain, light microscopy)",24hrs post-injury (sample taken),Yes,no stats,"Edema and lymphocytes observed in sample for methylprednisolone 
treatment group (only qualitative statement however).",,Methylprednisolone shows some benefit in functional recovery (which is matched by deferoxamine). ,Functional assessment is very limited (inclined plane test).,Study focuses on assessing whether deferoxamine can provide benefits equivalent to methyprednisolone (rather than assessing effectiveness of methylprednisolone itself).,No,
Louis,Molloy et al.,2001,Questionnaire survey of the views of the delegates at the European Cervical Spine Research Society meeting on the administration of methylprednisolone for acute traumatic spinal cord injury.,10.1097/00007632-200112150-00017,English,United Kingdom,excluded,Out of scope,No assessments of interest,Survey results,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Samantaray et al.,2011,"Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: Effect of dosing, route of administration, and therapy delay",10.1007/s11064-011-0498-y,English,United States,excluded,Out of scope,No assessments of interest,"No functional outcomes assessed (neuroinflammatory response, apotosis)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Galloway et al.,2000,Role of topical steroids in reducing dysfunction after nerve injury,10.1097/00005537-200011000-00026,English,United States,excluded,Non-sci population,,Sciatic nerve injury,,,rats,Sprague Dawley,30,,,,,,,,all male,,,adult (no precise age reported),,,,,,,250g to 300g,,,,,,,Sciatic nerve crush injury,,,,,-,Dexamethasone,,,4mg/mL,during wound closure,,,,,,functional,"Sciatic Functional Index (De Medinaceli et al., 1982)",,,"pre-operative;
post-operative on days 2, 4, 7, 11, 14, 18, 22, 25, 32",,Yes,no effect,Improved SFI score for both treatment and control group w/ no statistically significant difference at day 32,,,,,,,,,,,,
Louis,Lee et al.,2010,Magnesium in a Polyethylene Glycol Formulation Provides Neuroprotection after Unilateral Cervical Spinal Cord Injury,10.1097/BRS.0b013e3181d2d6c5,English,"Canada, South Korea",included,,,,,,rats,Sprague Dawley,28,11,,,11,,,6 animals excluded due to excessive injury force,all male,male,100,not reported,,,,,,Not reported,300g to 350g,,,300,350,g,,unilateral cervical hemicontusion at C4-C5,C4 - C5,Not reported,contusion,1.5mm displacement injury via impactor tip,6 weeks,"Magnesium (MgCl2)
in PEG formulation",magnesium,,190micromol/kg,beginning two hours post-injury,,10 minutes,"5 infusions, each 6hrs apart",intravenously,,functional,"horizontal ladder test;
cylinder rearing test;
catwalk gait analysis;
sensory testing (forelimb withdrawal under mechanical stimulation)",,"horizontal ladder: 110cm long, 15cm wide, 2mm rung diameter, irregular spacing in the central 60cm, 6 runs per animal, total number of forelimb slips and steps assessed via video;
cylinder: topless, clear cylinder w/ 30cm diameter, 50cm height, 20 rears per animal, percent forelimb use assessed;
catwalk: 120cm long, 5 nonstop runs per animal, stride length ratio, forepaw print area ratio, swing duration, swing speed ratio, percent normal walking pattern (and others) assessed;
sensory testing: assessed using Von Frey monofilament device, each forepaw assessed 3 times","pre-injury;
post-injury: weeks 1, 2, 4, 6",,Not reported,mixed effects (assessment),"horizontal ladder: statistically significant fewer errors in MgCl2 treated animals at week 6;
cylinder rearing: no difference at week 6;
catwalk: no difference at week 6;
sensory: no difference at week 6",histopathology,extent of white and grey matter secondary damage,6 weeks post-injury,Not reported,positive effect,"overall white matter sparing significantly greater in treatment group
(white matter sparing at indiviudal sections not significant)",,"MgCl2 shows benefits in 
functional recovery and histological assessments",dosage (potentially too high for clinical use),,No,
Louis,Sonmez et al.,2013,"Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat",10.1097/BRS.0b013e3182895587,English,Turkey,included,,,,,,rats,Sprague Dawley,80,20,,,40,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,400g to 450g,,,400,450,g,,contusion injury at T10,T10,Not reported,contusion,50g/cm impact at the dorsal surface of spinal cord (Allen's method),4 weeks,Minocycline hydrochloride (dissolved in saline),minocycline,,"group 1: 1mg/kg
group 2: 90mg/kg initially, 45mg/kg subsequently","groups 1, 2: initial dose immediately post-injury",,24 hours,"group 1: every 4hrs for 24hrs
group 2: every 12hrs for 24hrs",multiple,"group 1: intravenously
group 2: intraperitoneally",functional,BBB locomotor scale,,"Possibly no asssessment pre-injury; 
exposure to open field pre-injury","post-injury days 1, 7, 14, 21, 28",,Not reported,positive effect,"statistically significant improved
scores for both treatment groups from day 7 onwards",histopathology,"assessment of intracellular edema,
axonal changes, mitochondrial changes, apoptosis",2 to 24 hours post-injury,Not reported,positive effect,"preservation of spinal cord ultrastructure in treatment groups,
reduced apoptosis in treatment groups",,"Minocycline shows benefits in functional recovery
and structural preservation; 
no difference between methods for administration",,multiple testing for BBB scores? ,No,
Louis,Pan et al.,2013,Major vault protein promotes locomotor recovery and regeneration after spinal cord injury in adult zebrafish,10.1111/ejn.12038,English,"China, United States",excluded,Out of scope,No drug of interest,No drug of interest (specific protein assessed),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Himmelseher et al.,1999,Management of acute spinal cord injury with corticosteroids,https://www.ai-online.info/archiv/1999/10-1999/zur-gabe-von-kortikosteroiden-nach-akuter-spinaler-traumatisierung.html,German,Germany,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Cuzzocrea et al.,2008,Effect of 17 beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma,10.1097/shk.0b013e31814545dc,English,"Italy, United States",included,,,,,,mice,CD1,240,40,,,40,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,25g to 30g,,,25,30,g,,compression injury at T6/T7,T6 - T7,Not reported,compression,"aneurysm clip (closing force 24g), applied for 1min",10 days,Estradiol (beta-17 estradiol),estradiol,,"group 1: 300microgram/kg;
group 2: 600microg/kg at 3hrs and 6hr post-injury","1hr pre-injury; 3hrs, 6hrs, 24hrs post-injury",,10 days,daily for 10 days post-injury,subcutaneous,,functional,modified BBB hindlimb locomotor scale,,,post-injury: days 1 to 10,,Not reported,no stats,no results for statistical assessments reported in text (Fig. 11 includes some results of test(s) for statistical significance but contradicts information in text),"histopathology;
immunohistochemistry","tissue composition (hematoxylin-eosin and Luxol fast blue staining, light microscopy);
expression of iNOS, nitrotyrosine, COX-2",24hrs post-injury (sample taken),"tissue composition: yes;
immunohistochemistry: not reported",positive effect,"tissue composition: statistically significant reduction in histological score for estradiol treatment group;
immunohistochemistry: in estradiol treatment group statistically significant reduced staining for iNOS, nitrotyrosine, COX-2",,"Estradiol shows beneficial effects in mice subjected to SCI by reducing degree of damage to spinal cord; expression of iNOS, nitrotyrosine and COX-2; and apoptosis. ",Pretreatment seems to be required.,"One group received estradiol and an estrogen receptor antagonist (ICI 182,780), which reduced effect of estradiol and made this group more similar to SCI-only -- good experiment to show estradiol's effect.",Yes (drug of interest + drug not of interest),
Louis,Wang et al.,2018,Effects of dexamethasone on autophagy and apoptosis in acute spinal cord injury,10.1097/WNR.0000000000001076,English,China,excluded,Out of scope,Ex-vivo,In-vitro model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ren et al.,2017,Polyethylene glycol-induced motor recovery after total spinal transection in rats,10.1111/cns.12713,English,China,included,,,,,,rats,Not reported,15,6,1,,9,,,,all male,male,100,not reported,,,,,,Not reported,not reported,,,,,,,complete transection at T10,T10,complete,transection,complete transection,28 days,Polyethylene glycol (PEG-600),polyethylene glycol,,0.5ml,immediately after inflcting injury and before closure ,,1 dose,,intrathecally,,"functional;
electrophysiology","BBB locomotor scale;
SSEP",,"SSEP: post-operative recording still under sedation,
stimulating electrode placed on right sciatic nerve, recording electrode on sensory cortex","BBB: post-injury days 1, 3, 5, 7, 9, 15, 21, 28;
SSEP: pre-, intra-, post-operatively",,"BBB: Yes;
SSEP: Not reported",mixed (stats/no stats),"statistically significant recovery in BBB scores for treatment group on day 28;
only qualitative evaluation for SSEPs",neuroanatomy,DTI to assess tissue connectivity,weeks 2 and 4 post-injury,Not reported,positive effect,"improved tissue connectivity in treatment group based on
fractional anisotropy measurements","intravenous administration of solution w/
antibiotics for 3 days following surgery","immediate application of PEG (fusogen) 
can reverse paralysis following severance of SC",,"multiple testing?;
effect might rely on absence of strong force during injury",No,
Louis,Chen et al.,2020,Construction of injectable silk fibroin/polydopamine hydrogel for treatment of spinal cord injury,10.1016/j.cej.2020.125795,English,China,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Sprague Dawley,10,5,,,5,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,220g,~220,,,,g,,lateral hemisection at T9/10,T9 - T10,incomplete,transection,lateral hemisection,14 days,dopamine,dopamine,,2mg/mL,immediately after inflcting injury and before closure ,,"no duration, silk-fibroin dopamin hydrogel left on site of injury",,intrathecally,,,,,,,,,,,immunohistochemistry,"beta-tubulin III, DAPI, GFAP stain",2 weeks post-injury,Not reported,positive effect,increased neuronal and reduced glial cell count in treatment group,antibiotics (not further specified) for 3 days following surgery,"Dopamine, applied via a silk-fibroin composite hydrogel, can support neuronal growth after SCI.",,Dose chosen based on in-vitro experiments. ,No,
Louis,Acartürk et al.,2004,Mega dose corticosteroid treatment for traumatic superior orbital fissure and orbital apex syndromes,10.1097/01.sap.0000106424.54415.dc,English,Turkey,excluded,Non-sci population,,Superior Orbital Fissure/Apex Syndromes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Faden et al.,1984,Megadose corticosteroid therapy following experimental traumatic spinal injury,10.3171/jns.1984.60.4.0712,English,United States,included,,,,,,cats,SPF (specific pathogen-free),32,4,,,7,5,,,not reported,not reported,,not reported,,,,,,Not reported,3kg (0.25),3,0.25,,,kg,,contusion injury at C7,C7,moderate - severe,contusion,"modified Allen's method, 20g weight dropped from 40cm",6 weeks,dexamethasone,dexamethasone,,"bolus: 2mg/kg
infusion:2mg/kg/hr","bolus: 1hr post-injury
infusion: following bolus for 6hrs",,bolus + infusion,,not reported,,functional,modified Tarlov scale,,score reported as sum over fore- and hindlimbs,weekly,,Yes,no effect,,histopathology,"extent of injury (lesions),
hematoxylin-eosin stain, Luxol-fast blue stain;
histopathological score based on (approximate) volume of injury",6 weeks post-injury,Not reported,no effect,,"Bicillin (600'000 units, post-operatively, intramuscular)","Megadose corticosteroid treatment does not provide
benefit as measured by neurological or histopathological scores.",,Study of dexamethasone was aborted early as five out of seven animals receiving drug died. Injury severity in Methyprednisolone group reduced accordingly.,No,
Louis,Faden et al.,1984,Megadose corticosteroid therapy following experimental traumatic spinal injury,10.3171/jns.1984.60.4.0712,English,United States,included,,,,,,cats,SPF (specific pathogen-free),32,11,3,,10,4,,,not reported,not reported,,not reported,,,,,,Not reported,3kg (0.25),3,0.25,,,kg,,contusion injury at C7,C7,moderate - severe,contusion,"modified Allen's method, 20g weight dropped from 30cm",6 weeks,methylprednisolone,methylprednisolone,Yes,"day 1: 30mg/kg, days 2 and 3: 15mg/kg, day 4: 12 mg/kg , day 5: 9mg/kg, day 6: 7.5mg/kg, day 7: 6mg/kg, day 8: 4.5mg/kg, day 9: 3mg/kg",,,9 days,daily,multiple,"intravenously for initial dose, intramuscularly otherwise",functional,modified Tarlov scale,,score reported as sum over fore- and hindlimbs,weekly,,Yes,no effect,,histopathology,"extent of injury (lesions),
hematoxylin-eosin stain, Luxol-fast blue stain;
histopathological score based on (approximate) volume of injury",6 weeks post-injury,Not reported,no effect,,"Bicillin (600'000 units, post-operatively, intramuscular)","Megadose corticosteroid treatment does not provide
benefit as measured by neurological or histopathological scores.",,Study of dexamethasone was aborted early as five out of seven animals receiving drug died. Injury severity in Methyprednisolone group reduced accordingly.,No,
Louis,Zheng et al.,2017,Melatonin alleviates acute spinal cord injury in rats through promoting on progenitor cells proliferation,10.1016/j.jsps.2017.04.025,English,China,excluded,Retracted,,Retracted,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Xu et al.,2019,Melatonin ameliorates spinal cord injury by suppressing the activation of inflammasomes in rats,10.1002/jcb.27794,English,China,included,,,,,,rats,Sprague Dawley,Not reported,,,,,,,,not reported,not reported,,not reported,,,,,,Not reported,200g (20),200,20,,,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,10g impactor dropped from 25mm height (Allen's method),4 weeks,Melatonin,melatonin,,12.5mg/kg,post-injury (not further specified),,10 days,daily for 10 days,intraperitoneally,,functional,BBB locomotor scale,,,"BBB: pre-injury (day 0), 
post-injury days 1, 3, 7, 14, 21, 28",,Yes,no stats,effect unclear as no statistical result (p-value or similar) is reported; see Section 3.1 and Figure 1,histopathology,"Spinal cord water content;
apoptosis via TUNEL assay","not reported (presumably
after day 28/final functional assessment)",Not reported,positive effect,"Melatonin reduces water content and number of apoptotic 
cells in treatment group",,"Melatonin can provide inhibition of inflammasomes
and thereby improve recovery from SCI",,Some important information (e.g. p-values for BBB score comparisons) missing,No,
Louis,Xu et al.,2019,Melatonin ameliorates spinal cord injury by suppressing the activation of inflammasomes in rats.,10.1002/jcb.27794,English,China,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Tavukcu et al.,2014,Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats,10.1111/1440-1681.12216,English,Turkey,excluded,Out of scope,No assessments of interest,No functional outcomes of interest assessed (erectile dysfunction),,,rats,Wistar albino,40,,,,,,,,"Not reported
(presumably all male)",,,not reported,,,,,,,250g to 300g,,,,,,,contusion injury at T7 between T10,,,,"10g impactor dropped from 10cm height 
(modified weight drop model; equiv. to 100g/cm)",-,"Melatonin;
tadalafil;
melatonin and tadalafil",,,10mg/kg,post-injury,,not further specified,daily for 7 days,multiple,,,,,,,,,,,,,,,,,,,,,,
Louis,Guo et al.,2019,Melatonin combined with chondroitin sulfate ABC promotes nerve regeneration after root-avulsion brachial plexus injury,10.4103/1673-5374.244796,English,China,excluded,Non-sci population,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Lee et al.,2012,Melatonin combined with exercise cannot alleviate cerebral injury in a rat model of focal cerebral ischemia/reperfusion injury,10.3969/j.issn.1673-5374.2012.13.005,English,South Korea,excluded,Non-sci population,,Ischemic brain injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Li et al.,2019,Melatonin Enhances Autophagy and Reduces Apoptosis to Promote Locomotor Recovery in Spinal Cord Injury via the PI3K/AKT/mTOR Signaling Pathway,10.1007/s11064-019-02838-w,English,China,included,,,,,,rats,Sprague Dawley,15,5,,,5,,,,all male,male,100,8 to 10 weeks,,,8,10,Weeks,,240g to 260g,,,240,260,g,,contusion injury at T10,T10,Not reported,contusion,Allen's method,4 weeks,Melatonin,melatonin,,12.5mg/kg,post-injury (not further specified),,7 days,daily,intraperitoneally,,functional,BBB locomotor scale,,,"post-injury days 1, 3, 7, 14, 21, 28",,Yes,positive effect,improved BBB scores (statistically significant from day 7 onwards),histological,Nissl staining,post-injury day 7,Not reported,positive effect,Increased number of neurons in spinal cord ventral horn (statistically significant),,Melatonin provides benefit as measured by locomotor function; hypothesis for method of action: increased autophagy and reduced apoptosis.,,,No,
Louis,Yang et al.,2020,Melatonin exerts neuroprotective effects by attenuating astro- and microgliosis and suppressing inflammatory response following spinal cord injury,10.1016/j.npep.2019.102002,English,China,included,,,,,,mice,C57BL/6,72,24,,,24,,,,all male,male,100,8 to 12 weeks,,,8,12,Weeks,,22g to 25g,,,22,25,g,,compression injury at T11,T11,Not reported,compression,bilateral compression for 30s,7 days,Melatonin,melatonin,,10mg/kg,one hour post-injury,,7 days,daily,intraperitoneally,,functional,Basso mouse scale,,mice exposed to test environemnt for three days pre-injury,pre-injury; post-injury days 1 to 7,,Not reported,positive effect,improved Basso mouse scores (statistically significant from day 5 onwards),histological,BrdU staining (to determine no. of surviving neurons at injury site) ,post-injury day 7,Not reported,positive effect,Improved survival of neurons in treatment group compared to control.,,Melatonin provides benefit as measured by improved functional recovery and reduced loss of neuronal cells at site of injury; potential mechanism: down regulation of pro-inflammatory cytokines reducing strength of secondary injury.,,,No,
Louis,Piao et al.,2014,Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats,10.1007/s00701-014-2119-4,English,"South Korea, China",included,,,,,,rats,Sprague Dawley,10,5,,,5,,,,all female,female,0,8 weeks,8,,,,Weeks,,250g to 300g,,,250,300,g,,photothrombotic injury at T8/T9,T8 - T9,Not reported,others,"Rose Bengal dye at 50mg/kg concentration, five minutes later irradiation for three minutes",4 weeks,Melatonin,melatonin,,50mg/kg,one hour post-injury,,7 days,twice daily (every 12 hrs),intraperitoneally,,functional,BBB locomotor scale,,,"pre-injury; post-injury days 3, 7, 14, 21, 28",,Not reported,positive effect,improved BBB score (statistically significant at day 28),histopathology,"hematoxylin-eosin staining, immunohistochesmistry;
SCI water content","staining, immunohistochemistry: post-injury day 3 (72hrs);
water content: post-injury day 1 (24hrs)",Not reported,positive effect,"reduced lesion size in treatment group;
reduced water content in treatment group",Antibiotics for five days post-injury,"Melatonin provides benefit as measured by improved functional recovery; histological findings show smaller lesion size. Suggested mechanism: increased expression of MMP-9, which in turn limits secondary to SC.",,,No,
Louis,Zhang et al.,2019,Melatonin improves functional recovery in female rats after acute spinal cord injury by modulating polarization of spinal microglial/macrophages,10.1002/jnr.24409,English,"China, United States",included,,,,,,rats,Wistar,61,12,,,12,,,7 animals died after surgery but before group assignment,all female,female,0,adult (no precise age reported),,,,,,Adult,220g to 250g,,,220,250,g,,contusion injury at T10,T10,Not reported,contusion,10g impactor dropped from 25mm height,7 days,Melatonin,melatonin,,50mg/kg,immediately post-injury,,7 days,daily,intraperitoneally,,functional,BBB locomotor scale,,,post-injury days 1 to 7,,Yes,positive effect,improved BBB score (statistically significant at day 7),histopathology,"hematoxylin-eosin staining,
immunofluorescence",post-injury day 7,Yes (for measurement of cavity area),positive effect,"size of central cavity significantly smaller in treatment group;
significantly fewer apoptotic neurons in treatment group",,"Melatonin provides benefit as measured by improved functional outcome and reduced cavity size. Suspected mechanism: microglia polarisation, reduction in M1 microglial and increase in M2 microglial markers (M1: pro-inflammatory, M2: anti-inflammatory).",,,No,
Louis,Shen et al.,2017,Melatonin Inhibits Neural Cell Apoptosis and Promotes Locomotor Recovery via Activation of the Wnt/beta-Catenin Signaling Pathway After Spinal Cord Injury,10.1007/s11064-017-2251-7,English,China,included,,,,,,rats,Sprague Dawley,>= 38,>= 19,,,>= 19,,,counts derived from figure captions (unclear if overlaps between animals used for results reported in different figures exist or not),all female,female,0,adult (no precise age reported),,,,,,Adult,180g to 220g ,,,180,220,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,10g impactor dropped from 25mm height,1 week - 4 weeks,Melatonin,melatonin,,12.5mg/kg,not reported,,3 days,daily,intraperitoneally,,functional,BBB locomotor scale,,,"pre-injury; post-injury days 1, 3, 7, 14, 21, 28",,Yes,positive effect,improved BBB score (statistically significant from day 7 onwards),histological,Nissl staining,post-injury day 7,Not reported,positive effect,Increased number of neurons in spinal cord ventral horn (statistically significant),,Melatonin provides benefit as measured by improved functional recovery and increased number of neurons in treatment group. Suspected mechanism: Wnt/beta-catenin signaling pathway which reduces apoptosis.,,,No,
Louis,Li et al.,2014,Melatonin lowers edema after spinal cord injury,10.4103/1673-5374.147954,English,China,excluded,Out of scope,No assessments of interest,No outcome of interest assessed (edema in spinal cord),,,rats,Sprague Dawley,150,,,,,,,,all female,,,10 to 11 weeks,,,,,,,250g (22),,,,,,,compression injury at T12,,,,aneurysm clip applied for 5min,-,Melatonin,,,100mg/kg,immediately post-injury,,injection,daily for 2 days,intraperitoneally,,,,,,,,,,,,water content in spinal cord,"post-injury at 12hrs, 24hrs, 48hrs, 72hrs",Not reported,mixed effects,Reduced water content in treatment group (statistically significant from 24hrs onwards); no overall reduction in water content for treatment group.,,Melatonin might be used to reduce water content of spinal cord after SCI and thereby reduce edema.,,,,
Louis,Chang et al.,2008,Melatonin preserves superoxide dismutase activity in hypoglossal motoneurons of adult rats following peripheral nerve injury,10.1111/j.1600-079X.2007.00505.x,English,Taiwan,excluded,Non-sci population,,Peripheral nerve injuries,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Shu et al.,2018,Melatonin promotes neuroprotection of induced pluripotent stem cells-derived neural stem cells subjected to H2O2-induced injury in vitro,10.1016/j.ejphar.2018.02.027,English,China,excluded,Out of scope,No drug of interest,Experiments on iPSC-derived neural stem cells ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Esposito et al.,2009,Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury,10.1111/j.1600-079X.2008.00633.x,English,Italy,included,,,,,,mice,Not reported,40,10,,,10,,,only counted SCI + vehicle as control,Not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,,compression injury at T6/T7,T6 - T7,Not reported,compression,"aneurysm clip with closing force of 24 g, applied for 1min",20 days,Melatonin,melatonin,,50mg/kg,injection at 1/6/12 hours post-injury,,3 doses,,not reported,,functional,BBB locomotor scale (modified),,,post-injury every day for 20 days,,Not reported,positive effect,improved BBB score (statistically significant),histopathology,hematoxylin-eosin staining,post-injury at 24hrs,Yes,positive effect,lower histological score (corresponding to less damage) for treatment group compared to control,,"Melatonin provides benefit as measured by improved functional recovery (although effect size seems to be small) and reduced tissue damage. Suspected mechanism: MAPK cascade(s), which might be inhibited by melatonin.",,,No,
Louis,Esposito et al.,2008,Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury,10.1111/j.1600-079X.2008.00569.x,English,Italy,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,mice,Not reported,40,10,,,10,,,only counted SCI + vehicle as control,Not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,,compression injury at T6/T7,T6 - T7,Not reported,compression,"aneurysm clip with closing force of 24 g, applied for 1min",24 hours,Melatonin,melatonin,,50mg/kg,"30min pre-injury,
1, 6, 12hrs post-injury",,4 doses,,not reported,,,,,,,,,,,histopathology,hematoxylin-eosin staining,post-injury at 24hrs,Yes,positive effect,reduced histological score,,Melatonin provides benefit after SCI as measured by reduction in histological score. Potential mechanisms involve suppression of matrix metalloproteinase activity and TNF-alpha production.,,,,
Louis,Jing et al.,2019,Melatonin treatment alleviates spinal cord injury-induced gut dysbiosis in mice,10.1089/neu.2018.6012,English,China,included,,,,,,mice,C57BL/6,64,16,,,16,,,only counted SCI + vehicle as control,all female,female,0,adult (no precise age reported),,,,,,Adult,18g to 22g,,,18,22,g,,contusion injury at T10,T10,Not reported,contusion,70 kilodyne using Infinite Horizons Impactor,4 weeks,Melatonin,melatonin,,10mg/kg,not reported,,4 weeks,daily for 7 days,intraperitoneally,,functional,"Basso mouse scale;
gait analysis (DigiGait)",,gait analysis: pre-training for 7 days pre-injury,"BMS: pre-injury; post-injury days 3, 7, 14, 21, 28;
gait analysis: pre-injury, post-injury day 28",,Yes,mixed effects (assessment),"improved BMS score (statistically significant from day 14 onwards); 
some gait parameters improved (more time spent in swing phase/less time spent in stance phase), other gait parameters unchanged from SCI only",,,,,,,Subset of animals received antibiotics pre-injury to induce gut dysbiosis. ,"Melatonin provides benefit as measured by improved functional recovery (BMS score). Suspected mechanism: melatonin counteracts gastrointestinal dysfunction, correlating with increased metabolic rate and improved functional recovery. Melatonin might act on gut microbiota to achieve this effect. ",,,No,
Louis,Wu et al.,2014,Melatonin Treatment Protects Against Acute Spinal Cord Injury-Induced Disruption of Blood Spinal Cord Barrier in Mice,10.1007/s12031-014-0430-4,English,China,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,mice,C57BL/6,114,30,,,54,,,"only counted SCI + vehicle as control;
large (unspecified) share of animals in treatment group used for determining optimal dose, but not subjected to assessments of interest ",all male,male,100,not reported,,,,,,Not reported,20g to 25g,,,20,25,g,,contusion injury at T10,T10,Not reported,contusion,5g impactor dropped from 10mm height (impact force 50g/mm),48 hours,Melatonin,melatonin,,"5mg/kg, 10mg/kg, 25mg/kg, 50mg/kg, 100mg/kg",immediately post-injury,,1 dose,,intraperitoneally,,,,,,,,,,,"histopathology;
immunohistochemistry","histopathology: blood-spinal cord barrier permeability assessed using Evan's Blue, apoptosis via TUNEL assay;
immunohistochemistry: stain for blood vessel integrity and tight junction protein",,Not reported,positive effect,"statistically significant reduction in blood-SC barrier permeability (compared to SCI w/o treatment);
statistically significant reduction in apoptosis (compared to SCI w/o treatment);
effects on blood vessel integrity and presence of tight junction protein qualitatively positive",,"Melatonin at 50mg/kg administered immediately after SCI
reduces apoptosis and microvessel loss around injury, protects
tight junction proteins and reduces permeability of the blood-SC barrier.",,"Optimal dose chosen based on experimental results as 50mg/kg, as all other dosing levels did not produce statistically significant differences in measured outcomes.",No,
Louis,Fee et al.,2010,"Melatonin-analog, beta-methyl-6-chloromelatonin, supplementation in spinal cord injury",10.1016/j.brainres.2010.04.047,English,United States,included,,,,,,rats,Sprague Dawley,26 - 28,08.Oct,,,16 - 18,6,,only animals treated with higher dose died,all female,female,0,6 to 8 weeks,,,6,8,Weeks,Adult,190g to 252g,,,190,252,g,,contusion injury at T10 (moderate-to-severe),T10,moderate - severe,contusion,"IH impacting device, 200kdyn force",2 weeks,beta-methyl-6-chloromelatonin,melatonin,,"10mg/kg, 100mg/kg","15min, 6hrs post-injury",,7 days,daily,intraperitoneally,,functional,BBB locomotor scale,,,"post-injury days 2, 7, 14",,Not reported,no effect,statistically significant improvement in BBB score for 10mg/kg treatment group on day 7; no significant difference on day 14,histopathology,"tissue composition via eriochrome cyanine stain (spared tissue, length of injury)",post-injury day 14,Not reported,no effect,,"cefazolin (33mg/kg), enrofloxin (85mg/kg), impramine (2mg/kg) post-operatively and twice daily on days 0, 1, 2 post-injury",Low dose regime can provide some benefits in functional recovery but no effect observed for neuroanatomical recovery. High-dose regime is most likely toxic.,,"100mg/kg dosing regime most likely toxic (6 of 8 animals died within 24hrs of SCI, one euthanised)",No,
Louis,Jing et al.,2016,Meliorating microcirculatory with melatonin in rat model of spinal cord injury using laser Doppler flowmetry,10.1097/WNR.0000000000000686,English,China,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Sprague Dawley,36,12,,,12,,,only counted SCI + vehicle as control,all female,female,0,8 weeks,8,,,,Weeks,Adult,220g (20),220,20,,,g,,contusion injury at T10,T10,Not reported,contusion,"NYU weight drop model, 10g impactor w/ 3mm tip dropped from 25mm",24 hours,Melatonin,melatonin,,50mg/kg,30min post-injury,,24 hours,twice daily,intraperitoneally,,,,,,,,,,,"histopathology;
perfusion","histopathology: blood-SC barrier permeability assessed by Evan's blue stain, edema formation assessed by water content;
perfusion assessed by laser doppler perfusion imaging (measures blood flow and oxygen saturation)","blood-SC barrier permeability: 24hrs post-injury;
edema: immediately post-injury
laser doppler perfusion imaging for blood flow: 24hrs post-injury;
laser doppler assessment of oxygen concentration: pre-injury and 30min, 24hrs, 48hrs post-injury",Not reported,mixed effects,"blood-SC barrier: melatonin reduces (statistically significant) permeability as measured by reduced extravasation of Evan's blue;
blood flow: melatonin improves (statistically significant) blood flow in rostral and caudal regions but not at injury epicenter
",,"Melatonin improves microcirculation after SCI in regions rostral and caudal to injury epicenter, which could have beneficial effect on recovery.",laser doppler flowmetry is sensitive to calibration and movement artefacts,"Melatonin dose chosen based on previous experiments.
Claim that mircrocirculation can have beneficial effect on recovery but no animals later than 24hrs to 48hrs post-injury. 
No functional assessment; makes claim of benefit difficult to assess.",No,
Louis,"Feldman, McCauley",2018,Mesenchymal Stem Cells and Transforming Growth Factor-(3) (TGF-(3)) to Enhance the Regenerative Ability of an Albumin Scaffold in Full Thickness Wound Healing,10.3390/jfb9040065,English,United States,excluded,Out of scope,No assessments of interest,Study on healing of pressure ulcers in SCI patients,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wilson et al.,2018,"Natural History, Predictors of Outcome, and Effects of Treatment in Thoracic Spinal Cord Injury: A Multi-Center Cohort Study from the North American Clinical Trials Network.",10.1089/neu.2017.5535,English,"Canada, United States",included,,,,prospective,retrospective,human,,86,54,,,31,,,1 patient with missing MP information,female: 21 (25.6%),mixed,74.4,40.4 yrs (15.8),40.4,15.8,,,Years,,not reported,,,,,,,"blunt injury between T1 and L1; AIS A 55 (64%), AIS B 11 (12.8%), AIS C 13 (15.1%), AIS D 7 (8.1%)",T1 - L1,mixed,,"motor vehicle accident: 40 (46.2%), fall: 30 (35.5%), all terrain vehicle: 6 (7.5%), assault: 2 (2.2%), pedestrian: 3 (3.2%), other: 5 (5.4%)",mean length of stay: 18.4 (33.8) days,Methylprednisolone,methylprednisolone,,NASCIS-2 protocol,NASCIS-2 protocol,,NASCIS-2 protocol,NASCIS-2 protocol,not reported,,neurological,"ISNCSCI motor score, ASIA grade","neurological (motor), injury severity",Neurological recovery defined as increase in ASIA grade and/or improvement of motor score.,"within 7 days of injury, 1 to 3 months post-injury, 3 to 6 months post-injury, 6 to 12 months post-injury",,Not reported,mixed effects (assessment),Methylprednisolone has no significant effect on neurological recovery if included as part of multivariate analysis (together w/ AIS grade and timing of surgery). In bivariate analysis methylprednisolone shows a statistically significant negative effect on motor score recovery. ,,,,,,,,Administration of methylprednisolone does not have a significant effect on neurological recovery (multivariate analysis; potentially negative effect if considering bivariate analysis).,Small sample size due to thoracic level injuries being less common. ,Specific focus on thoracic level injuries as these are less studied.,No,
Louis,Jeffrey-Gauthier et al.,2018,Facilitation of locomotor spinal networks activity by buspirone after a complete spinal cord lesion in mice,10.1089/neu.2017.5476,English,Canada,included,,,,,,mice,CD1,19,5,,,5,,,"Separate group with two injuries (hemisection, transection) not included (total of 9 animals of which only 5 seem to have been included for analysis).",all female,female,0,not reported,,,,,,Not reported,25g (5),,,,,,,"complete transection at T8 for all mice;
9 mice initially subjected to left hemisection at T7, allowed three weeks recovery combined w/ treadmill training before complete transection;
only group with only complete transection included",T8,complete,transection,complete transection by microscissors (confirmed by postmortem assessment),3 weeks,Buspirone,buspirone,,8mg/kg,post-injury day 2,,3 weeks,daily,intraperitoneally,,functional,Gait analysis,,"custom software; belt speed fixed at 12m/min; anatomical landmarks highlighted for translation into x-y-coordinate system and analysis of joint excursion; longest locomotor bouts (per session) analysed; measurements recorded: step number, phase coupling between fore- and hindlimb (only pre-transection), phase coupling between hindlimbs, stance and swing duration, paw placement (relative to hip)","post-injury days 2, 8, 15, 21",,Not reported,mixed effects (assessment),"significantly increased step occurrence on days 2, 8, 15, 21 for treatment group,
no significant effect on phase coupling, mixed effects on hip excursion (significantly improved on days 2, 8, 15 but not day 21),
paw positioning, swing and drag duration changed but mostly not statistically significant",histopathology,lesion size (T7 hemisection) as percentage of severed white matter,post-injury (transection) at 3 weeks (6 weeks post-injury for hemisection),not reported,no effect,no drug (buspirone) administered,"perioperative: carprofen (10mg/kg subcutaneously),
buprenorphine (0.1mg/kg subcutaneously)","buspirone has significant (?) acute effect (immediately around training episodes) on locomotor recovery; 
long-lasting effects (recovery over time) limited;
mechanistic understanding incomplete but 5HT_1a/7 agonist function suspected to be relevant","locomotion had to be induced by stimulation (perineal pinching) which is applied by experimenter and not completely standardised;
unclear what long-term effects can be expected",multiple testing? (potentially major problem as many comparisons/tests performed),No,
Louis,Fehlings et al.,2018,Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial,10.1089/neu.2017.5434,English,"Canada, United States",excluded,Out of scope,No drug of interest,No drug of interest (rho inhibitor VX-210),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Rabchevsky et al.,2003,Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats,10.1089/089771503322144572,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (creatine supplement in diet),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Evaniew et al.,2015,Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry,10.1089/neu.2015.3963,English,Canada,included,,,,prospective,retrospective,human,,2009,1555,,,44,,2,"steroid status unknow n=318, steroids other than NASCIS-II MPS n=91","MPSS: female 8 (17.4%)
Control: female 344 (22.1%)",mixed,78,"MPSS: 45.9 yrs (16.6)
Control: 45.0 yrs (18.6)",45.9,16.6,,,Years,,not reported,,,,,,,"MPSS: ASIA A 21, ASIA B 6, ASIA C 8, ASIA D 11; cervical 32, thoracic 14
Control: ASIA A 536, ASIA B 152, ASIA C 264, ASIA D 384; cervical 796, thoracic 458",cervical - thoracic,mixed,,"MPSS: high energy 21, low energy 25
Control: high energy 791, low energy 685, unknown 79",-,Methylprednisolone,methylprednisolone,,NASCIS-2 protocol,NASCIS-2 protocol,,NASCIS-2 protocol,NASCIS-2 protocol,not reported,,neurological,ISNCSCI motor score,neurological (motor),"Improvement in total, lower extremity and 
upper extremity scores","baseline: time of admission
final: time of discharge from acute care or inpatient rehabilitation",,Not reported,no effect,"No effect on functional recovery for NASCIS-2 methylprednisolone treatment.
Neither in direct comparison of recovery nor in negative bionomial regression. No effect regardless of comparison of treatment group w/ matched controls or full set of controls.",,,,,,,,Methylprednisolone administered according to NASCIS-2 protocol does not improve motor score recovery. ,"Small number of patients receiving NASCIS-2 methylprednisolone.
No standardised timing of initial ISNCSCI exam, potential confounding introduced by variability in time of exam.","Large number of patients w/o methylprednisolone treatment; propensity score matching for comparison.
Patients w/ incomplete data excluded, no imputation.",No,
Louis,Leech et al.,2014,Effects of Serotonergic Medications on Locomotor Performance in Humans with Incomplete Spinal Cord Injury,10.1089/neu.2013.3206,English,United States,included,,,,prospective,prospective,human,,10,10,,,10,,,"comparison pre and post exposure in chronic patients, i.e., patients are their own control",all male,male,100,44 (10),44,10,,,Years,,not reported,,,,,,,incomplete SCI (ASIA D); level of injury between C2 and C7 (see table 1); LEMS between 36 and 49,cervical,incomplete,Not reported,not reported,95 months (87) ,"Cyproheptadine (5HT antagonist);
Escitalopram oxalate (SSRI, selective serotonin reuptake inhibitor)",cyproheptadine,,"cyproheptadine: 8mg;
escitalopram: 10mg",-,,-,-,oral,,"walking function;
electrophysiology","overground walking performance;
treadmill walking performance;
EMG","neurological (motor), functional (mobility and spasticity), electrophysiology","overground: patient asked to walk as fast as safely possible by assessor, assistive devices as normally used by patient, ;
treadmill: start at 0.1m/sec, increase by 0.1m/sec every two minutes until support of harness required or termination requested by patient, kinematic parameters (joint excursion) and oxygen consumption (VO2) assessed;
EMG: lower extremity EMG activity during treadmill walking","before drug administration,
4.5hrs after drug administration",,Yes,mixed effects (assessment),"most assessed outcomes showed no statistically significant change;
maximum gait speed (overground) statistically significantly reduced by cyproheptadine;
some statistically significant changes (both positive and negative) to joint excursion;
statistically significant increase in EMG activity for escitalopram in overground walking and decrease in EMG activity for cycproheptadine in treadmill walking",,,,,,,,"Single-dose administration of 5HT medication does not lead
to improvement in locomotor function. ",,,No,
Louis,Leech et al.,2014,Effects of Serotonergic Medications on Locomotor Performance in Humans with Incomplete Spinal Cord Injury,10.1089/neu.2013.3206,English,United States,included,,,,prospective,prospective,human,,10,10,,,10,,,"comparison pre and post exposure in chronic patients, i.e., patients are their own control",all male,male,100,44 (10),44,10,,,Years,,not reported,,,,,,,incomplete SCI (ASIA D); level of injury between C2 and C7 (see table 1); LEMS between 36 and 49,cervical,incomplete,Not reported,not reported,95 months (87) ,"Cyproheptadine (5HT antagonist);
Escitalopram oxalate (SSRI, selective serotonin reuptake inhibitor)",escitalopram,,"cyproheptadine: 8mg;
escitalopram: 10mg",-,,-,-,oral,,"walking function;
electrophysiology","overground walking performance;
treadmill walking performance;
EMG","neurological (motor), functional (mobility and spasticity), electrophysiology","overground: patient asked to walk as fast as safely possible by assessor, assistive devices as normally used by patient, ;
treadmill: start at 0.1m/sec, increase by 0.1m/sec every two minutes until support of harness required or termination requested by patient, kinematic parameters (joint excursion) and oxygen consumption (VO2) assessed;
EMG: lower extremity EMG activity during treadmill walking","before drug administration,
4.5hrs after drug administration",,Yes,mixed effects (assessment),"most assessed outcomes showed no statistically significant change;
maximum gait speed (overground) statistically significantly reduced by cyproheptadine;
some statistically significant changes (both positive and negative) to joint excursion;
statistically significant increase in EMG activity for escitalopram in overground walking and decrease in EMG activity for cycproheptadine in treadmill walking",,,,,,,,"Single-dose administration of 5HT medication does not lead
to improvement in locomotor function. ",,,No,
Louis,Smith et al.,2005,Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease,10.1016/j.ejmech.2005.04.017,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (derivatives of 4-aminopyridine, which itself is not of interest)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Thompson, Hornby",2013,Divergent Modulation of Clinical Measures of Volitional and Reflexive Motor Behaviors following Serotonergic Medications in Human Incomplete Spinal Cord Injury,10.1089/neu.2012.2515,English,United States,included,,,,prospective,prospective,human,,12,12,,,12,,,"comparison pre and post exposure in chronic patients, i.e., patients are their own control",female: 2 (16.7%),mixed,83.3,50.5 yrs (median),50.5,,42.5,60.5,Years,median,not reported,,,,,,,"incomplete SCI; AIS C: 5, AIS D: 7; 
C1 to C4: 2, C4 to C8: 7, T1 to T10: 3;
median LEMS at baseline: 41",cervical - thoracic,incomplete,Not reported,not reported,"93 months (median), 63-235 (range?)","cyproheptadine;
escitalopram
",cyproheptadine,,8mg,-,,-,-,oral,,functional,"strength;
spastic reflexes;
walking function
","neurological (motor), functional (mobility and spasticity)","LEMS;
modified Ashworth scale (mAsh), Spinal Cord Assessment Tools for Spastic Reflexes (SCATS);
overground at fastest possible velocity, assistive devices allowed where required, velocity, step length and cadence measured","before drug administration,
4.5hrs after drug administration",,presumably yes,mixed effects (assessment),"cyproheptadine (5-HT antagonist): decrease in median LEMS (not signficant), decrease in mAsh and SCATS (significant);
escitalopram (SSRI): increase in median LEMS (not significant), increase in mAsh and SCATS (significant);
comparison: significant difference between cyproheptadine and escitalopram groups for LEMS, highly signfificant difference between groups for mAsh and SCATS;
minimal effect of either drug on walking performance (only small but significant reduction in speed for cyproheptadien group)
",,,,,,,,Modulating 5-HT availability has effect on strength and spasticity but not locomotor function in chronic SCI patients.,,,No,
Louis,"Thompson, Hornby",2013,Divergent Modulation of Clinical Measures of Volitional and Reflexive Motor Behaviors following Serotonergic Medications in Human Incomplete Spinal Cord Injury,10.1089/neu.2012.2515,English,United States,included,,,,prospective,prospective,human,,12,12,,,12,,,"comparison pre and post exposure in chronic patients, i.e., patients are their own control",female: 2 (16.7%),mixed,83.3,50.5 yrs (median),50.5,,42.5,60.5,Years,median,not reported,,,,,,,"incomplete SCI; AIS C: 5, AIS D: 7; 
C1 to C4: 2, C4 to C8: 7, T1 to T10: 3;
median LEMS at baseline: 41",cervical - thoracic,incomplete,Not reported,not reported,"93 months (median), 63-235 (range?)","cyproheptadine;
escitalopram
",escitalopram,,10mg,-,,-,-,oral,,functional,"strength;
spastic reflexes;
walking function
","neurological (motor), functional (mobility and spasticity)","LEMS;
modified Ashworth scale (mAsh), Spinal Cord Assessment Tools for Spastic Reflexes (SCATS);
overground at fastest possible velocity, assistive devices allowed where required, velocity, step length and cadence measured","before drug administration,
4.5hrs after drug administration",,presumably yes,mixed effects (assessment),"cyproheptadine (5-HT antagonist): decrease in median LEMS (not signficant), decrease in mAsh and SCATS (significant);
escitalopram (SSRI): increase in median LEMS (not significant), increase in mAsh and SCATS (significant);
comparison: significant difference between cyproheptadine and escitalopram groups for LEMS, highly signfificant difference between groups for mAsh and SCATS;
minimal effect of either drug on walking performance (only small but significant reduction in speed for cyproheptadien group)
",,,,,,,,Modulating 5-HT availability has effect on strength and spasticity but not locomotor function in chronic SCI patients.,,,No,
Louis,Festoff et al.,2006,"Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury",10.1111/j.1471-4159.2006.03799.x,English,United States,excluded,Out of scope,No control group,Another drug of interest was given to control group.,,,rats,Sprague Dawley,33,12,,,21,,,control group treated with tetracycline,all female,,0,adult (no precise age reported),,,,,,,300g to 325g,,,,,,,contusion injury at T9,,,,"NYU weight drop model, 10g impactor dropped from 25mm (25gcm impact force)",-,Minocycline,,,90mg/kg (total),"single dose: 30min or 1hr or 24hrs post-injury
multiple doses: 30mg/kg at 30min, 1hr and 24hrs post-injury",,injection,,intraperitoneally,,functional,BBB locomotor scale,,"animals trained beginning 1 week pre-injury;
assessment by three observers","pre-injury,
post-injury days 1, 2, 3, 7, 10, 14, 17, 21, 24, 28",,Yes,positive effect,"regardless of dosing regime followed, statistically significant improvement in recovery observed from day 2 (multi-dose) or day 7 (any of the single-dose regimes) onwards when compared to SCI control","histopathology;
immunohistochemistry","tissue sparing via hematoxylin-eosin / Nissl and HAM-56 stains;
apoptosis via anti-capase-3",post-injury day 28,Not reported,positive effect,"decreased tissue loss in minocycline treated animals (only qualitative assessemnt),
statistically significant reduction in cavity size in minocyclin treatment group compared to tetracycline control at injury site and in caudal segments",,Minocycline improves functional recovery. Multi-dose regime leads to more rapid recovery but recovery plateaus at same level for all dosing regimes. ,"Small sample sizes (n=4, n=2) for different treatment groups.",,No,
Louis,Suzuki et al.,1995,Effects of nicorandil on the recovery of reflex potentials after spinal cord ischaemia in cats,10.1111/j.1476-5381.1995.tb16668.x,English,Japan,excluded,Out of scope,Other,unclear and mixed SCI (transection and ischemia; potentially some assessment ex-vivo),,,cats,Not reported,55,10,,,10,,,,not reported,not reported,not reported,adult (no precise age reported),,,,,,Adult,2.1kg to 3.5kg,,,2.1,3.5,kg,,arterial occlusion injury ,,,ischemia,aorta and bilateral internal mammary arteries were occluded twice for 10min w/ at least 110min between occlusion,not reported,nitroprusside,nitroprusside,,"group 1: 5microgram/kg per min;
group 2: 8microgram/kg per min","starting 10 minutes before second occlusion, lasting until 
90 min after reperfusion",,infusion for 110min,,intravenously,,"electrophysiology;
physiology","mono- and polysynaptic reflex potentials (M/PSR);
spinal cord/regional blood flow, blood pressure",,"M/PSR potentials measured at L7 ipsilateral or S1 ventral root;
spinal cord blood flow via Laser-Doppler flowmetry, BP via left femoral artey","M/PSR prior to injury and multiple time points after reperfusion;
spinal cord blood flow and blood pressure continuously",,Not reported,mixed effects (dosage) + mixed effects (assessment),"lower dose (5ug/kg) showed no effect on recovery of PSR potentials,
higher dose (8ug/kg) showed negative effect on recovery of PSR potentials;
no effect on spinal cord blood flow and negative effect on blood pressure (decreased)",,,,,,,,K+ channel openers can benefit recovery after ischemia in spinal cord (which can be introduced by traumatic injury). ,,,No,
Louis,Holtz et al.,1989,Blocking weight-induced spinal cord injury in rats: effects of TRH or naloxone on motor function recovery and spinal cord blood flow.,10.1111/j.1600-0404.1989.tb03865.x,English,Sweden,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,,all male,male,100,not reported,,,,,,Not reported,320g to 380g,,,320,380,g,,compression injury at T7/T8,T7 - T8,Not reported,compression,compression plate applied to exposed dura w/ load of 35g for 5min,4 days,Naloxone,naloxone,,"bolus: 2mg/kg
infusion: 2mg/kg/h 
total: 10mg/kg ","bolus: 1hr post-injury
infusion: following bolus",,4 hours,,intravenously,,functional,inclined plane test,,,post-injury days 1 to 4,,Not reported,no effect,,perfusion,spinal cord blood flow assessed via 14C-IAP autoradiography,post-injury day 4,Not reported,no effect,,,Naloxone does not improve functional recovery or blood flow in the spinal cord after injury.,,Potentially level of injury has influence on results as other studies report beneficial effect of naloxone.,No,
Louis,Park et al.,2012,Beneficial effects of endogenous and exogenous melatonin on neural reconstruction and functional recovery in an animal model of spinal cord injury,10.1111/j.1600-079X.2011.00925.x,English,South Korea,included,,,,,,rats,Sprague Dawley,36,12,,,12,,,Assume that rats were always split equally between different groups.,all male,male,100,8 weeks,8,,,,Weeks,Adult,250g to 260g,,,250,260,g,,contusion injury centered at T10,T10,Not reported,contusion,"NYU weight drop model, 10g impactor dropped from 25mm","3 days, 2 weeks, 4 weeks",Melatonin,melatonin,,10mg/kg,post-injury day 1,,4 weeks,twice daily,subcutaneous,,functional,BBB locomotor scale,,,"post-injury days 1, 3, 7, 14, 21, 28",,Yes,positive effect,"statistically significant improvement in BBB score for melatonin treatment group compared to control (within L/D and L/L) from day 14 onwards;
statistically significant improvement in BBB score in control group under L/D condition compared to control group in L/L condition from day 21 onwards",,,,,,,,Both exogeneous and endogenous melatonin improve functional recovery (statistically significant) beginning from days 14 and 21 post-injury respectively.,,Two different light/dark regimes used to study effect of natural melatonin production.,No,
Louis,Ates et al.,2006,"Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury",10.1111/j.1745-7254.2006.00416.x,English,Turkey,included,,,,,,rats,Wistar,90,15,,,15,3,,some animals in bigger groups excluded from analysis to balance groups,all male,male,100,14 to 16 weeks,15,0.9,14,16,Weeks,Adult,200g to 250g,221.5,28,200,250,g,,contusion injury at between T7 and T10,T7 - T10,Not reported,contusion,"5g impactor dropped from 10cm, 50g/cm force","24 hours, 6 weeks",Methylprednisolone,methylprednisolone,No,30mg/kg,immediately post-injury,,1 dose,single dose,intraperitoneally,,functional,"motor function scale according to Gale et al. (1985);
inclined plane test",,"all animals assessed for normal function pre-injury;
scale ranges from 0 (no movement of hindlimbs) to 6 (normal walking)","post-injury,
then weekly (weeks 1 to 6)",Yes,Yes,no stats,statistically significant improvement in motor function score and inclined plane test results but only between time points (not between groups),histopathology,"hematoxylin-eosin stain, size of lesion as percentage of whole spinal cord area",post-injury week 6 (day 42),Not reported,positive effect,statistically significant reduction in lesion size in group treated w/ methylprednisolone when compared w/ injury control group,"gentamycin (no dose specified, twice daily for days 1, 2, 3 post-operatively)",Methylprednisolone has beneficial effect on recovery after SCI as indicated by reduced lesion size in chronic phase and functional recovery. (Resveratrol shows stronger effect in functional recovery and higher activity in biochemical analysis compared to methylprednisolone.),,"Some mortatility in treatment and control groups, number of animals in each group equalised by excluding some animals at random from groups w/ more animals.",Yes (drug of interest + drug not of interest),
Louis,Ates et al.,2006,"Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury",10.1111/j.1745-7254.2006.00416.x,English,Turkey,included,,,,,,rats,Wistar,90,15,,,15,,,some animals in bigger groups excluded from analysis to balance groups,all male,male,100,14 to 16 weeks,15,0.9,14,16,Weeks,Adult,200g to 250g,221.5,28,200,250,g,,contusion injury at between T7 and T10,T7 - T10,Not reported,contusion,"5g impactor dropped from 10cm, 50g/cm force","24 hours, 6 weeks",Ethanol,ethanol,,"1ml, 2% solution",immediately post-injury,,1 dose,single dose,intraperitoneally,,functional,"motor function scale according to Gale et al. (1985);
inclined plane test",,"all animals assessed for normal function pre-injury;
scale ranges from 0 (no movement of hindlimbs) to 6 (normal walking)","post-injury,
then weekly (weeks 1 to 6)",,Yes,no stats,statistically significant improvement in motor function score and inclined plane test results but only between time points (not between groups),histopathology,"hematoxylin-eosin stain, size of lesion as percentage of whole spinal cord area",post-injury week 6 (day 42),Not reported,no effect,,"gentamycin (no dose specified, twice daily for days 1, 2, 3 post-operatively)",,,,Yes (drug of interest + drug not of interest),
Louis,Rossignol et al.,1998,Pharmacological activation and modulation of the central pattern generator for locomotion in the cat,10.1111/j.1749-6632.1998.tb09061.x,English,Canada,excluded,Review,,,,,cats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Yingli et al.,2014,Microvascular protective role of pericytes in melatonin-treated spinal cord injury in the C57BL/6 mice,10.3760/cma.j.issn.0366-6999.20140858,English,China,included,,,,,,mice,C57BL/6,81,27,,,27,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,18g to 22g,,,18,22,g,,contusion injury at T10,T10,moderate,contusion,"impact force 50 kilodyne, Infinite Horizons Impactor",2 weeks,Melatonin,melatonin,,10mg/kg,start of treatment not reported,,2 weeks,twice daily,intraperitoneally,,functional,Basso mouse scale (BMS),,,"post-injury days 2, 7, 10, 14",,Not reported,positive effect,statistically significant increase in improvement in BMS score for Melatonin treatment group,"histopathology;
immunohistochemistry","Evan's blue assay;
edema formation (dry/wet weight);
TUNEL stain;
lycopersicon esculentum agglutinin lectin (LEA; analysed quantitatively) and anti-PDGFR-beta labelling","post-injury day 7 
(not fully clear for TUNEL)",Not reported,positive effect,"decrease in Evan's blue leakage (statistically significant) in Melatonin treatment group compared to SCI control;
reduced water content/edema formation (statistically significant) in Melatonin treatment group compared to SCI control;
increased LEA-positive area and pericyte coverage (statistically significant) in Melatonin treatment group compared to SCI control",,"Melatonin treatment provides benefit in functional recovery. 
One suspected mechanism through which this is achieved is a reduction in microvasculature loss arising from pericytes. ",,,No,
Louis,Yune et al.,2007,Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury,10.1523/JNEUROSCI.1661-07.2007,English,"South Korea, United States",included,,,,,,rats,Sprague Dawley,108,38,,,38,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,"NYU weight drop model, 10g impactor dropped from 25mm",5 weeks,Minocycline,minocycline,,"bolus: 90mg/kg 
subsequent: 45mg/kg","group 1: immediately post-injury
group 2: 2hrs post-injury",,3 days,twice daily,intraperitoneally,,functional,"BBB locomotor scale;
inclined plane test;
footprint recording;
horizontal grid walking",,,"day 1 post-injury, 
weekly thereafter",,Yes,positive effect,"statistically significant increase in BBB score and inclined plane angle for group treated w/ minocycline (both treatment regimes);
statistically significant reduction in error rate for grid walking test for group treated w/ minocycline (both treatment regimes);
qulaitative assessment of paw placement (footprint recording) shows result for minocycline treatment group to be similar to normal (vehicle treated control, methylprednisolone treated group show strong hindlimb drag)","histopathology;
immunohistochemistry","histopathology: Luxol fast blue stain (myelin), axonal density w.r.t. sham group;
immunohistochemistry: TUNEL assay; 
antibody assays against p-p38MAPK, p75-NTR, proNGFm, cleaved caspase 3; 
DAPI labelling",histopathology: day 38 post-injury,Not reported,positive effect,"statistically significant reduction of axonal loss in rostral and caudal regions (relative to injury), qualitatively observed reduction in myelin and axon loss;
",,,,,No,
Louis,Yune et al.,2007,Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury,10.1523/JNEUROSCI.1661-07.2007,English,"South Korea, United States",included,,,,,,rats,Sprague Dawley,108,20,,,20,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,"NYU weight drop model, 10g impactor dropped from 25mm",5 weeks,methylprednisolone,methylprednisolone,No,30 mg/kg,"group 1: immediately post-injury
group 2: 2hrs post-injury",Yes,3 days (6 doses),twice daily,intraperitoneally,,functional,"BBB locomotor scale;
inclined plane test;
footprint recording;
horizontal grid walking",,,"day 1 post-injury, 
weekly thereafter",Yes,Yes,no effect,,"histopathology;
immunohistochemistry","histopathology: Luxol fast blue stain (myelin), axonal density w.r.t. sham group;
immunohistochemistry: TUNEL assay; 
antibody assays against p-p38MAPK, p75-NTR, proNGFm, cleaved caspase 3; 
DAPI labelling",histopathology: day 38 post-injury,Not reported,positive effect,"statistically significant reduction of axonal loss in rostral and caudal regions (relative to injury), qualitatively observed reduction in myelin and axon loss;
",,,,,No,
Louis,Liu et al.,2013,Minocycline inhibited the pro-apoptotic effect of microglia on neural progenitor cells and protected their neuronal differentiation in vitro,10.1016/j.neulet.2013.03.011,English,"Hong Kong, China",excluded,Non-sci population,Ex-vivo,In-vitro results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zhang et al.,2017,Metformin ameliorates BSCB disruption by inhibiting neutrophil infiltration and MMP-9 expression but not direct TJ proteins expression regulation,10.1111/jcmm.13235,English,China,included,,,,,,rats,Sprague Dawley,>= 80,>= 40,,,>= 40,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,220g to 250g,,,220,250,g,,compression injury at T9,T9,Not reported,compression,"vascular clip, closing force 30g, applied for 1 min",3 days - 2 weeks,Metformin,metformin,,50mg/kg,immediately post-injury,,2 weeks,daily,intraperitoneally,,functional,BBB locomotor scale,,,"post-injury days 1, 3, 7, 14 ",,Yes,positive effect,statistically significant increase in BBB score for,"histopathology;
immunohistochemistry","Evan's blue assay;
oedema measurement (relative weight dry and wet);
anti-CD31, anti-Ly6G, anti-MMP-9, anti-Occludin stains","Evan's blue: day 3 post-injury;
oedema measurement: day 3 post-injury;
immunohistochemistry: not clear, potentially day 5 post-injury based on Fig. 5",Not reported,positive effect,"statistically significant reduction in Evan's blue leakage for Metformin treatment group compared to SCI control;
statistically significant reduction in water content (oedema) for Metformin treatment group compared to SCI control;
",,"Metformin shows beneficial effect after SCI by reducing disruption to the blood-SC barrier, providing better functional recovery.",,,No,
Louis,Downing et al.,2012,Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair,10.1016/j.jconrel.2012.05.034,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (rolipram),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Maric et al.,2008,Levodopa Therapy in Incomplete Spinal Cord Injury,10.1089/neu.2008.0583,English,Switzerland,included,,,,prospective,prospective,human,,12,12,,,12,,,"prospective, randomized placebo-controlled,  double-blind crossover design",female: 4 (33.3%),mixed,66.7,52.7 yrs (17.2),52.7,17.2,,,Years,,Not reported,,,,,,,"incomplete SCI, ASIA C: 9, ASIA D: 3;
injury level: L3 - 1, T5 - 1, T10 - 1, T12 - 3, C5 - 3, C4 - 2, C6 - 1",,incomplete,,Not reported,"1 to 6 months (inclusion criterion);
time since injury 7.3 wks (3.5)","Levodopa (L-Dopa) extended release,
administered w/ dopa decarboxlyase inhibitor",levodopa,,"200mg,
inhibitor: 50mg",-,,"regime 1: 6 weeks L-Dopa, 6 weeks placebo;
regime 2: 6 weeks placebo, 6 weeks L-dopa","single tablet (morning, min. 30 prior to breakfast, min 1hr before physiotherapy), 
five days per week",oral,,functional,"ASIA Motor score;
Walking Index for SCI II (WISCI II);
Spinal Cord Independence Measure II (SCIM II)","neurological (motor), functional (mobility and general)","ASIA motor score assessed by physician;
WISCI II assessed by physiotherapists;
SCIM II assessed by specially trained nurses",weekly,,Yes,no effect,No statistically significant differences in any of the scores.,,,,,,,,L-Dopa does not provide benefit in motor recovery after incomplete SCI. ,"Plasma levels of L-Dopa not monitored, unclear if previously reported steady level achieved.
Potential age-dependent effect, which could not be accounted for due to small sample size.",One patient excluded post-hoc as maximum scores were attained within 3 weeks from trial start and no further improvements possible.,No,
Louis,Park et al.,2014,Neuroprotective role of hydralazine in rat spinal cord injury-attenuation of acrolein-mediated damage,10.1111/jnc.12628,English,United States,included,,,,,,rats,Sprague Dawley,42 - 72,13,,,13,,,,all male,male,100,not reported,,,,,,Not reported,200g to 250g,,,200,250,g,,contusion injury at T10; moderate or severe,T10,mixed,contusion,"NYU weight drop model, 10g impactor;
moderate: 25mm height, severe: 37.5mm height",4 weeks,Hydralazine,hydralazine,,5mg/kg,immediately post-injury,,2 weeks,daily,intraperitoneally,,"functional;
neurological","BBB locomotor scale;
foot withdrawal under mechanical stimuli",,"BBB: open field assessment after 5min period for adaptation, hindlimbs assessed separately, average score reported;
foot withdrawal: assessment after 10min period for adaptation, using calibrated von Frey filaments, stimuli presented in 1min intervals","pre-injury for both;
BBB: post injury days 1, 7, 14, 21, 28;
foot withdrawal: post injury days 14, 21, 28",,Not reported,positive effect,"statistically significant improvement in BBB score for hydralazine treatment group compared to SCI control from day 7 onwards;
statistically significant increase in withdrawal threshold (reduced hypersensitivity) for hydralazine treatment for days 14, 21 and 28",histopathology,"Luxol fast blue and Cresyl violet stain, measurement of intact tissue and cyst area;",,"Yes (Luxol, Cresyl stain)",positive effect,"statistically significant reduction in size of cyst for treatment group 
compared to SCI control (injury severity not reported)",,Hydralazine treatment shows beneficial effects after SCI as measured by functional recovery and pain sensivity as well as reduced cyst size (indicating severe tissue damage). The suspected mechanism of action is hydralazine's acrolein scavaging property.,"In clinical use, hydralazine's vasodilation effect and risk of hypotension migh be problematic. ",,No,
Louis,Stirling et al.,2004,"Minocycline Treatment Reduces Delayed Oligodendrocyte Death, Attenuates Axonal Dieback, and Improves Functional Outcome after Spinal Cord Injury",10.1523/JNEUROSCI.5275-03.2004,English,Canada,included,,,,,,rats,Wistar,24,12,,,12,,,,not reported,not reported,not reported,adult (no precise age reported),,,,,,Adult,not reported,,,,,,,complete transection at C7/C8,C7 - C8,complete,transection,complete transection by wire knife and microscissors; confirmed postmortem,7 days - 14 days,Minocycline,minocycline,,50mg/kg,30min post-injury,,2 days,twice daily,intraperitoneally,,functional,footprint analysis,,"acceleration/deceleration excluded, repeat when animals
paused on track;
measurements for toe spread, interlimb coordination and angle of rotation","pre-injury; post-injury days 3, 5, 7,14",,Yes,mixed effects (assessment),"statistically significant improvement in forelimb-hindlimb coordination and reduction in hindlimb angle of rotation on days 7 and 14 for Minocycline treatment group;
statistically significant improvement in toespread only on day 7 for Minocycline treatment group",immunohistochemistry,"anti-active-caspase-3;
Hoechst stain",days 7 or 14 post-injury,Not reported,positive effect,"statistically significant reduction in number of apoptotic cell profiles per 10um in Minocycline treatment group on days 7 and 14;
statistically significant reduction in amount of axon dieback (distance between closest intact corticospinal tract fibers and center of lesion) in Minocycline treatment group on days 7 and 14;
statistically significant reduction in lesion size in Minocycline treatment group on days 7 and 14",,"Minocycline treatment shows positive effects on functional outcome after SCI.
It is suspected that this benefit is derived from reduction of the scondary injury response as marked by reduced lesion size and apoptosis.",,,No,
Louis,Gao et al.,2016,Combination of melatonin and Wnt-4 promotes neural cell differentiation in bovine amniotic epithelial cells and recovery from spinal cord injury,10.1111/jpi.12311,English,China,excluded,Out of scope,No drug of interest,Cell transplant,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Yin et al.,2019,Edaravone inhibits autophagy after neuronal oxygen-glucose deprivation/recovery injury,10.1080/00207454.2018.1550399,English,China,excluded,Out of scope,No drug of interest,No drug of interest (edaravone); in-vitro results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zeman et al.,2006,Œ≤<inf>2</inf>-adrenoreceptor agonist-enhanced recovery of locomotor function after spinal cord injury is glutathione dependent,10.1089/neu.2006.23.170,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (clenbuterol),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Weaver et al.,2005,"Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment",10.1089/neu.2005.22.1375,English,Canada,included,,,,,,rats,Wistar,66,33,,,26,,,,female: 52 (78.8%),mixed,21.2,not reported,,,,,,Not reported,not reported,,,,,,,"group 1: severe compression injury at T4 (52 rats, all female)
group 2: moderate compression injury at T12 (14 rats, all male)",T4 + T12,mixed,compression,"clip applied for 60sec;
group 1: 50g closing force, group 2: 35g closing force","2 weeks, 6 weeks, 12 weeks",Methylprednisolone,methylprednisolone,No,"bolus: 30mg/kg 
subsequently: 15mg/kg (later doses)","2hrs, 24hrs, 48hrs post-injury",Yes,3 doses,,intravenously,,"functional;
neurological","BBB locomotor scale;
response to mechanical stimuli",,"BBB: two independent observers, avg. score across hindlimbs and observers and week;
mechanical stimuli: only assessed in moderate injury group, induced by Semmes-Weinstein monofilament generating 15mN force, assessment of responsiveness in dorsal trunk (dermatomes corresponding to T9-T11) and at hindpaws, testing session with 10 stimuli lasting 3sec separated by 5sec break and no. of responsese counted","BBB: twice weekly, starting from post-injury day 1;
mechanical stimulus: weekly at trunk, every 2nd week at hindpaws",Yes,Yes,no effect,"no statistically significant differences in locomotor recovery over 6 or 12 weeks between Methylprednisolone treatment and SCI control group (also no effect for combined treatment, i.e. MP + Ab);
no significant effect on sensitivity to mechanical stimuli at either trunk or paw level in Methylprednisolone treatment group compared to SCI control group","histopathology;
immunohistochemistry","luxol blue, solochrome cyanin;
anti-NF200 antibody stain","week 2 post-injury (luxol blue);
weeks 6 or 12 post-injury (all other)",Yes,positive effect,"statistically significantly larger amount of neurofilament (reduction in tissue loss) for Methylprednisolone treatment group in areas rostral and caudal to injury epicenter;
statistically significantly more myelin either only rostral to injury site (severe injury T4, 2 weeks post-injury) or rostral and caudal (severe injury T4, 6 weeks post-injury and moderate injury T12, 12 weeks post-injury) in Methylprednisolone treatment group",,"Immunosuppressive therapy using Methylprednisolone does not benefit neurological outcomes after SCI. More selective treatments using only monoclonal Ab could provide targeted benefits, which might however be lost in a combination treatment.",Potentially relatively lower dosing scheme could have reduced effect on functional recovery.,,Yes (drug of interest + drug not of interest),
Louis,Moutaery et al.,2000,Effect of aluminum on neurological recovery in rats following spinal cord injury,10.3171/spi.2000.93.2.0276,English,Saudi Arabia,included,,,,,,rats,Sprague Dawley,32,,,,,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,180g to 200g,,,,,,,compression injury at T7/T8,T7 - T8,Not reported,compression,35g curved compression plate applied for 5min,-,Aluminium sulfate,aluminum,,"(i) 0%
(ii) 0.25%
(iii) 0.5%
(iv) 1%",-,,30 days,continuously available,oral,,"functional;
physiological;
electrophysiological","modified Tarlov score, angled plane score, vocal/sensory score;
corticomotor evoked potentials",,"vocal/sensory score: noxious stimulus at hindlimb, vocalization and/or withdrawal scored;
EMG: active disc electrode on right motor cortex area, needle electrodes in lateral muscle of left hindlimb and left hindpaw","functional: pre-injury, post-injury days 1 to 10;
vitamin E: pre-injury, post-injury 4hrs, 24hrs, days 5 and 10;
EMG: pre-injury, post-injury 4hrs, 24hrs, day 10
",,Yes,mixed effects (dosage),"recovery in functional assessment outcomes negatively affected by aluminium in dose-dependent fashion, mostly statistically significant;
aluminium pre-treatment reduced vitamin E levels in SCI animals but not sham (statistically significant);
recovery in CMEP at day 10 reduced by aluminium treatment, latency increase worsened by aluminium treatment",histopathology,hematoxylin and eosin stain; vitamin E levels in spinal cord tissue (based on 50mg sample of tissue in liquid chromatography),not reported (presumably day 10),Yes,negative effect,pretreatment produced (qualitatively) more sever structural changes,"gentamicin (2mg/kg, daily, intramuscularly, post-injury days 1 to 3)",Aluminium pretreatment results in dose-dependent negative effect on functional recovery. (Matches previously reported neurotoxic effect if accumulated in CNS.),,,No,
Louis,Khalatbary et al.,2010,Effects of epigallocatechin gallate on tissue protection and functional recovery after contusive spinal cord injury in rats,10.1016/j.brainres.2009.09.109,English,Iran,excluded,Out of scope,No drug of interest,No drug of interest (epigallocatechin gallate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Nakauchi et al.,1996,Effects of lecithinized superoxide dismutase on rat spinal cord injury,10.1089/neu.1996.13.573,English,Japan,excluded,Out of scope,No drug of interest,No drug of interest (superoxide dismutase [enzyme]),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Hall et al.,1995,Lack of Effect of Postinjury Treatment with Methylprednisolone or Tirilazad Mesylate on the Increase in Eicosanoid Levels in the Acutely Injured Cat Spinal Cord,10.1089/neu.1995.12.245,English,United States,excluded,Out of scope,No assessments of interest,,,,cats,Not reported,48,06.Dec,,,12,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,approx. 3kg,~3.0,,,,kg,,compression injury at L3,L3,Not reported,compression,180g weight applied for 5min ,1 hour - 4 hours,Methylprednisolone,methylprednisolone,,"group 1: 30mg/kg;
group 2: 30mg/kg, 15mg/kg","group 1: 30min post-injury;
group 2: 30min post-injury, 2.5hrs post-injury",,1 dose - 2 doses,,intravenously,,,,,,,,,,,perfusion,spinal cord blood flow (via laser doppler flowmetry),"group 1: pre-injury to 1hr post-injury;
group 2: pre-injury to 4hrs post-injury",Not reported,positive effect,methylprednisolone prevents hyperperfusion response at 1hr and 4hrs post-injury (no statistical difference to uninjured sham operation group but statistically significant reduction compared to injured vehicle treated control),,Methylprednisolone primarily acts as a neuroprotective agent by inhibition if oxygen radical-induced lipid peroxydation as opposed to an antiinflammatory effect [...]. (Tirilazad shows similar effects but does not have glucocorticoid receptor-mediated activity.),,,No,
Louis,Welin et al.,2009,Effects of N-acetyl-cysteine on the survival and regeneration of sural sensory neurons in adult rats,10.1016/j.brainres.2009.06.038,English,Sweden,excluded,Non-sci population,,Sciatic nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Pointillart et al.,1993,Effects of Nimodipine on Posttraumatic Spinal Cord Ischemia in Baboons,10.1089/neu.1993.10.201,English,France,excluded,Out of scope,No drug of interest,No drug of interest (nimodipine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,de Mesquita Coutinho et al.,2016,Effects of tacrolimus and erythropoietin in experimental spinal cord lesion in rats: Functional and histological evaluation,10.1038/sc.2015.172,English,Brazil,included,,,,,,rats,Wistar,60,12,2,,12,1,,,all male,male,100,adult (no precise age reported),,,,,,Adult,320g to 340g,,,320,340,g,,contusion injury between T8 and T12,T8 - T12,moderate,contusion,"NYU weight drop model, 10g impactor dropped from 25mm",6 weeks,Tacrolimus,tacrolimus,,1mg/kg,5min post-injury,,injection,,not reported,,"functional;
neurological","BBB locomotor scale;
Motor-evoked potential (MEP)",,"BBB: two independent examiners, in case of disagreement lower score used;
MEP: four-channel EMG, one monopolar electrod placed in lumbar region, two electrodes on head (frontal and occipital regions), responses captured via pairs of electrodes placed on fore- and hindlimbs","BBB: days 2, 7, 14, 21, 28, 35, 42 post-injury;
MEP: day 42 post-injury",,"BBB: Yes;
MEP: not reported",mixed effects (assessment),"no difference in BBB score at end of study (day 42);
significant difference in amplitute for MEP exam at day 42, showing a reduction in amplitude and increase in latency indicating a negative effect of tacrolimus",histopathology,"presence/extent of necrosis, hemorrhage, hyperemia, nerve degeneration, cellular infiltrate;
axon neuron count (toluidine blue stain, only neurons w/ diameter geq 15um)",day 42 post-injury,Yes,mixed effects (assessment),,"cefazolin (5mg/kg, intraperitoneally, immediately post-injury and following three days);
meloxicam (7mg/kg, intramuscularly, daily for seven days post-injury);
tramadol hydrochloride (5mg/100g, intramuscularly, daily for five days post-injury)","No difference in locomotor function recovery, electrophysiological exam and histopathological results with tacrolimus (nor EPO or combined treatment).",Ideal dosage (amount as well as timing) not yet known.,"Two rats in each group (control, different treatment regimes), total of eight animals, died.",Yes (drug of interest + drug not of interest),
Louis,Minnema et al.,2019,"SCING - Spinal Cord Injury Neuroprotection with Glyburide: A pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA",10.1136/bmjopen-2019-031329,English,United States,excluded,Out of scope,Other,"Description of study design, results yet to be published",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Takami et al.,2002,Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome,10.1089/089771502753754118,English,United States,included,,,,,,rats,Fischer,52,9,,,8,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,160g to 180g,,,160,180,g,,contusion injury at T9,T9,moderate,contusion,"NYU weight drop model, 10g impactor dropped from 12.5mm",12 weeks,Methylprednisolone,methylprednisolone,,30 mg/kg,"5min, 2hrs, 4hrs post-injury",Yes,3 doses,,intravenously,,functional,BBB locomotor scale,,assessment by two observers,"pre-injury, 
weekly from week 1 post-injury onwards",Yes,Yes,no effect,,histopathology,"tissue damage via staining w/ cresyl violet;
retrograde neuronal tracing using fast blue and citifluor;
overall histology via staining w/ toluidine blue",week 12 post-injury,"Yes (for secondary tissue damage and loss);
not reported for retograde neuronal tracing",mixed effects (assessment),"methylprednisolone treatment has a statistically significant positive effect on
the volume of damaged tissue (reduced) and the volume of tissue lost (reduced) in comparison to untreated, injured controls as well as on the amount of healthy tissue near the injury epicenter (as a fraction of healthy tissue in healthy controls);
methylprednisolone has no effect on thickness of lateral white matter columns or axonal preservation","Bicillin (0.02mL/100mg w/ 300U/mL, intramuscularly, pre-injury and post-injury days 2, 4 and 6)","All treatments, including methylprednisolone, reduce spinal tissue damage but do not result in an improved functional recovery compared to untreated but injured control animals. The neuroprotective effect on tissue is long-lasting (min. 12 weeks). ",Fischer rats are more inbred strain and might show inflammatory responses specific to the strain.,,Yes (drug of interest + drug not of interest),
Louis,Soenmez et al.,2007,Erythropoietin attenuates neuronal injury and potentiates the expression of pCREB in anterior horn after transient spinal cord ischemia in rats,10.1016/j.surneu.2006.11.045,English,Turkey,excluded,Out of scope,No drug of interest,No drug of interest (erythropoietin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Farooque et al.,2001,Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice,10.1089/089771501750055811,English,Sweden,excluded,Out of scope,No drug tested,No pharmacological treatment (neuronal nitirc oxide synthase and TNF-alpha deficient mice studied),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Chikawa et al.,2001,Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: Transcriptional regulation of inflammatory and neurotrophic genes,10.1089/089771501750055802,English,Japan,included,,,,,,rats,Wistar,41,10,,,11,,,,all male,male,100,7 to 8 weeks,,,7,8,Weeks,Adult,280g to 310g,,,280,310,g,,compression injury at T10,T10,Not reported,compression,30g weight applied for 5min,6 weeks,Methylprednisolone,methylprednisolone,No,30mg/kg,30min post-injury,,1 dose,,intravenously,,functional,"BBB locomotor scale;
Tarlov motor scale;
inclined plane test;
footprint analysis",,,"BBB, Tarlov, inclined plane:
pre-injury, half day post-injury, days 1 to 8 post-injury, then every other day for three weeks post-injury;
footprint analysis:
pre-injury, week 6 post-injury",No,Yes,no effect,statistically significantly higher scores/angles in days 1 to 3 post-injury but subsequently no significant difference between methylprednisolone treatment group and control,,,,,,,,No beneficial effect on functional outcome from methylprednisolone treatment alone. (Potential improvements to be derived from combination with superoxide dismutase.),,,Yes (drug of interest + drug not of interest),
Louis,Ellis et al.,2016,Morphine amplifies mechanical allodynia via TLR4 in a rat model of spinal cord injury,10.1016/j.bbi.2016.08.004,English,"United States, Australia",excluded,Non-sci population,,Injury pattern (nerve root avulsion) not of interest.,,,rats,Sprague Dawley,118 - 124,30 - 35,,,30 - 35,,,Counts estimated from figure captions.,all male,male,100,not reported,,,,,,Not reported,325g to 350g,,,325,350,g,,unilateral (left) dorsal root avulsion at T13,T13,Not reported,others,,15 days - 71 days,Morphine,morphine,,10mg/kg,post-injury days 8 to 14,,1 week,daily,subcutaneous,,neurological,"mechanical reactivity;
thermal reactivity",,"mechanical: Semmes-Weinstein monofilaments applied for 8s to each hind paw and withdrawal response observed, 50% withdrawal threshold calculated;
thermal: Hargreaves test for withdrawal response to heat stimulus on plantar surfaces of hind paws and tail","mechanical: post-injury days 14, 21, 28, 35, some groups continued for weeks 6 to 10;
thermal: 30min post morphine administration",,Yes,negative effect,"statistically significant reduction in withdrawal threshold (increased allodynia) in morphine treatment group;
statistically significant analgesic effect during administration of morphine (not necessarily pos/neg but simply expected effect of drug?)",,,,,,,"Combi-Pen-48 antibiotic (0.2ml, at surgery and daily for post-surgery days 1 to 4)","Morphine has the potential to enhance allodynia (suspected involvement of TLR4 receptors, which can be targetd using (+)-naltrexone to potentially prevent this effect). ",,(+)-naltrexone is not a drug of interest but seems to alleviate the negative effects of morphine (see Figure 5).,Yes (drug of interest + drug not of interest),
Louis,Aceves et al.,2019,Morphine increases macrophages at the lesion site following spinal cord injury: Protective effects of minocycline,10.1016/j.bbi.2019.01.023,English,United States,included,,,,,,rats,Sprague Dawley,90,19,,,19,,,,all male,male,100,90 to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,contusion injury at T12,T12,moderate,contusion,"Infinite Horizons impactor, 150kdynes impact force, 1s dwell time",3 weeks,morphine,morphine,,90microgram,24hrs post-injury,,1 dose,,intrathecally,,"functional;
neurological","BBB locomotor scale;
tapered beam test, ladder walk test;
tail-flick test;
response to mechanical stimuli;
tactile reactivity",,"BBB: animals allowed to acclimatize to observation environment beginning three days pre-injury;
tapered beam, ladder walk: animals allowed to acclimatize to observation beginning three days before assessment (day 18 post-injury), including some task specific training;
tail-flick: assesses thermal reactivity, animals allowed to acclimatize 15min prior to assessment, heat intensity determined based on response in healthy rat, two test performed and latency of last flick recorded;
mechanical stimuli: von Frey filaments applied to plantar surface of hindpaw, stimuli every 2s until motor and vocal response observed, each hindpaw assessed twice;
tactile reactivity: girdle test, animals handled 5min prior to test to ensure animals are calm, von Frey filament applied to 44 different pts. in girdle region, vocalisation response recorded (indicating noxious stimulus as there is usually no response to this stimulus)","BBB: day 1 post-injury prior to drug administration, daily for days 2 to 7 post-injury, every other day for days 9 to 15 post-injury, days 18 and 21 post-injury;
tapered beam, ladder walk: day 21 post-injury;
tail-flick: just before and immediately after drug administration, day 21 post-injury;
response to mechanical stimuli: day 21 post-injury;
tactile reactivity: day 21 post-injury",,"Yes (BBB);
Not reported (others)",mixed effects (assessment),"morphine alone reduces functional recovery at week 3 post-injury significantly as measured w/ BBB score, tapered beam and ladder walk test (compared to SCI control);
minocycline blocks adverse effect of morphine on functional recovery (no statistically significant differece between morphine + minocycline and SCI control + minocycline groups);
only minor difference in sensory reactivity as measured by slightly increase tail flick latency minocycline (50ug) treatment group, no differences otherwise (due to either minocycline or morphine or combination)",histopathology,"cresyl violet stain;
luxol fast blue stain",day 21 post-injury,Yes (observer delimiting lesion area),no effect,,"Pfizerpen / penicillin G  potassium (100'000 units/kg, immediately and 48hrs post-injury)","Morphine (and other opioids) can affect functional recovery following SCI negatively.
Antiinflammatory drugs, such as minocycline appear able to reduce this negative impact. ",,,Yes (drug of interest + drug of interest),
Louis,Aceves et al.,2019,Morphine increases macrophages at the lesion site following spinal cord injury: Protective effects of minocycline,10.1016/j.bbi.2019.01.023,English,United States,included,,,,,,rats,Sprague Dawley,90,19,,,23,,,,all male,male,100,90 to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,contusion injury at T12,T12,moderate,contusion,"Infinite Horizons impactor, 150kdynes impact force, 1s dwell time",3 weeks,minocycline,minocycline,,"group 1: 50 microgram
group 2: 100 microgram",24hrs post-injury,,1 dose,,intrathecally,,"functional;
neurological","BBB locomotor scale;
tapered beam test, ladder walk test;
tail-flick test;
response to mechanical stimuli;
tactile reactivity",,"BBB: animals allowed to acclimatize to observation environment beginning three days pre-injury;
tapered beam, ladder walk: animals allowed to acclimatize to observation beginning three days before assessment (day 18 post-injury), including some task specific training;
tail-flick: assesses thermal reactivity, animals allowed to acclimatize 15min prior to assessment, heat intensity determined based on response in healthy rat, two test performed and latency of last flick recorded;
mechanical stimuli: von Frey filaments applied to plantar surface of hindpaw, stimuli every 2s until motor and vocal response observed, each hindpaw assessed twice;
tactile reactivity: girdle test, animals handled 5min prior to test to ensure animals are calm, von Frey filament applied to 44 different pts. in girdle region, vocalisation response recorded (indicating noxious stimulus as there is usually no response to this stimulus)","BBB: day 1 post-injury prior to drug administration, daily for days 2 to 7 post-injury, every other day for days 9 to 15 post-injury, days 18 and 21 post-injury;
tapered beam, ladder walk: day 21 post-injury;
tail-flick: just before and immediately after drug administration, day 21 post-injury;
response to mechanical stimuli: day 21 post-injury;
tactile reactivity: day 21 post-injury",,"Yes (BBB);
Not reported (others)",mixed effects (assessment),"effect of only minocycline on BBB locomotor scores, tapered beam and ladder walk not tested (Fig 5, 6);
no effect of only minocycline on tail flick latency (Fig 4);
effect of only minocycline on mechanical reactivity not tested",histopathology,"cresyl violet stain;
luxol fast blue stain",day 21 post-injury,Yes (observer delimiting lesion area),no effect,,"Pfizerpen / penicillin G  potassium (100'000 units/kg, immediately and 48hrs post-injury)","Morphine (and other opioids) can affect functional recovery following SCI negatively.
Antiinflammatory drugs, such as minocycline appear able to reduce this negative impact. ",,,Yes (drug of interest + drug of interest),
Louis,Aceves et al.,2019,Morphine increases macrophages at the lesion site following spinal cord injury: Protective effects of minocycline,10.1016/j.bbi.2019.01.023,English,United States,included,,,,,,rats,Sprague Dawley,90,19,,,23,,,,all male,male,100,90 to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,contusion injury at T12,T12,moderate,contusion,"Infinite Horizons impactor, 150kdynes impact force, 1s dwell time",3 weeks,morphine + minocycline,morphine + minocycline,,"group 1: 90microgram morphine + 50microgram minocycline
group 2: 90microgram morphine + 100microgram minocycline","24hrs post-injury (minocycline first, morphine 15min later)",,1 dose,,intrathecally,,"functional;
neurological","BBB locomotor scale;
tapered beam test, ladder walk test;
tail-flick test;
response to mechanical stimuli;
tactile reactivity",,"BBB: animals allowed to acclimatize to observation environment beginning three days pre-injury;
tapered beam, ladder walk: animals allowed to acclimatize to observation beginning three days before assessment (day 18 post-injury), including some task specific training;
tail-flick: assesses thermal reactivity, animals allowed to acclimatize 15min prior to assessment, heat intensity determined based on response in healthy rat, two test performed and latency of last flick recorded;
mechanical stimuli: von Frey filaments applied to plantar surface of hindpaw, stimuli every 2s until motor and vocal response observed, each hindpaw assessed twice;
tactile reactivity: girdle test, animals handled 5min prior to test to ensure animals are calm, von Frey filament applied to 44 different pts. in girdle region, vocalisation response recorded (indicating noxious stimulus as there is usually no response to this stimulus)","BBB: day 1 post-injury prior to drug administration, daily for days 2 to 7 post-injury, every other day for days 9 to 15 post-injury, days 18 and 21 post-injury;
tapered beam, ladder walk: day 21 post-injury;
tail-flick: just before and immediately after drug administration, day 21 post-injury;
response to mechanical stimuli: day 21 post-injury;
tactile reactivity: day 21 post-injury",,"Yes (BBB);
Not reported (others)",mixed effects (assessment),"effect of combination on BBB locomotor scores, tapered beam and ladder walk not tested (Fig 5, 6);
negative effect of combination on tail flick latency (Fig 4);
effect of combination on mechanical reactivity not tested",histopathology,"cresyl violet stain;
luxol fast blue stain",day 21 post-injury,Yes (observer delimiting lesion area),no effect,,"Pfizerpen / penicillin G  potassium (100'000 units/kg, immediately and 48hrs post-injury)","Morphine (and other opioids) can affect functional recovery following SCI negatively.
Antiinflammatory drugs, such as minocycline appear able to reduce this negative impact. ",,,Yes (drug of interest + drug of interest),
Louis,Woller et al.,2014,Morphine Self-Administration following Spinal Cord Injury,10.1089/neu.2013.3293,English,United States,included,,,,,,rats,Sprague Dawley,72,18,,,18,,,,all male,male,100,90 to 110 days,,,90,110,Days,,350g to 400g,,,350,400,g,,contusion injury at T12,T12,moderate,contusion,10g impactor dropped from 12.5mm,6 weeks,Morphine,morphine,,"1.5mg per administration, at most 30mg per 24hrs","group 1 (acute): access to self-administration from post-injury days 1 to 7;
group 2 (early chronic): access to self-administration from post-injury days 14 to 20;
group 3 (late chronic): access to self-administration from post-injury days 35 to 41",,7 days,,intrathecally,,"functional;
neurological","BBB locomotor scale;
mechanical reactivity;
girdle test;
thermal reactivity",,"BBB: open field, acclimatization for 5min per day for 3 days pre-injury;
mechanical reactivity: von Frey monofilaments applied to plantar surface of hind paws, increasing intensity until withdrawal response;
girdle test: von Frey filament (26g force) applied along grid in girdle area, vocalizations recorded;
thermal reactivity: tail flick test w/ halogen light focused on tail until withdrawal (max 8s to avoid tissue damage)","BBB: post-injury days 1 to 7, 9, 11, 13, 15, 18, 21,24, 27, 30, 34, 38, 42;
all sensory tests: post-injury days 1 and 42 (acute administration), 
days 1, 14, and 42 (early chronic administration), 
days 1, 35 and 42 (late chronic administration)",,"Yes (BBB);
Not reported (others)",no effect,"morphine administration in acute phase does not affect locomotor recovery or sensory scores at day 42;
morphine administration in early chronic phase does not affect locomotor recovery or sensory scores at day 42;
morphine administration in late chronic phase does not affect sensory scores at day 42 (locomotor recovery not further monitored as no effect observed in early chronic administration)",,,,,,,"penicillin G potassium (100'000 U/kg, intraperitoneally, immediately after surgery and post-surgery day 2)","Morphine abuse liability is not reduced in chronic phase after SCI.
There is no effect of morphine on functional recovery if administered at any stage in the chronic phase or in the acute phase.",,"Potentially relevant: amount of morphine self-administered compared between sham and injury group.
Late chronic administration group only added after no effects in early chronic administration observed",No,
Louis,Wang et al.,2010,Morphological changes of the neural cells after blast injury of spinal cord and neuroprotective effects of sodium beta-aescinate in rabbits,10.1016/j.injury.2009.12.003,English,China,excluded,Out of scope,No drug of interest,No drug of interest (sodium b-aescinate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kasai et al.,2011,Ethanol extract of Chinese propolis facilitates functional recovery of locomotor activity after spinal cord injury,10.1155/2011/749627,English,Japan,excluded,Out of scope,No drug of interest,No drug of interest (ethanol extract of Chinese propolis),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,de la Torre Valdovino et al.,2016,Tamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats.,10.1155/2016/9561968,English,Mexico,included,,,,,,cats,Not reported,9,3,,,3,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,3.5 to 4kg,,,3.5,4,kg,,hemisection at T12,T12,incomplete,transection,,30 days,Tamoxifen,tamoxifen,,1mg/kg,"post-injury days 0, 1, 2",,3 doses,,intraperitoneally,,functional,kinematic profile,,"200cm long acrylic passway, video contrasting dots on iliac crest, hip, knee, ankle and fifth metatarsal phalangeal joints;
recording at 30fps, frame-by-frame analysis to mark cartesian coordinates of joint marks, analysis of at least 3 consecutive strides;
joint angular displacement (JAD) calculated, hindlimb pendulum like movement calculated","pre-injury, 
days 4, 16, 30 post-injury",,Not reported (automated analysis),no effect,"earlier recovery of normal locomotion w/ tamoxifen treatment, but recovery by day 30 post-injury also in control group (Tables 2 and 3, Figures 7 and 8)","histopathology;
immunohistochemistry","hematoxylin and eosin stain, toluidine blue stain;
axonal myelin area via lightmicroscopy;
neuron count via anti-FOX3 (neurons), DAPI",day 30 post-injury,Not reported,mixed effects (assessment),"qualitative assessment of tissue integrity (in general) and axons in particular showed similarity between healthy control and treatment group while injured control showed strong tissue damage (sections 3.1 and 3.2);
myelin thickness in treatment group much less reduced compared to injured control (statistically significant; section 3.3);
neuronal cell count not statistically significant reduced in some regions for treatment group when compared w/ healthy control while count in injured control reduced in almost all regions (Figure 6)","Gentamicin (2mg/kg, intramuscularly, pre-injury/prophylaxis and post-injurey days 1 to 3);
Ketoprofen (2.5mg/kg, intramuscularly, pre-injury/pain prevention)","Tamoxifen benefits tissue integrity and preservation of neurons after SCI. Effect on functional recovery is less clear, with both injured groups recovering almost normal functionality by day 30 post-injury while treatment group recovers earlier.",,,No,
Louis,"Bowden, Stokic",2009,Clinical and neurophysiologic assessment of strength and spasticity during intrathecal baclofen titration in incomplete spinal cord injury: Single-subject design,10.1080/10790268.2009.11760770,English,United States,excluded,Case report,,Single subject study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Li et al.,2020,Sodium Tanshinone IIA Silate Exerts Microcirculation Protective Effects against Spinal Cord Injury in Vitro and in Vivo,10.1155/2020/3949575,English,China,excluded,Out of scope,No drug of interest,No drug of interest (sodium tanshinone IIA silate/extract from danshen),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Guo et al.,2015,N-acetylcysteine treatment following spinal cord trauma reduces neural tissue damage and improves locomotor function in mice,10.3892/mmr.2015.3390,English,China,included,,,,,,mice,C57BL/6,>= 94,>= 19,,,>= 19,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,18g to 22g,,,18,22,g,,contusion injury at T9,T9,moderate,contusion,"Infinite Horizons impactor, 50kdynes impact force",1 day - 28 days,N-acetylcysteine,acetylcysteine,,100mg/kg,"1 day pre-injury, post-injury days 1 to 28 ",,4 weeks,daily,intraperitoneally,,functional,"BBB locomotor scale;
motor performance on rotarod;
ability to traverse wire grid",,"rotarod, grid: three repeats for each test, mean score used","BBB: days 1 and 3 post-injury, then weekly until day 28 post-injury;
rotarod, grid: days 26, 27, 28 post-injury",,Not reported,no stats,statistically significant positive effect on rotarod (longer time) and grid walking test (fewer faults) for acetylcysteine treatment group compared to SCI control; statistically significantly negative effect on BBB score starting at post-injury day 14,"histopathology;
immunohistochemistry","hematoxylin and eosin stain (tissue integrity);
Nissl (neurons) and luxol fast blue (myelin) stain;
anti-NeuN (neuronal nuclei), DAPI","day 1 (only hematoxylin and eosin stain) 
day 28 post-injury","Yes (hematoxylin and eosin);
not reported for others",positive effect,"statistically significant reduction in histological score (lower is better) for acetylcysteine treatment group compared to SCI control (day 28);
statistically significant increase in white matter sparing at epicenter as well as in rostral and caudal regions for acetylcysteine group;
statistically significant increase in neuron count at epicenter as well as in rostral and caudal regions for acetylcysteine group",,"N-acetylcysteine promotes long-term functional recovery after SCI, reduces tissue damage and promotes neuronal survival.",,,No,
Louis,Genovese et al.,2007,N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury,10.1097/01.shk.0000239775.41022.54,English,Italy,excluded,Out of scope,No drug of interest,No drug of interest (N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Faden et al.,1988,"N-Methyl-d-Aspartate Antagonist MK801 Improves Outcome Following Traumatic Spinal Cord Injury in Rats: Behavioral, Anatomic, and Neurochemical Studies",10.1089/neu.1988.5.33,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (MK801/(+)-5-methyl-10,ll-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Duan et al.,2018,Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury,10.1111/cns.12801,English,"China, Australia",excluded,Out of scope,No drug of interest,No drug of interest (Nafamostat mesylate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Duan et al.,2018,Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury.,10.1111/cns.12801,English,"China, Australia",excluded,Duplicate,,Duplicate of previous entry (693),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Black et al.,1991,Naloxone and experimental spinal cord injury: effect of varying dose and intensity of injury.,10.1089/neu.1991.8.157,English,United States,included,,,,,,rats,Sprague Dawley,100,30,,,70,,,,mixed,mixed,not reported,not reported,,,,,,Not reported,200g to 225g,,,200,225,g,,contusion injury at T8,T8,mixed,contusion,"10g impactor dropped from either 
groups 1 to 4: 2.5cm
groups 5 to 8: 5cm
groups 9 to 10: 17.5cm",4 weeks,Naloxone,naloxone,,"three different doses (crossed w/ different levels of injury severity):
groups 2, 6: 1mg/kg
groups 3, 7, 10: 4mg/kg
groups 4, 8: 10mg/kg","bolus: 30min post-injury 
infusion: 1hr post-injury for 23hrs",,23.5 hours,,subcutaneous,,functional,"modified Tarlov scale;
inclined plane test",,"Tarlov: left and right hindlimb recorded separately, mean score reported;
inclined plane: lateral position, three repeats and mean angle reported","pre-injury (just before);
post-injury days 1 to 7,
then weekly",,Yes,mixed effects (dosage) + mixed effects (regime),"most combinations of injury severity and naloxone dose do not show statistically significant differences in recovery compared to SCI control;
some combinations of 4mg/kg dose and injury severities show statistically significantly better results for some assessments",histopathology,hematoxylin and eosin stain,day 28 post-injury,Not reported,no effect,"no effect on residual tissue volume (white and gray matter);
statistically significant correlation between residual tissue volume and Tarlov score","ambipen (ampicillin?, 0.1ml, intramuscularly, post-injury days 1 and 2)","Overall weak evidence for beneficial effect of naloxone on recovery of motor function; if benefit was found this was for higher injury severity.
Consistent finding of significant correlation of injury severity and recoery.",,,No,
Louis,Black et al.,1986,Naloxone and experimental spinal cord injury: Part 1. High dose administration in a static load compression model.,10.1227/00006123-198612000-00004,English,United States,included,,,,,,rats,Sprague Dawley,20,10,,,10,,,,female: 10 (50%),mixed,50,63 to 70 days,,,63,70,Days,Young,not reported,,,,,,,compression injury at T12,T12,moderate,compression,"110g weight via static load device, duration of impact not reported",4 weeks,Naloxone,naloxone,,10mg/kg,"45min post-injury, 3hrs post-injury;
days 1 and 2 post-injury",,2 days,twice daily,intraperitoneally,,functional,"modified Tarlov scale;
inclined plane test",,"Tarlov: left and right hindlimb recorded separately, mean score reported;
inclined plane: three repeats (head up, head down, lateral) and mean angle reported","post-injury days 1 to 7,
then weekly for thee more weeks",,Yes,no effect,"small differences in trajectory of recovery but 
no difference at day 28 post-injury",histopathology,hematoxylin and eosin stain (area of residual white and gray matter measured),day 28 post-injury,Not reported,no effect,,"ambipen (penicillin G benzathine/procaine, 0.1ml, intramuscularly, days 1 and 2 post-injury);
gentamycin (0.3ml, intramuscularly, days 1 and 2 post-injury)",Naloxone does not benefit moptor recovery (in contrast to previously published results).,"Different injury model (positive effects found in dynamic weight drop models which are associated w/ different morphology at injury site).
Level of injury (lower than previous studies reporting positive effects).",,No,
Louis,Black et al.,1986,Naloxone and experimental spinal cord injury: Part 2. Megadose treatment in a dynamic load injury model,10.1227/00006123-198612000-00005,English,United States,included,,,,,,rats,Sprague Dawley,43,21,1,,22,1,,,female: 20 (47.6%),mixed,51.2,not reported,,,,,,Not reported,200g to 225g,,,200,225,g,,contusion injury at T8,T8,Not reported,contusion,10g impactor dropped from 5cm,4 weeks,Naloxone,naloxone,,"group 1: 100mg/kg (bolus), 50mg/kg (infusion) both intraperitoneally;
group 2: 150mg/kg (bolus), 75mg/kg (infusion) both subcutaneously","bolus: 30min post-injury
infusion: 1hr post-injury for 23hrs",,23.5 ho,,multiple,"group 1: intraperitoneally
group 2: subcutaneous",functional,"modified Tarlov scale;
inclined plane test",,"Tarlov: left and right hindlimb recorded separately, mean score reported; 
inclined plane: three repeats (head up, head down, lateral) and mean angle reported","post-injury days 1 to 7,
then weekly for thee more weeks",,Yes,no effect,,histopathology,hematoxylin and eosin stain (area of residual white and gray matter measured),day 28 post-injury,Not reported,no effect,,"ambipen (penicillin G benzathine/procaine, 0.1ml, intramuscularly, days 1 and 2 post-injury);
gentamycin (0.3ml, intramuscularly, days 1 and 2 post-injury)",Megadose of naloxone does not ehance neurological recovery.,,,No,
Louis,Wang et al.,2020,Metformin Promotes Axon Regeneration after Spinal Cord Injury through Inhibiting Oxidative Stress and Stabilizing Microtubule,10.1155/2020/9741369,English,China,included,,,,,,rats,Sprague Dawley,80,20,,,20,,,,all female,female,0,not reported,,,,,,Not reported,220g to 250g,,,220,250,g,,compression injury at T9,T9,Not reported,compression,vascular clip (closing force 15g) applied for 1min,1 week - 2 weeks,Metformin,metformin,,50mg/kg,immediately post-injury,,1 week - 2 weeks,daily,intraperitoneally,,functional,"BBB locomotor scale;
footprint analysis",,"BBB: three investigators, no details on how scores were accumulated","BBB: post-injury days 1, 3, 5, 7, 14;
footprint analysis: post-injury day 14",,Yes,mixed (stats/no stats),"statistically significantly higher BBB score at days 7 and 14 for Metformin treatment score (absolute score still low);
reduced toe dragging and improved crawling in Metformin treatment group (Figure 2i)","histopathology;
immunohistochemistry","hematoxylin and eosin stain (preserved area in relation to total area), Nissl stain (count of ventral motor neurons);
primary AB for Ace-tubulin, GFAP, NeuN, GAP43, HO-1, NQO1, Tyr-tubulin (rate of positive cells calculated);
TUNEL assay","day 7 post-injury (all);
day 14 post-injury (AB)","Yes (AB positive cell count);
not reported for others",positive effect,"statistically significant increase in percentage of preserved tissue for Metformin treatment group;
statistically significant reduction in no. of apoptotic cells in Metformin treatment group (Figure 3b);
statistically significant increase in GAP43 fluorescence intensity (neuroprotective protein), NeuN-positive cells (reduced loss of neurons)","cefazolin (50mg/kg, intraperitoneally, no details of duration or frequency of treatment)",Metformin significantly reduces damage to the spinal cord and improves functional recovery. ,"Unclear efficacy of metformin if administered by route other than intraperitoneal injection.
Metformin typically used to treat diabetes; unclear how interaction would be for diabetic SCI patients.",Extensive study of potential mechanism included.,Yes (drug of interest + drug not of interest),
Louis,"Alilain, Goshgarian",2007,MK-801 upregulates NR2A protein levels and induces functional recovery of the lpsilateral hemidiaphragm following acute C2 hemisection in adult rats,10.1080/10790268.2007.11753950,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (MK801),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Cox et al.,2015,"Nanoparticle Estrogen in Rat Spinal Cord Injury Elicits Rapid Anti-Inflammatory Effects in Plasma, Cerebrospinal Fluid, and Tissue",10.1089/neu.2014.3730,English,United States,excluded,Out of scope,No assessments of interest,No assessment of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Scafidi et al.,2011,Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain,10.1159/000323178,English,United States,excluded,Non-sci population,,Traumatic brain injury model; no drug of interest (Acetyl-L-carnitine/acetylcarnitine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Lin et al.,2019,NEP-1-40-modified human serum albumin nanoparticles enhance the therapeutic effect of methylprednisolone against spinal cord injury,10.1186/s12951-019-0449-3,English,China,included,,,,,,rats,Sprague Dawley,>= 63,>= 7,,,>= 7,,,,all female,female,0,8 to 10 weeks,,,8,10,Weeks,,150g to 220g,,,150,220,g,,contusion injury between T9 and T11,T9 - T11,Not reported,contusion,15g impactor dropped from 10cm,4 weeks,Methylprednisolone (MP),methylprednisolone,No,not reported (100microliter injection but w/o dose information),immediately post-injury,Yes,1 dose,,intrathecally,,functional,BBB locomotor scale,,BBB: two technicians assessed each animal,"post-injury days 1, 3, 7, 10, 14, 21, 28",Yes,Yes,no stats,no detailed analysis reported but Figure 10 suggests that there is no difference between saline treated control and MP/MPS treatment,histopathology,heamtoxylin and eosin stain,"post-injury days 1, 3, 7",Not reported,no stats,"only qualitative descriptions provided but improved neuronal cell count at post-injury day 1 for MP/MPS treatment compared to saline control, reduction in inflammatory cells at post-injury day 3 in MP/MPS treatment compared to saline control, and increased proliferation of astrocytes, fibroblasts and vessel reconstruction at post-injury day 7 in MP/MPS treatment compared to saline control","cefazolin (100mg/kg, intrasmuscularly, daily for post-injury days 1 to 7)","(Author summary mostly w.r.t. nanoparticle delivery system and its advantages as this was focus of study.)Some positive effects w.r.t. histological results for positive controls receiving MP/MPS but largest improvements observed for nanoparticle system (suspected to be achieved by slower, more continuous release of MP by this system).",,MP(S) group only represented positive control in study. Focus is on development of nanoparticle system for MP delivery and potential benefits.,No,
Louis,Lin et al.,2019,NEP-1-40-modified human serum albumin nanoparticles enhance the therapeutic effect of methylprednisolone against spinal cord injury,10.1186/s12951-019-0449-3,English,China,included,,,,,,rats,Sprague Dawley,>= 63,>= 7,,,>= 7,,,,all female,female,0,8 to 10 weeks,,,8,10,Weeks,,150g to 220g,,,150,220,g,,contusion injury between T9 and T11,T9 - T11,Not reported,contusion,15g impactor dropped from 10cm,4 weeks,Methyprednisolone sodium succinate (MPS),methylprednisolone sodium succinate,No,not reported (100microliter injection but w/o dose information),immediately post-injury,,1 dose,,intrathecally,,functional,BBB locomotor scale,,BBB: two technicians assessed each animal,"post-injury days 1, 3, 7, 10, 14, 21, 28",,Yes,no stats,no detailed analysis reported but Figure 10 suggests that there is no difference between saline treated control and MP/MPS treatment,histopathology,heamtoxylin and eosin stain,"post-injury days 1, 3, 7",Not reported,no stats,"only qualitative descriptions provided but improved neuronal cell count at post-injury day 1 for MP/MPS treatment compared to saline control, reduction in inflammatory cells at post-injury day 3 in MP/MPS treatment compared to saline control, and increased proliferation of astrocytes, fibroblasts and vessel reconstruction at post-injury day 7 in MP/MPS treatment compared to saline control","cefazolin (100mg/kg, intrasmuscularly, daily for post-injury days 1 to 7)","(Author summary mostly w.r.t. nanoparticle delivery system and its advantages as this was focus of study.) Some positive effects w.r.t. histological results for positive controls receiving MP/MPS but largest improvements observed for nanoparticle system (suspected to be achieved by slower, more continuous release of MP by this system).""",,,No,
Louis,Gupta et al.,2006,"Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord",10.1016/j.biomaterials.2005.11.015,English,Canada,excluded,Out of scope,No pure effect studied,"Drug of interest combined w/ other drug(s) as part of hydrogel, effect cannot be distinguished",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zhou et al.,2020,Scopoletin Activates Adenosine Monophosphate-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway and Improves Functional Recovery after Spinal Cord Injury in Rats,10.1159/000503866,English,China,excluded,Out of scope,No drug of interest,No drug of interest (Scopoletin/6-methoxy-7-hydroxycoumarin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Koyanagi, Tator",1997,"Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat",10.1080/01616412.1997.11740815,English,Canada,included,,,,,,rats,Wistar,25,5,,,20,,,Assume that animals were divided equally between different groups.,all male,male,100,not reported,,,,,,Not reported,334g to 536g,,,334,556,g,,compression injury at C8/T1,C8 - T1,Not reported,compression,clip (closing force 51g) applied fo 1min,4hrs,Methylprednisolone,methylprednisolone,Yes,"group 1: 30mg/kg
group 2: 60mg/kg
group 3: 120mg/kg
group 4: 240mg/kg",30min post-injury,,1 dose,,intravenously,,neurological,evoked potentials measured,,"ascending pathways assessed via somatosensory and cerebellar evoked potentials following sciatic nerve stimulation;
descending pathways assessed via posterior fossa evoked potential following cerebellar stimulation","pre-injury;
1.5hrs, 2.5hrs, 3.5hrs post-injury",,Not reported,no effect,Evoked potentials did not recover by the time of final assessment for any treatment group.,"histopathology;
perfusion","luxol fast blue, hematoxylin and eosin stains;
spinal cord blood flow (at C8/T1 and C7, using hydrogen clearance method)","4hrs post-injury (stains);
pre-injury and 1hr, 2hr, 3hrs post-injury (SCBF)",Not reported,no effect,"no difference between any treatment group and SCI control in quantitative histological analysis;
no difference in SCBF between treatment groups and SCI control, except for small transient negative effects in some dosing regimes",,"No beneficial effect of methylprednisolone treatment (at any level) on SCBF, histological outcomes or evoked potentials.
Potential effects might be possible to observe for moderate injuries and/or if subjects are studied for longer periods.","Potentially different injury to vasculature based on SCI mechanism (clip compression vs. weight drop). 
Exact region of blood flow measurement migth be different to other studies. 
Time period studied post-injury might have been too short for positive effects of methylprednisolone to develop.","Potential issue with Figure 4A, supposedly showing SCBF at injury site (C8/T1) but seems to be copy of Figure 3.",No,
Louis,Haghighi et al.,1996,Pretreatment with NMDA receptor antagonist MK801 improves neurophysiological outcome after an acute spinal cord injury,10.1080/01616412.1996.11740463,English,"United States, Venezuela",excluded,Out of scope,No drug of interest,No drug of interest (Dizocilpine Maleate/MK801 inhibitor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Hook et al.,2017,Neurobiological effects of morphine after spinal cord injury,10.1089/neu.2016.4507,English,United States,included,,,,,,rats,Sprague Dawley,36,9,,,9,,,,all male,male,100,90 to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,contusion injury at T12,T12,moderate,contusion,"150kdyne impact force, 1sec dwell time (moderate injury)",8 days,Morphine,morphine,,"10mg, 20mg, 30mg (via 5mg/h infusion)","days 1 and 2 post-injury: 10mg
days 3 and 4 post-injury: 20mg 
days 5 to 7 post-injury: 30mg",,7 days,daily,intravenously,,"functional;
neurological","BBB locomotor scale;
mechanical reactivity;
thermal reactivity",,"mechanical reactivity: von Frey filaments applied to plantar surface of hindpaws (ABBA scheme) until withdrawal and/or vocalisation, in case of no response termination at 300g; 
thermal reactivity: tail flick test w/ halogen lamp as heat source, two tests (2min apart), latency in second test recorded, in case of no response termination at 8sec exposure","BBB: 24hrs post-injury;
reactivity: post-injury days 1, 3, 5, 7
before and 30min after morphine administration ",,"Yes (BBB);
Not reported (others)",negative effect,"morphine administration reduced locomotor recovery by post-injury day 7 when compared to control;
morphine administration reduced reactivity to both thermal and mechanical stimuli, while inducing hypersensitivity to mechanical stimuli in absence of morphine","histopathology;
immunohistochemistry","luxol fast blue, cresyl violet stains;
primary AB for NeuN (neurons), GFAP (astrocytes), OX42/CD11b/c (microglia), DAPI","post-injury day 8 
(24hrs after final morphine dose)","Yes (histopathology);
Not reported (immunohistochemistry",negative effect,"morphine administration increased lesion size both at injury site and in rostral segments;
morphine administration reduced number of neurons, astrocytes and microglia compared to control (neurons, astrocytes absent, microglia still present)","penicillin G potassium (100'000U/kg, intraperitoneally, immediately post-operation and on day 2)",Morphine administration in acute phase decreases recovery of locomotor function while incrasing pain reactivity and cell loss (at lesion site). ,,,No,
Louis,Yang et al.,2016,Tamoxifen inhibits inflammatory pathways and improves locomotor function in traumatic spinal cord injury in rats,10.1166/jbt.2016.1409,English,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wu et al.,2016,Neuromuscular interaction is required for neurotrophins-mediated locomotor recovery following treadmill training in rat spinal cord injury,10.7717/peerj.2025,English,China,included,,,,,,rats,Sprague Dawley,84,12,,,12,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,220g to 250g,,,220,250,g,,contusion injury at T10,T10,incomplete,contusion,"NYU weight drop model, 10g impactor dropped from 25mm",5 weeks,Botulinum toxin type A (BTX-A),botulinum toxin,,1ng/kg,"post-injury (no exact time point specified, see Fig. 1B)",,1 dose,,intramuscular,injection into gastrocnemius bilaterally,functional,BBB locomotor scale,,"two observers, no details on how scores are aggregated","post-injury days 2, 7, 14, 21, 28, 35 ",,Yes,no stats,"no results reported for SCI + BTX (see Figure 1, caption of Figure 4 claims motor function improvement inhibited by BTX-A but no data shown or reported)","histopathology;
immunohistochemistry","cresyl violet stain;
primary AB for NeuN (neurons), c-fos (depolarised neurons), BDNF (neurotrophic), TrkB (BDNF receptor); DAPI",post-injury day 35 (based on Fig 1B),Not reported,negative effect,BTX-A reduces number of NeuN-positive motor neurons and density of c-fos compared to control in non-TT groups ,Trimethoprim (only if bladder infection developed; 0.85mg/kg),"Treadmill training (TT) improves recovery of locomotor function after SCI, potentially by affecting BDNF and TrkB expression in distal part of spinal cord. ",,Focus seems to be on effect of treadmill training (TT) rather than effect of BTX-A injection. ,No,
Louis,Yu et al.,2014,FENBENDAZOLE IMPROVES PATHOLOGICAL AND FUNCTIONAL RECOVERY FOLLOWING TRAUMATIC SPINAL CORD INJURY,10.1016/j.neuroscience.2013.10.039,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (Fenbendazole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Guth et al.,1994,Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury,10.1073/pnas.91.25.12308,English,United States,included,,,,,,rats,Sprague Dawley,54,6,,,8,2,,,all female,female,0,not reported,,,,,,Not reported,170g to 200g,,,170,200,g,,compression injury at T8,T8,Not reported,compression,no. 5 Dumont jewelers forceps applied for 2 sec,3 weeks,indomethacin,indomethacin,,0.2mg,no exact start time specified,,injection,daily,intraperitoneally,,functional,modified Tarlov scale,,"0 - complete hindlimb paralysis, 1 - minimal movement, 2 - clear movement but no weight support, 3 - hindlimbs used for crawling but no weight support, 4 - hindlimbs used for weight support but not walking, 5 - (nearly) normal function",post-injury days 10 and 21,,Yes,no effect,"no statistically signifcant
difference to control group",histopathology,hematoxylin and eosin stain,post-injury day 21,Not reported,no effect,"no statistically signifcant difference in area of lesion or
relative size of cavity",,"Combination treatment (including drugs which are not of interest)
provides benefit both in terms of reduced lesion size and improved functional outcome. 
Indomethacin alone does not provide benefit in comparison with control group.",,,Yes (drug of interest + drug not of interest),
Louis,Lee et al.,2012,Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury,10.1093/brain/aws171,English,South Korea,included,,,,,,mice,C57BL/6,72 - 262,15 - 122,,,15 - 122,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,18g to 22g,,,18,22,g,,contusion injury at T9,T9,moderate,contusion,50kdyn force ,1 hour - 4 weeks,fluoxetine,fluoxetine,,10mg/kg,immediately post-injury,,2 weeks,daily,intraperitoneally,,functional,BBB locomotor scale (mouse version),,consensus score (average) for each time point,"post-injury days 7, 10, 14, 21, 28",,Yes,positive effect,"statistically significantly improved BBB score
starting from post-injury day 10 onwards","histopathology; 
immunohistochemistry;
blood-spinal cord barrier permeability","TUNEL assay; 
number of blood cells infiltrating SC via FACS, ELISA for TNF-alpha, IL1-beta and IL6 expression; 
Evan's blue assay (extravasation of dye assessed)","TUNEL assay post-injury day 1; 
FACS post-injury days 1 and 5, ELISA post-injury day 1; 
post-injury day 1",Not reported,positive effect,"fluoxetine signifcantly reduces the number of apoptotic cells in and near the lesion area; 
fluoxetine signifcantly reduces the increase in blood cells infiltrating SC and singnificantly reduces the expression of TNF-alpha, IL1-beta and IL6 expression; 
fluoxetine significantly reduces amount of extravasation and fluorescence intensity ",,"Fluoxetine provides neuroprotective effect after SCI by preventing disruption to blood-spinal cord barrier and inhibiting activation of matrix metalloproteases. 
Fluoxetine also reduces inflammatory response as well as apoptotic cell death and improves functional recovery.",,,No,
Louis,Gao et al.,2020,Neuroprotection of melatonin on spinal cord injury by activating autophagy and inhibiting apoptosis via SIRT1/AMPK signaling pathway,10.1007/s10529-020-02939-5,English,China,included,,,,,,rats,Sprague Dawley,48,12,,,12,,,,all male,male,,not reported,,,,,,Not reported,260g to 300g,,,260,300,g,,contusion injury at T9/10,T9 - T10,Not reported,contusion,10g impactor dropped from 2.5cm (Allen's method),2 weeks - 7 weeks,melatonin,melatonin,,10mg/kg,"immediately post-injury, post-injury days 1 and 2",,2 days,daily,intraperitoneally,,functional,BBB locomotor scale,,independent assessment by three experimenters,"pre-injury;
post-injury days 1, 3, 7, 14, 21, 28, 35, 42",,Yes,positive effect,"statistically significantly higher BBB score for melatonin 
treatment group from post-injury day 14 onwards; 
plateau reached at post-injury day 35","histopathology; 
immunohistochemistry","TUNEL and Nissl staining;
primary Ab for NeuN, Beclin-1 (autophagy marker), LC-3B (autophagosome formation marker)",post-injury day 14,Not reported,positive effect,"loss of Nissl bodies signifcantly reduced in melatonin treatment group compared to SCI group;
proportion of apoptotic cells after SCI significantly reduced in melatonin treatment group compared to SCI group; 
statistically significant increase in Beclin-1 and LC-3B expression in melatonin treatment group",antibiotics (not further specified; 50'000 Units/kg on post-injuriy days 1 to 3),"Melatonin can inhibit apoptosis of nerve cells and reduce loss of motor neurons.
Melatonin further promotes motor recovery. 
A possible mechanism indicated involves the SIRT1/AMPK pathway.",Autophagy behaviour only assessed for neurons but no other cell types.,Effect of melatonin can be inhibited by administering EX527 simultaneously.,Yes (drug of interest + drug not of interest),
Louis,Gorio et al.,2005,Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury,10.1073/pnas.0508479102,English,"Italy, United States",included,,,,,,rats,Sprague Dawley,>= 72,>= 18,,,>= 26,8,,"all animals which died in control group received higher MPSS dose (60mg/kg);
assume that n>=18 per experimental group means that at least 18 animals remained in MPSS group (30mg/kg)",not reported,not reported,,adult (no precise age reported),,,,,,Adult,240g to 260g,,,240,260,g,,contusion injury at T9,T9,Not reported,contusion,"UTS-impactor: impounding piston, driving 2mm into spinal cord w/ force of 1 Newton for 1 sec",4 weeks,methylprednisolone,methylprednisolone sodium succinate,No,30mg/kg,not reported,,injection,not reported,intraperitoneally,,functional,BBB locomotor scale,,"independent assessment by four experimenters,
average reported","24hrs post-injury, 
post-injury days 4, 7, 11, 14, 18, 21, 25, 28",,Yes,no effect,no improvement in BBB score in MPSS treatment group compared to sham,"histopathology; 
immunohistochemistry","hematoxylin and eosin stain; 
primary Ab for GFAP, ED-1; 
ELISA for MIP-2 (analogue of IL-8), TNF-alpha, IL-6, IL-1beta ",post-injury day 28,Not reported,mixed effects,"no reduction in lesion size in MPSS treatment group;
MPSS supported reduction in MIP-2 and IL-1beta levels, prevented increase in TNF-alpha, reduced peak concentration of IL-6
(similar to eryhtopoietin)","buprenorphine (post-injury, before awakening; 0.03mg/kg); 
penicillin G (post-injury, before awakening; 10'000U/kg)","Methylpredinosolone treatment appears to have no beneficial effect on recovery after SCI despite attenuating the inflammatory response. 
Methylprednisolone, if co-administered with erythopoietin, counteracts the beneficial effects achieved by erythopoietin alone.",,,Yes (drug of interest + drug not of interest),
Louis,Scali et al.,2013,Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury,10.1038/srep02217,English,Italy,included,,,,,,rats,Long Evans,39 - 102,19 - 59,,,14 - 31,,,,all male,male,100,adult (two to three months),,,2,3,Months,Adult,Not reported,,,,,,Not reported,compression injury of dorsal funiculus at C4,C4,Not reported,compression,"forceps inserted into spinal cord parenchyma, closed for 20sec",6 weeks,fluoxetine,fluoxetine,,"0.2g/l drinking water, 
corresponds to 16.45 (0.36) mg/kg/day","starting 21 days pre-injury, 
days 1 to 7 post-injury",,4 weeks,continuously (drinking water),oral,,functional,"Montoya staircase reaching; 
horizontal ladder; 
footprint analysis",,"staircase: rats trained for three weeks pre-injury to retrieve and eat as many sugar pellets as possible, post-injury number of pellets eaten and number of pellets displaced (eaten or not) recorded, accuracy calculated as pellets eaten divided by pellets displaced; 
ladder: rats trained for three days pre-injury, irregular spacing of rungs, assessment on 60cm stretch of ladder via video recording, number of forepaw steps made and slips assessed over three trials; 
footprint analysis: mean distance between fore- and hindlimb footprints calculated based on 5 consecutive steps",weekly for post-injury weeks 1 to 6,,Not reported,mixed effects (timing),"improved performance (total no. of pellets, accuracy) in staircase test for fluoxetine treatment group starting in week 2 post-injury; 
accelerated recovery for fluoxetine treatment group but no difference in outcome for ladder walking test; 
improved outcome for footprint analysis for fluoxetine treatment group at weeks 3 and 5 post-injury but not consistent across entire study period",neuroanatomy,sprouting of corticospinal fibers assessed by BDA tracer,post-injury day 21,Not reported,positive effect,fluoxetine treatment group showed fibers sprouting while control group did not,,"Fluoxetine improves functional recovery after SCI markedly, which is accompanied by increased neuronal plasticity.",,Unclear applicability to real world as treatment started prior to injury.,No,
Louis,Dixit et al.,2018,Neuroprotective effect of agmatine in mouse spinal cord injury model: Modulation by imidazoline receptors,10.4103/jnsbm.JNSBM_239_17,English,India,included,,,,,,mice,Albino,145,30,,,5,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,22g to 27g,,,,,,,compression injury between T10 and T12,T10 - T12,Not reported,compression,compression w/ 5g weight for 30sec,,clonidine,clonidine,,0.1mg/kg,days 1 to 14 post-injury ,,2 weeks,daily,intraperitoneally,,functional,"BBB locomotor scale (mouse version adapted to local protocol), beam walk test",,"observation in open field, including a horizontal 
ladder for 1min",post-injury day 14,,Not reported,no effect,"treatment w/ only clonidine does not show 
a significant effect on locomotor score",,,,,,,"gentamicin (40mg/kg, twice daily, post-operative days 1 to 3)",,,,Yes (drug of interest + drug not of interest),
Louis,Zhang et al.,2014,Neuroprotective effect of apigenin in rats after contusive spinal cord injury,10.1007/s10072-013-1566-7,English,China,included,,,,,,rats,Sprague Dawley,60,12,,,12,,,,not reported,not reported,,not reported,,,,,,Not reported,180g to 220g,,,180,220,g,,contusion injury at T10,T10,severe,contusion,"NYU weight drop model, 10g weight dropped from 12.5mm",3 days,methylprednisolone sodium succinate,methylprednisolone sodium succinate,No,not reported,not reported,,not reported,not reported,not reported,,functional,BBB locomotor scale,,,"post-injury days 1, 2, 3",,Not reported,no stats,treatment effect of MP not discussed explicitly but values reported in Table 1 suggests that MP treatment group showed best functional recovery as measured by BBB,immunohistochemistry,"ELISA w/ primary Ab for IL-1beta, TNF-alpha, ICAM-1",Not reported,Not reported,positive effect,statistically significant reduction in expression levels of all three targeted factos in MP treatment group compared to injured control,,(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),,"Very poor reporting of data (time and/or dose information often missing), only partial analysis of some data, very limited discussion of comparison between proposed treatment (apigenin) and active control (MP).",No,
Louis,Nazli et al.,2015,Neuroprotective effect of atorvastatin in spinal cord ischemia-reperfusion injury,10.6061/clinics/2015(01)10,English,Turkey,included,,,,,,rabbit,New Zealand white rabbit,32,8,,,16,,,,not reported,not reported,,not reported,,,,,,Not reported,2.4kg to 3.5kg,,,2.4,3.5,kg,,arterial occlusion injury,thoracic,Not reported,ischemia,"abdominal aorta occluded for 20min 
(two clamps: one distal to renal artery, one proximal to bifurcation)",3 days,atorvastatin,atorvastatin,,2.5mg/kg/day,14 days pre-injury,,"group 1: 2 days
group 2: only pre-treatment",daily,oral,,functional,Tarlov scale,,,"post-injury at 12hrs, 24hrs, 
48hrs 72hrs",,Yes,positive effect,"both atorvastatin treatment regimes result in improved Tarlov scores at all time points assessed; 
there was no difference between the two treatment regimes",histopathology,"hematoxylin and eosin stain 
(score from 0 to 3, 0 equivalent to 
no change and 3 to severe change)",post-injury 72hrs,Yes,positive effect,"both atorvastatin treatment regimes yield histopathological results similar to uninjured control group and 
w/ significantly less vacuolization than the injured control group","cefazolin (10mg/kg, pre-operatively, single dose)","Pre-ischemic atorvastatin treatment shows neuroprotective effects. 
Acute withdrawal of atorvastatin does not have a negative effect on outcomes.",,,No,
Louis,Li et al.,2014,Neuroprotective effect of bone marrow stromal cell combination with atorvastatin in rat model of spinal cord injury,PMID: 25663994,English,China,included,,,,,,rats,Wistar,100,20,,,20,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,contusion injury between T8 and T10,T8 - T10,Not reported,contusion,modified Allen's method; plastic impactor placed directly above dura and 10g weight dropped from 10cm,5 weeks,atorvastatin,atorvastatin,,10mg/kg,24hrs post-injury ,,1 dose,,subcutaneous,,functional,"BBB locomotor scale; 
horizontal grid",,"BBB assessed by two examiners, mean value reported; 
horizontal wire grid w/ irregular spacing (hind paw fully protruding through grid counted as misstep; fraction of missteps of total number of steps reported)","BBB: pre-injury, post-injury days 1, 3, 7, 14, 21, 28, 35; 
horizontal grid: rats allowed on grid weekly, only assessed at post-injury day 35",,Not reported,no effect,"treatment w/ only atorvastatin had no effect on BBB locomotor score or 
fraction of missteps in grid test in comparison to SCI control group",immunohistochemistry,"staining for CD34 positive endothelial cells 
(to assess formation of microvasculature)",post-injury day 35,Yes,positive effect,treatment w/ only atorvastatin increases microvasculature density in comparison to SCI control group,,,,,Yes (drug of interest + drug not of interest),
Louis,Bharne et al.,2013,Neuroprotective effect of cocaine- and amphetamine-regulated transcript peptide in spinal cord injury in mice,10.1016/j.neuropharm.2012.10.028,English,India,included,,,,,,mice,Swiss,105,5,,,18,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,30g to 35g,,,30,35,g,,contusion injury between T10 and T12,T10 - T12,Not reported,contusion,"5g weight dropped from 2cm, allowed to remain for 30sec",4 weeks,methylprednisolone,methylprednisolone,No,"group 1: 20mg/kg 
group 2: 30mg/kg 
group 3: 40mg/kg",30min post-injury,,1 dose,,intravenously,,functional,"BBB locomotor scale (mouse version adapted to local protocol), horizontal ladder test (adapted to local protocol)",,"basic movement assessed initialy (max. score of 5), 
if basic movement present ladder test followed (allowing animals to achieve max. score of 10)","pre-injury, post-injury days 
1, 4, 7, 10, 14, 21, 28",,Not reported,mixed effects (dosage),higher doses (30mg/kg and 40mg/kg) of MP show statistically significant improvement in locomotor recovery,"histopathology; 
immunohistochemistry","Luxol fast blue and cresyl violet stain; 
primary Ab to GFAP, GFAP-positive astrocytes w/ intact nucleus counted;
potential issue w/ group size as discussed in Remarks/Comments field","post-injury days 3, 7, 14, 21, 28",Not reported,positive effect,treatment w/ higher dose of MP (40mg/kg) reduces count of GFAP-positive astrocytes and fraction of tissue area w/ cysts,"gentamicin (40mg/kg, intramuscularly, twice daily, post-operative days 1 to 3)","Single dose of MP after SCI facilitates locomotor recovery and reduces level of GFAP-positive astrocytes, which provides potential explanation for beneficial effect on locomotor recovery.",,"Histological/immunohistochemical analyses at five different time points, various treatment groups typically contain five to six animals; suggests that results might only be based on one animal per group?
MP treatment acts ""only"" as a control for CART and combination (CART + MP) treatment.",Yes (drug of interest + drug not of interest),
Louis,Cayli et al.,2006,Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury,10.1016/j.ijdevneu.2006.04.003,English,Turkey,included,,,,,,rats,Albino,72,12,,,36,,,"Two control groups (SCI only, SCI + vehicle), only SCI + vehicle reported",all female,female,0,adult (no precise age reported),,,,,,Adult,200g to 250g,,,200,250,g,,contusion injury between T7 and T10,T7 - T10,Not reported,contusion,"Allen's method, impact force of 50g/cm",6 weeks,"group 1: etomidate
group 2: methylprednisolone
group 3: etomidate + methylprednisolone",etomidate + methylprednisolone,,"etomidate: 2mg/kg, 
methylprednisolone: 30mg/kg",immediately post-injury,,1 dose,,intraperitoneally,,functional,"modified Tarlov scale, 
inclined plane test",,,post-injury weeks 1 to 6,,Yes,positive effect,"all treatment regimes produce significantly better motor score recovery than controls (SCI, SCI + vehicle); 
no significant differences between different treatment regimes",histopathology,"hematoxylin and eosin stain 
(fraction of lesion area relative to total issue)",post-injury week 6,Not reported,positive effect,"all treatment regimes reduce lesion area significantly compared to controls (SCI, SCI + vehicle); 
no significant differences between different treatment regimes","gentamycin (twice daily for post-injury days 1 to 3, no dose or route reported, only for animals not sacrified at post-injury day 7)",Etomidate prevents secondary damage after SCI as effectively as MP. Mechanisms of action are likely different but a combination of both drugs does not increase neuroprotective effects or improve recovery.,,,Yes (drug of interest + drug of interest),
Louis,Cayli et al.,2006,Neuroprotective effect of etomidate on functional recovery in experimental spinal cord injury.,10.1016/j.ijdevneu.2006.04.003,English,Turkey,excluded,Duplicate,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Cong, Chen",2016,Neuroprotective Effect of Ginsenoside Rd in Spinal Cord Injury Rats,10.1111/bcpt.12562,English,China,included,,,,,,rats,Sprague Dawley,108,18,,,18,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,contusion injury at T8,T8,Not reported,contusion,"10g impactor dropped from 5cm, allowed to remain for 3min",2 weeks,dexamethasone,dexamethasone,,1mg/kg,"1hr pre-injury, 
post-injury days 1 to 14",,2 weeks,daily,intraperitoneally,,functional,BBB locomotor scale,,"three independent examiners, 
mean score reported","post-injury days 1, 4, 7, 10, 14",,Yes,positive effect,dexamethasone treatment results in faster and more extensive recovery compared to SCI control group,"histopathology; 
immunohistochemistry","hematoxylin and eosin stain, Nissl stain, TUNEL assay;
primary Ab stain for NeuN, ELISA for TNF-alpha, IL-1beta, IL-6",post-injury day 14,Not reported,positive effect,"dexamethasone produces neuroprotective effect (increase in count of surviving neurons as indicated by increased no. of Nissl bodies and NeuN-positive cells, reduced count of TUNEL-positive cells) and 
reduces inflammatory response as indicated by lower TNF-alpha, IL-1beta, IL-6 levels","penicillin (200'00U/day, intramuscularly, daily for post-injury days 1 to 14)",,,,No,
Louis,Tan et al.,2015,Neuroprotective effect of methylprednisolone combined with placenta-derived mesenchymal stem cell in rabbit model of spinal cord injury,PMID: 26464639,English,China,included,,,,,,rabbit,New Zealand rabbit,40,10,,,10,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,2.5kg to 3.5kg,,,2.5,3.5,kg,,contusion injury between T8 and T10,T8 - T10,Not reported,contusion,10g impactor dropped from 10cm,4 weeks,methylprednisolone,methylprednisolone,No,"bolus: 60mg/kg 
maintenance: 30mg/kg","bolus: immediately post-injury 
maintenance: 4hrs post-injury, post-injury days 1 to 3",,3 days,twice daily,intravenously,,functional,Tarlov scale,,,"pre-injury, 
post-injury weeks 1 to 4",,Not reported,positive effect,methylprednisolone improves functional recovery significantly,histopathology,hematoxylin and eosin stain,post-injury week 4,Yes,positive effect,methylprednisolone reduces hemorrhage and edema significantly,,,,"Very little data shown, especially for analysis of histopathology results.",Yes (drug of interest + drug not of interest),
Louis,Cakir et al.,2003,Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury,10.1016/S0967-2109(03)00077-2,English,Turkey,included,,,,,,rabbit,Japanese white rabbit,30,6,,,6,,,,not reported,not reported,,not reported,,,,,,Not reported,2.4kg to 3.5kg,,,2.4,3.5,kg,,arterial occlusion injury,thoracic,Not reported,ischemia,"abdominal aorta occluded for 45min
(two clamps, one distal to renal artery, one proximal to bifurcation)",48 hours,N-acetylcysteine,acetylcysteine,,50mg/kg,15min prior to clamp release/30 min into ischemic period,,1 dose,,not reported,,functional,Tarlov scale,,,48hrs post-injury,,Not reported,positive effect,N-acetylcysteine significantly reduced motor dysfunction.,"histopathology;
immunohistochemistry","hematoxylin and eosin stain; 
primary Ab for Bcl-2",48hrs post-injury,"Not reported (histopathology); 
yes (immunohistochemistry)",mixed effects,"N-acetylcysteine treatment which resulted in full functional recovery (4/6 rabbits) was also associated
with minimal cellular infiltrate, good preservation of nerve cells and absence of Bcl-2 positive cells. ",,"N-acetylcysteine provides neuroprotective effect 
resulting in functional recovery.",,Histopathological and immunohistochemical evaluation with very limited data and mostly aggregate statements across treatment regimes.,No,
Louis,An et al.,2020,"Neuroprotective effect of novel celecoxib derivatives against spinal cord injury via attenuation of COX-2, oxidative stress, apoptosis and inflammation",10.1016/j.bioorg.2020.104044,English,China,excluded,Out of scope,No drug of interest,Derivative of drug of interest; drug of interest not assessed,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Khalatbary, Ahmadvand",2012,Neuroprotective effect of oleuropein following spinal cord injury in rats,10.1179/1743132811Y.0000000058,English,Iran,excluded,Out of scope,No drug of interest,No drug of interest (oleuropin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Bi et al.,2019,Neuroprotective effect of omega-3 fatty acids on spinal cord injury induced rats,10.1002/brb3.1339,English,China,excluded,Out of scope,No assessments of interest,No assessment of interest (protein/mRNA/DNA quantification),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kaur et al.,2016,Neuroprotective effect of propofol against excitotoxic injury to locomotor networks of the rat spinal cord in¬†vitro,10.1111/ejn.13353,English,Italy,excluded,Out of scope,Ex-vivo,Ex vivo study (isolated spinal cord),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gao et al.,2015,Neuroprotective Effect of Simvastatin via Inducing the Autophagy on Spinal Cord Injury in the Rat Model,10.1155/2015/260161,English,China,included,,,,,,rats,Sprague Dawley,81,27,,,27,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,240g to 260g,,,240,260,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,10g impactor dropped from 2.5cm,5 weeks,simvastatin,simvastatin,,10mg/kg,1hr post-injury,,2 days,twice daily,intraperitoneally,,functional,BBB locomotor scale,,"three independent examiners,
mean score reported","pre-injury, post-injury days 
1, 3, 7, 14, 21, 28, 35",,Yes,positive effect,"initial recovery similar, from post-injury day 14 onward simvastatin treatment group
showed significantly better recovery","histopathology;
immunohistochemistry","Nissl staining;
primary Ab for CSPG, Caspase-3",post-injury day 7,Not reported,positive effect,"simvastatin treatment significantly reduced loss of Nissl bodies and anterior horn motor neurons;
simvastatin treatment significantly reduced levels of CSPG (contributing to glial scar formation) and Caspase-3 (apoptotic marker)",,simvastatin has potential neuroprotective effect after induce SCI via reduction in apoptosis and glial scar formation as well as via induction of autophagy,,"only one dose assessed, claimed to be optimal based on literature",No,
Louis,Wang et al.,2013,Neuroprotective effect of topiramate on spinal cord injury in rats,10.3969/j.issn.1001-1242.2013.05.004,Chinese,China,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wang et al.,2012,Neuroprotective effect of vaccination with autoantigen-pulsed dendritic cells after spinal cord injury,10.1016/j.jss.2011.06.066,English,China,excluded,Out of scope,No drug of interest,No drug of interest (injection of dendritic cells and spinal cord homogenate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Tan et al.,2020,Neuroprotective effects of a ketogenic diet in combination with exogenous ketone salts following acute spinal cord injury.,10.4103/1673-5374.280327,English,"China, Canada",excluded,Out of scope,No drug of interest,"No drug of interest (ketogenic diet, ketone salt supplementation)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gaviria et al.,2000,"Neuroprotective effects of a novel NMDA antagonist, Gacyclidine, after experimental contusive spinal cord injury in adult rats",10.1016/S0006-8993(00)02581-6,English,France,excluded,Out of scope,No drug of interest,No drug of interest (gacyclidine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Karaoglan et al.,2008,Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats,10.1016/j.surneu.2007.03.041,English,Turkey,excluded,Out of scope,No drug of interest,"No drug of interest (Ac.YVAD.cmk, selective Caspase-1 inhibitor)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Hou et al.,2016,Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats,PMID: 27114797,English,China,included,,,,,,rats,Wistar,40,8,,,8,,,,all male,male,100,8 weeks to 10 weeks,,,8,10,Weeks,Adult,200g to 300g,,,200,300,g,,compression injury between T6 and T8,T6 - T8,Not reported,compression,vascular clip (30g closing force) applied for 1 minute,3 weeks,methylprednisolone,methylprednisolone,No,30 mg/kg,following wound closure after injury,Yes,1 dose,,intraperitoneally,,functional,"BBB locomotor scale;
grid walking test",,"BBB: two examiners, observation for 4min, no information on score aggregation;
grid walking: 40cm by 45cm grid w/ 2cm^2 spaces, missteps counted, no information on duration of observation","BBB: post-injury days 7, 14, 21, 28, 35, 42;
grid: post-injury days 7, 14, 21, 28, 35, 42, 49",Yes,"BBB: yes;
grid: not reported",positive effect,methylprednisolone treatment resulted in significantly better functional outcome,"histopathology;
immunochemistry","hematoxylin and eosin stain (scoring of edema, vascular congestion, neuronal degeneration, inflammation w/ higher scores representing worse outcomes; count of normal motor neurons in anterior part of spinal cord);
ELISA for Caspase-3, TNF-alpha, myeloperoxidase (MPO)",post-injury day 21,"H&E stain: yes;
ELISA: not reported",positive effect,"reduction in pathological score compared to trauma-only group and increase in number of normal motor neurons for methylprednisolone treatment group;
significant reduction in Caspase-3 and MPO activity as well as TNF-alpha levels in methylprednisolone treatment group",,(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),,"Poor reporting of functional results (inclined plane test reported but not described in methods, results for grid walking test missing, figures do not show results for active control [methylprednisolone]). Included as MP as active control group but results should be treated w/ caution as reporting for active control is very sparse",No,
Louis,Wang et al.,2014,Neuroprotective effects of autophagy induced by rapamycin in rat acute spinal cord injury model,10.1159/000357382,English,China,included,,,,,,rats,Sprague Dawley,>= 66,>= 28,,,>= 22,, ,Information for group size missing for functional assessments (cf. Figure 6),all female,female,0,8 weeks,,,8,8,Weeks,Adult,200g to 220g,,,200,220,g,,contussion injury at T10,T10,Not reported,contusion,"Allen weight drop model, 8g impactor dropped from 2.5cm",30 days,methylprednisolone,methylprednisolone,No,30mg/kg,4hrs post-injury,,30 days,daily,intravenously,,functional,Gale scale,,"scale ranges from 0 to 6, 0 indicates no muscle strenght or sensation, 6 indicates normal walking","day 1, 3, 10, 14, 21, 30",No,,positive effect,"from post-injury day 14 onwards, methylprednisolone treatment group shows significantly better motor function recovery than vehicle treated control ",,,,,,,,(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),,"Very limited results for active control receiving methylprednisolone reported (only functional data w/ separate details on MP group, no information on staining or microscopy results).",Yes (drug of interest + drug not of interest),
Louis,Sozbilen et al.,2018,Neuroprotective Effects of C-terminal Domain of Tetanus Toxin on Rat Brain Against Motorneuron Damages After Experimental Spinal Cord Injury,10.1097/BRS.0000000000002357,English,Turkey,included,,,,,,rats,Sprague Dawley,28,7,,,7,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,200g to 300g,,,200,300,g,,compression injury between T8 and T10,T8 - T10,Not reported,compression,aneurysm clip (30g closing force) applied for one minute,8 days,methylprednisolone,methylprednisolone,No,"bolus: 30mg/kg;
maintenance: 5.4mg/kg/h","bolus: within 1hr of wound closure after injury;
maintenance: immediately following bolus",,23hrs,,multiple,"bolus: intraperitoneally
maintenance: subcutaneous (interscapular area)",functional,BBB locomotor scale,,"two examiners, no details on how scores 
were aggregated","post-injury days 0, 1, 3, 7, 8",No,Not reported,positive effect,statistically significantly improved locomotor recovery in positive control/methylprednisolone,,,,,,,,(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),,Methylprednisolone only provided positive/active control.,No,
Louis,Yilmaz et al.,2015,Neuroprotective effects of clopidogrel in experimental spinal cord injury,https://www.acarindex.com/pdfs/712505,Turkish,Turkey,included,,,,,,rats,Sprague Dawley,21,7,,,7,,,,all female,female,0,not reported,,,,,,Not reported,180g to 220g,,,180,220,g,,contusion injury between T7 and T10,T7 - T10,Not reported,contusion,10g weigtht dropped from 10cm ,21 days,clopidogrel,clopidogrel,,5mg/kg,"days 1, 3, 5, 7 post-injury",,4 doses,,intragastrically,,functional,"inclined plane test, Drummond and Moore motor function score",,"inclined plane: average of two scores from two positions; Drummond and Moore: 0=paraplegic, no evidence of lower extremity motor function to 4=normal motor function","post-injury days 1, 7, 14, 21",,Yes,positive effect,statistically significantly higher inclined plane score and Drummond and Moore scores for treatment compared to injured control group,histopathology,"hematoxylin and eosin stain (scored from 0=normal GM/WM and vascular structures to 4=axonal swelling, axonal spherocytes, sever necrosis, polymorph leukocyte infiltrations)",post-injury 21,Yes,no stats,,,Clopidogrel significantly improves motor function after SCI; proposed mechanism of action (anti-inflammatory and anti-oxidant effects) not confirmed by histological analysis.,,,No,
Louis,Pourkhodadad et al.,2018,Neuroprotective effects of combined treatment with minocycline and olfactory ensheathing cells transplantation against inflammation and oxidative stress after spinal cord injury,10.22074/cellj.2019.6126,English,Iran,excluded,Out of scope,No pure effect studied,Drug of interest but only in combination with either application of Dulbecco's Modified Eagle's Medium (DMEM) or transplant of olphactory ensheathing cells (OECs),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Chen et al.,2015,Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury.,10.1111/cns.12429,English,"Taiwan, China",included,,,,,,rats,Wistar,Not reported,Not reported,,,Not reported,,,,all female,female,0,not reported,,,,,,Not reported,300g to 320g,,,300,320,g,,contussion injury at T10,T10,Not reported,contusion,"NYU weight drop model, impactor dropped from 5cm",30 days,methylprednisolone,methylprednisolone,No,"bolus: 0.1mg (equivalent to 30mg/kg in humans);
maintenance: 0.018mg/hr (equivalent to 5.4mg/kg*hr in humans)","bolus: immediately post-injury
maintenance: 1hr post-injury",Yes,23hrs,,intrathecally,,functional,BBB locomotor scale,,"independent examiners, no details on how many or how scores were aggregated","post-injury days 0, 3, 6, 9, 12,15, 18, 21, 24, 27, 30",Yes,Yes,positive effect,"from day 18 onwards significantly better recovery of motor 
function in MP treatment group compared to SCI control group",immunohistochemistry,"primary Ab for Cd11b, GFAP, Neurocan, Neurofilament, 
PCNA, Phosphacan, TGF-beta1, TNF-alpha, Vimentin","6hrs post-injury, post-injury
days 3, 7, 30",Not reported,mixed effects,"reduction in expression of TGF-1beta at day 3 but not 7; significant reduction in expression of neurocan but not phosphocan from post-injury day 3 onwards; increase in axon marker neurofilament at post-injury day 30; increase in GFAP expression and reduction in OX42 as well as vimentin at day 14; no effect on expression of TNF-alpha levels (post-injury days 3, 7, 14)",,i.t. (intrathecally) administration results preferable as drug concentration in spinal cord and drug effect increased; no conclusion reported w.r.t. methylprednisolone but some positive effects reported both in functional and immunohistochemical results but newly investigated agent G-CSF appears to provide stronger positive effects across all assessed variables,,,No,
Louis,Gaviria et al.,2000,Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects,10.1089/neu.2000.17.19,English,France,excluded,Out of scope,No drug of interest,No drug of interest (gacyclidine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Liao et al.,2002,Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in Vitro,10.1006/exnr.2001.7841,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (ginsenosides), in vitro study (cell culture)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Jones et al.,2001,Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons,10.1016/S0165-0173(01)00107-2,English,United States,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Colak et al.,2003,Neuroprotective effects of GYKI 52466 on experimental spinal cord injury in rats,10.3171/spi.2003.98.3.0275,English,Turkey,excluded,Out of scope,No drug of interest,"No drug of interest (GYKI 52466, which is an AMPA receptor antagonist)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ok et al.,2012,Neuroprotective effects of hypothermia after spinal cord injury in rats: comparative study between epidural hypothermia and systemic hypothermia.,10.1097/BRS.0b013e31826ff7f1,English,South Korea,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,282g to 322g,300,,282,322,g,,contusion injury at T9,T9,severe,contusion,10g impactor dropped from 2.5cm,6 weeks,methylprednisolone,methylprednisolone,No,30 mg/kg,"30min, 6hrs, 24hrs post-injury",Yes,3 doses,,intraperitoneally,,functional,BBB locomotor scale,,"two observers, no information on how scores were aggregated",weekly for 6 weeks,Yes,Yes,no stats,,"histopathology;
immunohistochemistry","TUNEL stain;
primary Ab for OX-42",post-injury week 6,Yes,positive effect,"significant reduction in TUNEL positive (apoptotic) cells,
significant reduction in OX-42 positive cells","gentamicin (post-surgery, 20mg/kg, intramuscularly)",(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),,Methylprednisolone only provided positive/active control.,No,
Louis,Kurt et al.,2009,Neuroprotective effects of infliximab in experimental spinal cord injury,10.1016/j.surneu.2008.01.038,English,Turkey,excluded,Out of scope,No assessments of interest,"No outcome of interest (""level of lipid peroxides in traumatized spinal cord tissue were measured as thiobarbituric acid-reactive material"")",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Sharma et al.,2006,Neuroprotective effects of melanocortins in experimental spinal cord injury. An experimental study in the rat using topical application of compounds with varying affinity to melanocortin receptors,10.1007/s00702-005-0404-3,English,Sweden,excluded,Out of scope,No drug of interest,No drug of interest (novel Melacure compounds),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Yacoub et al.,2014,Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury,10.1089/neu.2013.3037,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (oxycyte, a fluorocarbon)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kazanci et al.,2017,Neuroprotective effects of pregabalin against spinal cord ischemia-reperfusion injury in rats,10.5137/1019-5149.JTN.17959-16.1,English,Turkey,included,,,,,,rats,Wistar,32,8,,,8,,,,not reported,not reported,,adult (no precise age reported),,,,,,Adult,250g (20),250,20,,,g,,arterial occlusion injury,thoracic,Not reported,ischemia,"aorta clamped for 30min (two clamps, applied inferior to left renal artery)",24 hours,"methylprednisolone, pregabalin",methylprednisolone + pregabalin,,"methylprednisolone: 30mg/kg
pregabalin: 30mg/kg","methylprednisolone: immediately after reperfusion
pregabalin: days -7 to -1 pre-injury",,"methylprednisolone: 1 dose
pregabalin: 7 days",pregabalin: daily,intraperitoneally,,functional,"BBB locomotor scale,
inclined plane test",,,24hrs post-injury,,Not reported,positive effect,both MP and pregabalin show significant improvement of BBB score and max. angle in inclined plane test compared to injured control,"histopathology;
immunohistochemistry","hematoxylin and eosin stain, methylene blue stain followed by uranyl acetate and lead citrate (myelination status);
ELISA w/ Ab for Caspase-3, TNF-alpha, IL-1beta, Glutathione Peroxidase, Tissue Catalase",24hrs post-injury,"H&E stain: yes;
others: not reported",positive effect,"statistically significantly lower histopathology score for both treatment groups, statistically significantly reduced loss of motor neurons for treatment groups, reduction in histological damage for treatment groups (reduced hemorrhage, edema [Fig. 2]), partial protection of myelination by MP treatment but no protection of myelination by pregabalin treatment;
statistically significant improvement for all proteins assessed via ELISA for both treatment groups (increase for beneficial, decrease for harmful), no statistically significant differences between treatment groups",,"Pregabalin and MP protects spinal cord against I/R injury by attenuating lipid peroxidation, inflammatory markers and caspase dependent apoptotic pathways. It also helps to preserve histopathological, ultrastructural findings and helps to improve clinical outcome.",No long-term follow up; pregabalin needs to be assessed for time- and dose-dependent effects.,Relatively similar in methods to 753.,No,
Louis,Moriya et al.,2017,Neuroprotective effects of pregabalin in a rat model of intracisternal facial nerve avulsion,10.23736/S0390-5616.16.03263-X,English,Japan,excluded,Non-sci population,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Festoff et al.,2004,Neuroprotective effects of recombinant thrombomodulin in controlled contusion spinal cord injury implicates thrombin signaling,10.1089/0897715041526168,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (human recombinant thrombomodulin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kahveci et al.,2014,Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats,10.1016/j.ejphar.2014.07.042,English,Turkey,included,,,,,,rats,Wistar,40,8,,,16,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,250g (20),250,20,,,g,,compression injury at T7,T7,Not reported,compression,aneurysm clip (70g closing force) applied for 1 min,24 hours,"methylprednisolone, rosuvastatin",methylprednisolone + rosuvastatin,,"methylprednisolone: 30mg/kg
rosuvastatin: 20mg/kg",immediately following injury,,1 dose,,intraperitoneally,,functional,"BBB locomotor scale,
inclined plane test",,"two independent observers, no information on how scores were aggregated",24hrs post-injury,,Yes,positive effect,"statistically significantly higher BBB scores and max. angle for both treatment groups compared to control,
no difference between treatment groups","histopathology;
immunohistochemistry","hematoxylin and eosin stain, methylene blue stain followed by uranyl acetate and lead citrate (myelination status), normal motor neuron count (across three sections, average reported);
ELISA w/ Ab for Caspase-3, TNF-alpha, Tissue Myeloperoxidase (MPO)",24hrs post-injury,"H&E stain: yes;
others: not reported",positive effect,"statistically significantly lower histopathology score for both treatment group (rosuvastatin, MP) but no difference between groups, statistically significantly higher avg. number of normal motor neurons in both treatment groups, ultrastructural assessment showed both treatments protecting myelinated axons of all size (small, medium, large) but rosuvastatin achieving statistically significantly better protection than MP;
statistically significant decrease in all three protein levels/activities assessed for both rosuvastatin and MP, no significant difference between the two treatment groups",,"The biochemical, histopathological, ultrastruc- tural analyses and the functional tests revealed that ROS exhibits meaningful neuroprotective effects over SCI through antiapoptotic, anti-inflammatory, and antioxidant effects by reducing lipid peroxidation.","No assessment of delayed reactions (positive or negative) to treatments or dose-dependent effects and
no comparison with other statins.",Relatively similar in methods to 750.,No,
Louis,Ye et al.,2011,Neuroprotective effects of salvianolic acid B on secondary spinal cord damage,10.3969/j.issn.1673-5374.2011.03.005,English,China,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Xian-Hui et al.,2016,Neuroprotective effects of the Buyang Huanwu decoction on functional recovery in rats following spinal cord injury.,10.1179/2045772314Y.0000000273,English,China,included,,,,,,rats,Wistar,40,10,,,10,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,300g to 350g,,,300,350,g,,contusion injury between T8 and T12,T8 - T12,severe,contusion,10g impactor dropped from 2.5cm,4 weeks,methylprednisolone,methylprednisolone,No,"""high dose"" (no precise dose reported)",2hrs post-injury,Yes,4 weeks,daily,not reported,,functional,BBB locomotor scale,,"four independent examiners, no details on how scores were aggregated; outliers (difference to group mean greater than 2 s.d.) excluded from statistical analysis","pre-injury, post-injury days 1, 7, 14, 21, 28 ",Yes,Yes,positive effect,statistically significant recovery of locomotor function in MP treatment group,histopathology,TUNEL stain,post-injury day 28,Not reported,positive effect,statistically significant reduction in fraction of apoptotic cells in TUNEL stain,,(no conclusion reported w.r.t. methylprednisolone as this only acted as active control),Exclusion of outliers from statistical analysis.,Methylprednisolone only provided positive/active control.,No,
Louis,Kong et al.,2017,Neuroprotective Effects of Valproic Acid in a Rat Model of Cauda Equina Injury,10.1016/j.wneu.2017.08.150,English,China,excluded,Non-sci population,,Cauda equina injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Samantaray et al.,2010,Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats.,10.1111/j.1749-6632.2009.05357.x,English,United States,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wu et al.,2010,Evaluation of the sodium-glutamate blocker riluzole in a preclinical model of ervical spinal cord injury.,10.1055/s-0030-1267047,English,"United States, Canada",excluded,Out of scope,No drug of interest,No drug of interest (riluzole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Qian et al.,2000,High-dose methylprednisolone may do more harm for spinal cord injury,10.1054/mehy.2000.1165,English,United States,excluded,Opinion,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Cordaro et al.,2017,Fumaric Acid Esters Attenuate Secondary Degeneration after Spinal Cord Injury.,10.1089/neu.2016.4678,English,"Italy, United States",excluded,Out of scope,No drug of interest,No drug of interest (monomethyl/dimethyl fumarate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Dong et al.,2020,Novel Approach for Efficient Recovery for Spinal Cord Injury Repair via Biofabricated Nano-Cerium Oxide Loaded PCL With Resveratrol to Improve in Vitro Biocompatibility and Autorecovery Abilities,10.1177/1559325820933518,English,China,excluded,Out of scope,No drug of interest,No drug of interest (nanoparticles loaded w/ resveratrol); in-vitro results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kuypers et al.,2013,Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord,10.1016/j.expneurol.2013.02.014,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (ethidium bromide)/assessment of ethidium bromide induced demyelination as an injury model,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Sahin et al.,2011,"The effects of medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the spinal cord injury",10.1179/016164110X12807570510095,English,Turkey,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Wistar,48,24,,,12,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,170g to 361g,,,170,361,g,,compression injury between T10 and T12,T10 - T12,Not reported,compression,aneurysm clip (1.37N to 1.72N closing pressure) applied for 1 minute,6 hours,medroxy progesterone acetate,medroxyprogesterone acetate,,8mg/kg,30min post-injury,,1 dose,,intraperitoneally,,,,,,,,,,,immunohistochemistry,"ELISA w/ Ab for TNF-alpha, IL-1beta","1hr,  6hrs post-injury",Not reported,mixed effects,"statistically significant reduction in IL1-beta at 1hr but not 6hrs;
statistically significant reduction in TNF-alpha at 6hrs but not 1hr",,medroxy progresterone acetate significantly reduces TNF-alpha levels (known pro-inflammatory cytokine involved in secondary injury),,,No,
Louis,Kouhzaei et al.,2013,Protective effect of low molecular weight polyethylene glycol on the repair of experimentally damaged neural membranes in rat's spinal cord,10.1179/1743132812Y.0000000133,English,Iran,included,,,,,,rats,Wistar,>= 31,Not reported,,,31,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,compression injury at T11,T11,Not reported,compression,titanium clip (1.16N closing force) applied for 15sec,Not reported,polyethylene glycole,polyethylene glycol,,"200 Da, 400 Da, 600 Da, 1000 Da, 2000 Da",immediately post-injury,,5 minutes,,intrathecally,"solution aspirated after five minutes, site of injury washed w/ Krebs' solution,
applied to injury directly and suspicion of damage to the dura",electrophysiology,spinal cord evoked potential recording,,"electrodes positioned at T1/2 and L1/2, reference electrode on paravertebral muscle;
amplituted of first negative peak w/ maximum stability (based on reference recordings in control group) assessed","5min, 10min, 15min, 20min, 25min post-injury",,Not reported,mixed effects (dosage),"re-establishment of ""normal"" negative peak characteristics mostly for lower molecular weights (<1000Da);
statistically significant recovery of amplitude for PEGs w/ 200Da and 400Da molecular weight",(only assessed in vitro),,,,,,,"in vivo results show that intial phase of recovery is more pronounced in PEG w/ larger molecular weights but at cost of plateau being reached earlier and at a lower level of recovery;
size of PEG affects total recovery achieved",,,No,
Louis,Oudega et al.,1999,Long-term effects of methylprednisolone following transection of adult rat spinal cord,10.1046/j.1460-9568.1999.00666.x,English,United States,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Fischer,146,Not reported,,,Not reported,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,160g to 180g,,,160,180,g,,complete transection at T8,T8,complete,transection,,8 weeks,methylprednisolone sodium succinate,methylprednisolone sodium succinate,,30mg/kg,"5min, 2h, 4h post-injury",,3 doses,,intravenously,,,,,,,,,,,"histopathology;
immunohistochemistry","histopathology: neuronal tracing using biotinylated dextran amine (BDA) injected two weeks before animals were killed and distance of axons nearest to lesion site determined as well as total number of labelled fibers, stainining with cresyl violet and computerised image analysis to determine cavitation;
immunohistochemistry: primary Ab for neurofilaments (NF, recognising axons), GAP-43 (recognising neurons), ED1 (recognising microglia, macrophages) - ED1 positive cells counted in every 10th segment for estimate of total number","weeks 1,  2, 4 and 8 post-injury",Not reported,positive effect,"statistically significant reduction in ED1-positive cells in treatment group at all timepoints;
statistically significant reduction in tissue loss close to lesion (0 to 1mm) in treatment group at weeks 2, 4, 8;
reduced die-back of vestibulospinal but not corticospinal fibres in treatment group at all timepoints as measured by distance to lesion site; 
reduced death of vestibulospinal fibres at early timepoints (weeks 1, 2 and 4) but not later timepoint or in corticospinal fibres",,"treatment with MP induces long-lasting reduction 
in invasion/activation by/of macrophages and spinal tissue loss",,no correlation between ED1-positive cells and tissue loss observed,No,
Louis,Sperling et al.,2019,Galantamine improves functional recovery and reduces lesion size in a rat model of spinal cord injury,10.1016/j.brainres.2019.146424,English,Brazil,excluded,Out of scope,No drug of interest,No drug of interest (galantamine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Park et al.,2020,Gallic acid attenuates blood-spinal cord barrier disruption by inhibiting Jmjd3 expression and activation after spinal cord injury,10.1016/j.nbd.2020.105077,English,South Korea,excluded,Out of scope,No drug of interest,No drug of interest (gallic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ferrero-Gutierrez,2013,New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats,10.14670/HH-28.89,English,Spain,excluded,Out of scope,No pure effect studied,Albumin (drug of interest) scaffold seeded w/ adipose-derived stem cells and olfactory ensheathing cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Qian et al.,2005,High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients,10.1038/sj.sc.3101681,English,United States,excluded,Out of scope,No assessments of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zandieh et al.,2003,The effect of ketamine/xylazine anesthesia on sensory and motor evoked potentials in the rat,10.1038/sj.sc.3101400,English,Austria,excluded,Out of scope,No pure effect studied,Drug of interest only in combination w/ other drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,"Li, Tator",1999,"Effects of MK801 on evoked potentials, spinal cord blood flow and cord edema in acute spinal cord injury in rats",10.1038/sj.sc.3100941,English,Canada,excluded,Out of scope,No drug of interest,No drug of interest (MK801),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Sun et al.,2012,GELDANAMYCIN ACCELERATED PERIPHERAL NERVE REGENERATION IN COMPARISON TO FK-506 IN VIVO,10.1016/j.neuroscience.2012.07.026,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (FK-506, Geldanamycin); Non-SCI population (saphenous and/or tibial nerve injuries)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gonzalez et al.,2001,Glucocorticoid effects on Fos immunoreactivity and NADPH-diaphorase histochemical staining following spinal cord injury,10.1016/S0006-8993(01)02717-2,English,Argentina,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,rats,Sprague Dawley,48 - 72,24 - 36,,,24 - 36,,,,all male,male,100,not reported,,,,,,Not reported,250g to 300g,,,250,300,g,,complete transection at T7/T8,T7 - T8,complete,transection,,48 hours,dexamethasone,dexamethasone,,5mg/kg,"group 1: 5 min post-injury
group 2: 5min, 6hrs, 18hrs, 46hrs post-injury",,1 - 4 doses,,not reported,,,,,,,,,,,"histopathology;
immunohistochemistry","NADPH-d stain using nitroblue tetrazolium;
primary Ab for Fos; quantitative image analysis of at least ten random image sections for both (neurons showing NADPH-d stain, Fos-positive nuclei)","i) 2hrs, 4hrs post-injury
ii) 48hrs post-injury",Not reported,mixed effects,"no clear effect in either direction across all time points;
transitory increase in Fos expression in treatment group for laminae I to III but no difference in lamina X;
reduction (but not always statistically significant) in NADPH-d positive neurons in treatment group",,"effect of dexamethasone varies (between positive and negative) depending on region and time post-injury considered, potentially benefitting motor function recovery (hypothetical) but at cost of increased nociception",,,No,
Louis,Matsumoto et al.,2008,Glutamine synthetase protects the spinal cord against hypoxia-induced and GABA<inf>A</inf> receptor-activated axonal depressions,10.1016/j.surneu.2007.07.011,English,"United States, Japan",excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Aceves et al.,2016,Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury,10.1038/sc.2016.28,English,United States,included,,,,,,rats,Sprague Dawley,120,8,,,8,,,,all male,male,100,90 to 110 days,,,90,110,Days,,300g to 350g,,,300,350,g,,contusion injury at T12/T13,T12 - T13,moderate,contusion,"Infinite Horizon impactor, impact force 150 kdyne, 1 second dwell time",3 weeks,morphine ([+]-morphine enantiomer),morphine,,0.32micomol,24hrs post-injury,,3 weeks,"days 2 - 7: daily
days 9 - 15: every 2nd day
days 18, 21",intrathecally,drug administration always before functional and neurological assessments,"functional;
neurological","BBB locomotor scale, ladder walk test, beam walk test; thermal sensitivity (tail flick), mechanical sensitivity (von Frey filaments), tactile reactivity (girdle test)",,,"BBB: post-injury but before first drug administration to obtain baseline, days 1 to 7, 9, 11, 13, 15, 18, 21 post-injury; ladder and beam walk: post-injury day 21 post-injury;
neurological: not entirely clear but most likely days 1 and 21 post-injury (before and after drug administration)",,"BBB: yes;
all others: not reported",no effect,"no statistically significant effect on motor score recovery
(negative effect expected) or increased/decreased sensitivity to pain",histopathology,"Luxol fast blue and Cresyl violet stain,
assessment of spared tissue (lesion size, spared white and gray matter)",day 21 post-injury,Yes (investigator delimiting cystic formations and/or areas of dense gliosis),,,"penicillin G potassium (Pfizerpen), 100'000U immediately and on day 2 post-injury",No effect of [+]-morphine on recovery (while potentially a negative effect on motor function recovery was expected).,,,No,
Louis,Aceves et al.,2017,Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury,10.1089/neu.2016.4601,English,United States,excluded,Out of scope,No pure effect studied,Drug of interest only in combination w/ other drug (nor-Binaltorphimine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Barbeau et al.,1993,Noradrenergic agonists and locomotor training affect locomotor recovery after cord transection in adult cats,10.1016/0361-9230(93)90270-L,English,Canada,excluded,Case report,,Seems like results are reported for single animal,,,cats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Guizar-Sahagun et al.,2005,"Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats",10.1016/j.neuroscience.2004.09.056,English,Mexico,included,,,,,,rats,Long Evans,42,14,,,14,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 240g,,,210,240,g,,"group 1: contusion injury at T9
group 2: compression injury at T9",T9,mixed,multiple,"group 1: NYU weight drop model (10g impactor dropped from 25mm)
group 2: extradural clip (135g force) applied for 5s",8 weeks,"group 1, group 2: methylprednisolone sodium succinate",methylprednisolone sodium succinate,No,30mg/kg,"group 1: 20min, 4hrs, 10hrs, 20hrs post-injury
group 2: 15min post-injury",,"group 1: 4 doses
group 2: 1min (controlled via fluid administration using syringe pump)",,multiple,"group 1: intraperitoneally
group 2: likely intravenously but not clearly described","functional;
physiological","BBB locomotor scale, spinal cord blood flow",,"group 1: BBB locomotor scale
group 2: spinal cord blood flow laser-Doppler flowmetry, relative change to pre-injury baseline assessed (conversion from arbitrary units produced by flowmeter)","group 1: pre-injury, post-injury day 1 then weekly for 8 weeks
group 2: pre-injury, post-injury 10min then every 10min for 100min",,"group 1: Yes
group 2: not reported",mixed effects (assessment),"no effect on locomotor function recovery;
statistically significant improvement in spinal cord blood flow","only group 1: histopathology;
immunohistochemistry","Luxol fast blue, Cresyl violet, FluoroRuby stain (neurons in red nuclei in brain);
primary Ab for GFAP","Luxol fast blue, Cresyl violet, Ab for GFAP: 8 weeks post-injury;
FluoroRuby: 5 days post-injury (not entirely clear)","Luxol fast blue, Cresyl violet, Ab for GFAP: yes;
FluoroRuby: not reported",no effect,"no effect on tissue sparing in regions adjacent to injury site,
no effect on survival of neurons in red nuclei","ciprofloxacine lactate (starting post-surgery, every 12hrs for 7 days, 8mg/kg);
acetaminophen (via drinking water, approx. 64mg/kg/day for 3 weeks post-injury)",(no conclusion specifically for MPSS),,MPSS used as an active control,No,
Louis,Sharma et al.,2007,Drug delivery to the spinal cord tagged with nanowire enhances neuroprotective efficacy and functional recovery following trauma to the rat spinal cord.,10.1196/annals.1403.014,English,"Sweden, United States, India",excluded,Out of scope,No drug of interest,"No drug of interest (proprietary compounds from pharmaceutical company, details on compounds cannot be identified)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,De La Torre et al.,1975,Pharmacologic treatment and evaluation of permanent experimental spinal cord trauma,10.1212/wnl.25.6.508,English,United States,included,,,,,,dogs,Beagle,32,8,,,8,,,,all female,female,0,not reported,,,,,,Not reported,8kg to 11kg,,,8,11,kg,,contusion injury at T11,T11,Not reported,contusion,"lead cylinder (8mm diameter, 20g weight) dropped from 25cm resulting in 500g/cm force at impact",90 days,mannitol,mannitol,,"1mg/kg, 0.75mg/kg","1hr post-injury (1mg/kg), 16hrs post-injury (0.75mg/kg)",,2 doses,,intravenously,,"functional;
electrophysiology","modified Tarlov scale; 
somatosensory evoked potential (SSEP)",,"locomotor function: modified Tarlov scale;
SSEP: stimulating electrode at right femoral nerve, recording electrode on somatosensory cortex at midline","locomotor function: daily for 90 days post-injury;
SSEP: pre-injury and 30min, 1/2/3/4hrs post-injury",,"locomotor: yes;
SSEP: not reported",no stats,"no difference to saline control for mannitol treatment group,
improvements of varying degree (qualitative description!) in all dogs (two fully recovered, two reflex standing, three w/ muscle tone) in dexamethasone treatment group;
results for SSEP not discussed by treatment group but generally good correlation between presence of SSEP and eventual (partial) recovery observed across all groups",histopathology,"Nissl stain, hematoxylin and eosin stain",90 days post-injury,not reported,no effect,"no detailed reporting of results for individual treatment groups;
large central cavity near lesion site observed across all groups;
axonal shrinkage in mannitol and dexamethasone treatment groups comparable to saline controls","cephaloridine (250mg, post-operatively);
Bacitracin (30cc of 10'000U, subcutaneously);
oxytreacycline and hydrocortisone ointment (no dose reported, topical application to back)","dexamethasone shows some potential in reversing paralysis following SCI, no benefit from mannitol treatment; 
o/w focus on dimethyl sulfoxide (DMSO) as this provides greatest benefits",,,No,
Louis,De La Torre et al.,1975,Pharmacologic treatment and evaluation of permanent experimental spinal cord trauma,10.1212/wnl.25.6.508,English,United States,included,,,,,,dogs,Beagle,32,8,,,8,,,,all female,female,0,not reported,,,,,,Not reported,8kg to 11kg,,,8,11,kg,,contusion injury at T11,T11,Not reported,contusion,"lead cylinder (8mm diameter, 20g weight) dropped from 25cm resulting in 500g/cm force at impact",90 days,dexamethasone,dexamethasone,,0.75mg/kg,1hr post-injury,,1 dose,,intramuscular,,"functional;
electrophysiology","modified Tarlov scale; 
somatosensory evoked potential (SSEP)",,"locomotor function: modified Tarlov scale;
SSEP: stimulating electrode at right femoral nerve, recording electrode on somatosensory cortex at midline","locomotor function: daily for 90 days post-injury;
SSEP: pre-injury and 30min, 1/2/3/4hrs post-injury",,"locomotor: yes;
SSEP: not reported",no stats,"no difference to saline control for mannitol treatment group,
improvements of varying degree (qualitative description!) in all dogs (two fully recovered, two reflex standing, three w/ muscle tone) in dexamethasone treatment group;
results for SSEP not discussed by treatment group but generally good correlation between presence of SSEP and eventual (partial) recovery observed across all groups",histopathology,"Nissl stain, hematoxylin and eosin stain",90 days post-injury,not reported,no effect,"no detailed reporting of results for individual treatment groups;
large central cavity near lesion site observed across all groups;
axonal shrinkage in mannitol and dexamethasone treatment groups comparable to saline controls","cephaloridine (250mg, post-operatively);
Bacitracin (30cc of 10'000U, subcutaneously);
oxytreacycline and hydrocortisone ointment (no dose reported, topical application to back)","dexamethasone shows some potential in reversing paralysis following SCI, no benefit from mannitol treatment; 
o/w focus on dimethyl sulfoxide (DMSO) as this provides greatest benefits",,,No,
Louis,Yates et al.,2014,Effects of methylprednisolone and 4-chloro-3-hydroxyanthranilic acid in experimental spinal cord injury in the guinea pig appear to be mediated by different and potentially complementary mechanisms,10.1038/sc.2014.118,English,United States,included,,,,,,guinea pig,Hartley,106 - 148,47 - 68,,,47 - 68,,,based on Table 1 but not entirely clear if counts are distinct animals,all female,female,0,not reported,,,,,,Not reported,460g (105),460,105,,,g,,compression injury at T12,T12,Not reported,compression,spinal cord compressed to 1.2mm across 5mm for 15s,12 days,methylprednisolone,methylprednisolone,,"group 1: 60mg/kg and 30mg/kg
group 2: 30mg/kg and 15mg/kg
group 3: 60mg/kg
group 4: 60mg/kg","group 1, group 2: 30min (higher dose) and 2/4/6hrs (lower dose) post-injury
group 3: 5hrs post-injury
group 4: 10hrs post-injury",,"group 1, group 2: 4 doses
group 3, group 4: 1 dose",,intraperitoneally,,"functional;
electrophysiology","toe spread, proprioceptive placing response;
somatosensory evoked potential (SSEP)",,"locomotor function: toe-spread and proprioceptive placing response (toe spread via rapid turn of animal, proprioceptive via manual extension of hind limb);
sensory function: receptive field area of cutaneus trunci muscle (CTM);
SSEP: recording electrodes placed on somatosensory cortex, stimulation via electrodes placed over calcaneus bone and half way up tibia","functional: 5hrs, days 1, 2, 3, 7 and 12 post-injury;
SSEP: pre-injury, 1h, days 1 and 12 post-injury",,not reported for any of the assessment,mixed effects (dosage) + mixed effects (assessment),"higher MP dose, multiple dose regime resulted in significantly better functional recovery and reduction in decline of receptive field area for CTM reflex;
no effect on electrophysiology (no difference to pre-injury amplitude in SSEP);
single dose MP regime at 5hrs provided benefit in reduced decline of CTM receptive field area (but only statistically significant at day 3)",,,,,,,,MP treatment can attenunate secondary injury following SCI thereby positively affecting functional recovery.,,"QUIN (quinolic acid, neurotoxin) levels analysed as this is suspected to be involved in secondary injury; assessment not relevant for categories in this table but potentially interesting.",No,
Louis,Flamm et al.,1982,Experimental spinal cord injury: Treatment with naloxone,10.1227/00006123-198202000-00009,English,United States,included,,,,,,cats,Mongrel,28,10,,,18,,,,not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,not reported,contusion injury at T9,T9,Not reported,contusion,"20g weight dropped from 20cm, resulting in 400g-cm impact force",3 months - 6 months,naloxone,naloxone,,"group 1, group 2, group 3: 10mg/kg
group 4: 1mg/kg","group 1: 45min and 3hrs post-injury
group 2, group 4: 45min and 3hrs post-injury intravenuous bolus, twice daily intraperitoneal bolus for days 1 and 2 post-injury
group 3: 5hr intravenenous infusion beginning 45min post-injury, bolus twice daily for days 1 and 2 post-injury",,"group 1: 2 doses
group 2, group 3, group 4: 2 days","group 2, group 3, group 4: twice daily",intraperitoneally,,"functional;
sensory;
electrophysiology",categorisation of walking ability (paraplegia/poor walker/walker); somatosensory evoked potentials (SSEP),,"sensory assessments not reported as results difficult to interpret;SSEP: stimulation via sciatic nerve, recording at contralateral somatosensory cortex","functional: weekly for 3 to 6 months post-injury;
sensory: not reported;
electrophysiology: pre-injury, hourly for 5hrs post-injury, day 3 post-injury, weekly for 3 to 6 months weeks post-injury",,"functional: yes;
sensory: not reported;
electrophysiology:",no stats,"high bolus dose (regardless of route of administration) provide beneficial effect w.r.t. recovery of walking function;
only one animal recovered w/ initial infusion, lower dose regime had no effect on recovery;
electrophysiological response present at 24hrs post-injury for high-dose bolus treatment groups, lost intermittently but recovered in all animals regaining some walking function",,,,,,,"penicillin, chloramphenicol (post-operative,
no dose or route reported)",High dose naloxone treatment following SCI can enable long-term functional recovery and help preserve neurologic function as measured by SSEPs. ,,,No,
Louis,"Wallace, Tator",1986,Failure of naloxone to improve spinal cord blood flow and cardiac output after spinal cord injury,10.1227/00006123-198604000-00006,English,Canada,included,,,,,,rats,Wistar,14,7,,,7,,,,all female,female,0,not reported,,,,,,Not reported,198g to 231g,,,198,231,g,,compression injury at T1,T1,Not reported,compression,compression clip w/ 50g closing force applied for 1min,1 hour,naloxone,naloxone,,"10mg/kg (bolus), 2mg/kg/hr (infusion)","bolus at 20min post-injury, infusion for 1hr following directly after bolus",,1 hour,,intravenously,,physiology,spinal cord blood flow (SCBF),,SCBF determined using radioactively labelled microspheres,"initial injection of microspheres at 15min post-injury, second injection of microspheres at end of naloxone infusion (1h20min post-injury)",,not reported,no effect,no statistically significant effect of naloxone treatment on SCBF,,,,,,,,Naloxone treatment does not appear to improve post-traumatic systemic hypotension and/or spinal cord ischemia.,,,No,
Louis,"Wallace, Tator",1986,Failure of blood transfusion or naloxone to improve clinical recovery after experimental spinal cord injury,10.1227/00006123-198610000-00001,English,Canada,included,,,,,,rats,Wistar,30,10,,,10,,,,all female,female,0,not reported,,,,,,Not reported,280g to 330g,,,280,330,g,,compression injury at T1,T1,Not reported,compression,compression clip w/ 50g closing force applied for 1min,15 weeks,naloxone,naloxone,,"10mg/kg (bolus), 2mg/kg/hr (infusion)","bolus at 15min post-injury, infusion for 2hrs following bolus dose",,2 hours,,intravenously,,functional,inclined plane test,,inclined plane test,weekly for 15 weeks post-injury,,not reported,no effect,note that authors refer to Fig. 2 but there seems to be an error in the print -- Fig. 2 is copy of Fig. 1; discussion of inclined plane test results in text very limited but states that P > 0.05,histopathology,"luxol fast blue, hematoxylin and eosin stain",week 15 post-injury,not reported,no effect,consistent severe injury across all groups (different treatments and control),,No significant effect of naloxone treatment on clinical recovery or histopathology (see Table 3).,,,No,
Louis,"Liu, Bao",2015,"HYDROGEN PEROXIDE ADMINISTERED INTO THE RAT SPINAL CORD AT THE LEVEL ELEVATED BY CONTUSION SPINAL CORD INJURY OXIDIZES PROTEINS, DNA AND MEMBRANE PHOSPHOLIPIDS, AND INDUCES CELL DEATH: ATTENUATION BY A METALLOPORPHYRIN",10.1016/j.neuroscience.2014.10.063,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (hydrogen peroxide only used to induce SCI),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Hashimoto et al.,2007,"Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls",10.1523/JNEUROSCI.4805-06.2007,English,"Japan, United States",excluded,Out of scope,No drug tested,No drug tested (Osteopontin knock-out mice compared w/ wild type),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ziemlinska et al.,2014,Overexpression of BDNF increases excitability of the lumbar spinal network and leads to robust early locomotor recovery in completely spinalized rats,10.1371/journal.pone.0088833,English,"Poland, Germany, China",excluded,Out of scope,No drug tested,No drug tested (PBS and viral vectors to express BDNF or GFP),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Liu-Snyder et al.,2007,Neuroprotection from secondary injury by polyethylene glycol requires its internalization,10.1242/jeb.02756,English,United States,excluded,Out of scope,Ex-vivo,In-vitro results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Cho et al.,2010,Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury,10.1242/jeb.035162,English,United States,included,,,(chitosan is not on list of drugs of interest but glucosamine compound -- glucosamine is on list),,,guinea pig,Cavia porcellus,14,6,,,8,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,not reported,,,,,,not reported,compression injury in mid-thoracic region,thoracic,Not reported,compression,forceps w/ 8mm spacer closed for 15sec,2 weeks,chitosan,glucosamine,,not reported,within 30min post-injury,,1 dose,,subcutaneous,,elctrophysiology,somatosensory evoked potentials (SSEP),,"subdermal electrodes for stimulation in hindlimbs, recording electrodes on somatosensory cortex, reference electrode at ipsilateral pinna of ear ","pre-injury, post-injury but before drug administration, day 1 and week 1, week 2 post-injury ",,not reported,positive effect,normal SSEP established before injury and completely lost immediately following injury; administration of chitosan resulted in recovery of SSEPs within 30min in all treated animals remaining stable during followup; control group showed no recovery; difference in recovery statistically significant,,,,,,,,"Chitosan can immediately restore membrane integrity, act as a neuroprotective agent and clearly targets damaged tissues directly.",,majority of study focuses on ex-vivo experiments and conclusions largely based on this; results appear suspiciously clean,No,
Louis,Stampas et al.,2020,The first 24 h: opioid administration in people with spinal cord injury and neurologic recovery,10.1038/s41393-020-0483-x,English,"United States, Canada",excluded,Out of scope,No control group,No control group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zadeh-Ardabili et al.,2017,Palm Vitamin E reduces locomotor dysfunction and morphological changes induced by spinal cord injury and protects against oxidative damage,10.1038/s41598-017-14765-3,English,"Malaysia, Iran",included,,,,,,rats,Sprague Dawley,72,30,,,30,,,,all male,male,0,8 weeks,,,8,8,Weeks,,200g to 300g,,,200,300,g,,compression injury at T12,T12,mild,compression,mild (30% to 33% compression); stopper forceps applied for 20s,4 weeks,vitamin E (from palm oil),vitamin e,,100mg/kg,not reported,,28 days,daily,oral,administered via esophageal feeding tube,functional,BBB locomotor scale,,BBB locomotor scale,"pre-injury, post-injury days 1, 3, 7, 14, 21, 28",,not reported,positive effect,statistically significantly higher BBB score in SCI + vitamin E group from day 14 onwards compared to SCI-only group,histopathology,"hematoxylin and eosin stain, lesion volume estimated via assessor drawn injury border and automatic image processing","days 3, 7, 14, 21, 28 post-injury",not reported,positive effect,"statistically significant reduction in lesion size for treated SCI group on days 14, 21, 28 post-injury (Figure 2A), potentially also on day 7 while larger lesion size in treated SCI group on day 3 post-injury (Fig 4C)","topical antibiotic (not further specified) applied to incision site; 5% Baytril (intraperitoneal, 2mg/kg/day for one week post-surgery); buprenorphine (5ug/kg, every 8hrs, as required - unclear what this means, how long treatment lasted)",Palm vitamin E shows anti-trauma (?) and antioxidant properties resulting in reduced lesion size and improved locomotor function.,,significant difference in BBB locomotor scale reported but Fig. 2 shows mostly overlapping CIs so not entirely sure; incosistency between Figure content and caption (Fig 2),No,
Louis,Murray et al.,2010,Recovery of motoneuron and locomotor function after spinal cord injury depends on constitutive activity in 5-HT<inf>2C</inf> receptors,10.1038/nm.2160,English,"Canada, United States",excluded,Out of scope,No control group,"Chronic SCI population in humans w/o control, S2 injury in rats, in-vitro experiments",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gok et al.,2009,Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G,10.1016/j.jocn.2008.04.024,English,"Turkey, United States",included,,,,,,rats,Wistar,32,8,,,8,,,assumes equal distribution of animals between experimental groups,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 250g,,,210,250,g,,contusion injury between T7 and T9,T7 - T9,Not reported,contusion,"weight drop model, impact force of 50g/cm",24 hours,albumin,albumin,,400mg/kg of 25% human albumin;,immediately post-injury,,1 dose,,intraperitoneally,,functional,"BBB locomotor scale, inclined plane test",,"BBB locomotor scale, inclined plane test",24hrs post-injury,,Yes,no effect,,histopathology,"staining w/ uranyl acetate and lead citrate,
assessed via transmission electron microscopy",24hrs post-injury,Yes,no effect,,,"IgG treatment after SCI results in better functional outcomes
and improved outcomes for histological and biochemical markers.",,,No,
Louis,Gok et al.,2009,Immunomodulation of acute experimental spinal cord injury with human immunoglobulin G,10.1016/j.jocn.2008.04.024,English,"Turkey, United States",included,,,,,,rats,Wistar,32,8,,,8,,,assumes equal distribution of animals between experimental groups,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 250g,,,210,250,g,,contusion injury between T7 and T9,T7 - T9,Not reported,contusion,"weight drop model, impact force of 50g/cm",24 hours,immunoglobulin G,immune globulin,,400mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,functional,"BBB locomotor scale, inclined plane test",,"BBB locomotor scale, inclined plane test",24hrs post-injury,,Yes,positive effect,IgG treatment results in significantly increased angle for inclined plane test and improved BBB score,histopathology,"staining w/ uranyl acetate and lead citrate,
assessed via transmission electron microscopy",24hrs post-injury,Yes,positive effect,treatment with (human) IgG result in lower histological and biochemical markers of neurological injury,,"IgG treatment after SCI results in better functional outcomes
and improved outcomes for histological and biochemical markers.",,,No,
Louis,Khajoueinejad et al.,2019,Immunomodulatory effects of Calcitriol in acute spinal cord injury in rats,10.1016/j.intimp.2019.105726,English,Iran,included,,,,,,rats,Sprague Dawley,36,12,,,12,,,,all female,female,0,11 weeks,,,11,11,Weeks,,not reported,,,,,,not reported,contusion injury at T9/10,T9 - T10,Not reported,contusion,"weight drop model, 10g weight dropped from 12.5mm",12 weeks,calcitriol,calcitriol,,1microgram/kg,days 1 to 7 post-injury,,7 days,daily,intraperitoneally,,functional,BBB locomotor scale,,BBB locomotor scale,"days 2 and 7 post-injury, then weekly for weeks 2 to 12 post-injury",,Yes,positive effect,"statistically significant improvement for treatment group
in BBB score at weeks 2 to 4 and weeks 8 to 12",histopathology,"luxol fast blue and cresyl violet stain,
hematoxylin and eosin stain",week 12 post-injury,Not reported,mixed effects,"no effect on cavity size, small positive effect (higher count) on motoneurons in ventral horn at and immediately adjacent to lesion centre;
reduced infiltration by leukocytes in treatment group ","cefazolin (50mg/kg, daily, days 1 to 7 post-injury)",Calcitriol can provide neuroprotective effects after SCI as indicated by reduced leukocyte infiltration and improved functional outcomes.,,,No,
Louis,Pinkernelle et al.,2013,Prolonged Minocycline Treatment Impairs Motor Neuronal Survival and Glial Function in Organotypic Rat Spinal Cord Cultures,10.1371/journal.pone.0073422,English,Germany,excluded,Out of scope,Ex-vivo,In-vitro/cell culture results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Sandrow-Feinberg et al.,2010,PEGylated interferon-Œ≤ modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury,10.1016/j.expneurol.2010.01.009,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (PEG-ylated Interferon-beta),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kim et al.,2013,Inosine enhances axon sprouting and motor recovery after spinal cord injury,10.1371/journal.pone.0081948,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (inosine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Askarifirouzjaei et al.,2019,Implications of immunotherapy with high-dose glatiramer acetate in acute phase of spinal cord injury in rats,10.1080/08923973.2019.1566362,English,Iran,excluded,Out of scope,No drug of interest,No drug of interest (glatiramer acetate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Lim et al.,2013,Improved outcome after spinal cord compression injury in mice treated with docosahexaenoic acid,10.1016/j.expneurol.2012.09.015,English,"United Kingdom, Taiwan, United States",included,,,,,,mice,C57BL/6,57,14,,,26,,,,all female,female,0,not reported,,,,,,Not reported,19g to 21g,,,19,21,g,,compression injury at T12 (vertebra level),T12,moderate,compression,10g weight applied via 2mm by 1.5mm platform for 5min,4 weeks,docosahexaenoic acid,omega 3,,"group 1: bolus only at 100nmol/kg, 250nmol/kg, 500nmol/kg
group 2: 500 nmol/kg (+ control diet)
group 3: (saline +) 400mg/kg/day (dietary supplement)
group 4: 500 nmol/kg + 400mg/kg/day (dietary supplement)",30min post-injury,,"group 1, 2: 1 dose
group 3: 4 weeks
group 4: 1 dose, 4 weeks","group 3, group 4: daily",intravenously,,functional,Basso mouse scale,,Basso mouse scale incl. subscores,"daily for first week post-injury,
then daily or every three days for weeks two to four post-injury",,Yes,mixed effects (dosage) + mixed effects (regime),"higher DHA doses (250, 500) provide show statistically significant improvement in BMS;
DHA bolus injection alone or in combination results in statistically significantly better recovery of locomotor function; small but not statistically significant positive effect of DHA enriched diet in addition to bolus dose compared to bolus dose only;
no benefit from DHA enriched diet alone",immunohistochemistry,"primary Ab for mouse NeuN (neuronal survival),
mouse APC (oligodendrocyte survival), mouse SMI32 (non-phosphorylated 200kd neurofilament),
rabbit Iba1 (microglia and macrophages); additional staining w/ bis-benzymide (Hoechst) for nucleus detection","days 1, 3, 7 and 28 post-injury",Not reported,positive effect,"statistically singificant increase in neuron survival (NeuN positive cells) at day 28, approaching levels of uninjured control in dorsal horn, for both groups receiving DHA bolus;
similar observations for oligodendrocyte survival (APC positive cells) but not approaching normal levels;
similar observations for neurofilament protection (SMI32  positive axons);
similar observations for reduction in microglia/macrophage activation (statistically significantly fewer active microglia/macrophage in either DHA bolus injection group, possibly some positive effect of DHA diet alone in some regions (ventral white matter))","buprenorphine (0.12mg/kg, post-surgery, intramuscularly)","neuroprotective effect of DHA injections post-injury confirmed but no statistically significant benefit from DHA dietary supplementation while DHA diet independently does not provide benefit;
early increase to high levels of effective DHA might be required for treatment to be effective as dietary supplement alone only slowly raises effective DHA levels reducing its beneficial effect",potentially period of study for DHA dietary supplement too short to detect significant effect,docosahexaenoic acid is not on list of drugs of interest but an omega 3 fatty acid; omega 3 is on list of drugs of interest,No,
Louis,Vogelaar et al.,2015,Pharmacological suppression of CNS scarring by deferoxamine reduces lesion volume and increases regeneration in an in vitro model for astroglial-fibrotic scarring and in rat spinal cord injury in vivo,10.1371/journal.pone.0134371,English,Germany,excluded,Out of scope,No drug of interest,No drug of interest (deferoxamine mesylate); in-vitro results only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,n,,,,,,,,,,,,,,,,,
Louis,Popovich et al.,2014,Independent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury,10.1016/j.expneurol.2014.06.020,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (Taxol/paclitaxel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Popovich et al.,2012,Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injury,10.1016/j.expneurol.2010.11.016,English,United States,included,,,,,,rats,Long Evans,>= 77,>= 10,,,>= 10,,,,all female,female,0,approx. 10 weeks,10,,,,Weeks,,247g (8),247,8,,,g,,"group 1: unilateral contusion injury at C5
group 2, group 3: unilateral contusion injury at C6",C5 - C6,moderate,contusion,"group 1: impactor (1.5mm, 10g) dropped from 25mm, placement of impactor tip at approx. 0.3mm from midline to achieve unilateral injury
group 2, group 3: impactor (10g) dropped from 25mm, placement at 5 degree angle to dorso-ventral axis",7 days,glibenclamide,glibenclamide,,"group 1: 200ng/h infusion
group 2, group 3: 10ug/kg loading, 200ng/h infusion","group 1: starting 2-3min post-injury
group 2, group 3: loading dose immediately post-injury, infusion starting 2-3min post-injury",,"group 1: continuous
group 2, group 3: 1 dose, continuous",,multiple,"infusion: subcutaneous
bolus: intraperitoneal",functional,"inclined plane test, paw placement, rearing, inclined plane test, paw placement, BBB locomotor scale",,"group 1: inclined plane test, paw placement, rearing;
group 2: none;
group 3 : inclined plane test, paw placement, BBB locomotor scale;
total no. of forelimb paw placements and duration of rearing recorded from video playback","group 1: 24hrs post-injury
group 2: n.a.
group 3: 24hrs, day 3 and 7 post-injury",,Yes,mixed effects (regime),"i) no effect on acute functional recovery (up to 24hrs post-injury)
ii) n.a.
iii) significant improvement in BBB score at 24hrs for treatment group, significant improvement in inclined plane test between days 1 and 7 (but unclear if significant results also applies to between group comparison)","group 1, group 2: hemorrhage
group 3: hemorrhage, histology","group 1: spectrophotometric assessment using Drabkin's reagent
group 2: manual analysis of scanned images from slices of spinal cord
group 3: manual analysis of scanned images, staining with eriochrome cyanine and cresyl violet","group 1: 6hrs, 12hrs, 24hrs post-injury
group 2: not reported explicitly
group 3: 24hrs and day 7 post-injury",Not reported,mixed effects,"group 1: no difference between treatment and control
group 2: no detailed results reported
group 3: significant attenuation of acute hemorrhage in treatment group, statistically significant reduction in lesion size at day 7 for treatment group",,results from previous study showing positive effect of glibenclamide on acute hemorrhage after SCI,"exact mechanism/type of injury is critical to show these effects (see Figs. 3 and 4);
high variability in functional assessment data (combined w/ small group sizes!)","Glibenclamide (drug assessed) not on list, but also known as glyburide which is on list;
relatively brief description of experimental protocol beyond SCI in experiment iii) -- extraction based on assumption that protocol remained unchanged from ii);
very small sample sizes for experiment iii) (at most 2 animals per assessment)",No,
Louis,"Pukos, McTigue",2020,Delayed short-term tamoxifen treatment does not promote remyelination or neuron sparing after spinal cord injury,10.1371/journal.pone.0235232,English,United States,included,,,,,,mice,C57BL/6,36,17,,,19,,,,"female: 19, male: 17",mixed,47,12 weeks,12,,,,Weeks,,not reported,,,,,,not reported,contusion injury at T9,T9,moderate,contusion,"moderate severity (75 kDyne impact force), Infinite Horizon device",6 weeks,"tamoxifen (dissolved in corn oil, corn oil as control)",tamoxifen,,300mg/kg,days 19 to 22 post-injury,,4 doses,daily,oral,,functional,Basso mouse scale; horizontal ladder walk test; gross motor activity (activity box),,"Basso mouse scale: assessed by two independent raters; horizontal ladder: automated count of missteps, average of three complete trials reported; gross motor activity: assessed using ""activity box"" for 10 minutes","Basso mouse scale and horizontal ladder: days 1, 7, 14, 21, 28, 35, 42 post-injury; gross motor activity: days 1, 8, 15, 22, 29, 36, 41 post-injury; both: 1 week pre-injury",,Yes,no effect,"no effect in treatment group, any recovery observed occurred before treatment/control was administered","histopathology;
immunohistochemistry","histopathology: stain for myelin using toluidine blue/borax to assess white matter sparing;
immunohistochemistry: primary Ab for NeuN, GAP-43, NF-H, GST-pi, CD68, GFAP, NG2, Kv1.2, Caspr to assess total axon counts, neuronal survival, quantity of Nodes of Ranvier, proliferating cell and oligodendrocyte count",day 42 post-injury,Yes,no effect,"no effect on lesion size or neuron/axon loss/survival,
no effect on proliferating cell count or oligodendrocyte count",,Short-term delayed administration of tamoxifen has no effect on recovery after SCI. ,,Difference between male/female mice considered but none observed.,No,
Louis,Durham-Lee et al.,2012,Induction of angiopoietin-2 after spinal cord injury,10.1016/j.neuroscience.2011.09.058,English,United States,included,,,,,,rats,Sprague Dawley,97 - 128,45 - 59,,,43 - 60,,,,all male,male,100,not reported,,,,,,Not reported,225g to 250g,,,225,250,g,,contusion injury at T10,T10,moderate,contusion,"moderate severity (150 kDyne impact force), Infinite Horizon device",10 weeks,amiloride,amiloride,,5mg/kg (days 1 to 10) and 10mg/kg (days 11 to 35),beginning 24hrs post-injury days 1 to 35 post-injury ,,5 weeks,daily,intraperitoneally,,functional,BBB locomotor scale,,,"daily for days 1 to 14 post-injury, then weekly until day 35 post-injury ",,Not reported,positive effect,"statistically significant improvement in avg. BBB scores for treatment group on days 21, 28 and 35 post-injury",immunohistochemistry,"primary Ab for Ang-1 and Ang-2, anti-RECA-1, endothelial cell antigen, GFAP, NG2, APC; DAPI stain","24hrs post-injury, days 3, 7, 14, 21, 35 post-injury",Not reported,positive effect,amiloride treatment is associated w/ increased Ang-2 levels (statistically significant at day 35 post-injury) and correlates with statistically significant improved locomotor recovery (Fig 4),"buprenorphine (0.1 mg/kg, twice daily for days  1 to 3 post-injury, subcutaneously), Baytril (2.7mg/kg, twice daily, day 1 post-injury until return of bladder function",treatments benefitting angiogenesis show potential in improving recovery after SCI,,,No,
Louis,Francos-Quijorna et al.,2017,"Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury",10.1523/JNEUROSCI.1395-17.2017,English,"Spain, Germany, United States, Canada",excluded,Out of scope,No drug of interest,"No drug of interest (Maresin 1, MaR1)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Chedly et al.,2017,Physical chitosan microhydrogels as scaffolds for spinal cord injury restoration and axon regeneration,10.1016/j.biomaterials.2017.05.024,English,France,excluded,Out of scope,No drug of interest,No drug of interest (chitosan hydrogel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Perez-Espejo et al.,1996,"The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: A qualitative experimental study",10.1016/S0090-3019(96)00200-5,English,United States,included,,,,,,rats,Sprague Dawley,39,9,,,10,,,,all male,male,100,not reported,,,,,,Not reported,465g to 585g,,,465,585,g,,compression injury at T10/T11,T10 - T11,Not reported,compression,45g weight applied via 4mm by 4mm compression device for 1min,4 weeks,methylprednisolone,methylprednisolone,No,30mg/kg,immediately post-injury,,1 dose,,intraperitoneally,,"functional;
electrophysiological","inclined plane test, toe spread, modified Tarlov scale,
cortical somatosensory evoked potentials",,"inclined plane test, toe spreading and modified Tarlov scale;
active needle electrod on midscalp, reference electrode at hard palate, stimulation via two needle electrodes on plantar surface of right hind paw","days 3, 5, 7, 14, 21, 28 post-injury;
pre-injury, day 28 post-injury",Yes,Yes,mixed (stats/no stats),"statistically significant improvement in inclined plane test and modified Tarlov scale for MP treatment group, no statistically significant change in toe spreading;
no quantitative comparison between MP treatment and control group for evoked potentials but some recovery in treatment group observed","histopathology,
immunohistochemistry","light and electron microscopy (hematoxylin and eosin stain), quantitative analysis via pixel count from sectioned image, 
mouse antibeta tubulin and IgG",day 28 post-injury,Not reported,mixed effects,"unclear if any result is statistically significant; 
reduction in lesion size for MP treatment group, no effect on immunofluorescence","ampicillin (50mg/kg, pre-injury, every 6hrs for 24hrs post-injury, intramuscularly),
buprenorphine (0.01mg/kg, post-injury, subcutaneously)",single mega-dose bolus injection of MP can have beneficial effect on recovery after SCI,,,No,
Louis,Patel et al.,2017,Pioglitazone treatment following spinal cord injury maintains acute mitochondrial integrity and increases chronic tissue sparing and functional recovery,10.1016/j.expneurol.2017.03.021,English,United States,included,,,,,,mice,C57BL/6,64,19,,,29,,,One animal died but not specified which group this belonged to.,all male,male,100,not reported,,,,,,Not reported,not reported,,,,,,not reported,contusion injury at T9,T9,severe,contusion,"severe injury (75 kdyn impact force), Infinite Horizon impactor",4 weeks,pioglitazone,pioglitazone,,10mg/kg,"15min post-injury, post-injury days 1 to 5",,5 days,daily,intraperitoneally,,functional,"Basso mouse scale (BMS), gridwalk test",,"Basso mouse scale: assessed by two researchers independently; gridwalk test: training of mice pre-injury, min. three passes recorded and results from best run (least slips) reported","pre-injury, days 1, 3, 7, 14, 21, 28 post-injury for Basso mouse scale; day 28 post-injury for gridwalk",,Not reported,positive effect,"statistically significant improvement in locomotor function for treatment group starting from day 7 post-injury (increased BMS score),
statistically significant increase in BMS subscore at day 28 post-injury and reduction in number of footfalls at day 28 post-injury","histopathology,
immunohistochemistry","Eriochrome Cyanine stain for assessment of white and grey matter preservation;
primary Ab for ionized calcium-binding adapter molecule 1 (IBA-1) and glial fibrillary acidic protein (GFAP), size of stained regions vs. entire section assessed","not exactly reported, presumably day 28 post-injury",Yes,mixed effects,"statistically significant increase in spared tissue (both grey and white matter) for treatment group;
no difference in effect on microglia/macrophages","enrofloxacin (Baytril; 2.5ml/kg, subcutaneously, daily following administration of pioglitazone, days 1 to 5 post-injury)",treatment group shows significantly improved hindlimb motor recovery throughout the post-injury period and at terminal assessments,,relatively high number of mice died (8 of 30) for long-term behavioral assessments,No,
Louis,Nash et al.,2002,Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord,10.1523/jneurosci.22-16-07111.2002,English,United States,included,,,,,,rats,Sprague Dawley,61,10,,,10,,,,not reported,not reported,,adult (no precise age reported),,,,,,Adult,300g to 400g,,,300,400,g,,transection of the dorsal corticospinal tract (CST) between C2 and C4,C2 - C4,incomplete,transection,transection of dorsal corticospinal tract,52 days,methylprednisolone (used as an active control),methylprednisolone,No,30mg/kg,"1hr post-injury, every 6hrs for 24hrs post-injury",,5 doses,,intravenously,,functional,directed forepaw reaching (DFR),,"box w/ two compartments, major compartment for animal, minor compartment w/ 14 subdivision each w/ food pellet and small hole to reach for food; animals' access to food restricted during training and assessment periods; training periods pre-surgery and post-surgery before assessments; successful attempts (reaching w/ food pellet retrieval, no dropped food pellet or similar) as fraction of total attempts reported","pre-injury, twice daily for five days in week 6 post-injury",,Not reported,positive effect,statistically significantly better performance in methylprednisolone treatment group compared to lesion-only and vehicle contol groups,histopathology,"biotin dextran tetramethylrhodamine (tracer to label CST axons caudal to the lesion site in spinal cord), total BDT labelled axons counted",day 52 post-injury,Not reported,mixed effects,improved axon count at distances close to lesion site (1mm to 7mm) but little to no axons present at distances >=10mm,"buprenorphine (0.1mg/kg, immediately post-surgery)",MP was found to promote axonal regeneration and improve functional recovery after SCI when compared with untreated rats but MP alone is not sufficient to fully restore function as assessed by DFR,,relatively high number of mice died (15 of 61) for long-term behavioral assessments; MP only used as as an active control,Yes (drug of interest + drug not of interest),
Louis,Lankhorst et al.,2000,Combined treatment with alpha MSH and methylprednisolone fails to improve functional recovery after spinal injury in the rat,10.1016/S0006-8993(00)02025-4,English,Netherlands,included,,,,,,rats,Wistar,48,12,,,12,,,assumes equal distribution of animals between experimental groups,all female,female,0,11 weeks,11,,11,11,Weeks,,200g to 240g,,,200,240,g,,moderate contusion injury at T8,T8,moderate,contusion,10g impactor dropped from 12.5mm,8 weeks,methylprednisolone (used as an active control),methylprednisolone,No,30 mg/kg,30min post-injury,Yes,1 dose,,intravenously,,"functional;
electrophysiological","BBB locomotor scale;
rubrospinal motor evoked potentials (rMEP)",,"rMEP: bipolar stimulation of red nucleus, bipolar recording via epidural electrode below T11 (no. of peaks, amplitude and latency of first positive peak, sum of all peaks)","days 1 and 7 post-injury, then weekly for weeks 2 to 8 post-injury",Yes,Yes,no effect,no effect for methylprednisolone treatment only,,,,,,,"gentamycin (twice daily, days 1 to 3 post-injury)",some small but non-significant improvements in MP-only group at later stage in recovery (day 42 post-injury onward),,,Yes (drug of interest + drug not of interest),
Louis,Li et al.,2020,Polydopamine/carboxylic graphene oxide-composited polypyrrole films for promoting adhesion and alignment of Schwann cells,10.1016/j.colsurfb.2020.110972,English,China,excluded,Out of scope,No drug of interest,"In-vitro experiments, no drug of interest (composite biofilm)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Liu et al.,2010,L-Dopa effect on frequency-dependent depression of the H-reflex in adult rats with complete spinal cord transection,10.1016/j.brainresbull.2010.07.005,English,United States,included,,,,,,rats,Sprague Dawley,56,15,,,7,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,200g to 250g,,,200,250,g,,complete transection at T8/T9,T8 - T9,complete,transection,,30 days,L-Dopa (levodopa),carbidopa levodopa,,1.4mg/kg,start of treatment post-injury not reported; treatment five days/week; no duration (no. of weeks) of treatment reported,,30 days,5 days/week,oral,,electrophysiological,frequency dependent depression (FDD) of H-reflex,,"stimulating electrode at tibial nerve beneath the cal- caneal tendon, recording electrode over the 4th and 5th interosseous muscles; amplitude (change) of H-wave measured",Not reported,,Not reported,positive effect,"preservation/restoration of FDD for H-reflex by treatment for some stimulation frequencies (5Hz, 10Hz)",,,,,,,carbidopa (1.4 mg/kg co-administered w/ L-Dopa),"L-Dopa treatment preserves/restores FDD of H-reflex, potentially via effect on organisation of spinal cord circuitry",,,No,
Louis,Yang et al.,2020,L-Theanine improves functional recovery after traumatic spinal cord injury in rats,10.1016/j.jfma.2019.11.009,English,Taiwan,included,,,,,,rats,Wistar,98,14,,,28,,,,all male,male,,approx. 3 months,3,,,,Months,,300g to 320g,,,300,320,g,,compression injury at T5 to T8,T5 - T8,Not reported,compression,aneurysm clip (closing force 55g) applied for 1min,72 hours,L-Theanine (N-ethyl-L-glutamine),glutamine,,"group 1: 10mg/kg
group 2: 30mg/kg","bolus within 60min of surgery, 6hrs and 24hrs post-injury",,3 doses,,intrathecally,,functional,"BBB locomotor scale, inclined plane test, toe-spread test, hindfoot bar grab test",,"two independent examiners;
qualitative assessment of toe spread (no spread, minimal spread w/ flaccid toes, partial spread, normal spread) and toe grab (no response, response but no grab, weak grab, normal grab and pull movement)","days 1, 4, 7, 10, 14 post-injury",,Yes,mixed effects (dosage),statistically significant improvement of performance on all functional/behavioural tests for higher does of L-Theanine (30mg/kg) at day 14 post-injury compared to SCI w/o treatment,immunohistochemistry,"ELISA w/ primary Abs for TNF-alpha, IL-1beta and IL-6",72hrs post-injury,Not reported,positive effect,"statistically significant reduction in TNF-alpha, IL-1beta, IL-6 levels for both dosing schemes
(10mg/kg significant at p < 0.01, 30mkg/kg significant at p < 0.001)",,L-Theanine treatment reduces inflammation post-injury and promotes functional recovery,"clinical efficacy (optimal dosing and treatment timing) not determined,
mechanism of function and safety in human use needs to be determined",six rats died (natural causes) during study,No,
Louis,Parker et al.,1979,Lack of functional recovery from spinal cord trauma following dimethylsulphoxide and epsilon amino caproic acid therapy in dogs,10.1016/s0034-5288(18)32844-3,English,United States,excluded,Out of scope,No drug of interest,"No drug of interest (dimethylsulphoxide, epsilon amino caproic acid)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Pannu et al.,2007,"Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury",10.1111/j.1471-4159.2006.04354.x,English,United States,included,,,,,,rats,Sprague Dawley,24,6,,,18,,,,all female,female,0,not reported,,,,,,Not reported,225g to 250g,,,225,250,g,,moderate contusion injury at T12,T12,moderate,contusion,"5g weight dropped from 8cm, impactor w/ 3mm diameter",6 weeks,Lipitor (atorvastatin),atorvastatin,,5mg/kg,"group 1: bolus 2hrs post-injury
group 2: bolus 4hrs post-injury
group 3: bolus 6hrs post-injury",,6 weeks,daily,oral,,functional,BBB locomotor scale,,assessment by two investigators,"day 3 post-injury, then weekly for weeks 2 to 6 post-injury",,Yes,positive effect,statistically significant improvement over spontaneous recovery in vehicle treated control starting from day 3 post-injury in all treatment groups,"histopathology,
immunohistochemistry","hematoxylin and eosin stain, luxol fast blue stain (myelin);
primary Ab for inducible nitiric oxide synthase (iNOS), TNF-alpha, IL-1beta, ED-1, myeloperoxidase (MPO), amyloid precursor protein (APP), glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), CD34 -- counts of immunopositive cells from sections from at least three animals averaged","24hrs post-injury, except tissue for TNF-alpha/IL-1beta analysis at 6hrs post-injury
(only for treatment group starting at 2hrs post-injury, injured control and sham)",Yes,positive effect,"significant (unclear if confirmed w/ statistical test) reduction in tissue loss and demyelination in treatment group;
reduction in infiltration by peripheral immune cells (Fig. 4), levels of pro-inflammatory markers (TNF-alpha, IL-1beta, iNOS)",none,"atorvastatin shows therapeutic potential for post-injury treatment of SCI; suspected mechanisms include prevention of blood-spinal cord-barrier breakdown and reduction in secondary injury (inflammation, neuronal apoptosis)",,,No,
Louis,Mann et al.,2010,Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury,10.1016/j.expneurol.2009.11.006,English,Canada,included,,,,,,rats,Sprague Dawley,99,25,,,20,5,,,all male,male,100,not reported,,,,,,Not reported,320g to 340g,,,320,340,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,"impactor deliviring 1.5mm displacement injury at 300m/s, peak force between 200kdyn to 260kdyn",42 days,atorvastatin,atorvastatin,,5mg/kg,bolus 1hr post-injury,,1 week,daily,oral,"group 1: holding technique using cloth wrapped around animal (significant number of animals died)
group 2: holding technique scruffing hair at neck, holding at neck
group 3: drug mixed with speical chocolate-flavored rat feed","functional,
neurological","BBB locomotor scale, 
mechanical reactivity",,mechanical reactivity using von Frey monofilaments,"BBB locomotor scale: pre-injury, days 2, 4, 7, 14, 28, 42;
mechanical reactivity: day 42 post-injury",,Yes,no effect,"group 1: no difference
group 2: no difference
group 3: no difference","histopathology,
immunohistochemistry","Eriochrome Cyanine (EC) for white/gray matter assessment,
Ab for ED1 for macrophage/microglia quantification",day 42 post-injury,Not reported,no effect,,"buprenorphine (0.02mg/kg, pre-injury and twice daily on days 1 and 2 post-injury, subcutaneous injection)",no consistent beneficial effect for atorvastatin or simvastatin treatment could be shown,,"Experiments i) and ii) very similar but high mortality in experiment i), holding technique for drug administration (orally in both experiments) adapted;
explicit reference to Pannu et al. (2007), paper 815 (above), questioning the strong positive results reported therein",No,
Louis,Mann et al.,2010,Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury,10.1016/j.expneurol.2009.11.006,English,Canada,included,,,,,,rats,Sprague Dawley,99,42,,,37,4,,,all male,male,100,not reported,,,,,,Not reported,320g to 340g,,,320,340,g,,contusion injury at T9/T10,T9 - T10,Not reported,contusion,"impactor deliviring 1.5mm displacement injury at 300m/s, peak force between 200kdyn to 260kdyn",45 days,simvastatin,simvastatin,,"group 1, group 2, group 3: 20mg/kg/day
group 4: 20mg/kg/day (days 1 to 3 post-injury), 5mg/kg/day (days 4 to 45 post-injury)",bolus 1hr post-injury ,,"group 1, group 2, group 3: 1 week
group 4: 45 days",daily,multiple,"group 1: holding technique using cloth wrapped around animal (significant number of animals died)
group 2: holding technique scruffing hair at neck, holding at neck
group 3: drug mixed with speical chocolate-flavored rat feed
group 4: subcutaneous","functional,
neurological","BBB locomotor scale, 
horizontal ladder test,
mechanical reactivity",,mechanical reactivity using von Frey monofilaments,"BBB locomotor scale: pre-injury, days 2, 4, 7, 14, 28, 42, 45 post-injury;
horizontal ladder test: day 45 post-injury;
mechanical reactivity: day 42 post-injury",,Yes,mixed effects (assessment) + mixed effects (regime),"group 1: statistically significant improvement for BBB scores but no effect for mechanical reactivity for 
group 2: no difference
group 3: no difference 
group 4: no difference","histopathology,
immunohistochemistry","Eriochrome Cyanine (EC) for white/gray matter assessment,
Ab for ED1 for macrophage/microglia quantification",day 42 post-injury,Not reported,mixed effects (regime),,"buprenorphine (0.02mg/kg, pre-injury and twice daily on days 1 and 2 post-injury, subcutaneous injection)",no consistent beneficial effect for atorvastatin or simvastatin treatment could be shown,,"Experiments i) and ii) very similar but high mortality in experiment i), holding technique for drug administration (orally in both experiments) adapted;
explicit reference to Pannu et al. (2007), paper 815 (above), questioning the strong positive results reported therein",No,
Louis,Takenaga et al.,2006,Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production,10.1016/j.jconrel.2005.10.022,English,Japan,excluded,Out of scope,No drug of interest,"No drug of interest (Lecithinized superoxide dismutase, PC-SOD)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,King et al.,2006,"Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat",10.1523/JNEUROSCI.5539-05.2006,English,United Kingdom,included,,,,,,rats,Wistar,55,8,,,5,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,200g to 250g,,,200,250,g,,hemisection between T7 and T9,T7 - T9,Not reported,transection,hemisection from midline to lateral edge using iris scissors,7 days,alpha-linolenic acid (AHA),omega 3,,250nmol/kg,30min post-injury,,1 dose,,intravenously,,functional,"BBB locomotor scale, beam walk test, horizontal ladder walk test",,animals habituated to test environments for one week pre-injury,"i) days 1, 3, 5, 7 post-injury
ii) day 1, weeks 1, 4, 6 post-injury",,Not reported,positive effect,statistically significantly better performance in all three tests for days 5 and 7 post-injury,"histopathology,
immunohistochemistry","Luxol fast blue,
Ab for NeuN (neurons), APC (oligodendrocytes), GFAP (astrocytes), ED1 (macrophages), oh8G (RNA/DNA oxidation)",days 7 and 42 post-injury,Not reported,positive effect,"reduced lesion size, increased number of NeuN-labelled cells (neurons)",,omega 3 fatty acids show therapeutic potential after SCI,"dosing and choice of exact compound need to be refined;
unclear what delay of treatment start and route of administration is acceptable",,No,
Louis,King et al.,2006,"Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat",10.1523/JNEUROSCI.5539-05.2006,English,United Kingdom,included,,,,,,rats,Wistar,55,19,,,21,,,,all male,male,100,adult (no precise age reported),,,,,,Adult,200g to 250g,,,200,250,g,,"group 1: hemisection between T7 and T9
group 2: compression injury at T12","group 1: T7 - T9 
group 2: T12",Not reported,multiple,,6 weeks,docosahexaenoic acid (DHA),omega 3,,250nmol/kg,30min post-injury,,1 dose,,intravenously,,functional,"BBB locomotor scale, beam walk test, horizontal ladder walk test",,"group 1: BBB locomotor scale, beam walk test, horizontal ladder walk test
group 2: BBB locomotor scale;
animals habituated to test environments for one week pre-injury","group 1: days 1, 3, 5, 7 post-injury
group 2: day 1, weeks 1, 4, 6 post-injury",,Not reported,positive effect,"group 1: statistically significantly better performance in all three tests for days 5 and 7 post-injury
group 2: statistically significantly better result in BBB scores","histopathology,
immunohistochemistry","Luxol fast blue,
Ab for NeuN (neurons), APC (oligodendrocytes), GFAP (astrocytes), ED1 (macrophages), oh8G (RNA/DNA oxidation)",days 7 and 42 post-injury,Not reported,positive effect,"reduced lesion size, increased number of NeuN-labelled cells (neurons)",,omega 3 fatty acids show therapeutic potential after SCI,"dosing and choice of exact compound need to be refined;
unclear what delay of treatment start and route of administration is acceptable",,No,
Louis,Fujimoto et al.,2000,Potent protective effects of melatonin on experimental spinal cord injury,10.1097/00007632-200004010-00003,English,Japan,included,,,,,,rats,Wistar,139,10,,,10,,,,all male,male,100,not reported,,,,,,Not reported,225g to 280g,,,225,280,g,,compression injury at T12,T12,Not reported,compression,25g weight placed on spinal cord (extradurally) for 20 min,3 weeks,melatonin,melatonin,,2.5mg/kg,"5min, 1hr, 2hrs, 3hrs, 4hrs post-injury",,5 doses,,intraperitoneally,,functional,"Tarlov motor scale, inclined plane test, footprint analysis",,max. angle which could be maintained for min. 5 sec recorded; distance between central pad of hindpaws and distance between two steps of each side recorded,"days 1, 2, 4, 7, 10, 12, 14, 16, 18, 21 post-injury for Tarlov and inclined plane; day 21 post-injury for footprint",,Yes,mixed effects (assessment),"statistically significantly improved motor function in inclined plane test, no effect in Tarlov scale or footprint analysis",histopathology,"Kluever-Barrera stain (characterisation of lesion by cyst formation, cavitation, gliosis, swollen axons; injury index (area injured/total area) calculated)",day 21 post-injury,Not reported,positive effect,statistically significantly lower injury index in melatonin treatment group,,"""Melatonin proved to be useful in preventing pathologic events associated with traumatic cord injury in rats.""",,,No,
Louis,Schiaveto-de-Souza et al.,2013,Effect of melatonin on the functional recovery from experimental traumatic compression of the spinal cord,10.1590/1414-431X20132322,English,Brasil,included,,,,,,rats,Wistar,60,20,,,20,,,,all male,male,100,not reported,,,,,,Not reported,250g to 300g,,,250,300,g,,compression injury at T9,T9,Not reported,compression,"spacer reducing average spinal canal introduced under T9 lamina
group 1: 35%, group 2: 50% ",7 weeks,melatonin,melatonin,,2.5mg/kg,"5min, 1hr, 2hrs, 3hrs, 4hrs post-injury",,5 doses,,intraperitoneally,,functional,"open field test, open field test (rearing), BBB locomotor scale, inclined plane test",,"Open field: circular box w/ 12 equal size fields, no. of fields entered and frequency of standing of hindlimbs recorded","pre-injury, days, 1, 7, 14, 21, 28, 35 post-injury",,Not reported,mixed effects (assessment) + mixed effects (regime),"no effect on no. of squares crossed in open field, statistically significant increase in rearing frequency for 35% injury group, consistently positive effect (statistically significant increase) on BBB scores in 35% injury group and positive effect on BBB scores in 50% group on days 21 and 28, statistically significant positive effect on mean max. angle in treatment groups (days 1 to 35 for 35% injury, days 28 and 35 for 50% injury)",histopathology,"cell-density quantification, NADPH-d positive neuron denstiy",day 35 post-injury,Yes,no effect,,,Melatonin provides beneficial effect on locomotor function/behavior as measured by BBB score and incline plane test; early start of treatment might be critical (but no data shown). ,,,No,
Louis,Coleman and Geisler,2004,Injury severity as primary predictor of outcome in acute spinal cord injury: Retrospective results from a large multicenter clinical trial,10.1016/j.spinee.2003.12.006,English,United States,excluded,Out of scope,No drug tested,"No drug assessed (quality of clinical attributes as features for prediction of recovery assessed, all patients received methylprednisolone but no focus on drug effect)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Gensel et al.,2017,Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment,10.1038/srep40144,English,United States,excluded,Out of scope,No assessments of interest,no functional/neurological assessment,,,mice,C57BL/6,57,,,,,,,,all female,female,0,4 months,,,4,4,Months,,not reported,,,,,,not reported,moderate to sever contusion injury at T9,T9,moderate - severe,contusion,"Infinite Horizon impactor, 75 kdyn displacement",7 days,azithromycin,azithromycin,,"group 1: 10mg/kg
group 2:  40mg/kg
group 3: 160mg/kg",30min post-injury,,7 days,daily,oral,,,,,,,,,,,immunohistochemistry,"primary Ab for CD206 (M2 macrophages), Arginase 1 (M2 macrophages), CD86 (M1 macrophages), MARCO (M1 macrophages), Iba 1, GFAP, biotynilated Tomato lection; quantification of proportional areas of macrophages",dyas 3 and 7 post-injury,Yes,mixed effects,"immunomodulation after SCI (reduction in M1 macrophage labelling, increase in M2 macrophage labelling); dose-dependent effect (all statistically significant for reduction in M1 at day 3, effect of 160mg/kg greatest; only statistically significant for M2 at day 3 for 40mg/kg, day 7 for 160mg/kg)","buprenorphine (post-surgery, 1mg/kg, subcutaneous), enrofloxacin (post-surgery and days 1 to 5 post-injury, 5mg/kg, subcutaneous)","""...findings of the current study demonstrate that azithromycin treatment, initiated after SCI, alters the macrophage response to injury.""",,Focus of study is on gene expression. Some outlier removal in statistical analysis.,No,
Louis,Karami et al.,2013,Crocin improved locomotor function and mechanical behavior in the rat model of contused spinal cord injury through decreasing calcitonin gene related peptide (CGRP),10.1016/j.phymed.2013.07.013,English,Iran,included,,,,,,rats,Wistar,25,5,,,5,,,,all female,female,0,not reported,,,,,,Not reported,200g to 250g,,,200,250,g,,contusion injury at L1,L1,Not reported,contusion,"NYU weight drop device, 10g impactor (2mm diameter) dropped from 25mm",8 weeks,ketoprofen,ketoprofen,,0.5mg/kg,day 14 post-injury,,1 dose,,intraperitoneally,,"functional,
neurological","BBB locomotor scale,
mechanical reactivity, thermal reactivity",,"mechanical reactivity: von Frey filaments, range 0.021g to 300g, mean value from five to ten repeats;
thermal reactivity: preheated plate 50 degree Celsius, latency to licking paw recorded, one trial per session, cutoff 100s","week 1 pre-injury, weeks 1 to 8 post-injury",,"BBB scale: not reported,
mech. and therm. reactivity: yes",no effect,"no effect on BBB locomotor scale,
no effect on mechanical or thermal reactivity",,,,,,,"cefazolin (days 1 to 3 post-injury, twice daily, 50mg/kg, intramuscularly)","no effect of ketoprofen (standard analgesic) on any behavioural outcome observed, incl. mechanical and thermal reactivity ",,Ketoprofen was used as active control.,No,
Louis,Zhou et al.,2020,Proanthocyanidin promotes functional recovery of spinal cord injury via inhibiting ferroptosis,10.1016/j.jchemneu.2020.101807,English,China,excluded,Out of scope,No drug of interest,No drug of interest (proanthocyanidin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kim et al.,2012,Progesterone produces antinociceptive and neuroprotective effects in rats with microinjected lysophosphatidic acid in the trigeminal nerve root,10.1186/1744-8069-8-16,English,South Korea,excluded,Non-sci population,,Trigeminal nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Tan et al.,2020,Prognosis Evaluation Using F-18-Alfatide II PET in a Rat Model of Spinal Cord Injury Treated With Estrogen,10.1177/1536012120909199,English,China,included,,,,,,rats,Sprague Dawley,45,15,,,15,,,,all male,male,100,7 weeks,7,,,,Weeks,,approx. 250g,250,,,,g,,contusion injury at T10,T10,Not reported,contusion,Allen's method (8g weight dropped from 40mm),2 weeks,estrogen (17beta-estradiol),estrogen,,25ug/kg,immediately post-injury,,3 days,twice daily,subcutaneous,,functional,BBB locomotor scale,,,"days 1, 3, 7, 14, 28 post-injury",,Yes,positive effect,statistically significantly better BBB score recvoery starting from day 3 post-injury,immunohistochemistry,"primary Ab for CD31, CD61, beta-III tubulin","days 3, 7, 14, 28 post-injury",Not reported,positive effect,"increase in both CD31 and CD61 positive cell counts (CD31 for (improved) vascular structure, CD31 and CD61 for (increased) angiogenesis)",,"Estrogen administration after SCI can promote angiogenesis, benefitting local recovery by improved blood supply. Improved functional recovery in treatment group was also observed. ",,,No,
Louis,Inoue et al.,2014,"Medical and surgical management after spinal cord injury: Vasopressor usage, early surgerys, and complications",10.1089/neu.2013.3061,English,United States,excluded,Out of scope,No control group,No control group,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Smith et al.,1995,THE POTENTIAL OF 21-AMINOSTEROIDS (LAZAROIDS) AS NEUROPROTECTIVE THERAPIES IN CNS INJURY,10.2165/00023210-199503030-00001,English,United States,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Figueroa et al.,2013,Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury,10.1016/j.neuroscience.2013.09.012,English,United States,excluded,Out of scope,No control group,Only combination of two Omega3 compounds administered.,,,rats,Sprague Dawley,42 - 62,Aug.18,,,Aug.18,,,,all female,female,0,not reported,,,,,,Not reported,not reported,,,,,,not reported,contusion injury at T9/T10,T9 - T10,Not reported,contusion,"NYU weight drop device, 10g impactor dropped from 12.5mm",8 - 12 weeks,"docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) (both omega 3 fatty acid)",omega 3,,"DHA: 12.82g per 100g, EPA: 6.91g per 100g (both part of modified rat chow)","8 weeks pre-injury, 8 weeks post-injury",,16 weeks,daily,oral,,neurological,thermal reactivity,,"baseline withdrawal latency of 12s for calibration, 20s cutoff, five repeats per trial, min. and max. latency excluded, percentage change from baseline reported","weekly until week 8 post-injury, starting once plantar paw placement re-established (no precise time reported)",,Yes,positive effect,no statistically significant difference to sham operated animals for treatment group but statistically significant difference between control diet and enriched diet,immunohistochemistry,"primary Ab for phosphorylated p38 (p-p38), NeuN, CD11b, GAP43, CGRP",week 12 post-injury,Yes,positive effect,"statistically significant reduction in p-p38 positive neurons (p-p38 implicated in nociception and neuronal hyperexcitability), CGRP and GAP43 positive sprouting nociceptive fibers","cefazolin (days 1 to 5 post-injury, 25mg/kg, subcuateneously), buprenorphine (days 1 to 3 post-injury, 0.05mg/kg, subcutaneously)","""...dietary O3PUFAs prophylaxis attenuates the development of thermal hyperalgesia following SCI...""",,8 week pre-injury treatment makes this infeasible for actual application?,,
Louis,"Ibarra, Diaz-Ruiz",2006,Protective effect of cyclosporin-A in spinal cord injury: an overview.,10.2174/092986706778201503,English,Mexico,excluded,Review,No drug of interest,No drug of interest (cyclosporin-A),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wang et al.,2015,Propofol injection combined with bone marrow mesenchymal stem cell transplantation better improves electrophysiological function in the hindlimb of rats with spinal cord injury than monotherapy,10.4103/1673-5374.155440,English,China,included,,,,,,rats,Wistar,80,20,,,20,,,,all female,female,0,4 weeks,,,4,4,Weeks,,200g to 250g,,,200,250,g,,contusion injury at T8/T9,T8 - T9,Not reported,contusion,modified Allen's method (10g weight dropped from 2.5cm),4 weeks,propofol,propofol,,2mL/kg/hr,6hrs post-injury,,4 hours,,intravenously,,"functional,
electrophysiological","BBB locomotor scale, Tarlov scale, inclined plane test;
somatosensory evoked potentials, motor evoked potentials",,"somatosensory evoked potentials: stimulating electrod on hindlimb, recording electrode under scalp at intersection of healing line of coronal and saggital suture, stimulation frequency 3Hz;
motor evoked potentials: stimulating electrode below scalp in motor cortex area, stimulation frequency 1Hz; 
both: changes in latency and amplitude of evoked potentials recorded","functional: days 1 and 3, weeks 1, 2, 3 and 4 post-injury;
evoked potentials: week 4 post-injury",,Not reported,mixed effects (assessment),"statistically significant improvement in recovery of BBB score at weeks 1 and 2, inclined plane results at day 3 and weeks 1, 2, 3, and 4 and recovery of Tarlov score at weeks 2, 3 and 4;
statistically significant recovery in evoked potentials at week 4 in propofol treatment group compared to injured control (reduced latency, increased amplitude)",immunohistochemistry,"hematoxylin and eosin stain,
horseradish peroxidase (HRP) retrograde nerve tracing (HRP administered at 4 weeks, growth for 3 days before rats were sacrificed for assessment)",week 4 post-injury,Not reported,positive effect,"reduced cavity size in propofol treatment group compared to injured control (only qualitatively reported),
statistically significant increase in number of HRP-positive nerve fibres in propofol treatment group",,"propofol treatment after SCI improves functional recovery and
positively affects evoked potentials (reduced latency, increased amplitude)",,"some potential inconsistency in how results of statistical tests are reported (Table 1) control group is sometimes reported statistically significantly different to itself;
propofol treatment only control for combined propofol and stem cell treatment",Yes (drug of interest + drug not of interest),
Louis,Whetstone et al.,2017,Protease-activated receptor-1 supports locomotor recovery by biased agonist activated protein C after contusive spinal cord injury,10.1371/journal.pone.0170512,English,"United States, Taiwan",excluded,Out of scope,No drug tested,Comparison of KO and WT mice w.r.t. proposed secondary injury mechanism,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zhang et al.,2020,Mannitol reduces spinal cord edema in rats with acute traumatic spinal cord injury,10.2174/1570180816666190731112158,English,China,included,,,,,,rats,Sprague Dawley,78,30,,,30,,,,all female,female,0,12 weeks,,,12,12,Weeks,,210g to 230g,,,210,230,g,,contusion injury at T10,T10,mild,contusion,Infinite Horizon Impactor (impact force 125kdyn),5 weeks,mannitol,mannitol,,10ml/kg of 20% mannitol,bolus immediately post-injury,,7 days,daily,intravenously,,functional,BBB locomotor scale,,"two observers, reported score averaged across all assessments for group","days 1, 7, 14, 21, 28, 35, 42 post-injury",,Yes,positive effect,statistically significantly improved recovery of BBB score in mannitol treatment group compared to injured control,histopathology,"hematoxylin and eosin stain, edema assessment via water content","H&E stain: day 7 post-injury, edema assessment: days 1, 3 and 7 post-injury",Not reported,positive effect,"reduced cavitation in mannitol treatment group (assessed qualitatively, Fig. 4), statistically significantly reduced water content in mannitol treatment groupm at days 3 and 7 post-injury","benzylpenicillin sodium (80000U/100g, daily, days 1 to 3 post-injury, intraperitoneally)",mannitol treatment can improve functional recovery and reduce edema after traumatic SCI,"small sample size, assessment of edema not continued beyond day 7 post-injury, no insights w.r.t. molecular mechanism",,No,
Louis,Yates et al.,2009,Modafinil normalized hyperreflexia after spinal transection in adult rats,10.1038/sc.2008.154,English,"United States, Japan",included,,,,,,rats,Sprague Dawley,48,16,,,16,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,200g to 300g,,,200,300,g,,transection (complete) at T10,T10,complete,transection,,30 days,modafinil,modafinil,,4mg/kg,starting on day 7 post-injury,,Not reported,Not reported,oral,,electrophysiological,assessment of H-reflex,,"reflex assessed at varying stimulation frequencies (0.2Hz, 1Hz, 5Hz, 10Hz), 0.2Hz to determine threshold and maximal response levels; first five responses for each frequency discarded, following ten responses averaged; change in response w.r.t. frequency reported as percentage change w.r.t. 0.2Hz to determine depression of H-reflex as function of stimulation freq.; amplitude of H-wave assessed",day 30 post-injury,,Not reported,positive effect,statistically signficant difference between modafinil treatment group and injured control w.r.t. reflex amplitude at varying frequencies (modafinil treatment group similar to uninjured control),,,,,,,,modafinil treatment can normalise the loss of frequency-dependent depression of H-reflex typically observed after SCI,"unclear molecular mechanism, spasticity not addressed",,No,
Louis,Blesch et al.,2001,Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression,10.1038/sj.gt.3301480,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (gene therapy via viral vector),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Erten et al.,2003,Protective effect of melatonin on experimental spinal cord ischemia,10.1038/sj.sc.3101508,English,"Turkey, United States",excluded,Out of scope,No assessments of interest,No assessment/evaluation of interest (spectrophotometrical measurements of enzyme levels),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ha et al.,2020,Protective effect of rhodioloside and bone marrow mesenchymal stem cells infected with HIF-1-expressing adenovirus on acute spinal cord injury.,10.4103/1673-5374.266920,English,China,excluded,Out of scope,No drug of interest,No drug of interest (rhodioloside and/or mesenchymal stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Bonnet et al.,2020,Motor and sensitive recovery after injection of a physically cross-linked PNIPAAm-g-PEG hydrogel in rat hemisectioned spinal cord,10.1016/j.msec.2019.110354,English,France,excluded,Out of scope,No drug of interest,No drug of interest (poly(N-iso- propylacrylamide)-poly(ethylene glycol) hydrogel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Xue et al.,2010,Improving Outcomes of Neuroprotection by Minocycline Guides from Cell Culture and Intracerebral Hemorrhage in Mice,10.2353/ajpath.2010.090361,English,Canada,excluded,Non-sci population,,Intracerebral hemorrhage or in-vitro cell culture,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Iwasa et al.,1989,Protective effect of vitamin E on spinal cord injury by compression and concurrent lipid peroxidation,10.1016/0891-5849(89)90067-1,English,Japan,included,,,,,,rats,Wistar,548,,,,,,,,all male,male,100,not reported,,,,,,Not reported,200g to 240g,,,200,240,g,,compression injury at T12,T12,Not reported,compression,"group 1: 20g weight placed on spinal cord (extradurally) for 5min
group 2: 40g weight placed on spinal cord (extradurally) for 5min",1 day,vitamin E,vitamin e,,"group 1a, group 2a: 2 IU/100g 
group 1b, group 2b: 50 IU/100g",pre-treatment for weeks 8 to 10,,,daily,oral,via supplemented rat chow,"functional,
electrophysiological,
physiological","Tarlov scale;
spinal cord evoked potentials (SCEPs);
spinal cord blood flow (SCBF)",,"SCEPs: recording electrode placed on posteromedial surface at C2/C3, 
stimulating electrode place on posteromedial surface at L1, stimulation frequency 6Hz;
SCBF: hydrogen gas clearing method","Tarlov scale: days 1 to 7 post-injury;
SCEPs: before, during and after injury;
SCBF: before, during injury and in 30min intervals for 6hrs post-injury ",,Not reported,positive effect,"statistically significantly higher Tarlov scale scores for treatment group regardless of weight applied during injury;
SCEPs partially recovered to pre-injury state in treatment group regardless of weight applied, partially recovered in control group for injury induced w/ 20g but less compared to treatment group;
SCBF statistically significantly increased in treatment group (throughout recording period for 20g injury, beginning 3.5hrs post-injury in 40g injury)",histopathology,"hematoxylin and eosin staining,
relative size of area of bleeding to area of spinal cord saggital section calculated",6hr post-injury,Not reported,positive effect,"statistically significantly lower bleeding index (i.e. area of spinal cord 
affected by bleeding) in treatment group in both injury severities;
reduced cavitation and demyelination at day 7 post-injury reported but no data shown",p,pretreatment with vitamin E before SCI has positive effect in preventing motor disturbance and tissue damage post-injury,,,No,
Louis,Stys,1995,Protective effects of antiarrhythmic agents against anoxic injury in CNS white matter,10.1038/jcbfm.1995.53,English,Canada,excluded,Non-sci population,,Optic nerve injury studied in-vitro,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Reece et al.,2008,Early adenosine receptor activation ameliorates spinal cord reperfusion injury,10.2459/JCM.0b013e3282eee836,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (ATL-146e -- adenosine receptor agonist),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al.,2007,Protective effects of brain-derived neurotrophic factor gene-modified human umbilical cord blood stem cells on spinal cord injury following transplantation,https://caod.oriprobe.com/articles/12708450/Protective_effects_of_brain_derived_neurotrophic_factor_gene_modified_.html,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (brain-derived neurotrophic factor (BDNF) gene-modified human umbilical cord blood stem cells (HUCBSCs)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Sengelaub et al.,2018,Protective Effects of Estradiol and Dihydrotestosterone following Spinal Cord Injury,10.1089/neu.2017.5329,English,United States,included,,,,,,rats,Sprague Dawley,47,05.Nov,,,06.Jul,,,,all female,female,0,approx. 12 weeks,12,,,,,Adult,Not reported,,,,,,not reported,contusion injury at T9,T9,severe,contusion,"NYU impactor device, 10g impactor dropped from 25mm",4 weeks,estradiol,estradiol,,"no exact dosing information, implant size/weight chosen to achieve maximal physiologically normal levels",implants to deliver hormone(s) applied immediately post-injury,,4 weeks,continuous,subcutaneous,,"functional,
physiological","BBB locomotor scale;
micturition (voiding behaviour)",,"BBB: two observers;
micturition: metabolic cage w/ free access to food and water for 16hrs, voiding assessed for volume and frequency by computerized system ","BBB: weeks 1, 2, 3, 4 post-injury;
micturition: week 3 post-injury",,"BBB: yes;
micturition: not applicable",mixed effects (assessment),"no effect on BBB locomotor scale results (all treatment regimes);
positive effect on voiding behaviour: single hormone treatment statistically significantly increased voiding frequency and reduced volume of individual voids compared to untreated control but still worse than uninjured control, combined hormone treatment resulted in voiding frequency and individual volumes resembling normal behaviour (frequent voiding w/ little volume)",histopathology,Luxol fast blue and cresyl violet and eosin stain (lesion volume and extent assessment via percent volume of spared grey and white matter and overall tissue),,,mixed effects,treatment w/ only estradiol resulted in reduced lesion volume (statistically significant) and increased spared tissue volume (statistically significant) while other treatments did not differ when compared to untreated controls,,"effects of different hormones (active metabolites thereof) vary w.r.t. assessed function or neuroanatomical characteristic;
overall use of hormones can provide effective treatment independent of lesion size",,,Yes (drug of interest + drug of interest),
Louis,Sengelaub et al.,2018,Protective Effects of Estradiol and Dihydrotestosterone following Spinal Cord Injury,10.1089/neu.2017.5329,English,United States,included,,,,,,rats,Sprague Dawley,47,05.Nov,,,06.Aug,,,,all female,female,0,approx. 12 weeks,12,,,,,Adult,Not reported,,,,,,not reported,contusion injury at T9,T9,severe,contusion,"NYU impactor device, 10g impactor dropped from 25mm",4 weeks,dihydrotestosterone,testosterone,,"no exact dosing information, implant size/weight chosen to achieve maximal physiologically normal levels",implants to deliver hormone(s) applied immediately post-injury,,4 weeks,continuous,subcutaneous,,"functional,
physiological","BBB locomotor scale;
micturition (voiding behaviour)",,"BBB: two observers;
micturition: metabolic cage w/ free access to food and water for 16hrs, voiding assessed for volume and frequency by computerized system ","BBB: weeks 1, 2, 3, 4 post-injury;
micturition: week 3 post-injury",,"BBB: yes;
micturition: not applicable",mixed effects (assessment),"no effect on BBB locomotor scale results (all treatment regimes);
positive effect on voiding behaviour: single hormone treatment statistically significantly increased voiding frequency and reduced volume of individual voids compared to untreated control but still worse than uninjured control, combined hormone treatment resulted in voiding frequency and individual volumes resembling normal behaviour (frequent voiding w/ little volume)",histopathology,Luxol fast blue and cresyl violet and eosin stain (lesion volume and extent assessment via percent volume of spared grey and white matter and overall tissue),,,mixed effects,treatment w/ only estradiol resulted in reduced lesion volume (statistically significant) and increased spared tissue volume (statistically significant) while other treatments did not differ when compared to untreated controls,,"effects of different hormones (active metabolites thereof) vary w.r.t. assessed function or neuroanatomical characteristic;
overall use of hormones can provide effective treatment independent of lesion size",,,Yes (drug of interest + drug of interest),
Louis,Sengelaub et al.,2018,Protective Effects of Estradiol and Dihydrotestosterone following Spinal Cord Injury,10.1089/neu.2017.5329,English,United States,included,,,,,,rats,Sprague Dawley,47,05.Nov,,,05.Jun,,,,all female,female,0,approx. 12 weeks,12,,,,,Adult,Not reported,,,,,,not reported,contusion injury at T9,T9,severe,contusion,"NYU impactor device, 10g impactor dropped from 25mm",4 weeks,"estradiol, dihydrotestosterone",estradiol + testosterone,,"no exact dosing information, implant size/weight chosen to achieve maximal physiologically normal levels",implants to deliver hormone(s) applied immediately post-injury,,4 weeks,continuous,subcutaneous,,"functional,
physiological","BBB locomotor scale;
micturition (voiding behaviour)",,"BBB: two observers;
micturition: metabolic cage w/ free access to food and water for 16hrs, voiding assessed for volume and frequency by computerized system ","BBB: weeks 1, 2, 3, 4 post-injury;
micturition: week 3 post-injury",,"BBB: yes;
micturition: not applicable",mixed effects (assessment),"no effect on BBB locomotor scale results (all treatment regimes);
positive effect on voiding behaviour: single hormone treatment statistically significantly increased voiding frequency and reduced volume of individual voids compared to untreated control but still worse than uninjured control, combined hormone treatment resulted in voiding frequency and individual volumes resembling normal behaviour (frequent voiding w/ little volume)",histopathology,Luxol fast blue and cresyl violet and eosin stain (lesion volume and extent assessment via percent volume of spared grey and white matter and overall tissue),,,mixed effects,treatment w/ only estradiol resulted in reduced lesion volume (statistically significant) and increased spared tissue volume (statistically significant) while other treatments did not differ when compared to untreated controls,,"effects of different hormones (active metabolites thereof) vary w.r.t. assessed function or neuroanatomical characteristic;
overall use of hormones can provide effective treatment independent of lesion size",,,Yes (drug of interest + drug of interest),
Louis,Korimova et al.,2012,Protective effects of glucosamine-kynurenic acid after compression-induced spinal cord injury in the rat,10.2478/s11535-012-0096-2,English,"Slovakia, Hungary",excluded,Out of scope,No drug of interest,No drug of interest (kynurenic acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Mokarizadeh et al.,2016,Local Polyethylene Glycol in Combination with Chitosan Based Hybrid Nanofiber Conduit Accelerates Transected Peripheral Nerve Regeneration,10.3109/08941939.2015.1098758,English,Iran,excluded,Non-sci population,,Sciatic nerve injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Rad et al.,2015,Interaction of polyethylene glycol (PEG) with the membrane-binding domains following spinal cord injury (SCI): Introduction of a mechanism for SCI repair,10.3109/1061186X.2014.956668,English,Iran,excluded,Non-sci population,,In-silico study,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Mekhail et al.,2015,Purine-crosslinked injectable chitosan sponges promote oligodendrocyte progenitor cells' attachment and differentiation,10.1039/c4bm00215f,English,Canada,excluded,Out of scope,No drug of interest,"No drug of interest (chitosan sponge crosslinked using guanosine 5’-diphosphate), in-vitro study",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Patel et al.,2014,N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma,10.1016/j.expneurol.2014.04.026,English,"United States, Sweden",included,,,,,,rats,Sprague Dawley,141,24,1,1,24,,,,all female,female,0,Not reported,,,,,,Not reported,225g to 250g,,,225,250,g,,contusion injury at L1/L2,L1 - L2,Not reported,contusion,"Infinite Horizon impactor device, 250kdyn impact force",6 weeks,N-acetylcysteine amide,acetylcysteine,,"group 1: 150mg/kg/day
group 2: 300mg/kg/day",bolus 15min post-injury,,7 days,continuous,subcutaneous,,functional,"BBB locomotor scale,
gait recording",,"gait recording: ventral-view videos w/ single high-speed camera, 
multiple indices of gait quality calculated (regularity, coordinated pattern, plantar stepping, percentage of hindlimb steps that are dorsal)","BBB: day 2 post-injury, weeks 1 to 6 post-injury;
gait recording: week 6 post-injury",,"BBB: yes;
gait recording: not reported",mixed effects (dosage) + mixed effects (assessment),"statistically significant improvement in BBB score compared to injured control for both doses;
statistically significant improvement in gait analysis indices for 150mg/kg/day",histopathology,"MRI scan, eriochrome cyanine-cresyl violet stain;
percentage tissue sparing at epicenter calculated",,Yes,positive effect,"MRI shows reduced lesion size (qualitatively);
statistically significant reduction in volume of injured tissue (total) and increased sparing of tissue at epicenter (absolute and percentage)",,"extended treatment with N-acetylcysteine amide (NACA) has positive effect on recovery of hindlimb function after SCI, reduces lesion volume; 
potentially acts through effect on mitochondrial bioenergetics",,,No,
Louis,Osuna-Carrasco et al.,2016,Quantitative analysis of hindlimbs locomotion kinematics in spinalized rats treated with Tamoxifen plus treadmill exercise,10.1016/j.neuroscience.2016.07.023,English,Mexico,included,,,,,,rats,Sprague Dawley,24,6,,,6,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,250g to 300g,,,250,300,g,,"penetrating injury at T13/L1 (unilateral, see Fig 1)",T13 - L1,Not reported,contusion,"no laminectomy or similar, projectile discharged to break laminae and penetrate spinal cord",30 days,tamoxifen,tamoxifen,,1mg/kg,"bolus within 30min of injury, 24 and 48 hours post-injury",,3 doses,,intraperitoneally,,functional,gait recording,,"locomotion training (treadmill, plexi glas walkway) and reference recordings pre-injury; post-injury: video recording of gait, angular control curves constructed based on markers applied to limbs, alignment of angular control curves post-injury to control curves, similarity score calculated (discrete Frechet distance)",days 15 and 30 post-injury,,Not reported,mixed effects (assessment),"statistically significant difference (lower distance, i.e. higher similarity) for knee and ankle at day 15 post-injury and for ankle at day 30 (tamoxifen treatment vs. untreated injured control) in ipsilateral hindlimb, no difference in contralateral hindlimb",histopathology,hematoxylin and eosin stain,day 30 post-injury,Not reported,positive effect,statistically significant reduction in lesion size for tamoxifen treatment group (compared to injured control),"enroxil (2mg/kg, days 1 to 3 post-injury)",angular parameters of gait recovered and morphological parameters improved in tamoxifen treatment group,,combination of tamoxifen with regular exercise also assessed but not included,No,
Louis,Fehlings et al.,2012,Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial,10.3171/2012.4.AOSPINE1259,English,"Canada, United States",excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Schueltke et al.,2010,Quercetin attenuates inflammatory processes after spinal cord injury in an animal model,10.1038/sc.2010.45,English,"Canada, Germany, Saudi Arabia",excluded,Out of scope,No drug of interest,No drug of interest (quercetin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Fan et al.,2019,Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats,10.1186/s12974-019-1613-2,English,China,excluded,Out of scope,No drug of interest,No drug of interest (quercetin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Schueltke et al.,2003,Quercetin promotes functional recovery following acute spinal cord injury,10.1089/089771503767168500,English,Canada,excluded,Out of scope,No drug of interest,No drug of interest (quercetin),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Zhang et al.,2014,Quercetin Promotes Neuronal and Behavioral Recovery by Suppressing Inflammatory Response and Apoptosis in a Rat Model of Intracerebral Hemorrhage,10.1007/s11064-014-1457-1,English,China,excluded,Non-sci population,,"Intracerebral hemorrhage, no drug of interest (quercetin)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Wasilewska-Sampaio et al.,2005,"Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound",10.1096/fj.05-3812com,English,Brasil,excluded,Non-sci population,,In-vitro experiments only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ren et al.,2019,Reconstruction of the spinal cord of spinal transected dogs with polyethylene glycol,10.25259/SNI-73-2019,English,"China, South Korea",included,,,,,,dogs,beagle,12,5,,,7,,,,all female,female,0,Not reported,,,,,,Not reported,8kg,8,,,,kg,,complete transection at T10,T10,complete,transection,,6 months,polyethylene glycol (PEG),polyethylene glycol,,2ml,immediately post-injury,,1 dose,,topical,,functional,BBB locomotor scale (canine),,scale ranges from 0 to 20,"pre-injury, days 0, 3, 31, 59, 180 post-injury",,Not reported,positive effect,"statistically significantly higher BBB score for treatment group at days 3, 31, 59","histopathology, 
immunohistochemistry
tractography","hematoxylin-eosin and Chromotropic acid 2R-Brilliant Green (C-2R-G) stain,
primary Ab for 5-HT (anti-serotonin) and neurofilament 200 (NF200),
diffusion tensor imaging via MRI","histopathology: day 180 post-injury,
immunohistochemistry: day 180 post-injury,
tractography: weeks 2, 4 and day 180 post-injury",Not reported,mixed effects,"statistically significantly smaller cyst area and increased myelin sheath ratio in treatment group but no difference in scar size,
histopathological finding supported by immunohistochemistry but only discussed qualitatively,
apparent diffusion coefficient statistically significantly different at 6 months while fractional anisotropy not statistically significantly different at 6 months",,"paralysis following full section of the spinal cord can be reversed by immediate topical application of a fusogen (polyethylen glycol), likely due to axonal sprouting across to fusion interface","no statistical comparison of BBB score at day 180 possible due to loss of animals (2 in control, 1 in treatment group)",,No,
Louis,Hashimoto et al.,2011,Recovery from rocuronium by sugammadex does not affect motor evoked potentials,PMID: 21861428,Japenese,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Akel,2017,Recovery from spinal cord infarction associated with cannabis use,10.1080/10790268.2016.1258969,English,United States,excluded,Case report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Feringa et al.,1976,Recovery in rats after spinal cord injury,10.1212/wnl.26.9.839,English,United States,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Geisler et al.,1991,"RECOVERY OF MOTOR FUNCTION AFTER SPINAL-CORD INJURY - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH GM-1 GANGLIOSIDE",10.1056/NEJM199106273242601,English,United States,excluded,Out of scope,No drug of interest,No drug of interest (GM-1 ganglioside -- group of drugs),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Johnstone et al.,2013,Reduced extracellular zinc levels facilitate glutamate-mediated oligodendrocyte death after trauma,10.1002/jnr.23208,English,United States,excluded,Out of scope,Ex-vivo,In-vitro experiments only,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Ashki et al.,2006,Nitric oxide reversibly impairs axonal conduction in guinea pig spinal cord,10.1089/neu.2006.23.1779,English,"Canada, United States",excluded,Non-sci population,,"In-vitro experiments only, did not induced a trauma",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Bracken et al.,1992,Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study,10.3171/jns.1992.76.1.0023,English,United States,included,,,,prospective,retrospective,human,,487,171,,,162,,,"427 surviving patients included in analysis, number of deaths per group not specified but no statistically significant difference between the different groups",Not reported,not reported,not reported,Not reported,,,,,,,Not reported,,,,,,,Not reported,,Not reported,,,,"i) methylprednisolone
ii) naloxone
iii) placebo",methylprednisolone,,"30mg/kg bolus,
5.4mg/kg/hr infusion","bolus (both drugs) at 15min post-injury,
infusion starting 1hr post-injury for 23hrs",,24h,continuous,not reported,,"functional;
neurological","motor score;
light touch (LT) and pin prick (PP) scores",neurological (motor and sensory),"motor scores assessed in 14 muscle segments, scores from 0 (no contraction) to 5 (normal function);
sensory scores assessed in 29 segments, scores: 1 (absent), 2 (decreased), 3 (normal)","week 6 post-injury, 
month 6 post-injury,
year 1 post-injury (range from 365 to 425 days acceptable)",,Yes,mixed effects (timing),"statistically significant improved motor and sensory scores for patients receiving methylprednisolone and
no effect for patients receiving naloxone if administered within 8 hours;
no effect (approaching negative effect) for both drugs if adminstered later than 8 hours;
no effect w.r.t. reported complications",,,,,,,"various drugs reported to have been delivered before admission to study (no detailed information),
various surgical procedures reported (no detailed information)","""Increased recovery of neurological function after acute spinal cord injury in patients treated with meth- ylprednisolone within 8 hours of injury, as compared with those treated with placebo, was seen at 6 weeks and at 6 months after injury and continued to be observed I year after injury.""",,,No,
Louis,Bracken et al.,1992,Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data: Results of the second National Acute Spinal Cord Injury Study,10.3171/jns.1992.76.1.0023,English,United States,included,,,,prospective,retrospective,human,,487,171,,,154,,,"427 surviving patients included in analysis, number of deaths per group not specified but no statistically significant difference between the different groups",Not reported,not reported,not reported,Not reported,,,,,,,Not reported,,,,,,,Not reported,,Not reported,,,,"i) methylprednisolone
ii) naloxone
iii) placebo",naloxone,,"5.4mg/kg bolus,
4.0mg/kg/hr infusion","bolus (both drugs) at 15min post-injury,
infusion starting 1hr post-injury for 23hrs",,24h,continuous,not reported,,"functional;
neurological","motor score;
light touch (LT) and pin prick (PP) scores",neurological (motor and sensory),"motor scores assessed in 14 muscle segments, scores from 0 (no contraction) to 5 (normal function);
sensory scores assessed in 29 segments, scores: 1 (absent), 2 (decreased), 3 (normal)","week 6 post-injury, 
month 6 post-injury,
year 1 post-injury (range from 365 to 425 days acceptable)",,Yes,no effect,"statistically significant improved motor and sensory scores for patients receiving methylprednisolone and
no effect for patients receiving naloxone if administered within 8 hours;
no effect (approaching negative effect) for both drugs if adminstered later than 8 hours;
no effect w.r.t. reported complications",,,,,,,"various drugs reported to have been delivered before admission to study (no detailed information),
various surgical procedures reported (no detailed information)","""Increased recovery of neurological function after acute spinal cord injury in patients treated with meth- ylprednisolone within 8 hours of injury, as compared with those treated with placebo, was seen at 6 weeks and at 6 months after injury and continued to be observed I year after injury.""",,,No,
Louis,Bracken and Holford,1993,Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2,10.3171/jns.1993.79.4.0500,English,United States,included,,,,prospective,retrospective,human,,487,171,,,162,,,,Not reported,not reported,not reported,Not reported,,,,,,,Not reported,,,,,,,Not reported,,Not reported,,Not reported,Not reported,"i) methylprednisolone 
ii) naloxone 
iii) placebo",methylprednisolone,,Not reported,Not reported,,,,not reported,,"functional;
neurological","motor score;
light touch (LT) and pin prick (PP) scores",neurological (motor and sensory),"motor scores assessed in 14 muscle segments, scores from 0 (no contraction) to 5 (normal function);
sensory scores assessed in 29 segments, scores: 1 (absent), 2 (decreased), 3 (normal)","week 6 post-injury, 
month 6 post-injury,
year 1 post-injury (range from 365 to 425 days acceptable)",,Not reported,no effect,"no statistically significant effect w.r.t. functional or neurological recovery based on treatment regimen;
interesting/relevant observation w.r.t. how recovery is achieved (at level of injury/below level of injury, change in level/change in severity)",,,,,,,,"no effect shown but research hypotheses generated;
distinction in recovery process (by level vs. by severity) relevant, protective effect at lesion and/or below;
timing of treatment most likely relevant (<= 8hrs)",results shown are from post-hoc analysis and clinical trial design did not account for statistical power considerations related to this analysis,,,
Louis,Bracken and Holford,1993,Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2,10.3171/jns.1993.79.4.0500,English,United States,included,,,,prospective,retrospective,human,,487,171,,,154,,,,Not reported,not reported,not reported,Not reported,,,,,,,Not reported,,,,,,,Not reported,,Not reported,,Not reported,Not reported,"i) methylprednisolone 
ii) naloxone 
iii) placebo",naloxone,,Not reported,Not reported,,,,not reported,,"functional;
neurological","motor score;
light touch (LT) and pin prick (PP) scores",neurological (motor and sensory),"motor scores assessed in 14 muscle segments, scores from 0 (no contraction) to 5 (normal function);
sensory scores assessed in 29 segments, scores: 1 (absent), 2 (decreased), 3 (normal)","week 6 post-injury, 
month 6 post-injury,
year 1 post-injury (range from 365 to 425 days acceptable)",,Not reported,no effect,"no statistically significant effect w.r.t. functional or neurological recovery based on treatment regimen;
interesting/relevant observation w.r.t. how recovery is achieved (at level of injury/below level of injury, change in level/change in severity)",,,,,,,,"no effect shown but research hypotheses generated;
distinction in recovery process (by level vs. by severity) relevant, protective effect at lesion and/or below;
timing of treatment most likely relevant (<= 8hrs)",results shown are from post-hoc analysis and clinical trial design did not account for statistical power considerations related to this analysis,,,
Louis,Michael-Titus,2007,Omega-3 fatty acids and neurological injury,10.1016/j.plefa.2007.10.021,English,United Kingdom,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Louis,Kaptanoglu et al.,2005,Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury,10.3171/spi.2005.3.1.0053,English,Turkey,included,,,,,,rats,Wistar,40,8,,,8,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 250g,,,210,250,g,,contusion injury between T7 and T9,T7 - T9,moderate,contusion,"weight drop method, 40g/cm weight",24 hours,methylprednisolone,methylprednisolone,No,30mg/kg,immediately post-injury ,,1 dose,,intraperitoneally,,functional,inclined plane test,,,24hrs post-injury,No,Yes,no effect,"no effect for methylprednisolone, statistically significantly better result (higher angle) for mexiletine treated group",,,,,,,,mexiletine treatment improves early functional recovery after traumatic SCI,,,No,
Louis,Kaptanoglu et al.,2005,Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury,10.3171/spi.2005.3.1.0053,English,Turkey,included,,,,,,rats,Wistar,40,8,,,8,,,,all female,female,0,adult (no precise age reported),,,,,,Adult,210g to 250g,,,210,250,g,,contusion injury between T7 and T9,T7 - T9,moderate,contusion,"weight drop method, 40g/cm weight",24 hours,mexiletine,mexiletine,,10mg/kg,immediately post-injury ,,1 dose,,intraperitoneally,,functional,inclined plane test,,,24hrs post-injury,,Yes,positive effect,"no effect for methylprednisolone, statistically significantly better result (higher angle) for mexiletine treated group",,,,,,,,mexiletine treatment improves early functional recovery after traumatic SCI,,,No,
Lucie,Xing et al,2016,Repeated systemic administration of morphine promotes recovery of locomotor function after spinal cord injury in rats,https://e-century.us/files/ijcem/9/2/ijcem0017202.pdf,English,,included,,,,,,rats,Sprague Dawley,56,24,4,,25,3,,,male 100%,male,100,not reported (adults),,,,,,Adult,range: [260-280](g),,,260,280,g,,level: T10; severity: not reported,T10,Not reported,compression,"laminectomy + compressive SCI (dura intact from laminectomy, spinal cord compressed from both lateral sides for 20s using a microvessel clip with a closing force of 8g)",28 days,morphine hydrochloride,morphine,,10 mg/kg,2h after injury,,7 days,daily,subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, inclined plane test, tail-flick test, tactile sensory test with Von Frey filaments",,"BBB: move freely for 4 min in an open field with a nonskid floor, score from 0 to 21 (complete hind limb paralysis to normal locomotion); inclined plane testL assess equilibrium and residual strength of fore and hind limbs, maintain position on a movable plane with a rough surface adjusted by 5 degrees increments to a max angle of 90 degrees, max angle that rat support weight for 5s recorded as the inclined plane score; tail-flick test: thermal nociceptive thresholds, dsital one-third of the tail immersed in water maintained at 52 +/- 0.5 degrees celsius, nociceptive endpoint was characteristic withdrawal of the tail from the warm water, an average of 3 consecutive trials separated by 5 min interval was designated the nociceptive threshold; Von Frey test: tactile sensory thresholds, hind paw plantar surface using a modified version of the up-down method, wire mesh floor and aclimate for 15 min before testing, 10 filaments applications used and 30-60s separated each touch, tactile sensory threshold was defined as the lowest gram force needed to produce hind paw withdrawal during at least 50% of its application","BBB: prior to surgery and then 1, 7, 14, 21 and 28 days after SCI, inclined plane test: same as BBB; tail-flick and Von Frey tests: prior to surgery and day 28 after surgery",,yes,mixed effects (assessment),BBB: significantly higher score starting day 7 until end of the experiment in morphine group compared to control group; inclined plane test: significantly higher score starting day 14 until end of the experiment in morphine group compared to control group; tail-flick test and tactiale sensory threshold: no significant difference between treated and controls after 28 days,histological assessment,white matter sparing,28 days,not reported,positive effect,% of white matter sparing significantly higher in morphine group compared to control group,"anesthesia: sodium pentobarbital (50 mg/kg, IP); postop: 2 mL sterical saline IP; euthanasia: deeply anesthesized and transcardially perfused with saline followed by 4% paraformaldehyde",observations suggest that repeated systemic administration of morphine during an acute stage of SCI promotes recovery of locomotor function without promoting development of hyperalgesia and allodynia.,"did not investigate the effects of different doses of morphine and days of morphine use on neurological outcome, observed only for a period of 28 days after SCI","use pentobarbital, saline",No,
Matthias,Nadkarni et al,1999,"Pentoxifylline effect on functional, biochemical and histological ratings after experimental spinal cord impact",10.1097/00003246-199901001-00086,English,,excluded,Abstract,,"SOCIETY OF CRITICAL CARE MEDICINE; 28TH EDUCATIONAL AND SCIENTIFIC SYMPOSIUM; SAN FRANCISCO, CALIFORNIA, USA; JANUARY 23-27, 1999: POSTER SYMPOSIA PRESENTATIONS",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2018,Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury,10.18632/oncotarget.23877,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (Resveratrol, chloroquine phosphate)",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Mu et al,2000,Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury,10.1089/neu.2000.17.773,English,,included,,,,,,rats,Long Evans,36,9,,,9,,,"2 treatment groups not of interest, n == 9 each",female 100%,female,0,not reported (adults),,,,,,Adult,range: [225-250](g),,,225,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop contusion (NYU impactor, impactor rod dropped from 12.5mm)",6 weeks,"riluzole (not of interest, not further reported), methylprednisolone (MP), and combination (not reported)",methylprednisolone,No,30 mg/kg,2h after injury,Yes,2 doses,2h and 4h after injury,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"open-field, circular molded-plastic swimming pool with a dimpled floor (36-inch diameter, 9-inch wall height), acllimate for 5 days prior to surgery, 2 examiners, 4min period for scoring, mean score obtained for each individual subject for each test day and group mean obtained from the individual subject man scores were recorded",weekly until week 6 included,Yes,yes,no effect,BBB: no significant difference between MP group and vehicule group,histological assessment,"spared tissue, myelin index: obtained by dividing the diameter of the axoplasm by the diameter of the axon including the myelin",6 weeks,yes,no effect,"spared tissue: no apperant difference, no statistical difference in percentage of spared tissue between MP alone and vehicle group; myelin index: not tested between vehicle group and MP alone groups, MP alone and laminectomy alone (no SCI) significantly different, so MP did not make it go back to ""normal""","anesthesia: pentobarbital (40 mg/kg); euthanasia: anesthesia with pentobarbital (40 mg/kg), perfused with 150 mL of saline followed by 150 mL of 4% glutaraldehyde and 4% paraformaldehyde","In this study, only the combination treatment was found to significantly improve behavioral recovery as assessed using the BBB open field locomotor scale. In addition, the combination treatment promoted tissue sparing at the lesion epicenter, but had no clear effect on the index of myelination. The results of this study clearly demonstrate the potential beneficial effects of a combination approach in the treatment of traumatic SCI",not reported,"use pentobarbital, saline",Yes (drug of interest + drug not of interest),
Lucie,Anderson et al,1988,Pretreatment with Alpha Tocopherol Enhances Neurologic Recovery After Experimental Spinal Cord Compression Injury,10.1089/neu.1988.5.61,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (alpha tocopherol),,,cats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhou et al,2020,Promoting 3D neuronal differentiation in hydrogel for spinal cord regeneration,10.1016/j.colsurfb.2020.111214,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (3D gelatin methacryloyl  +/- Bone mesenchymal stem cells (BMSCs) and neural stem cells (NSCs)),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kamencic et al,2001,Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function,10.1096/fj.00-0228com,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest ( L-2-oxothiazolidine-4-carboxylat),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kazama et al,2001,Protection of the spinal cord with pentobarbital and hypothermia,10.1016/S0003-4975(00)02546-7,English,,included,,,,,,rabbit,Japenese white,54,12,,,42,,,see details in table 2,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [2.8-3.5](kg),,,2.8,3.5,kg,,level: aorta ligature distal to the renal artery and proximal to the bifurcation; severity: not reported,thoracic,Not reported,ischemia,"laparotomy + ischemic injury (abdominal aorta exposed inferiorly to the left renal artery and down to the bifurcation, aorta encircled with a silk ligature distal to the renal artery and proximal to the bifurcation to facilitate secure occlusion, posterior mesenteric artery was also encircled with a silk ligature, occlusion for 20 or 40 minutes depending on groups)",48h,"pentobarbital (+/- hypothermia, only normothermia reported)",pentobarbital,,5 or 10 or 20 mg/kg,20 minutes before aortic occlusion,,one dose over a several-minute period,-,intravenously,,neurological/functional/behavioral assessment,Tarlov scale,,"0=spastic paraplegia and no movement of the lower limbs, 1=spastic paraplegia and slight movement of the lower limbs, 2= good movement of the lower limbs but unable to stand, 3=able to stand but unable to walk normally, 4=complete recovery",48h after injury,,yes,mixed effects (dosage) + mixed effects (regime),occlusion for 20 minutes: both 5 and 10 mg/kg groups showed better tarlov's score compared to vehicle group; occlusion for 40 minutes: not 5 mg/kg but 10 and 20 mg/kg groups showed significantly better tarlov's score compared to vehicle group,histological assessment,"necrosis, macrophage infiltration",48h,not reported,no stats,spinal cords from animals that suffered paraplegia showed marked coagulative necrosis with macrophage infiltration of the central gray matter; cords of animals with no motor function deficits showed only minimal cellular infiltrates in the gray matter; findings were invariable among the same Tarlov scales groups irrespective of treatment modality,"premedication: ketamine hydrochloride (30 mg/kg, IM), anesthesia: GOF (1.5% halothane, 1:1 oxygen and nitroux oxide) delivered by nose cone; during surgery: anticoagulation with 200 units of heparin before aortic cross-clamping",Pentobarbital showed dose-dependent protective effects of the spinal cord. Moderate hypothermia alone also showed protective effects. Combined use of pentobarbital and hypothermia resulted in highly significant recovery of spinal cord function.,not reported,"important comment: ""caution is required concerning the use of barbiturate anesthesia for animals in experiments on spinal cord protection. A number of experimental studies have been done under barbiturate anesthesia. The results of these studies should be interpreted cautiously because barbiturate anesthesia can modify the outcome of neurological function; use ketamine, heparin",No,
Lucie,Genovese et al,2007,"Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury",10.1016/j.freeradbiomed.2007.05.012,English,,included,,,,,,mice,CD1,Not reported,Not reported,,,Not reported,,,Not reported,male 100%,male,100,not reported (adults),,,,,,Adult,range: [25-30](g),,,25,30,g,,level: T5-T8; severity: not reported,T5 - T8,Not reported,compression,laminectomy + compression (extradural compression using an aneurysm clip with a closing force of 24g),"24h, 10 days","dexamethasone, roxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron III chloride (FeTSPP, not of interest so not further reported)",dexamethasone,,1 mg/kg,1h after injury,,"2 doses (1h and 6h) for mice sacrificed at 24h, 10 days in mice for motor assessment",daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB score,,-,once a day for 10 days,,not reported,positive effect,BBB score in dexamethasone group significantly higher than in the vehicle group,histological assessment,"count of damaged neurons, six-point scale on gray matter changes: 0=no lesion observed, 1=gray matter contained 1 to 5 eosinophilic neurons, 2=gray matter contained 5 to 10 eosinophilic neurons, 3=more than 10 eosinophilic neurons, 4=small infarction (less than one third of the gray matter area), 5=moderate infarction (one third to one half of the gray matter area, 6=large infarction (more than half of the gray matter area), scores for each sections averaged to produce a final score for an individual mouse",24h,yes,mixed (stats/no stats),"histological scores significantly lower in dexamethasone group compared to vehicle group, dexamethasone significantly reduced the presence of edema and the alteration of the white matter (no stats)","anesthesia: chloral hydrate (40 microg/kg), postop: 1.0 cc saline administered subcutaneously to replace blood volume lost during surgery","Taken together, our results clearly demonstrate that FeTSPP treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma similarly to dexamethasone, a well-known antiinflammatory agent which we have used as positive control",not reported,"use chloral hydrate, saline; dexamethasone is not the main drug of interest in the paper",No,
Lucie,Cho et al,2005,Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity,10.1016/j.jvs.2005.05.052,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (CGS19755, MK-801)",,,rabbit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Abd-El-Basset et al,2018,Dibutyryl Cyclic Adenosine Monophosphate Rescues the Neurons From Degeneration in Stab Wound and Excitotoxic Injury Models,10.3389/fnins.2018.00546,English,,excluded,Non-sci population,,no SCI performed by traumatic brain injury,,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Keller et al,2019,Nociceptor-dependent locomotor dysfunction after clinically-modeled hindlimb muscle stretching in adult rats with spinal cord injury,10.1016/j.expneurol.2019.03.006,English,,excluded,Out of scope,Other," look at the motor dysfunction caused by stretching after SCI, and argue it is due to TRPV1. They test this hypothesis by depleting TRPV1 using capsaicin (that would be the drug of interest) given when rats are neonates",,,rats,Sprague Dawley,24,,,,,,,,female 100%,,,neonates (treatment at 2 days of age),,,,,,,not reported,,,,,,,level: T9; severity: moderate,,,,"laminectomy + weight drop contusion (NYU MASCIS impactor, 25 g/cm)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,,2019,FGF10 Enhances Peripheral Nerve Regeneration via the Preactivation of the PI3K/Akt Signaling-Mediated Antioxidant Response,10.3389/fphar.2019.01224,English,,excluded,Non-sci population,,Peripheral nerve injury model,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,,2011,Quadriplegia after parathyroidectomy in a hemodialysis patient,10.1016/j.aat.2010.07.001,English,,excluded,Case report,,Case report,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,,2014,Safety and efficacy of corticosteroid use in neurologic trauma.,10.1177/0897190013516500,English,,excluded,Review,,Review of adult humans,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yu et al,2017,Salvianolic acid A ameliorates the integrity of blood-spinal cord barrier via miR-101/Cul3/Nrf2/HO-1 signaling pathway,10.1016/j.brainres.2016.12.007,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (zinc protoporphyrin IX, salvianolic acid A)",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Heller et al,2019,Relation of selenium status to neuro-regeneration after traumatic spinal cord injury,10.1016/j.jtemb.2018.10.006,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bobo,Pan et al,2013,Protective effect of tacrolimus postconditioning on oxidative stress injury provoked by spinal cord ischemia-reperfusion in rats,10.3760/cma.j.issn.0376-2491.2013.47.020,Chinese,China,included,,,,,,rats,Sprague Dawley,90,30,,,30,,,"30 in each of ischemia-repurfusion group, tacrolimus postconditioning group and sham operation group",male 100%,male,100,,,,,,,Adult,range: [270-320] (g),,,270,320,g,,,,Not reported,ischemia,Ischemia-repurfusion injury prepared by means of catheterization through femoral artery and balloon dilatation,not reported,tacrolimus,tacrolimus,No,0.5mg/kg,20 mins after injury,,single dose,20 min after injury,intravenously,,functional assessment,BBB Locomotor test,,21 point scale,14 days post injury,No,yes,positive effect,BBB score for tacrolimus group was 14.1 which was higher than ischemeia repurfusion (IR) group of 10.4 (P < 0.01),immunohistochemistry and biochemical analysis,"flurospectrophotometry, antioxidant enzyme activity andoxidation product content detection","15 minutes; 15 minutes, 1, 6, and 24 hours",not noted,positive effect,"level of ROS- fluoresence intensity in TP group was 79 which is higher than the sham operation group but much lower than the ischemia-repuerfusion group (P < 0.01); activity of SOD was significantly higher in TP group than in IR group at all time points, activities of CAT and GSH-PX were significantly hgiher in TP group that ischemia reperfusion group at 1 and 6 hours after reperfusion; content of MDA in tacrolimus group was significantly less than ischemia-repurfusion group at all time points",anesthsia: 10% chloral hydrate (400mh/kg),"tacrolimus postconditioning can improve activity of endogenous antioxidant enzymes, decrease production og oxygen free radicals, suppress lipid peroxidation, and thereby promote functional recovery after spinal cord ischemia-reperfusion injury",not reported,,No,
Lucie,Thompson et al,2011,Methods to quantify pharmacologically induced alterations in motor function in human incomplete SCI.,10.3791/2148,English,,excluded,Out of scope,Other,"Looks like a Protocol (agreed, excluded)",,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lee et al,2020,Sequentially induced motor neurons from human fibroblasts facilitate locomotor recovery in a rodent spinal cord injury model,10.7554/eLife.52069,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (human fibroblasts),,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pereira et al,2009,Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats,10.1016/j.expneurol.2009.07.030,English,,included,,,,,,rats,Wistar,40,15,,,15,,,sham n = 4,female 100%,female,0,not reported (adults),,,,,,Adult,~ 200 g,200,,,,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion (2.5 mm impactor tip, 200-kdyn contusion with the infinite horizon spinal cord injury device)",7 weeks,methylprednisolone sodium succinate (MPSS),methylprednisolone sodium succinate,Yes,"30 mg/kg, then 5.4 mg/kg/h",10 min after SCI,,24h,first shot then continuous,intraperitoneally,,neurological/functional/behavioral assessment,"BBB score, inclined plane, beam walk, horizontal ladder, footprint analysis, 3D kinemtic data",,"BBB score: 0=no spontaneous hindlimb movement, 21=normal locomotion, open field, 100*100cm transparent plexiglas box, walls of 11cm, 4 min, 2 examiners; inclined plane: largest angle at which a rat could maintain a stable position for 5s, 28*30cm floor with 20*25cm grooved, grooves 1mm deep and 5 mm apart, rubber surface; beam walk: 7 beams of different width were used as narrow pathways, 1.7cm=1, increments of 1 cm to 7.7cm=1, rats placed on widest beam and ability to cross without foot slips within 2 trials observed, repeated on successively narrower beams, narrowest beam recorded for each rat; horizontal ladder: ladder constructed using 5mm rungs separated 2.5cm apart, 25 rungs, had to cross 4 times and total number of foot falls recorded; footprint analysis: confined walkway measuring 42cm long and 8.2cm wide with a dark shelter at the end, white paper on the floor, hind paws pressed down onto a finger paint-soaked sponge, base of support determined by measuring the core to core distance of the central pads of the hind paws; 3D kinematic data: hindlimb joint angles measured at the flexor side of each joint, knee position was computed indirectly","BBB score and inclined plane: before injury, 2 days after injury, then once a week until week 7; beam walk and horizontal ladder task: 2 weeks postop and then weekly until week 7; footprint analysis: 3 weeks postop and then weekly until week 7",,not reported,no effect,"BBB, beam walk score, angle of inclined plane, % missteps in horizontal latter test, base of support from footprint analysis, kinematic data at week7: no significant difference between MP and saline groups ",histological assessment,"lesion length, lesion volume, area at lesion epicenter, total cross sectional area of spinal cord at the lesion epicenter, % lesion area/spinal cord area",7 weeks,not reported,no effect,none of the numerical differences observed between the two experimental groups was significant,"anesthesia: ketamine (80 mg/kg), medetomidine (0.2 mg/kg); postop: 10 ml of 0.9% sodium chloride and 30 mg/kg of sulfadiazine and trimethoprim SC, sulfadiazine and trimethoprim twice a day for up to 1 week; euthanasia: anesthesia with ketamine 80 mg/kg and medetomidine 0.2 mg/kg, perfused through the heart with 300 ml PBS followed by 300 ml of 4% paraformaldehyde in cold 0.1M PBS","Altogether, our results support data previously reported by several authors, suggesting that MPSS does not lead to improved functional outcome following experimental acute SCI",not reported,"report of no effect from MP; use ketamine, medetomidine",No,
Lucie,Vo et al,2020,Serum albumin as a predictor of neurological recovery after spinal cord injury: a replication study,10.1038/s41393-020-00536-x,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Cain et al,2007,Serum albumin improves recovery from spinal cord injury,10.1002/jnr.21265,English,,included,,,,,,rats,Harlan Sprague Dawley,20,10,,,10,,,,male 100%,male,100,not reported,,,,,,Not reported,2 groups: [150-175](g) for direct injections and [225-250](g) for IV injections,,,150,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion ( Infinite Horizons injury device, exposed cord was impacted by a piston with a force of 125 (150–175 g animals) or 150 kdynes (225–250 g animals))",28 days,albumin (rat in direct injection or human serum albumin in IV injections),albumin,,rat albumin: 200 microg in 4microL of saline; human albumin:  1 g/kg of a 30% solution of human serumalbumin (Sigma) in 0.9% saline,direct injection: immediately after injury; IV injection: 3 min after injury,,single dose,-,multiple,direct injection: intrathecal; IV injections,neurological/functional/behavioral assessment,"BBB score, activity measures",,"BBB: ranges from 0 (no hind limbmovement) to 21 (normal movement-coordinated gait with parallel paw placement), activity: recording the number of times photobeams are obstructed in an x, y, and z axis oriented grid system, 6 5-min period","direct injection: days 1, 8, 9, and 14 after injury; IV injection: day 1, 7, 14, 28 after injury; activity measure: day 18",,yes,positive effect,"BBB with human albumin: There was significant improvement (P<0.05) in BBB scores for albumin-treated animals at days 7, 14, and 28after injury; BBB direct rat albumin injection: significant improvement in BBB scores at days 8, 9, and 14 after injury (P<0.05 for all); activity measure in rat albumin group: significant differences between control and treated animals in the total distance traveled(P<0.02), the total number of rears (P<0.01), and the total number of beams breaks (P<0.001); activity measure human albumin: significant improve-ments, i.e., an increase in the distance traveled in the first 15 min in the PAS (Fig. 8) (P0.001 on days 7,14, and 28)",-,-,-,-,,-,"anesthesia: pentobarbital (50 mg/kg, IP)","Post-injury injection of albumin intravenously or into the site of injury immediately after injury both improved significantly locomotor function according to Basso-Beattie-Bresnahan assessment and spontaneous locomotor activity recorded with a photobeam activity system. Albumin has  multiple mechanisms whereby it may be neuroprotective, and it is a potentially useful agent for treating neuro-traumas",not reported,use pentobarbital,No,
Lucie,Tong et al,2018,Serum Albumin Predicts Long-Term Neurological Outcomes After Acute Spinal Cord Injury,10.1177/1545968317746781,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xing et al,2011,RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury,10.1016/j.expneurol.2011.06.018,English,,excluded,Out of scope,No assessments of interest,Out of scope: no result of interest,,,rats,Sprague Dawley,108,,,,,,,,female 100%,,,not reported,,,,,,,range: [180-250](g),,,,,,,level: T8; severity: moderate,,,,laminectomy + weight drop (NYU impactor as reported in Dill et al. 2008; Fu et al. 2007),"5, 7 days, 4, 6 weeks","naproxen, ibuprofen, indomethacin",,,"naproxen: 40 mg/kg/day, ibuprofen: 60 mg/kg/day, indomethacin: 4 mg/kg/day",1h after injury,,"5, 7, 28 days (depending on experiments)",daily,subcutaneous,,-,-,,-,-,,-,,-,histological assessment,myelin quantification,4 or 6 weeks,yes,positive effect,"we observed significantly increased LFB staining signals (sign of increased myelination) at different white matter areas of the spinal cord in SCI rats treated with ibuprofen or indomethacin, particularly with the former drug. In contrast, non-RhoA-inhibiting NSAIDnaproxen did not increase LFB staining signal in the spinal cord",anesthesia: ketamine (70 mg/kg) and xylazine (8 mg/kg); euthanasia: transcardially perfused with 100 ml phosphate buffer saline and then with 300 ml of 4% paraformaldehyde and 2% glutaraldehyde,"This study, together with previous reports, supports that RhoA signal is an important therapeutic target for promoting recovery of injured CNS and that RhoA-inhibiting NSAIDs provide great therapeutic potential for CNS axonal injuries in adult mammals.",not reported,no neurological test and weak on the histology part,,
Lucie,Jia et al,2019,"Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, anti-neuroinflammatory and anti-apoptotic properties",10.3892/mmr.2019.10537,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (icariin),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liang et al,2019,Simvastatin and simvastatin- Ezetimibe improve the neurological function and attenuate the endothelial inflammatory response after spinal cord injury in rat,http://www.annclinlabsci.org/content/49/1/105.long,English,,included,,,,,,rats,Sprague Dawley,30,8,,,8,,,sham n = 6,male 100%,male,100,3 months,3,,,,Months,,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + drop weight contusion (force of 800 g.cm, weight of 20g, height of 40 cm, dropped on footplate of diameter of 0.2 cm, dropped weight 5 times)",1 week,"simvastatin, ezetimibe and combinaison (all, including combination are drugs of interest)",simvastatin,,10 mg/kg,1h after injury,,3 doses,"1h, 24h and 72h after injury",oral,,neurological/functional/behavioral assessment,BBB scale,,-,"before injury, 24h, 72h and 7 days after injury",,not reported,positive effect,significantly better than no-treatment on day 7 only,histological assessment,area of injury,7 days,not reported,no stats,The area of injury was the largest in the no-treatment group. The simvastatin and combination therapy reduced the area of injury (no stastistical test),"anesthesia: pentobarbital sodium (50 mg/kg, IP); euthanasia: deeply anesthetized and perfused with saline, followed by 4% (w/v) paraformaldehyde in 0.1 mol/L PBS","The treatment groups, especially the combination treatment group, showed better neurological function scores. Simvastatin and simvastatin- ezetimibe all could improve the neurological function and attenuate the endothelial inflammatory response after spinal cord injury in rat",not reported,"use pentobarbital, saline",No,
Lucie,Liang et al,2019,Simvastatin and simvastatin- Ezetimibe improve the neurological function and attenuate the endothelial inflammatory response after spinal cord injury in rat,http://www.annclinlabsci.org/content/49/1/105.long,English,,included,,,,,,rats,Sprague Dawley,30,8,,,8,,,sham n = 6,male 100%,male,100,3 months,3,,,,Months,,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + drop weight contusion (force of 800 g.cm, weight of 20g, height of 40 cm, dropped on footplate of diameter of 0.2 cm, dropped weight 5 times)",1 week,"simvastatin, ezetimibe and combinaison (all, including combination are drugs of interest)",ezetimibe + simvastatin,,"simvastatin: 10 mg/kg, ezetimibe: 10 mg/kg",1h after injury,,3 doses,"1h, 24h and 72h after injury",oral,,neurological/functional/behavioral assessment,BBB scale,,-,"before injury, 24h, 72h and 7 days after injury",,not reported,positive effect,combination of treatment significantly better than no-treatment group starting 24h after injury until day 7,histological assessment,area of injury,7 days,not reported,no stats,The area of injury was the largest in the no-treatment group. The simvastatin and combination therapy reduced the area of injury (no stastistical test),"anesthesia: pentobarbital sodium (50 mg/kg, IP); euthanasia: deeply anesthetized and perfused with saline, followed by 4% (w/v) paraformaldehyde in 0.1 mol/L PBS","The treatment groups, especially the combination treatment group, showed better neurological function scores. Simvastatin and simvastatin- ezetimibe all could improve the neurological function and attenuate the endothelial inflammatory response after spinal cord injury in rat",not reported,"use pentobarbital, saline",Yes (drug of interest + drug of interest),
Lucie,Gao et al,2016,Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/beta-catenin signaling pathway after spinal cord injury,10.1111/jnc.13382,English,,included,,,,,,rats,Sprague Dawley,>= 54,>= 18,,,>= 18,,,numbers uncelar derived from figures,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: not reported (intend to induce hind limb paralysis and neurogenic bladder),T9 - T10,Not reported,contusion,"laminectomy + weight-drop (2-mm diameter impactor, weight 10g, dropped from height of 25mm)","3, 7, 14 days after SCI, 7 weeks",simvastatin,simvastatin,,10 mg/kg,immediately after injury,,2 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"ranged from 0 (complete paralysis) to 21 (unimpaired locomotion), open-field locomotor activity score was determined by observing and calculating the behaviors involving all hind limb joint movements, plantar placement, forelimb and hind limb coordination, and trunk stability","24h, 72h after SCI and then weekly for 7 weeks ",,yes,positive effect,simvastatin group significantly better than vehicle group starting 2 weeks after injury until the end of the experiment (7 weeks),histological assessment,"number of motor neurons, proportion of lesion size, TUNEL assay",14 days,not reported,positive effect,"proportion of lesion size significantly lower in simvastatin group compared to vehicle group, number of survival neurons significantly greater than in the vehicle group; significantly less cell TUNEL positive in treatment group compared to control","anesthesia: chloral hydrate (0.33 mL/kg, IP); postop: antibiotics were administered for 3 consecutive days after surgery","This study is the first to report that simvastatin exerts neuroprotective effects by reducing neuronal apoptosis, and promoting functional and pathological recovery after SCI by activating the Wnt/b-catenin signaling pathway",not reported,use chloral hydrate,No,
Lucie,Han et al,2012,Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat,10.1016/j.neulet.2012.05.071,English,,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,sham n = 10,female 100%,female,0,not reported,,,,,,Not reported,range: [260-280](g),,,260,280,g,,level: T10; severity: moderate,T10,moderate,contusion,laminectomy + weight-drop contusion (weight of 10g from 4cm onton an impounder of 0.2cm diameter gently placed on the spinal cord),4 weeks,simvastatin,simvastatin,,5 mg/kg,immediately after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"BBB scale, inclined plane",,"BBB: walk around freely in a circular field for 4 min while the movements of the hind limbs were closely observed, 2 observers; inclined plane test: maximum inclination at which the rat could maintain its position for 5 s was recorded as the final angle","day 1 and 3, then weekly until euthanasia",,yes,positive effect,"simvastatin group significantly better in terms of BBB and inclined plane test starting day 7 and 14 respectively, compared to vehicle group",histological assessment,"cavity volume, lesion size",4 weeks,not reported,mixed (stats/no stats),"cavity size significantly reduced in simvastatin group comapred to vehicle group, The mean lesion volume in the simvastatin group was smaller than that of the control group",anesthesia: pentobarbital (50 mg/kg intraperitoneally); euthanasia: anes-thetized and perfused transcardially with 4% paraformaldehyde in PBS,"simvastatin can help to repair spinal cord injury in rat, where the underlying mechanism appears to involve the mobilization of bone marrow stromal cells to the injured area and higher expression of BNDF and VEGF",not reported,use pentobarbital,No,
Lucie,Han et al,2011,Simvastatin treatment improves functional recovery after experimental spinal cord injury by upregulating the expression of BDNF and GDNF,10.1016/j.neulet.2010.09.007,English,,included,,,,,,rats,Sprague Dawley,32,8,,,16,,,sham n = 8,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T10; severity: moderate,T10,moderate,contusion,laminectomy + weight-drop contusion (weight of 10g from 4cm onton an impounder of 0.2cm diameter gently placed on the spinal cord),56 days,simvastatin,simvastatin,,5 or 10 mg/kg,1 day after injury,,5 weeks,daily,oral,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, inclined plane, motor evoked potentials (MEP), somatosensory evoked potentials (SEP)",,"BBB: walk around freely in a circular field for 4 min while the movements of the hind limbs were closely observed, 2 observers, 0 indicates no motor activity and 21 indicates a normal performance; inclined plane test: maximum inclination at which the rat could maintain its position for 5 s was recorded as the final angle; MEP: transcranial stimulation with two needle electrodes placed subcutaneously over the skull; the anode was placed over the sensorimotor cortex and the cathode, on the hard palate, single square electrical pulses (25 mA, 50 ms); SEP: elicited by applying stimuli (2 mA, 100 ms, 2.72 Hz) to the tibial nerve at the ankle. The active recording needle electrode was placed subcutaneously over the contralateral sensorimotor area; both MEP and SEP: latency and amplitude reported","BBB and inclined plane: day 1 and 3, then weekly until euthanasia; MEP and SEP: 56 days post SCI",,BBB and inclined plane: yes; MEP and SEP: not reported,mixed effects (dosage) + mixed effects (assessment),"simvastatin groups significantly better in terms of BBB and inclined plane test starting day 14 and 21 respectively, compared to vehicle group; 10 mg/kg group significantly higher scores for both assessments compared to the 5 mg/kg group; MEP and SEP: latency significantly reduced (+) with both treatment comapred to vehicule, amplitude significantly higher in simvastatin 10 mg/kg, but not in simavastatin 5 mg/kg, both compared to vehicle group",histological assessment,area of spare white tissue,8 weeks,not reported,mixed effects (assessment) + mixed effects (dosage),"significantly more % of area of spared white matter in both treatment groups compared to vehicle, with higher soe being more effective (significantly better than lower dose group at certain distances from the epicenter)","anesthesia: pentobarbital sodium (50 mg/kg, IP); euthanasia: pentobarbital sodium (80 mg/kg, IP) and perfused transcardially with 0.9% saline, followed by 4% paraformaldehyde","These findings suggest that simvastatin treatment starting 1 day after SCI can significantly improve locomotor recovery, and this neuroprotective effect may be related to the upregulation of BDNF and GDNF. Therefore, simvastatin may be useful as a promising therapeutic agent for SCI.",not reported,similarities in the phrasing and data reported between this paper and the 2 above; use pentobarbital,No,
Lucie,Chan et al,2005,Dose-dependent beneficial and detrimental effects of ROCK inhibitor Y27632 on axonal sprouting and functional recovery after rat spinal cord injury,10.1016/j.expneurol.2005.08.011,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Y27632),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Han et al,2020,Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury,10.1111/jcmm.15501,English,,included,,,,,,rats,Sprague Dawley,>= 108,>= 24,,,>= 24,,,"sham >= 24, other treamtent group >= 12",female 100%,female,0,6-8 weeks,,,6,8,Weeks,,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + weight drop contusion (MACSIS/NYU Impactor, 10 g forces, 3 cm height)","1, 3, 5, 7, 14, 28 days",sitagliptin or sitagliptin+exendin9-39 (not further reported),sitagliptin,,10 mg/kg,after injury,,up to 28 days,daily,oral,,neurological/functional/behavioral assessment,"BBB scale, footprint analysis",,"BBB: open experimental field and allowed to move freely for 5 minutes. 5 investigators, score ranging from 0 (complete paralysis) to 21 (normal locomotion); footprint analysis: dipping the animal's posterior limb with red dye and fore limb with blue dye. All of the rats were tested in a confined walkway (about a 10cm wide by 100 cm long white paper), and then the hindlimb motion trajectories printed on the white runway were collected","BBB: 0, 3, 7, 14 and 28 days; footprint analysis: 14 days after injury",,yes,mixed (stats/no stats),BBB: scores signficantly higher in sitagliptin group compared to vehicle; footprint analysis: Sitagliptin treatment group performed a coordinated crawling and tail lift and slight staggering gait whereas SCI group still dragged their hind limbs (no stats),histological assessment,"percentage of cavity per section, quantification of ventral motoneurons",28 days,not reported,positive effect,"sitagliptin-treated group remarkably reducedtissue loss and cavity formation + percentage of cavity size signficiantly lower in treatment compare to vehicle group, and number of ventral motoneurons significantly higher in treatment comapred to vehicle group","anesthesia: 8% (w/v) chloral hydrate (3.5 mL/kg, ip); euthanasia: anesthetized by 8% (w/v) chloralic hydras (3.5 mL/kg, ip), transcardial perfusion with normal saline",sitagliptin may be a potential agent for axon regrowth and locomotor functional repair via GLP-1R-induced AMPK/ PGC-1α signalling pathway after SCI.,not reported,use chloral hydrate,Yes (drug of interest + drug not of interest),
Bobo,Li et al,2011,The protective effects of valproic acid on acute spinal cord injury in rats,10.3969/j.issn.1001-1242.2011.04.011,Chinese,,excluded,No access,,,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Harada et al,2006,Role of prostacyclin in the development of compression trauma-induced spinal cord injury in rats,10.1089/neu.2006.23.1739,English,,excluded,Article retracted,,article retracted,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lanza et al,2019,Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury,10.1007/s12035-018-1347-7,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (sodium butyrate),,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Lanza et al,2019,Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury.,10.1007/s12035-018-1347-7,English,,excluded,Duplicate,,same article just above,,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Roonprapunt et al,2003,Soluble cell adhesion molecule L1-Fc promotes locomotor recovery in rats after spinal cord injury,10.1089/089771503322385809,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (soluble chimeric dimer of mouse L1 cell adhesion molecule and human Fc),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bobo,He et al,2016,Propofol intervention affects spinal cord edema and hindlimb electrophysiology in a model of spinal cord injury,10.3969/j.issn.2095-4344.2016.05.006,Chinese,,included,,,,,,rats,Sprague Dawley,65,20,,,20,,,"45 SCI (20 SCI, 20 propofol, 2 died after SCI, 3 had unsuccessful injuries), 20 sham",female 100%,female,100,3 months,,,,3,Months,Adult,range [250-300] (g),,,250,300,g,,level T8; severity: not reported,T8,Not reported,contusion,modified Allen's method: 10g weight dropped from 2.5cm,not reported,propofol,propofol,No,2ml/kg,for 4 hours after injury,,single dose,immediately after injury,intravenously,via tail vein,functional assessment and neurological,"BBB Locomotor test, inclined plate test, motor evoked potentials, somatosensory evoked potentials",,BBB- 21 point scale,"before injury, 1 and 3 days after injury and at 1-4 weeks after injury",Yes,not reported,positive effect,"from 1-4 weeks after SCI, all BBB scores were higher than SCI group (statistically significant); from 1-4 weeks after SCI, rats in propofol group did better at each inclined plate test (1,2,3,4 weeks)- statistically significant; propofol group showed significant recovery of motor evoked potentials and somatosensory evoked potentials, shortened latency and increased amplitude, difference was signifcant compared with the sham group and SCI group",immunochemistry,"TUNEL assay, RT-PCR, hematoxylin-eosin staining",72 hours after injury; hematoxylin-eoin staing (4 weeks post injury),not noted,positive effect,"at 72 hours after SCI, the expression of water channel protein, matrix metalloproteinase mRNA and protein in the spinal cord tissue of the injured area was higher in the propofol group than in the sham group (stat significant); the expression of water channel proten, matrix metalloproteinase mRNA and protein in the spinal cord  tissue of the injured area of the rats in the propofol group was significantly reduced compared with that in the spinal cord injury group",anesthesia: 10% chrloral hydrate (350mg/kg),"propofol can reduce neuronal cell apoptosis, decrease spinal cord edema related gene expression and improve electrophysiological function and limb motor function after SCI",,,No,
Lucie,Wang et al,2015,Panax notoginseng saponins improve recovery after spinal cord transection by upregulating neurotrophic factors,10.4103/1673-5374.162766,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Panax notoginseng saponins),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Datto et al,2015,Does being female provide a neuroprotective advantage following spinal cord injury?,10.4103/1673-5374.165213,English,,excluded,Review,,,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fandel et al,2013,Spinal cord injury induced changes of nuclear receptors PPAR alpha and LXR beta and modulation with oleic acid/albumin treatment,10.1016/j.brainres.2013.08.022,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (oleic acid+albumin but no group with albumin alone),,,rats,Wistar,,,,,,,,,male 100%,,,2-3 months old,,,,,,,range: [250-300](g),,,,,,,level: T9; severity: not reported,,,,"laminectomy + contusion (MASCIS impactor, weight drop of 11g from height of 12 mm onto a cylindrical flat-tippes impactor with a 2.5mm diameter, placed at the midline aver the intact dura)",28 days,mixture of oleic aid and albumin (OA/albumin complex),,,10 microL,immediately following surgery,,4 weeks,every 3 days,intrathecally,,-,-,,-,-,,-,,-,histological assessment,cell counting,28 days,yes,,"When IR cells were counted manually a significant reduction of PPARα appeared at 1–2 mm distance from the lesion site (ANOVA, F ¼25.8, 34.5,14.3, po0.001 for dorsal, lateral and ventral samples, results of post hoc tests are indicated in Fig. 7a–c). Quantitative measurements of PPARα fluorescence levels showed similar effects as cell counting (Fig. 7d–f). However, given the variability of the data the changes over all were not significant (ANOVA, p40.1).","anesthesia: sodium pentobarbital (65 mg/kg, IP), xylazine (10 mg/kg, IP), atropine (0.8 mg/kg, IP); postop: daily antibiotic 0.1 mL 2.5% enrofloxacin for 3 days; euthanasia: overdose of sodium pentobarbital followed by transcardial perfusion with saline and then with 4% paraformaldehyde in 0.1M PB",Spinal cord injury induced changes of nuclear receptors PPARα and LXRβ and intrathecal injections of oleic acid/albumin reduced the lesion-induced PPARα immunoreactivity,not reported,,,
Matthias,Mathais et al,2018,Spontaneous Cervical Spinal Epidural Hematoma Associated with Dabigatran,10.1016/j.wneu.2018.01.199,English,,excluded,Case report,,,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Holmberg et al,2008,Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury,10.1016/j.expneurol.2008.07.020,English,,included,,,,,,rats,Long Evans,>= 27,>= 3 - 6,,,>= 24 - 42,,,counts very unclear,female 100%,female,0,not reported (adults),,,,,,Adult,range: [200-220](g),,,200,220,g,,level: T8-T9; severity: not reported,T8 - T9,Not reported,contusion,"laminectomy + contusion (weight drop method, impact rod og 10g with NYU impactor device from height of 25mm)",4 weeks,simvastatin,simvastatin,,"intraventricular: 0.25 microL/h, oral gavage low dose: 0.57 mg/kg/day, oral gavage high dose: 2.3 mg/kg/day",not reported,,4 weeks,"intraventricular: continuous via osmotic pump, oral gavage: once daily",multiple,intraventricular or oral,neurological/functional/behavioral assessment,BBB score,,open field,"1, 3, 7 days post-injury, once weekly afterwards until week 4",,not reported,no effect,"only significant difference with control in the intraventricular group at week 3 but not at week 4, all other test between control and any treatment group was not significant",histological assessment,spared white matter tissue area,4 weeks,not reported,no effect,white matter area was not affected by simvastatin treatment ,"anesthesia: sodium pentobarbital (45 mg/kg, i.p.), postop care: buprenorphine (0.02 mg/kg, s.c., twice a day for the first 2 days) for pain, cephazolin (40 mg/kg, s.c., twice a day for 1 week), saline solution (Normasol R, 5 ml, s.c.) was administered twice daily for 1 week for prevention of dehydratation, euthanasia: transcardial perfusion with 4% PFA","Although statins permit neurite outgrowth in the presence of inhibitory molecules (Holmberg et al., 2006) and decrease astrocyte activation and CSPG expression, this did not translate to robust functional improvements.",not reported,"use buprenorphine, pentobarbital, saline",No,
Matthias,Bamba et al,2017,Polyethylene glycol restores axonal conduction after corpus callosum transection,10.4103/1673-5374.206645,English,,excluded,Non-sci population,,The corpus callosum was subsequently transected ,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lapointe et al,2008,Tail Pinching-Induced Hindlimb Movements Are Suppressed by Clonidine in Spinal Cord Injured Mice,10.1037/0735-7044.122.3.576,English,,excluded,Out of scope,No control group,,,,mice,CD1,29,,,,,,,,male 100%,male,100,not reported (adults),,,,,,Adult,range: [30-35](g),,,30,35,g,,level: T9-T10; severity: complete,T9 - T10,,transection,"laminectomy + complete transection (intervertebrally, using microscissors, all remaining fibers were severed wuth scissors tips by scraping the inner vertebral walls)",1 day,clonidine,clonidine,,0.25 or 5.0 mg/kg,"6 or 41 days after transection, before testing",,2 days,once on 2 consecutive days,intraperitoneally,,neurological/functional/behavioral assessment,"average combined score (ACOS), Antri Orsal and Barthe assessment method (AOB), tail pinching",,"ACOS: semiquantitative method reporting amplitude incidence and frequency (number per minute) of non-locomotor movements and locomotor-like movements; AOB: 22 discriminative scores, grouped into 4 categories or levels, 0=no movement, 1=weak limb jerks, 2=weak rythmic movement s with no bilateral alternation, 3=large ryth,..[same as 2], 4=weak rhythmic movements with occasional bilateral alternation, 5=large rhythmic movements with occasional bilateral alternation, 6=weak rhythmic movements with frequent bilateral alternation; tail pinching: custom-made pinching device calibrated to generate a constant force of 600 g, only on second day of testing",immediately and 20 minutes after treatment (day 6 or 41 after transection),,not reported,mixed effects,"clonidine at day 6 and 7: no change in ACOS, AOB or (non)-locomotor movements before and after injection of clonidine, no comparison with a control not treated, no comparison between the groups with differents doses, no difference with tail pinching; clonidine at day 41 and 42: non-locomotor movements and ACOS significantly lower before and after injection (regardless of dose) when combined with tail pinching, also AOB with low dose",-,-,-,-,,-,"preop: lactate Ringer’s solution (1.0 ml, s.c.), an analgesic (buprenorphine; 0.1 mg/kg, s.c.) and an antibiotic (Baytril; 5 mg/kg, s.c.) was given 30 minutes before the surgery; anesthesia: not reported; postop care: daily administration of lactate-Ringer’s solution (2 *1.0 ml, s.c.), buprenorphine (2 *0.1mg/kg, s.c.), and Baytril (5 mg/kg, s.c.) was provided for the following 3 days",results suggest that the prolocomotor effects of clonidine reported elsewhere must depend upon stimuli or factors that remain to be identified,not reported,no control group,,
Lucie,Kondratskaya et al,2019,Locomotor central pattern generator excitability states and serotonin sensitivity after spontaneous recovery from a neonatal lumbar spinal cord injury,10.1016/j.brainres.2018.12.001,English,,excluded,Out of scope,Ex-vivo,Out of scope: spinal cord studied ex-vivo,,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sobrido-Cameán et al,2020,Taurine Promotes Axonal Regeneration after a Complete Spinal Cord Injury in Lampreys,10.1089/neu.2019.6604,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,lampreys,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Williams et al,2015,Testosterone Recovery after Polytrauma and Scrotal Injury in Patients from Operation Enduring Freedom and Operation Iraqi Freedom,10.1016/j.juro.2014.08.105,English,,excluded,Non-sci population,,scrotal injuries,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2018,Lithium promotes recovery of neurological function after spinal cord injury by inducing autophagy,10.4103/1673-5374.241473,English,,included,,,,,,rats,Sprague Dawley,72,18,,,18,,,"one treatment group not of interest and sham, both n = 18",male 100%,male,100,not reported (adults),,,,,,Adult,range: [230-270](g),,,230,270,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop contusion (NYU impactor, 10g rod dropped from a height of 25 mm)","6h, 1, 3 and 7 days, 4 weeks ",lithium chloride,lithium,,30 mg/kg,6h after injury,,until sacrifice,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB score,,"0=complete paralysis, 21=normal based on range and extent of motion, weight loading, coordination of the forelimbs and hindlimbs and motion of the forepaw, hindpaw and tail, 3 independent examiners, average score taken as final score for each rat at each time point","before surgery, 6h after, 1, 2, 3, and 4 weeks after surgery",,yes,positive effect,"BBB scores were significantly higher in the lithium group than in the SCI and 3-MA groups at 1, 2, 3 and 4 weeks after SCI",histological assessment,(only immunohistochemistry),"6h, 1, 3 and 7 days after injury",yes,,-,"anesthesia: chloral hydrate (300 mg/kg, IP); postop: penicillin 20 U/kg IP once daily until bladder function was reestablished","findings show that lithium reduces neuronal damage after acute SCI and promotes neurological recovery by inducing autophagy. The neuroprotective mechanism of action may not be entirely dependent on the enhancement of autophagy, and furthermore, 3-MA might not completely inhibit all autophagy pathways.",not reported,"use chloral hydrate, penicillin",No,
Lucie,Nantwi et al,1999,Spontaneous Functional Recovery in a Paralyzed Hemidiaphragm Following Upper Cervical Spinal Cord Injury in Adult Rats,10.1177/154596839901300404,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hu et al,2013,Tetramethylpyrazine accelerates the function recovery of traumatic spinal cord in rat model by attenuating inflammation,10.1016/j.jns.2012.10.009,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Tetramethylpyrazine),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2016,Tetramethylpyrazine improves the recovery of spinal cord injury via Akt/Nrf2/HO-1 pathway,10.1016/j.bmcl.2016.01.015,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Tetramethylpyrazine),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kijma et al,2019,The acute phase serum zinc concentration is a reliable biomarker for predicting the functional outcome after spinal cord injury,10.1016/j.ebiom.2019.03.003,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,multiple,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tedeshi et al,2016,The Calcium Channel Subunit Alpha2delta2 Suppresses Axon Regeneration in the Adult CNS,10.1016/j.neuron.2016.09.026,English,,included,,,,,,mice,C57BL/6,>= 28,>= 15,,,>= 13,,,based on figure 7 taking into account both the initial study and the blind replicate,female 100%,female,0,7-8 weeks old,,,7,8,Weeks,,not reported,,,,,,Not reported,level: T11-T12; severity: complete,T11 - T12,Not reported,multiple,"laminectomy + spinal cord was crushed with #5 modified forceps, positioned to server dorsal column axons completely, additional experiments included a dorsal hemisection model using a microknife","2, 4 weeks",pregabalin (PGB),pregabalin,,46 mg/kg,1h or 14 days after injury,,until the end of the study,"3 times a day for 1 week, then 2 times a day until the end of the study",intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","Von Frey testing, sciatic nerve stimulation",,"Von Frey: plantar threshold was measured using retractable monofilaments (Ugo Basile) calibrated to deliver a target force spanning from 0.4 (normal) to 4 gr (diminished light touch). A quick withdrawal of the hind paw was considered as a positive response. Signs of supraspinal sensitization (i.e. sustained paw withdrawal and/or licking the paw) were also annotated. A pause of 20-30 sec was given to allow sensory receptors to reach baseline levels between each monofilament application. After 20 stimuli presentations, the lowest force, which produced a retraction at least 50% of the time, determined the response threshold; Sciatic nerve stimulation: left sciatic nerve was exposed at the mid-thigh level and electrically stimulated at 5 Hz for 5 min using a square pulse stimulator followed by a 5 min pause",7 days after first injection,,not reported,negative effect,"target force significantly higher in the PGB group compared to vehicle, supraspinal sensitization significanrlt reduced in PGB group compared to vehicle",histological assessment,"quantification of dorsal column regeneration: number of regenerating axons, lesion area","2, 4 weeks",yes,mixed effects (assessment) + mixed effects (regimen),"crush: significantly longer length of the longest axon in group treatment with PGB, significantly more regenerating axons at lesion level and rostral to it in PGB group compared to vehicle; hemisection: significantly higher percent of axons in PGB group, lesion area not significantly different",anesthesia: mixture of ketamine (100 mg/kg body weight) and xylazine (10 mg/kg body weight),"Alpha2delta2 pharmacological blockade through Pregabalin (PGB) administration enhanced axon regeneration in adult mice after spinal cord injury (SCI). As PGB is already an established treatment for a wide range of neurological disorders, our findings suggest that targeting Alpha2delta2 may be a novel treatment strategy to promote structural plasticity and regeneration following CNS trauma",not reported,"very dense paper, use ketamine",No,
Lucie,Côté et al,2004,Step training-dependent plasticity in spinal cutaneous pathways,10.1523/JNEUROSCI.1486-04.2004,English,,excluded,Out of scope,No drug tested,Out of scope: no drug tested,,,cats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,De Nicola et al,2003,Steroid effects on glial cells - Detrimental or protective for spinal cord function?,10.1196/annals.1286.030,English,,excluded,Out of scope,No assessments of interest,Out of scope: no outcome of interest,,,rats,Sprague Dawley,at least 16,,,,,,,,male 100%,,,not reported,,,,,,,range: [250-300](g),,,,,,,level: T10; severity: not reported,,,,laminectomy + transection (sharp edge of a 25-G needle),75h after injury,progesterone,,,4 mg/kg,1h after injury,,4 doses in total,"once a day (24h, 48h and 72h after injury)",multiple,,-,-,,-,-,,-,,-,histological assessment,,"75h after injury, 3h atfer last dose",not reported,,,not reported,"progesterone effects may be supportive of neuronal recuperation, as shown for several neuronal function parameters that were normalised by progesterone treatment of spinal cord injured animals, progesterone effects on glial cells go in parallel with morphological and biochemical evidence of survival of damaged motoneurons",not reported,no neurological assessment,,
Matthias,Schumacher et al,2000,Steroid synthesis and metabolism in the nervous system: Trophic and protective effects,10.1023/A:1007152904926,English,,excluded,Review,,,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Döring et al,2015,"Stimulation of Monocytes, Macrophages, and Microglia by Amphotericin B and Macrophage Colony-Stimulating Factor Promotes Remyelination",10.1523/JNEUROSCI.1797-14.2015,English,,excluded,Non-sci population,,no SCI per se but lysolecithin-induced demyelination instead,,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Bydon et al,2014,The Current Role of Steroids in Acute Spinal Cord injury,10.1016/j.wneu.2013.02.062,English,,excluded,Review,,,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Dulin et al,2013,The Dual Cyclooxygenase/5-Lipoxygenase Inhibitor Licofelone Attenuates P-Glycoprotein-Mediated Drug Resistance in the Injured Spinal Cord,10.1089/neu.2012.2587,English,,excluded,Out of scope,No assessments of interest,Out of scope: no outcome of interest (interested in drug delivery to the spinal cord),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nategh et al,2016,Subarachnoid space transplantation of Schwann and/or olfactory ensheathing cells following severe spinal cord injury fails to improve locomotor recovery in rats,PMID: 27832687,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Schwann cells or olfactory ensheathing cell),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kim et al,2017,Lithium ameliorates rat spinal cord injury by suppressing glycogen synthase kinase-3 beta and activating heme oxygenase-1,10.5115/acb.2017.50.3.207,English,,included,,,,,,rats,Sprague Dawley,30,10,,,10,,,sham n = 10,female 100%,female,0,7-8 weeks,,,7,8,Weeks,,range: [200-250](g),,,200,250,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,compression,"laminectomy + compression injury (clip compression with vascular clip, applied vertically to the exposed spinal cord at an occlusion presure of 15-20g for 1 min)","0, 4, 7 and 14 days",lithium chloride,lithium,,80 mg/kg/day,30 min after injury,,3 days,"not reported ""identical doses were given on each of the next 3 days""",intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"double-blinded, average scores were calculated for each group and use to compare the severity of hind-limb anaysis",daily from day 1 to 14 after injury,,yes,positive effect,BBB scores significantly higher starting day 8 until end of experimetn in lithium treated group compared to control group,histological assessement,"cellularity, edema, inflammatory cells infiltration, microglia activation, vacuoles","0, 4, 7, 14 days",not reported,no stats,"severe edema and hemorrhage were evident in the lithium-treated group, accumulation of round-type inflammatory cells (Fig. 2D); activated microglia; and small, round vacuoles were evident in the core regions of spinal cords of the lithium-treated group by 4 DPI ",anesthesia: zoletil 50 (IM); euthanasia: perfused with 4% v/v paraformaldehyde in PBS,"GSK-3β becomes activated after SCI, and that a non-specific enzyme inhibitor, lithium, ameliorates rat SCI by increasing phosphorylation of GSK-3β and the associated molecules Nrf-2 and HO-1",not reported,,No,
Matthias,Wang et al,2011,Supplement moderate zinc as an effective treatment for spinal cord injury,10.1016/j.mehy.2011.06.037,English,,excluded,Opinion,,"medical hypothesis, non-original",,,multiple,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sanli et al,2012,"Effect of curcumin on lipid peroxidation, early ultrastructural findings and neurological recovery after experimental spinal cord contusion injury in rats",10.5137/1019-5149.JTN.5193-11.1,English,,included,,,,,,rats,Wistar,40,8,,,8,,,"sham n = 8, 2 other group n = 8 not of interest",female 100%,female,0,not reported (adults),,,,,,Adult,range: [210-250](g),,,210,250,g,,level: T7-T9; severity: moderate,T7 - T9,moderate,contusion,"laminectomy + weight drop contusion (50 g/cm weight drop, stainless steel rod with rounded surface 3mm in diameter whiching 10g though a 5cm guided tube positioned perpendicular to the center of the spinal cord, dura left intact from the laminectomy)","immediately after surgeyr for sham group, 24h for all other groups","methylprednisolone sodium succinate (MPSS), (dimethyl sulfoxide and curcumiin also tested but not of interest so not further reported)",methylprednisolone sodium succinate,No,30 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane test, modified Tarlov's motor scale",,"inclined plane test: rat placed on mat with body axis perpendicular to the axis of an inclined plane, angle of the plane maximized so that a rat could maintain itself for at least 5 sec; Tarlov's score: 0= no spontaneous movement, 5=normal walking behavior",before surgery and 24h after surgery,,yes,no effect,inclined test: no difference between trauma-no treatment group and group with trauma and MPSS; Tarlov's scale: no statisitcally significant difference between trauma and MPSS groups,histological assessment,"grading system for quantitative evaluation of ultrastructural findings from 0 to 3 about mitochondria, small- medium- and large-diameter myelinated axons",24h after SCI,yes,mixed effects (assessment),"mitochondria: MPSS group better than trauma group (significant), small- medium- and large-diameter myelinated axons: no difference between trauma and MPSS group","anesthesia: xylasine (10 mg/kg, IM), ketamine hydrochloride (60 mg/kg), disinfection with 10% of polyvinylpyrrolidone/iodine","Since ultrastructural and neurological findings does not support biochemical finding, our findings do not exclude the possibility that curcumin has a protective effect on the spinal cord ultrastructure and neurological recovery after SCI. A combination of curcumin with other vehicle may also have a considerable synergy in protecting spinal cord",not reported,use ketamine,No,
Lucie,Huang et al,2017,Intradiencephalon injection of histamine inhibited the recovery of locomotor function of spinal cord injured zebrafish,10.1016/j.bbrc.2017.05.158,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (histamine),,,fish,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Youn Lee et al,2010,Ethanol Extract of Bupleurum falcatum Improves Functional Recovery by Inhibiting Matrix Metalloproteinases-2 and -9 Activation and Inflammation after Spinal Cord Injury.,10.5607/en.2010.19.3.146,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ethanol extract of Bupleurum falcatum),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Salimi et al,2020,Combined Therapy Following Spinal Cord Injury: Synergistic Neuroprotective Effects of Ceftriaxone and N-acetylcysteine,10.5812/ircmj.98995,English,,included,,,,,,rats,Wistar,28,7,,,7,,,,male 100%,male,100,10-11 weeks (adults),,,10,11,Weeks,Adult,range: [280-300](g),,,280,300,g,,level: T10; severity: moderate,T10,moderate,contusion,lainectomy + contusion (NSRC impactor with force of 150 kilodyne),6 weeks,"ceftriaxone, N-acetylcysteine and combination",ceftriaxone,,100 mg/kg,not reported,,7 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB score,,"evaluated for each rat according to the movement of each joint, each paw position, coordination, and stepping from 0=no observable hindlimb movement to 21=normal movement, including consistently coordinated stepping with parallel paw position during locomotion",weekly for 6 weeks,,yes,positive effect,"all treated groups were significantly better than control group, combination group significantly better than acetylcysteine alone, but not ceftriaxone alone",histological assessment,"tissue injury indices as cytoarchitectural disorganization (lymphocyte infiltration, axonal swelling, spared tisue, pyknotic nuclei, vacuolation, cystic degenration and large cystic cavity), severity of histopathological lesion documented as 0=none, 1=very low, 2=low, 3=moderate, 4=severe, 5=very severe",6 weeks,yes,positive effect,"all treatment groups had significantly better (lower) histological scores compared to saline control group, no significant difference between the 3 treatment groups","anesthesia: inhalation of isoflurane-oxygen mixture with the induction dose of 5% for 5 min and a maintenance dose of 2%-3% during surgery, postop: 0.05 mg/kg ketoprofen SC immediately after surgery, repeated the next day for pain, first week after surgery: daily cirpofloxacin (8 mg/kg/day, IP) in 2 mL saline to prevent infection and dehydration","Treatment with ceftriaxone and N-acetylcysteine, either separately or in combination, promotes locomotor recovery following SCI, which is associated with the effective reduction of the histopathological lesion.",not reported,"use isoflurane, ketoprofen",No,
Lucie,Salimi et al,2020,Combined Therapy Following Spinal Cord Injury: Synergistic Neuroprotective Effects of Ceftriaxone and N-acetylcysteine,10.5812/ircmj.98995,English,,included,,,,,,rats,Wistar,28,7,,,7,,,,male 100%,male,100,10-11 weeks (adults),,,10,11,Weeks,Adult,range: [280-300](g),,,280,300,g,,level: T10; severity: moderate,T10,moderate,contusion,lainectomy + contusion (NSRC impactor with force of 150 kilodyne),6 weeks,"ceftriaxone, N-acetylcysteine and combination",acetylcysteine,,150 mg/kg,not reported,,7 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB score,,"evaluated for each rat according to the movement of each joint, each paw position, coordination, and stepping from 0=no observable hindlimb movement to 21=normal movement, including consistently coordinated stepping with parallel paw position during locomotion",weekly for 6 weeks,,yes,positive effect,"all treated groups were significantly better than control group, combination group significantly better than acetylcysteine alone, but not ceftriaxone alone",histological assessment,"tissue injury indices as cytoarchitectural disorganization (lymphocyte infiltration, axonal swelling, spared tisue, pyknotic nuclei, vacuolation, cystic degenration and large cystic cavity), severity of histopathological lesion documented as 0=none, 1=very low, 2=low, 3=moderate, 4=severe, 5=very severe",6 weeks,yes,positive effect,"all treatment groups had significantly better (lower) histological scores compared to saline control group, no significant difference between the 3 treatment groups","anesthesia: inhalation of isoflurane-oxygen mixture with the induction dose of 5% for 5 min and a maintenance dose of 2%-3% during surgery, postop: 0.05 mg/kg ketoprofen SC immediately after surgery, repeated the next day for pain, first week after surgery: daily cirpofloxacin (8 mg/kg/day, IP) in 2 mL saline to prevent infection and dehydration","Treatment with ceftriaxone and N-acetylcysteine, either separately or in combination, promotes locomotor recovery following SCI, which is associated with the effective reduction of the histopathological lesion.",not reported,"use isoflurane, ketoprofen",No,
Lucie,Salimi et al,2020,Combined Therapy Following Spinal Cord Injury: Synergistic Neuroprotective Effects of Ceftriaxone and N-acetylcysteine,10.5812/ircmj.98995,English,,included,,,,,,rats,Wistar,28,7,,,7,,,,male 100%,male,100,10-11 weeks (adults),,,10,11,Weeks,Adult,range: [280-300](g),,,280,300,g,,level: T10; severity: moderate,T10,moderate,contusion,lainectomy + contusion (NSRC impactor with force of 150 kilodyne),6 weeks,"ceftriaxone, N-acetylcysteine and combination",ceftriaxone + acetylcysteine,,ceftriaxone: 100 mg/kg + acetylcysteine: 150 mg/kg,not reported,,7 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB score,,"evaluated for each rat according to the movement of each joint, each paw position, coordination, and stepping from 0=no observable hindlimb movement to 21=normal movement, including consistently coordinated stepping with parallel paw position during locomotion",weekly for 6 weeks,,yes,positive effect,"all treated groups were significantly better than control group, combination group significantly better than acetylcysteine alone, but not ceftriaxone alone",histological assessment,"tissue injury indices as cytoarchitectural disorganization (lymphocyte infiltration, axonal swelling, spared tisue, pyknotic nuclei, vacuolation, cystic degenration and large cystic cavity), severity of histopathological lesion documented as 0=none, 1=very low, 2=low, 3=moderate, 4=severe, 5=very severe",6 weeks,yes,positive effect,"all treatment groups had significantly better (lower) histological scores compared to saline control group, no significant difference between the 3 treatment groups","anesthesia: inhalation of isoflurane-oxygen mixture with the induction dose of 5% for 5 min and a maintenance dose of 2%-3% during surgery, postop: 0.05 mg/kg ketoprofen SC immediately after surgery, repeated the next day for pain, first week after surgery: daily cirpofloxacin (8 mg/kg/day, IP) in 2 mL saline to prevent infection and dehydration","Treatment with ceftriaxone and N-acetylcysteine, either separately or in combination, promotes locomotor recovery following SCI, which is associated with the effective reduction of the histopathological lesion.",not reported,"use isoflurane, ketoprofen",Yes (drug of interest + drug of interest),
Lucie,Xia et al,2013,Sustained delivery of dbcAMP by poly(propylene carbonate) micron fibers promotes axonal regenerative sprouting and functional recovery after spinal cord hemisection,10.1016/j.brainres.2013.09.027,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (poly(propylene carbonate) (PPC) electrospun fibers as vehicle for the sustained delivery of dibutyryl cyclic adenosine monophosphate (dbcAMP)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2008,Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury,10.1016/j.biomaterials.2008.07.050,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Glial cell line derived neurotrophic factor  loaded in biodegradable poly(lactic acid-co-glycolic acid)),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hanna et al,2016,Sustained release of neurotrophin-3 via calcium phosphate-coated sutures promotes axonal regeneration after spinal cord injury,10.1002/jnr.23730,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (peripheral nerve grafts (PNGs) asscaffolds for axonal growth while delivering neurotrophin-3 (NT-3) via calcium phosphate (CaP) coatings on surgicalsutures),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Carlson et al,2003,Sustained spinal cord compression - Part I: Time-dependent effect on long-term pathophysiology,10.2106/00004623-200301000-00014,English,,excluded,Out of scope,No drug tested,No treatment tested,,,dogs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xu et al,2018,Sustained-release of FGF-2 from a hybrid hydrogel of heparin-poloxamer and decellular matrix promotes the neuroprotective effects of proteins after spinal injury,10.2147/IJN.S152246,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (fibroblast growth factor 2),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2021,Synaptic remodeling in mouse motor cortex after spinal cord injury,10.4103/1673-5374.295346,English,,excluded,Out of scope,No drug tested,No treatment tested,,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ni et al,2018,Synchrotron radiation imaging reveals the role of estrogen in promoting angiogenesis after acute spinal cord injury in rats,10.1097/BRS.0000000000002629,English,,included,,,,,,rats,Sprague Dawley,>= 24,>= 8,,,>= 8,,,sham >= 8,male 100%,male,100,not reported (adults),,,,,,Adult,range: [280-300](g),,,280,300,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + weight drop contusion (modified Allen impact method, moderate vertical impact load, dropped a constant weight of 8g from a vertical height of 4 cm)","3, 7, 28 days",estrogen,estrogen,,10 g/kg,30 min after injury,,1 week,daily,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"2 investigators, final score for each animal was obtained by calculating the average value obtained from the 2 investigators","1, 3, 7, 14, 21, 28 days",,yes,positive effect,BBB scores in the estrogen groups were significantly higher than in the vehicle group,histological assessment,"lesion area measurement, cystic cavity",28 days,not reported,positive effect,Treatment with low doses of estrogen generated a significantly smaller lesion area and larger spared tissue area compared to treatment with saline groups at the injury epicenter and in regions extending away from the epicenter both rostrally and caudally ,"anesthesia: ketamine (80 mg/kg), xylazine (10 mg/kg); euthanasia: anesthesia + heparinized saline, fixation with 10% buffered formalin",The results indicated that synchrotron radiation is a powerful imaging tool for visualizing angiogenesis after acute SCI. Estrogen treatment exerted a neuroprotective effect on acute SCI treatment by promoting angiogenesis and reducing the injury-induced lesion area could be recommended as a potential preclinical treatment approach for acute SCI.,not reported,use ketamine,No,
Lucie,Xiao Jianru et al,1998,Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury,https://medcentral.net/doi/epdf/10.5555/cmj.0366-6999.111.05.p443.01,English,,included,,,,,,cats,house cats,72,18,,,18,,,2 treatment groups not of interest,male 100%,male,100,not reported,,,,,,Not reported,range: [2.5-3.5](kg),,,2.5,3.5,kg,,level: C6; severity: not reported,C6,Not reported,contusion,"laminectomy + weight drop contusion (modified Allen method, 20g weight dropped from a height of 22.5cm though a guide tube onto a 10 mm^2 impact plate, dura intact)",6 weeks,naloxone,naloxone,,2 mg/kg/h,2h after injury,,5 days,"continuous infusion for 4h, once per day",not reported,,neurological/motor assessment,motor function (modified Tarlov scale),,"modification of the 6-point ordinal scale, forelimb and hindlimb scored separately, 0=abscence of voluntary movement, 5=normal motor function, total neurologic functional score obtained by adding the scores for the forelimb and hindlimb",weekly,,not reported,positive effect,total neurologic functional scores were significantly higher in animals treated with naloxone than in saline treated controls 6 weeks after injury,histological assessment,"blood spinal cord barrier (BSCB) permeability, water content of cervical cord, percentage of area of remained cord tissue to that of total cross section","6 h for water content, 6 weeks",not reported,positive effect,water content decreased in naloxone treatment group 6h after injury compared with control group (p<0.05); viable area in naloxone treated animals was significantly more than in the saline treated controls both in gray and white matter,anesthesia: pentobarbital sodium (40 mg/kg); euthanasia: anesthesia with pentobarbital sodium and sacrificed by perfusion with 4% glutaraldehyde and cacodylate buffer,combined blockade by 2 kinds of autolesion mediator receptor can more effectively inhibit secondary damage production and development after cervical cord injury and improve neurologic function,not reported,no route reported,Yes (drug of interest + drug not of interest),
Lucie,Baffour et al,1995,Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury,10.3171/jns.1995.83.1.0105,English,,included,,,,,,rats,Sprague Dawley,58,8,2,,10,4,,other groups not of interest,male or female,mixed,Not reported,not reported,,,,,,Not reported,282 (g) (average),282,,,,g,,level: T1; severity: moderate,T1,moderate,compression,"laminectomy + compression (extradural clip compression, 22g injury force for 1 min)",4 weeks,"Methylprednisolone sodium succinate (MP), basic fibroblast growth factor (not of interest, not further reported), combination (not reported)",methylprednisolone sodium succinate,No,"30 mg/kg, then 5.4 mg/kg/hour",1h after injury,,24h,continuous (osmotic minipump),intravenously,,neurological/functional/behavioral assessment,modified Gale scale,,"scores reflect percentage improvement of function from 100 for a normal unoperated rat to 0 for a completely paralysed animal, each hindlimb assessed separately and higher score taken when differences, motor score from 0=no movement in hindlimb and no weight bearing, to 5=normal walking, toe spred from 0=none, to 2=normal full toe spread, placing from 0=no attempt to place foot to 2=normal placing, walking reflex (extension, pain, pressure) fron 0=no withdrawal, to 3=hyperactive withdrawal reflex, righting from 0=no attempt to right itself, 2=normal righting counter to direction of roll, inclined plane test graded by incrementation of 5 degrees between 30 and 50 degrees, swim test: from 0=sinks to bottom, no attempt to swim to 2=normal swim and climb, synchronous hindlimb movements","1, 2, 3, and 4 weeks after surgery",,yes,no stats,"difference between control and MP alone groups not tested, but trend for MP group to have higher scores than control group, cannot state anything about the significance of this difference",histological assessment,capillary counts and density,4 weeks after injury,not reported,no effect,"overall significant differences among the groups in gray matter capillary density counts but no individual comparison was significant, same fore white matter capillary density counts","anesthesia: sodium pentobarbital (60 mg/kg, IP), preop: 0.2 ml cotrimoxazole (40 mg/ml sulfamethoxazole and 8 mg/ml trimethoprim), continued postop for 5 days, postop: 5 ml of 6% hetastarch in 0.9% sodium chloride solution to compensate for blood loss during surgery, and they were allowed to breathe a gas mixture of 95% oxygen and 5% carbon dioxide for 1 hour, oral ascorbic acid 10 mg daily during the study period; euthanasia: sodium pentobarbital","these results show: 1) possible synergism exists between methylprednisolone and bFGF, such that combinations of these drugs significantly enhance neurological recovery, 2) bFGF exhibits a dose–response effect in function but not in capillary density, and 3) heated, inactivated bFGF is not therapeutically effective","1) Active bFGF shows a dose–response therapeutic effect, whereas inactive bFGF is ineffective, 2) compression model,  findings may not necessarily apply to other cord injury models in which weight-dropping (impact), distraction, or laceration techniques are used, 3) moderate injury, unclear whether findings apply to more severe injury, 4) neurological function tests and the use of clinical scales to grade these tests in our study may be criticized for being subjective, 5) no evidence that topically administered bFGF penetrated the spinal cord of the animals treated with this drug, because we did not measure bFGF content of cord tissues and did not specifically evaluate the neurotrophic effects of bFGF, 6) annot explain the mechanisms by which bFGF worked in our study",lots of limitations acknowledged,Yes (drug of interest + drug not of interest),
Lucie,Park et al,2010,Synergistic effect of melatonin on exercise-induced neuronal reconstruction and functional recovery in a spinal cord injury animal model,10.1111/j.1600-079X.2010.00751.x,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (melatonin + exercise studied, not melatonin alone)",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2015,Synergistic effects of Buyang Huanwu decoction and embryonic neural stem cell transplantation on the recovery of neurological function in a rat model of spinal cord injury,10.3892/etm.2015.2248,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (Buyang Huanwu decoction, neural stem cells)",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Qi et al,2017,Synthesis of methylprednisolone loaded ibuprofen modified dextran based nanoparticles and their application for drug delivery in acute spinal cord injury,10.18632/oncotarget.20649,English,,included,,,,,,rats,Sprague Dawley,40,16,,,16,,,,male 100%,male,100,6-8 weeks old,,,6,8,Weeks,,range: [180-220](g),,,180,220,g,,level: T8; severity: moderate,T8,moderate,contusion,"laminectomy + weight-drop contusion (modified allen's technique, intact dura, 1.2mm-diameter metal cylinder weighing 12g, dropping from a height of 3.0cm in vertical plastic tube directlyy onto the exposed spinal cord, injury force of 36 g.cm)",7 days,"methylprednisolone, nanoparticules (ibuprofen modified Dextran copolymer) loaded with methylprednisolone",methylprednisolone,No,80 mg/kg,15 min after injury,,single dose,-,multiple,"nanoparticles+MP: IP, MP alone: IV",neurological/functional/behavioral assessment,"inclined plane test, modified Tarlov scoring system",,"inclined plane test: horizontally placed on smooth wooden platform, from horizontal 0 degree position, one side elevated by 5 degrees every 5 seconds, max angle at which the rat was able to stay on the board for a minimum of 5 seconds taken as the value for hindlimb motor function of that rat; modified tarlov's scale: score from 0=no movement of the lover limbs and spastic paraplegia, 1=slight movement of the lower limbs and spastic paraplegia, 2=good movement of the lower limbs but still inability to stand, 3=ability to stand but inability to walk, 4=ability to walk but can not lasting, 5= ability to walk but inability to run, 6=complete recovery of hind-limb function","1, 3, 5, and 7 days post op",No,not reported,positive effect,"significant improvement for both test in MP and MP-loaded NP groups compared to saline and balnk NP group, also in both test MPloaded NP group significantly better than free MP group",histological assessment,"congestion, hemorrhage, edema, necrosis and neuronal viability, complete neuron numbers counted at 5 randomly selected fields per sample",7 days after injury,not reported,positive effect,"denaturation and degree of necrosis in MP groups was significantly alleviated compared to saline group and blank NP group, MP-loaded NP group had more nerve cells with integrity, significantly decrease degree of tissue edema and inflammatory cell infiltration and more active gliocyte proliferation than in free MP group","anesthesia: pelltobarnitalum natricum (30 mg/kg); post op to prevent infection gentamicin (3 mg/kg, IM daily for the first 3 post op days); euthanasia: 10% chloral hydrate 350 mg/kg, intubated from the left ventricle to the ascending aorta through the chest incision then heart was perfused",study indicates that synthesis of MP loaded ibuprofen modified dextran based nanoparticles has a great potential in the synergetic effect treatment for SCI and nanoparticles based drug delivery system will become a powerful weapon of human conquest of disease,not reported,also reported MP-loaded nanoparticles,No,
Lucie,Yune et al,2004,Systemic administration of 17 beta-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats,10.1089/089771504322972086,English,,included,,,,,,rats,Sprague Dawley,>= 120,>= 25,,,>= 56,,,,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: mild,T9 - T10,mild,contusion,"laminectomy + weight-drop contusion (10 gm rod, 2.5mm diameter, from height of 12.5mm)",18 or 28 days,17b-Estradiol (E2),estradiol,,"3, 100 or 300 microg/kg",pre-treatment 1-2h prior to injury or post-treatment immediately after SCI,,single dose,-,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"ranges from 0 to 21, 0=no locomotor function and 21=normal performance, walk freely in a 90cm^2 field (width and length) for 5 min","started 1 day after injury and continued for 30 days (from plot: day 1, 3, 5, 7, 10, 12, 15, 20, 24 and 30)",,yes,mixed effects (dosage),"BBB score in 100 microg/kg pre-treatment group significantly better than the control group, other pre-treatment groups not significantly different from control group, BBB score in 100 microg/kg post-treatment group significantly better than the control group",histological assessment,"lesion area analysis: total lesion area, area of caviatation at the epicenter; TUNEL assay",18 or 28 days after injury,not reported,mixed effects (dosage),lesion areai n  spinal  cords  treated  with  17b-estradiol  (100 mg/kg) was  significantly  reduced  at  both  18  and  28  days  after SCI  when  compared  to  vehicle  controls; significnatly less TUNEL positive cells in 100 and 300 mg/kg groups compared to vehicle but not 3 mg/kg,"anesthesia: chloral hydrate (50 mg/kg, IP); euthanasia: anesthesia and perfused via cardiac puncture with 0.1 M PBS","These data suggest that after SCI, 17b-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.",not reported,chloral hydrate,No,
Lucie,Peng et al,2009,Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury,10.1073/pnas.0902531106,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Brilliant blue G),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nacar et al,2014,Systemic administration of atorvastatin improves locomotor functions and hyperacute-acute response after experimental spinal cord injury: An ultrastructural and biochemical analysis,10.5137/1019-5149.JTN.8131-13.1,English,,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,one sham n = 8,male 100%,male,100,not reported,,,,,,Not reported,range: [250-320](g),,,250,320,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop contusion (impounder 0.3cm in diameter placed gently over the dura, dropping of 4g sterile weight from a height of 10cm directly onto the impounder 40 g.cm force)",24h,"polyethylene glycol (PEG), atorvastatin",polyethylene glycol,,equal volume of PEG and of solvent with atorvastatin for PEG group (vehicle),immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"modified tarlov's grading scale, inclined plane test",,"tarlov's grading scale: 1=no movement to 5=normal motor function, avergae score of the 2 evaluators as final score per rat; inclined plane test: maximum angle at which an animal can supports its weight measured in a scale from 0 to 90 degrees, animals placed transversely on the inclined plane and the highest angle a rat can stand over for 5 sec was regarded as the capacity angle of the rat",24h after injury,,yes,no stats,"tarlov's scale: atorvastatin group significantly better than control group, PEG group no different from control group; inclined plane test: atorvastatin group significantly better than control group, PEG group no different from control group",histological assessment,ultrastructure examinations,24h,not reported,no stats,the ultrastructural appearance of trauma+PEG (vehicle) group did not show any marked difference from the SCI only group;  examination of the atorvastatin (AT) group showed the least amount of changes in ultrastructural level,anesthesia: ketamine (80 mg/kg) and xylazine (10 mg/kg) both IP; euthanasia: high dose of anesthesia and intracardiac perfusion performed with 0.9% NaCl,"Atorvastatin improved locomotor recovery after rat SCI. The results were further confirmed with a statistically significant decrease of IL-1β, IL-6 and lipid peroxide levels. This finding revealed the anti-inflammatory and beneficial effect of atorvastatin on rat SCI.",efficacy of atorvastatin on a long-term basis is not beyond the scope of this study and may be regarded as the primary limitation of this agent.,,No,
Lucie,Nacar et al,2014,Systemic administration of atorvastatin improves locomotor functions and hyperacute-acute response after experimental spinal cord injury: An ultrastructural and biochemical analysis,10.5137/1019-5149.JTN.8131-13.1,English,,included,,,,,,rats,Sprague Dawley,32,8,,,8,,,one sham n = 8,male 100%,male,100,not reported,,,,,,Not reported,range: [250-320](g),,,250,320,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + weight drop contusion (impounder 0.3cm in diameter placed gently over the dura, dropping of 4g sterile weight from a height of 10cm directly onto the impounder 40 g.cm force)",24h,"polyethylene glycol (PEG), atorvastatin",atorvastatin,,0.2 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"modified tarlov's grading scale, inclined plane test",,"tarlov's grading scale: 1=no movement to 5=normal motor function, avergae score of the 2 evaluators as final score per rat; inclined plane test: maximum angle at which an animal can supports its weight measured in a scale from 0 to 90 degrees, animals placed transversely on the inclined plane and the highest angle a rat can stand over for 5 sec was regarded as the capacity angle of the rat",24h after injury,,yes,positive effect,"tarlov's scale: atorvastatin group significantly better than control group, PEG group no different from control group; inclined plane test: atorvastatin group significantly better than control group, PEG group no different from control group",histological assessment,ultrastructure examinations,24h,not reported,no stats,the ultrastructural appearance of trauma+PEG (vehicle) group did not show any marked difference from the SCI only group;  examination of the atorvastatin (AT) group showed the least amount of changes in ultrastructural level,anesthesia: ketamine (80 mg/kg) and xylazine (10 mg/kg) both IP; euthanasia: high dose of anesthesia and intracardiac perfusion performed with 0.9% NaCl,"Atorvastatin improved locomotor recovery after rat SCI. The results were further confirmed with a statistically significant decrease of IL-1β, IL-6 and lipid peroxide levels. This finding revealed the anti-inflammatory and beneficial effect of atorvastatin on rat SCI.",efficacy of atorvastatin on a long-term basis is not beyond the scope of this study and may be regarded as the primary limitation of this agent.,,Yes (drug of interest + drug of interest),
Lucie,Yune et al,2008,Systemic administration of PEP-1-SOD1 fusion protein improves functional recovery by inhibition of neuronal cell death after spinal cord injury,10.1016/j.freeradbiomed.2008.07.016,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (PEP-1–SOD),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kajana et al,2009,Systemic administration of rolipram increases medullary and spinal cAMP and activates a latent respiratory motor pathway after high cervical spinal cord injury,10.1080/10790268.2009.11760769,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Vallières et al,2006,Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord,10.1002/glia.20266,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (lipopolysaccharide),,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sauerbeck et al,2013,Systemic iron chelation results in limited functional and histological recovery after traumatic spinal cord injury in rats,10.1016/j.expneurol.2013.05.011,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (deferasirox),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Baptiste et al,2009,Systemic polyethylene glycol promotes neurological recovery and tissue sparing in rats after cervical spinal cord injury,10.1097/NEN.0b013e3181a72605,English,,included,,,,,,rats,Wistar,88,39,6,,36,3,,not all numbers match between text and figure 1,female 100%,female,0,"not reported (""mature"")",,,,,,Adult,range: [250-300](g),,,250,300,g,,level: C7-T1; severity: moderately severe,C7 - T1,moderate - severe,compression,laminectomy + compression injury (1-min extradural clip compression with a modified anurysm clip precalibrated to deliver a closing force of 35g),"2, 4, 8 and 24h post-SCI, 6 weeks",polyethylene glycol (PEG),polyethylene glycol,,"30% PEG treatment consisted of the 2-kd formulation at 30% weight by weight in sterile ringer's lactate vehicle, which roughly corresponded to 1 g/kg (PEG 2 kd)",15 min after injury,,single dose,-,intravenously,,neurological/functional/behavioral assessment,"BBB score, inclined plane test",,"BBB: 22-point scale with 0=complete loss of neurological hindlimb function, 21=normal walking ability; takes into consideration hindlimb movement, trunk position and stability, stepping, coordination, paw placement, toe clearance and tail position, representing sequential recovery stages that rats attain after SCI, 4-min session; inclined plane: quantify forelimb-hindlimb strength and coordination, hinged board that can be raised or lowered at 5-degree increments, positioned in a perpendicular position relative to the plane, and IP scores were assigned based on the maximum angle that the animal could right itself into a parallel position relative to the plane and maintain its position for 5 seconds","BBB: initiated before SCI, inclined test initiated 1 week post-SCI, both: weekly assessment for 6 weeks after SCI",,yes,mixed effects (assessment),BBB significantly better at week 6 (only but last time point) for treated animals compared to control group; no significant difference in inclined plane test,histological assessment,"morphometric assessment of cervical spinal cord tissue sparing: substraction of cavity area from the area of the entire spinal cord cross section, normalised as a percentage of the total corss-sectional area to assess tissue preservation, cavitation",not reported,yes?,positive effect,"increase in preserved spinal tissue resulting from PEG treatments was significantly greater than that seen in saline-treated animals at 700 microm caudal (p = 0.011), 0 microm epicenter (p = 0.013), and 700 microm rostral (p = 0.004). At distances greater than 700 microm caudal or rostral relative to the epicenter, differences between saline- and 30% PEG treatment effects were not statistically significant.","anesthesia: halothane 1.5%-2.0% and N2O 1L per minute, postop: rehydratation with 5ml of sterile ringer's lactate solution, buprenorphine hydrochloride (0.05 mg/kg) for pain management; euthanasia: deeply anesthetized by halothane (1%-2%) and 1:1 mixture of O2/N2O, killed by decapitation","Collectively, these results indicate that PEG protects key axonal cytoskeletal proteins after SCI, and that the protection is associated with axonal preservation. The modest extent of locomotor recovery after treatment with PEG suggests, however, that this compound may not confer sufficient neuroprotection to be used clinically as a single treatment.",not reported,,No,
Lucie,Mallei et al,2005,"The nitrosteroid NCX 1015, a prednisolone derivative, improves recovery of function in rats after spinal cord injury",10.1016/j.brainres.2005.08.057,English,,included,,,,,,rats,Sprague Dawley,>= 60,>= 20,,,>= 20,,,"one treatment group not of interest n = 20, number of behavioral assessment only ",female 100%,female,0,not reported (adults),,,,,,Adult,range: [230-250](g),,,230,250,g,,level: T8; severity: not reported,T8,Not reported,contusion,"laminectomy + weight-drop contusion (impounder tip lowered onto the dura, 10g weight dropped 2.5cm onto the impounder)","1, 4, 14 days","prednisolone, NCX 1015 (a derivative from prednisolone, not of interest so not further reported)",prednisolone,,37 micromol/kg,3.5h after injury,,"single dose (if sacrificed 24h atfer injury) or 3 days, (4 days for the treatment with 74 micromol/kg which was disontinued)",daily,subcutaneous,,neurological/functional/behavioral assessment,BBB score,,"free open field, 110*110 cn, acclimate before injury, 4 min observation, 21=normal locomotion, 0- no locomotion","day 1, 4, 7, 11, 14 after SCI",,yes,no effect,no statistical difference between the prednisolone and control group,histological assessment,cell counting (number of motor neurons),1 and 4 days after injury,yes,not reported,not evaluated for prednisolone but only for NC 1015,"anesthesia: ketamine and xylazine (80, 10 mg/kg respectively, IP); portop: 5 ml ringer's solution for hydratation, penicillin G for prevention of infection (40'00 U/kg, IP) the night before and after the operation, then suspension of sulfamethoxazole (20 mg/kg) and trimethoprim (4 mg/kg) twice a day for 2 days, orally; euthanasia: anesthesia with ketamine/xylazine, intracardially perfused with 4% paraformladehyde in 0.1M PB",NCX 1015 appears to combine the anti-inflammatory with the neuroprotective effects that are needed to attenuate apoptosis processes set in motion by SCI,not reported,"use ketamine, penicillin",No,
Lucie,Madsen et al,1998,Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats,10.1006/exnr.1998.6974,English,,included,,,,,,rats,Sprague Dawley,>= 45,>= 19,,,>= 26,,,numbers unclear,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T9; severity: not reported,T9,Not reported,others,"laminectomy + photothrombotic SCI (rose bengal (40 mg/kg, in sterile saline, Sigma) was administered intravenously, 5 minutes later, circular region of the exposed cord was photoilluminated using a xenon fiberoptic light source with a 2-nm-diameter collimator placed 2 mm above the dura for 10 min)",1-28 days,tacrolimus,tacrolimus,,0.25 mg/kg,10 min after injury,,3 doses,"10 min, 24h and 48h after injury",multiple,"first dose IV, second and third doses IP",neurological/functional/behavioral assessment,"inclined plane test, five-point modified Tarlov scale, BBB scale",,"inclined plane test: measurement of grip strength and ability to maintain posture, rubberized surface and varying the angle of the apparatus, angle at which the animal could maintain for at least 5 s without slipping was noted and the average for three trials was recorded; Tarlov's scale: open fiel behavior assessment","1, 4, 7, 14, 21 and 28 days after injury",,yes,mixed effects (assessment),"for open-fiel scores, tacrolimus group showed a significantly better performance than vehicle-treated controls, the inclined plane measurements likewise showed significant superior performance in the tacrolimus group vs controls at 28 days postinjury",histological assessment,"lesion size, volume of lesion, volume preserved 10-mm segment spinal cord, maximal lesional area, spinal cord width caudal to lesion",28 days,yes,no effect,no between-group differences in lesion size,"anesthesia: chloral hydrate (400 mg/kg), rose bengal (40 mg/kg, IV), 40 mg of cefazolin per day IM for 1 week after surgery; euthanasia: cardon dioxide nacrosis followed by cardiac perfusion with heparinized saline and 4% paraformaldehyde in 0.1 MPO4 buffer","tacrolimus, a drug which is already approved for use in humans, as well as other FKBP-12 ligands which do not inhibit calcineurin, could potentially enhance functional outcome after CNS injury in humans",not reported,use chloral hydrate,No,
Lucie,Qiao-Li et al,2010,Tacrolimus promotes repair and regeneration of injured spinal cord following neural stem cells transplantation in rats,10.3969/j.issn.1673-8225.2010.23.013,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (tacrolimus + stem cells but no tacrolimus alone group),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Lewis et al,2011,Neuroprotection for the Warrior: Dietary Supplementation With Omega-3 Fatty Acids,10.7205/MILMED-D-10-00466,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Colón et al,2016,Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats,10.1089/neu.2015.4111,English,,included,,,,,,rats,Sprague Dawley,126,>= 29,,,>= 22,,,"80 rats were used for the behavioral, and histological and immunofluorescence studies, and 15 rats were used for the western blot experiments. A total of 31 rats were excluded; details of groups unclear",female 100%,female,0,not reported (adults),,,,,,Adult,230 (g),230,,,,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + weight-drop contusion (MACSIS impactor device, 10g rod dropped from 12.5mm height over the exposed spinal cord and compression maintained for 5s)",35 days,tamoxifen,tamoxifen,,0.71 mg/day,immediately or 24h after injury,,21 days after SCI,continuous (pellet),subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, grid walk test, narrow beam crossing test",,"BBB: open field, plastic pool, 2 examiners, score between 0 and 21 based on joint movement, paw position, weight support, coordination, toe clearance (among other parameters), average score of both limbs for each animal; grid walk test: evaluate coordination when crossing horizontal ladder (3 ft long, bars separated by 1 or 2 in), separators alternated randomly to prevent habituation, report number of errors (failure to correctly position the paw on the grid) and the number of correct paw positions, averaged between right and left hindlimbs; narrow beam crossing test: evaluate recovery of equilibrium when crossing a narrow surface, 2*2cm square and round 2cm diameter beams at 36-44 cm from the grounds and scores for ability to cross from one side to the other, total score for both beams combined, and average reported for each animal","1 week before SCI, day2 after injury, then weekly at 7, 14, 21, 28, and 35 days post-injury",,yes,mixed effects (assessment) + mixed effects (timing),"tamoxifen groups had significantly higher BBB scores at day 35 compared to control group, tamoxifen given immediately after injury but not 24h significantly improved the total beam score but not later treatment, both tamoxifen group performed less errors and more correct paw positions than control group in the grid walk test",histological assessment,"amount of white matter spared tissue on this area in density per unit area (density/area), % of cells that approximately survived after SCI",35 days after injury,not reported,positive effect,significantly more spared tissue and preserved cells in both treatment groups compared to control,"anesthesia: ketamine/xylazine/acepromazine (87.5/4.2/0.8 mg/kg); postop: antibiotic injection (25 mg/kg cefazolin 7 days), SC saline, eyedrops (to prevent excessive dryness to the cornea) and buprenorphine (0.05 mg/kg) twice a day for 3 days; euthanasia: anesthesia and sacrificed by intracardial perfusion with cold PBS followed by fixation in 4% paraformaldehyde",tamoxifen as a potential therapeutic agent to treat SCI up to 24 h after the trauma,not reported,,No,
Lucie,Mosquera et al,2014,Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: Their antioxidant effect and role of estrogen receptor alpha,10.1016/j.brainres.2014.03.002,English,,included,,,,,,rats,Sprague Dawley,>= 51,>= 14,,,>= 17,,,counts unclear,female 100%,female,0,not reported (adults),,,,,,Adult,250(g),250,,,,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"ovariectomy + laminectomy + weight-drop contusion (NYU impactor, 10g rod, 2.5mm diameter dropped from height of 12.5mm)",28 days,"17-β Estradiol 3-benzoate (E2), tamoxifen (TAM), MPP Dihydrochloride (antagonist of the E2 receptor)",estradiol,,3 mg,immediately after ovariectomy,,30 days?,continuous (Silastic tubes and pellet),subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,"open field, pre-trained rats, plastic pool for 4 min, 2 observers, evaluate hindlimb movements, stepping and coordination, right and left hindlimbs scored individually and reported as average score for each animal at each time point","7, 14, 21, 28 days post injury",,yes,positive effect,E2 and TAM groups had significantly higher BB score than control group,histological assessment,"total emptied area standardized over the total tissue area, spared white matter, lesion cavity using density per unit area",28 days after injury,not reported,mixed effects (assessment),E2 and TAM groups had significantly reduced lesion area anf higher level of spared tissue compared to control group in the lesion epicenter but not rostral or caudal,"anesthesia: Ketamine/Xylazine/Acepromazine, 87.5/4.2/0.8 mg/kg; postop: cefazolin and buprenex twice daily for 7 and 3 days respectively","estradiol improves functional outcome, and these protective effects are mediated by the ER-α dependent and independent-mechanisms. Tamoxifen’s effects during late stages of SCI support the use of this drug as a long-term alternative treatment for this condition",not reported,"lots of similarities with papers from above, is there an actual overlap in the data?",Yes (drug of interest + drug not of interest),
Lucie,Mosquera et al,2014,Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: Their antioxidant effect and role of estrogen receptor alpha,10.1016/j.brainres.2014.03.002,English,,included,,,,,,rats,Sprague Dawley,>= 51,>= 14,,,>= 10,,,counts unclear,female 100%,female,0,not reported (adults),,,,,,Adult,250(g),250,,,,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"ovariectomy + laminectomy + weight-drop contusion (NYU impactor, 10g rod, 2.5mm diameter dropped from height of 12.5mm)",28 days,"17-β Estradiol 3-benzoate (E2), tamoxifen (TAM), MPP Dihydrochloride (antagonist of the E2 receptor)",tamoxifen,,15 mg,immediately after ovariectomy,,30 days?,continuous (Silastic tubes and pellet),subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,"open field, pre-trained rats, plastic pool for 4 min, 2 observers, evaluate hindlimb movements, stepping and coordination, right and left hindlimbs scored individually and reported as average score for each animal at each time point","7, 14, 21, 28 days post injury",,yes,positive effect,E2 and TAM groups had significantly higher BB score than control group,histological assessment,"total emptied area standardized over the total tissue area, spared white matter, lesion cavity using density per unit area",28 days after injury,not reported,positive effect,E2 and TAM groups had significantly reduced lesion area anf higher level of spared tissue compared to control group in the lesion epicenter and rostral but not caudal,"anesthesia: Ketamine/Xylazine/Acepromazine, 87.5/4.2/0.8 mg/kg; postop: cefazolin and buprenex twice daily for 7 and 3 days respectively","estradiol improves functional outcome, and these protective effects are mediated by the ER-α dependent and independent-mechanisms. Tamoxifen’s effects during late stages of SCI support the use of this drug as a long-term alternative treatment for this condition",not reported,"lots of similarities with papers from above, is there an actual overlap in the data?",No,
Matthias,Salgado et al,2015,Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury.,10.4103/1673-5374.153685,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tian et al,2009,Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats,10.1111/j.1471-4159.2009.06077.x,English,,included,,,,,,rats,Sprague Dawley,96,37,,,37,,,assuming sham n = 22,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T12; severity: not reported,T12,Not reported,contusion,laminectomy + weight drop (25 g centimeter force (gcf) injury was induced by dropping a 10 gweight from a height of 2.5 cm),"1, 3, 7 days after SCI",tamoxifen (TAM),tamoxifen,,5 mg/kg,30 min after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"trained for 1 week and baseline score prior to injury, open-feild, 2 observers, 21-point scale from 0 to 21 (no observable locomotor movements to normal locomotor movements), under same conditions and at the same time period on each scheduled testing date",every day post-injury within the first week,,yes,positive effect,TAM group had significantly higher BB score than control starting at day 3 until end of experiment,histological assessment,"neuronal cell death, tissue edema, BSCB permeability, TUNEL assay",day 1 and 3 after injury,yes,positive effect,"treatment with tamoxifen significantly attenuated the amount of Evans blue leakage after SCI compared to vehicle-treated group (TAM decreases BSCB permeability); TAM decreased the cord edema formation, no difference within the lesion ; TAM significantly decreased the number of apoptotic neuronal cells; significantly less TUNEL positive neurons in TMX group compared to control group",anesthesia: ntraperitoneal(i.p.) injection of ketamine (80 mg/kg) and xylazine (10 mg/kg); postop: dextrose and penicillin (IP); euthanasia: transcardially  perfused  with  saline  followed  by  ice-cold  4%paraformaldehyde,"results demonstrate that tamoxifen provides neuroprotective effects for treatment of SCI-related pathology and disability, and is therefore a potential neuroprotectant for human spinal cord injury therapy",not reported,"use ketamine, penicilin",No,
Lucie,Nikulina et al,2004,The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery,10.1073/pnas.0402595101,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (rolipram),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Colón et al,2016,Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.,10.4103/1673-5374.189164,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kitchen et al,2020,Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema,10.1016/j.cell.2020.03.037,English,,included,,,,,,rats,Sprague Dawley,>= 72,>= 18,,,>= 18,,,numbers unclear,female 100%,female,0,6-8 weeks,,,6,8,Weeks,,range: [170-220](g),,,170,220,g,,level: T8; severity: not reported,T8,Not reported,compression,partial laminectomy + crush bilaterally using calibrated watchmaker's forceps,"3, 7, 28 days, 6 weeks",trifluoperazine (TFP),trifluoperazine,,"5 microg in 2,5 microL volume",immediately after injury,,single dose,-,intrathecally,,"neurological/functional/behavioral/sensory assessment, electrophysiology","horizontal ladder crossing test, tape sensing and removal test",,"horizontal ladder crossing test: 0.9-m-long horizontal ladder, 15.5cm diameter, randomly adjusted rungs with variable gaps of 3.5-5.0cm, total number of steps taken to cross the ladder and number of left and right rear paw slips were recorded, mean error rate was calculated by dividing the number of slips by the total number of steps taken; tape sensing and removal test: touch perception from the left hind paw, animals held with both hind-paws extended and recorded time it took for the animal to detect and remove a 15*15mm piece of tape, used to calculate the mean sensing time; electrophysiology: compound action potential (CAP) area and amplitude","training for 1 week before functional testing, baseline 2-3days before injury, day 2 after injury and then weekly for 6 weeks",,yes,positive effect,"CAP area and amplitude significantly increased in treatment group compared to vehicle, mean sensign time decreased in treatment compared to vehicle group, mean ratio of slips/total steps significantly slower in treatment compared to vehicle group",histological assessment,"cavity size, percent water content (BSCB)","3, 7, 28 days, 6 weeks",not reported,positive effect,"Treatment with 41 mM TFP significantly reduced BSCB breakdown 7 days after dorsal coulmn crush around the lesion site;  TFP also suppressed the normal process of cavitation that occurs at lesion sites after dorsal coulmn crush, significantly reducing the cavity area 6 weeks after dorsal coulmn crush at all depths through the dorsal coulmn compared to vehicle group","electrophysiology: anesthesia with 5% isoflurane and maintained with 1.5% isoflurane, pancuronium bromide (0.3 mg/kg, IP)","Inhibition of calmodulin in a rat spinal cord injury model with the licensed drug trifluoperazine inhibited AQP4 localization to the blood-spinal cord barrier, ablated CNS edema, and led to accelerated functional recovery compared with untreated animals. ",not reported,so much information in this paper,No,
Lucie,Namjoo et al,2018,Targeting axonal degeneration and demyelination using combination administration of 17 beta-estradiol and Schwann cells in the rat model of spinal cord injury,10.1002/jcb.27361,English,,included,,,,,,rats,Wistar,24,6,,,6,,,"2 treatment groups not of interest (n = 6 for each), 2 rats for extraction of stem cells (not counted in total)",male 100%,male,100,not reported (adults),,,,,,Adult,range: [300-350](g),,,300,350,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusive SCI (50g weight placed on the exposed spinal cord for 5 min, weight's tip with concave shape with an area of 6.6 mm^2 (3.0-2.2mm) to ensure equal pressure distribution on the spinal cord)",21 days,17β‐estradiol (E2),estradiol,,25 microg/kg,immediately after injury,,24h,"4 doses: 0, 3, 6, and 24h after SCI",intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"open area, observed for 5 minutes, 2 testers, score from 0=paralysis to 21 points=normal gait","day 7, 14 and 21 after injury",,not reported,positive effect,BBB significantly higher in E2 group compared to control group,histological assessment,"number of cavities, lesion area, myeline sparing",day 21 after injury,not reported,mixed (stats/no stats),"lesion area significantly lower in E2 group comapred to control, number of cavities reduced in treatment group compared to control, myelin sparing significantly higher in E2 group compared to control","anesthesia: IP 80 mg/kg ketamine, 20 mg/kg xylazine; postop: daily 1mL lactated Ringer's solution plus 4 mL/kg gentamicin for 5 days, IM 200 mg/kg metamizole sodium for pain therapy during and after surgery then twice a day for 5 days; euthanasia: deep ether anesthesia, transcardial perfusion with 4% PFA in PBS","pplication of E2 and SCs could be effective when axons undergo demyelination and degenerative processes, and their combination could partly provide cumulative outcomes.","start immediately after injury not realistic in real life, low physiological dose of E2, type of species and severity of injury may change the results significantly",use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Radulovic et al,2016,Targeting the thrombin receptor modulates inflammation and astrogliosis to improve recovery after spinal cord injury,10.1016/j.nbd.2016.04.010,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (use knockout mice for PAR1, a thrombin receptor instead)",,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Salzman et al,1993,HALOTHANE ANESTHESIA IS NEUROPROTECTIVE IN EXPERIMENTAL SPINAL-CORD INJURY - EARLY HEMODYNAMIC MECHANISMS OF ACTION,PMID: 8488342,English,,excluded,Out of scope,No control group,"Out of scope: effect of anesthesia tested, no proper control group",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Boetel et al,1997,The surgical treatment of acute spinal paralysed patients,10.1038/sj.sc.3100407,English,,excluded,Out of scope,No drug tested,"Out of scope: looking at the effect of surgery, no drug tested",,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Borgens et al,2002,Behavioral recovery from spinal cord injury following delayed application of polyethylene glycol,10.1242/jeb.205.1.1,English,,included,,,,,,guinea pig,Not reported,29,13,1,,15,,,,not reported,not reported,not reported,not reported (adults),,,,,,Adult,300 (g),300,,,,g,,level: T10-T11; severity: severe,T10 - T11,severe,compression,"laminectomy + compression injury (dura removed, constant-displacement 15 s compression of the cord using specially constructed forceps possessing a détente)",4 weeks,polyethylene glycol,polyethylene glycol,,"Mr 1800, 50 % w/v in distilled water",7h after injury,,2 min,-,intrathecally,,"electrophysiology, neurological assessment","SEPs, cutaneus trunci muscle (CTM) reflex",,"CTM reflex: rippling of the skin on the back of the animal following light tactile stimulation, receptive field is determined prior to injury by stimulating the back skin of the sedated animal by lightly touching it with a monofilament probe, determine the region of CTM loss (areflexia) and subsequent recovery, when it occurred; 4 components evaluaed: area of recovery of receptive fields below level of lesion, direction of peak skin movement in normally functioning and recovered receptice fields following injury, distance of skin movement during peak skin contraction, velocity of skin contraction following tactile stimulation; SEPs: subdermal electrodes stimulated nerve impulses from tibial nerver of hindleg (stimuli trains in sets of 200 at 3 Hz; stimulus amplitude <3 mA square wave, 200 μs in duration), electrodes located abovethe level of the controlateral cortex with reference elctrode located in the ipsilateral pinna of the ear, medial nerve of the forelimb was stimulated, initiating evoked potentials in a neural circuit above the level of the crush injury","24h, 3 days, 2 weeks, 1 month post-treatment",,no (justified in the text),mixed effects (assessment),"CTM: significantly more animals recovered refelx activity in treatment compared to control group, total area of PEG-mediated recovery was not statistically different from that occurring spontaneously, rest of CTM related items are onlly comparision before and after injury on the same animal and not compared between control and treatment group; the proportion of animals recovering an SSEP in the experimental population, which was 87 % for the first day after PEG treatment and by week 4 had reached 100 %. Not one sham-treated animal recovered conduction over the same period (significantly more recovered in treatment group comapred to control)",-,-,-,-,,-,anesthesia: IM 100 mg/kg ketamine HCl and 20 mg/kg xylazine; sedation for behavioral and physiological testing: 0.1 ml of sodium pentobarbital 50 mg/ml,repair of nerve membranes by polymeric sealing can provide a novel means for the rapid restoration of function following spinal cord injury,not reported,use ketamine,No,
Lucie,Hao et al,1991,BENEFICIAL EFFECT OF THE OPIOID RECEPTOR ANTAGONIST NALTREXONE ON HYPERSENSITIVITY INDUCED BY SPINAL-CORD ISCHEMIA IN RATS - DISASSOCIATION WITH MK-801,10.3233/RNN-1991-3504,English,,included,,,,,,rats,Sprague Dawley,75,>= 13,,,>= 15,,,numbers unclear,female 100%,female,0,not reported,,,,,,Not reported,200 (g),200,,,,g,,level: T10; severity: not reported,T10,Not reported,others,"laminectomy + ischemia via photochemical technique user laser irradiation and photoactivatable intravascular dyes (erythrosin B 32.5 mg/kg dissolved in 0.9% saline and injected IV then irradiation for 1 min under laser beam, tunable argon ion laser operating at 514.5 nm near the absorption maximum of Erythrosin B, irradiated with average power 0.16W delivered via a beam chopped operating at 500 Hz with 2.4W peak power, 6.7% duty cycle",3 weeks,"naltrexone, Dizocilpine (MK-801, not of interest so no further reported)",naltrexone,,5 mg/kg or 10 mg/kg or 20 mg/kg,10 min before injury,,single dose,-,intravenously,,neurological/functional/behavioral assessment,"touch-evoked agitation, vocalization threshold to mechanical pressure",,"touch-evoked agitation: skin was briskly stroked with the point of a pencil in a rostral to caudal direction, response graded as 0=no response, 1=moderate efforts to avoid the probe, transient vocalization, 2=vigorous efforts to escape the stimlus, frequent and sustained vocalisation in response to the probe; vocalization threshold to mechanical pressure: von Frey hairs to produce graded pressure from 0.021g to 410g, von frey haire gently pressed on the skin until the filament became bent, test on different parts of the body to avoid sensitizing the skin, thrshold to vocalization in respoonse to pressure within a relatively large skin area was recorded and mapped, single or rare vocalisation not taken as threshold","24h after irradiation, daily during the first 5 days post-injury",,not reported,mixed effects (dosage),"touch-evoked agitation: significant decrease in vocalization threshold to pressure in 10 and 20mg/kg group compared to control, no difference with no treatment group when given saline or 5 mg/kg naltrexone; vocalization threshold to mechanical pressure: significant overall decrease in vocalisation threshold in 10 and 20 mg/kg groups within 5 days post-irradiation but did not decrease the incidence of allodynia during 24h after irradiation","histological assessment (13 animals, 5 with treatment of 20 mg/kg naltrexone, 8 controls)",lesion area related to total cross-sectional area,3 weeks,not reported,no stats,"5/8 controls with normal appearance, 3/8 with signs of damage, mean of 8.8 (1.4) % of the total cross-sectional area for transverse are of the lesion, all treated rats had no abnormalities","anesthesia: chloral hydrate (300 mg/kg, IP); euthanasia: anesthesia with chloral hydrate then perfused via left ventricle with normal saline 100 ml room temperature followed by 1% paraformaldehyde and 2% glutaraldehyde in a 0.15 M PB","beneficial effect of an opioid antagonist on experimental spinal cord injury, naltrexone pretreatment prior to spinal ischemia significantly decreases the incidence and severity of allodynia at 10 and 20 mg/kg but not 5 mg/kg and also seesm to improve the morphological outcome",low incidence of apparent damage even in control animals,use chloral hydrate,Yes (drug of interest + drug not of interest),
Lucie,Fargo et al,2004,Testosterone Manipulation Protects Motoneurons from Dendritic Atrophy after Contralateral Motoneuron Depletion,10.1002/cne.10991,English,,excluded,Non-sci population,,depleted motoneurons in the spinalnucleus of the bulbocavernosus with saporin,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Clark et al,2008,Testosterone replacement therapy and motor function in men with spinal cord injury: A retrospective analysis,10.1097/PHM.0b013e318168bbec,English,USA,included,,,,retrospective,retrospective,human,,530,480,,,50,,,,male 100%,male,100,"complete SCI: intervention group 32.7 (14.3), comparison group: 32.0 (11.8); incomplete SCI: intervention group 40.7 (16.0), comparison group 40.4 (14.3)",,,,,,,not reported,,,,,,,"level: complete SCI: intervention group 7 paraplegia and 17 paraplegia, comparison group 103 paraplegia, 131 tetraplegia; incomplete SCI intervention group 10 paraplegia, 16 tetraplegia, comparison group 99 paraplegia 147 tetraplegia; AIS grade: complete group, all A n=258, imcomplete SCI intervention group B=5, C=10, D=11, comparison group B=70, C=86, D=90",,mixed,,not reported,"days since injury: complete SCI intervention 21 [12.0-44.5], comparison group 17 [10.0-33.0], incomplete SCI intervention group 10.0 [7.0-18.0], comparison group 11.0 [6.0-9.0]",testosterone cypionat (based on screening for low testosterone at rehabilitation admission),testosterone,,200mg,"days since injury: complete SCI intervention 21 [12.0-44.5], comparison group 17 [10.0-33.0], incomplete SCI intervention group 10.0 [7.0-18.0], comparison group 11.0 [6.0-9.0]",,not reported,monthly,intramuscular,,motor/functional assessment,"discharge motor score, FIM discharge score","neurological (motor), functional (general)",not reported,"discharge with length of stay of: complete intervention 30.0[27.0-36.5], complete comparison 44.5 [30.0-61.0], incomplete intervention 30.0[24.0-43.0] and incomplete comparison 30.0[21.0-46.0] days",,no (retrospective analysis),mixed effects (assessment) + mixed effects (subgroup),"Men in the intervention group with impairment scale grades C and D (incomplete) had statistically significant different (better) discharge motor scores than men in the comparison group (p=0.006 and p=0.01 respectively), no statistically difference for men with AIS B, no difference in discharge adjusted FIM scores for men with incomplete injuries, no differences int he adjusted discharge ASIA motor scores or adjusted dischage FIM scores for men with complete injuries",-,-,-,-,,-,-,The data support a relationship between testosterone replacement therapy and strength gains in men with residual motor function after SCI. Prospective studies are necessary to validate these findings.,"groups were not randomized and differed in racial composition and length of stay, assumption that a proportion of the comparison group had low testosterone and did not receive testosterone replacement therapy",treatment only if low testosterone levels,,
Matthias,Thompson et al,2013,The therapeutic role of interleukin-10 after spinal cord injury.,10.1089/neu.2012.2651,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xu et al,2015,Clinical study of ganglioside (GM) combined with methylprednisolone (MP) for early acute spinal injury.,http://www.pjps.pk/wp-content/uploads/pdfs/28/2/Supplementary/8-SUP-207.pdf,English,China?,excluded,Out of scope,No control group,No control group for comparison with treatment,,,human,,53,,,,,,,,"male: n=31 (58.5%), female: n=22 (41.5%)",,,"range: [16-63](years), treatment group: 35.1(1.8), control group: 36.2 (2.1)",,,,,,,not reported,,,,,,,"level: not reported; severity: AIS A n=7 (13.2%), B n=12 (22.6%), C n=13 (24.5%), D n=21 (24.5%)",,,,not reported,-,"methylprednisolone (MP, control group), ganglioside (GM, experimental group)",,,MP: 30 mg/kg for first dose then 5.4 mg/kg/h then 40mg; GM: 100g,"MP: within 8h after injury, GM: not reported",,"GM: 10 days, MP: 10 days? ","MP: ""30mg/kg within 8 hours of injury, and then they were treated by a 23-hour continuous infusion in 5.4mg/kg per hour. After the continuous treatment, they were injected by 40mg MP with 250ml 5% glucose solution four times a day and after 3 days of continuous infusion, it turned 2 times a day and kept on 3 days""; GM: once a day",intravenously,,neurological/functional assessment,clinical indexes,,"Complete remission: basic body senses, limb muscle forces and sphincter functions can be restored. Some complications can be cured and patients can live by their own. Significant: the basic body senses, limb muscle forces and sphincter functions for patients can be greatly improved. Besides, some complications can be effectively controlled. Effective: There are some improvements in the basic body senses, limb muscle forces and sphincter functions. Ineffective: There is no a clinical improvement or even aggravation for patients.",not reported,,not reported,,remission rates and total rates of effects in the experiment GM group (50.0% and 92.3% respectively) were both higher than those in the control MP group (40.7% and 85.2% respectively). There was a marked difference between the two groups (P<0.05) and it was of statistic significance,-,-,-,-,,-,"Patients in the two groups all received regular treatment such as giving the nutrition support, strengthening the warmth, keeping the skin clean and respiratory tract fluent. Patients with uroschesis just kept their catheter which would let out every 3 or 5 hours. And their bladders were douched by the 0.1% furacilin once or twice a day.","GM has better curative effects than MP, for it is able to promote the recovery of nerve function for patients and greatly improve the prognosis.",not reported,"not sure we should include, no control group",,
Lucie,Ruhollah Hosseini et al,2017,Coadministration of Dexamethasone and Melissa officinalis Has Neuroprotective Effects in Rat Animal Model with Spinal Cord Injury,10.22074/cellj.2016.4868,English,,included,,,,,,rats,Wistar,36,5,,,7,,,"2 sham n = 5 each, 2 treatment groups not of interest n = 7 each",male 100%,male,100,not reported (adults),,,,,,Adult,range: [190-220](g),,,190,220,g,,level: T12-L1; severity: not reported,T12 - L1,Not reported,contusion,"laminectomy + weight-drop contusion (10g weight, stainless steel rod, 3mm diameter tip, dropped vertically in the center of the exposed dura from height of 25mm)",57 days,"melissa officinalis (MO, not further reported since it is not a drug of interest), dexamethasone (DEX)",dexamethasone,,1 mg/kg,3h after injury,,7 days,daily,intramuscular,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, hot-water test, EMG recordings",,"BBB: 21 point scale, rating weight support, stepping ability, coordination and toe clearance, mean value of both examiners; hot-water test: response to heat stimulation measured by latency of hind limb paw withdrawal to hot-water of 50 degrees Celsius, both paws tested 3 times (6 trials in total), mena of the 6 trials recorded, non-responders were removed from hot-water container after 60s; EMGs: record hind limb flexor muscle bilaterally, 23 gauge needles for 10 s, recreuitment index of motor units was acquired via compression of 10 s of recording to 1 s by EMG software, scored on an ordinal scale from 0 to ++++","BBB and hot-water test: 1,7,14,21,28,35,42,49 and 56 days after injury; EMG; day 56",,"BBB: yes, hot-water test and EMG: not reported",positive effect,BBB: DEX significantly improved locomotor function in rats as compared to SCI group; sensory heat reponse: treatment with DEX decreased latency time in comparison with SCI group after day 28; EMG: DEX significantly improved the recruitment index compared to SCI group,histological assessment,"lesion area, cavity, surrounding damaged tissue, number of lower motor neurons, densities of myelin",day 57,yes,positive effect,"cavity area: significantly reduced in DEX compared to SCI group, number of ventral horn motor neurons: significantly increased in DEX compared to SCI group; density of myelin significantly higher in DEX group compared to control","anesthesia: ketamine hydrochloride (80 mg/kg, IP), xylazine hydrochloride (10 mg/kg, IP); postop: gentamicin twice a day for the first 3 days (40 mg/kg, IM) as prophylaxis against urinary tract infection, SC with 25 ml/kg lactated Ringer's for 2 days after SCI as once a day; euthanasia: anesthesia 100 mg/kg sodium pentobarbital, Ip, intra-cardially perfused with 0.9% saline followed by 10% buffered formalin",Results showed that combination of dexamethasone and melissa officinalis could be considered as a neuroprotective agent in spinal cord injury,not reported,,Yes (drug of interest + drug not of interest),
Lucie,Strickland et al,2014,"The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine",10.1016/j.neuint.2014.05.005,English,,excluded,Out of scope,No assessments of interest,Out of scope: no results of interest,,,rats,Sprague Dawley,,,,,,,,,male 100%,,,90-110 days,,,,,,,range: [300-350](g),,,,,,,level: T12; severity: moderate,,,,"laminectomy + contusion (MASCIS device, 10g  impactor outfitted with a 2.5mm tip to drop 12.5mm)",2 or 15 days,morphine sulfate,,,90 microg dissolved in 2 microL of distilled water,24h or 14 days after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"BBB scale, nociceptive reactivity",,"BBB: open enclosure (99cm diameter, 23cm deep), 0= no movement of hindlimbs (ankle, knee, or hip), 1=intermediate milestones include slight movement of 1 joint, 7=extensive movements of all 3 joints, 10=occasional weight supported stepping in the abscence of coordination, 14=consistent weight supported stepping with consistent forelimb-hindlimb coordination, observation for 4 min; nociceptive reactivity: thermal reactivity using radiant heat in the tail-flick test, halogen light focused onto the rat's tail, temperature set to elicit a baseline tail-flick response in 3-4 s on average, in testing the latency to flick the tail away from the radiant heat source was recorded, failed to respond after 8s heat exposure, 2 tests at 2-min intervals, second test recorded, blank trials also performed 1 min before or after each sensory test to detect false alarm in absence of stimuli (none recorded)",BBB: day 1 and 13 post injury; nociception: immediately before and 30min after morphine administration,,"BBB: yes, nociception: not reported",,,-,-,-,-,,-,anesthesia: isoflurane (5% gas) for initiation and then 2-3% for maintenance; postop 100'000 units/kg penicillin G potassium (Pfizerpen) immediately after surgery and again 2 days later; euthanasia: 100 mg/kg pentobabrital IP,"miR21 and other SCI-sensitive miRNAs may constitute therapeutic targets, not only for improving functional recovery following SCI, but also for attenuating the effects of SCI on pain sensitivity",not reported,"treatment effect on neurological recovery is not the primary outcome of this paper, focus is on miRNA profiles",,
Lucie,Li et al,2003,Combined therapy of methylprednisolone and brain-derived neurotrophic factor promotes axonal regeneration and functional recovery after spinal cord injury in rats,https://reader.elsevier.com/reader/sd/pii/S152994300100256X?token=9A9AED2EE85A6BE2EAC30CC2EA9A1E3A32B9880F1E7582D1D8D5441729E8637CBAFE342FD52C48E6807CBB4687E732BB&originRegion=eu-west-1&originCreation=20220401153616,English,,excluded,Abstract,,Abstract,,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pedram et al,2018,Therapeutic effects of simultaneous Photobiomodulation therapy (PBMT) and Meloxicam administration on experimental acute spinal cord injury: Rat animal model,10.1016/j.jphotobiol.2018.09.022,English,,included,,,,,,rats,Fischer-344 Wistar,24,6,,,6,,,2 other treatment groups not of interest,male 100%,male,100,8-12 weeks,,,8,12,Weeks,,range: [300-350](g),,,300,350,g,,level: T8-T9; severity: not reported,T8 - T9,Not reported,compression,"laminectomy + fogarty embolectomy catheter filled with saline and advanced for the balloon of the catheter to rest at T8-9, balloon rapidly inflated with 20 microL normal saline and after 5min, deflated and removed",4 weeks,"photobiomodulation therapy (not of interest so not further reported), meloxicam",meloxicam,,1.0 mg/kg then 0.5 mg/kg,after injury,,2 weeks,once per day (doses decreased after 1 week),subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,"0=complete paralysis, 21=normal gate, 1 observer, cirvular plate 90cm diameter surrounded by 21cm high wall, 2 min observation and recording on video",day 0 (after recovery from anesthesia) then once a week for 4 weeks,,yes,positive effect,singificant difference in median BBB score between treatment and control gourp from week 2 until end of the experiment (week 4),histological assessment,"evaluated in 4 points of each spinal cord section including 3 areas of gray matter and 1 region of white matter, semi-quantitative scoring system, 3 different sections scored on both right and left hemicords, average number considered as the final score of each rat; gray matter: percentage of unusual or dead neurons in 3 parts of gray matter including ventral horn, intermediate column and dorsal horn from 0 to 3:0 (no injured or dead neuron), 1 (mild injury) < 10% of the cells were injured, 2 (moderate injury) 10%–50% of the cells were injured, and 3 (severe injury) > 50% of cells were injured; White matter: acute injury to the white matter was scored according to the amount of vacuolization of ventral and ventrolateral regions of the white matter from 0 to 3 including: 0 (normal, no vacuolization), 1 (mild injury) vacuolization in < 10% of the area, 2 (moderate injury) vacuolization in 10%–50% of the area, and 3 (severe injury) vacuolization in > 50% of the area.",4 weeks,yes,no effect,"no significant difference between treatment and control groups, for none of the regions, for none of the characteristics looked at",anesthesia: ketamin (75 mg/kg) and xylazine (10 mg/kg); postop: antibiotic therapy with enrofloxacin (10 mg/kg q 24h) for 1 week; euthanasia: pentobarbital sodium (100 mg/kg) followed by 200 ml 0.1M PB and 300 ml 4% PBS containing 1% glutaraldehyde and 4% paraformaldehyde,According to the results of this study we can conclude that simultaneous and separate application of PBMT and Meloxicam play an effective role in treatment of acute spinal cord injuries,not reported,use ketamine,Yes (drug of interest + drug not of interest),
Lucie,Sharma et al,2004,Comparison of methylprednisolone with dexamethasone in treatment of acute spinal injury in rats,http://nopr.niscair.res.in/bitstream/123456789/23435/1/IJEB%2042(5)%20476-480.pdf,English,,included,,,,,,rats,Wistar,50,10,,,30,,,3 MP group,of either sex,mixed,Not reported,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,"level: ""lower dorsal region""; severity: reversible injury",thoracic,mixed,compression,"laminectomy on 3 levels + compression (exposed dura, compressed by placing an object of 25g weight for 2 min)",8 days,"methylprednisolone sodium succinate (MPSS), dexamethasone",methylprednisolone sodium succinate,No,"30, 15 and 7.5 mg/kg","1, 8 or 24h after injury",,"7 days (change of doses after 3 days, then after 2 days)",once daily,not reported,,neurological/functional/behavioral assessment,Eugene D Means and Douglas K Anderson's motility score,,"3 sub scores: mobility score (from no movements of hind limbs to normal), running score (from falls frequently when running to normal), climbing score (from uses only fore limbs to normal)",daily for 7 days,,not reported,no stats,"On calculation of the mean recovery index, it was observed that MPSS produced better clinical recovery as compared to dexamethasone, given after 1 hr following cord trauma and these results were statistically significant; no comparison with controls? no table or graph with neurological results?",histological assessment,"edema in white matter and gray matter, neuronal degeneration, necrosis, hematomyelia",8 days after injury,not reported,no effect,none of the results presented were significantly different,anesthesia: not reported; euthanasia: IP sodium pentobarbital ,"results suggested that MPSS was effective in promoting post traumatic clinical and histological recovery and to a greater extent, when given 1 hr after trauma. MPSS is more effective than dexamethasone in reducing edema when both are given after interval of 1hr.",not reported,"very light neurological results: no comparison with control gorup, no comparison of different treatment regimen; very low sample size might explain non significant results in the histology assessment",No,
Lucie,Sharma et al,2004,Comparison of methylprednisolone with dexamethasone in treatment of acute spinal injury in rats,http://nopr.niscair.res.in/bitstream/123456789/23435/1/IJEB%2042(5)%20476-480.pdf,English,,included,,,,,,rats,Wistar,50,10,,,10,,,,of either sex,mixed,Not reported,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,"level: ""lower dorsal region""; severity: reversible injury",thoracic,mixed,compression,"laminectomy on 3 levels + compression (exposed dura, compressed by placing an object of 25g weight for 2 min)",8 days,"methylprednisolone sodium succinate (MPSS), dexamethasone",dexamethasone,,"6, 3 and 1.5 mg/kg",1h after injury,,"7 days (change of doses after 3 days, then after 2 days)",once daily,not reported,,neurological/functional/behavioral assessment,Eugene D Means and Douglas K Anderson's motility score,,"3 sub scores: mobility score (from no movements of hind limbs to normal), running score (from falls frequently when running to normal), climbing score (from uses only fore limbs to normal)",daily for 7 days,,not reported,no stats,"On calculation of the mean recovery index, it was observed that MPSS produced better clinical recovery as compared to dexamethasone, given after 1 hr following cord trauma and these results were statistically significant; no comparison with controls? no table or graph with neurological results?",histological assessment,"edema in white matter and gray matter, neuronal degeneration, necrosis, hematomyelia",8 days after injury,not reported,no effect,none of the results presented were significantly different,anesthesia: not reported; euthanasia: IP sodium pentobarbital ,"results suggested that MPSS was effective in promoting post traumatic clinical and histological recovery and to a greater extent, when given 1 hr after trauma. MPSS is more effective than dexamethasone in reducing edema when both are given after interval of 1hr.",not reported,"very light neurological results: no comparison with control gorup, no comparison of different treatment regimen; very low sample size might explain non significant results in the histology assessment",No,
Lucie,Guptarak et al,2014,The cancer drug tamoxifen: A potential therapeutic treatment for spinal cord injury,10.1089/neu.2013.3108,English,,included,,,,,,rats,Sprague Dawley,99,40,,,44,,,no treatment n = 15,male 100%,male,100,not reported,,,,,,Not reported,range: [225-250](g),,,225,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,contusion with an Infinite Horizons Impactor using a force of 150 kdynes (1 sec dwell time),"35 days, 81 days",tamoxifen (TMX),tamoxifen,,1 mg/day,2h after injury or 42 days after injury,,14 or 28 days,continuous,subcutaneous,,neurological/functional/behavioral assessment,BBB scale,,-,daily on the first 14 days and once weekly thereafter,,yes,mixed effects (timing),early TMX: both treatment for 14 and 28 days improved recovery with significantly higher BBB than controls after 16 days until end of observation (no difference between TMX groups); delayed treatment: no difference between treatment and control groups,histological assessment,"cavity size, spared oligodendrocytes",35 days,not reported,positive effect,"Tamoxifen (TMX) spares oligodendrocytes and reduces cavitation (significant), Our quantitative assessment of cavity sizes in AQP4-immunolabeled lesion sites (AQP4 delineated cavity borders; see Fig. 5) showed significant (*p = 0.0035) 1.83-fold smaller lesion sizes in TMX-treated injured spinal cords (n = 5/ group; Fig. 3F).","anesthesia: pentobarbital (50 mg/kg, IP); euthanasia: anesthesia pentobarbital (150 mg/kg, IP), transcardial perfusion with 0.9% saline containing heparin",TMX is a promising candidate for the therapeutic treatment of SCI and a possible intervention for other neuropathological conditions associated with demyelination and AQP4 dysfunction,not reported,,No,
Lucie,Xia et al,2017,The combination of db-cAMP and ChABC with poly(propylene carbonate) microfibers promote axonal regenerative sprouting and functional recovery after spinal cord hemisection injury,10.1016/j.biopha.2016.12.045,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (dibutyryl cyclic adenosine monophosphate and chondroitinase ABC),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Fung et al,1990,The combined effects of clonidine and cyproheptadine with interactive training on the modulation of locomotion in spinal cord injured subjects,10.1016/0022-510X(90)90017-H,English,,excluded,Case report,,two cases only,,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kermani et al,2016,Effect of aspirin on spinal cord injury: An experimental study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876300/pdf/IJMS-41-217.pdf,English,,included,,,,,,rats,Wistar,100,20,,,40,,,2 group sham and inteact n = 20 each,male 100%,male,100,not reported (adults),,,,,,Adult,range: [200-250](g),,,200,250,g,,level: T8; severity: moderate,T8,moderate,contusion,"laminectomy + weight drop (10g rod dropped from 50 mm, impounder left for 20 seconds)","24h, 6 weeks",aspirin,acetylsalicylic acid,,80 mg/kg or 20 mg/kg,1h after injury,,3 doses,"1h, 6h and 24h after injury",intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"open field, 2 observers, averages between examiners taken, BBB for each hind limb with average of the 2 limbs rounded down",one a week for 6 weeks,,yes,positive effect,Both of groups treated with high-dose aspirin (mean±SE =20.86±0.14) and low-dose aspirin (mean±SE =20.57±0.20) demonstrated a higher mean BBB score than the control group (mean±SE =12.00±0.22) (p<0.001); no difference between the different doses of aspirin,biochemical investigation (not reported),"lipid peroxidation, catalase level",-,-,,-,"anesthesia: ketamine hydrochloride (50 mg/kg), xylazine hydrochloride (5 mg/kg), both IP",data provide evidence in support of the potential effects of aspirin in biochemical and neurobehavioral recovery after SCI; results of the present study showed that aspirin led to partial functional recovery in an animal model of SCI,"1) did not know the exact effects of aspirin on SCI, we examined only low and high doses, 2) dose-response assessment in pharmacological investigations and also in those similar to the current study is crucial, 3) should have taken into account pre-treatment and various post-injury periods, 4) multiple pahtological mechanisms and biochemical responses thus no single agent is likely to provide complete neuroprotection from secondary injuries, combination drug therapy may become a feasible option for the future treatment of SCI",use ketamine,No,
Lucie,Sayin et al,2013,The dose-dependent neuroprotective effect of alpha-lipoic acid in experimental spinal cord injury,10.5114/ninp.2013.36207,English,,included,,,,,,rats,Sprague Dawley,56,8,,,8,,,4 treatment groups not of interest n = 8 for each and one sham group n = 8,female 100%,female,0,not reported (adults),,,,,,Adult,range: [210-300](g),,,210,300,g,,level: T9; severity: not reported,T9,Not reported,compression,laminectomy + compression (aneurysm clip extradurally for 1 min with force of 30+/-2g),24h,"methylprednisolone sodium succinate (MPSS), alpha-lipoic acid (ALA, not further reported)",methylprednisolone sodium succinate,No,30 mg/kg,immediately after injury ,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, inclined plane test",,"BBB: open field, two examiners, 4 min, 21 points max, evaluates movements of joints, weight support, plantar placement of the pa, weight-supported plantar steps, for limb-hind limb coordination, average of both legs were used; inclined plane: max slope at which rats maintained themselves for 5 seconds",24h after SCI,,yes,positive effect,MPSS group significantly better than the trauma group in terms of BBB score and inclined plane outcome,histological assessment,haemorrhage and cellular edema,24h after SCI,yes,no stats,MPSS group showed evidence of haemorrhage with minimal cellular edema,"anesthesia: sodium pentobarbital (20 mg/kg, IP); euthanasia: overdose of pentobarbital (200 mg/kg)",Alpha lipoic acid at a dose range of 50-150 mg/kg is as effective as MPSS (30 mg/kg) in neuroprotection after SCI. ,not reported,use pentobarbital,No,
Lucie,Ritfeld et al,2014,The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair,10.1016/j.biomaterials.2013.11.062,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest, looking at the effect of polyurethane-based reverse thermal gel, poly(ethylene glycol)epoly(serinol hexamethylene urethane)(ESHU) on bone marrow stromal cell (BMSC) transplant survival",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Grissom et al,1994,The effect of anesthetics on neurologic outcome during the recovery period of spinal cord injury in rats,10.1213/00000539-199407000-00013,English,,excluded,Non-sci population,,spinal cord dinjury pressure rather than real injury,,,rats,Sprague Dawley,25,12,,,5,,,,female 100%,female,0,not reported,,,,,,Not reported,range: [300-400](g),,,300,400,g,,level: T12; severity: progressive neurologic deficit from which recovery could occur,T12,,,"laminectomy + rectangular casein plastic mass inserted in the epidural space and with a blunt probe, advanced in a cephalad direction a distance of 2mm",30 days,"ketamine, fentanyl, isoflurane",ketamine,,75 mg/kg then 4mg,7 or 8 days postimplantation,,"4h exposure; ketamine: than increment every 30 minutes, fentanyl: increments ""as needed"", isoflurane: during the exposure period",-,intramuscular,,neurological/functional/behavioral assessment,inclined plane test,,"movable inclined ramp with a ridged mat on which the animals were placed for evaluation, angle increased in 5 degrees increments untile the animal could not maintain itself in a horizontal position on the for 5 s, max angle of the ramp plane at which the rat could remain perpendicular to the midline axis of the plane was recorded each day, ramp inclination of 35 degrees or less at any time was considered to have a near maximum neurologic deficit (could maintain themselves even with complete paralysis)",day before injury and then daily,,not reported,negative effect,ketamine group demonstrated a significantly poorer recovery level (P< 0.05) relative to the reference group; pattern not repeated in either the fentanyl- or the isoflurane-exposed animals,-,-,-,-,,-,"anesthesia: halothane 3% halothane; postop: gentamicin (1 mg/kg, IM) for 7 days; euthanasia: 50 mg IP thiopental, left ventricule cannulated and infused with heparinized saline (1 U/mL), perfusion continued with 20% formalin for 10 min",the fentanyl group attained maximum recovery first but did not recover to a level different on the average from the reference group; ketamine group demonstrated a poorer recovery level relative to the other anesthetic porotocols,small sample size,"found negative effect of ketamine on recovery, use gentamicin",No,
Lucie,Grissom et al,1994,The effect of anesthetics on neurologic outcome during the recovery period of spinal cord injury in rats,10.1213/00000539-199407000-00013,English,,excluded,Non-sci population,,spinal cord dinjury pressure rather than real injury,,,rats,Sprague Dawley,25,12,,,4,,,,female 100%,female,0,not reported,,,,,,Not reported,range: [300-400](g),,,300,400,g,,level: T12; severity: progressive neurologic deficit from which recovery could occur,T12,,,"laminectomy + rectangular casein plastic mass inserted in the epidural space and with a blunt probe, advanced in a cephalad direction a distance of 2mm",30 days,"ketamine, fentanyl, isoflurane",fentanyl,,50 microg/kg then 10 microg/kg,7 or 8 days postimplantation,,"4h exposure; ketamine: than increment every 30 minutes, fentanyl: increments ""as needed"", isoflurane: during the exposure period",-,subcutaneous,,neurological/functional/behavioral assessment,inclined plane test,,"movable inclined ramp with a ridged mat on which the animals were placed for evaluation, angle increased in 5 degrees increments untile the animal could not maintain itself in a horizontal position on the for 5 s, max angle of the ramp plane at which the rat could remain perpendicular to the midline axis of the plane was recorded each day, ramp inclination of 35 degrees or less at any time was considered to have a near maximum neurologic deficit (could maintain themselves even with complete paralysis)",day before injury and then daily,,not reported,no effect,ketamine group demonstrated a significantly poorer recovery level (P< 0.05) relative to the reference group; pattern not repeated in either the fentanyl- or the isoflurane-exposed animals,-,-,-,-,,-,"anesthesia: halothane 3% halothane; postop: gentamicin (1 mg/kg, IM) for 7 days; euthanasia: 50 mg IP thiopental, left ventricule cannulated and infused with heparinized saline (1 U/mL), perfusion continued with 20% formalin for 10 min",the fentanyl group attained maximum recovery first but did not recover to a level different on the average from the reference group; ketamine group demonstrated a poorer recovery level relative to the other anesthetic porotocols,small sample size,use gentamicin,No,
Lucie,Grissom et al,1994,The effect of anesthetics on neurologic outcome during the recovery period of spinal cord injury in rats,10.1213/00000539-199407000-00013,English,,excluded,Non-sci population,,spinal cord dinjury pressure rather than real injury,,,rats,Sprague Dawley,25,12,,,4,,,,female 100%,female,0,not reported,,,,,,Not reported,range: [300-400](g),,,300,400,g,,level: T12; severity: progressive neurologic deficit from which recovery could occur,T12,,,"laminectomy + rectangular casein plastic mass inserted in the epidural space and with a blunt probe, advanced in a cephalad direction a distance of 2mm",30 days,"ketamine, fentanyl, isoflurane",isoflurane,,3% then 2.25%,7 or 8 days postimplantation,,"4h exposure; ketamine: than increment every 30 minutes, fentanyl: increments ""as needed"", isoflurane: during the exposure period",-,inhalation,,neurological/functional/behavioral assessment,inclined plane test,,"movable inclined ramp with a ridged mat on which the animals were placed for evaluation, angle increased in 5 degrees increments untile the animal could not maintain itself in a horizontal position on the for 5 s, max angle of the ramp plane at which the rat could remain perpendicular to the midline axis of the plane was recorded each day, ramp inclination of 35 degrees or less at any time was considered to have a near maximum neurologic deficit (could maintain themselves even with complete paralysis)",day before injury and then daily,,not reported,no effect,ketamine group demonstrated a significantly poorer recovery level (P< 0.05) relative to the reference group; pattern not repeated in either the fentanyl- or the isoflurane-exposed animals,-,-,-,-,,-,"anesthesia: halothane 3% halothane; postop: gentamicin (1 mg/kg, IM) for 7 days; euthanasia: 50 mg IP thiopental, left ventricule cannulated and infused with heparinized saline (1 U/mL), perfusion continued with 20% formalin for 10 min",the fentanyl group attained maximum recovery first but did not recover to a level different on the average from the reference group; ketamine group demonstrated a poorer recovery level relative to the other anesthetic porotocols,small sample size,use gentamicin,No,
Lucie,Baysefer et al,2003,Effect of mannitol in experimental spinal cord injury: an ultrastructural and electrophysiological study.,https://www.researchgate.net/profile/Serdar-Kahraman/publication/8979811_Effect_of_mannitol_in_experimental_spinal_cord_injury_An_ultrastructural_and_electrophysiological_study/links/54fc4e8b0cf20700c5e9698d/Effect-of-mannitol-in-experimental-spinal-cord-injury-An-ultrastructural-and-electrophysiological-study.pdf?origin=publication_detail,English,,included,,,,,,rats,Sprague Dawley,50,20,,,20,,,sham n = 10,male 100%,male,100,not reported,,,,,,Not reported,range: [250-300](g),,,250,300,g,,level: T6-T7; severity: not reported,T6 - T7,Not reported,compression,laminectomy + compression (aneurysm clip with a closing force of 50g extradurally for 10 seconds),2 weeks,mannitol,mannitol,,2 g/kg of 20% mannitol,immediately after injury,,2 doses,immediately and 3h after injury,intraperitoneally,,neurological assessment and electrophysiology,clinical grading; SSEPs,,"clinical grading: 0=no difference from normal rats; 1=crawling with mild difficulty, 2=some voluntary movement to support the hindquarters, 3=no voluntary movement; SSEPs: electrode over the somatosensory cortex elicited by applying cathodal stimuli intensity 10 mA pulse duration of 50 msec and presentation rate 7.5 Hz, to the left sciatic nerve, all responses recorded, averaged and replicated, graded as 1=no difference from normal rats, 2=abnormal potentials prolonged latency and decreased amplitude, 3=no potentials","clinical grading: 2 weeks; SSEPs: ""in the third week postop""?",,not reported,positive effect,there were statistically significant differences in the clinical grading and electrophysiological grading between the mannitol-treated group and the trauma- alone group with the treatment group doing better than control,histological assessment,ultrastructure findings,2 weeks,not reported,no stats,less axonal degenerations were found in the white matter in samples obtained from the mannitol-treated rats than the trauma-alone rats at 2 weeks post-injury,anesthesia: 10 mg/kg xylazine and 30 mg/kg ketamine hydrochloride IM,administration of 2 g/kg of 20% mannitol produces significant improvement in the neural structures and protects the spinal cord following injury,not reported,use ketamine,No,
Lucie,Farooque et al,1994,EFFECT OF THE 21-AMINOSTEROID U74006F AND METHYLPREDNISOLONE ON MOTOR FUNCTION RECOVERY AND EDEMA AFTER SPINAL-CORD COMPRESSION IN RATS,https://doi.org/10.1111/j.1600-0404.1994.tb01630.x,English,,included,,,,,,rats,Sprague Dawley,102,30,,,30,,,see table 1,male 100%,male,100,not reported,,,,,,Not reported,range: [300-450](g),,,300,450,g,,level: T8-T9; severity: not reported,T8 - T9,Not reported,compression,laminectomy + compression (5min compression with a slightly curved rectangular plate measuring 2.2*5.0mm and carrying a weight of 35g),"4h, 1, 4, 9, 21 days","tirilazad mesylate (not further reported since it is not a drug of interest), methylprednisolone sodium succinate (MPSS)",methylprednisolone sodium succinate,No,30 mg/kg,60 min after injury,,single dose,-,intravenously,,neurological/functional assessment,inclined plane test,,"rat placed transversely on an inclined plane covered with rubber with ridges 0.2cm high, max inclination at which the rat maintained its position transversely for 5s termed as cpacity angle",daily for 14 days and again on day 21,,not reported,no effect,"MP significantly better in terms of angle of inclined plane for day 1, 4, and 9 but not significantly different at day 21",histological assessment,water content,"4h, 1, 4, 9, 21 days",not reported,no effect,no apparent significant difference between MPSS and control group in terms of water content,"anesthesia: fluanisone (2.5 mg/ml), midazolam (1.25 mg/ml) SC",a single i. v. injection of U74006 or MP given 60 min after compression of the spinal cord improved  motor  function without effecting oedema expressed as water conten,not reported,"report positive results but does not look significant on the figures, used midazolam",No,
Matthias,Mizushima et al,2001,"The effect of cardiac arrest on the blood-testis barrier to albumin, tumor necrosis factor-alpha, pituitary adenylate cyclase activating polypeptide, sucrose, and verapamil in the mouse",PMID: 11229799,English,,excluded,Out of scope,No assessments of interest,effect of cardiac arrest on testis in mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Paredes-Espinosa et al,2011,Effect og glycine administration on motor function in rats after traumatic injury of the spinal cord,https://www.medigraphic.com/pdfs/arcneu/ane-2011/ane113c.pdf,Spanish,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (glycine),,,rats,Wistar,,,,,,,,,male 100%,,,not reported,,,,,,,range: [280-350](g),,,,,,,level: T8; severity: ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yang et al,2003,Effects of corticosteroid and electroacupuncture on experimental spinal cord injury in dogs.,https://vetsci.org/pdf/10.4142/jvs.2003.4.1.97,English,,excluded,Out of scope,No assessments of interest,Out of scope: speed of recovery studied rather than if they would recover or not,,,dogs,not reported,20,,,,,,,,mixed,,,range: [2-4](years),,,,,,,range:[2.5-7.0](g),,,,,,,level: L3; severity: 25% of the spinal cord was compressed,,,,laminectomy + insertion of a foreign object (bone fragment)compressing about 25% of the spinal cord,not reported,methyl prednisolone succinate (MPSS) and prednisolone acetate (PDS),,,"MPSS: 30 mg/kg, PDS: 2 mg/kg (""dosage of PDS was tapered according to clinical signs and complications"")","MPSS: 48h after induction of compression, PDS: PDS: after the 6 doses of MPSS q6h starting 48h after SCI",,"MPSS: 6 doses, 36h; PDS: not reported",MPSS: q6h; PDS: bid,multiple,,"neurological (motor and sensory), electrophysiology","postural reaction, superficial pain and deep pain; somatosensory evoked potentials (SEPs)",,"SEPs: represented as spinal conduction velocity, channel 1 was located on the subdermal region between the 5th and 6th lumbar vertebra and the channel 2 was positioned between the 11th and 12th thoracic vertebra",motor and sensory: every day until responded normally,,not reported,,is there a comparison between corticoseteroid group and control only?,-,-,-,-,,-,"premedication: acepromazine maleate (0.01 mg/kg, IV), ampicillin (20 mg/kg, IM), enrofloxacin (5 mg/kg, SC); anesthesia: thiopental sodium (15 mg/kg, IV), maintained with isoflurane (1.5MAC); during surgery: lactate ringer's solution with 5% dextrose (10 ml/kg/h, IV drip); postop: with PDS, cimetidine (5 microg/kg), misoprostol (5 microg/kg), vit B1 (1 mg/kg) orally","according to these results, it was considered that the combinatopn of corticosteroid and electroacupuncture was the most therapeutically effective for ambulatory paresis due to SCI in dogs",not reported,"no real comparison with control group, treatment effect on time of recovery not on the extent of recovery since all subjects recovered",,
Lucie,Delaviz et al,2008,The effect of fetal olfactory mucosa on tissue sparing and locomotor recovery after spinal cord hemisection in rats,https://celljournal.org/library/upload/article/Delaviz.pdf,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (cyclosporineA for immunosupression + fetal olfactory mucosa or fetal respiratory mucosa),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Golding et al,2006,The effect of glutamine on locomotor performance and skeletal muscle myosins following spinal cord injury in rats,10.1152/japplphysiol.00428.2006,English,,included,,,,,,rats,Wistar,30,7,,,7,,,2 sham groups no SCI no treatment and laminectomy n = 8 for each,male 100%,male,100,11 weeks,11,,,,Weeks,,range: [238-351](g),,,238,351,g,,level: T6; severity: complete paraplegia,T6,paraplegia,compression,"laminectomy + compression (modified aneurism clip, 30-g force for 5s)",6 weeks,glutamine,glutamine,,1 mmol/kg,1h after injury,,1 week,every 12h,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane method, BBB scale",,"inclined plane: maximum angle that a rat can maintain without falling off an angled board, start at 25 degress and increased at 5 degrees increments until the rat could no longer maintain its position or until a max angle of 55 degrees was reached; BBB: open-file, 21-point scale, 0=total paralysis or no hindlimb movement, 21=normal locomotion, 10=able to take occasional steps",once per week,,not reported,positive effect,"inclined plane: Treated SCI rats performed significantly better than untreated rats at weeks 3,4,5 (P<0.001), and 6 (P<0.01); BBB: Treated rats’ mean BBB scores were significantly higher than those of untreated rats at week 1 (P<0.01) and weeks 2–6 (P<0.001) post-surgery",-,-,-,-,,-,"anesthesia: 5% halothane mixed with pure oxygen and later maintained with 2.5% halothane; post op: analgesic buprenorphine 0.05 mg/kg SC for 5 injections in decresing doses in 12h intervals; euthanasia: 5% halothane, intracardiac perfusion with a cold, nonheparinized saline drip attached to an IV needle","findings suggest glutamine improves functional recovery and helps preservemyosin profile by reducing secondary SCI, thereby maintaining morenerves",not reported,,No,
Matthias,Hansebout et al,1975,Effects of local hypothermia and of steroids upon recovery from experimental spinal cord compression injury,https://europepmc.org/article/med/1188593,English?,,excluded,No access,,,,,dogs,canine,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Abdanipour et al,2019,"The effect of lithium chloride on BDNF, NT3, and their receptor mRNA levels in the spinal contusion rat models",10.1080/01616412.2019.1588507,English,,included,,,,,,rats,Not reported,32,8,,,8,,,2 sham groups one not injured one with laminectomy both n = 8,female 100%,female,0,8-12 weeks,,,8,12,Weeks,Adult,range: [200-250](g),,,200,250,g,,level: L1; severity: severe,L1,severe,contusion,"laminectomy + weight-drop contusion (10g metal rod with 2mm diameter, dropped from a 25 mm height)",28 days,lithium chloride (LiCl),lithium,,20 mg/kg,3 days after SCI,,14 days,not reported,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"open fiel test, 4 minutes, circular plastic with 110 cm in diameter and 50 cm in height","3, 7, 14, 21, 28 days after SCI",,not reported,positive effect,LiCl group had a significantly higher mean BBB score compared to control group starting at day 7 until the end of the experiment,histological assessment,"lesion area, percentage of cavity volume, TUNEL assay",28 days after SCI,not reported,positive effect,"mean of cavity significantly decreased in the LiCl-treated group (9.18 ± 1.39) compared with the non-treatment group (14.64 ± 1.03), The percentage of apoptotic cells in the lesion area significantly decreased in the LiCl-treated group (2.78% ± 0.38) compared with the non-treatment group (5.79% ± 0.27) (P < 0.05)","anesthesia: not reported; postop: lactated ringer's solution (SC, 5 mL, 3 times per day), cefzolix (50 mg/kg, IM, twice daily for the first week after surgery); euthanasia: anesthesia with ketamine (100 mg/kg) and xylazine (10 m/kg), transcardailly perfused wih 4% paraformaldehyde in PBS","LiCl protects neural cells and effectively enhances locomotor function, which was done through up-regulation of endogenous BDNF expression in rats with SCI.",no possibility to evaluate the expression of related specific proteins (financial an political restrictions due to the crisis between Iran and western world in 2019),,No,
Matthias,Jeon et al,2014,The effect of long-term oral dantrolene on the neuromuscular action of rocuronium,10.4097/kjae.2014.66.2.153,English,,excluded,Case report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Toksoz et al,2013,The effect of long-term oral tadalafil treatment on corpus cavernosum function in an experimental spinal cord transection rat model,10.1038/sc.2013.61,English,,excluded,Out of scope,No assessments of interest,to investigate effects on the corpus cavernosum function,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2020,The effect of Matrigel as scaffold material for neural stem cell transplantation for treating spinal cord injury,10.1038/s41598-020-59148-3,English,,excluded,Out of scope,No drug of interest,"not sure if the aim is out of scope [Lucie: Agreed, no drug of interest (Matrigel and neural stem cells tested)",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Charn et al,2011,The effect of minocycline on motor neuron recovery and neuropathic pain in a rat model of spinal cord injury,10.3340/jkns.2011.49.2.83,English,,included,,,,,,rats,Sprague Dawley,15,5,,,5,,,sham n = 5,male 100%,male,100,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,level: T10; severity: complete,T10,incomplete,transection,laminectomy + hemisection (right half was transected completely by microblade),28 days,minocycline,minocycline,,40 mg/kg,30 min before injury,,28 days,every second day,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, von Frey test",,"BBB: 2 observers, semiquantitative based on the 21-point scale; von Frey: withdrawal response to mechanical stimulation with von Frey filaments, 15 minutes adaptation, each hindpaw was stimulated to cause slight bending for 3-5sec with con Frey filaments (0.16, 0.4, 0.6, 1, 1.4, 2, 4, 6, 8, 10, 15, 26g), initially using probe of 0.16g and increased gradualy until a filament consistently produced a withdrawal response to more than 3 of 5 stimuli, 50% probability threshold of mechanical paw withdrawal were calculated","before operation, day 1, 2, 4, 7, 10, 14, 20 and 28 after surgery",,yes,mixed effects (assessment),"BBB: Administration of minocycline significantly attenuated the decrease in BBB score that was induced by hemisection, BB score was significantly better than in the control group (hemisection without treatment); von frey: 50% withdrawal threshold (g) significantly higher at day 4 in treatment group compared to control, but not at any other day, i.e. no difference overall in between treatment and contro",histological assessment,"vacuolisation, necrosis",28 days,not reported,no stats,"no comaprison between the control and treatment groups, only vague description (spinal cord was completely destroyed, necrotic tissue and glial cells observed, vacuolation and infiltration of inflammatry cells noted, no neuronal necrosis in the gray matter, increase in glial nuclei, group treated with minocycline showed a decreased numbers of microglia and astrocytes)","anesthesia: tiletamine+zolazepam (27.78 mg/kg), xylazine (0.647 mg/kg); euthanasia: anesthesia as before, perfused with heparinized saline and 500 ml of 4% paraformaldehyde in PB","By inhibiting microglia and astrocyte activation, minocycline may facilitate motor recovery and attenuate mechanical hyperalgesia in individuals with spinal cord injuries","relatively small number of experimental rats, did not quantify the resulting lesion size secondary to SCI",no histological results that can be exploited (acknowledged in the limitations),No,
Lucie,Warner et al,2019,The Effect of Non-Gabapentinoid Anticonvulsants on Sensorimotor Recovery After Human Spinal Cord Injury,10.1007/s40263-019-00622-6,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (group of drugs instead),,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Barbeau et al,2003,The effect of noradrenergic drugs on the recovery of walking after spinal cord injury.,10.1038/sj.sc.3101374,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Stutzmann et al,1996,The effect of riluzole on post-traumatic spinal cord injury in the rat,10.1097/00001756-199601310-00003,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (riluzole),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ohtake et al,2014,The effect of systemic PTEN antagonist peptides on axon growth and functional recovery after spinal cord injury,10.1016/j.biomaterials.2014.02.037,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (PTEN antagonist peptide),,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Agrawal et al,1997,The effect of the sodium channel blocker QX-314 on recovery after acute spinal cord injury,10.1089/neu.1997.14.81,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (QX-314),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Īldan et al,1995,The effect of the treatment of high-dose methylprednisolone on Na+-K+/Mg+2 ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat,https://reader.elsevier.com/reader/sd/pii/0090301995002197?token=9218EAB4F08456BA5C29C2984E1882667521D528F4B3E44370912DA24CC1D7E392D3B27A4E92C0BEDB5D48053B6BF74D&originRegion=eu-west-1&originCreation=20220323133833,English,,excluded,Non-sci population,,"I think that the aim is out of scope [Lucie: Agreed, looking at cerebral contusion and not SCI]",,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gul et al,2010,The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats,10.1016/j.jocn.2009.05.041,English,,included,,,"Again, I think that the aim is out of scope [Lucie: would disagree, part of treatment of interest, neurological and histological assessment]",,,rats,Wistar,40,10,,,10,,,sham n = 10,male 100%,male,100,not reported (adults),,,,,,Adult,range: [230-250](g),,,230,250,g,,level: T10; severity: not reported,T10,Not reported,compression,"laminectomy + compression (clip method, using aneurysm clip for 60s)",24h,"methylprednisolone (MP, group 3 and 4), dexmedetomidine hydrochloride (DH, group 4 only)",methylprednisolone,No,30 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"gross neurologic examination, rivlin and tator's inclined plane test, paraplegia status (tail pinch)",,"gross neurologic examination: pinching the rat's tail to cause pain, rivlin and tator's inclined plane test: maximum angle at which the rats, on a flat platform, could maintain a stationary position for at least 5 minutes, paraplegia status: identified in all rats by applying a painful stimulus to the tail",12h and 24h ,No,not reported,not reported,not reported,histological assessment,"edema, congestion, hemorrhage, neuronal degeneration and neuronal loss, neuronal cell count (cell counts/mm^2)",24h after SCI,not reported,mixed (stats/no stats),"edema and prominent hemorrhage with neuronal degeneration, mean neuronal cell counts not significantly different from control group","anesthesia: ketamine hydrochloride (IP, 60 mg/kg); euthanasia: lehtal dose of ketamine hydrochloride","dexmedetomidine may have a neuroprotective effect in spinal cord injury, and its effects may be partially attributed to inhibition of lipid peroxidation",not reported,neurological assessment results not reported,No,
Lucie,Gul et al,2010,The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats,10.1016/j.jocn.2009.05.041,English,,included,,,"Again, I think that the aim is out of scope [Lucie: would disagree, part of treatment of interest, neurological and histological assessment]",,,rats,Wistar,40,10,,,10,,,sham n = 10,male 100%,male,100,not reported (adults),,,,,,Adult,range: [230-250](g),,,230,250,g,,level: T10; severity: not reported,T10,Not reported,compression,"laminectomy + compression (clip method, using aneurysm clip for 60s)",24h,"methylprednisolone (MP, group 3 and 4), dexmedetomidine hydrochloride (DH, group 4 only)",dexmedetomidine,,10 microg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"gross neurologic examination, rivlin and tator's inclined plane test, paraplegia status (tail pinch)",,"gross neurologic examination: pinching the rat's tail to cause pain, rivlin and tator's inclined plane test: maximum angle at which the rats, on a flat platform, could maintain a stationary position for at least 5 minutes, paraplegia status: identified in all rats by applying a painful stimulus to the tail",12h and 24h ,,not reported,not reported,not reported,histological assessment,"edema, congestion, hemorrhage, neuronal degeneration and neuronal loss, neuronal cell count (cell counts/mm^2)",24h after SCI,not reported,mixed (stats/no stats),"modest histopathological changes included mild congestion and edema, significantly higher number of mean neuronal cell counts compared to control and MP alone group, no significantly different from the sham group in terms of eman neuronal cell counts","anesthesia: ketamine hydrochloride (IP, 60 mg/kg); euthanasia: lehtal dose of ketamine hydrochloride","dexmedetomidine may have a neuroprotective effect in spinal cord injury, and its effects may be partially attributed to inhibition of lipid peroxidation",not reported,neurological assessment results not reported,No,
Matthias,Duh et al,1994,The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment,10.1227/00006123-199408000-00009,English,,excluded,Out of scope,No assessments of interest,"Again, I think that the aim is out of scope [Lucie: Agreed, out of scope, no treatment of interest, looking at the effet of surgery instead]",,,human,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Impellizzeri et al,2012,"The effects of a polyphenol present in olive oil, oleuropein aglycone, in an experimental model of spinal cord injury in mice",10.1016/j.bcp.2012.02.001,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest ( ole aglycone),,,mice,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ye et al,2004,The effects of ciliary neurotrophic factor on neurological function and glial activity following contusive spinal cord injury in the rats,10.1016/j.brainres.2003.10.036,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ciliary neurotrophic factor),,,rats,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Robert et al,2010,The Effects of Different Rehabilitation Strategies on the Functional Recovery of Spinal Cord Injured Rats An Experimental Study,10.1097/BRS.0b013e3181e3fc5f,English,,excluded,Out of scope,No assessments of interest,only different rehab methods on outcome,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Bavetta et al,1999,The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: Neuroprotection and local regeneration,10.1006/exnr.1999.7119,English,,excluded,Out of scope,No assessments of interest,"axonal sprouting only, no functional tests",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lang-Lazdunski et al,2001,The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats,10.1097/00000539-200105000-00029,English,,included,,,"strange SCI model, no info on the level? ",,,rats,Sprague Dawley,79,20,3,,40,1,,"sham n = 15, treatment has 2 groups of n = 20 each",male 100%,male,100,not reported,,,,,,Not reported,range: [350-375](g),,,350,375,g,,level: not reported; severity: not reported,cervical,Not reported,ischemia,thoracotomy + ischemia (aortic arch plus left subclavian artery cross-clamping for 14 min by use of 2 micro vessel clips),"24, 48, 96h",tacrolimus (FK506),tacrolimus,,1 mg/kg,30 min before clamping or at the onset of reperfusion (2 groups),,single dose,-,intravenously,,neurological/functional/behavioral assessment,motor sensory deficit index (MSDI),,"walking with lower extremities from 0=normal to 4=no movement, drags lower extremities, pain sensation from 0=normal, withdrawal to toe pinch to 2=no reaction to toe pinch; for each animal, at each time point, fincal index was sum of pain sensation and walking with lower extremities score, with maximum deficit indicated by a score of 6",at 24h and then daily up to 96h,,not reported,positive effect,Neurologic outcome was significantly better in tacrolimus-treated rats at any time considered ,histological assessment,"neutrophilic infiltration in the gray matter, rexed classification (localisation of damaged neurons in gray matter), degree of gray matter ischemic damage: 0= normal hitopathology, no detectable changes, 3= damage affecting more than 50% of the scored area, for 3 regions: dorsal horn, intermediate gray matter, ventral horn; final score ranged between 0 (normal spinal cord) and 9 (more than 50% postischemic damage); TUNEL assay","24, 48 or 96h ",yes,mixed (stats/no stats) + mixed (assessment),"histopathologic changes in tacrolimus-treated animals were milder than those observed in the Control group and occurred with mild to moderate neutrophilic infiltration in the gray matter, compared with major neutrophilic infiltration in the Control group; number of intact motor neurons per section was significantly more in tacrolimus-treated animals compared to control; number of necrotic neurons (TUNEL) is not significantly different in the different areas","anesthesia: 3% halothane for induction, 1.5% halothane in balance with oxygen for maintainance; euthanasia: 3% halothane, transcardially perfused with 100 ml of 0.9% saline solution at 4 degrees Celsius. ",Tacrolimus can improve eurologic recovery and attenuate spinal cord injury induced by transient thoracic aortic cross-clamping,not reported,,No,
Lucie,Rosado et al,2014,"Effects of methylprednisolone, dantrolene, and their combination on experimental spinal cord injury",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152024/pdf/ijcep0007-4617.pdf,English,,included,,,check SCI model,,,rats,Wistar,25,not reported,,,not reported,,,no details reported,male 100%,male,100,12 weeks,12,,,,Weeks,,300 (g),300,,,,g,,level: T12; severity: severe,T12,severe,contusion,laminectomy + weight drop (70 g/cm loading on the dorsal surface of the spinal cord),8 days,"methylprednisolone sodium succinate (MPSS), dantrolene or combination of both",methylprednisolone sodium succinate,No,30 mg/kg,3h after laminectomy,,single dose,-,intravenously,,neurological/functional/behavioral assessment,BBB scoring system,,"5 min, 2 observers, filmed","24h before surgery (day 0), then daily starting 24h after surgery until 7th day after surgery",,yes,no effect,There was no significant difference between the mean scores obtained in the control or any treatment groups at any of the time points (P>0.05),histological assessment,"neuronal and glial loss, TUNAL assay",day 8,not reported,mixed (stats/no stats),"histological patterns observed were similar in all groups with injury regardless of treatment scheme in the epicenter region with malacia that was diffuse, affecting white and gray matter (no stats); no significant difference in TUNEL assay between control and any of the treatment groups","anesthesia: tramadol (2 mg/kg, SC), induction and maintenance was carried out with isoflurane (gaz), prophylactic antibiotic therapy (cephalothin, 30 mg/kg, SC); euthanasia: overdose of sodium thiopental IP, transcardiac perfusion with 200 ml PBS and 4% buffered formaldehyde","methylprednisolone sodium succinate, dantrolene sodium, or the combination of these drugs did not reduce neuronal and glial loss, intrinsic pathway apoptosis, or promote functional recovery",not reported,"explicitly looking at combination of 2 drugs of interest (MPSS and dantrolene), use tramadol",No,
Lucie,Rosado et al,2014,"Effects of methylprednisolone, dantrolene, and their combination on experimental spinal cord injury",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152024/pdf/ijcep0007-4617.pdf,English,,included,,,check SCI model,,,rats,Wistar,25,not reported,,,not reported,,,no details reported,male 100%,male,100,12 weeks,12,,,,Weeks,,300 (g),300,,,,g,,level: T12; severity: severe,T12,severe,contusion,laminectomy + weight drop (70 g/cm loading on the dorsal surface of the spinal cord),8 days,"methylprednisolone sodium succinate (MPSS), dantrolene or combination of both",dantrolene,,10 mg/kg,1h after laminectomy,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,BBB scoring system,,"5 min, 2 observers, filmed","24h before surgery (day 0), then daily starting 24h after surgery until 7th day after surgery",,yes,no effect,There was no significant difference between the mean scores obtained in the control or any treatment groups at any of the time points (P>0.05),histological assessment,neuronal and glial loss,day 8,not reported,mixed (stats/no stats),"histological patterns observed were similar in all groups with injury regardless of treatment scheme in the epicenter region with malacia that was diffuse, affecting white and gray matter (no stats); no significant difference in TUNEL assay between control and any of the treatment groups","anesthesia: tramadol (2 mg/kg, SC), induction and maintenance was carried out with isoflurane (gaz), prophylactic antibiotic therapy (cephalothin, 30 mg/kg, SC); euthanasia: overdose of sodium thiopental IP, transcardiac perfusion with 200 ml PBS and 4% buffered formaldehyde","methylprednisolone sodium succinate, dantrolene sodium, or the combination of these drugs did not reduce neuronal and glial loss, intrinsic pathway apoptosis, or promote functional recovery",not reported,"explicitly looking at combination of 2 drugs of interest (MPSS and dantrolene), use tramadol",No,
Lucie,Rosado et al,2014,"Effects of methylprednisolone, dantrolene, and their combination on experimental spinal cord injury",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152024/pdf/ijcep0007-4617.pdf,English,,included,,,check SCI model,,,rats,Wistar,25,not reported,,,not reported,,,no details reported,male 100%,male,100,12 weeks,12,,,,Weeks,,300 (g),300,,,,g,,level: T12; severity: severe,T12,severe,contusion,laminectomy + weight drop (70 g/cm loading on the dorsal surface of the spinal cord),8 days,"methylprednisolone sodium succinate (MPSS), dantrolene or combination of both",methylprednisolone sodium succinate + dantrolene,,"MPSS: 30 mg/kg, dantrolene: 10 mg/kg",MPSS: 3h after laminectomy; dantrolene: 1h after laminectomy,,2 doses (1 per treatment),-,multiple,"MPSS: IV, dantrolene: IP",neurological/functional/behavioral assessment,BBB scoring system,,"5 min, 2 observers, filmed","24h before surgery (day 0), then daily starting 24h after surgery until 7th day after surgery",,yes,no effect,There was no significant difference between the mean scores obtained in the control or any treatment groups at any of the time points (P>0.05),histological assessment,neuronal and glial loss,day 8,not reported,mixed (stats/no stats),"histological patterns observed were similar in all groups with injury regardless of treatment scheme in the epicenter region with malacia that was diffuse, affecting white and gray matter (no stats); no significant difference in TUNEL assay between control and any of the treatment groups","anesthesia: tramadol (2 mg/kg, SC), induction and maintenance was carried out with isoflurane (gaz), prophylactic antibiotic therapy (cephalothin, 30 mg/kg, SC); euthanasia: overdose of sodium thiopental IP, transcardiac perfusion with 200 ml PBS and 4% buffered formaldehyde","methylprednisolone sodium succinate, dantrolene sodium, or the combination of these drugs did not reduce neuronal and glial loss, intrinsic pathway apoptosis, or promote functional recovery",not reported,"explicitly looking at combination of 2 drugs of interest (MPSS and dantrolene), use tramadol",Yes (drug of interest + drug of interest),
Lucie,Yang et al,2003,Effects of resveratrol on secondary damages after acute spinal cord injury in rats,http://www.chinaphar.com/article/download/9182/9846,English,,excluded,Out of scope,No assessments of interest,Out of scope: no result of interest,,,rats,Sprague Dawley,90,,,,,,,,"""of either sex""",,,3-4 months old,,,,,,,range: [180-220](g),,,,,,,level: T8; severity: not reported,,,,"laminectomy + weight drop (dropping a rod weighing 10 g, from a 25-mm height directly to the intact dura)","1, 24, 48h after injury","resveratrol (Red, not of interest so no further reported), methylprednisolone (MP)",,,100 mg/kg,"at 1, 24 or 48h after injury",,single dose,-,intraperitoneally,,-,-,,-,-,,-,,-,histological assessment,tissue edema,"1, 24, 48h after injury",not reported,no effect,MPSS showed no remarkable effect (no significant influence on tissue water content),"anesthesia: sodium pentobarbital (30 mg/kg, IP), ""no prophylactic antibiotics were given to avoid possible drug interactions""",Both resveratrol (Res) and MPSS effectively protected the spinal cord from secondary spinal cord injures. But the effects of Res 50 and 100 mg/kg were stronger in improving the energy metabolism system and inhibiting the lipid peroxidation in the local injured spinal cord after SCI than MPSS at the dose of 100 mg/kg. Res might have greatly potent therapeutic effects on SCI.,not reported,"very light results, not sure it should be included",,
Lucie,Boran et al,2005,Erythropoietin enhances neurological recovery after experimental spinal cord injury.,https://www.burakorhanboran.com/wp-content/uploads/2021/07/Erythropoietin.pdf,English,,included,,,,,,rats,Wistar,70,20,,,20,,,sham n = 10,male 100%,male,100,not reported,,,,,,Not reported,range: [180-220](g),,,180,220,g,,level: T6-7; severity: not reported,T6 - T7,Not reported,contusion,laminectomy + weight drop (5g steel bullet dropped through a 10 cm tube onto the dorsal surface of the spinal cord exerting an impact of 50g/cm),14 days,"methylprednisolone (MP), recombinant erythropoietin (rhEP)",methylprednisolone,No,30 mg/kg,within 60 min following injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,swimming test,,"swimming pool with a diameter of 50 cm and a water depth of 30 cm, wire mesh ladder attached to the side of the pool, rats placed in the pool ont at a time, observed swimming in and climbing out of the pool, 0=no use of hindlimbs, 1= partial use of hind limbs 2= normal use of both hind limbs","twice daily for 14 days starting at day 0 (reported: day 1, 4, 7, 10, 14)",No,yes,no effect,"MP: MP group not significantly different from the control group until day 14; rhEP: rhEP group significantly better than control group from the start, also better than MP group from the start",-,-,-,-,,-,"anesthesia: ketamine hydrochloride (60 mg/kg), fentanyl citrate (0.05 mg/kg) both IM",erythropoietin enhances neurological recovery following spinal cord injury and it seemsto be more effective than methylprednisolone at the given doses,not reported,,No,
Lucie,Boran et al,2005,Erythropoietin enhances neurological recovery after experimental spinal cord injury.,https://www.burakorhanboran.com/wp-content/uploads/2021/07/Erythropoietin.pdf,English,,included,,,,,,rats,Wistar,70,20,,,20,,,sham n = 10,male 100%,male,100,not reported,,,,,,Not reported,range: [180-220](g),,,180,220,g,,level: T6-7; severity: not reported,T6 - T7,Not reported,contusion,laminectomy + weight drop (5g steel bullet dropped through a 10 cm tube onto the dorsal surface of the spinal cord exerting an impact of 50g/cm),14 days,"methylprednisolone (MP), recombinant erythropoietin (rhEP)",epoetin,,5000 IU/kg,within 60 min following injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,swimming test,,"swimming pool with a diameter of 50 cm and a water depth of 30 cm, wire mesh ladder attached to the side of the pool, rats placed in the pool ont at a time, observed swimming in and climbing out of the pool, 0=no use of hindlimbs, 1= partial use of hind limbs 2= normal use of both hind limbs","twice daily for 14 days starting at day 0 (reported: day 1, 4, 7, 10, 14)",,yes,positive effect,"MP: MP group not significantly different from the control group until day 14; rhEP: rhEP group significantly better than control group from the start, also better than MP group from the start",-,-,-,-,,-,"anesthesia: ketamine hydrochloride (60 mg/kg), fentanyl citrate (0.05 mg/kg) both IM",erythropoietin enhances neurological recovery following spinal cord injury and it seemsto be more effective than methylprednisolone at the given doses,not reported,,No,
Lucie,Alibai et al,2014,Erythropoietin plus methylprednisolone or methylprednisolone in the treatment of acute spinal cord injury: a preliminary report.,PMID: 24901857,English,Iran,excluded,Out of scope,No control group,,,prospective,human,,30,,,,,,,,"male: n=23 (76.7%), female: n=7 (23.3%)",mixed,76.7,range: [18-65](years),,,,,,,not reported (no significant difference between groups),,,,,,,"level: cervical n=18, thoracic: n=12; severity: mean on ASIA score on admission (range) in MP group 2(1-4) and in the erythropoietin group 2.07(1-4)",,,,"motor vehicle accident: n=22 (66%), falls: n=8 (34%)",followed for 6 months after injury,methylprednisolone sodium succinate (MPSS) +/- recombinant human erythropoietin (rhEPO),"methylprednisolone sodium succinate, epoetin",,"MPSS: 30 mg/kg initially and 5.4 mg/kg after, rhEPO: 500 units/kg","MPSS: upon admission, rhEPO: on admission",,"MPSS: 23h if admitted within 3h after SCI, 47h if admitted within 3-6h after injury; rhEPO: 24h","MPSS: every hour, rhEPO: first dose upon admission, second dose 24h later",intravenously,,neurologic functions assessment,ASIA impariment scale; rectal and urinary sphincter function; sexual dysfunction,injury severity,"modified from the Frankel classifications: A=complete, no sensory or motor function is preserved in sacral segments S4-S5 to E=normal: sensory and motor function are normal; rectal and urinary sphincter function; sexual dysfunction","ASIA: on admission, after 24, 48, 72h, 1 week, 1 month and 6 months; sphincters: admission and one month later, sexual dysfunction: 6 months later",,yes,mixed effects,"ASIA: no significant difference in neurological exam on admission, 24h and 48h after admission, but significant difference at one week, one month and 6 months after admission (less severe injuries when given both rhEPO and MPSS compared to MPSS alone); sphincters: no significant difference in improvement of sphincter function in the 2 groups; sexual dysfunction: incidence not statistically different in between the 2 groups at presentation and 6 months after follow up",-,-,-,-,,-,-,MPSS plus rhEPO started within 6 hours after acute spinal injury may be more effective  than MPSS plus placebo in improvement  of  neurologic dysfunction. More studies with larger sample sizes are warranted. ,not reported,"randomized controlled double-blind clinical trial, exclusion of patients needing surgical intervention",,
Matthias,Gambardella et al,1995,Experimental incomplete spinal cord injury: Treatment with a combination of nimodipine and adrenaline,PMID:  8568556,English,,excluded,Out of scope,No drug of interest,"Combinatorial treatment, no single drug groups",,,rabbit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Matthias,Gambardell et al,1995,Experimental incomplete spinal cord injury: treatment with a combination of nimodipine and adrenaline.,PMID: 8568556,English,,excluded,Duplicate,,Duplicate of row 1018,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Black et al,1971,Experimental spinal cord injury in monkeys: Comparison of steroids and local hypothermia,PMID: 5001069,English,,excluded,Out of scope,No assessments of interest,Out of scope (drug effect on hyperthermia),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Song et al,1998,Experimental study on the efficacy of methyl prednisolone in the treatment of traction injury of spinal cord in rabbits,PMID: 10437099 ,Chinese,,excluded,No access,,,,,rabbit,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Geisler et al,1992,GM-1 ganglioside in human spinal cord injury.,PMID: 1613811,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nayduch et al,1994,High-dose methylprednisolone after acute spinal cord injury.,https://doi.org/10.4037/ccn1994.14.4.69,English,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ghazali et al,2016,Histological Analysis of Motoneuron Survival and Microglia Inhibition After Nerve Root Avulsion Treated with Nerve Graft Implantation and Minocycline: An Experimental Study,http://www.ukm.my/jsm/pdf_files/SM-PDF-45-11-2016/08%20Faizul%20Ghazali.pdf,English,,excluded,Non-sci population,,Not SCI studied but avulsion injury of cervical ventral roots instead,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hook et al,2007,The impact of morphine after a spinal cord injury,10.1016/j.bbr.2007.02.035,English,,included,,,,,,rats,Sprague Dawley,106,>= 6,,,>= 18,,,no details on the break down of experiement 2,male 100%,male,100,90-110 days,,,90,110,Days,,range: [350-400](g),,,350,400,g,,level: T12-13; severity: moderate,T12 - T13,moderate,contusion,"laminectomy + contusion (MASCIS impactor, 10-g impactor outfitted with a 2.5 mm tip to drop 12.5mm)",21 days,morphine sulfate,morphine sulfate,,"5, 10 or 20 mg/kg",24h after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, ladder walk, beam walk, sensory function (von Frey filaments), nociceptive reactivity (thermal)",,"BBB: open fiel, 4 min, 2 observers; ladder and beam walk: recorded how many times the subjects did not successfully place their hindpaws (their paws slipped between the rungs), based on the number of slips, the rats were given scores for the left and right legs separately; they received a score of 11 if they made no slips, 10 if they made one, reducing incrementally to 1 if they made more than 10 slips andb0 if they did not plantar place, ats could receive a maximum score of 22; sensory function: progressively stronger tactile stimuli applied sequentially at approximately 2 s intervals until subjects exhibited a paw withdrawal (motor response) and vocalization,  tested twice on each foot in a counterbalanced ABBA order, stimulus intensity was reported using the formula provided by Semmes-Weinstein: Intensity = log10 (10,000 * g force),  sensory reactivity using nociceptive stimuli (a gradually incremented shock and radiant heat) = intermittent tail shock (1,5 mA, 0.08s duration, mean stimulation interval of 2.0s, level of reactivity and incidence of vocalization were recorded","baseline before treatment 24h after injury, then 30 min after treatment, BBB: every other day from day 9 to 15, every third day on day 18 and 21; sensory function: day 1 and day 21",,yes,mixed effects (assessment),"significant difference between control and treatment groups for tail flick latency, vocalisation incidence, movement score during shock in experiment 1; significantly longer tail-flick latency and decreased incide of vaclisation in treatment groups compared to control; BBB not statistically different with or without treatment, higher thrshold for vocal reaction to shock in treatment group compared to control, no difference in beam walk and ladder task and tactile reactivity",histological assessment,"total cross-sectional area, spared tissue, spared gray/white matter",21 days after injury,yes,negative effect,"morphine treatment significantly increased the size of the relative lesion (damaged + missing area) at the maximal point of injury, significantly more tissue was missing in morphine group, an effect attributable to a loss of white matter, morphine did not affect the amount of gray matter remaining at the center of the lesion","anesthesia: pentobarbital (50 mg/kg ,IP); postop: penicillin G potassium (100 000 units/kg) immediately after surgery and again 2 days later, 2.5 ml of saline; euthanasia: 100 mg/kg pentobarbital IP, perfused intracardially with 4% paraformaldehyde",results suggest that nociceptive stimulation affects recovery despite a blockade of pain-elicited behavior,not reported,organisation of the paper was a bit confusing to me,No,
Lucie,Simpson et al,1991,The influence of long-term nifedipine or indomethacin therapy on neurologic recovery from experimental spinal cord injury,10.1097/00002517-199112000-00003,English,,included,,,,,,rats,Sprague Dawley,60,>= 12,,,>= 9,,,based on neurological testing,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,level: mid thoracic region; severity: acute paraplegia,thoracic,paraplegia,contusion,"laminectomy + weight drop (50 g/cm impact, 5g weight rounded at the surface, contact with the cord after being dropped 10 cm vertically through a calibrated tube)",6 weeks,"nifedipine, indomethacin",nifedipine,,10 mg/kg,immediately after injury,,not reported (1 week? based on one sentence in discussion about indomethacin),continuous (pumps),multiple,initial injection: IP; continuous pump: SC,"electrophysiology, motor and sensor functions","somatosensory evoked potentials (SSEP), corticomotor evoked potentials (CMEPs), spontaneous movement, response to noxious stimulation, inclined plane assessemnt",,"all 2 independent examiners, noxious stimulation: vocalisation present or not, sensory response normal, withdrawal only or no response; spontaneous motor activity: normal, less than normal but active, barely demonstrable or absent; inclined plane: maximal angle in degrees at which the animal could still ascend was recorded; SSEPs: electrode epidurally over the right primary sensory cortex and along the course of the left sciatic nerve; CMEPs: electrodes placed into the lateral muscle mass of the left hindlimb and foot pad","immediately, 1 day, 1, 3 and 6 weeks after injury (CMEPs and SSEPs also right before injury)",,not reported,no effect,"SSEP complex, CMEP complex, vocal response, sensory score, motor score, locomotor score all not significant at week 6 compared to control vehicle group",histological assessment,"petechial hemorrhages, myelin edema, pyknosis graded from minimum to severe, axonal dystrophy, Wallerian degeneration, arachnoid thickening, volume of tissue loss",6 weeks after SCI,yes,mixed (stats/no stats),"degree of axonal dystrophy (p<0.056) and arachnoid thickening (p<0.033) was greater in nifedipine group compared with control, nifedipine had greater degree of axonal dystrophy (p<0.008), Wallerian degeneration (p<0.022), and arachnoid thickening (p<0.076) comapred to indomethacin group; no comparison between indomethacin and control group (probably not significant based on the number in table 4)","anesthesia: ketamine hydrochloride (100 mg/kg, IM),; sacrifice: decapitation",Only indomethacin significantly improved neurological function and reduced the severity of histopathological change,not reported,"duration of treatment not reported, not all stats reported for the histological assessment but trend towards negative effects in treatment group",No,
Lucie,Simpson et al,1991,The influence of long-term nifedipine or indomethacin therapy on neurologic recovery from experimental spinal cord injury,10.1097/00002517-199112000-00003,English,,included,,,,,,rats,Sprague Dawley,60,>= 12,,,>= 10,,,based on neurological testing,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [250-350](g),,,250,350,g,,level: mid thoracic region; severity: acute paraplegia,thoracic,paraplegia,contusion,"laminectomy + weight drop (50 g/cm impact, 5g weight rounded at the surface, contact with the cord after being dropped 10 cm vertically through a calibrated tube)",6 weeks,"nifedipine, indomethacin",indomethacin,,2 mg/kg,immediately after injury,,not reported (1 week? based on one sentence in discussion about indomethacin),continuous (pumps),multiple,initial injection: IP; continuous pump: SC,"electrophysiology, motor and sensor functions","somatosensory evoked potentials (SSEP), corticomotor evoked potentials (CMEPs), spontaneous movement, response to noxious stimulation, inclined plane assessemnt",,"all 2 independent examiners, noxious stimulation: vocalisation present or not, sensory response normal, withdrawal only or no response; spontaneous motor activity: normal, less than normal but active, barely demonstrable or absent; inclined plane: maximal angle in degrees at which the animal could still ascend was recorded; SSEPs: electrode epidurally over the right primary sensory cortex and along the course of the left sciatic nerve; CMEPs: electrodes placed into the lateral muscle mass of the left hindlimb and foot pad","immediately, 1 day, 1, 3 and 6 weeks after injury (CMEPs and SSEPs also right before injury)",,not reported,mixed effects (assessment),"locomotor score significantly better in treatment group, vocal repsonse increased compared to control gorup, all other not significant",histological assessment,"petechial hemorrhages, myelin edema, pyknosis graded from minimum to severe, axonal dystrophy, Wallerian degeneration, arachnoid thickening, volume of tissue loss",6 weeks after SCI,yes,no stats,"degree of axonal dystrophy (p<0.056) and arachnoid thickening (p<0.033) was greater in nifedipine group compared with control, nifedipine had greater degree of axonal dystrophy (p<0.008), Wallerian degeneration (p<0.022), and arachnoid thickening (p<0.076) comapred to indomethacin group; no comparison between indomethacin and control group (probably not significant based on the number in table 4)","anesthesia: ketamine hydrochloride (100 mg/kg, IM),; sacrifice: decapitation",Only indomethacin significantly improved neurological function and reduced the severity of histopathological change,not reported,"duration of treatment not reported, no comparison with control group reported for histology",No,
Lucie,Lai et al,2013,The integration of NSC-derived and host neural networks after rat spinal cord transection,10.1016/j.biomaterials.2012.12.046,English,,excluded,Out of scope,No drug of interest,No drug of interest: neural stem cells,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,He et al,2017,Inhibiting endoplasmic reticulum stress by lithium chloride contributes to the integrity of blood-spinal cord barrier and functional recovery after spinal cord injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375994/pdf/ajtr0009-1012.pdf,English,,included,,,,,,rats,Sprague Dawley,>= 24,>= 8,,,>= 8,,,"based on the BBB score figure, details unclear",female 100%,female,0,not reported (adults),,,,,,Adult,range: [220-250](g),,,220,250,g,,level: T9; severity: moderate,T9,moderate,compression,laminectomy + compression (vascular clip 15g force for 1 min),"1 day, 28 days",lithium chloride (LiCl),lithium,,20 mg/kg,2h before injury,,28 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, footprint analysis",,"BBB: 21-point scale, open field, 5 min, crawling ability assessed from 0=no limb moveent or weight support to 21=normal locomotion; footprint analysis: fore and hiindpaws dipped in red and blue ink respectively, crosses a narrwo box 1m long and 7cm wide","BBB: 1, 3, 7 ,14, 21 and 28 days after injury, footprint analysis: 4 weeks after injury",,not reported,mixed (stats/no stats),"BBB: ats received treatment of LiCl showed improved BBB scores as compared to their non- treated controls at 14, 21 and 28 days; footprint analysis:  LiCl improved forelimb-hindlimb coordination in rats 28 d after injury, which was contrast to non- treated SCI group showing inconsistent coordi- nation and extensive drags (no stats)",histological assessment,blood-spinal cord barrier disruption,1 day after SCI,not reported,positive effect,"BSCB influx of Evans Blue dyes was significantly reduced in the SCI group that received treatment of LiCl, concentration-dependent decrease in Evans Blue dye fluorescence in the injured spinal cords at 1 d after SCI when compared to the no-treatment group after SCI","anesthesia: pentobarbital sodium 2% (40 mg/kg, IP), euthanasia: perfused with PBS and 4% paraformladehyde","LiCl treatment alleviates BSCB disruption and promote the neurological function recovery after SCI, partly through inhibiting the activation of ER stress",not reported,,No,
Lucie,Yao et al,2007,Inhibitory effect of 6-hydroxy dopamine and MK-801 on spinal cord edema,https://pesquisa.bvsalud.org/portal/resource/pt/wpr-407999,Chinese,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Kolenda et al,1997,Interstitial adenosine and serotonin in the feline lumbar spinal cord during short-term ischaemia,https://www.biomed.cas.cz/physiolres/pdf/46/46_295.pdf,English,,excluded,Out of scope,No drug tested,Out of socpe: adenosine and serotonin are not treatment given to the animals but elements that are monitored within the spinal cord after ischemia,,,cats,not reported,10,,,,,,,,not reported,,,not reported (adults),,,,,,,range: [2.9-4.3](kg),,,,,,,level: L4-7; severity: not reported,,,,"laminectomy + ischemia (snare occlusion applied to the descending aorta just below left subclavian artery, blood volume reduction 25-60 ml, ischaemic periods lasted from 1-7 min, repeated as long as a complete restoration of spinal circulaiton and reflexes was realised, median8, min4, max 14 ischaemic periods per experiment, tim eintervals between ischaemic periods depended on restoration of preischaemic reflex and microcirculation levels, varied frm 30 min to 2h)",not reported,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Joshi et al,2015,"The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury",10.1093/brain/awv125,English,,excluded,Out of scope,No drug of interest,No drug of interest (Nutlin-3 a cis-imidazoline analog),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zelenay et al,2016,The neurite outgrowth inhibitory Nogo-A-AŒî20 region is an intrinsically disordered segment harbouring three stretches with helical propensity,10.1371/journal.pone.0161813,English,,excluded,Non-sci population,,No SCI applied + no drug of interest (Nogo-A-delta20),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hu et al,2015,The Neuroprotective Effect of Tetramethylpyrazine Against Contusive Spinal Cord Injury by Activating PGC-1Œ± in Rats,10.1007/s11064-015-1606-1,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ligustrazine/Tetramethylpyrazine),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Bobo,Fan et al,2005,Magnesium sulfate for spinal cord ischemia-reperfusion injury in rabbits,https://pesquisa.bvsalud.org/portal/resource/pt/wpr-409391,Chinese,,excluded,No access,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Almad et al,2011,The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice,10.1016/j.expneurol.2011.09.023,English,,included,,,,,,mice,C57BL/6,>= 51,7,,,7,,,only study 2 is of interest,female 100%,female,0,not reported (adults),,,,,,Adult,range: [17-23](g),,,17,23,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + contusion injury (Infinite horizons device, pre-set force of 75 [75-81] kdyn (study I, II, IV) or 65 kdyn [65-72] (study III))","3 (study II), 7 (study II), 14 (study III), 20 (study IV), 28 (study I, II) days ","gemfibrozil, fenofibrate (study III)",fenofibrate,,50 mg/kg,2h after injury,,14 days,daily,oral,,neurological/functional/behavioral assessment,BMS,,locomotor scores and sub-scores averaged for both hindlimbs,"1, 3, 7, 10, 14, 21 and 28 days after injury",,yes,no effect,"study I: controls significantly higher BMS scores than group with gemfibrozil, both in total BMS and sub-scores, study II: no difference between treatment and controls; study III: no difference between treatments (gemfibrozil and fenofibrate) and controls; study IV: no difference between treatment and control",histological assessment,"tissue sparing analysis, are of spared white matter and sparred gray matter, Cavalieri method used","study I: 28 days, study II: 3, 7, 28 days, study III: 14 days; study IV: 20 days",yes,no effect,"study I: no difference in spare white or gray matter between treatment and controls (trend towards less spared white matter in treatment compared to controls); study II: no differences between treatment and controls; study III: no significant difference between treatments and controls but gemfibrozil tended to have less spared tissue, not the case for fenofibrate treated group; study IV: no difference to less spared tissues in treated versus control groups","anesthesia: ketamine (80 mg/kg, IP), xylazine (10 mg/kg, IP); over surgery 2cc of saline; post-op care: antibiotics (gentomicin, 5 mg/kg) and saline to maintain hydration for 5 days; euthanasia: overdose of ketamine/xylazine (1.5 times the surgery dose) and intracardially perfused with 0.1 M PBS followed by 4% paraformaldehyde","PPAR-α agonists yield either no effect or worsen recovery from spinal cord injury, at least at the doses and the time points of drug delivery tested here. Further, patients sustaining spinal cord injury while taking gemfibrozil might be prone to exacerbated tissue damage.",not reported,,No,
Lucie,McTigue et al,2007,The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury,10.1016/j.expneurol.2007.02.009,English,,included,,,,,,rats,Sprague Dawley,44,19,,,25,,,split in 3 studies,female 100%,female,0,not reported (adults),,,,,,Adult,range: [214-245](g),,,214,245,g,,level: T8; severity: moderate,T8,moderate,contusion,"partial laminectomy + contusion (computer controlled impact probe lowered to the dural surface, probe rapidly impacted SC to a depth of 0.7mm (study I) or 0.8mm (study II and III) over 23ms, producing a closed-dural contusion injury)","5 weeks, 7 days",pioglitazone,pioglitazone,,"10 mg/kg or 1 mg/kg (only in study I), 10 mg/kg in study II and III",15 min after injury,,7 days,every 12h,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, BBB subscores",,"2 observers, socres avergaed for each hindlimb and used to create group mean at each day; subscores: stepping, coordination and toe clearance for each limb from 0=none to 3=consistent, paw placement from 0=rotate/rotated to 2=parallel/parallel; tail: from 0=down, 2=up; instability: yes=0, no=1","1, 3, 5, 7, 10, 14, 21, 28 and 35 days after injury",,yes,mixed effects (dosage) + mixed effects (assessment),"study I: total BB not significantly different at day 35, but total subscores significantly greater than vehicule at day 14, 21 and 28 in high dose regime, treated groups recovered the abilitu to consistently step sooner than controls (significant), treated rats were consistently stepping compared to controls at day 35 (no test), treated group more frequent cordination compared to control (significant at day 28, trend at day 35), significant interaction toe clearance*treatment; study II: treatment caused significant increase in BBB score at day 7, total overall subscores were greater in treated compared control group at day 21, 28, 35 (significant), coordination scores did not reach significance, toe clearance (significant at day 21 and 35, ns otherwise) and paw position (significant at day 28 only) improved by treatment ",histological assessment,"stereological measurments of spared white and gray matter, lesion area and cross-sectional area (study I and II), motor neuron counts (study I), ",35 days (study I and II) or 7 days (study III),not reported,mixed effects (assessment) + mixed effects (dosage),"study I: high dose significantly more white matter spared rostrally compared to low dose treatment, low dose significantly more white matter spared rostrally compared to control, high dose significantly more spared gray matter only rostrally (1.5 mm), no difference in lesion area, cross section area greater in high dose rostrally compared to control; high dose significantly more motor neuros rostrally and caudally to epicenter compared to vehicule group; study II: more spared gray matter rostrally in treated compared control group (significant), white matter not signnificantly different ","anesthesia: ketamine (80 mg/kg, IP), xylazine (10 mg/kg, IP); antibiotic for 5 days atfer injury; euthanasia: deeply anesthesized with ketamine/xylazine and perfused intracardially with cold PBS collowed by 4% paraformaldehyde","results reveal that clinical treatment with Pioglitazone, an FDA_approved drug used currently for diabetes, may be feasible and promising strategy for promoting anatomical and functional repair after SCI",not reported,would down grade the statements of the paper; good example on how confusing results can be,No,
Jaimie and Lucie,Ko et al,2006,Motor Recovery Effect of Minocycline in Spinal Cord Injured Rats,http://www.e-arm.org/journal/view.php?number=1541,Korean,,included,,,,,,rats,Sprague Dawley,40,20,,,20,,,2 injury mechanisms,not reported,not reported,Not reported,11 weeks,11,,,,Weeks,,300-350,,,300,350,g,,,T9 - T10,mild - moderate,contusion,weight drop (10 gm from a height of 2.5 or 5 cm),28 days,minocycline,minocycline,,90 then 45 mg/kg,immediately after injury,,"24h, 3 doses",every 12 h,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,measures the range of motion of the lower extremities of rats by measuring each join and dividing it into mild and moderate with a toal score of 21 points,"1, 7, 14, 21, and 28 days after SCI",,,positive effect,"significantly better BBB score from day 7 until day 28, for both injury severity (p<0.05)",,,,,,,,"After injury, BBB scores were significantly higher in minocycline treated rats as compared to the control. Minocycline might have beneficial effects on the recovery cascade after SCI.",not reported,,No,No
Lucie,Suwanna et al,2014,Neuroprotection by diarylpropionitrile in mice with spinal cord injury,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464390/pdf/EXCLI-13-1097.pdf,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (Diarylpropionitrile),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al,1988,Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism,https://jpet.aspetjournals.org/content/jpet/245/2/742.full.pdf,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (nalmefene),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al,1988,Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.,PMID: 3367315,English,,excluded,Duplicate,,Duplicate: see paper above,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Greene et al,1996,Pharmacological management of spinal cord injury: Current status of drugs designed to augment functional recovery of the injured human spinal cord,https://pubmed.ncbi.nlm.nih.gov/8938603//,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wu et al,2017,Pitavastatin inhibits proinflammatory cytokines and provides improvement in terms of its motor function in secondary injuries of the spinal cord mouse models,https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Pitavastatin+inhibits+proinflammatory+cytokines+and+provides+improvement+in+terms+of+its+motor+function+in+secondary+injuries+of+the+spinal+cord+mouse+models&btnG=,English,,excluded,Out of scope,No assessments of interest,Out of scope: no assessment of interest,,,mice,not reported,40,,,,,,,,not reported,,,6 weeks ,,,,,,,18-22 (g),,,,,,,level: T6-T7; severity: not reported,,,,"laminectomy + compression (extradurally, aneurysm clip, 24g closure force)",10 days,methylprednisolone,,,30 mg/kg,immediately after SCI,,single dose,-,intraperitoneally,,neurological assessment,motor disturbance grading (BMS scale),,-,every day for 10 days,,not reported,,,,,,,,,,,,,,
Lucie,Marciniak et al,2008,The use of botulinum toxin for spasticity after spinal cord injury,10.1097/PHM.0b013e318168ceaf,English,USA,excluded,Out of scope,No assessments of interest,only subjective patient reported outcome assessed,,,human,humans,28,,,,,,,,not reported,not reported,not reported,"mean: 48, range: [20-76](years)",,,,,,,not reported,,,,,,,"level: not reported; severity: AIS A:n=5, AIS B/C/D:n=23",,,,"traumatic: n=20, (motor vehicle crash: n=3, falls:n=8, gun shot wound:n=4, diving:n=3, knife wound: n=1, blunt trauma:n=1), neurodegenerative/hereditary spastic paraplegia: n=2, non-traumatic:n=6, (stenosis:n=1, syrinx:n=1, transverse myelitis:n=2, unknwon:n=1)",not reported,botulinum toxin (BTX),botulinum toxin,,average dose from 10 to 118 units (muscle-dependent),"within 1 year of the onset of SCI (n=5), 12 months or more after onset of SCI (n=23)",,from 1 to 10 injections per muscle,-,intramuscular,,functional,self-identified percent improvement based on functional goal,,-,not reported,,-,not tested,"indication for ambulation: 56% reported improvement, upper-limb function as targeted goal: 78% improvement, hygiene as indication: 67% improvement, pain: 83% improvement, difficulty in positionning: 71% improvement; 60% improvement when injection within first 12 months, 65% if injection after 12 month, 70% non-AIS A with improvement, 40% improvement for AIS A; no controls so not statistical test for control-treatment, but for different gorups (upper VS lower limb, AIS A or non-AIS A, timing before or after 12 months, all are not significant)",-,-,-,-,,-,17/28 (60.7%) were on oral antispasticity ,Botulinum toxin seems to be an effective treatment for focal spasticity and for reducing disability im person siwth SCI. Randomized trials are needed to confirm the value of this treatment in the setting of SCI,"did not control for the amount of time between injection and follow-up, self-reporting measures, 5 different indications for injections (pain, positioning, ambulation, upper-extremity function and hygiene), spasticity also affected by time of thed ay, concurrent illness and emotional state for which they did not control for (since it is a retrospective study)",light results description,,
Lucie,Singh et al,2012,Theophylline regulates inflammatory and neurotrophic factor signals in functional recovery after C2-hemisection in adult rats,10.1016/j.expneurol.2012.08.009,English,,excluded,Out of scope,No assessments of interest,look at respiratory function,,,rats,Sprague Dawley,34,5,,,12,,,different control groups,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-320](g),,,250,320,g,,level: C2; severity: complete hemisection,C2,incomplete,transection,left C2 spinal cord hemisection,"2, 5, 17 days",theophylline,theophylline,,20 mg/kg,day 2,,3 days,3 times daily,oral,,electrophysiology,EMG,,qualitative recording of the diaphragmatic activity under spontaneous breathing conditions,"24h, 5 days, 17 days depending on experimental group (i.e. at the end of the experiment)",,not reported,no stats,"administration of theophylline partially restored function to the paralyzed left diaphragm, recovery persisted after cessation of treatment for 12 days ",-,-,-,-,,-,"anesthesia: ketamine (70 mg/kg, IP), xylazine (7 mg/kg); euthanasia: chloral hydrate (400 mg/kg, IP), decapitated","results suggest that enhanced resolution of early inflammatory processes and expression of pro-survival factors may underlie theophylline-induced respiratory recovery, results identify potential targets for gene and drug therapied",not reported,"very light results section, wonder how decapitation affects the tissue collection when the injury is so high (C2)",No,
Lucie,Hüttemann et al,2010,Theophylline treatment improves mitochondrial function after upper cervical spinal cord hemisection,10.1016/j.expneurol.2010.01.020,English,,excluded,Out of scope,No assessments of interest,look at respiratory function,,,rats,Sprague Dawley,12,4,,,4,,,sham n = 4,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-320](g),,,250,320,g,,level: C2; severity: complete hemisection,C2,incomplete,transection,left C2 spinal cord hemisection,3 days,theophylline,theophylline,,20 mg/kg,not reported,,3 days,3 times daily,oral,,electrophysiology,EMG assessment of respiratory activity in the left and right hemidiaphragm,,platinum electrodes inserted into the crural area of the left and right hemidiaphragm to record EMG activity,24h after hemisection,,not reported,no stats,"hemisection at C2 resulted in absence of EMG activity in the ipsilateral diaphragm, in contrast administration of theophylline for 3 days post injury partially restores function to the pralyzed hemidiaphragm under spontaneously-breathing conditions",-,-,-,-,,-,"anesthesia: ketamine (70 mg/kg, IP), xylazine (7 mg/kg); euthanasia: anesthesia via chloral hydrate (400 mg/kg, IP) and decapitated with a guillotine","Cervical spinal cord hemisection (C2HS) increases energy demand and activated mitochondrial respiration, and theophylline treatment improves energy levels through activation of the mitochondrial OxPhos process to provide energy for tissue repair and functional recovery after paralysis in the C2HS model",not reported,very light results to be reported,No,
Lucie,Nantwi et al,1998,Theophylline-induced recovery in a hemidiaphragm paralyzed by hemisection in rats - Contribution of adenosine receptors,10.1016/S0028-3908(97)00190-1,English,,excluded,Out of scope,No assessments of interest,look at respiratory function,,,rats,Sprague Dawley,41,6,,,6,,,other treatment groups not of interest,female 100%,female,0,not reported (adults),,,,,,Adult,range: [250-350](g),,,250,350,g,,level: C2; severity: complete hemisection,C2,incomplete,transection,left C2 spinal cord hemisection,not reported,"enprofylline, theophylline or combination",theophylline,,15 mg/kg,"""acutely""",,single dose,-,not reported,,electrophysiology,electrophysiological activity in the hemidiaphragm ipsilateral to hemisection,,monitoring of signal from the phrenic nerve,24h after hemisection,,not reported,no stats,"respiratory-related activity in the hemidiaphragm and phrenic nerve ipsilateral to the hemisection was first detected within 10 min atfer administration of theophylline and lasted 2-3h in the majority of cases (5/6), no functional restitution was observed in control animls",-,-,-,-,,-,"anesthesia: 4% chloral hydrate (400 mg/kg, IP), IM atropy (0.1 mg/kg) 10 min before anesthetic, topical antiseptic, betadine",adenosie receptor antagonism is implicated in hmidiphragmatic recovery after hemisection and theophylline may be useful in the treatment of spinal cord injured patients with respiratory deficits,not reported,very light results to be reported,Yes (drug of interest + drug not of interest),
Catherine,Lesar et al,1994,Standardized dosing tables to reduce errors involving high-dose methylprednisolone for acute spinal cord injury.,PMID: 10137851,English,,excluded,Opinion,,Treatment regulations for hospitals based on other studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Çelik et al,2015,Therapeutic Effects of Vitamin D-3 on Motor Functions Following Experimental Spinal Cord Injury,10.4274/tnd.76588,English,,included,,,,,,rats,Sprague Dawley,21,7,,,7,,,sham n = 7,not reported,not reported,not reported,not reported,,,,,,Not reported,range: [180-220](g),,,180,220,g,,level: T7-9; severity: paraplegic,T7 - T9,paraplegia,contusion,"laminectomy + weight-drop (modified Allen's method, 10g weight through 10 cm glass tube 0.5 diameter)",3 weeks,vitamin D3,vitamin d,,1 microg/kg,day 1 after injury,,"4 doses, 7 days",every second day,intraperitoneally,,neurological/functional/behavioral assessment,"inclined plane test, clinical motor exam (Drummond and Moore)",,"inclined plane test: Rivli and Tator, clinical motor exam (Drummond and Moore): Drummond and Moore critera","day 1, 7, 14 and 21 after SCI",,not reported,no stats,"Inclined plane test scores and motor function scores of vitamin D3 group were significantly higher than the trauma group at 1st, 2nd and 3rd weeks",histological assessment,"necrosis, cavities, lesion area",3 weeks,not reported,no stats,"The extent of the damage in vitamin D3 group cross-sections covered a larger area than the trauma group, which did not receive the medication, and the morphological changes in the damaged region were at least as severe as the trauma group",anesthesia: 2 mg/kg ketamine HCl IP; euthanasia: anesthesia + ?,we have investigated the therapeutic effects of vitamin D3 and found out that it has a positive impact to the recovery process of the spinal cord injury,not reported,"very light result section, not clear what the statistical tests are actually testing",No,
Lucie,Kim,1995,Studies about the effect of excitatory amino acid receptor antagonist on traumatic spinal cord injury,https://www.koreascience.or.kr/article/JAKO199501919852346.pdf,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (dextrorphan),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hu et al,2020,Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury,10.1111/jcmm.15478,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (NGF in hydrogel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhao et al,2017,Thermosensitive heparin-poloxamer hydrogels enhance the effects of GDNF on neuronal circuit remodeling and neuroprotection after spinal cord injury,10.1002/jbm.a.36134,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (hydrogel),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Park et al,2007,"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats",10.1124/jpet.106.113472,English,,included,,,,,,rats,Sprague Dawley,>= 54,>= 21,,,>= 33,,,details unclear,not reported,not reported,not reported,not reported (adults),,,,,,Adult,range: [300-325](g),,,300,325,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + weight-drop (10g weight, from a height of 12.5mm)","7 days, 42 days","pioglitazone, PPAR􏰀 antagonist GW9662 and rosiglitazone (last two not of interest so not further reported)",pioglitazone,,"0.5, 1.5, 3 mg/kg",5 min or 2h or 4h after injury,,"1 to 4 doses, 2 days",every 12h,intraperitoneally,,neurological/functional/behavioral assessment,"BBB, Thermal Sensitivity",,"BBB: 21-point open-field locomotor scale, each rat was placed in a 3-foot diameter circular plastic molded tub (rats were acclimatized to the observation tub for 2 days before injury), and the movements were scored for 4 min by two evaluators, score for each animal was computed as the average of the scores of the two evaluators; themal sensitivity: latency of hind paw withdrawal to thermal noxious stimulus was measured, strength of stimulation was adjusted to produce a baseline latency of 8 to 9 s, decrease in withdrawal latency of more or 􏰆3 s was considered as the presence of neuropathic pain","BBB: days 1, 3, 7, 14, 21, 28, 35, and 42 (or up to the day the animal was killed); thermal sensitivity: 1 day before the injury and day 28 after SCI",,yes,mixed effects (dosage) + mixed effects (regime),"pioglitazone group showed significantly higher BBB scores after 7 days until 42 days compared to control; more efficacious scheme was pioglitazone wiht 4 doses and first dose 5 min after injury; thermal sensitivity: at 28 days after SCI, the vehicle-treated rats showed a significant decrease over baseline in the latency in withdrawing the paw from the heated source indicating neuropathic pain. Pioglitazone (Pio)-treated rats subjected to SCI showed no change in the thermal delay over baseline, indicating the easing of neuropathic pain (significant difference between treated and control group)",histological assessment,"lesion length, area and volume, numbers of surviving ventral horn motor neurons",day 7 or 28,yes,positive effect,"treatment significantly decreased the length, area, and volume of the lesion compared with the vehicle-treated controls measured at 1 week after SCI; the mean numbers of surviving neurons were significantly higher in the pioglitazone/SCI groups than in the control group at 1mm rostral, 2mm rostral, 3 mm rostral, 3 mm caudal and 2mm caudal levels but not 1mm caudal and epicenter not tested","anesthesia: halothane induction 4%, maintenance 2% in oxygen and nitrous oxide 50:50 mixture; euthanasia: anesthesia with halothane and transcardiac perfusion with 0.1 M PBS followed by 4% paraformaldehyde in PBS","the present study showed that treatment with PPAR􏰀 agonists (rosiglitazone and pioglitazone) decreases secondary neuronal damage, astrogliosis, microglial activa- tion, myelin loss, and neuropathic pain and improves motor function recovery after SCI",not reported,scheme of drug delivery/euthanasia time not always clear,Yes (drug of interest + drug not of interest),
Lucie,Duerstock et al,2002,Three-dimensional morphometry of spinal cord injury following polyethylene glycol treatment,https://doi.org/10.1242/jeb.205.1.13,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,guinea pig,Not reported,17,,,,,,,no details on the subgroups,not reported,not reported,not reported,not reported (adults),,,,,,Adult,300 (g),300,,,,g,,"level: T10-12; severity: ""very severe""",T10 - T12,severe,compression,"laminectomy + compression (dura removed dorsal hemisphere compressed for 15s, using blunted watchmakers' forceps possessing a detente to standardize the displacement of the spinal cord)",1 month,polyethylene glycol (PEG),polyethylene glycol ,,"Mr 1800, 50% in water",immediately after injury or 7h after injury,,single dose,-,intrathecally,,-,-,,-,-,,-,,-,"histological assessment, 3d reconstruction","volume and surface area measurements, intact parenchyma, cysts, cavitation",1 month post-SCI,yes,mixed effects (assessment),"volume of cavitation significantly slower in both PEG treated groups comapred to control (more reduced when PEG delayed), lower volume of intact parenchyma in control compared to treated groups (more intact parenchyma when delayed PEG), surface area of lesion reduced compared to control, all the rest not significantly different (lesion volume, surface area of intact parenchyma and surface area of cavitation)","anesthesia: IM 0.1 ml.100g-1 BM solution of 100 mg/kg ketamine HCl and 20 mg/kg xylazine; postop: 3ml lactated Ringer's solution s.c.; euthanasia: 0.2 ml of ketamine HCl, 0.2 ml xylazine, overdose sodium pentobarbital 0.8 ml of 1 g.ml-1, perfused/fixed with 6% paraformaldehyde, 0.5% glutaraldehyde in PB",three-dimensional computer evaluation showed that the functional recovery produced by topical application of a hydrophilic polymer is accompanied by a reduction in spinal cord damage,not reported,new method of 3d reconstruction of the spinal cord,No,
Lucie,Hanci et al,2010,The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats,https://jag.journalagent.com/travma/pdfs/UTD-65807-RESEARCH_ARTICLE-HANCI.pdf,English,,excluded,Out of scope,No assessments of interest,Out of scope: no neurological/functional or histological assessement (look at malonyldialdehyde and superoxide dismutase levels only),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Afhami et al,2016,The demyelination and altered motor performance following electrolytic lesion in the ventrolateral white matter of spinal cord in male rats: Benefit of post-injury administration of estradiol,http://ppj.phypha.ir/article-1-1182-en.pdf,English,,included,,,,,,rats,Sprague Dawley,83,>= 12,,,>= 12,,,30 rats for histological assessments and 53 rats for behavioral assessments,male 100%,male,100,not reported (adults),,,,,,Adult,range: [220-300](g),,,220,300,g,,level: T8-9; severity: not reported,T8 - T9,Not reported,others,"laminectomy + electrolytic lesion (tungsten electrode 5 microm tip, 1M Ohm, pointed to the right ventrolateral funiculus with stereotaxic coordinated lateraltiy to midline of 0.5-0.7 mm and depth of 1.6-1.9mm, lesion made with brief current pulse of 300 micro amper, 90s passed through the electrode)","7, 14, 28 days",17beta-estradiol (E2),estradiol,,4 mg/kg,30 min after injury,,single dose,-,intraperitoneally,,neurological/functional/behavioral assessment,"rotarod, open field test",,"rotarod: pre-trained, rotating rod at 20 rpm, max duration of 2 min, 5trials per rat before reading taken, total of 3 trials recorded to calculate mean endurance time; open field test: locomotor activity during 5 min, pre-trianed to the text box for 5 days, individually placed in specific corner, total distance moved in 5 min considered as measure of motor performance, endurance time and distance moved","rotarod: day 0, 7, 14, 28 post injury; open field: prior to surgery, 7, 14 and 28 days post injury",,not reported,no effect,rotarod: E2 significantly improved motor performance at day 14 but not at day 28; open field: E2 significantly improved motor activity at 7 and 14 dpi but not at day 28 compared to control group,histological assessment,"demyelination, white matter sparing","7, 14, 28 days post-injury",yes,no effect,"Estradiol- treated animals represented less extent of demyelination (only significant at day 7), no difference in extent of demyelination at the lesion center (1 mm) (A) , 0.5-1.5 mm caudal (B) and 1.5-2.5 mm caudal (C)","anesthesia: keatmine (IP, 60 mg/kg), xylazine (10 mg/kg, IP); post op: 5 ml saline solution SC for rehydration, penicillin to present infection; euthanasia: anesthesia+perfused transcardially with 150 ml PBS followed by 250 ml of 4% paraformaldehyde","results indicate that demyelination after lesion in ventrolateral funiculus may be a contributing factor to limited motor performance, and suggest that pharmacological doses of estradiol may have an early protective effect through sparing of white matter",not reported,use penicillin,No,
Lucie,Karadeniz et al,2005,The effects of N-acetylcystein and methylprednisolone on spinal cord ischemia-reperfusion,https://www.researchgate.net/publication/287553470_The_effects_of_N-acetylcystein_and_methylprednisolone_on_spinal_cord_ischemia-reperfusion,Turkish,,excluded,Out of scope,No assessments of interest,Out of scope: No measurments of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gezici et al,2017,The therapeutic effects of etanercept-methotrexate combination on experimental spinal cord injury,https://www.alliedacademies.org/articles/the-therapeutic-effects-of-etanerceptmethotrexate-combination-on-experimental-spinal-cord-injury.pdf,English,,included,,,,,,rats,Sprague Dawley,40,8,,,8,,,"5 groups in totla, 8 rats in each",female 100%,female,0,not reported (adults),,,,,,Adult,250-300 (g),,,250,300,g,,level: T7-9; severity: not reported,T7 - T9,Not reported,compression,"laminectomy + compression (extradural compression, aneurysm clip, closing force of 24g, compressed for 1 min)",10 days,methotrexate (MTX),methotrexate,,0.5 mg/kg,immediately after injury,,single dose,-,intraperitoneally,,neurological assessment,grading of motor disturbance (Drummond and Moore scale),,"score from 0 to 4, 0=paraplegic with no evidence of lower extremity motor function; 1=poor lower extremity motor function, flicker of movement, weak antigravity movement only; 2=moderate lower extremity function with good antigravity strength but inability to draw legs under body and/or hop; 3=the ability to draw legs under body and hop, but not normally; 4=normal motor function","1, 3, 5, 10 days after SCI",,yes,positive effect,significant difference when compare treatment versus control (SCI) group from day 1 to 10,histological assessment,"myelin structure and loss, axonal swelling, vacuolization, necrosis score (1) White matter degeneration, characterized by oedema, formation of cysts, demyelination and infiltration of macrophages, cystic necrosis and cytoarchitectonic disorganization; 2) Haemorrhage in white or gray matter; 3) Neuronal loss, sometimes with vacuolization and inflammatory infiltration in gray matter; 4) Signs of hypoxic injury: nuclear retraction and pyknosis, as well as intense eosinophilic staining of the pericardium), semi-quantification: <1% of total scanned area: score 0; 1-24% of total area: score 1; 25-49%: score 2; 50-74%: 3; and finally>75%: score 4; apoptosis score",10 days after SCI,yes,mixed (stats/no stats),significantly different necrosis score and number of apoptotic cells in treatment group compared to control group (treatment group has less necrosis and less apoptotic cells); methotrexate group similar with injury group in terms of myelin loss and vacuolization (no stats),anesthesia: 10 mg/kg xylazine and 60 mg/kg ketamine hydrochloride both IM; euthanasia: deep anesthesia,"Combined-treatment group had a statistically significant better outcome in preventing apoptosis, but there was no difference according to the clinical results compared to monotherapies",not reported,combination of etanacerpt and methotrexate tested,Yes (drug of interest + drug not of interest),
Lucie,Winkler et al,2002,"Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury - An experimental study in the rat using electrophysiological and morphological approaches",10.1007/s00726-001-0138-y,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (topical dynorphin A (1–17) antiserum),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Narin et al,2017,Topiramate as a neuroprotective agent in a rat model of spinal cord injury,10.4103/1673-5374.221164,English,,included,,,,,,rats,Wistar,40,10,,,10,,,"1 sham n = 10, 1 SCI only n = 10, consider control to be SCI + vehicle",male 100%,male,100,6-8 weeks,,,6,8,Weeks,,range: [150-200](g),,,150,200,g,,level: T8-10; severity: not reported,T8 - T10,Not reported,contusion,"laminectomy + contusion (Allen's method, dropping 5g weight of sperical lead through a 10-cm guide tube, perpendicular to the exposed spinal cord)","24h, 4 weeks",topiramate (TPM),topiramate,,40 mg/kg,30 min after injury,,2 days,every 12h,multiple,first dose: IP; subsequently: oral,neurological/functional/behavioral assessment,"hind limb motor function score (MFS), inclined plane score (IPS)",,"MFS: scale from 0 to 6, 0=no movement of the hindlimbs, 3=alternate stepping and propulsive movements of hindlimbs, no weight support, 6=normal walking, 1min observation on horizontal plane 0.7*0.9 m^2, hip/knee/ankle joint movements recorded; IPS: highest angle at which a rat can support its weight for 5s on an inclined plane 30*60 cm^2 measured at 0-90 degrees",4 weeks post SCI,,yes,positive effect,MFS and IPS significantly higher in TPM group comapred to SCI only and SCI+vehicule (p=0.001),histological assessment,"lesion size and spinal cord cross-sectional area at lesion epicenter level, proportion of the lesion size to total area of spinal cord on each section recorded as percentage, 3 sections with largest lesion area evaluated and percentage averaged per animal",4 weeks,yes,no effect,no statistical difference in spinal cord lesion area between TPM and controls (trend toward smaller lesion in TPM group),"anesthesia: ketamine hydrochloride (60 mg/kg, IP), xylazine (8 mg/kg, IP); euthanasia: anesthesia+intracardiac perfusion of saline",study suggests that administration of TPM exerts neuroprotective effects on SCI,not reported,,No,
Lucie,Gensel et al,2012,Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury,10.1371/journal.pone.0033519,English,,included,,,,,,rats,Long Evans,52,16,,,16,,,"8 animals per group, 3 groups *2 because of the 2 severities tested, 4 animals died and were replaced but no details on the group assigned",female 100%,female,0,75-85 days old,,,75,85,Days,,236(2)(g),236,2,,,g,,level: C5; severity: moderate and severe,C5,multiple,contusion,"laminectomy + contusion (right unilateral, MASCIS/NYU injury device, 10-g weight from either 12.5mm or 6.25mm)",48h,"topiramate, NBQX (not of interest, not reported afterwards)",topiramate,,3 microL of 10mM solution,15 min after injury,,single dose,-,intrathecally,,neurological/functional/behavioral assessment,"forelimb grooming function, BBB",,"forelimb grooming function: six-point scoring system depending upon the area of the head contacted by the animal's forelimb: 0=no contact to any part of the face or head, 5=area of the head behind the ears; BBB: 13-point sub-scoring system, values to each hindlimb for toe drags, paw position, tail position and trunk instability",2 days,,not reported,no effect,"severe injuries only: better grooming scores for topiramate group compared to control but not significant, no significant difference between topiramate and control in grooming or BBB; no difference following moderate contusion",histological assessment,"proportion of spared tissue, oligodendrocyte sparing",2 days after injury,not reported,mixed effects (assessment) + mixed effects (regimen),"topiramate group after severe injury had significantly more spared tissue compared to control group, topiramate treatment significantly improved oligodendrocyte sparing after severe SCI in the dorsal column white matter but not in the ventral white matter, compared to control group","anesthesia: sodium pentobarbital (45-60 mg/kg), prophylactic antibiotics (cefazolin, 25 mg/kg); euthanasia: anesthesia with ketamine-xylazine, transcardially perfused 0.5 mL of 2% lidocaine HCl, 0.1 mL of heparin, 300-500 mL of 0.9% NaCl and 500-1000mL of 4% paraformaldehyde","Topiramate, delivered 15-minutes after SCI, increases tissue sparing and preserves oligodendrocytes and neurons when compared to vehicle treatment. In addition, topiramate is more effective than the AMPA-receptor antagonist, NBQX.",not reported,,No,
Lucie,Zhang et al,2021,Total flavonoids of hawthorn leaves promote motor function recovery via inhibition of apoptosis after spinal cord injury,10.4103/1673-5374.286975,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (total flavonoids of hawthorn leaves, components described in paper but none of them was part of drugs of interest's list)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ferbert et al,2017,"Tracking Spinal Cord Injury: Differences in Cytokine Expression of IGF-1, TGF-B1, and sCD95I Can Be Measured in Blood Samples and Correspond to Neurological Remission in a 12-Week Follow-Up",10.1089/neu.2015.4294,English,,excluded,Out of scope,No drug tested,Out of scope: no treatment tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Yoshizaki et al,2019,Tranexamic acid reduces heme cytotoxicity via the TLR4/TNF axis and ameliorates functional recovery after spinal cord injury,10.1186/s12974-019-1536-y,English,,included,,,,,,mice,C57BL/6,92,>= 20,,,>= 20,,,details are unclear,female 100%,female,0,8-10 weeks,,,8,10,Weeks,,not reported,,,,,,Not reported,level: T9; severity: moderate,T9,moderate,contusion,"contusion (70 kdyn, using Infinite Horizons Impactor)","1, 3, 7 days, 6 weeks","tranexamic acid (not of interest so not reported), heparin sodium",heparin,,1 U/g of body weight,1 and 12h after injury,,2 doses,-,subcutaneous,,neurological/functional/behavioral assessment,"BMS, footprint analysis, grid walk test, locomotion analsyis with MotoRater apparatus",,"BMS: 3 examiners, 4 min, score for each hindpaw; foot print analysis: paper-covered narrow runway (80 cm length, 4cm width); grid test walk: 50-cm grid with 3 patterns (easy, medium and hard), sum of the number of grips for all 3 patterns used; MotoRater apparatus: locmotor quantification of different body sites, kinetic analysis, recorded height of the iliac crest, stride width, paw rotation, water depth of swimming course, toe and ankle rang of motion, measurments taken on each side for three consecutive steps were averaged","BMS: 7 days after SCI and then weekly until 6 weeks; foot print, grid walk and MotoRater: 6 weeks after injury",,yes,mixed effects (assessment),"BMS: no statistical difference between control and heparin (trend toward heparin being worse than control); grid walk: heparin significantly fewer grips than control group (p<0.05); gait analysis: paw rotation significantly larger and stride width significantly lower in the heparin group compared to control (i.e. worse outcome in heparin group), significantly worse range of motion in swimming but not on the ground for the heparin group compared to control",histological assessment,"intralesional RBC volume, intralesional bleeding area, spared white matter area, ratio of injured to normal tissue",1 and 7 days after injury,not reported,negative effect,"intralesional RBC volume significantly higher in heparin compared to control group, wider and more injured tissue in heparin compared to control","anesthesia: pentobarbital (75 mg/kg, IP); euthanasia: re-anesthesised and transcardially perfused with normal saline followed by 45 paraformaldehyde",The administration of tranexamic acid (TXA) ameliorated the intralesional cytotoxicity both by reducing the intralesional bleeding volume and preventing heme induction of the TLR4/TNF axis in the SCI lesion. Our findings suggest that TXA treatment may be a therapeutic option for acute-phase SCI.,not reported,"present negative effects for heparin (not the main drug studied in the paper), only trend for the neurological assessment",No,
Lucie,Wang et al,2020,Transcriptome Analysis Reveals the Effects of Troxerutin and Cerebroprotein Hydrolysate Injection on Injured Spinal Cords in Rats,10.1155/2020/3561235,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (troxerutin and cerebroprotein hydrolysate),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gris et al,2004,"Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function",10.1523/JNEUROSCI.5343-03.2004,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (anti-CD11d monoclonal antibody),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhao et al,2016,Transplantation of Cerebral Dopamine Neurotrophic Factor Transducted BMSCs in Contusion Spinal Cord Injury of Rats: Promotion of Nerve Regeneration by Alleviating Neuroinflammation,10.1007/s12035-014-9000-6,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (transplantation of Bone marrow-derived mesenchymal stem cells overexpressing cerebral dopamine neurotrophic factor) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Xu et al,2011,Transplanted L1 expressing radial glia and astrocytes enhance recovery after spinal cord injury,10.1089/neu.2011.1783,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (neural stem cells transplantation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Alexanian et al,2011,Transplanted neurally modified bone marrow-derived mesenchymal stem cells promote tissue protection and locomotor recovery in spinal cord injured rats,10.1177/1545968311416823,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (transplant of neurally modified bone marrow-derived mesenchymal stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hains et al,2000,Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury,10.1006/exnr.2000.7439,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (transplant of adrenal meduallary chromaffin cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al,1999,Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function,10.1523/jneurosci.19-11-04370.1999,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (fibroblasts genetically modified to express brain-derived neurotrophic factor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2016,Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier,10.1038/srep25794,English,,excluded,Out of scope,No drug of interest,"Out of scope: no treatment of interest, no functional/histological recovery assessment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sun et al,2013,Treadmill step training promotes spinal cord neural plasticity after incomplete spinal cord injury,10.3969/j.issn.1673-5374.2013.27.005,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment tested but treadmill training instead,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Fouad et al,2000,Treadmill training in incomplete spinal cord injured rats,10.1016/S0166-4328(00)00244-8,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment tested but treadmill training instead,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Park et al,2005,Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor,10.1089/ten.2005.11.913,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (bone marrow cell transplantation and granulocyte macrophage-colony stimulating factor),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Arias,1987,"Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone",10.1016/0090-3019(87)90054-1,English,,included,,,,,,rats,Wistar,>= 42,6,5,,6,2,,"see survival paragraph, no size group for sham",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,"level: T3, severity: ""made paraplegic""",T3,paraplegia,compression,laminectomy + Rivlin and Tator method (vascular clip extradurally for 2 minutes),10 weeks,"thyrotropin-releasing hormon (TRH), naloxone, dexamethasone",naloxone,,0.8 mg per dose,45 and 120 minutes after injury,,2 doses (2h),-,intraperitoneally,,neurological/functional/behavioral assessment,inclined plane test,,"Rivlin and Tator method, highest angle at which an animal could maintain itself for 5 seconds was recorded",weekly for 10 weeks,,not reported,no stats,TRH and naloxone groups showed a higher mean angle than dexamethasone and saline groups (no statiscal test reported),histological assessment,"cord and pyramidal cavitation size, six-point grading scale at the level of maximum damage: 0=absence of lesion, 1=1%-20% area affected, 2=21%-40%, 3=41%-60%, 4=61%-80%, 5=85%-99%, 6=100% destruction of the surface",10 weeks after injury,not reported (same remark as for the neurological assessment),not reported,no real description of the treatment effect on recovery,"anesthesia: 40 mg/kg IP pentobarbital, euthanasia: intracardiac perfusion method",TRH and naloxone are therapeutically beneficial in the treatment of SCI and that dexamethasone is ineffective,not reported,no statistical test reported compared the control and treatment groups?,No,
Lucie,Arias,1987,"Treatment of experimental spinal cord injury with TRH, naloxone, and dexamethasone",10.1016/0090-3019(87)90054-1,English,,included,,,,,,rats,Wistar,>= 42,6,5,,6,8,,"see survival paragraph, no size group for sham",male 100%,male,100,not reported,,,,,,Not reported,range: [200-250](g),,,200,250,g,,"level: T3, severity: ""made paraplegic""",T3,paraplegia,compression,laminectomy + Rivlin and Tator method (vascular clip extradurally for 2 minutes),10 weeks,"thyrotropin-releasing hormon (TRH), naloxone, dexamethasone",dexamethasone,,0.6 mg per dose,45 and 120 minutes after injury,,2 doses (2h),-,intraperitoneally,,neurological/functional/behavioral assessment,inclined plane test,,"Rivlin and Tator method, highest angle at which an animal could maintain itself for 5 seconds was recorded",weekly for 10 weeks,,not reported,no stats,TRH and naloxone groups showed a higher mean angle than dexamethasone and saline groups (no statiscal test reported),histological assessment,"cord and pyramidal cavitation size, six-point grading scale at the level of maximum damage: 0=absence of lesion, 1=1%-20% area affected, 2=21%-40%, 3=41%-60%, 4=61%-80%, 5=85%-99%, 6=100% destruction of the surface",10 weeks after injury,not reported (same remark as for the neurological assessment),not reported,no real description of the treatment effect on recovery,"anesthesia: 40 mg/kg IP pentobarbital, euthanasia: intracardiac perfusion method",TRH and naloxone are therapeutically beneficial in the treatment of SCI and that dexamethasone is ineffective,not reported,no statistical test reported compared the control and treatment groups?,No,
Lucie,Naftchi et al,1991,Treatment of mammalian spinal cord injury with antioxidants,10.1016/0736-5748(91)90002-4,English,,included,,,,,,cats,Mongrel,30,6,,,6,,,one other treatment group not of interest,not reported,not reported,,not reported,,,,,,Not reported,not reported,,,,,,Not reported,"level: T8 (n=8), T4 (n=12), severity: not reported",T4,Not reported,contusion,"laminectomy + contusion with Allen's method (T8 group), or contusion weight drop (20g weight, 25 cm onto the exposed dura), or control group with 500 g-cm impact",26h,"methylprednisolone sodium succinate (MP), epsilon-aminocaproic acid (EACA)",methylprednisolone sodium succinate + aminocaproic acid,,"MP: 35 mg/kg, EACA: 350 mg/kg",45 min after injury,,single bolus,-,intraperitoneally,,"neurological assessment (only GA group), electrophysiology","somatosensory evoked potentials (SEPs), sensory and motor evaluations (paraplegia status)",,"SEPs: require intact ascending pathways; motor evaluation: 3 categories, 1=paraplegia, absence of voluntary hindlimb gait patterns, 2=partial paraplegia, 3=ambulators","SEPs: before and after laminectomy, after contusion and at hourly intervals for 3h, motor evaluation: before injury, weekly post injury",,"SEPs: not reported, motor evaluation: yes",not reported,not reported,histological assessment,hemorrhage,26h,not reported,no stats,"marked reduction in blood extravasation, inflammation and a significnt preservation of structural membrane integrity by combined MP and EACA treatment","anesthesia: pentobarbital (30 mg/kg, IV), penicillin for 3 days after surgery","The agents used in these studies produce theur ameliorating effects by virtue of their anti-inflammatory, antioxidant, and membrane stabilizing properties and enhancing the regional microcirculation",not reported,no SEPs or motor function results?,Yes (drug of interest + drug of interest),
Lucie,Yeo et al,1976,Treatment of paraplegic sheep with hyperbaric oxygen,10.5694/j.1326-5377.1976.tb140823.x,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (hyperbaric 100% oxygen),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Grumme et al,1995,"TREATMENT OF PATIENTS WITH SEVERE HEAD-INJURY BY TRIAMCINOLONE - A PROSPECTIVE, CONTROLLED MULTICENTER CLINICAL-TRIAL OF 396 CASES",10.1007/BF02576791,English,,excluded,Non-sci population,,patients with severe head injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Glantz et al,1994,Treatment of radiation-induced nervous system injury with heparin and warfarin,10.1212/wnl.44.11.2020,English,,excluded,Non-sci population,,no SCI patient,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Avila-Martin et al,2011,"Treatment of rat spinal cord injury with the neurotrophic factor Albumin-Oleic acid: Translational application for paralysis, spasticity and pain",10.1371/journal.pone.0026107,English,,excluded,Out of scope,No drug of interest,No drug of interest: neurotrophic factor albumin-oleic acid,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Romero-Ramírez et al,2020,Treatment of rats with spinal cord injury using human bone marrow-derived stromal cells prepared by negative selection.,10.1186/s12929-020-00629-y,English,,included,,,,,,rats,Wistar,26,9,1,2,5,1,0,very detailed in figure1,male 100%,male,100,6-8 weeks old,,,6,8,Weeks,,304 (14) (g),304,14,,,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + contusion (impactor rod positioned centrally at T9-T10 over the spinal cord midline, contusion applied by pressing it against the dorsal surface of the tissue, when a force of 2N was reached the rod was immediately retracted [zero dwell time])",10 weeks,methylprednisolone (MP),methylprednisolone,No,30 mg/kg,1h after injury,Yes,5 doses,every 8h,intraperitoneally,,"neurological/functional assessment, pain ","BBB scale, rotarod locomotor function test, Von Frey test of mechanical allodynia/hyperalgesia",,"BBB: scale from 0=no hind limb movement and 21=normal movements coordinated gait with parallel paw placement; 0-7=return of isolated movements in the trhee joints of hip knee and ankle, 8-13=return of paw placement and coordinated movements with the forelimbs etc; rotarod locomotor function test: required the rats to maintain their body on a rotating rod, 4 training session of 5 min each, constant speed of 5 rpm of the rotating rod, roataion speed accelerated from 5 rpm to 15 rpm over a period of 3 min, readout was the time that the rats were able to stay on the ratating rod before falling off (mean over 2 repetitions separated by at least 15 min); Von Frey test: rats placed in cages with wire mesh bottom, filament pressed perpendivularly to the plantar surface of the hind paw until it buckled and held for 2-5s, response considered positive if animal exhibited any nocifensive behavior such as a brisk withdrawal or licking of the paw, both hind paws stimulated and paw withdrawal threshold determined using the simplified up-down method","BBB: pre-SCIm day 2, 4 after injury and then once per week for the next 9 weeks; Rotarod test: tao and 1 day before injury, day 4 and 7 after injury and then weekly; Von Frey test: before SCI and at the end of the 9 weeks observation period",Yes,"BBB: yes, Rotarod test: not reported, Von Frey test: not reported",mixed (stats/no stats),"BBB: no significant difference between MP and control group at week 9, trend towards MP being worse than control (control significantly better at week 1 and 5, MP group average always below control group average); Rotarod test: no signficant difference between groups (high variability since lots of rats refused the test); Von Frey test: no hyperalgesia/allodynia in bmSC implanted animals, while this occurred in 1/5 rats treated with MP and 3/9 rats iin control group (no statistical test associated)",histology assessment,max anterior-posterior extension fo the tissue lesion and the tissue loss in the lesion center,10 weeks after injury,yes,no effect,"no quantitative differences between the treatment groups regarding the tissue loss in the center of the lesion; lesion centers, characterized by a fluid-filled cavity and scar formation was also without significant effect of treatment","anesthesia: 5% isoflurane/95% oxygen then 2.5% isoflurane via inhalation of a vaporizer, analgesic buprenorfine 0.05 mg/kg; after anesthesia: 2*2.5 mL isotonic saline SC, antibiotic marbofloxacine 5 mg/kg; postop: first 3 days, 2 daily SC injections of buprenorfine 0.05 mg/kg, SC 5 mg/kg marbofloxacine at day of surgery, day 2 and 4, if UTI marbofloxacine 5 mg/kg SC every 48h until urine clear and without blood; ethanasia: IP injection of 100 mg/kg sodium pentobarbital","Human bmSC that were prepared by negative selection without expansion in culture have neuroprotective properties after SCI. Given the effect size on motor function, implantation in the acute phase was not sufficient to induce spinal cord repair. Due to their immune modulatory properties, allogeneic implants of bmSC can be used in combinatorial therapies of SCI.","study underpowered due to low sample size, Rotarod did not reached signficance threshold due to high variability, human bmSC not used directly after extraction",,Yes (drug of interest + drug not of interest),
Lucie,Csókay et al,2001,Treatment of severe double spinal cord injuries,10.1038/sj.sc.3101180,English,,excluded,Case report,,Clinical case series,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Setoguchi et al,2004,Treatment of spinal cord injury by transplantation of fetal neural precursor cells engineered to express BMP inhibitor,10.1016/j.expneurol.2003.12.007,English,,excluded,Out of scope,No drug of interest,No drug of interest: fetal neural precursor cells engineered to express bone morphogenetic protein,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Holtz et al,2018,Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study,10.1038/s41393-018-0165-0,English,,excluded,Out of scope,No pure effect studied,Out of scope: not a spcific treatement tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zaech et al,1976,Treatment results of spinal cord injuries in the swiss paraplegic centre of basle,10.1038/sc.1976.9,English,,excluded,Out of scope,No pure effect studied,Out of scope: not a spcific treatement tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Avila-Martin et al,2017,Treatment with albumin-hydroxyoleic acid complex restores sensorimotor function in rats with spinal cord injury: Efficacy and gene expression regulation.,10.1371/journal.pone.0189151,English,,excluded,Out of scope,No drug of interest,No drug of interest: albumin-hydroxyoleic acid complex ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Furuya et al,2013,Treatment with basic fibroblast growth factor-incorporated gelatin hydrogel does not exacerbate mechanical allodynia after spinal cord contusion injury in rats,10.1179/2045772312Y.0000000030,English,,excluded,Out of scope,No drug of interest,No drug of interest: basic fibroblast growth factor-incorporated gelatin hydrogel,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Paterniti et al,2009,Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma,10.1007/s00210-009-0414-z,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2009,Treatment with immunosuppressants FTY720 and tacrolimus promotes functional recovery after spinal cord injury in rats,10.1620/tjem.219.295,English,,included,,,,,,rats,Sprague Dawley,48,12,,,12,,,"2 treatment groups not of interest, n = 12 each",male 100%,male,100,not reported,,,,,,Not reported,range: [280-320](g),,,280,320,g,,level: T9-T10; severity: not reported,T9 - T10,Not reported,contusion,"laminectomy + weight-drop contusion (10g-rod, 25mm height)",21 or 42 days,tacrolimus,tacrolimus,,0.5 mg/kg,30 min after injury,,single dose,-,oral,,"neurological/functional assessment, electrophysiology","BBB scale, inclined plane test, footprint analysis, somatosensory evoked potentials",,"BBB: open-field, 0=flaccid paralysis, 21 = normal gait, 90cm diameter plastic wasing pool, 4cm height, averaged for each group; inclined plane test: max angle on the inclined plane upon which the animal can maintain a stable position for 5 sec, board incrementally raised to increase angles, angle scores averaged for each group; footprint analysis: walking patterns of the hindlimbs recorded with ink during continuous locomotion across a 90cm runway, stride length on each side and the stride width between the two sides were calculated, both were averaged per group; SSEPs: recorded on sensory cortex of the brain, subdermal electodes stimulated nerve impulses from the tibial nerves of both hindlimbs (trains in sets of 200 at 3Hz, stimulus amplitude 3mA squre wave, 200 micros in duration), active electrode into the interspinous ligament at T10, measures anplitude and latency of the evoked potentials, averaged per group","BBB and inclined plane test: before surgery, 3, 7, 14, 21, 28 , 35 and 42 days after surgery; footprint analysis: day 42; SSEPs: 21 and 42 days after injury",,not reported,mixed effects (assessment),"BBB: Both the FTY720 + tacrolimus-treated group and the FTY720- and tacrolimus- treated groups showed significantly improved hindlimb performance compared to the saline-treated control group, FTY720 + tacrolimus-treated group demonstrated a higher mean BBB score (P < 0.05) than those of the FTY720- and tacrolimus-treated groups,  no statistical difference in mean BBB scores between the FTY720- and the tacrolimus-treated groups; inclined plane test: All three treatment groups demonstrated significantly higher mean angle scores than that of saline-treated control group, FTY720 + tacrolimus-treated group showed a higher mean angle score than those of the FTY720- and tacrolimus-treated groups, No differences in mean angle scores were observed between the FTY720- and the tacrolimus-treated groups; footprint analysis: greater mean stride length and a shorter mean stride width in FTY720 + tacroli- mus-treated group than in the other three groups, No differences were found in the mean stride width among the FTY720-, tacrolimus- and saline-treated control groups, significantly greater mean stride lengths in the FTY720- and the tacrolimus-treated groups than in the saline-treated control group; electrophysiology: FTY720-, tacrolimus- and FTY720 + tacrolimus-treated groups showed significantly higher (P < 0.05) mean amplitude and shorter (P < 0.05) mean latency of SSEPs compared with those of saline-treated control group, FTY720 + tacrolimus-treated group showed a significantly higher (P < 0.05) mean ampli- tude and a shorter (P < 0.05) mean latency of SSEPs compared with those of the FTY720- and tacrolimus-treated groups, no significant differences (P > 0.05) in either mean amplitude or mean latency of SSEPs between the FTY720- and tacrolimus-treated groups",histological assessment,structure of axons and myelin,21 days after injury,not reported,no stats,"only a few pathological changes in the FTY720 + tacrolimus treated group:  axons appeared as slightly oval structures, compact myelin proportional to the axon diameter, little intramyelinic vacuolization;  varying degrees of change in the other three groups after SCI: formation of swollen axonal profiles, a decrease in the number of healthy-looking, large-diameter axons, and a disruption in myelin structure,  axons appeared to have lost their round or oval shapes (most obvious in the saline-treated control group),  white matter showed overt splitting of the myelin lamellae, evident loss of myelin compaction and much intramyelinic vacuolization,  in the FTY720-treated group axons retained their round or oval shapes but there was intramyelinic vacuolization and some loss of myelin compaction,  changes in the tacrolimus-treated group were similar to those observed in the FTY720-treated group but the loss of myelin compaction was more obvious in tacrolimus-treated group","anesthesia: pentobarbital (50 mg/kg, IP); euthanasia: perfused intracardially with saline followed by 2% glutaraldehyde and 4% paraformaldehyde in 0.1 M sodium cacodylate buffer",results suggest that the combination of FTY720 and tacrolimus could be a potentially effective therapeutic strategy to treat SCI,not reported,,Yes (drug of interest + drug not of interest),
Lucie,Nakagawa et al,2019,Treatment With the Neutralizing Antibody Against Repulsive Guidance Molecule-a Promotes Recovery From Impaired Manual Dexterity in a Primate Model of Spinal Cord Injury,10.1093/cercor/bhx338,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (antibody treatment against repulsive guidance molecule-a),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pitts et al,1995,TREATMENT WITH THYROTROPIN-RELEASING-HORMONE (TRH) IN PATIENTS WITH TRAUMATIC SPINAL-CORD INJURIES,10.1089/neu.1995.12.235,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment of interest (thyrotropin-releasing hormone),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Xiong et al,2018,Tree shrew neural stem cell transplantation promotes functional recovery of tree shrews with a hemi-sectioned spinal cord injury by upregulating nerve growth factor expression,10.3892/ijmm.2018.3553,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nazari-Robati et al,2019,"Trehalose attenuates spinal cord injury through the regulation of oxidative stress, inflammation and GFAP expression in rats",10.1080/10790268.2018.1527077,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nasouti et al,2019,Trehalose protects against spinal cord injury through regulating heat shock proteins 27 and 70 and caspase-3 genes expression,10.1515/jbcpp-2018-0225,English,,excluded,Out of scope,No drug of interest,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Faden et al,1989,TRH Analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies,10.1016/0006-8993(89)90509-X,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (YM-14673, thyrotropin-releasing hormone)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Rolls et al,2008,Two faces of chondroitin sulfate proteoglycan in spinal cord repair: A role in microglia/ macrophage activation,10.1371/journal.pmed.0050171,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (xyloside to inhibit chondroitin sulfate proteoglycan),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Zhang et al,2014,Two-photon-excited fluorescence microscopy as a tool to investigate the efficacy of methylprednisolone in a mouse spinal cord injury model.,10.1097/BRS.0000000000000218,English,,included,,,,,,mice,YFP-H transegnic and CX3CR1-GFP,36,12,,,12,,,sham n = 12,not reported,not reported,,8-10 weeks,,,8,10,Weeks,,23-25 (g)(average),,,23,25,g,,level: L1; severity: severe,L1,severe,compression,"laminectomy + compression injury (exposed spinal cord with intact dura, gently laid a 2*1 mm platform, weight 20g, oriented longitudinally, over the spinal cord for 5 minutes)",1 week,methylprednisolone (MP),methylprednisolone,Yes,30 mg/kg,30 min after injury,,3 doses,"30 minutes, 6h, 24h after injury",intravenously,,neurological/functional/behavioral assessment,BMS,,"hind limb motor function in an open field, 10-point scale (0=complete hind limb paralysis, 9=no locomotor deficits)",daily for the first week after SCI,,yes,positive effect,group treated with MP had significantly better BMS score than the control group 72h after injury,histological assessment,"necrosis , cavity, survival rate of axons, microglial/macrophaes proliferation",1 week after injury,not reported,positive effect,"survival rate of axons significantly better in MP treated group compared to control, greater necrosis and cavity in control compared to MP treated group, microglia/macrophages proliferation greater in group control compared to group treated with MP","anesthesia: ketmine-xylazine (120 mg/kg) injected in abdominal cavity; antibiotics administered during the experiment after surgery; euthanasia: anesthesia perfused them transcardially with 15 mL PBS, 4% paraformaldehyde","2PEF microscopy is useful for detecting early changes, indicating axonal disruption in compression SCI> MP therapy may help alleviate axonal progressive damage and reduce the proliferation of microglia/macrophages in acute SCI","scanning depth of 2PEF microscopy is limited to 800 microM and the 2-photon laser is unable to penetrate deeper tissue, growth of granulation and connective tissue on the spinal dura mater might affect the image quality in long-term observation, might be better to employ the number of detections techniques to ascertain MP-induced neuroprotectice effects in SCI",,No,
Lucie,Zang et al,2016,Two-step production of monoamines in monoenzymatic cells in the spinal cord: a different control strategy of neurotransmitter supply?,10.4103/1673-5374.197124,English,,excluded,Review,,Invited review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,,2018,Type III disc herniation in a dog,not found,English,,excluded,Out of scope,No drug of interest,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2018,Ultrashortwave radiation promotes the recovery of spinal cord injury by inhibiting inflammation via suppression of the MK2/TNF-Œ± pathway,10.3892/ijmm.2018.3786,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (ultrashortwave radiation),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Erel et al,2010,"Ultrastructural Changes in the Liver after Experimental Spinal Cord Injury in Rats: Effects of Methylprednisolone, Immunoglobulin G and Albumin",10.5137/1019-5149.JTN.2462-09.1,English,,excluded,Out of scope,No assessments of interest,Out of scope: no outcome of interest (histology of the liver only),,,rats,Wistar,48,,,,,,,,female 100%,,,not reported (adults),,,,,,,range: [210-250](g),,,,,,,level: T7-T10; severity: not reported,,,,"laminectomy + weight drop (Allen's method, 50g-cm)",24h,"methylprednisolone sodium succinate (MPSS), albumin, IgG",,,"MPSS: 30 mg/kg, albumin: 5 mg/kg, IgG: 400 mg/kg",immediately after trauma,,single dose,-,intraperitoneally,,,,,,,,,,,,,,,,,,,,,,
Lucie,Tai et al,1997,Ultrastructural characteristics of glutamatergic and GABAergic terminals in cat lamina IX before and after spinal cord injury,10.1080/10790268.1997.11719481,English,,excluded,Out of scope,No drug of interest,Out of scope: no treatment tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Dasari et al,2008,Umbilical cord blood stem cell mediated downregulation of Fas improves functional recovery of rats after spinal cord injury,10.1007/s11064-007-9426-6,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (human umbilical cord blood stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ba et al,2017,Update on critical care for acute spinal cord injury in the setting of polytrauma,10.3171/2017.7.FOCUS17396,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Sarkar et al,2017,UPLC-MS/MS assay of riluzole in human plasma and cerebrospinal fluid (CSF): Application in samples from spinal cord injured patients,10.1016/j.jpba.2017.08.045,English,,excluded,Out of scope,No assessments of interest,Out of scope: not looking at treatment effect (study on new technique for detection of riluzole),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liang et al,2019,Upregulated protein O-GlcNAcylation promoted functional and structural recovery of the contused spinal cord injury in rats by Thiamet-G treatment,10.1080/01616412.2019.1611202,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (Thiamet-G, O-GlcNAcase inhibitor)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Wang et al,2020,Upregulation of microRNA-200a in bone marrow mesenchymal stem cells enhances the repair of spinal cord injury in rats by reducing oxidative stress and regulating Keap1/Nrf2 pathway,10.1111/aor.13656,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (lentivirus-mediated miR-200a gene-modified bone marrow mesenchymal stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Pan et al,2003,Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier,10.1385/JMN:21:2:173,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug tested,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Daemen et al,2008,Upregulation of the GABA-transporter GAT-1 in the spinal cord contributes to pain behaviour in experimental neuropathy,10.1016/j.neulet.2008.08.001,English,,excluded,Non-sci population,,No SCI but chronic constriction injury (neuropathic pain model),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Rabinowitz et al,2008,Urgent surgical decompression compared to methylprednisolone for the treatment of acute spinal cord injury,10.1097/BRS.0b013e31818786db,English,,included,,,,,,dogs,Beagle Hounds,18,6,,,6,,,one group with cord decompression but no relevant control group to comapred them,male 100%,male,100,not reported (adults),,,,,,Adult,range: [10-12](kg),,,10,12,kg,,"level: L4, severity: not reported",L4,Not reported,compression,"laminectomy + constriction (nylon electrical cable band, 2.8 mm wide, was placed circumferentially around the dura at the L4 pedicle level, and the canal area was constricted by 60% of its original value, decompression 6h after compression was initiated for group with decompresion)",2 weeks,methylprednisolone (MP),methylprednisolone,No,30 mg/kg and 5.4 mg/kg/hour,1 hour after injury,,23h,continuous,intravenously,,"neurological/functional/behavioral assessment, electrophysiology","Tarlov scale, somatosensory evoked potentials",,"revised tarlov scale: 1=flaccid hind limbs, 2=tone in hind limb, 3=purposeful hind limb motion, 4=stands with assistance, 5=stands unassisted, 6=limited ambulation, 7=full ambulation, 8=climbs a 20 degrees incline ramp half way, 9=climbs 20 degrees incline ramp",daily,,not reported,no effect,"Tarlvo score: decompression+MP VS no-decompression+MP significant (better with decompression), decompression+MP VS decompression+no-MP not significant, decompression+MP VS decompression+sham not significantly different; SEPs: no statistically significant difference in recovery among any of the groups tested",histological assessement,"central necrosis, cystic cavitation, percentge of total spinal cord involvment",2 weeks,not reported,no effect,"nosignificant difference in the percentage of spinal cord involvment between groups except belox the level of injury, MP without decompression group had slighlty more involvement thant th 2 decompression groups (p=0.043), no difference in gray matter to white matter ratio","anesthesia: methohexital (5 mL/kg), ventilated on oxygen and 1.5% halothane; euthanasia: IV pentobarbital","surgical decompression 6h after injury, with or without MP, is more effective for improving neurologic recovery than MP alone","circular decompresssion of the spinal cord may not be an ideal model for traumatic spinal cord injury, power to detect anything but large differences is limited due to sample size, functional analyses in dogs using current grading scales may not be sensitive enough to reflect clinically relevant neurological changes",,No,
Lucie,Scott et al,2005,Uric acid protects against secondary damage after spinal cord injury,10.1073/pnas.0500307102,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (uric acid),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Nicholas et al,2009,Use and Determinants of the Methylprednisolone Protocol for Traumatic Spinal Cord Injury in South Carolina Acute Care Hospitals,10.1097/TA.0b013e318190bf49,English,,excluded,Out of scope,No assessments of interest,Out of scope: no treatment effect studied,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gainer Jr et al,1977,Use of crocetin in experimental spinal cord injury,10.3171/jns.1977.46.3.0358,English,,excluded,Out of scope,No drug of interest,"Out of scope: no treatment of interest (crocetin, a carotenoid compound)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Mutch et al,1993,USE OF NEUROANESTHESIA ADJUNCTS (HYPERVENTILATION AND MANNITOL ADMINISTRATION) IMPROVES NEUROLOGICAL OUTCOME AFTER THORACIC AORTIC CROSS-CLAMPING IN DOGS,10.1161/01.STR.24.8.1204,English,,excluded,Out of scope,No pure effect studied,"Out of scope: drug of interest (mannitol) coupled with hypocapnia for testing effect of hypocapnia, no pure effect of mannitol tested",,,dogs,Mongrel,19,,,,,,,,not reported,,,not reported,,,,,,,21(3)(kg),,,,,,,level: distal to left subclavian artery; severity: not reported,,,,"ischemia: aorta was cross clamped 2.5cm distal to the left subclavian artery, left in place for 30 minutes",24h,mannitol and hyperventilation (hypocapnia),,,"2g/kg first, then 1g/kg/h",during surgical preparation (before injury),,"booster, than continuous infusion",,intravenously,,neurological/functional/behavioral assessment,Tarlov score,,"Tarlov score: severity of plegia, one vet, grade 0=no voluntary movement, spastic or flaccid paraplegia, grade 4 = complete recovery",Tarlov score: 24h after injury,,Tarlov score: yes,positive effect,"significant increased incidence and severity of paraplegia were seen in control group, all 10 animals in treatmnet group could walk, and 4/10 showed complete recovery, in group control 4/9 were paraplegic",histological assessment,"total number of neurons in the anterior spinal cord, cells were considered dead if the cytoplasm was diffusely eosinophilic and total if the cells demonstrated basophilic stippling (that is, contained Nissl substance), ratio of dead to total anterior spinal cord neurons was calculated",24h after injury,yes,positive effect,mean value of the ratio of dead to total neurons in treatment group was significantly better from the ratio in control group,"anesthesia: methohexital (19+/-5 mg/kg, IV), 500 mL lactated Ringer's, anesthesia maintained with isoflurane in oxygen (1.4% end-tidal, 1 minimal alveolar concentration); all wound infiltrated with 0.5% bupivacaine after completion of the expriment; postop: Oxygen was administered by face cone at 5L.min-1, and lactated Ringer's was infused at 100mL*h-1 until the next day, buprenorphine (0.015 mg.kg-1) was administered intramuscularly for analgesia, if necessary, morphine 0.5mg*kg-1 was administered the next morning; euthanasia: euthanyl injection",protocol using standard neuro anesthesia adjuncts (mannitol administrtion and deliberate hyperventilation) is associated with improved neurological outcome after thoracic aortic cross-clamping of 30 minutes' duration in dogs anesthetized with methohexital.,not reported,pvalues are significant but barely (0.04) and sample size is quite small so I would interpret caefully,,
Lucie,Allbutt et al,2007,"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease",10.1016/j.jneumeth.2006.07.006,English,,excluded,Non-sci population,,"No SCI, Parkinson's disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Narozny et al,2004,Usefulness of high doses of glucocorticoids and hyperbaric oxygen therapy in sudden sensorineural hearing loss treatment,10.1097/00129492-200411000-00010,English,,excluded,Non-sci population,,"No SCI, patients with sudden sensorineural hearing loss",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Gutierrez et al,2003,Using an evidence-based protocol to guide rehabilitation and weaning of ventilator-dependent cervical spinal cord injury patients,10.1682/JRRD.2003.10.0099,English,,excluded,Out of scope,No drug of interest,"Out of scope, no treatment tested but rehabilitation protocol to improve ventilatory muscle strength instead",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Shen et al,2005,Using methylprednisolone to supplement direct current electrical field in promoting spinal-cord regeneration.,10.1055/s-2005-871752,English,,excluded,Out of scope,No pure effect studied,"Out of scope: not looking at MP alone but MP combined with electrical therapy, no pure effect of MP tested or reported",,,dogs,Healthy,33,,,,,,,,not reported,,,range: [1.5-2](years),,,,,,,range: [10-12](kg),,,,,,,level: T13-L1; severity: complete,,,,"laminectomy + weight-drop (Allen's method, metal bar weighing 54.5g, diameter of 0.5cm, saddle-shaped end similar to the contour of the spinal cord, dropped from 10cm height (54.5 gcf) fell freely and vertically and hit the spinal cord through a glass tube 0.6cm in core diameter)","1, 2, or 3 months",methylprednisolone,,,"""large dose""",2h after injury,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhao et al,2016,Using NGF heparin-poloxamer thermosensitive hydrogels to enhance the nerve regeneration for spinal cord injury,10.1016/j.actbio.2015.10.014,English,,excluded,Out of scope,No drug of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Koffler et al,2014,Using templated agarose scaffolds to promote axon regeneration through sites of spinal cord injury,10.1007/978-1-4939-0777-9_13,English,,excluded,Out of scope,Other,Out of scope: protocol paper,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Martiñon et al,2007,Vaccination with a neural-derived peptide plus administration of glutathione improves the performance of paraplegic rats,10.1111/j.1460-9568.2007.05650.x,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (nonpathogenic derivatives of CNS-associated peptides (DCAP) +/-  glutathione monoethyl ester (GSHE)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Hauben et al,2001,Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: Comparison with other myelin antigens,10.1073/pnas.011585298,English,,excluded,Out of scope,No drug of interest,"Out of scope: no drug of interest (myelin basic protein, ovalbumin, altered (nonencephalitogenic) MBP peptide (Ala-91), Nogo-A- derived peptide p472)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Liu et al,2009,Vaccination with dendritic cells pulsed with homogenate protein of spinal cord promotes functional recovery from spinal cord injury in mice,10.1038/sc.2008.112,English,,excluded,Out of scope,No drug of interest,Out of scope: no drug of interest (vaccination with immature dendritic cells (DCs) pulsed with homogenate protein of spinal cord (hpDCs)),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Penas et al,2011,Valproate reduces CHOP levels and preserves oligodendrocytes and axons after spinal cord injury,10.1016/j.neuroscience.2011.01.012,English,,included,,,,,,rats,Sprague Dawley,42,12,,,18,,,based on table 1,female 100%,female,0,11 weeks,11,,,,Weeks,,range: [240-270](g),,,240,270,g,,level: T8; severity: not reported,T8,multiple,contusion,"laminectomy + contusion (forces of 150 or 250 kDyn, infinite horizon impactor device)",3 or 35 days after injury,valproate,valproic acid,,"150 mg/kg, 300 mg/kg",3h after injury,,3 weeks,"every 24h or every 12h for the first week, then every 24h",intraperitoneally,,"neurological/functional/behavioral assessment, electrophysiology","BBB scale, motor evoked potentials, compound action potentials",,"both: 250 kDyn contusion, VPA during 35 days post-injury, BBB: open-fiel walking scoring system, 5 min, one animal at a time, circular enclosure 90cm diameter*24cm wall height, 2 observers, ordinal scale from 0=no discernable hindlimb movement to 21=consistent, coordinated gait with parallel paw placement of the hindlimb and consistent trunk stability, score obtained by averaging the values from both examiners; electrophysiology: anesthesia with sodium pentobarbital 30mg/kg, IP, assessment of peripheral nerve conduction and spinal reflexes, sciatic nerve stimulated with pulse of 0.1 ms duration up to supra-maximal intensity through needles insertes percutaneously at the sciatic noch, compound muscle action potentials, including the direct muscle response (M wave) and the monosynaptic reflex response (H wave), of the tibialis anterior muscle were recorded, H/M maximal amplitude ratio was calculated, motor evoked potentials (MEPs) were elicited by transcranial stimulation with two needle electrodes placed s.c. over the skull, delivering pulses of 0.1 ms duration and 25 mA intensity, and recorded from the tibialis anterior muscle, measures amplitude and latency of the evoked potentials","BBB: 3, 7, 14 and 28 days after surgery, electrophysio: 14 and 28 days post-injury",,yes,mixed effects (assessment) + mixed (stats/no stats),"BBB: VPA-treated animals showed higher partial recovery of locomotion than saline-treated animals reaching significantly higher scores at 35 days; electrophysiology: latency and amplitude of the M wave elicited by stimulation of the sciatic nerve did not vary with respect to normal values, however the amplitude of the H wave increased in all injured rats, the mean amplitude of MEPs was slightly higher in the group treated with VPA than in the saline group at 14 and 28 days post-lesion. Thus, although VPA did not induce significant differences in electrophysiological tests, the mean amplitude of MEPs was slightly higher in the group treated with VPA than in the saline group at 14 and 28 days post-lesion.",histological assessment,"motoneurons and oligodendrocytes counting, tissue sparing",35 days after injury,yes,mixed effects (assessment),"total volume of the lesion indicated a significant effect of VPA, VPA treatment significantly increased the area of total tissue preserved as well as that of white matter at the epicenter and at 1mm adjacent caudal section of the spinal cord but not the rest of the cord, VPA treatment also reduced the myelin loss, rats treated with VPA showed an increased density of axonal profiles at levels both rostral and caudal to the lesion (but not all levels)","anesthesia: pentobarbital (40 mg/kg, IP), euthanasia: anesthesia and then decapitated, or transcardiac perfusion with 4% paraformaldehyde in PBS ",This study demonstrates that treatment with VPA reduces demyelination and axonal loss and promotes tissue and oligodendrocyte sparing as well as functional recovery in a rat model of SCI. ,not reported,,No,
Lucie,Chu et al,2015,Valproic Acid Arrests Proliferation but Promotes Neuronal Differentiation of Adult Spinal NSPCs from SCI Rats,10.1007/s11064-015-1618-x,English,,included,,,,,,rats,Sprague Dawley,135,>= 9,,,>= 19,,,"Ninety-eight (98) animals were randomized to the four groups (Sham, Sham + VPA, SCI and SCI + VPA) and sacrificed at day 15, 22, 29 and 36 after SCI for tissue examination. Other ten (10) animals of the group SCI and SCI ? VPA were injected biotinylated dextran amines (BDA) for tracking of the nerve fibers in corticospinal track. The rest 27 rats were randomized to the three groups (Sham, SCI and SCI ? VPA) and maintained for behavioral test.",male 100%,male,100,not reported (adults),,,,,,Adult,range: [180-220](g),,,180,220,g,,level: T10; severity: not reported,T10,Not reported,compression,laminectomy + compressive SCI (transient 1-min extradural compression using an aneurysm clip at a closing force of 30g),"15, 22, 29, 36 and 56 days",valproic acid (VPA),valproic acid,,150 mg/kg,day 15 after injury,,7 days,every 12h,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"4 min, scores on 21-point scale, 0=mo spontaneous movement, 21=normal locomotion, 14 = plantar stepping with full weight support and complete forelimb-hindlimb coordination",one a week for 8 weeks post-SCI,,yes,positive effect,"Compared to the saline-treated SCI control group, the VPA-treated SCI group exhibited a significantly increased BBB score from 4 weeks to the end point (P < 0.05, n = 9)",histological assessment,"bleeding spots, cyst, glial scar, number of nerve fibers of corticospinal tract",36 days after injury,not reported,mixed (stats/no stats),"Cyst and glial scar were distinct in saline-treated rats at the 36 day after SCI, but them were obviously reduced in the VAP-treated group (no stats); nerve fibers of corticospinal tract had a numerical increase after VPA delayed treatment, but there was no statistically significant difference when compared to SCI group","anesthesia: chloral hydrate (300 mg/kg, IP); euthanasia: chloral hydrate (500 mg/kg), intracardially perfused with 0.1 M PBS followed by 4% paraformaldehyde",study provide the first evidence that administration of VPA enhances the neurogenic potential of neural stem/precursor cells after SCI and reveal the therapeutic value of delayed treatment of VPA to SCI,not reported,didn't test neural stem/precursor cells in animals with behavioural/histo assessment; use chloral hydrate,No,
Lucie,Lee et al,2012,Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury,10.1111/j.1471-4159.2012.07731.x,English,,included,,,,,,rats,Sprague Dawley,>= 30,>= 15,,,>= 15,,,details are unclear,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: moderate or moderately severe,T9 - T10,mixed,contusion,"laminectomy + contusion (25 gm-cm or 50 gm-cm, NYU impactor)","1, 5, 35 days after injury",valproic acid (VPA),valproic acid,,150 or 300 mg/kg (only 300 mg/kg for functional and histology assessments),immediately after injury,,5 days,every 12h,subcutaneous,,neurological/functional/behavioral assessment,"BBB scale, grid walk test, footprint analysis",,"BBB: open-field; grid walk: assess ability to control and place the hindlimb precisely, horizontal grid, count the number of foot falls (mistake) in foot placing; footprint analysis: both animal's forepaws and hindpaws were dipped in red and blue dye (non-toxic) and walked acress a narrow box (1m long and 7 cm wide), footprints scannes and images analyzed","BBB: 0, 1, 7, 14, 21, 28, 35 days after injury; grid walk test and footprint analysis: day 35",,yes,positive effect,"BBB: VPA significantly increased the hindlimb locomotor function, 21–35 days after injury as compared with that observed in vehicle-treated control; grid walking test: number of mistakes (footfalls on thegrid walk) in VPA-treated groups was significantly lowerthan vehicle-treated group; footprint analysis: VPA-treated rats showed fairly consistent forelimb–hindlimb coordination and very little toe dragging. By contrast, vehicle-treated animals showed inconsistent coordination and extensive drags as revealed by ink streaks extending from both hindlimbs",histological assessment,"lesion volume: rostrocaudal boundaries of the tissue danage were defined by the presence of inflammatory cells, the loss of neurons, the existence of degenerating neurons and cyst formation, areas at each longitudinal level are determined, and the total lesion volume is derived by mean of numerical integration of sequential areas; TUNEL assay",35 days after injury,not reported,positive effect,total lesion volume was signif-icantly decreased upon VPA as compared with that of vehicle treatment; number of TUNEL cells significantly decreased both at day 1 and 5,"anesthesia: chloral hydrate (500 mg/kg); euthanasia: chloral hydrate (500 mg/kg), perfused via cardiac puncture with 0.1 M PBS and then 4% parafrmaldehyde in 0.1 MPBS",results demonstrated that VPA improves functional recovery by attenuating BSCB disruption via inhibition of MMP-9 activity after SCI,not reported,2 contusion severity reported but not sure which one had the animals used for functional/histo assessment; use chloral hydrate,No,
Lucie,Lu et al,2013,Valproic acid attenuates microgliosis in injured spinal cord and purinergic P2X<inf>4</inf> receptor expression in activated microglia,10.1002/jnr.23200,English,,included,,,,,,rats,Sprague Dawley,41,15,,,17,,,no detail on the rest of the rats used,female 100%,female,0,not reported (adults),,,,,,Adult,250 (30) (g),250,30,,,g,,level: T9-T10; severity: severe,T9 - T10,severe,contusion,laminectomy + contusion (NYU impactor 10g from height of 50mm),31 days,valproic acid (VPA),valproic acid,,"1.5 ug, delivery rate of 1.0 ul/hr",5 - 10 minutes after injury,,3 days,continuous,intrathecally,,neurological/functional/behavioral assessment,BBB scale,,"2 observers, open field with molded plastic surface for 4 min, scale from 0 to 21, 0=hindlimb locomotion ability totally lost, 21 = normal hindlimb locomotion ability","3, 5, 7, 9, 12, 14, 16, 18, 21, 31 days post-injury",,yes,positive effect,BBB significanlty better in VPA treated group compared to control group,histological assessment,tissue loss,31 days after injury,not reported,no stats,more preserved tissues were observed in the lesion center of the VPA-treated group compared with that found in the vehicle-treated animals (no stats),"anesthesia: pentobarbital (50 mg/kg, i.p.); postop: antiobiotic using sodiuim ampicillin (80 mg/kg) 1 week after injury; euthanasia: perfused intracardially with 0.9% ice-cold NaCl, then 4% paraformaldehyde in 0.1 M PBS","Here we describe two major findings. First, intraspinal infusion with VPA for 3 days effectively reduces P2X4R levels in the LC of the spinal cord derived from rats with SCI, along with an increased level of antioxidant enzymes (catalase and Mn-SOD) and a decline in SCI-associated gliosis. Second, the direct application of VPA onto LPS-stimulated microglia cultures caused significant reduction in P2X4R mRNA expression in activated microglia.",not reported,use ampicillin,No,
Lucie,Lv et al,2012,Valproic acid improves locomotion in vivo after SCI and axonal growth of neurons in vitro,10.1016/j.expneurol.2011.11.042,English,,included,,,,,,rats,Wistar,>= 36,>= 12,,,>= 12,,,details are unclear,female 100%,female,0,not reported,,,,,,Not reported,range: [200-230](g),,,200,230,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + contusion (NYU impactor, 10g rod from 12.5mm)","6 weeks, 1 week",valproic acid (VPA),valproic acid,,300 mg/kg,8h after surgery,,1 week,twice daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, footprint analysis",,"BBB: evaluate gross hindlimb performance, open field locomotor test, videotaped for 4 min in plastic wading pool with smooth floor (90 cm diameter, 7cm wall height), 21-point rating scale, 0=no spontaneous movement, 21=normal locomotion, 14=plantar stepping with full weight support and complete forelimb-hindlimb coordination; footprint analysis: define the deficits of fine motor control, paws inked and footprints were made on paper covering a narrow runway of 1m length and 7 cm widhh, series of at least eight sequential steps was used to determine the mean values of limb rotation and of base of support",weekly for 6 weeks after SCI,,yes,positive effect,"rats treated by VPA had higher scores in BBB test, starting from week 4 and lasting to endpoint; SCI rats injected by VPA showed better performance in footprint analysis. Reduced foot exorotation and support were found in animals with VPA-injection",histological assessment,"lesion size: total volume was calculated by summing the lesion area in each section and multiplying by the distance between sections, TUNEL assay",6 weeks,not reported,positive effect,"the mean lesion volume of rats treated by VPA was much smaller than that of controls (p<0.05), significantly less TUNEL positive celss in VPA group compared to control",anesthesia: 1.5-2% isoflurane (inhalated),"delayed injection of VPA promoted the recovery of SCI rats, with a marked increased levels of GDNF and BDNF transcripts, which further explains the protective effects of VPA against SCI",not reported,use isoflurane,No,
Lucie,Lv et al,2011,Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition,10.1016/j.brainres.2011.03.040,English,,included,,,,,,rats,Wistar,>= 36,>= 12,,,>= 12,,,details are unclear,female 100%,female,0,not reported,,,,,,Not reported,range: [200-220](g),,,200,220,g,,level: T8; severity: moderate,T8,moderate,contusion,"laminectomy + contusion (NYU impactor, rod dropped from a height of 12.5mm)","12h, 1d, 3d, 1week, 2 weeks or 8 weeks",valproic acid (VPA),valproic acid,,300 mg/kg,immediately after injury,,2 weeks,twice daily,intraperitoneally,,neurological/functional/behavioral assessment,"BBB scale, narrow beam test, footprint analysis",,2 observers,weekly for 8 weeks after operation,,yes,positive effect,"animals treated with VPA showed significant differences from the controls in BBB score starting between 4 weeks and until the endpoint at 8 weeks; beam test scores were significantly higher in rats receiving VPA than that of controls; footprint analysis showed significantly less foot exorotation and reduced based of support, indicative of improved trunk stabilty",histological assessment,TUNEL assay,8 weeks,yes,positive effect,"VPA treatment significantly alleviated apoptotic cells (Fig. 4), as shown by both Hoechst (Control, 52.50±9.87%; VPA, 38.23±9.31%; p=0.029) and TUNEL (Control, 50.90±8.96%; VPA, 29.01±5.39%; p=0.016)",-," reduction in histone acetylation; VPA was neuroprotective in the SCI model, and the mechanism may involve HDAC inhibition and protective protein induction",not reported,,No,
Catherine,Wang et al,2020,Valproic Acid Labeled Chitosan Nanoparticles Promote the Proliferation and Differentiation of Neural Stem Cells After Spinal Cord Injury,10.1007/s12640-020-00304-y,English,,excluded,Out of scope,No drug of interest,Effect of valproic accid on stem cell proliferation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Ogawa et al,2014,Valproic acid promotes neural regeneration of olfactory epithelium in adult mice after methimazole-induced damage,10.2500/ajra.2014.28.4027,English,,excluded,Non-sci population,,No spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhang et al,2018,Valproic Acid Promotes Survival of Facial Motor Neurons in Adult Rats After Facial Nerve Transection: a Pilot Study,10.1007/s12031-018-1051-0,English,,excluded,Non-sci population,,Not spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Wu et al,2013,VALPROIC ACID PROTECTION AGAINST THE BRACHIAL PLEXUS ROOT AVULSION-INDUCED DEATH OF MOTONEURONS IN RATS,10.1002/micr.22130,English,,excluded,Non-sci population,,Not spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Lee et al,2014,Valproic Acid Protects Motor Neuron Death by Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress-Mediated Cytochrome C Release after Spinal Cord Injury,10.1089/neu.2013.3146,English,,excluded,Out of scope,No assessments of interest,"only histology, no neuro/functional assessment",,,rats,Sprague Dawley,>= 10,>= 5,,,>= 5,,,details are unclear,male 100%,male,100,not reported (adults),,,,,,Adult,range: [250-300](g),,,250,300,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + contusion (weight-drop, NYU impactor, 10g*25mm)","day 1, day 3",valproic acid (VPA),valproic acid,,300 mg/kg,immediately after injury,,"""for the indicated time period""",every 12h,subcutaneous,,-,-,,-,-,,-,,-,histological assessment,"count of ventral horn motor neurons, TUNEL assay",day 3 after injury,not reported,mixed effects (assessment),"the loss of ventral horn motor neuron rostrally and caudally from the lesion site was significantly alleviated in valproic acid-treatment group as compared with vehicle controls (p<0.05), significant at 2mm and 3mm both caudally and rostrally but not at the epicenter not at 1mm and 4mm; significantly less TUNEL positive cells in VPA group compared to control","anesthesia: chloral hydrate (500 mg/kg, IP); other experiment with JNK inhibitor SP600125 (10 microg/250g) and broad-spectrum ROS scavenger Mn III tetrakis (4-benzoic acid) porphyrin (2.5 mg/kg) in 2% dimethyl sulfoxide through intraspinal injection; euthanasia: chloral hydrate 500 mg/kg, perfused via cardiac puncture with 0.1 PBS, pH 7.4, 4% paraformaldehyde in 0.1M PBS, pH 7.4",results suggest that cell death of motor neurons after SCI is mediated through oxidative stress and ER stress-mediated cytochrome c release and VPA-inhibited cytochrome c release by attenuating ROS-induced JNK activation followed by Mcl-1 and Bim phos- phorylation and ER stress-coupled CHOP expression,not limited,"very limited results related to what we are interested in (neuro/funct absent, very light on histo), use chloral hydrate",No,
Lucie,Hao et al,2013,Valproic acid reduces autophagy and promotes functional recovery after spinal cord injury in rats,10.1007/s12264-013-1355-6,English,,included,,,,,,rats,Sprague Dawley,>= 10,>= 5,,,>= 5,,,details are unclear,female 100%,female,0,not reported (adults),,,,,,Adult,range: [220-250](g),,,220,250,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion (weight-drop, 10-g rod, tip diameter of 2.5mm, height of 25mm)","1, 2, 6, 24, 48, 72h, 6 weeks",valproic acid (VPA),valproic acid,,300 mg/kg,immediately after injury,,2 weeks,twice daily,intraperitoneally,,neurological/functional/behavioral assessment,BBB scale,,"3 trained observers, averaged among observers",weekly for 6 weeks,,yes,positive effect,BBB significantly higher VPA treated group compared to control,histological assessment,number of motoneurons,42 days after injury,not reported,mixed effects (assessment),"""trend"" of increase in the number of motoneurons near the injury epicenter in VPA-treated rats comapred to control, VPA increased the number of motoneurons at 2mm both rostral and caudal to the epicenter (significantly different comapred to control)","anesthesia: 10% chloral hydrate (0.3 mL/100g, IP)","our results demonstrated the characteristics of autophagy expression following SCI, and found that VPA reduced autophagy and enhanced motor function",not reported,use chloral hydrate,No,
Lucie,Wang et al,2020,Valproic acid-labeled chitosan nanoparticles promote recovery of neuronal injury after spinal cord injury,10.18632/aging.103125,English,,included,,,,,,rats,Sprague Dawley,58,12,,,12,,,2 other groups not of interest and sham n=10,male 100%,male,100,not reported (adults),,,,,,Adult,range: [180-220](g),,,180,220,g,,level: T10; severity: moderate,T10,moderate,contusion,"laminectomy + contusion (weight-drop, guided 5g rod dropped from height of 80 mm)",28 days,"valproic acid (VA), chitosan nanoparticules (CN), combinaison of both (VA-CN)",valproic acid,,80 mg/kg,1h after injury,,5 days,once daily,intravenously,,neurological/functional/behavioral assessment,BBB scale,,"final score for each animal was obtained by averaging vlues from both investigtors, rats with perineal infections, limb wounds or tail and foot grazing were elimintated from the test","1, 3, 7, 14, 28 days",,not reported,no effect,"VA and CN group not significantly different from control, VA+CN group significantly better than control group",histological assessment,lesion cavity volume,4 weeks after injury,not reported,no effect,"VA and VA+CN have significantly lower lesion cavity area/section area compared to control, CN alone not significantly better than control group","anesthesia: 4% isoflurane, postop: penicillin G (40'000 U, IM, daily for 3 days) to prevent infection; euthanasia: anesthesia and transcardially exsanguinated with 150 ml physiological saline followed by fixation","Administration of VA-CN could enhance the recovery of neuronal injury, suppress the reactive astrocytes and inflammation, and improve the blood spinal cord barrier disruption after SCI in rats.",not reported,"use isoflurane, penicillin",Yes (drug of interest + drug not of interest),
Catherine,Garett et al,2010,Vasopressin receptor antagonist use in a neurologic rehabilitation center,10.1080/10790268.2010.11689675,English,,excluded,Case report,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nasirinezhad et al,2015,Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats,10.1186/1744-8069-11-2,English,,excluded,Out of scope,No drug of interest,Viral vectors,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Zhang et al,2015,Visual bone marrow mesenchymal stem cell transplantation in the repair of spinal cord injury,10.4103/1673-5374.153688,English,,excluded,Out of scope,No drug of interest,Out of scope (stem cells),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Engesser-Cesar et al,2007,Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord,10.1016/j.neuroscience.2006.10.016,English,,excluded,Non-sci population,,No spinal cord injury induced,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Chen et al,2014,Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries,10.1007/s11064-014-1241-2,English,,excluded,Review,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Yao et al,2020,Wireless Epidural Electrical Stimulation in Combination With Serotonin Agonists Improves Intraspinal Metabolism in Spinal Cord Injury Rats,10.1111/ner.13344,English,,excluded,Out of scope,No drug of interest,Epidural Stimulation,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Nakayama et al,2007,Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury.,10.1016/j.neures.2007.02.014,English,,excluded,Out of scope,No drug of interest,Out of scope (no drug of interest),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Wehner et al,2017,Wnt signaling controls pro-regenerative Collagen XII in functional spinal cord regeneration in zebrafish,10.1038/s41467-017-00143-0,English,,excluded,Out of scope,No drug of interest,No drug effect studied,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Xu et al,2015,Wogonin Prevents Rat Dorsal Root Ganglion Neurons Death via Inhibiting Tunicamycin-Induced ER Stress In Vitro,10.1007/s10571-014-0134-x,English,,excluded,Non-sci population,,No spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Ning et al,2013,X-irradiation for inhibiting glial scar formation in injured spinal cord,10.3969/j.issn.1673-5374.2013.17.006,English,,excluded,Out of scope,No drug of interest,No drug effect studied,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Chen et al,2018,Zafirlukast in combination with pseudohypericin attenuates spinal cord injury and motor function in experimental mice,10.2147/DDDT.S154814,English,,excluded,Out of scope,No drug of interest,Out of scope (no drug of interest),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Catherine,Vivinetto et al,2020,Zeb2 Is a Regulator of Astrogliosis and Functional Recovery after CNS Injury,10.1016/j.celrep.2020.107834,English,,excluded,Out of scope,No drug of interest,Out of scope,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al,2019,Zinc improves functional recovery by regulating the secretion of granulocyte colony stimulating factor from microglia/macrophages after spinal cord injury,10.3389/fnmol.2019.00018,English,,included,,,,,,mice,C57BL/6,182,>= 7,,,>= 7,,,details are unclear,"50% male, 50% female",mixed,50,not reported (adults),,,,,,Adult,range: [22-25](g),,,22,25,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + contusive injury (impactor 2mm diameter, 12.5g, 5cm in height)",3 or 21 or 28 days,zinc gluconate (ZnG),zinc,,30 mg/kg,2h after injury,,3 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BMS scale,,-,"0, 1, 3, 5, 7, 10, 14, 21 and 28 days after injury",,not reported,positive effect,ZnG group significantly higher BMS score compared to control group starting day 14 until end of study (p<0.05),histological assessment,number of viable spinal motoneurons,21 days after injury,not reported,positive effect,"number of motoneurons in the spinal ventral horn of mice treated with ZnG was higher than that of vehicle, P<0.001 ","anesthesia: 10% chloral hydrate (0.33 mg/kg, IP); euthanasia: cardiac perfusion with 0.9% sodium chloride, then 4% paraformaldehyde","results indicate that the administration of zinc increases the expression of G-CSF secreted by microglia/macrophages , which then leads to reduced levels of neuronal apoptosis after SCI","1) after the intraperitoneal injection of ZnG, the concentration of local Zn2+ remained unknown, did not determine the concentration of local Zn2+ at the injury site; 2) effects of G-CSF on other central nervous system cells and other cytokines are still unclear, will also be necessary to identify the local concentration of Zn2+ and clarify other mechanisms of neuroprotective effect of G-CSF",use chloral hydrate,No,
Lucie,Lin et al,2020,Zinc promotes autophagy and inhibits apoptosis through AMPK/mTOR signaling pathway after spinal cord injury,10.1016/j.neulet.2020.135263,English,,included,,,,,,mice,C57,>= 12,>= 6,,,>= 6,,,"unclear which mice are re used for multiple assessemnt, n>= 6 based on the Nissl cells assessment",male 100%,male,100,10-12 weeks old,,,10,12,Weeks,,range: [22-28](g),,,22,28,g,,level: T10; severity: not reported,T10,Not reported,contusion,"laminectomy + contusion (allen's method, 2mm diameter 10g impounder dropped from 25mm height)",7 days or 28 days after injury,ZnSO4 (zinc),zinc,,30 mg/kg,Not reported,,Not reported,once daily,subcutaneous,,neurological/functional/behavioral assessment,BMS scale,,"0=no ankle movement, 9=normal function, average scores for each group of mice","0, 1, 3, 7, 14, 21, 28 days post injury",,yes,positive effect,BMS significantly higher in Zn group compared to control,histological assessment,number of neurons in grey matter,7 day after SCI,not reported,positive effect,number of neurons in Zn group was significantly more than that in vehicule group,"anesthesia: chloral hydrate (10%, 0.3 ml/kg, IP)",findings suggested that zinc through promoting neurons autophagy and inhibiting apoptosis,not reported,no scheme or duration of treatment reported; use chloral hydrate,No,
Lucie,Li et al,2020,Zinc promotes functional recovery after spinal cord injury by activating Nrf2/HO-1 defense pathway and inhibiting inflammation of NLRP3 in nerve cells,10.1016/j.lfs.2020.117351,English,,included,,,,,,mice,C57BL/6,>= 15,>= 6,,,>= 6,,,"unclear which mice are re used for multiple assessemnt, n>= 6 based on the Nissl cells assessment","50% male, 50% female",mixed,50,10-12 weeks old,,,10,12,Weeks,,range: [20-25](g),,,20,25,g,,level: T9; severity: moderate,T9,moderate,contusion,"laminectomy + contusion  (weight drop, 2mm diameter, 12.5g, 5cm in height)",3 or 28 days after injury,"ZnG (zinc?), ml385 (inhibitor of Nrf2, which is on the signaling pathway of zinc that is targeted by the treatment via zinc)",zinc,,30 mg/kg,2h after injury,,3 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BMS scale,,"observation of ankle joint activity of hind limb, touch of sole and dorsum of foot, trunk stability and tali position, grades from 0 (motor function of hind limbs completely impaired) to 9 (completely normal), 3 days before the experiment mice were adapted to exercise on the open table for 10 min every day, 2 examiners for 5 min","1, 3, 5, 7, 10, 14, 28 days after injury",,yes,positive effect,significant difference in behavior between SCI-ZnG group and SCI-Vehicle group and SCI-ZnG ML385 group on 28 days after SCI (zinc better than zinc+ML385 or control),histological assessment,"scar and cavity area of the spinal cord, number of neurons, mitochondria structure, edema, hemorrhagic and necrotic tisues",3 or 28 days after injury,not reported,mixed (stats/no stats),"number of motoneurons in the spinal ventral horn of mice treated with ZnG was higher than that of vehicle and ZnG + ML385 mice (statistically significant); the congestion, edema and structural damages in the spinal cord of SCI rats were showed to be notably relieved after Zinc treatment (no stats); In SCI-Vehicle group, the nucleus of neurons was contracted and the chromatin was condensed. Mitochondria were swollen, vesicle and ridge disappeared. Zinc treatment restored the abnormal ultrastructure, while SCI + ZnG + ml385 reversed the effect of zinc (no stats); proportion of TUNEL-positive cells in the SCI + ZnG group was significantly lower than that in the carrier group (P < .001)","anesthesia: 1% sodium pentobarbital at 50 mg/kg (IP); euthanasia: anesthesia with chloral hydrate 10%, 0.33 ml/kg, intracardially perfused with saline 0.9% then paraformaldehyde 4%",Zinc has a protective effect on spinal cord injury by inhibiting oxidative damage and nlrp3 inflammation,"It should be pointed out that this study has some limitations. First, inflammatory activation of NLRP-3 may be affected by other cytokines and pathways. Secondly, the metabolism of zinc in mice is not clear. Later, our experimental group will further study the effect of zinc ion on spinal cord injury. In further research, the effect of zinc should be evaluated at different doses and different routes of administration. In various pathological stages and different administration time, mice were studied. At the same time, we should consider the differences in pathology and physiology between human and animal in clinical research",use pentobarbital,No,
Lucie,Lin et al,2020,Zinc provides neuroprotection by regulating NLRP3 inflammasome through autophagy and ubiquitination in a spinal contusion injury model,10.1111/cns.13460,English,,included,,,,,,mice,C57BL/6,>= 20,>= 6,,,>= 6,,,"unclear, n=20 for BMS in Fig 2 (not clear if 20 per group or in total)","50% male, 50% female",mixed,50,8 weeks old,8,,,,Weeks,,range: [20-25](g),,,20,25,g,,level: T9-T10; severity: moderate,T9 - T10,moderate,contusion,"laminectomy + contusion  (allen's method: weight drop using impactor RWD, 2mm diameter, 12.5g, 20mm in height)","day 3, day 28","zinc gluconate, zinc",zinc,,30 mg/kg,2h after injury,,3 days,once daily,intraperitoneally,,neurological/functional/behavioral assessment,BMS scale,,"scores from 0 to 9 (9=normal, 0=completely paralysed), open field arena, move freely for 5 minutes, range of motion coordination, paw posture, trunk stability and posture of the hind limbs and tail observed and scores, 3 examiners, repeated 3 times","1, 3, 7, 14, 21, 28 days after injury",,yes,no effect,The scores of the vehicle group were not statistically different from those of the zinc treat-ment group until three weeks postcontusion ,histological assessment,"number of living neurons, number of neuron cells",?,not reported,positive effect,"The number of living neurons in the anterior horn of the zinc group was higher than that in the vehicle group, number of neurons in the ventral horn of the spinal cord ","anesthesia: 10% chloral hydrate (0.3mL/100g), fentanyl (0.03 mg/kg); euthanasia: anesthesia as for surgery, intracardially perfused with 0.9% normal saline followed by 4% sodium methyl benzoate","zinc can regulate NLRP3 inflammasome by activating autophagy and ubiquitination modification, zinc's treatment can protect nerve cells after spinal cord injury and promote motor function recovery providing a new promising treatment strategy for the treatment of spinal cord injury in clinic",the research study was not carried out on transgenic mice with zinc transporter knockout due to technological limitations;  we did not conduct experimental research in the clinic,use chloral hydrate,No,
Catherine,Yagi et al,2015,Zonisamide Enhances Neurite Elongation of Primary Motor Neurons and Facilitates Peripheral Nerve Regeneration In Vitro and in a Mouse Model,10.1371/journal.pone.0142786,English,,excluded,Non-sci population,,Not spinal cord injury,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lucie,Li et al.,2017,Zonisamide-loaded triblock copolymer nanomicelles as a novel drug delivery system for the treatment of acute spinal cord injury,10.2147/IJN.S128705,English,,excluded,Non-sci population,,"No SCI applied, spinal cord collected to make in vitro assay",,,rats,Sprague Dawley rats,28,,,,,,,,"Female (28, 100%)",,,,,,,,,,250±20 g,,,,,,,"T10, hemisection right side",,,,hemi-cut with a sharp blade,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,